1	The	DT	O	the	det	4	SENT_1	[p1l383t81r429b102],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l447t83r532b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l551t83r740b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l759t83r938b109],
5	of	IN	O	of	_	0	SENT_1	[p1l958t81r986b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_1	[p1l998t83r1197b102],

1	l	NN	O	l	_	0	SENT_2	[p1l90t184r93b303],
2	ORIGINAL	NNP	O	ORIGINAL	nn	3	SENT_2	[p1l579t234r803b260],
3	ARTICLE	NN	O	article	dep	1	SENT_2	[p1l815t234r1001b260],
4	I	PRP	O	I	dep	1	SENT_2	[p1l1488t184r1491b303],

1	Crizotinib	NNP	O	Crizotinib	_	0	SENT_3	[p1l93t378r396b433],
2	versus	CC	O	versus	_	0	SENT_3	[p1l423t396r612b433],
3	Chemotherapy	NNP	O	Chemotherapy	conj_versus	1	SENT_3	[p1l642t378r1088b448],
4	in	IN	O	in	_	0	SENT_3	[p1l1113t378r1170b432],
5	Advanced	NNP	O	Advanced	prep_in	1	SENT_3	[p1l1196t378r1488b433],

1	ALK-Positive	JJ	O	alk-positive	amod	3	SENT_4	[p1l392t462r766b516],
2	Lung	NN	O	lung	nn	3	SENT_4	[p1l794t466r949b531],
3	Cancer	NN	O	cancer	_	0	SENT_4	[p1l976t465r1186b516],

1	Alice	NNP	PERSON	Alice	nn	3	SENT_5	[p1l306t584r387b615],
2	T.	NNP	PERSON	T.	nn	3	SENT_5	[p1l398t587r428b615],
3	Shaw	NNP	PERSON	Shaw	_	0	SENT_5	[p1l443t584r540b621],
4	,	,	O	,	_	0	SENT_5	[p1l443t584r540b621],
5	M.D.	NNP	O	M.D.	nn	14	SENT_5	[p1l557t587r647b621],
6	,	,	O	,	_	0	SENT_5	[p1l557t587r647b621],
7	Ph.D.	NNP	O	Ph.D.	appos	14	SENT_5	[p1l665t584r764b621],
8	,	,	O	,	_	0	SENT_5	[p1l665t584r764b621],
9	Dong-Wan	NNP	PERSON	Dong-Wan	appos	14	SENT_5	[p1l781t587r959b625],
10	Kim	NNP	PERSON	Kim	nn	14	SENT_5	[p1l976t587r1049b621],
11	,	,	O	,	_	0	SENT_5	[p1l976t587r1049b621],
12	M.D.	NNP	O	M.D.	appos	14	SENT_5	[p1l1066t587r1156b621],
13	,	,	O	,	_	0	SENT_5	[p1l1066t587r1156b621],
14	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_5	[p1l1173t584r1272b621],
15	,	,	O	,	_	0	SENT_5	[p1l1173t584r1272b621],

1	Kazuhiko	NNP	PERSON	Kazuhiko	nn	2	SENT_6	[p1l168t633r321b664],
2	Nakagawa	NNP	PERSON	Nakagawa	_	0	SENT_6	[p1l336t633r518b674],
3	,	,	O	,	_	0	SENT_6	[p1l336t633r518b674],
4	M.D.	NNP	O	M.D.	appos	2	SENT_6	[p1l535t636r626b670],
5	,	,	O	,	_	0	SENT_6	[p1l535t636r626b670],
6	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_6	[p1l643t633r742b670],
7	,	,	O	,	_	0	SENT_6	[p1l643t633r742b670],
8	Takashi	NNP	PERSON	Takashi	nn	9	SENT_6	[p1l755t633r884b664],
9	Seto	NNP	PERSON	Seto	appos	4	SENT_6	[p1l899t635r981b670],
10	,	,	O	,	_	0	SENT_6	[p1l899t635r981b670],
11	M.D.	NNP	O	M.D.	appos	4	SENT_6	[p1l998t636r1088b670],
12	,	,	O	,	_	0	SENT_6	[p1l998t636r1088b670],
13	Lucio	NNP	PERSON	Lucio	nn	14	SENT_6	[p1l1105t636r1193b664],
14	Criné	NNP	PERSON	Criné	appos	4	SENT_6	[p1l1207t635r1307b670],
15	,	,	O	,	_	0	SENT_6	[p1l1207t635r1307b670],
16	M.D.	NNP	O	M.D.	appos	4	SENT_6	[p1l1324t636r1414b670],
17	,	,	O	,	_	0	SENT_6	[p1l1324t636r1414b670],
18	Myung-Ju	NNP	O	Myung-Ju	nn	19	SENT_6	[p1l136t685r295b723],
19	Ahn	NNP	PERSON	Ahn	appos	4	SENT_6	[p1l308t682r385b719],
20	,	,	O	,	_	0	SENT_6	[p1l308t682r385b719],
21	M.D.	NNP	O	M.D.	appos	4	SENT_6	[p1l402t685r492b719],
22	,	,	O	,	_	0	SENT_6	[p1l402t685r492b719],
23	Tommaso	NNP	PERSON	Tommaso	nn	25	SENT_6	[p1l505t685r679b713],
24	De	NNP	PERSON	De	nn	25	SENT_6	[p1l695t685r738b713],
25	Pas	NNP	PERSON	Pas	appos	4	SENT_6	[p1l754t685r819b719],
26	,	,	O	,	_	0	SENT_6	[p1l754t685r819b719],
27	M.D.	NNP	O	M.D.	appos	4	SENT_6	[p1l836t685r926b719],
28	,	,	O	,	_	0	SENT_6	[p1l836t685r926b719],
29	Benjamin	NNP	PERSON	Benjamin	nn	30	SENT_6	[p1l943t685r1101b723],
30	Besse	NNP	PERSON	Besse	appos	4	SENT_6	[p1l1118t685r1222b719],
31	,	,	O	,	_	0	SENT_6	[p1l1118t685r1222b719],
32	M.D.	NNP	O	M.D.	appos	4	SENT_6	[p1l1239t685r1329b719],
33	,	,	O	,	_	0	SENT_6	[p1l1239t685r1329b719],
34	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_6	[p1l1346t682r1445b719],
35	,	,	O	,	_	0	SENT_6	[p1l1346t682r1445b719],
36	Benjamin	NNP	PERSON	Benjamin	nn	37	SENT_6	[p1l101t734r277b772],
37	]	NNP	O	]	appos	4	SENT_6	[p1l101t734r277b772],
38	.	.	O	.	_	0	SENT_6	[p1l101t734r277b772],

1	Solomon	NNP	PERSON	Solomon	nn	23	SENT_7	[p1l289t731r441b768],
2	,	,	O	,	_	0	SENT_7	[p1l289t731r441b768],
3	M.B.	NNP	LOCATION	M.B.	appos	23	SENT_7	[p1l455t734r534b768],
4	,	,	O	,	_	0	SENT_7	[p1l455t734r534b768],
5	B.S.	NNP	O	B.S.	appos	23	SENT_7	[p1l548t733r613b768],
6	,	,	O	,	_	0	SENT_7	[p1l548t733r613b768],
7	Ph.D.	NNP	O	Ph.D.	appos	23	SENT_7	[p1l628t731r719b768],
8	,	,	O	,	_	0	SENT_7	[p1l628t731r719b768],
9	Fiona	NNP	PERSON	Fiona	appos	23	SENT_7	[p1l734t734r818b762],
10	Blackhall	NNP	PERSON	Blackhall	nn	23	SENT_7	[p1l831t731r975b768],
11	,	,	O	,	_	0	SENT_7	[p1l831t731r975b768],
12	M.D.	NNP	O	M.D.	appos	23	SENT_7	[p1l989t734r1074b768],
13	,	,	O	,	_	0	SENT_7	[p1l989t734r1074b768],
14	Ph.D.	NNP	O	Ph.D.	appos	23	SENT_7	[p1l1088t731r1180b768],
15	,	,	O	,	_	0	SENT_7	[p1l1088t731r1180b768],
16	Yi-LongWu	NNP	O	Yi-LongWu	appos	23	SENT_7	[p1l1190t734r1382b772],
17	,	,	O	,	_	0	SENT_7	[p1l1190t734r1382b772],
18	M.D.	NNP	O	M.D.	appos	23	SENT_7	[p1l1396t734r1480b768],
19	,	,	O	,	_	0	SENT_7	[p1l1396t734r1480b768],
20	Michael	NNP	PERSON	Michael	appos	23	SENT_7	[p1l138t780r268b811],
21	Thomas	NNP	PERSON	Thomas	nn	23	SENT_7	[p1l281t780r429b817],
22	,	,	O	,	_	0	SENT_7	[p1l281t780r429b817],
23	M.D.	NNP	O	M.D.	_	0	SENT_7	[p1l446t783r536b817],
24	,	,	O	,	_	0	SENT_7	[p1l446t783r536b817],
25	Kenneth	NNP	PERSON	Kenneth	nn	26	SENT_7	[p1l553t780r722b820],
26	]	NNP	O	]	appos	23	SENT_7	[p1l553t780r722b820],
27	.	.	O	.	_	0	SENT_7	[p1l553t780r722b820],

1	O’Byrne	NNP	O	O’Byrne	nn	6	SENT_8	[p1l737t782r882b821],
2	,	,	O	,	_	0	SENT_8	[p1l737t782r882b821],
3	M.D.	NNP	O	M.D.	appos	6	SENT_8	[p1l899t783r989b817],
4	,	,	O	,	_	0	SENT_8	[p1l899t783r989b817],
5	Denis	NNP	PERSON	Denis	appos	6	SENT_8	[p1l1006t783r1100b811],
6	Moro-Sibilot	NNP	PERSON	Moro-Sibilot	_	0	SENT_8	[p1l1117t780r1336b817],
7	,	,	O	,	_	0	SENT_8	[p1l1117t780r1336b817],
8	M.D.	NNP	O	M.D.	dep	6	SENT_8	[p1l1353t783r1444b817],
9	,	,	O	,	_	0	SENT_8	[p1l1353t783r1444b817],

1	D.	NNP	PERSON	D.	nn	3	SENT_9	[p1l223t832r256b860],
2	Ross	NNP	PERSON	Ross	nn	3	SENT_9	[p1l273t832r350b860],
3	Camidge	NNP	PERSON	Camidge	_	0	SENT_9	[p1l364t829r523b870],
4	,	,	O	,	_	0	SENT_9	[p1l364t829r523b870],
5	M.D.	NNP	O	M.D.	dep	3	SENT_9	[p1l541t832r631b866],
6	,	,	O	,	_	0	SENT_9	[p1l541t832r631b866],
7	Ph.D.	NNP	O	Ph.D.	appos	5	SENT_9	[p1l648t829r747b866],
8	,	,	O	,	_	0	SENT_9	[p1l648t829r747b866],
9	Tony	NNP	PERSON	Tony	nn	10	SENT_9	[p1l760t832r843b870],
10	Mok	NNP	PERSON	Mok	appos	5	SENT_9	[p1l858t829r939b866],
11	,	,	O	,	_	0	SENT_9	[p1l858t829r939b866],
12	M.D.	NNP	O	M.D.	appos	5	SENT_9	[p1l956t832r1046b866],
13	,	,	O	,	_	0	SENT_9	[p1l956t832r1046b866],
14	Vera	NNP	PERSON	Vera	nn	15	SENT_9	[p1l1059t832r1134b860],
15	Hirsh	NNP	PERSON	Hirsh	appos	5	SENT_9	[p1l1151t829r1251b866],
16	,	,	O	,	_	0	SENT_9	[p1l1151t829r1251b866],
17	M.D.	NNP	O	M.D.	appos	5	SENT_9	[p1l1268t832r1358b866],
18	,	,	O	,	_	0	SENT_9	[p1l1268t832r1358b866],

1	Gregory	NNP	PERSON	Gregory	nn	2	SENT_10	[p1l172t880r337b919],
2	]	NNP	O	]	_	0	SENT_10	[p1l172t880r337b919],
3	.	.	O	.	_	0	SENT_10	[p1l172t880r337b919],

1	Riely	NNP	PERSON	Riely	nn	8	SENT_11	[p1l354t878r438b919],
2	,	,	O	,	_	0	SENT_11	[p1l354t878r438b919],
3	M.D.	NNP	O	M.D.	appos	8	SENT_11	[p1l455t881r545b915],
4	,	,	O	,	_	0	SENT_11	[p1l455t881r545b915],
5	Ph.D.	NNP	O	Ph.D.	appos	8	SENT_11	[p1l562t878r661b915],
6	,	,	O	,	_	0	SENT_11	[p1l562t878r661b915],
7	Shrividya	NNP	PERSON	Shrividya	appos	8	SENT_11	[p1l676t878r829b919],
8	Iyer	NNP	PERSON	Iyer	_	0	SENT_11	[p1l845t881r911b919],
9	,	,	O	,	_	0	SENT_11	[p1l845t881r911b919],
10	Ph.D.	NNP	O	Ph.D.	appos	8	SENT_11	[p1l928t878r1027b915],
11	,	,	O	,	_	0	SENT_11	[p1l928t878r1027b915],
12	Vanessa	NNP	PERSON	Vanessa	nn	13	SENT_11	[p1l1040t881r1181b909],
13	Tassell	NNP	PERSON	Tassell	conj_and	10	SENT_11	[p1l1193t878r1320b915],
14	,	,	O	,	_	0	SENT_11	[p1l1193t878r1320b915],
15	B.S.	NNP	O	B.S.	conj_and	10	SENT_11	[p1l1337t880r1408b915],
16	,	,	O	,	_	0	SENT_11	[p1l1337t880r1408b915],
17	Anna	NNP	PERSON	Anna	nn	18	SENT_11	[p1l189t929r277b958],
18	Polli	NNP	PERSON	Polli	conj_and	10	SENT_11	[p1l293t927r372b964],
19	,	,	O	,	_	0	SENT_11	[p1l293t927r372b964],
20	B.S.	NNP	O	B.S.	conj_and	10	SENT_11	[p1l389t929r460b964],
21	,	,	O	,	_	0	SENT_11	[p1l389t929r460b964],
22	Keith	NNP	PERSON	Keith	nn	24	SENT_11	[p1l477t927r558b958],
23	D.	NNP	PERSON	D.	nn	24	SENT_11	[p1l575t930r608b958],
24	Wilner	NNP	PERSON	Wilner	conj_and	10	SENT_11	[p1l621t927r740b964],
25	,	,	O	,	_	0	SENT_11	[p1l621t927r740b964],
26	Ph.D.	NNP	O	Ph.D.	appos	8	SENT_11	[p1l758t927r857b964],
27	,	,	O	,	_	0	SENT_11	[p1l758t927r857b964],
28	and	CC	O	and	_	0	SENT_11	[p1l872t927r931b958],
29	Pasi	NNP	PERSON	Pasi	nn	31	SENT_11	[p1l949t930r1013b958],
30	A.	NNP	PERSON	A.	nn	31	SENT_11	[p1l1026t929r1175b967],
31	janne	NNP	PERSON	janne	appos	8	SENT_11	[p1l1026t929r1175b967],
32	,	,	O	,	_	0	SENT_11	[p1l1026t929r1175b967],
33	M.D.	NNP	O	M.D.	appos	8	SENT_11	[p1l1192t930r1283b964],
34	,	,	O	,	_	0	SENT_11	[p1l1192t930r1283b964],
35	Ph.D.	NNP	O	Ph.D.	appos	8	SENT_11	[p1l1300t927r1389b958],
36	.	.	O	.	_	0	SENT_11	[p1l1300t927r1389b958],

1	ABSTRACT	NN	O	abstract	_	0	SENT_12	[p1l679t1035r901b1058],

1	BAC	NN	O	bac	nn	2	SENT_13	[p1l93t1151r148b1170],
2	KG	NN	O	kg	tmod	24	SENT_13	[p1l154t1151r190b1170],
3	no	DT	O	no	det	6	SENT_13	[p1l197t1151r236b1170],
4	u	NN	O	u	nn	6	SENT_13	[p1l242t1151r258b1170],
5	N	NN	O	n	nn	6	SENT_13	[p1l266t1151r283b1170],
6	D	NN	O	d	dep	2	SENT_13	[p1l290t1151r308b1170],
7	In	IN	O	in	_	0	SENT_13	[p1l91t1197r126b1224],
8	single-group	JJ	O	single-group	amod	9	SENT_13	[p1l138t1194r349b1234],
9	studies	NNS	O	study	prep_in	24	SENT_13	[p1l362t1194r488b1232],
10	,	,	O	,	_	0	SENT_13	[p1l362t1194r488b1232],
11	chromosomal	JJ	O	chromosomal	amod	12	SENT_13	[p1l502t1194r734b1225],
12	rearrangements	NNS	O	rearrangement	nsubjpass	24	SENT_13	[p1l746t1201r1010b1234],
13	of	IN	O	of	_	0	SENT_13	[p1l1023t1194r1062b1225],
14	the	DT	O	the	det	20	SENT_13	[p1l1067t1194r1119b1225],
15	anaplastic	JJ	O	anaplastic	amod	20	SENT_13	[p1l1131t1194r1300b1233],
16	lymphoma	NN	O	lymphoma	nn	20	SENT_13	[p1l1311t1194r1490b1233],
17	kinase	NN	O	kinase	nn	20	SENT_13	[p1l91t1245r197b1275],
18	gene	NN	O	gene	nn	20	SENT_13	[p1l209t1254r285b1284],
19	(	NN	O	(	nn	20	SENT_13	[p1l299t1247r384b1280],
20	ALK	NN	O	alk	prep_of	12	SENT_13	[p1l299t1247r384b1280],
21	)	CD	NUMBER	)	dep	20	SENT_13	[p1l299t1247r384b1280],
22	have	VBP	O	have	aux	24	SENT_13	[p1l398t1244r470b1275],
23	been	VBN	O	be	auxpass	24	SENT_13	[p1l482t1244r559b1275],
24	associated	VBN	O	associate	_	0	SENT_13	[p1l570t1244r739b1275],
25	with	IN	O	with	_	0	SENT_13	[p1l749t1244r824b1275],
26	marked	JJ	O	marked	amod	28	SENT_13	[p1l835t1244r960b1275],
27	clinical	JJ	O	clinical	amod	28	SENT_13	[p1l972t1244r1091b1275],
28	responses	NNS	O	response	prep_with	24	SENT_13	[p1l1102t1254r1263b1283],
29	to	TO	O	to	_	0	SENT_13	[p1l1276t1251r1307b1275],
30	crizotinib	NN	O	crizotinib	prep_to	24	SENT_13	[p1l1319t1245r1487b1282],
31	,	,	O	,	_	0	SENT_13	[p1l1319t1245r1487b1282],
32	an	DT	O	a	det	36	SENT_13	[p1l91t1304r130b1325],
33	oral	JJ	O	oral	amod	36	SENT_13	[p1l142t1294r204b1325],
34	tyrosine	NN	O	tyrosine	nn	36	SENT_13	[p1l215t1295r343b1333],
35	kinase	NN	O	kinase	nn	36	SENT_13	[p1l355t1294r459b1325],
36	inhibitor	NN	O	inhibitor	appos	30	SENT_13	[p1l470t1294r611b1325],
37	targeting	VBG	O	target	partmod	36	SENT_13	[p1l622t1295r770b1334],
38	ALK	NNP	O	ALK	dobj	37	SENT_13	[p1l778t1297r858b1326],
39	.	.	O	.	_	0	SENT_13	[p1l778t1297r858b1326],

1	Whether	IN	O	whether	complm	4	SENT_14	[p1l870t1294r1011b1325],
2	crizotinib	NN	O	crizotinib	nsubj	4	SENT_14	[p1l1021t1294r1176b1325],
3	is	VBZ	O	be	cop	4	SENT_14	[p1l1188t1295r1213b1325],
4	superior	JJ	O	superior	csubj	13	SENT_14	[p1l1225t1295r1357b1333],
5	to	TO	O	to	_	0	SENT_14	[p1l1367t1301r1398b1325],
6	standard	JJ	O	standard	amod	7	SENT_14	[p1l1410t1301r1489b1325, p1l92t1344r165b1375],
7	chemotherapy	NN	O	chemotherapy	prep_to	4	SENT_14	[p1l177t1344r413b1383],
8	with	IN	O	with	_	0	SENT_14	[p1l423t1344r499b1375],
9	respect	NN	O	respect	prep_with	7	SENT_14	[p1l512t1351r632b1383],
10	to	TO	O	to	_	0	SENT_14	[p1l644t1351r675b1375],
11	efficacy	NN	O	efficacy	prep_to	4	SENT_14	[p1l689t1344r820b1383],
12	is	VBZ	O	be	cop	13	SENT_14	[p1l831t1345r857b1375],
13	unknown	JJ	O	unknown	_	0	SENT_14	[p1l871t1344r1040b1375],
14	.	.	O	.	_	0	SENT_14	[p1l871t1344r1040b1375],

1	METHODS	NNS	O	method	nsubj	3	SENT_15	[p1l94t1441r246b1461],
2	We	PRP	O	we	nsubj	3	SENT_15	[p1l90t1487r142b1515],
3	conducted	VBD	O	conduct	_	0	SENT_15	[p1l156t1485r327b1515],
4	a	DT	O	a	det	9	SENT_15	[p1l340t1495r358b1515],
5	phase	NN	O	phase	nn	9	SENT_15	[p1l370t1485r467b1523],
6	3	CD	NUMBER	3	num	9	SENT_15	[p1l481t1487r508b1522],
7	,	,	O	,	_	0	SENT_15	[p1l481t1487r508b1522],
8	open-label	JJ	O	open-label	amod	9	SENT_15	[p1l524t1485r698b1523],
9	trial	NN	O	trial	dobj	3	SENT_15	[p1l712t1485r781b1515],
10	comparing	VBG	O	compare	xcomp	3	SENT_15	[p1l794t1485r976b1524],
11	crizotinib	NN	O	crizotinib	dobj	10	SENT_15	[p1l989t1485r1152b1515],
12	with	IN	O	with	_	0	SENT_15	[p1l1165t1485r1240b1515],
13	chemotherapy	NN	O	chemotherapy	prep_with	10	SENT_15	[p1l1255t1485r1491b1523],
14	in	IN	O	in	_	0	SENT_15	[p1l91t1534r124b1564],
15	347	CD	NUMBER	347	num	16	SENT_15	[p1l140t1536r198b1565],
16	patients	NNS	O	patient	prep_in	13	SENT_15	[p1l214t1534r347b1573],
17	with	IN	O	with	_	0	SENT_15	[p1l362t1534r438b1565],
18	locally	RB	O	locally	advmod	19	SENT_15	[p1l454t1534r564b1573],
19	advanced	VBN	O	advance	prep_with	10	SENT_15	[p1l578t1534r732b1565],
20	or	CC	O	or	_	0	SENT_15	[p1l748t1544r783b1565],
21	metastatic	JJ	O	metastatic	amod	26	SENT_15	[p1l798t1534r971b1564],
22	ALK	NN	O	alk	nn	26	SENT_15	[p1l985t1534r1189b1573],
23	—	NN	O	—	nn	26	SENT_15	[p1l985t1534r1189b1573],
24	positive	JJ	O	positive	amod	26	SENT_15	[p1l985t1534r1189b1573],
25	lung	NN	O	lung	nn	26	SENT_15	[p1l1205t1534r1280b1573],
26	cancer	NN	O	cancer	prep_with	10	SENT_15	[p1l1295t1544r1404b1564],
27	who	WP	O	who	nsubj	29	SENT_15	[p1l1418t1534r1489b1565],
28	had	VBD	O	have	aux	29	SENT_15	[p1l91t1584r151b1615],
29	received	VBN	O	receive	rcmod	26	SENT_15	[p1l165t1584r296b1615],
30	one	CD	NUMBER	one	dobj	29	SENT_15	[p1l309t1594r367b1615],
31	prior	RB	O	prior	prep	29	SENT_15	[p1l380t1584r461b1623],
32	platinum-based	JJ	O	platinum-based	amod	33	SENT_15	[p1l472t1584r729b1623],
33	regimen	NN	O	regimen	pobj	31	SENT_15	[p1l742t1584r886b1623],
34	.	.	O	.	_	0	SENT_15	[p1l742t1584r886b1623],

1	Patients	NNS	O	patient	nsubjpass	4	SENT_16	[p1l901t1584r1030b1614],
2	were	VBD	O	be	auxpass	4	SENT_16	[p1l1042t1594r1119b1615],
3	randomly	RB	O	randomly	advmod	4	SENT_16	[p1l1133t1584r1291b1623],
4	assigned	VBN	O	assign	_	0	SENT_16	[p1l1302t1584r1444b1623],
5	to	TO	O	to	aux	6	SENT_16	[p1l1458t1590r1489b1615],
6	receive	VB	O	receive	xcomp	4	SENT_16	[p1l91t1634r203b1665],
7	oral	JJ	O	oral	amod	8	SENT_16	[p1l218t1634r283b1665],
8	treatment	NN	O	treatment	dobj	6	SENT_16	[p1l297t1640r462b1664],
9	with	IN	O	with	_	0	SENT_16	[p1l473t1634r549b1665],
10	crizotinib	NN	O	crizotinib	nn	11	SENT_16	[p1l564t1634r727b1665],
11	(	NN	O	(	prep_with	6	SENT_16	[p1l744t1636r814b1669],
12	250	CD	NUMBER	250	num	14	SENT_16	[p1l744t1636r814b1669],
13	mg	NN	O	mg	nn	14	SENT_16	[p1l829t1637r893b1673],
14	)	NN	O	)	tmod	11	SENT_16	[p1l829t1637r893b1673],
15	twice	RB	O	twice	advmod	16	SENT_16	[p1l910t1634r998b1665],
16	daily	RB	SET	daily	advmod	14	SENT_16	[p1l1014t1634r1094b1673],
17	or	CC	O	or	_	0	SENT_16	[p1l1108t1644r1142b1665],
18	intravenous	JJ	O	intravenous	amod	19	SENT_16	[p1l1155t1634r1349b1665],
19	chemotherapy	NN	O	chemotherapy	prep_with	6	SENT_16	[p1l1365t1634r1489b1665, p1l92t1753r216b1792],

1	with	IN	O	with	prep	19	SENT_17	[p1l227t1753r303b1784],
2	either	CC	O	either	dep	1	SENT_17	[p1l317t1753r413b1784],
3	pemetrexed	JJ	O	pemetrexed	amod	6	SENT_17	[p1l425t1753r620b1792],
4	(	NN	O	(	nn	6	SENT_17	[p1l636t1755r706b1788],
5	500	CD	NUMBER	500	num	6	SENT_17	[p1l636t1755r706b1788],
6	mg	NN	O	mg	conj	1	SENT_17	[p1l720t1763r774b1792],
7	per	IN	O	per	_	0	SENT_17	[p1l786t1763r841b1792],
8	square	NN	O	square	nn	9	SENT_17	[p1l854t1763r964b1792],
9	meter	NN	O	meter	prep_per	1	SENT_17	[p1l978t1759r1074b1784],
10	of	IN	O	of	_	0	SENT_17	[p1l1087t1753r1126b1784],
11	body-surface	JJ	O	body-surface	amod	13	SENT_17	[p1l1133t1753r1346b1792],
12	area	NN	O	area	nn	13	SENT_17	[p1l1360t1756r1440b1788],
13	)	NN	O	)	prep_of	9	SENT_17	[p1l1360t1756r1440b1788],
14	or	CC	O	or	_	0	SENT_17	[p1l1456t1763r1491b1784],
15	docetaxel	NN	O	docetaxel	prep_per	1	SENT_17	[p1l92t1803r249b1834],
16	(	CD	NUMBER	(	number	17	SENT_17	[p1l267t1806r316b1839],
17	75	CD	NUMBER	75	num	18	SENT_17	[p1l267t1806r316b1839],
18	mg	NN	O	mg	dep	15	SENT_17	[p1l334t1813r388b1843],
19	per	IN	O	per	_	0	SENT_17	[p1l403t1813r457b1842],
20	square	NN	O	square	nn	21	SENT_17	[p1l473t1813r583b1842],
21	meter	NN	O	meter	pobj	19	SENT_17	[p1l600t1806r705b1839],
22	)	CD	NUMBER	)	dep	19	SENT_17	[p1l600t1806r705b1839],
23	every	DT	SET	every	quantmod	24	SENT_17	[p1l724t1813r810b1842],
24	3	CD	SET	3	num	25	SENT_17	[p1l825t1805r842b1834],
25	weeks	NNS	NUMBER	week	tmod	22	SENT_17	[p1l858t1803r969b1834],
26	.	.	O	.	_	0	SENT_17	[p1l858t1803r969b1834],

1	Patients	NNS	O	patient	nsubjpass	11	SENT_18	[p1l987t1804r1119b1834],
2	in	IN	O	in	_	0	SENT_18	[p1l1136t1804r1169b1833],
3	the	DT	O	the	det	5	SENT_18	[p1l1186t1803r1237b1834],
4	chemotherapy	NN	O	chemotherapy	nn	5	SENT_18	[p1l1254t1803r1491b1842],
5	group	NN	O	group	prep_in	1	SENT_18	[p1l91t1863r188b1893],
6	who	WP	O	who	nsubj	7	SENT_18	[p1l198t1853r268b1884],
7	had	VBD	O	have	rcmod	5	SENT_18	[p1l280t1853r340b1884],
8	disease	NN	O	disease	nn	9	SENT_18	[p1l352t1853r470b1884],
9	progression	NN	O	progression	dobj	7	SENT_18	[p1l481t1854r675b1893],
10	were	VBD	O	be	auxpass	11	SENT_18	[p1l684t1864r761b1884],
11	permitted	VBN	O	permit	_	0	SENT_18	[p1l773t1853r935b1892],
12	to	TO	O	to	aux	13	SENT_18	[p1l946t1860r978b1884],
13	cross	VB	O	cross	xcomp	11	SENT_18	[p1l990t1863r1073b1884],
14	over	IN	O	over	prep	13	SENT_18	[p1l1085t1863r1153b1884],
15	to	TO	O	to	pcomp	14	SENT_18	[p1l1164t1860r1195b1884],
16	crizotinib	NN	O	crizotinib	pobj	15	SENT_18	[p1l1207t1853r1366b1884],
17	as	IN	O	as	_	0	SENT_18	[p1l1378t1864r1411b1884],
18	part	NN	O	part	prep_as	13	SENT_18	[p1l1423t1860r1491b1892],
19	of	IN	O	of	_	0	SENT_18	[p1l92t1903r131b1934],
20	a	DT	O	a	det	22	SENT_18	[p1l137t1913r154b1934],
21	separate	JJ	O	separate	amod	22	SENT_18	[p1l167t1910r305b1942],
22	study	NN	O	study	prep_of	18	SENT_18	[p1l319t1903r413b1942],
23	.	.	O	.	_	0	SENT_18	[p1l319t1903r413b1942],

1	The	DT	O	the	det	4	SENT_19	[p1l427t1903r489b1934],
2	primary	JJ	O	primary	amod	4	SENT_19	[p1l502t1903r638b1942],
3	end	NN	O	end	nn	4	SENT_19	[p1l650t1903r709b1934],
4	point	NN	O	point	nsubj	7	SENT_19	[p1l722t1903r811b1942],
5	was	VBD	O	be	cop	7	SENT_19	[p1l821t1913r884b1934],
6	progression-free	JJ	O	progression-free	amod	7	SENT_19	[p1l898t1903r1172b1942],
7	survival	NN	O	survival	_	0	SENT_19	[p1l1186t1903r1324b1934],
8	.	.	O	.	_	0	SENT_19	[p1l1186t1903r1324b1934],

1	RESULTS	NNS	O	result	nsubj	8	SENT_20	[p1l93t1993r221b2013],
2	The	DT	O	the	det	5	SENT_20	[p1l90t2037r152b2067],
3	median	JJ	O	median	amod	5	SENT_20	[p1l168t2037r293b2067],
4	progression-free	JJ	O	progression-free	amod	5	SENT_20	[p1l308t2036r582b2076],
5	survival	NN	O	survival	dep	1	SENT_20	[p1l598t2037r727b2067],
6	was	VBD	O	be	cop	8	SENT_20	[p1l740t2047r803b2067],
7	7.7	CD	DURATION	7.7	num	8	SENT_20	[p1l820t2039r864b2067],
8	months	NNS	NUMBER	month	_	0	SENT_20	[p1l879t2037r1006b2067],
9	in	IN	O	in	_	0	SENT_20	[p1l1022t2037r1054b2067],
10	the	DT	O	the	det	12	SENT_20	[p1l1069t2037r1121b2067],
11	crizotinib	JJ	O	crizotinib	amod	12	SENT_20	[p1l1136t2037r1299b2067],
12	group	NN	O	group	prep_in	8	SENT_20	[p1l1315t2046r1413b2076],
13	and	CC	O	and	_	0	SENT_20	[p1l1428t2037r1489b2067],
14	3.0	CD	DURATION	3.0	num	15	SENT_20	[p1l92t2089r140b2117],
15	months	NNS	NUMBER	month	conj_and	8	SENT_20	[p1l153t2087r280b2117],
16	in	IN	O	in	_	0	SENT_20	[p1l294t2087r326b2117],
17	the	DT	O	the	det	22	SENT_20	[p1l339t2087r391b2117],
18	chemotherapy	NN	O	chemotherapy	nn	22	SENT_20	[p1l404t2087r641b2125],
19	group	NN	O	group	nn	22	SENT_20	[p1l651t2096r750b2126],
20	(	CD	NUMBER	(	num	22	SENT_20	[p1l765t2087r891b2122],
21	hazard	NN	O	hazard	nn	22	SENT_20	[p1l765t2087r891b2122],
22	ratio	NN	O	ratio	prep_in	15	SENT_20	[p1l904t2087r980b2117],
23	for	IN	O	for	_	0	SENT_20	[p1l993t2086r1041b2117],
24	progression	NN	O	progression	prep_for	22	SENT_20	[p1l1052t2087r1251b2126],
25	or	CC	O	or	_	0	SENT_20	[p1l1264t2096r1298b2117],
26	death	NN	O	death	prep_for	22	SENT_20	[p1l1310t2087r1402b2117],
27	with	IN	O	with	_	0	SENT_20	[p1l1414t2087r1489b2117],
28	crizotinib	NN	O	crizotinib	prep_with	15	SENT_20	[p1l92t2137r263b2173],
29	,	,	O	,	_	0	SENT_20	[p1l92t2137r263b2173],
30	0.49	CD	NUMBER	0.49	appos	28	SENT_20	[p1l279t2139r356b2173],
31	;	:	O	;	_	0	SENT_20	[p1l279t2139r356b2173],
32	95	CD	NUMBER	95	number	33	SENT_20	[p1l371t2139r443b2167],
33	°	CD	NUMBER	°	dep	15	SENT_20	[p1l371t2139r443b2167],
34	/	:	O	/	punct	40	SENT_20	[p1l371t2139r443b2167],
35	o	NN	O	o	nn	40	SENT_20	[p1l371t2139r443b2167],
36	confidence	NN	O	confidence	nn	40	SENT_20	[p1l456t2136r639b2167],
37	interval	NN	O	interval	nn	40	SENT_20	[p1l652t2137r779b2167],
38	[	CD	NUMBER	[	num	40	SENT_20	[p1l795t2139r864b2173],
39	CI	NN	O	ci	nn	40	SENT_20	[p1l795t2139r864b2173],
40	]	NN	O	]	dep	33	SENT_20	[p1l795t2139r864b2173],
41	,	,	O	,	_	0	SENT_20	[p1l795t2139r864b2173],
42	0.37	CD	NUMBER	0.37	appos	40	SENT_20	[p1l879t2139r947b2167],
43	to	TO	O	to	_	0	SENT_20	[p1l961t2143r993b2167],
44	0.64	CD	NUMBER	0.64	prep_to	33	SENT_20	[p1l1007t2139r1086b2173],
45	;	:	O	;	_	0	SENT_20	[p1l1007t2139r1086b2173],
46	P	NN	O	p	dep	47	SENT_20	[p1l1101t2139r1251b2172],
47	<	JJR	O	<	dep	15	SENT_20	[p1l1101t2139r1251b2172],
48	0.001	CD	NUMBER	0.001	num	49	SENT_20	[p1l1101t2139r1251b2172],
49	)	NN	O	)	dep	47	SENT_20	[p1l1101t2139r1251b2172],
50	.	.	O	.	_	0	SENT_20	[p1l1101t2139r1251b2172],

1	The	DT	O	the	det	3	SENT_21	[p1l1266t2137r1328b2167],
2	response	NN	O	response	nn	3	SENT_21	[p1l1341t2146r1489b2175],
3	rates	NNS	O	rate	nsubj	6	SENT_21	[p1l91t2193r170b2217],
4	were	VBD	O	be	cop	6	SENT_21	[p1l182t2197r260b2217],
5	65	CD	NUMBER	65	number	6	SENT_21	[p1l274t2189r345b2217],
6	°	CD	NUMBER	°	_	0	SENT_21	[p1l274t2189r345b2217],
7	/	:	O	/	punct	8	SENT_21	[p1l274t2189r345b2217],
8	o	NN	O	o	dep	6	SENT_21	[p1l274t2189r345b2217],
9	(	CD	NUMBER	(	num	8	SENT_21	[p1l359t2189r441b2222],
10	95	CD	NUMBER	95	num	11	SENT_21	[p1l359t2189r441b2222],
11	°	NN	O	°	dep	8	SENT_21	[p1l359t2189r441b2222],
12	/	:	O	/	punct	8	SENT_21	[p1l359t2189r441b2222],
13	o	NN	O	o	nn	14	SENT_21	[p1l359t2189r441b2222],
14	CI	NN	O	ci	dep	8	SENT_21	[p1l454t2189r498b2223],
15	,	,	O	,	_	0	SENT_21	[p1l454t2189r498b2223],
16	58	CD	NUMBER	58	number	19	SENT_21	[p1l514t2189r552b2217],
17	to	TO	O	to	dep	19	SENT_21	[p1l566t2193r597b2217],
18	72	CD	NUMBER	72	number	19	SENT_21	[p1l611t2189r659b2222],
19	)	CD	NUMBER	)	appos	14	SENT_21	[p1l611t2189r659b2222],
20	with	IN	O	with	_	0	SENT_21	[p1l673t2187r749b2217],
21	crizotinib	NN	O	crizotinib	prep_with	14	SENT_21	[p1l762t2187r933b2224],
22	,	,	O	,	_	0	SENT_21	[p1l762t2187r933b2224],
23	as	IN	O	as	_	0	SENT_21	[p1l948t2197r981b2217],
24	compared	VBN	O	compare	prepc_as	6	SENT_21	[p1l996t2187r1161b2225],
25	with	IN	O	with	pcomp	24	SENT_21	[p1l1172t2187r1248b2217],
26	20	CD	NUMBER	20	number	27	SENT_21	[p1l1261t2189r1333b2217],
27	°	CD	NUMBER	°	amod	35	SENT_21	[p1l1261t2189r1333b2217],
28	/	:	O	/	punct	29	SENT_21	[p1l1261t2189r1333b2217],
29	o	NN	O	o	dep	27	SENT_21	[p1l1261t2189r1333b2217],
30	(	CD	NUMBER	(	number	31	SENT_21	[p1l1348t2189r1430b2222],
31	95	CD	NUMBER	95	dep	29	SENT_21	[p1l1348t2189r1430b2222],
32	°	NN	O	°	dep	31	SENT_21	[p1l1348t2189r1430b2222],
33	/	:	O	/	punct	29	SENT_21	[p1l1348t2189r1430b2222],
34	o	NN	O	o	nn	35	SENT_21	[p1l1348t2189r1430b2222],
35	CI	NN	O	ci	pobj	25	SENT_21	[p1l1443t2189r1487b2224],
36	,	,	O	,	_	0	SENT_21	[p1l1443t2189r1487b2224],

1	14	CD	NUMBER	14	number	4	SENT_22	[p1l93t2308r128b2336],
2	to	TO	O	to	dep	4	SENT_22	[p1l139t2312r170b2336],
3	26	CD	NUMBER	26	number	4	SENT_22	[p1l181t2308r230b2341],
4	)	CD	NUMBER	)	_	0	SENT_22	[p1l181t2308r230b2341],
5	with	IN	O	with	_	0	SENT_22	[p1l241t2306r315b2336],
6	chemotherapy	NN	O	chemotherapy	nn	8	SENT_22	[p1l326t2306r558b2344],
7	(	CD	NUMBER	(	num	8	SENT_22	[p1l569t2308r727b2341],
8	P	NN	O	p	prep_with	4	SENT_22	[p1l569t2308r727b2341],
9	<	JJR	O	<	dep	4	SENT_22	[p1l569t2308r727b2341],
10	0.001	CD	NUMBER	0.001	num	11	SENT_22	[p1l569t2308r727b2341],
11	)	NN	O	)	dep	9	SENT_22	[p1l569t2308r727b2341],
12	.	.	O	.	_	0	SENT_22	[p1l569t2308r727b2341],

1	An	DT	O	a	det	3	SENT_23	[p1l739t2308r786b2336],
2	interim	JJ	O	interim	amod	3	SENT_23	[p1l797t2306r918b2336],
3	analysis	NN	O	analysis	nsubj	7	SENT_23	[p1l928t2306r1057b2344],
4	of	IN	O	of	_	0	SENT_23	[p1l1068t2305r1107b2336],
5	overall	JJ	O	overall	amod	6	SENT_23	[p1l1110t2306r1219b2336],
6	survival	NN	O	survival	prep_of	3	SENT_23	[p1l1229t2306r1355b2336],
7	showed	VBD	O	show	_	0	SENT_23	[p1l1366t2306r1489b2336],
8	no	DT	O	no	det	10	SENT_23	[p1l91t2365r132b2386],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_23	[p1l145t2355r322b2395],
10	improvement	NN	O	improvement	dobj	7	SENT_23	[p1l332t2356r550b2394],
11	with	IN	O	with	_	0	SENT_23	[p1l558t2356r633b2386],
12	crizotinib	NN	O	crizotinib	prep_with	7	SENT_23	[p1l645t2356r804b2386],
13	as	IN	O	as	prep	7	SENT_23	[p1l816t2366r849b2386],
14	compared	VBN	O	compare	_	0	SENT_23	[p1l862t2356r1025b2394],
15	with	IN	O	with	prepc_compared_with	7	SENT_23	[p1l1035t2356r1109b2386],
16	chemotherapy	NN	O	chemotherapy	nn	19	SENT_23	[p1l1121t2356r1354b2394],
17	(	NN	O	(	nn	19	SENT_23	[p1l1366t2356r1489b2391],
18	hazard	NN	O	hazard	nn	19	SENT_23	[p1l1366t2356r1489b2391],
19	ratio	NN	O	ratio	pobj	7	SENT_23	[p1l91t2406r166b2436],
20	for	IN	O	for	_	0	SENT_23	[p1l179t2405r226b2436],
21	death	NN	O	death	prep_for	19	SENT_23	[p1l237t2406r327b2436],
22	in	IN	O	in	_	0	SENT_23	[p1l339t2406r371b2436],
23	the	DT	O	the	det	25	SENT_23	[p1l384t2406r434b2436],
24	crizotinib	JJ	O	crizotinib	amod	25	SENT_23	[p1l447t2406r606b2436],
25	group	NN	O	group	prep_in	21	SENT_23	[p1l618t2415r723b2445],
26	,	,	O	,	_	0	SENT_23	[p1l618t2415r723b2445],
27	1.02	CD	NUMBER	1.02	num	29	SENT_23	[p1l738t2408r813b2442],
28	;	:	O	;	_	0	SENT_23	[p1l738t2408r813b2442],
29	95	CD	NUMBER	95	dep	7	SENT_23	[p1l827t2408r897b2436],
30	°	CD	NUMBER	°	dep	29	SENT_23	[p1l827t2408r897b2436],
31	/	:	O	/	punct	29	SENT_23	[p1l827t2408r897b2436],
32	o	NN	O	o	nn	33	SENT_23	[p1l827t2408r897b2436],
33	CI	NN	O	ci	dep	29	SENT_23	[p1l909t2408r953b2443],
34	,	,	O	,	_	0	SENT_23	[p1l909t2408r953b2443],
35	0.68	CD	NUMBER	0.68	number	37	SENT_23	[p1l967t2408r1035b2436],
36	to	TO	O	to	dep	37	SENT_23	[p1l1048t2412r1079b2436],
37	1.54	CD	NUMBER	1.54	appos	33	SENT_23	[p1l1093t2408r1169b2442],
38	;	:	O	;	_	0	SENT_23	[p1l1093t2408r1169b2442],
39	P	NN	O	p	dep	33	SENT_23	[p1l1182t2408r1321b2441],
40	=	JJ	O	=	amod	42	SENT_23	[p1l1182t2408r1321b2441],
41	0.54	CD	NUMBER	0.54	tmod	40	SENT_23	[p1l1182t2408r1321b2441],
42	)	NN	O	)	dep	39	SENT_23	[p1l1182t2408r1321b2441],
43	.	.	O	.	_	0	SENT_23	[p1l1182t2408r1321b2441],

1	Common	JJ	O	common	amod	3	SENT_24	[p1l1336t2408r1489b2436],
2	adverse	JJ	O	adverse	amod	3	SENT_24	[p1l91t2525r211b2555],
3	events	NNS	O	event	nsubj	9	SENT_24	[p1l227t2531r327b2555],
4	associated	VBN	O	associate	partmod	3	SENT_24	[p1l343t2525r512b2555],
5	with	IN	O	with	_	0	SENT_24	[p1l526t2525r600b2555],
6	crizotinib	NN	O	crizotinib	prep_with	4	SENT_24	[p1l616t2525r775b2555],
7	were	VBD	O	be	cop	9	SENT_24	[p1l790t2535r867b2555],
8	visual	JJ	O	visual	amod	9	SENT_24	[p1l881t2525r976b2555],
9	disorder	NN	O	disorder	_	0	SENT_24	[p1l992t2525r1135b2562],
10	,	,	O	,	_	0	SENT_24	[p1l992t2525r1135b2562],
11	gastrointestinal	JJ	O	gastrointestinal	amod	13	SENT_24	[p1l1152t2525r1410b2564],
12	side	JJ	O	side	amod	13	SENT_24	[p1l1427t2525r1489b2555],
13	effects	NNS	O	effect	conj_and	9	SENT_24	[p1l92t2574r210b2612],
14	,	,	O	,	_	0	SENT_24	[p1l92t2574r210b2612],
15	and	CC	O	and	_	0	SENT_24	[p1l224t2575r285b2605],
16	elevated	JJ	O	elevated	amod	19	SENT_24	[p1l298t2575r431b2606],
17	liver	NN	O	liver	nn	19	SENT_24	[p1l442t2575r514b2606],
18	aminotransferase	NN	O	aminotransferase	nn	19	SENT_24	[p1l524t2574r818b2605],
19	levels	NNS	O	level	conj_and	9	SENT_24	[p1l830t2575r929b2612],
20	,	,	O	,	_	0	SENT_24	[p1l830t2575r929b2612],
21	whereas	IN	O	whereas	mark	28	SENT_24	[p1l942t2575r1078b2606],
22	common	JJ	O	common	amod	24	SENT_24	[p1l1091t2585r1239b2605],
23	adverse	JJ	O	adverse	amod	24	SENT_24	[p1l1251t2575r1373b2606],
24	events	NNS	O	event	nsubj	28	SENT_24	[p1l1386t2581r1488b2606],
25	with	IN	O	with	_	0	SENT_24	[p1l90t2625r166b2656],
26	chemotherapy	NN	O	chemotherapy	prep_with	24	SENT_24	[p1l181t2625r418b2664],
27	were	VBD	O	be	cop	28	SENT_24	[p1l430t2635r509b2656],
28	fatigue	NN	O	fatigue	advcl	9	SENT_24	[p1l524t2625r648b2664],
29	,	,	O	,	_	0	SENT_24	[p1l524t2625r648b2664],
30	alopecia	NN	O	alopecia	advcl	9	SENT_24	[p1l666t2625r812b2664],
31	,	,	O	,	_	0	SENT_24	[p1l666t2625r812b2664],
32	and	CC	O	and	_	0	SENT_24	[p1l830t2625r891b2656],
33	dyspnea	NN	O	dyspnea	conj_and	28	SENT_24	[p1l907t2625r1049b2664],
34	.	.	O	.	_	0	SENT_24	[p1l907t2625r1049b2664],

1	Patients	NNS	O	patient	nsubj	2	SENT_25	[p1l1066t2625r1198b2655],
2	reported	VBD	O	report	_	0	SENT_25	[p1l1215t2625r1357b2664],
3	greater	JJR	O	greater	amod	4	SENT_25	[p1l1372t2631r1490b2664],
4	reductions	NNS	O	reduction	dobj	2	SENT_25	[p1l91t2675r266b2706],
5	in	IN	O	in	_	0	SENT_25	[p1l281t2675r313b2705],
6	symptoms	NNS	O	symptom	prep_in	2	SENT_25	[p1l328t2681r500b2714],
7	of	IN	O	of	_	0	SENT_25	[p1l515t2675r554b2706],
8	lung	NN	O	lung	nn	9	SENT_25	[p1l561t2675r636b2714],
9	cancer	NN	O	cancer	prep_of	6	SENT_25	[p1l649t2685r758b2706],
10	and	CC	O	and	_	0	SENT_25	[p1l770t2675r832b2706],
11	greater	JJR	O	greater	amod	12	SENT_25	[p1l846t2681r964b2714],
12	improvement	NN	O	improvement	prep_in	2	SENT_25	[p1l977t2675r1199b2714],
13	in	IN	O	in	_	0	SENT_25	[p1l1211t2675r1244b2705],
14	global	JJ	O	global	amod	15	SENT_25	[p1l1258t2675r1361b2714],
15	quality	NN	O	quality	prep_in	12	SENT_25	[p1l1376t2675r1491b2714],
16	of	IN	O	of	_	0	SENT_25	[p1l92t2725r131b2756],
17	life	NN	O	life	prep_of	15	SENT_25	[p1l136t2725r189b2756],
18	with	IN	O	with	_	0	SENT_25	[p1l201t2725r277b2756],
19	crizotinib	NN	O	crizotinib	prep_with	17	SENT_25	[p1l290t2725r453b2756],
20	than	IN	O	than	prep	2	SENT_25	[p1l467t2725r543b2756],
21	with	IN	O	with	pcomp	20	SENT_25	[p1l555t2725r631b2756],
22	chemotherapy	NN	O	chemotherapy	pobj	21	SENT_25	[p1l644t2725r886b2764],
23	.	.	O	.	_	0	SENT_25	[p1l644t2725r886b2764],

1	CONCLUSIONS	NNS	O	conclusion	nsubj	14	SENT_26	[p1l92t2822r318b2841],
2	Crizotinib	NNP	O	Crizotinib	nsubj	4	SENT_26	[p1l92t2865r262b2895],
3	is	VBZ	O	be	cop	4	SENT_26	[p1l273t2865r299b2895],
4	superior	JJ	O	superior	parataxis	14	SENT_26	[p1l312t2865r449b2904],
5	to	TO	O	to	_	0	SENT_26	[p1l460t2871r492b2895],
6	standard	JJ	O	standard	amod	7	SENT_26	[p1l504t2865r651b2895],
7	chemotherapy	NN	O	chemotherapy	prep_to	4	SENT_26	[p1l663t2865r900b2904],
8	in	IN	O	in	_	0	SENT_26	[p1l909t2865r942b2895],
9	patients	NNS	O	patient	prep_in	7	SENT_26	[p1l952t2865r1085b2904],
10	with	IN	O	with	_	0	SENT_26	[p1l1096t2865r1171b2895],
11	previously	RB	DATE	previously	advmod	12	SENT_26	[p1l1182t2865r1353b2904],
12	treated	VBN	O	treat	prepc_with	4	SENT_26	[p1l1363t2865r1487b2902],
13	,	,	O	,	_	0	SENT_26	[p1l1363t2865r1487b2902],
14	advanced	VBD	O	advance	_	0	SENT_26	[p1l91t2915r245b2945],
15	non	JJ	O	non	amod	21	SENT_26	[p1l260t2915r509b2945],
16	—	JJ	O	—	amod	17	SENT_26	[p1l260t2915r509b2945],
17	small	JJ	O	small	amod	21	SENT_26	[p1l260t2915r509b2945],
18	—	NN	O	—	nn	21	SENT_26	[p1l260t2915r509b2945],
19	cell	NN	O	cell	nn	21	SENT_26	[p1l260t2915r509b2945],
20	lung	NN	O	lung	nn	21	SENT_26	[p1l524t2915r599b2954],
21	cancer	NN	O	cancer	dobj	14	SENT_26	[p1l613t2925r722b2945],
22	with	IN	O	with	_	0	SENT_26	[p1l734t2915r810b2945],
23	ALK	NN	O	alk	nn	24	SENT_26	[p1l822t2917r890b2945],
24	rearrangement	NN	O	rearrangement	prep_with	21	SENT_26	[p1l902t2921r1159b2954],
25	.	.	O	.	_	0	SENT_26	[p1l902t2921r1159b2954],

1	(	NN	O	(	nsubj	2	SENT_27	[p1l1178t2915r1313b2950],
2	Funded	VBN	O	fund	_	0	SENT_27	[p1l1178t2915r1313b2950],
3	by	IN	O	by	_	0	SENT_27	[p1l1328t2915r1366b2953],
4	Pfizer	NNP	ORGANIZATION	Pfizer	prep_by	2	SENT_27	[p1l1379t2914r1488b2951],
5	;	:	O	;	_	0	SENT_27	[p1l1379t2914r1488b2951],
6	ClinicalTrials	NNP	O	ClinicalTrials	dep	4	SENT_27	[p1l91t2965r387b3004],
7	.	.	O	.	_	0	SENT_27	[p1l91t2965r387b3004],

1	gov	NN	O	gov	nn	2	SENT_28	[p1l91t2965r387b3004],
2	number	NN	O	number	_	0	SENT_28	[p1l399t2965r537b3002],
3	,	,	O	,	_	0	SENT_28	[p1l399t2965r537b3002],
4	NCT00932893	NN	O	nct00932893	appos	2	SENT_28	[p1l551t2967r809b3000],
5	.	.	O	.	_	0	SENT_28	[p1l551t2967r809b3000],
6	)	SYM	O	)	dep	2	SENT_28	[p1l551t2967r809b3000],

1	NENGi_JMED368	NN	O	nengi_jmed368	_	0	SENT_29	[p1l476t3068r738b3096],
2	;	:	O	;	_	0	SENT_29	[p1l476t3068r738b3096],
3	25	CD	NUMBER	25	num	5	SENT_29	[p1l476t3068r738b3096],
4	NEJM.ORG	NN	O	nejm.org	nn	5	SENT_29	[p1l773t3074r897b3096],
5	jUNE20	NN	O	june20	dep	1	SENT_29	[p1l928t3074r1106b3096],
6	,2013	CD	NUMBER	,2013	dep	5	SENT_29	[p1l928t3074r1106b3096],

1	The	DT	O	the	det	5	SENT_30	[p1l750t3131r801b3155],
2	New	NNP	O	New	nn	5	SENT_30	[p1l810t3132r872b3155],
3	England	NNP	O	England	nn	5	SENT_30	[p1l881t3131r992b3162],
4	J	NNP	O	J	nn	5	SENT_30	[p1l1000t3132r1013b3155],
5	oumal	NN	O	oumal	_	0	SENT_30	[p1l1014t3131r1098b3155],
6	of	IN	O	of	_	0	SENT_30	[p1l1107t3131r1136b3155],
7	Medicine	NN	O	medicine	prep_of	5	SENT_30	[p1l1143t3131r1268b3155],

1	From	IN	O	from	dep	22	SENT_31	[p1l1531t1010r1592b1031],
2	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	4	SENT_31	[p1l1624t1008r1807b1032],
3	General	NNP	ORGANIZATION	General	nn	4	SENT_31	[p1l1836t1008r1930b1032],
4	Hospital	NNP	ORGANIZATION	Hospital	pobj	1	SENT_31	[p1l1961t1008r2063b1039],
5	(	CD	NUMBER	(	num	7	SENT_31	[p1l1532t1047r1615b1076],
6	A.T.S.	NNP	O	A.T.S.	nn	7	SENT_31	[p1l1532t1047r1615b1076],
7	)	NN	O	)	dep	4	SENT_31	[p1l1532t1047r1615b1076],
8	and	CC	O	and	_	0	SENT_31	[p1l1630t1045r1673b1069],
9	Lowe	NNP	PERSON	Lowe	nn	10	SENT_31	[p1l1689t1048r1751b1069],
10	Center	NNP	PERSON	Center	conj_and	4	SENT_31	[p1l1763t1047r1844b1069],
11	for	IN	O	for	_	0	SENT_31	[p1l1855t1045r1889b1069],
12	Thoracic	NNP	O	Thoracic	nn	13	SENT_31	[p1l1899t1045r2006b1069],
13	Oncology	NNP	O	Oncology	prep_for	10	SENT_31	[p1l2018t1047r2064b1069, p1l1529t1082r1609b1114],
14	and	CC	O	and	_	0	SENT_31	[p1l1618t1082r1661b1106],
15	Belfer	NNP	ORGANIZATION	Belfer	nn	16	SENT_31	[p1l1674t1082r1743b1106],
16	Institute	NNP	ORGANIZATION	Institute	conj_and	4	SENT_31	[p1l1754t1085r1853b1106],
17	for	IN	ORGANIZATION	for	_	0	SENT_31	[p1l1862t1082r1896b1106],
18	Applied	NNP	ORGANIZATION	Applied	nn	20	SENT_31	[p1l1904t1082r1998b1114],
19	Cancer	NNP	ORGANIZATION	Cancer	nn	20	SENT_31	[p1l2009t1084r2064b1106, p1l1529t1130r1566b1146],
20	Science	NNP	ORGANIZATION	Science	prep_for	16	SENT_31	[p1l1578t1124r1677b1150],
21	,	,	O	,	_	0	SENT_31	[p1l1578t1124r1677b1150],
22	Dana	NNP	PERSON	Dana	_	0	SENT_31	[p1l1693t1122r1853b1146],
23	.	.	O	.	_	0	SENT_31	[p1l1693t1122r1853b1146],

1	—	NN	O	—	_	0	SENT_32	[p1l1693t1122r1853b1146],
2	.	.	O	.	_	0	SENT_32	[p1l1693t1122r1853b1146],

1	Farber	NNP	ORGANIZATION	Farber	nn	8	SENT_33	[p1l1693t1122r1853b1146],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	8	SENT_33	[p1l1865t1124r1951b1146],
3	Institute	NNP	ORGANIZATION	Institute	nn	8	SENT_33	[p1l1965t1124r2064b1146],
4	(	NNP	O	(	nn	8	SENT_33	[p1l1532t1161r1617b1191],
5	P.A.j.	NNP	O	P.A.j.	nn	8	SENT_33	[p1l1532t1161r1617b1191],
6	)	NNP	O	)	nn	8	SENT_33	[p1l1532t1161r1617b1191],
7	,	,	O	,	_	0	SENT_33	[p1l1532t1161r1617b1191],
8	Boston	NNP	LOCATION	Boston	_	0	SENT_33	[p1l1634t1162r1726b1188],
9	;	:	O	;	_	0	SENT_33	[p1l1634t1162r1726b1188],
10	Seoul	NNP	ORGANIZATION	Seoul	nn	13	SENT_33	[p1l1741t1160r1807b1184],
11	National	NNP	ORGANIZATION	National	nn	13	SENT_33	[p1l1824t1160r1926b1184],
12	University	NNP	ORGANIZATION	University	nn	13	SENT_33	[p1l1943t1162r2065b1191],
13	Hospital	NNP	ORGANIZATION	Hospital	conj_and	8	SENT_33	[p1l1531t1197r1632b1228],
14	(	CD	NUMBER	(	num	16	SENT_33	[p1l1645t1199r1752b1228],
15	D.-W.K.	NNP	O	D.-W.K.	nn	16	SENT_33	[p1l1645t1199r1752b1228],
16	)	NN	O	)	dep	8	SENT_33	[p1l1645t1199r1752b1228],
17	and	CC	O	and	_	0	SENT_33	[p1l1763t1197r1807b1221],
18	Sungkyunkwan	NNP	ORGANIZATION	Sungkyunkwan	nn	20	SENT_33	[p1l1817t1197r2003b1229],
19	University	NNP	ORGANIZATION	University	nn	20	SENT_33	[p1l2014t1200r2064b1221, p1l1528t1237r1608b1266],
20	School	NNP	ORGANIZATION	School	conj_and	8	SENT_33	[p1l1616t1235r1698b1259],
21	of	IN	ORGANIZATION	of	_	0	SENT_33	[p1l1708t1235r1735b1259],
22	Medicine	NNP	ORGANIZATION	Medicine	prep_of	20	SENT_33	[p1l1741t1235r1859b1263],
23	,	,	O	,	_	0	SENT_33	[p1l1741t1235r1859b1263],
24	Samsung	NNP	ORGANIZATION	Samsung	nn	28	SENT_33	[p1l1870t1237r1985b1266],
25	Medical	NNP	ORGANIZATION	Medical	nn	28	SENT_33	[p1l1995t1235r2064b1258, p1l1529t1272r1561b1296],
26	Center	NNP	ORGANIZATION	Center	nn	28	SENT_33	[p1l1580t1274r1661b1296],
27	(	NNP	O	(	nn	28	SENT_33	[p1l1680t1274r1786b1303],
28	M.	NNP	O	M.	conj_and	8	SENT_33	[p1l1680t1274r1786b1303],
29	.	.	O	.	_	0	SENT_33	[p1l1680t1274r1786b1303],

1	—	NN	O	—	_	0	SENT_34	[p1l1680t1274r1786b1303],
2	.	.	O	.	_	0	SENT_34	[p1l1680t1274r1786b1303],

1	J.A.	NNP	PERSON	J.A.	nn	7	SENT_35	[p1l1680t1274r1786b1303],
2	)	NNP	O	)	nn	7	SENT_35	[p1l1680t1274r1786b1303],
3	,	,	O	,	_	0	SENT_35	[p1l1680t1274r1786b1303],
4	Seoul	NNP	LOCATION	Seoul	appos	7	SENT_35	[p1l1805t1272r1879b1300],
5	,	,	O	,	_	0	SENT_35	[p1l1805t1272r1879b1300],
6	South	NNP	LOCATION	South	appos	7	SENT_35	[p1l1898t1272r1969b1296],
7	Korea	NNP	LOCATION	Korea	_	0	SENT_35	[p1l1990t1275r2063b1300],
8	;	:	O	;	_	0	SENT_35	[p1l1990t1275r2063b1300],
9	Kinki	NNP	ORGANIZATION	Kinki	nn	12	SENT_35	[p1l1531t1310r1588b1333],
10	University	NNP	ORGANIZATION	University	nn	12	SENT_35	[p1l1598t1312r1720b1341],
11	Faculty	NNP	ORGANIZATION	Faculty	nn	12	SENT_35	[p1l1729t1310r1813b1341],
12	ofMedicine	NNP	O	ofMedicine	dep	7	SENT_35	[p1l1820t1310r1970b1338],
13	,	,	O	,	_	0	SENT_35	[p1l1820t1310r1970b1338],
14	Osakasayama	NNP	LOCATION	Osakasayama	nn	15	SENT_35	[p1l1979t1310r2064b1334, p1l1530t1356r1620b1378],
15	City	NNP	LOCATION	City	dep	7	SENT_35	[p1l1629t1349r1680b1378],
16	,	,	O	,	_	0	SENT_35	[p1l1629t1349r1680b1378],
17	Osaka	NNP	LOCATION	Osaka	nn	20	SENT_35	[p1l1689t1347r1766b1371],
18	(	NNP	O	(	nn	20	SENT_35	[p1l1777t1349r1853b1378],
19	K.N.	NNP	LOCATION	K.N.	nn	20	SENT_35	[p1l1777t1349r1853b1378],
20	)	NNP	O	)	dep	7	SENT_35	[p1l1777t1349r1853b1378],
21	,	,	O	,	_	0	SENT_35	[p1l1777t1349r1853b1378],
22	and	CC	O	and	_	0	SENT_35	[p1l1863t1347r1907b1371],
23	National	NNP	ORGANIZATION	National	nn	26	SENT_35	[p1l1918t1347r2020b1371],
24	Kyushu	NNP	ORGANIZATION	Kyushu	nn	26	SENT_35	[p1l2031t1350r2064b1378, p1l1530t1385r1588b1409],
25	Cancer	NNP	ORGANIZATION	Cancer	nn	26	SENT_35	[p1l1597t1387r1683b1409],
26	Center	NNP	ORGANIZATION	Center	dep	7	SENT_35	[p1l1691t1387r1776b1413],
27	,	,	O	,	_	0	SENT_35	[p1l1691t1387r1776b1413],
28	Fukuoka	NNP	LOCATION	Fukuoka	dep	7	SENT_35	[p1l1787t1385r1888b1409],
29	(	CD	NUMBER	(	num	28	SENT_35	[p1l1900t1387r1960b1416],
30	T.S.	NNP	O	T.S.	dep	28	SENT_35	[p1l1900t1387r1960b1416],
31	)	CD	NUMBER	)	number	32	SENT_35	[p1l1900t1387r1960b1416],
32	—	CD	NUMBER	—	dep	30	SENT_35	[p1l1969t1400r2001b1402],
33	both	DT	O	both	dep	32	SENT_35	[p1l2009t1385r2063b1409],
34	in	IN	O	in	_	0	SENT_35	[p1l1530t1425r1549b1446],
35	japan	NN	LOCATION	japan	prep_in	32	SENT_35	[p1l1558t1425r1636b1454],
36	;	:	O	;	_	0	SENT_35	[p1l1558t1425r1636b1454],
37	Azienda	NNP	ORGANIZATION	Azienda	nn	39	SENT_35	[p1l1648t1423r1747b1446],
38	Ospedale	NNP	ORGANIZATION	Ospedale	nn	39	SENT_35	[p1l1760t1423r1877b1454],
39	Perugia	NNP	ORGANIZATION	Perugia	dep	7	SENT_35	[p1l1891t1425r1987b1454],
40	,	,	O	,	_	0	SENT_35	[p1l1891t1425r1987b1454],
41	Perugia	NNP	ORGANIZATION	Perugia	appos	39	SENT_35	[p1l2002t1425r2064b1447, p1l1529t1463r1563b1491],
42	(	CD	NUMBER	(	num	41	SENT_35	[p1l1576t1462r1645b1491],
43	L.C.	NNP	O	L.C.	dep	41	SENT_35	[p1l1576t1462r1645b1491],
44	)	CD	NUMBER	)	num	43	SENT_35	[p1l1576t1462r1645b1491],
45	,	,	O	,	_	0	SENT_35	[p1l1576t1462r1645b1491],
46	and	CC	O	and	_	0	SENT_35	[p1l1657t1460r1700b1484],
47	European	NNP	ORGANIZATION	European	nn	48	SENT_35	[p1l1713t1463r1827b1491],
48	Institute	NNP	ORGANIZATION	Institute	dep	12	SENT_35	[p1l1840t1463r1940b1484],
49	ofOncology	NN	O	ofoncology	nn	52	SENT_35	[p1l1949t1460r2064b1484, p1l1529t1506r1573b1529],
50	(	CD	NUMBER	(	num	52	SENT_35	[p1l1583t1500r1668b1529],
51	T.D.P.	NN	O	t.d.p.	nn	52	SENT_35	[p1l1583t1500r1668b1529],
52	)	NN	O	)	conj_and	12	SENT_35	[p1l1583t1500r1668b1529],
53	and	CC	O	and	_	0	SENT_35	[p1l1679t1498r1723b1521],
54	Pfizer	NNP	ORGANIZATION	Pfizer	nn	55	SENT_35	[p1l1734t1498r1804b1521],
55	Italia	NNP	ORGANIZATION	Italia	conj_and	52	SENT_35	[p1l1813t1498r1869b1521],
56	(	CD	NUMBER	(	num	57	SENT_35	[p1l1880t1499r1949b1529],
57	A.P.	NNP	O	A.P.	dep	55	SENT_35	[p1l1880t1499r1949b1529],
58	)	CD	NUMBER	)	num	57	SENT_35	[p1l1880t1499r1949b1529],
59	,	,	O	,	_	0	SENT_35	[p1l1880t1499r1949b1529],
60	Milan	NNP	ORGANIZATION	Milan	conj_and	52	SENT_35	[p1l1960t1498r2026b1521],
61	—	CD	NUMBER	—	num	60	SENT_35	[p1l2034t1512r2065b1515],
62	all	DT	O	all	advmod	60	SENT_35	[p1l1529t1535r1554b1558],
63	in	IN	O	in	_	0	SENT_35	[p1l1566t1537r1586b1558],
64	Italy	NNP	LOCATION	Italy	prep_in	60	SENT_35	[p1l1599t1535r1653b1566],
65	;	:	O	;	_	0	SENT_35	[p1l1599t1535r1653b1566],
66	Institut	NNP	PERSON	Institut	nn	68	SENT_35	[p1l1666t1537r1752b1559],
67	Gustave	NNP	PERSON	Gustave	nn	68	SENT_35	[p1l1762t1537r1862b1559],
68	Roussy	NNP	PERSON	Roussy	conj_and	12	SENT_35	[p1l1874t1537r1964b1566],
69	,	,	O	,	_	0	SENT_35	[p1l1874t1537r1964b1566],
70	Villejuif	NNP	LOCATION	Villejuif	nn	73	SENT_35	[p1l1974t1535r2069b1566],
71	(	NNP	O	(	nn	73	SENT_35	[p1l1532t1574r1603b1603],
72	B.B.	NNP	PERSON	B.B.	nn	73	SENT_35	[p1l1532t1574r1603b1603],
73	)	NNP	O	)	appos	68	SENT_35	[p1l1532t1574r1603b1603],
74	,	,	O	,	_	0	SENT_35	[p1l1532t1574r1603b1603],
75	and	CC	O	and	_	0	SENT_35	[p1l1615t1572r1659b1596],
76	Thoracic	NNP	O	Thoracic	nn	78	SENT_35	[p1l1669t1572r1776b1596],
77	Oncology	NNP	O	Oncology	nn	78	SENT_35	[p1l1785t1572r1905b1603],
78	Unit	NNP	O	Unit	conj_and	12	SENT_35	[p1l1916t1575r1973b1600],
79	,	,	O	,	_	0	SENT_35	[p1l1916t1575r1973b1600],
80	Centre	NNP	ORGANIZATION	Centre	nn	83	SENT_35	[p1l1984t1574r2064b1596],
81	Hospitalier	NNP	ORGANIZATION	Hospitalier	nn	83	SENT_35	[p1l1531t1610r1666b1641],
82	Universitaire	NNP	ORGANIZATION	Universitaire	nn	83	SENT_35	[p1l1679t1612r1832b1634],
83	Grenoble	NNP	ORGANIZATION	Grenoble	appos	78	SENT_35	[p1l1845t1610r1965b1638],
84	,	,	O	,	_	0	SENT_35	[p1l1845t1610r1965b1638],
85	Grenoble	NNP	LOCATION	Grenoble	nn	87	SENT_35	[p1l1979t1612r2064b1634, p1l1530t1647r1565b1671],
86	(	CD	NUMBER	(	num	87	SENT_35	[p1l1577t1649r1684b1678],
87	D.M.-S	NN	O	d.m.-s	appos	78	SENT_35	[p1l1577t1649r1684b1678],
88	.	.	O	.	_	0	SENT_35	[p1l1577t1649r1684b1678],
89	)	SYM	O	)	dep	7	SENT_35	[p1l1577t1649r1684b1678],

1	—	NN	O	—	_	0	SENT_36	[p1l1695t1662r1727b1664],
2	both	CC	O	both	dep	3	SENT_36	[p1l1737t1647r1790b1671],
3	in	IN	O	in	dep	1	SENT_36	[p1l1803t1650r1822b1671],
4	France	NNP	LOCATION	France	pobj	3	SENT_36	[p1l1835t1650r1921b1675],
5	;	:	O	;	_	0	SENT_36	[p1l1835t1650r1921b1675],
6	Peter	NNP	PERSON	Peter	nn	7	SENT_36	[p1l1934t1650r1995b1671],
7	MacCallum	NNP	PERSON	MacCallum	dep	1	SENT_36	[p1l2007t1650r2064b1671, p1l1529t1754r1614b1778],

1	Cancer	NN	O	cancer	_	0	SENT_37	[p1l1636t1756r1722b1778],
2	Centre	NNP	O	Centre	nn	10	SENT_37	[p1l1742t1756r1828b1782],
3	,	,	O	,	_	0	SENT_37	[p1l1742t1756r1828b1782],
4	Melbourne	NNP	LOCATION	Melbourne	appos	10	SENT_37	[p1l1852t1754r1991b1782],
5	,	,	O	,	_	0	SENT_37	[p1l1852t1754r1991b1782],
6	VIC	NNP	ORGANIZATION	VIC	appos	10	SENT_37	[p1l2012t1756r2063b1782],
7	,	,	O	,	_	0	SENT_37	[p1l2012t1756r2063b1782],
8	Australia	NNP	LOCATION	Australia	appos	10	SENT_37	[p1l1528t1791r1636b1815],
9	(	CD	NUMBER	(	num	10	SENT_37	[p1l1653t1793r1740b1823],
10	B.J.S.	NNP	O	B.J.S.	dep	1	SENT_37	[p1l1653t1793r1740b1823],
11	)	NN	O	)	dep	10	SENT_37	[p1l1653t1793r1740b1823],
12	;	:	O	;	_	0	SENT_37	[p1l1653t1793r1740b1823],
13	Christie	NNP	ORGANIZATION	Christie	nn	23	SENT_37	[p1l1755t1791r1848b1815],
14	National	NNP	ORGANIZATION	National	nn	23	SENT_37	[p1l1864t1791r1966b1815],
15	Health	NNP	ORGANIZATION	Health	nn	23	SENT_37	[p1l1984t1791r2063b1815],
16	Service	NNP	ORGANIZATION	Service	nn	23	SENT_37	[p1l1529t1831r1617b1853],
17	Foundation	NNP	ORGANIZATION	Foundation	nn	23	SENT_37	[p1l1647t1829r1785b1853],
18	Trust	NNP	ORGANIZATION	Trust	nn	23	SENT_37	[p1l1813t1831r1882b1857],
19	,	,	O	,	_	0	SENT_37	[p1l1813t1831r1882b1857],
20	Manchester	NNP	LOCATION	Manchester	appos	23	SENT_37	[p1l1914t1829r2063b1857],
21	,	,	O	,	_	0	SENT_37	[p1l1914t1829r2063b1857],
22	United	NNP	LOCATION	United	appos	23	SENT_37	[p1l1530t1867r1610b1891],
23	Kingdom	NNP	LOCATION	Kingdom	dep	10	SENT_37	[p1l1629t1867r1738b1898],
24	(	CD	NUMBER	(	num	23	SENT_37	[p1l1758t1869r1825b1898],
25	F.B.	NNP	LOCATION	F.B.	dep	23	SENT_37	[p1l1758t1869r1825b1898],
26	)	CD	NUMBER	)	num	25	SENT_37	[p1l1758t1869r1825b1898],
27	;	:	O	;	_	0	SENT_37	[p1l1758t1869r1825b1898],
28	Guangdong	NNP	ORGANIZATION	Guangdong	nn	31	SENT_37	[p1l1842t1867r1988b1898],
29	Lung	NN	ORGANIZATION	lung	nn	31	SENT_37	[p1l2005t1869r2065b1898],
30	Cancer	NNP	ORGANIZATION	Cancer	nn	31	SENT_37	[p1l1529t1906r1615b1928],
31	Institute	NNP	ORGANIZATION	Institute	dep	10	SENT_37	[p1l1626t1906r1731b1932],
32	,	,	O	,	_	0	SENT_37	[p1l1626t1906r1731b1932],
33	Guangdong	NNP	ORGANIZATION	Guangdong	nn	41	SENT_37	[p1l1743t1904r1889b1935],
34	General	NNP	ORGANIZATION	General	nn	41	SENT_37	[p1l1899t1904r1994b1928],
35	Hospital	NNP	ORGANIZATION	Hospital	nn	41	SENT_37	[p1l2007t1906r2064b1928, p1l1530t1942r1587b1973],
36	,	,	O	,	_	0	SENT_37	[p1l2007t1906r2064b1928, p1l1530t1942r1587b1973],
37	Guangzhou	NNP	LOCATION	Guangzhou	appos	41	SENT_37	[p1l1611t1942r1761b1973],
38	,	,	O	,	_	0	SENT_37	[p1l1611t1942r1761b1973],
39	China	NNP	LOCATION	China	appos	41	SENT_37	[p1l1784t1942r1854b1965],
40	(	CD	NUMBER	(	num	41	SENT_37	[p1l1879t1944r1985b1973],
41	Y.-L.W.	NNP	O	Y.-L.W.	appos	31	SENT_37	[p1l1879t1944r1985b1973],
42	)	NN	O	)	dep	41	SENT_37	[p1l1879t1944r1985b1973],
43	;	:	O	;	_	0	SENT_37	[p1l1879t1944r1985b1973],
44	Thoraxklinik	NNP	O	Thoraxklinik	nn	47	SENT_37	[p1l2007t1942r2064b1965, p1l1530t1973r1629b1996],
45	im	NNP	O	im	nn	47	SENT_37	[p1l1650t1975r1679b1996],
46	Universitatsklinikum	NNP	ORGANIZATION	Universitatsklinikum	nn	47	SENT_37	[p1l1702t1973r1953b1997],
47	Heidelberg	NNP	ORGANIZATION	Heidelberg	dep	10	SENT_37	[p1l1977t1973r2064b1997, p1l1530t2010r1589b2041],
48	,	,	O	,	_	0	SENT_37	[p1l1977t1973r2064b1997, p1l1530t2010r1589b2041],
49	and	CC	O	and	_	0	SENT_37	[p1l1615t2010r1659b2034],
50	Translational	JJ	ORGANIZATION	translational	amod	56	SENT_37	[p1l1684t2010r1841b2034],
51	Lung	NN	ORGANIZATION	lung	nn	56	SENT_37	[p1l1869t2013r1929b2042],
52	Research	NNP	ORGANIZATION	Research	nn	56	SENT_37	[p1l1955t2010r2063b2034],
53	Center	NNP	ORGANIZATION	Center	nn	56	SENT_37	[p1l1529t2050r1610b2072],
54	Heidelberg	NNP	ORGANIZATION	Heidelberg	nn	56	SENT_37	[p1l1631t2048r1766b2079],
55	(	NNP	O	(	nn	56	SENT_37	[p1l1788t2048r1903b2079],
56	Member	NNP	O	Member	dep	10	SENT_37	[p1l1788t2048r1903b2079],
57	of	IN	O	of	_	0	SENT_37	[p1l1921t2048r1948b2072],
58	German	NNP	O	German	nn	59	SENT_37	[p1l1964t2050r2063b2071],
59	Center	NNP	O	Center	prep_of	56	SENT_37	[p1l1529t2087r1610b2109],
60	for	IN	O	for	_	0	SENT_37	[p1l1616t2085r1651b2109],
61	Lung	NN	ORGANIZATION	lung	nn	63	SENT_37	[p1l1660t2088r1720b2116],
62	Research	NN	ORGANIZATION	research	nn	63	SENT_37	[p1l1729t2085r1852b2116],
63	)	NN	O	)	prep_for	59	SENT_37	[p1l1729t2085r1852b2116],
64	,	,	O	,	_	0	SENT_37	[p1l1729t2085r1852b2116],
65	Heidelberg	NNP	LOCATION	Heidelberg	nn	70	SENT_37	[p1l1863t2085r2004b2116],
66	,	,	O	,	_	0	SENT_37	[p1l1863t2085r2004b2116],
67	Germany	NNP	LOCATION	Germany	appos	70	SENT_37	[p1l2013t2087r2064b2109, p1l1530t2131r1596b2154],
68	(	NNP	O	(	nn	70	SENT_37	[p1l1610t2125r1685b2154],
69	M.T.	NNP	LOCATION	M.T.	nn	70	SENT_37	[p1l1610t2125r1685b2154],
70	)	NNP	O	)	appos	63	SENT_37	[p1l1610t2125r1685b2154],
71	;	:	O	;	_	0	SENT_37	[p1l1610t2125r1685b2154],
72	ICORG	NNP	LOCATION	ICORG	dep	10	SENT_37	[p1l1699t2125r1790b2151],
73	,	,	O	,	_	0	SENT_37	[p1l1699t2125r1790b2151],
74	the	DT	O	the	det	80	SENT_37	[p1l1802t2123r1841b2147],
75	All	NNP	ORGANIZATION	All	nn	80	SENT_37	[p1l1851t2123r1881b2146],
76	Ireland	NNP	ORGANIZATION	Ireland	nn	80	SENT_37	[p1l1896t2123r1977b2146],
77	Cooperative	NNP	ORGANIZATION	Cooperative	nn	80	SENT_37	[p1l1990t2125r2064b2154, p1l1529t2163r1609b2184],
78	Oncology	NNP	ORGANIZATION	Oncology	nn	80	SENT_37	[p1l1624t2160r1743b2192],
79	Research	NNP	ORGANIZATION	Research	nn	80	SENT_37	[p1l1759t2160r1867b2184],
80	Group	NNP	ORGANIZATION	Group	appos	72	SENT_37	[p1l1883t2162r1966b2191],
81	,	,	O	,	_	0	SENT_37	[p1l1883t2162r1966b2191],
82	Dublin	NNP	LOCATION	Dublin	appos	72	SENT_37	[p1l1984t2160r2063b2184],
83	(	CD	NUMBER	(	num	85	SENT_37	[p1l1532t2200r1631b2229],
84	K.J.O.	NNP	O	K.J.O.	nn	85	SENT_37	[p1l1532t2200r1631b2229],
85	)	NN	O	)	dep	82	SENT_37	[p1l1532t2200r1631b2229],
86	;	:	O	;	_	0	SENT_37	[p1l1532t2200r1631b2229],
87	University	NNP	ORGANIZATION	University	dep	10	SENT_37	[p1l1649t2200r1779b2229],
88	of	IN	ORGANIZATION	of	_	0	SENT_37	[p1l1795t2198r1823b2221],
89	Colorado	NNP	ORGANIZATION	Colorado	nn	91	SENT_37	[p1l1834t2198r1960b2226],
90	,	,	O	,	_	0	SENT_37	[p1l1834t2198r1960b2226],
91	Aurora	NNP	LOCATION	Aurora	prep_of	87	SENT_37	[p1l1976t2199r2064b2222],

1	(	NN	O	(	nn	3	SENT_38	[p1l1532t2306r1632b2335],
2	D.R.C.	NN	O	d.r.c.	nn	3	SENT_38	[p1l1532t2306r1632b2335],
3	)	NN	O	)	_	0	SENT_38	[p1l1532t2306r1632b2335],
4	;	:	O	;	_	0	SENT_38	[p1l1532t2306r1632b2335],
5	Chinese	NNP	ORGANIZATION	Chinese	nn	6	SENT_38	[p1l1643t2304r1740b2328],
6	University	NNP	ORGANIZATION	University	dep	3	SENT_38	[p1l1752t2307r1874b2335],
7	of	IN	ORGANIZATION	of	_	0	SENT_38	[p1l1883t2304r1910b2328],
8	Hong	NNP	ORGANIZATION	Hong	nn	9	SENT_38	[p1l1917t2307r1985b2336],
9	Kong	NNP	ORGANIZATION	Kong	prep_of	6	SENT_38	[p1l1996t2306r2063b2335],
10	,	,	O	,	_	0	SENT_38	[p1l1996t2306r2063b2335],
11	Shatin	NNP	LOCATION	Shatin	nn	16	SENT_38	[p1l1529t2342r1612b2370],
12	,	,	O	,	_	0	SENT_38	[p1l1529t2342r1612b2370],
13	China	NNP	LOCATION	China	appos	16	SENT_38	[p1l1637t2342r1707b2365],
14	(	NNP	O	(	nn	16	SENT_38	[p1l1734t2344r1812b2373],
15	T.M.	NNP	LOCATION	T.M.	nn	16	SENT_38	[p1l1734t2344r1812b2373],
16	)	NNP	O	)	appos	9	SENT_38	[p1l1734t2344r1812b2373],
17	;	:	O	;	_	0	SENT_38	[p1l1734t2344r1812b2373],
18	McGill	NNP	ORGANIZATION	McGill	nn	21	SENT_38	[p1l1839t2342r1916b2366],
19	University	NNP	ORGANIZATION	University	nn	21	SENT_38	[p1l1943t2344r2065b2373],
20	Health	NNP	ORGANIZATION	Health	nn	21	SENT_38	[p1l1531t2379r1610b2403],
21	Centre	NNP	ORGANIZATION	Centre	dep	6	SENT_38	[p1l1625t2381r1711b2407],
22	,	,	O	,	_	0	SENT_38	[p1l1625t2381r1711b2407],
23	Montreal	NNP	LOCATION	Montreal	nn	26	SENT_38	[p1l1728t2379r1836b2403],
24	(	NNP	O	(	nn	26	SENT_38	[p1l1854t2381r1930b2410],
25	V.H.	NNP	ORGANIZATION	V.H.	nn	26	SENT_38	[p1l1854t2381r1930b2410],
26	)	NNP	O	)	appos	21	SENT_38	[p1l1854t2381r1930b2410],
27	;	:	O	;	_	0	SENT_38	[p1l1854t2381r1930b2410],
28	Memorial	NNP	O	Memorial	nn	31	SENT_38	[p1l1946t2379r2063b2403],
29	Sloan-Kettering	NNP	O	Sloan-Kettering	nn	31	SENT_38	[p1l1529t2417r1720b2448],
30	Cancer	NNP	O	Cancer	nn	31	SENT_38	[p1l1731t2419r1816b2441],
31	Center	NNP	O	Center	dep	6	SENT_38	[p1l1827t2419r1908b2441],
32	(	NNP	O	(	nn	36	SENT_38	[p1l1921t2419r2005b2448],
33	G.	NNP	O	G.	nn	36	SENT_38	[p1l1921t2419r2005b2448],
34	_	NNP	O	_	nn	36	SENT_38	[p1l1921t2419r2005b2448],
35	l.R.	NNP	O	l.R.	nn	36	SENT_38	[p1l1921t2419r2005b2448],
36	)	NNP	O	)	tmod	31	SENT_38	[p1l1921t2419r2005b2448],
37	and	CC	O	and	advmod	36	SENT_38	[p1l2019t2417r2063b2441],

1	Pfizer	NNP	ORGANIZATION	Pfizer	nn	5	SENT_39	[p1l1531t2523r1600b2547],
2	Oncology	NNP	ORGANIZATION	Oncology	nn	5	SENT_39	[p1l1608t2523r1727b2555],
3	(	NNP	O	(	nn	5	SENT_39	[p1l1737t2525r1798b2554],
4	S.	NNP	O	S.	nn	5	SENT_39	[p1l1737t2525r1798b2554],
5	|	NNP	O	|	_	0	SENT_39	[p1l1737t2525r1798b2554],
6	.	.	O	.	_	0	SENT_39	[p1l1737t2525r1798b2554],
7	)	NN	O	)	dep	5	SENT_39	[p1l1737t2525r1798b2554],

1	,	,	O	,	_	0	SENT_40	[p1l1737t2525r1798b2554],
2	New	NNP	LOCATION	New	nn	3	SENT_40	[p1l1809t2526r1864b2547],
3	York	NNP	LOCATION	York	_	0	SENT_40	[p1l1871t2523r1931b2551],
4	;	:	O	;	_	0	SENT_40	[p1l1871t2523r1931b2551],
5	and	CC	O	and	dep	7	SENT_40	[p1l1941t2523r1984b2547],
6	Pfizer	NNP	ORGANIZATION	Pfizer	nn	7	SENT_40	[p1l1996t2523r2065b2547],
7	Oncology	NNP	ORGANIZATION	Oncology	dep	3	SENT_40	[p1l1529t2561r1653b2592],
8	,	,	O	,	_	0	SENT_40	[p1l1529t2561r1653b2592],
9	La	NNP	PERSON	La	nn	10	SENT_40	[p1l1671t2563r1696b2585],
10	Jolla	NNP	PERSON	Jolla	appos	7	SENT_40	[p1l1707t2561r1769b2591],
11	,	,	O	,	_	0	SENT_40	[p1l1707t2561r1769b2591],
12	CA	NNP	LOCATION	CA	nn	14	SENT_40	[p1l1785t2563r1821b2585],
13	(	NNP	O	(	nn	14	SENT_40	[p1l1838t2563r1894b2592],
14	V.T.	NNP	O	V.T.	appos	7	SENT_40	[p1l1838t2563r1894b2592],
15	,	,	O	,	_	0	SENT_40	[p1l1838t2563r1894b2592],
16	K.D.W.	NNP	O	K.D.W.	appos	7	SENT_40	[p1l1912t2563r2007b2592],
17	)	CD	NUMBER	)	num	16	SENT_40	[p1l1912t2563r2007b2592],
18	.	.	O	.	_	0	SENT_40	[p1l1912t2563r2007b2592],

1	Address	NN	O	address	nsubj	2	SENT_41	[p1l2022t2561r2064b2585, p1l1529t2599r1593b2622],
2	reprint	VB	O	reprint	_	0	SENT_41	[p1l1606t2601r1687b2630],
3	requests	NNS	O	request	dobj	2	SENT_41	[p1l1699t2603r1802b2630],
4	to	TO	O	to	_	0	SENT_41	[p1l1813t2603r1837b2622],
5	Dr.	NNP	O	Dr.	nn	6	SENT_41	[p1l1850t2601r1883b2622],
6	Shaw	NNP	PERSON	Shaw	prep_to	2	SENT_41	[p1l1895t2599r1961b2622],
7	at	IN	O	at	_	0	SENT_41	[p1l1971t2603r1993b2622],
8	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	12	SENT_41	[p1l2005t2601r2064b2622, p1l1530t2636r1660b2660],
9	General	NNP	ORGANIZATION	General	nn	12	SENT_41	[p1l1669t2636r1763b2660],
10	Hospital	NNP	ORGANIZATION	Hospital	nn	12	SENT_41	[p1l1775t2636r1876b2667],
11	Cancer	NNP	ORGANIZATION	Cancer	nn	12	SENT_41	[p1l1885t2638r1971b2660],
12	Center	NNP	ORGANIZATION	Center	prep_at	6	SENT_41	[p1l1978t2638r2063b2664],
13	,	,	O	,	_	0	SENT_41	[p1l1978t2638r2063b2664],
14	Yawkey	NNP	O	Yawkey	nn	15	SENT_41	[p1l1528t2674r1617b2705],
15	7B	NN	O	7b	prep_at	6	SENT_41	[p1l1628t2676r1664b2702],
16	,	,	O	,	_	0	SENT_41	[p1l1628t2676r1664b2702],
17	32	CD	NUMBER	32	num	19	SENT_41	[p1l1676t2676r1703b2697],
18	Fruit	NNP	O	Fruit	nn	19	SENT_41	[p1l1715t2676r1770b2698],
19	St.	NNP	O	St.	prep_at	6	SENT_41	[p1l1780t2676r1816b2702],
20	,	,	O	,	_	0	SENT_41	[p1l1780t2676r1816b2702],
21	Boston	NNP	LOCATION	Boston	prep_at	6	SENT_41	[p1l1830t2676r1921b2702],
22	,	,	O	,	_	0	SENT_41	[p1l1830t2676r1921b2702],
23	MA	NNP	LOCATION	MA	prep_at	6	SENT_41	[p1l1935t2675r1977b2697],
24	02114	CD	DATE	02114	num	23	SENT_41	[p1l1986t2675r2063b2702],
25	,	,	O	,	_	0	SENT_41	[p1l1986t2675r2063b2702],
26	or	CC	O	or	_	0	SENT_41	[p1l1529t2720r1554b2735],
27	at	IN	O	at	advmod	12	SENT_41	[p1l1561t2716r1583b2735],
28	ashaw1@partners.org	NN	O	ashaw1@partners.org	prep_at	6	SENT_41	[p1l1590t2711r1868b2743],
29	.	.	O	.	_	0	SENT_41	[p1l1590t2711r1868b2743],

1	Drs.	NNP	O	Drs.	nn	2	SENT_42	[p1l1531t2764r1582b2785],
2	Shaw	NNP	PERSON	Shaw	nsubj	5	SENT_42	[p1l1592t2762r1660b2786],
3	and	CC	O	and	_	0	SENT_42	[p1l1667t2762r1713b2785],
4	Kim	NNP	PERSON	Kim	nsubj	5	SENT_42	[p1l1725t2764r1772b2785],
5	contributed	VBD	O	contribute	_	0	SENT_42	[p1l1781t2762r1932b2786],
6	equally	RB	O	equally	advmod	5	SENT_42	[p1l1941t2762r2032b2793],
7	to	TO	O	to	_	0	SENT_42	[p1l2039t2766r2064b2785],
8	this	DT	O	this	det	9	SENT_42	[p1l1528t2799r1575b2823],
9	article	NN	O	article	prep_to	5	SENT_42	[p1l1585t2799r1672b2823],
10	.	.	O	.	_	0	SENT_42	[p1l1585t2799r1672b2823],

1	This	DT	O	this	det	2	SENT_43	[p1l1528t2849r1582b2873],
2	article	NN	O	article	nsubjpass	4	SENT_43	[p1l1602t2849r1682b2873],
3	was	VBD	O	be	auxpass	4	SENT_43	[p1l1700t2857r1749b2873],
4	published	VBN	O	publish	_	0	SENT_43	[p1l1770t2849r1896b2880],
5	on	IN	O	on	_	0	SENT_43	[p1l1916t2857r1947b2873],
6	June	NNP	DATE	June	prep_on	4	SENT_43	[p1l1963t2851r2024b2879],
7	1	CD	DATE	1	num	6	SENT_43	[p1l2045t2851r2063b2877],
8	,	,	DATE	,	_	0	SENT_43	[p1l2045t2851r2063b2877],
9	2013	CD	DATE	2013	num	6	SENT_43	[p1l1529t2888r1596b2914],
10	,	,	O	,	_	0	SENT_43	[p1l1529t2888r1596b2914],
11	at	IN	O	at	_	0	SENT_43	[p1l1607t2891r1629b2910],
12	NEJM.org	NN	O	nejm.org	prep_at	4	SENT_43	[p1l1640t2889r1772b2917],
13	.	.	O	.	_	0	SENT_43	[p1l1640t2889r1772b2917],

1	N	NN	MISC	n	nn	3	SENT_44	[p1l1530t2940r1547b2960],
2	Englj	NNP	MISC	Englj	nn	3	SENT_44	[p1l1558t2938r1620b2967],
3	Med	NNP	O	Med	_	0	SENT_44	[p1l1631t2938r1681b2960],
4	2013	CD	DATE	2013	num	3	SENT_44	[p1l1689t2939r1902b2964],
5	;	:	O	;	_	0	SENT_44	[p1l1689t2939r1902b2964],
6	368:2385	CD	NUMBER	368:2385	number	7	SENT_44	[p1l1689t2939r1902b2964],
7	-94	CD	NUMBER	-94	dep	3	SENT_44	[p1l1689t2939r1902b2964],
8	.	.	O	.	_	0	SENT_44	[p1l1689t2939r1902b2964],

1	DOI	NNP	O	DOI	_	0	SENT_45	[p1l1530t2977r1585b2997],
2	:	:	O	:	_	0	SENT_45	[p1l1530t2977r1585b2997],
3	10.1056	CD	NUMBER	10.1056	dep	1	SENT_45	[p1l1594t2977r1713b3004],
4	/	:	O	/	punct	6	SENT_45	[p1l1594t2977r1713b3004],
5	N	NN	O	n	nn	6	SENT_45	[p1l1594t2977r1713b3004],
6	E	NN	O	e	dep	3	SENT_45	[p1l1718t2977r1891b3004],
7	]	CD	NUMBER	]	num	8	SENT_45	[p1l1718t2977r1891b3004],
8	Moa1214886	NN	O	moa1214886	dep	6	SENT_45	[p1l1718t2977r1891b3004],
9	Copyright	NN	O	copyright	nn	14	SENT_45	[p1l1529t3016r1623b3041],
10	©	CD	NUMBER	©	num	14	SENT_45	[p1l1632t3018r1653b3039],
11	2013	CD	DATE	2013	num	14	SENT_45	[p1l1663t3017r1711b3035],
12	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	14	SENT_45	[p1l1721t3016r1861b3035],
13	Medical	NNP	ORGANIZATION	Medical	nn	14	SENT_45	[p1l1870t3016r1947b3035],
14	Society	NNP	ORGANIZATION	Society	dep	3	SENT_45	[p1l1955t3017r2027b3041],
15	.	.	O	.	_	0	SENT_45	[p1l1955t3017r2027b3041],

1	2385	CD	DATE	2385	_	0	SENT_46	[p1l1987t3064r2063b3087],

1	The	DT	O	the	det	4	SENT_47	[p1l673t3319r719b3340],
2	NEW	NNP	O	NEW	nn	4	SENT_47	[p1l737t3321r822b3340],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_47	[p1l841t3321r1030b3340],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_47	[p1l1049t3321r1228b3347],
5	of	IN	O	of	_	0	SENT_47	[p1l1248t3319r1276b3346],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_47	[p1l1288t3321r1487b3340],

1	NAPLASTIC	NNP	O	NAPLASTIC	nn	3	SENT_48	[p2l336t119r837b176],
2	LYMPHOMA	NNP	O	LYMPHOMA	nn	3	SENT_48	[p2l866t119r1391b176],
3	KINASE	NNP	O	KINASE	nsubj	11	SENT_48	[p2l1417t120r1756b178],
4	(	CD	NUMBER	(	num	5	SENT_48	[p2l1787t104r2021b189],
5	ALK	NNP	O	ALK	dep	3	SENT_48	[p2l1787t104r2021b189],
6	)	CD	NUMBER	)	num	5	SENT_48	[p2l1787t104r2021b189],
7	IS	VBZ	O	be	cop	11	SENT_48	[p2l2055t120r2132b176],
8	avalidated	JJ	O	avalidated	amod	11	SENT_48	[p2l332t226r771b305],
9	tyrosine	NN	O	tyrosine	nn	11	SENT_48	[p2l799t228r1137b327],
10	kinase	NN	O	kinase	nn	11	SENT_48	[p2l1164t227r1438b306],
11	target	NN	O	target	dep	40	SENT_48	[p2l1466t243r1716b327],
12	in	IN	O	in	_	0	SENT_48	[p2l1738t228r1821b304],
13	several	JJ	O	several	amod	14	SENT_48	[p2l1850t227r2134b305],
14	cancers	NNS	O	cancer	prep_in	11	SENT_48	[p2l333t381r678b451],
15	,	,	O	,	_	0	SENT_48	[p2l333t381r678b451],
16	including	VBG	O	include	_	0	SENT_48	[p2l754t355r1164b456],
17	non	JJ	O	non	amod	23	SENT_48	[p2l1232t355r1875b434],
18	—	JJ	O	—	amod	23	SENT_48	[p2l1232t355r1875b434],
19	small	JJ	O	small	amod	23	SENT_48	[p2l1232t355r1875b434],
20	—	NN	O	—	nn	23	SENT_48	[p2l1232t355r1875b434],
21	cell	NN	O	cell	nn	23	SENT_48	[p2l1232t355r1875b434],
22	lung	NN	O	lung	nn	23	SENT_48	[p2l1944t355r2138b456],
23	cancer	NN	O	cancer	prep_including	11	SENT_48	[p2l12t510r311b580],
24	,	,	O	,	_	0	SENT_48	[p2l12t510r311b580],
25	anaplastic	JJ	O	anaplastic	amod	23	SENT_48	[p2l358t484r794b585],
26	large	JJ	O	large	amod	29	SENT_48	[p2l833t484r1234b585],
27	—	NN	O	—	nn	29	SENT_48	[p2l833t484r1234b585],
28	cell	NN	O	cell	nn	29	SENT_48	[p2l833t484r1234b585],
29	lymphoma	NN	O	lymphoma	tmod	25	SENT_48	[p2l1274t484r1756b585],
30	,	,	O	,	_	0	SENT_48	[p2l1274t484r1756b585],
31	and	CC	O	and	_	0	SENT_48	[p2l1802t484r1960b563],
32	pediatric	JJ	O	pediatric	amod	34	SENT_48	[p2l2000t510r2133b585, p2l12t612r289b691],
33	neuroblastoma	NN	O	neuroblastoma	nn	34	SENT_48	[p2l367t612r1133b691],
34	.1	NN	NUMBER	.1	tmod	25	SENT_48	[p2l367t612r1133b691],
35	'	''	O	'	_	0	SENT_48	[p2l367t612r1133b691],
36	3	CD	NUMBER	3	num	38	SENT_48	[p2l367t612r1133b691],
37	ALK	NN	O	alk	nn	38	SENT_48	[p2l1207t618r1381b690],
38	rearrangements	NNS	O	rearrangement	nsubj	54	SENT_48	[p2l1451t629r2132b713],
39	are	VBP	O	be	auxpass	40	SENT_48	[p2l11t767r140b819],
40	found	VBN	O	find	_	0	SENT_48	[p2l179t740r431b819],
41	in	IN	O	in	_	0	SENT_48	[p2l469t741r553b818],
42	approximately	RB	O	approximately	quantmod	43	SENT_48	[p2l591t740r1207b841],
43	5	CD	PERCENT	5	num	44	SENT_48	[p2l1243t745r1374b819],
44	%	NN	PERCENT	%	prep_in	40	SENT_48	[p2l1243t745r1374b819],
45	of	IN	O	of	_	0	SENT_48	[p2l1413t740r1513b819],
46	cases	NNS	O	case	prep_of	44	SENT_48	[p2l1534t767r1756b819],
47	of	IN	O	of	_	0	SENT_48	[p2l1798t740r1898b819],
48	nonsmall	JJ	O	nonsmall	amod	52	SENT_48	[p2l1918t766r2137b819, p2l13t868r432b947],
49	—	NN	O	—	nn	52	SENT_48	[p2l1918t766r2137b819, p2l13t868r432b947],
50	cell	NN	O	cell	nn	52	SENT_48	[p2l1918t766r2137b819, p2l13t868r432b947],
51	lung	NN	O	lung	nn	52	SENT_48	[p2l469t868r662b969],
52	cancer	NN	O	cancer	prep_of	46	SENT_48	[p2l698t894r978b947],
53	and	CC	O	and	_	0	SENT_48	[p2l1013t868r1171b947],
54	define	VB	O	define	conj_and	40	SENT_48	[p2l1210t868r1480b947],
55	a	DT	O	a	det	58	SENT_48	[p2l1518t895r1563b947],
56	distinct	JJ	O	distinct	amod	58	SENT_48	[p2l1600t868r1929b947],
57	molecular	JJ	O	molecular	amod	58	SENT_48	[p2l1962t894r2133b947, p2l11t996r305b1075],
58	subtype	NN	O	subtype	dobj	54	SENT_48	[p2l350t996r683b1097],
59	of	IN	O	of	_	0	SENT_48	[p2l732t996r831b1075],
60	lung	NN	O	lung	nn	61	SENT_48	[p2l860t996r1053b1097],
61	cancer	NN	O	cancer	prep_of	58	SENT_48	[p2l1098t1002r1498b1075],
62	.	.	O	.	_	0	SENT_48	[p2l1098t1002r1498b1075],

1	“	NN	O	“	npadvmod	22	SENT_49	[p2l1098t1002r1498b1075],
2	With	IN	O	with	_	0	SENT_49	[p2l1542t996r1755b1075],
3	an	DT	O	a	det	16	SENT_49	[p2l1802t1022r1905b1075],
4	estimated	VBN	O	estimate	amod	16	SENT_49	[p2l1953t997r2133b1075, p2l12t1124r278b1203],
5	1.3	CD	NUMBER	1.3	number	6	SENT_49	[p2l330t1130r450b1203],
6	million	CD	NUMBER	million	num	8	SENT_49	[p2l502t1124r817b1203],
7	new	JJ	O	new	amod	8	SENT_49	[p2l865t1150r1043b1204],
8	cases	NNS	O	case	dep	4	SENT_49	[p2l1088t1151r1310b1203],
9	of	IN	O	of	_	0	SENT_49	[p2l1362t1124r1462b1203],
10	non	JJ	O	non	amod	13	SENT_49	[p2l1492t1124r2134b1203],
11	—	JJ	O	—	amod	13	SENT_49	[p2l1492t1124r2134b1203],
12	small	JJ	O	small	amod	13	SENT_49	[p2l1492t1124r2134b1203],
13	—	NN	O	—	prep_of	8	SENT_49	[p2l1492t1124r2134b1203],
14	cell	NN	O	cell	nn	16	SENT_49	[p2l1492t1124r2134b1203],
15	lung	NN	O	lung	nn	16	SENT_49	[p2l11t1252r204b1353],
16	cancer	NN	O	cancer	prep_with	22	SENT_49	[p2l235t1278r515b1331],
17	worldwide	JJ	O	worldwide	amod	16	SENT_49	[p2l541t1252r991b1332],
18	each	DT	SET	each	det	19	SENT_49	[p2l1025t1252r1217b1331],
19	year	NN	SET	year	tmod	17	SENT_49	[p2l1245t1258r1485b1353],
20	,8	CD	NUMBER	,8	nsubj	22	SENT_49	[p2l1245t1258r1485b1353],
21	this	DT	O	this	dep	20	SENT_49	[p2l1519t1252r1679b1331],
22	translates	VBZ	O	translate	_	0	SENT_49	[p2l1715t1252r2132b1331],
23	into	IN	O	into	_	0	SENT_49	[p2l11t1381r180b1459],
24	more	JJR	O	more	mwe	25	SENT_49	[p2l214t1406r433b1459],
25	than	IN	O	than	quantmod	26	SENT_49	[p2l466t1380r663b1459],
26	60,000	CD	NUMBER	60,000	num	27	SENT_49	[p2l696t1386r982b1476],
27	patients	NNS	O	patient	prep_into	22	SENT_49	[p2l1014t1381r1355b1481],
28	with	IN	O	with	_	0	SENT_49	[p2l1386t1380r1581b1459],
29	ALK	NN	O	alk	npadvmod	31	SENT_49	[p2l1607t1381r2134b1481],
30	—	CD	NUMBER	—	num	29	SENT_49	[p2l1607t1381r2134b1481],
31	positive	JJ	O	positive	amod	33	SENT_49	[p2l1607t1381r2134b1481],
32	non	JJ	O	non	amod	33	SENT_49	[p2l12t1508r654b1587],
33	—	NN	O	—	prep_with	22	SENT_49	[p2l12t1508r654b1587],
34	small	JJ	O	small	amod	38	SENT_49	[p2l12t1508r654b1587],
35	—	NN	O	—	nn	38	SENT_49	[p2l12t1508r654b1587],
36	cell	NN	O	cell	nn	38	SENT_49	[p2l12t1508r654b1587],
37	lung	NN	O	lung	nn	38	SENT_49	[p2l687t1508r880b1609],
38	cancer	NN	O	cancer	tmod	33	SENT_49	[p2l912t1534r1193b1587],
39	annually	RB	SET	annually	advmod	38	SENT_49	[p2l1224t1508r1611b1609],
40	.	.	O	.	_	0	SENT_49	[p2l1224t1508r1611b1609],

1	Crizotinib	NNP	O	Crizotinib	nsubj	10	SENT_50	[p2l141t1636r580b1715],
2	is	VBZ	O	be	cop	10	SENT_50	[p2l623t1637r688b1715],
3	an	DT	O	a	det	10	SENT_50	[p2l733t1662r836b1715],
4	oral	JJ	O	oral	amod	10	SENT_50	[p2l880t1636r1045b1715],
5	small	JJ	O	small	amod	10	SENT_50	[p2l1089t1636r1744b1715],
6	—	NN	O	—	nn	10	SENT_50	[p2l1089t1636r1744b1715],
7	molecule	NN	O	molecule	nn	10	SENT_50	[p2l1089t1636r1744b1715],
8	tyrosine	NN	O	tyrosine	nn	10	SENT_50	[p2l1788t1637r2134b1737],
9	kinase	NN	O	kinase	nn	10	SENT_50	[p2l12t1764r290b1844],
10	inhibitor	NN	O	inhibitor	_	0	SENT_50	[p2l330t1764r712b1843],
11	targeting	VBG	O	target	partmod	10	SENT_50	[p2l750t1765r1149b1865],
12	ALK	NNP	O	ALK	dobj	11	SENT_50	[p2l1182t1772r1393b1860],
13	,	,	O	,	_	0	SENT_50	[p2l1182t1772r1393b1860],
14	MET	NN	O	met	conj_and	12	SENT_50	[p2l1436t1770r1658b1860],
15	,	,	O	,	_	0	SENT_50	[p2l1436t1770r1658b1860],
16	and	CC	O	and	_	0	SENT_50	[p2l1703t1764r1861b1843],
17	R081	NN	O	r081	conj_and	12	SENT_50	[p2l1900t1770r2133b1848],
18	tyrosine	NN	O	tyrosine	nn	19	SENT_50	[p2l12t1893r350b1993],
19	l	NN	O	l	tmod	11	SENT_50	[p2l383t1892r903b1972],
20	9	CD	NUMBER	9	num	21	SENT_50	[p2l383t1892r903b1972],
21	’	NN	O	’	nsubj	32	SENT_50	[p2l383t1892r903b1972],
22	1	CD	NUMBER	1	number	23	SENT_50	[p2l383t1892r903b1972],
23	°	CD	NUMBER	°	num	21	SENT_50	[p2l383t1892r903b1972],
24	In	IN	O	in	_	0	SENT_50	[p2l934t1900r1022b1970],
25	two	CD	NUMBER	two	num	29	SENT_50	[p2l1055t1909r1210b1972],
26	single	JJ	O	single	amod	29	SENT_50	[p2l1245t1892r1777b1993],
27	—	NN	O	—	nn	29	SENT_50	[p2l1245t1892r1777b1993],
28	group	NN	O	group	nn	29	SENT_50	[p2l1245t1892r1777b1993],
29	studies	NNS	O	study	prep_in	21	SENT_50	[p2l1812t1892r2129b1988],
30	,	,	O	,	_	0	SENT_50	[p2l1812t1892r2129b1988],
31	crizotinib	NN	O	crizotinib	appos	29	SENT_50	[p2l12t2020r432b2099],
32	showed	VBD	O	show	dep	11	SENT_50	[p2l480t2020r803b2099],
33	marked	JJ	O	marked	amod	35	SENT_50	[p2l849t2020r1176b2100],
34	antitumor	NN	O	antitumor	nn	35	SENT_50	[p2l1221t2021r1658b2099],
35	activity	NN	O	activity	dobj	32	SENT_50	[p2l1700t2021r2010b2121],
36	in	IN	O	in	_	0	SENT_50	[p2l2051t2021r2134b2098],
37	patients	NNS	O	patient	prep_in	32	SENT_50	[p2l11t2149r352b2249],
38	with	IN	O	with	_	0	SENT_50	[p2l395t2148r590b2227],
39	advanced	JJ	O	advanced	amod	52	SENT_50	[p2l636t2148r1032b2228],
40	ALK	NNP	O	ALK	nn	52	SENT_50	[p2l1071t2149r1598b2249],
41	—	CD	NUMBER	—	num	52	SENT_50	[p2l1071t2149r1598b2249],
42	positive	JJ	O	positive	amod	52	SENT_50	[p2l1071t2149r1598b2249],
43	non	JJ	O	non	amod	47	SENT_50	[p2l1644t2148r2133b2227, p2l12t2276r158b2355],
44	—	NN	O	—	nn	47	SENT_50	[p2l1644t2148r2133b2227, p2l12t2276r158b2355],
45	smallcell	NN	O	smallcell	nn	47	SENT_50	[p2l1644t2148r2133b2227, p2l12t2276r158b2355],
46	lung	NN	O	lung	nn	47	SENT_50	[p2l193t2276r385b2377],
47	cancer	NN	O	cancer	tmod	42	SENT_50	[p2l419t2302r718b2372],
48	,	,	O	,	_	0	SENT_50	[p2l419t2302r718b2372],
49	with	IN	O	with	_	0	SENT_50	[p2l754t2276r949b2355],
50	objective	JJ	O	objective	amod	51	SENT_50	[p2l986t2276r1359b2377],
51	response	NN	O	response	prep_with	47	SENT_50	[p2l1395t2302r1775b2377],
52	rates	NNS	O	rate	prep_with	32	SENT_50	[p2l1811t2293r2014b2355],
53	of	IN	O	of	_	0	SENT_50	[p2l2052t2276r2152b2355],
54	approximately	RB	O	approximately	quantmod	55	SENT_50	[p2l11t2404r602b2505],
55	60	CD	PERCENT	60	num	56	SENT_50	[p2l632t2409r816b2483],
56	%	NN	PERCENT	%	prep_of	52	SENT_50	[p2l632t2409r816b2483],
57	and	CC	O	and	_	0	SENT_50	[p2l849t2404r1002b2483],
58	a	DT	O	a	det	63	SENT_50	[p2l1035t2431r1080b2483],
59	median	JJ	O	median	amod	63	SENT_50	[p2l1112t2404r1425b2483],
60	progression	NN	O	progression	nn	63	SENT_50	[p2l1458t2404r2134b2505],
61	—	CD	NUMBER	—	num	63	SENT_50	[p2l1458t2404r2134b2505],
62	free	JJ	O	free	amod	63	SENT_50	[p2l1458t2404r2134b2505],
63	survival	NN	O	survival	conj_and	56	SENT_50	[p2l13t2532r345b2611],
64	of	IN	O	of	_	0	SENT_50	[p2l383t2532r483b2611],
65	8.1	CD	DURATION	8.1	num	66	SENT_50	[p2l503t2538r628b2611],
66	months	NNS	NUMBER	month	prep_of	63	SENT_50	[p2l667t2532r994b2611],
67	in	IN	O	in	_	0	SENT_50	[p2l1033t2533r1116b2610],
68	one	CD	NUMBER	one	prep_in	66	SENT_50	[p2l1155t2558r1306b2611],
69	of	IN	O	of	_	0	SENT_50	[p2l1346t2532r1445b2611],
70	the	DT	O	the	det	71	SENT_50	[p2l1465t2532r1598b2611],
71	studies	NNS	O	study	prep_of	52	SENT_50	[p2l1637t2532r1937b2611],
72	and	CC	O	and	cc	71	SENT_50	[p2l1976t2532r2134b2611],

1	9.7	CD	DURATION	9.7	num	2	SENT_51	[p2l12t2665r131b2737],
2	months	NNS	DURATION	month	nsubjpass	33	SENT_51	[p2l164t2659r486b2737],
3	in	IN	O	in	_	0	SENT_51	[p2l520t2660r602b2736],
4	the	DT	O	the	det	30	SENT_51	[p2l635t2659r765b2737],
5	other	JJ	O	other	amod	30	SENT_51	[p2l799t2659r1207b2737],
6	.11	CD	NUMBER	.11	number	7	SENT_51	[p2l799t2659r1207b2737],
7	»	CD	NUMBER	»	amod	30	SENT_51	[p2l799t2659r1207b2737],
8	12	CD	NUMBER	12	dep	7	SENT_51	[p2l799t2659r1207b2737],
9	In	IN	O	in	dep	8	SENT_51	[p2l1239t2667r1326b2736],
10	contrast	NN	O	contrast	pobj	9	SENT_51	[p2l1359t2676r1724b2754],
11	,	,	O	,	_	0	SENT_51	[p2l1359t2676r1724b2754],
12	standard	JJ	O	standard	amod	16	SENT_51	[p2l1763t2659r2134b2737],
13	single	JJ	O	single	amod	16	SENT_51	[p2l13t2787r540b2888],
14	—	JJ	O	—	amod	16	SENT_51	[p2l13t2787r540b2888],
15	agent	NN	O	agent	nn	16	SENT_51	[p2l13t2787r540b2888],
16	chemotherapies	NNS	O	chemotherapy	appos	10	SENT_51	[p2l574t2787r1252b2888],
17	in	IN	O	in	_	0	SENT_51	[p2l1291t2788r1374b2865],
18	the	DT	O	the	det	20	SENT_51	[p2l1413t2787r1546b2866],
19	general	JJ	O	general	amod	20	SENT_51	[p2l1583t2787r1900b2888],
20	population	NN	O	population	prep_in	16	SENT_51	[p2l1936t2813r2133b2888, p2l12t2915r309b2994],
21	of	IN	O	of	_	0	SENT_51	[p2l348t2915r447b2994],
22	patients	NNS	O	patient	prep_of	20	SENT_51	[p2l465t2916r799b3016],
23	with	IN	O	with	_	0	SENT_51	[p2l835t2915r1027b2995],
24	non	JJ	O	non	amod	29	SENT_51	[p2l1065t2915r1693b2994],
25	—	JJ	O	—	amod	29	SENT_51	[p2l1065t2915r1693b2994],
26	small	JJ	O	small	amod	29	SENT_51	[p2l1065t2915r1693b2994],
27	—	NN	O	—	nn	29	SENT_51	[p2l1065t2915r1693b2994],
28	cell	NN	O	cell	nn	29	SENT_51	[p2l1065t2915r1693b2994],
29	lung	NN	O	lung	prep_with	22	SENT_51	[p2l1730t2915r1920b3016],
30	cancer	NN	O	cancer	prep_in	2	SENT_51	[p2l1956t2941r2133b2994, p2l12t3069r139b3122],
31	have	VBP	O	have	aux	33	SENT_51	[p2l180t3043r370b3122],
32	been	VBN	O	be	auxpass	33	SENT_51	[p2l413t3043r615b3122],
33	associated	VBN	O	associate	_	0	SENT_51	[p2l658t3043r1102b3122],
34	with	IN	O	with	_	0	SENT_51	[p2l1141t3043r1337b3122],
35	response	NN	O	response	nn	36	SENT_51	[p2l1380t3069r1760b3144],
36	rates	NNS	O	rate	prep_with	33	SENT_51	[p2l1804t3060r2006b3122],
37	of	IN	O	of	_	0	SENT_51	[p2l2053t3043r2152b3122],
38	10	CD	PERCENT	10	num	39	SENT_51	[p2l15t3176r192b3250],
39	%	NN	PERCENT	%	prep_of	36	SENT_51	[p2l15t3176r192b3250],
40	or	CC	O	or	_	0	SENT_51	[p2l221t3197r308b3250],
41	lower	JJR	O	lower	conj_or	39	SENT_51	[p2l333t3171r562b3251],
42	and	CC	O	and	_	0	SENT_51	[p2l588t3171r741b3250],
43	median	JJ	O	median	amod	44	SENT_51	[p2l771t3171r1083b3250],
44	progression	NN	O	progression	conj_and	36	SENT_51	[p2l1111t3171r1787b3272],
45	—	CD	NUMBER	—	num	47	SENT_51	[p2l1111t3171r1787b3272],
46	free	JJ	O	free	amod	47	SENT_51	[p2l1111t3171r1787b3272],
47	survival	NN	O	survival	dep	44	SENT_51	[p2l1818t3171r2134b3250],
48	of	IN	O	of	_	0	SENT_51	[p2l12t3300r110b3379],
49	2	CD	DURATION	2	number	51	SENT_51	[p2l132t3306r179b3378],
50	to	TO	DURATION	to	dep	51	SENT_51	[p2l220t3317r301b3379],
51	3	CD	DURATION	3	num	52	SENT_51	[p2l342t3306r386b3379],
52	months	NNS	NUMBER	month	prep_of	47	SENT_51	[p2l430t3300r955b3379],
53	.13	CD	NUMBER	.13	number	54	SENT_51	[p2l430t3300r955b3379],
54	'15	CD	NUMBER	'15	num	52	SENT_51	[p2l430t3300r955b3379],

1	To	TO	O	to	_	0	SENT_52	[p2l137t3434r242b3507],
2	date	NN	O	date	prep_to	12	SENT_52	[p2l279t3428r475b3524],
3	,	,	O	,	_	0	SENT_52	[p2l279t3428r475b3524],
4	the	DT	O	the	det	5	SENT_52	[p2l516t3428r647b3507],
5	activity	NN	O	activity	nsubjpass	12	SENT_52	[p2l682t3429r985b3529],
6	of	IN	O	of	_	0	SENT_52	[p2l1016t3428r1115b3507],
7	standard	JJ	O	standard	amod	8	SENT_52	[p2l1133t3428r1504b3507],
8	chemotherapy	NN	O	chemotherapy	prep_of	5	SENT_52	[p2l1540t3428r2139b3529],
9	has	VBZ	O	have	aux	12	SENT_52	[p2l12t3556r156b3635],
10	not	RB	O	not	neg	12	SENT_52	[p2l214t3573r357b3635],
11	been	VBN	O	be	auxpass	12	SENT_52	[p2l408t3556r609b3635],
12	established	VBN	O	establish	_	0	SENT_52	[p2l666t3556r1148b3635],
13	in	IN	O	in	_	0	SENT_52	[p2l1203t3557r1286b3634],
14	ALK	NNP	O	ALK	nn	21	SENT_52	[p2l1335t3557r1862b3657],
15	—	CD	NUMBER	—	npadvmod	16	SENT_52	[p2l1335t3557r1862b3657],
16	positive	JJ	O	positive	amod	21	SENT_52	[p2l1335t3557r1862b3657],
17	nonsmall	JJ	O	nonsmall	amod	21	SENT_52	[p2l1918t3582r2137b3635, p2l13t3684r421b3763],
18	—	NN	O	—	nn	21	SENT_52	[p2l1918t3582r2137b3635, p2l13t3684r421b3763],
19	cell	NN	O	cell	nn	21	SENT_52	[p2l1918t3582r2137b3635, p2l13t3684r421b3763],
20	lung	NN	O	lung	nn	21	SENT_52	[p2l458t3684r648b3785],
21	cancer	NN	O	cancer	prep_in	12	SENT_52	[p2l683t3710r975b3763],
22	.	.	O	.	_	0	SENT_52	[p2l683t3710r975b3763],

1	Retrospective	JJ	O	retrospective	amod	2	SENT_53	[p2l1017t3685r1585b3785],
2	studies	NNS	O	study	nsubj	3	SENT_53	[p2l1624t3684r1917b3763],
3	suggest	VBP	O	suggest	_	0	SENT_53	[p2l1959t3711r2133b3785, p3l12t37r185b121],

1	that	IN	O	that	dep	6	SENT_54	[p3l216t20r389b99],
2	ALK	NN	O	alk	nn	3	SENT_54	[p3l415t26r590b98],
3	rearrangements	NNS	O	rearrangement	nsubjpass	6	SENT_54	[p3l620t37r1301b121],
4	may	MD	O	may	aux	6	SENT_54	[p3l1342t46r1520b121],
5	be	VB	O	be	auxpass	6	SENT_54	[p3l1555t20r1652b99],
6	associated	VBN	O	associate	_	0	SENT_54	[p3l1689t20r2134b99],
7	with	IN	O	with	_	0	SENT_54	[p3l7t148r202b227],
8	enhanced	VBN	O	enhance	amod	9	SENT_54	[p3l259t148r673b227],
9	sensitivity	NN	O	sensitivity	prep_with	6	SENT_54	[p3l730t149r1163b249],
10	to	TO	O	to	_	0	SENT_54	[p3l1214t165r1296b227],
11	pemetreXed	JJ	O	pemetrexed	amod	12	SENT_54	[p3l1351t148r2134b249],
12	—	NN	O	—	prep_to	9	SENT_54	[p3l1351t148r2134b249],
13	based	VBN	O	base	partmod	12	SENT_54	[p3l1351t148r2134b249],
14	chemotherapy	NN	O	chemotherapy	dobj	13	SENT_54	[p3l12t276r636b377],
15	,	,	O	,	_	0	SENT_54	[p3l12t276r636b377],
16	with	IN	O	with	_	0	SENT_54	[p3l679t276r874b355],
17	durations	NNS	O	duration	prep_with	13	SENT_54	[p3l917t276r1325b355],
18	of	IN	O	of	_	0	SENT_54	[p3l1370t276r1470b355],
19	response	NN	O	response	prep_of	17	SENT_54	[p3l1493t302r1874b377],
20	similar	JJ	O	similar	amod	19	SENT_54	[p3l1918t277r2133b355, p3l11t404r127b483],
21	to	TO	O	to	_	0	SENT_54	[p3l163t421r245b483],
22	those	DT	O	those	prep_to	20	SENT_54	[p3l287t404r518b483],
23	observed	VBN	O	observe	partmod	22	SENT_54	[p3l558t404r939b483],
24	with	IN	O	with	_	0	SENT_54	[p3l974t404r1169b483],
25	crizotinib	NN	O	crizotinib	prep_with	23	SENT_54	[p3l1209t404r1821b483],
26	.15	CD	NUMBER	.15	number	27	SENT_54	[p3l1209t404r1821b483],
27	’17	CD	NUMBER	’17	num	25	SENT_54	[p3l1209t404r1821b483],

1	We	PRP	O	we	nsubj	2	SENT_55	[p3l137t540r269b611],
2	conducted	VBD	O	conduct	_	0	SENT_55	[p3l301t532r734b611],
3	a	DT	O	a	dobj	2	SENT_55	[p3l765t559r809b611],
4	randomized	VBN	O	randomize	dep	3	SENT_55	[p3l839t532r1372b628],
5	,	,	O	,	_	0	SENT_55	[p3l839t532r1372b628],
6	controlled	VBN	O	control	dep	4	SENT_55	[p3l1410t532r1859b628],
7	,	,	O	,	_	0	SENT_55	[p3l1410t532r1859b628],
8	openlabel	NN	O	openlabel	nn	12	SENT_55	[p3l1897t558r2133b633, p3l11t660r227b756],
9	,	,	O	,	_	0	SENT_55	[p3l1897t558r2133b633, p3l11t660r227b756],
10	phase	NN	O	phase	dep	12	SENT_55	[p3l264t660r504b761],
11	3	CD	NUMBER	3	num	12	SENT_55	[p3l537t666r581b739],
12	trial	NN	O	trial	npadvmod	6	SENT_55	[p3l617t660r786b739],
13	of	IN	O	of	_	0	SENT_55	[p3l818t660r916b739],
14	crizotinib	NN	O	crizotinib	prep_of	6	SENT_55	[p3l930t660r1351b756],
15	,	,	O	,	_	0	SENT_55	[p3l930t660r1351b756],
16	as	IN	O	as	_	0	SENT_55	[p3l1389t687r1472b739],
17	compared	VBN	O	compare	prepc_as	6	SENT_55	[p3l1507t660r1918b761],
18	with	IN	O	with	pcomp	17	SENT_55	[p3l1946t660r2134b739],
19	standard	JJ	O	standard	amod	20	SENT_55	[p3l13t788r385b867],
20	chemotherapy	NN	O	chemotherapy	pobj	18	SENT_55	[p3l412t788r1011b889],
21	in	IN	O	in	_	0	SENT_55	[p3l1033t789r1115b866],
22	patients	NNS	O	patient	prep_in	20	SENT_55	[p3l1141t789r1475b889],
23	with	IN	O	with	_	0	SENT_55	[p3l1500t788r1692b867],
24	advanced	JJ	O	advanced	prep_with	22	SENT_55	[p3l1718t788r2129b884],
25	,	,	O	,	_	0	SENT_55	[p3l1718t788r2129b884],
26	previously	RB	DATE	previously	advmod	27	SENT_55	[p3l11t916r430b1017],
27	treated	VBN	O	treat	dep	4	SENT_55	[p3l459t916r744b995],
28	ALK	NNP	O	ALK	dep	30	SENT_55	[p3l769t917r1273b1017],
29	—	CD	NUMBER	—	num	28	SENT_55	[p3l769t917r1273b1017],
30	positive	JJ	O	positive	amod	32	SENT_55	[p3l769t917r1273b1017],
31	non	JJ	O	non	amod	32	SENT_55	[p3l1306t916r1920b995],
32	—	NN	O	—	dobj	27	SENT_55	[p3l1306t916r1920b995],
33	small	JJ	O	small	amod	37	SENT_55	[p3l1306t916r1920b995],
34	—	NN	O	—	nn	37	SENT_55	[p3l1306t916r1920b995],
35	cell	NN	O	cell	nn	37	SENT_55	[p3l1306t916r1920b995],
36	lung	NN	O	lung	nn	37	SENT_55	[p3l1951t916r2138b1017],
37	cancer	NN	O	cancer	dobj	4	SENT_55	[p3l12t1042r311b1095],
38	.	.	O	.	_	0	SENT_55	[p3l12t1042r311b1095],

1	METHODS	NNS	O	method	_	0	SENT_56	[p3l801t1313r1343b1372],

1	PATIENTS	NNS	O	patient	_	0	SENT_57	[p3l17t1547r384b1596],

1	Patients	NNS	O	patient	nsubj	3	SENT_58	[p3l11t1646r350b1724],
2	were	VBD	O	be	cop	3	SENT_58	[p3l381t1671r582b1724],
3	eligible	JJ	O	eligible	_	0	SENT_58	[p3l616t1645r925b1746],
4	for	IN	O	for	_	0	SENT_58	[p3l959t1645r1082b1724],
5	inclusion	NN	O	inclusion	prep_for	3	SENT_58	[p3l1111t1645r1503b1724],
6	in	IN	O	in	_	0	SENT_58	[p3l1535t1646r1618b1723],
7	the	DT	O	the	det	8	SENT_58	[p3l1651t1645r1784b1724],
8	study	NN	O	study	prep_in	3	SENT_58	[p3l1818t1645r2048b1746],
9	if	IN	O	if	mark	13	SENT_58	[p3l2076t1645r2152b1723],
10	they	PRP	O	they	nsubj	13	SENT_58	[p3l12t1773r189b1874],
11	had	VBD	O	have	aux	13	SENT_58	[p3l212t1773r365b1852],
12	locally	RB	O	locally	advmod	13	SENT_58	[p3l392t1773r662b1874],
13	advanced	VBN	O	advance	dep	8	SENT_58	[p3l685t1773r1066b1853],
14	or	CC	O	or	_	0	SENT_58	[p3l1095t1799r1182b1852],
15	metastatic	JJ	O	metastatic	amod	20	SENT_58	[p3l1208t1774r1635b1852],
16	non	JJ	O	non	amod	20	SENT_58	[p3l1663t1773r2133b1852, p3l12t1901r158b1980],
17	—	NN	O	—	nn	20	SENT_58	[p3l1663t1773r2133b1852, p3l12t1901r158b1980],
18	smallcell	NN	O	smallcell	nn	20	SENT_58	[p3l1663t1773r2133b1852, p3l12t1901r158b1980],
19	lung	NN	O	lung	nn	20	SENT_58	[p3l203t1901r396b2002],
20	cancer	NN	O	cancer	conj_or	8	SENT_58	[p3l440t1927r721b1980],
21	that	WDT	O	that	nsubj	23	SENT_58	[p3l764t1901r937b1980],
22	was	VBD	O	be	cop	23	SENT_58	[p3l974t1928r1136b1980],
23	positive	JJ	O	positive	rcmod	20	SENT_58	[p3l1183t1902r1514b2002],
24	for	IN	O	for	_	0	SENT_58	[p3l1560t1901r1684b1980],
25	ALK	NN	O	alk	nn	26	SENT_58	[p3l1721t1907r1895b1979],
26	rearrangements	NNS	O	rearrangement	prep_for	23	SENT_58	[p3l1933t1927r2133b1980, p3l12t2046r542b2130],
27	.	.	O	.	_	0	SENT_58	[p3l1933t1927r2133b1980, p3l12t2046r542b2130],

1	ALK	NN	O	alk	nn	2	SENT_59	[p3l571t2035r745b2107],
2	testing	NN	O	testing	nsubjpass	4	SENT_59	[p3l767t2030r1065b2130],
3	was	VBD	O	be	auxpass	4	SENT_59	[p3l1086t2056r1248b2108],
4	performed	VBN	O	perform	_	0	SENT_59	[p3l1279t2029r1735b2130],
5	centrally	RB	O	centrally	amod	12	SENT_59	[p3l1765t2029r2138b2130],
6	with	IN	O	with	_	0	SENT_59	[p3l7t2157r202b2236],
7	the	DT	O	the	det	8	SENT_59	[p3l235t2157r368b2236],
8	use	NN	O	use	prep_with	5	SENT_59	[p3l402t2184r541b2236],
9	of	IN	O	of	_	0	SENT_59	[p3l576t2157r675b2236],
10	a	DT	O	a	det	11	SENT_59	[p3l689t2184r733b2236],
11	breal	NN	O	breal	prep_of	8	SENT_59	[p3l765t2157r1261b2258],
12	<	JJR	O	<	dobj	4	SENT_59	[p3l765t2157r1261b2258],
13	.	.	O	.	_	0	SENT_59	[p3l765t2157r1261b2258],

1	—	NN	O	—	_	0	SENT_60	[p3l765t2157r1261b2258],
2	.	.	O	.	_	0	SENT_60	[p3l765t2157r1261b2258],

1	apart	RB	O	apart	dep	2	SENT_61	[p3l765t2157r1261b2258],
2	fluorescence	NN	O	fluorescence	_	0	SENT_61	[p3l1288t2157r1830b2236],
3	in	FW	O	in	nn	4	SENT_61	[p3l1863t2158r1946b2235],
4	situ	FW	O	situ	advmod	6	SENT_61	[p3l1980t2158r2134b2236],
5	hybridization	NN	O	hybridization	nn	6	SENT_61	[p3l12t2285r589b2386],
6	assay	NN	O	assay	rcmod	2	SENT_61	[p3l623t2312r863b2386],
7	,	,	O	,	_	0	SENT_61	[p3l623t2312r863b2386],
8	which	WDT	O	which	nsubj	9	SENT_61	[p3l899t2285r1162b2365],
9	has	VBZ	O	have	dep	43	SENT_61	[p3l1196t2285r1341b2364],
10	an	DT	O	a	det	14	SENT_61	[p3l1377t2311r1480b2364],
11	analytic	JJ	O	analytic	amod	14	SENT_61	[p3l1515t2285r1853b2386],
12	sensi	NN	O	sensus	nn	14	SENT_61	[p3l1889t2286r2133b2364],
13	—	NN	O	—	nn	14	SENT_61	[p3l1889t2286r2133b2364],
14	tivity	NN	O	tivity	dobj	9	SENT_61	[p3l12t2414r229b2514],
15	of	IN	O	of	_	0	SENT_61	[p3l266t2413r366b2492],
16	100	CD	PERCENT	100	number	17	SENT_61	[p3l391t2419r627b2492],
17	%	NN	PERCENT	%	amod	21	SENT_61	[p3l391t2419r627b2492],
18	(	CD	PERCENT	(	number	19	SENT_61	[p3l672t2418r883b2504],
19	95	CD	PERCENT	95	dep	20	SENT_61	[p3l672t2418r883b2504],
20	%	NN	PERCENT	%	dep	21	SENT_61	[p3l672t2418r883b2504],
21	confidence	NN	O	confidence	prep_of	14	SENT_61	[p3l924t2413r1395b2492],
22	interval	NN	O	interval	nn	25	SENT_61	[p3l1436t2413r1762b2492],
23	[	CD	NUMBER	[	num	25	SENT_61	[p3l1811t2419r1987b2509],
24	CI	NN	O	ci	nn	25	SENT_61	[p3l1811t2419r1987b2509],
25	]	NN	O	]	dep	21	SENT_61	[p3l1811t2419r1987b2509],
26	,	,	O	,	_	0	SENT_61	[p3l1811t2419r1987b2509],
27	98	CD	NUMBER	98	number	29	SENT_61	[p3l2033t2419r2132b2492],
28	to	TO	O	to	dep	29	SENT_61	[p3l12t2558r94b2620],
29	100	CD	NUMBER	100	prep_of	14	SENT_61	[p3l145t2547r320b2633],
30	)	CD	NUMBER	)	dep	29	SENT_61	[p3l145t2547r320b2633],
31	and	CC	O	and	_	0	SENT_61	[p3l372t2541r529b2620],
32	specificity	NN	O	specificity	prep_of	14	SENT_61	[p3l577t2541r1018b2642],
33	of	IN	O	of	_	0	SENT_61	[p3l1062t2541r1161b2620],
34	100	CD	PERCENT	100	number	35	SENT_61	[p3l1193t2546r1429b2620],
35	%	NN	PERCENT	%	amod	39	SENT_61	[p3l1193t2546r1429b2620],
36	(	CD	PERCENT	(	number	37	SENT_61	[p3l1480t2546r1691b2633],
37	95	CD	PERCENT	95	dep	38	SENT_61	[p3l1480t2546r1691b2633],
38	%	NN	PERCENT	%	dep	39	SENT_61	[p3l1480t2546r1691b2633],
39	CI	NN	O	ci	prep_of	32	SENT_61	[p3l1738t2547r1853b2637],
40	,	,	O	,	_	0	SENT_61	[p3l1738t2547r1853b2637],
41	97	CD	NUMBER	97	number	43	SENT_61	[p3l1905t2547r2003b2620],
42	to	TO	O	to	dep	43	SENT_61	[p3l2051t2558r2132b2620],
43	100	CD	NUMBER	100	appos	2	SENT_61	[p3l15t2674r255b2761],
44	)	CD	NUMBER	)	number	45	SENT_61	[p3l15t2674r255b2761],
45	}	CD	NUMBER	}	num	48	SENT_61	[p3l15t2674r255b2761],
46	Other	JJ	O	other	amod	48	SENT_61	[p3l288t2669r536b2748],
47	eligibility	NN	O	eligibility	nn	48	SENT_61	[p3l568t2669r976b2770],
48	criteria	NNS	O	criterion	nsubj	49	SENT_61	[p3l1006t2670r1310b2748],
49	included	VBD	O	include	rcmod	43	SENT_61	[p3l1341t2669r1707b2748],
50	an	DT	O	a	det	51	SENT_61	[p3l1740t2695r1843b2748],
51	age	NN	O	age	dobj	49	SENT_61	[p3l1876t2696r2019b2770],
52	of	IN	O	of	_	0	SENT_61	[p3l2053t2669r2152b2748],
53	at	IN	DURATION	at	quantmod	55	SENT_61	[p3l11t2814r90b2876],
54	least	JJS	DURATION	least	mwe	53	SENT_61	[p3l136t2797r335b2876],
55	18	CD	DURATION	18	num	56	SENT_61	[p3l385t2803r479b2876],
56	years	NNS	NUMBER	year	prep_of	51	SENT_61	[p3l528t2824r772b2898],
57	,	,	O	,	_	0	SENT_61	[p3l528t2824r772b2898],
58	progressive	JJ	O	progressive	amod	59	SENT_61	[p3l828t2798r1317b2898],
59	disease	NN	O	disease	appos	56	SENT_61	[p3l1370t2797r1680b2876],
60	after	IN	O	after	_	0	SENT_61	[p3l1731t2797r1934b2876],
61	one	CD	NUMBER	one	num	64	SENT_61	[p3l1983t2823r2134b2876],
62	prior	JJ	O	prior	amod	64	SENT_61	[p3l11t2926r224b3026],
63	platinum	NN	O	platinum	nn	64	SENT_61	[p3l302t2925r977b3026],
64	—	NN	O	—	prep_after	49	SENT_61	[p3l302t2925r977b3026],
65	based	VBN	O	base	partmod	64	SENT_61	[p3l302t2925r977b3026],
66	chemotherapy	NN	O	chemotherapy	nn	67	SENT_61	[p3l1061t2925r1671b3026],
67	regimen	NN	O	regimen	dobj	65	SENT_61	[p3l1749t2926r2129b3026],
68	,	,	O	,	_	0	SENT_61	[p3l1749t2926r2129b3026],
69	measurable	JJ	O	measurable	amod	70	SENT_61	[p3l12t3053r504b3132],
70	disease	NN	O	disease	appos	67	SENT_61	[p3l550t3053r860b3132],
71	as	IN	O	as	amod	70	SENT_61	[p3l906t3079r990b3131],
72	assessed	VBN	O	assess	partmod	70	SENT_61	[p3l1037t3053r1406b3132],
73	with	IN	O	with	_	0	SENT_61	[p3l1447t3053r1642b3132],
74	the	DT	O	the	det	75	SENT_61	[p3l1688t3053r1821b3131],
75	use	NN	O	use	prep_with	72	SENT_61	[p3l1866t3079r2006b3132],
76	of	IN	O	of	prep	75	SENT_61	[p3l2053t3052r2152b3132],

1	Response	NN	O	response	nn	3	SENT_62	[p3l11t3187r421b3280],
2	Evaluation	NN	O	evaluation	nn	3	SENT_62	[p3l483t3181r934b3260],
3	Criteria	NNS	O	criterion	nsubj	7	SENT_62	[p3l998t3182r1320b3259],
4	in	IN	O	in	_	0	SENT_62	[p3l1382t3182r1465b3258],
5	Solid	JJ	O	solid	amod	6	SENT_62	[p3l1531t3181r1743b3259],
6	Tumors	NNS	O	tumor	prep_in	3	SENT_62	[p3l1803t3187r2132b3260],
7	(	VBP	O	(	_	0	SENT_62	[p3l17t3315r432b3404],
8	RECIST	NN	O	recist	dobj	7	SENT_62	[p3l17t3315r432b3404],
9	)	CD	NUMBER	)	num	8	SENT_62	[p3l17t3315r432b3404],
10	,	,	O	,	_	0	SENT_62	[p3l17t3315r432b3404],
11	version	NN	O	version	dobj	7	SENT_62	[p3l466t3310r773b3388],
12	1.1,18	CD	NUMBER	1.1,18	num	11	SENT_62	[p3l810t3314r1031b3404],
13	and	CC	O	and	_	0	SENT_62	[p3l1064t3309r1222b3387],
14	an	DT	O	a	det	20	SENT_62	[p3l1254t3335r1356b3387],
15	Eastern	NNP	ORGANIZATION	Eastern	nn	20	SENT_62	[p3l1388t3316r1711b3387],
16	Cooperative	NNP	ORGANIZATION	Cooperative	nn	20	SENT_62	[p3l1743t3315r2133b3408, p3l12t3438r159b3516],
17	Oncology	NNP	ORGANIZATION	Oncology	nn	20	SENT_62	[p3l190t3437r604b3538],
18	Group	NNP	ORGANIZATION	Group	nn	20	SENT_62	[p3l631t3443r900b3537],
19	(	CD	NUMBER	(	num	20	SENT_62	[p3l937t3443r1258b3528],
20	ECOG	NNP	O	ECOG	conj_and	11	SENT_62	[p3l937t3443r1258b3528],
21	)	CD	NUMBER	)	num	23	SENT_62	[p3l937t3443r1258b3528],
22	performance	NN	O	performance	nn	23	SENT_62	[p3l1294t3436r1848b3537],
23	status	NN	O	status	dep	11	SENT_62	[p3l1881t3454r2132b3516],
24	of	IN	O	of	_	0	SENT_62	[p3l12t3564r113b3644],
25	o	NN	O	o	prep_of	23	SENT_62	[p3l129t3571r198b3661],
26	,	,	O	,	_	0	SENT_62	[p3l129t3571r198b3661],
27	1	CD	NUMBER	1	dobj	7	SENT_62	[p3l242t3571r309b3661],
28	,	,	O	,	_	0	SENT_62	[p3l242t3571r309b3661],
29	or	CC	O	or	_	0	SENT_62	[p3l350t3591r439b3644],
30	2	CD	NUMBER	2	number	31	SENT_62	[p3l471t3571r518b3643],
31	(	CD	NUMBER	(	dobj	7	SENT_62	[p3l559t3565r776b3656],
32	With	IN	O	with	_	0	SENT_62	[p3l559t3565r776b3656],
33	o	NN	O	o	prep_with	31	SENT_62	[p3l812t3571r858b3644],
34	indicating	VBG	O	indicate	partmod	31	SENT_62	[p3l893t3565r1335b3666],
35	that	IN	O	that	complm	40	SENT_62	[p3l1366t3565r1539b3643],
36	the	DT	O	the	det	37	SENT_62	[p3l1569t3565r1702b3643],
37	patient	NN	O	patient	nsubj	40	SENT_62	[p3l1735t3566r2037b3665],
38	is	VBZ	O	be	cop	40	SENT_62	[p3l2067t3566r2133b3643],
39	fully	RB	O	fully	advmod	40	SENT_62	[p3l12t3691r208b3792],
40	active	JJ	O	active	ccomp	34	SENT_62	[p3l243t3693r506b3788],
41	,	,	O	,	_	0	SENT_62	[p3l243t3693r506b3788],
42	1	CD	NUMBER	1	conj_or	8	SENT_62	[p3l555t3698r599b3770],
43	that	IN	O	that	complm	47	SENT_62	[p3l641t3692r813b3770],
44	the	DT	O	the	det	45	SENT_62	[p3l849t3692r982b3770],
45	patient	NN	O	patient	nsubj	49	SENT_62	[p3l1021t3693r1323b3792],
46	is	VBZ	O	be	cop	47	SENT_62	[p3l1357t3693r1423b3770],
47	ambulatory	JJ	O	ambulatory	dep	42	SENT_62	[p3l1464t3692r1964b3792],
48	but	CC	O	but	_	0	SENT_62	[p3l2000t3692r2139b3772],
49	restricted	JJ	O	restricted	dep	42	SENT_62	[p4l12t21r419b99],
50	in	IN	O	in	_	0	SENT_62	[p4l471t22r555b98],
51	strenuous	JJ	O	strenuous	amod	52	SENT_62	[p4l611t37r1028b100],
52	activity	NN	O	activity	prep_in	47	SENT_62	[p4l1084t22r1406b120],
53	,	,	O	,	_	0	SENT_62	[p4l1084t22r1406b120],
54	and	CC	O	and	_	0	SENT_62	[p4l1465t21r1623b99],
55	2	CD	NUMBER	2	conj_or	8	SENT_62	[p4l1677t27r1724b98],
56	that	IN	O	that	complm	60	SENT_62	[p4l1779t21r1952b99],
57	the	DT	O	the	det	58	SENT_62	[p4l2001t21r2134b99],
58	patient	NN	O	patient	nsubj	62	SENT_62	[p4l11t149r313b248],
59	is	VBZ	O	be	cop	60	SENT_62	[p4l337t149r403b226],
60	ambulatory	JJ	O	ambulatory	dep	55	SENT_62	[p4l434t148r933b248],
61	and	CC	O	and	_	0	SENT_62	[p4l958t148r1115b227],
62	capable	JJ	O	capable	dep	55	SENT_62	[p4l1146t148r1466b248],
63	of	IN	O	of	_	0	SENT_62	[p4l1497t147r1596b227],
64	self	NN	O	self	nn	66	SENT_62	[p4l1610t147r1969b226],
65	—	CD	NUMBER	—	num	66	SENT_62	[p4l1610t147r1969b226],
66	care	NN	O	care	prep_of	60	SENT_62	[p4l1610t147r1969b226],
67	but	CC	O	but	_	0	SENT_62	[p4l2000t148r2139b228],
68	is	VBZ	O	be	cop	69	SENT_62	[p4l11t278r77b355],
69	unable	JJ	O	unable	dep	55	SENT_62	[p4l127t277r414b356],
70	to	TO	O	to	aux	71	SENT_62	[p4l463t293r544b355],
71	Work	VB	O	work	xcomp	69	SENT_62	[p4l590t277r929b367],
72	”	CD	NUMBER	”	num	73	SENT_62	[p4l590t277r929b367],
73	)	CD	NUMBER	)	dobj	71	SENT_62	[p4l590t277r929b367],
74	.	.	O	.	_	0	SENT_62	[p4l590t277r929b367],

1	Patients	NNS	O	patient	nsubj	17	SENT_63	[p4l982t278r1321b355],
2	with	IN	O	with	_	0	SENT_63	[p4l1367t277r1563b356],
3	stable	JJ	O	stable	amod	5	SENT_63	[p4l1613t277r1859b355],
4	brain	NN	O	brain	nn	5	SENT_63	[p4l1909t277r2134b355],
5	metastases	NNS	O	metastase	prep_with	1	SENT_63	[p4l12t422r483b483],
6	that	WDT	O	that	nsubj	13	SENT_63	[p4l537t405r709b483],
7	had	VBD	O	have	aux	9	SENT_63	[p4l755t405r911b483],
8	been	VBN	O	be	auxpass	9	SENT_63	[p4l963t405r1163b483],
9	treated	VBN	O	treat	rcmod	5	SENT_63	[p4l1215t405r1513b483],
10	previously	RB	DATE	previously	advmod	9	SENT_63	[p4l1562t405r2001b504],
11	or	CC	O	or	_	0	SENT_63	[p4l2049t431r2137b483],
12	were	VBD	O	be	cop	13	SENT_63	[p4l7t559r209b612],
13	untreated	JJ	O	untreated	rcmod	5	SENT_63	[p4l252t533r664b612],
14	and	CC	O	and	_	0	SENT_63	[p4l706t533r863b612],
15	asymptomatic	JJ	O	asymptomatic	conj_and	13	SENT_63	[p4l905t534r1513b633],
16	were	VBD	O	be	cop	17	SENT_63	[p4l1551t559r1752b612],
17	eligible	JJ	O	eligible	_	0	SENT_63	[p4l1796t533r2129b634],
18	.	.	O	.	_	0	SENT_63	[p4l1796t533r2129b634],

1	All	DT	O	all	det	2	SENT_64	[p4l8t660r133b738],
2	patients	NNS	O	patient	nsubj	3	SENT_64	[p4l166t661r508b760],
3	provided	VBD	O	provide	_	0	SENT_64	[p4l543t660r918b760],
4	written	VBN	O	write	amod	6	SENT_64	[p4l947t661r1261b740],
5	informed	VBN	O	inform	amod	6	SENT_64	[p4l1295t659r1697b739],
6	consent	NN	O	consent	dobj	3	SENT_64	[p4l1733t677r2088b739],
7	.	.	O	.	_	0	SENT_64	[p4l1733t677r2088b739],

1	STU	NNP	O	STU	nn	5	SENT_65	[p4l12t935r154b985],
2	DY	NNP	O	DY	nn	5	SENT_65	[p4l173t936r268b984],
3	OVERSIGHT	NNP	O	OVERSIGHT	nn	5	SENT_65	[p4l300t935r761b985],
4	The	NNP	O	The	nn	5	SENT_65	[p4l8t1034r169b1112],
5	protocol	NN	O	protocol	nsubjpass	7	SENT_65	[p4l217t1034r578b1133],
6	was	VBD	O	be	auxpass	7	SENT_65	[p4l623t1060r785b1113],
7	approved	VBN	O	approve	_	0	SENT_65	[p4l836t1034r1226b1133],
8	by	IN	O	by	_	0	SENT_65	[p4l1276t1034r1373b1133],
9	the	DT	O	the	det	12	SENT_65	[p4l1419t1034r1552b1112],
10	institutional	JJ	O	institutional	amod	12	SENT_65	[p4l1601t1034r2134b1113],
11	review	NN	O	review	nn	12	SENT_65	[p4l12t1163r292b1241],
12	board	NN	O	board	agent	7	SENT_65	[p4l320t1162r568b1240],
13	or	CC	O	or	_	0	SENT_65	[p4l601t1188r689b1240],
14	independent	JJ	O	independent	amod	16	SENT_65	[p4l717t1162r1256b1261],
15	ethics	NNS	O	ethic	nn	16	SENT_65	[p4l1283t1162r1534b1240],
16	committee	NN	O	committee	conj_or	12	SENT_65	[p4l1569t1163r2030b1240],
17	at	IN	O	at	_	0	SENT_65	[p4l2060t1178r2139b1240],
18	each	DT	O	each	det	20	SENT_65	[p4l12t1290r205b1368],
19	participating	VBG	O	participate	amod	20	SENT_65	[p4l236t1291r798b1391],
20	site	NN	O	site	prep_at	7	SENT_65	[p4l828t1291r971b1368],
21	and	CC	O	and	_	0	SENT_65	[p4l1004t1290r1162b1369],
22	complied	VBN	O	comply	conj_and	7	SENT_65	[p4l1195t1290r1591b1390],
23	with	IN	O	with	_	0	SENT_65	[p4l1619t1290r1814b1369],
24	the	DT	O	the	det	27	SENT_65	[p4l1848t1290r1981b1368],
25	International	NNP	ORGANIZATION	International	nn	27	SENT_65	[p4l2013t1298r2133b1368, p4l12t1418r487b1497],
26	Ethical	NNP	ORGANIZATION	Ethical	nn	27	SENT_65	[p4l514t1418r816b1496],
27	Guidelines	NNS	ORGANIZATION	guideline	prep_with	22	SENT_65	[p4l843t1418r1304b1497],
28	for	IN	ORGANIZATION	for	_	0	SENT_65	[p4l1335t1417r1458b1497],
29	Biomedical	NNP	ORGANIZATION	Biomedical	nn	31	SENT_65	[p4l1482t1418r1964b1497],
30	Research	NNP	ORGANIZATION	Research	nn	31	SENT_65	[p4l1991t1425r2133b1501, p4l13t1546r289b1624],
31	Involving	NNP	ORGANIZATION	Involving	prep_for	27	SENT_65	[p4l323t1546r724b1647],
32	Human	JJ	ORGANIZATION	human	amod	33	SENT_65	[p4l756t1554r1080b1625],
33	Subjects	NNS	ORGANIZATION	subject	dobj	7	SENT_65	[p4l1117t1546r1489b1646],
34	,	,	O	,	_	0	SENT_65	[p4l1117t1546r1489b1646],
35	Good	JJ	O	good	amod	38	SENT_65	[p4l1529t1546r1767b1625],
36	Clinical	JJ	O	clinical	amod	38	SENT_65	[p4l1802t1546r2134b1625],
37	Practice	NN	O	practice	nn	38	SENT_65	[p4l11t1675r348b1753],
38	guidelines	NNS	O	guideline	appos	33	SENT_65	[p4l389t1674r858b1775],
39	,	,	O	,	_	0	SENT_65	[p4l389t1674r858b1775],
40	the	DT	O	the	det	41	SENT_65	[p4l905t1674r1038b1752],
41	Declaration	NN	O	declaration	conj_and	33	SENT_65	[p4l1077t1674r1579b1753],
42	of	IN	O	of	_	0	SENT_65	[p4l1620t1673r1720b1753],
43	Helsinki	NNP	LOCATION	Helsinki	prep_of	41	SENT_65	[p4l1742t1674r2129b1770],
44	,	,	O	,	_	0	SENT_65	[p4l1742t1674r2129b1770],
45	and	CC	O	and	_	0	SENT_65	[p4l11t1802r165b1881],
46	local	JJ	O	local	amod	47	SENT_65	[p4l188t1802r384b1881],
47	laws	NNS	O	law	conj_and	33	SENT_65	[p4l407t1802r612b1881],
48	.	.	O	.	_	0	SENT_65	[p4l407t1802r612b1881],

1	The	DT	O	the	det	2	SENT_66	[p4l639t1802r795b1880],
2	study	NN	O	study	nsubjpass	4	SENT_66	[p4l821t1802r1042b1902],
3	was	VBD	O	be	auxpass	4	SENT_66	[p4l1058t1828r1216b1881],
4	designed	VBN	O	design	_	0	SENT_66	[p4l1243t1802r1610b1903],
5	by	IN	O	by	_	0	SENT_66	[p4l1635t1802r1730b1902],
6	the	DT	O	the	det	7	SENT_66	[p4l1751t1802r1879b1880],
7	sponsor	NN	O	sponsor	agent	4	SENT_66	[p4l1905t1828r2133b1902, p4l13t1956r147b2009],
8	(	CD	NUMBER	(	num	7	SENT_66	[p4l198t1929r516b2021],
9	Pfizer	NNP	ORGANIZATION	Pfizer	dobj	4	SENT_66	[p4l198t1929r516b2021],
10	)	VBN	O	)	partmod	9	SENT_66	[p4l198t1929r516b2021],
11	together	RB	O	together	_	0	SENT_66	[p4l571t1930r941b2031],
12	With	IN	O	with	_	0	SENT_66	[p4l982t1930r1180b2009],
13	the	DT	O	the	det	14	SENT_66	[p4l1229t1930r1364b2008],
14	members	NNS	O	member	prep_together_with	19	SENT_66	[p4l1413t1930r1817b2009],
15	of	IN	O	of	_	0	SENT_66	[p4l1868t1929r1969b2009],
16	the	DT	O	the	det	17	SENT_66	[p4l2000t1930r2134b2008],
17	PROFILE	NNP	O	PROFILE	prep_of	14	SENT_66	[p4l11t2064r394b2141],
18	1007	CD	DATE	1007	num	17	SENT_66	[p4l440t2064r638b2137],
19	steering	VBG	O	steer	xcomp	10	SENT_66	[p4l681t2059r1027b2159],
20	committee	NN	O	committee	nsubj	22	SENT_66	[p4l1066t2059r1526b2137],
21	(	CD	NUMBER	(	num	20	SENT_66	[p4l1571t2065r1728b2149],
22	see	VBP	O	see	ccomp	19	SENT_66	[p4l1571t2065r1728b2149],
23	the	DT	O	the	det	25	SENT_66	[p4l1769t2058r1902b2136],
24	Supplementary	NNP	O	Supplementary	nn	25	SENT_66	[p4l1945t2064r2133b2158, p4l11t2185r501b2285],
25	Appendix	NNP	O	Appendix	dobj	22	SENT_66	[p4l526t2185r964b2285],
26	,	,	O	,	_	0	SENT_66	[p4l526t2185r964b2285],
27	available	JJ	O	available	amod	25	SENT_66	[p4l1002t2185r1373b2265],
28	with	IN	O	with	_	0	SENT_66	[p4l1402t2185r1598b2265],
29	the	DT	O	the	det	31	SENT_66	[p4l1631t2185r1764b2263],
30	full	JJ	O	full	amod	31	SENT_66	[p4l1797t2184r1946b2265],
31	text	NN	O	text	prep_with	27	SENT_66	[p4l1979t2202r2139b2263],
32	of	IN	O	of	_	0	SENT_66	[p4l12t2313r113b2393],
33	this	DT	O	this	det	34	SENT_66	[p4l131t2314r290b2392],
34	article	NN	O	article	prep_of	31	SENT_66	[p4l328t2314r595b2392],
35	at	IN	O	at	_	0	SENT_66	[p4l631t2331r710b2392],
36	NEJM.org	NN	O	nejm.org	nn	37	SENT_66	[p4l738t2321r1215b2415],
37	)	NN	O	)	prep_at	34	SENT_66	[p4l738t2321r1215b2415],
38	.	.	O	.	_	0	SENT_66	[p4l738t2321r1215b2415],

1	The	DT	O	the	det	2	SENT_67	[p4l1253t2314r1414b2392],
2	sponsor	NN	O	sponsor	nsubj	3	SENT_67	[p4l1451t2340r1795b2414],
3	collected	VBN	O	collect	_	0	SENT_67	[p4l1828t2314r2133b2393, p4l12t2442r107b2520],
4	the	DT	O	the	det	5	SENT_67	[p4l137t2442r265b2520],
5	data	NNS	O	datum	dobj	3	SENT_67	[p4l296t2442r473b2520],
6	and	CC	O	and	_	0	SENT_67	[p4l501t2442r654b2520],
7	analyzed	VBD	O	analyze	conj_and	3	SENT_67	[p4l683t2442r1047b2541],
8	them	PRP	O	they	dobj	7	SENT_67	[p4l1077t2442r1291b2520],
9	in	IN	O	in	_	0	SENT_67	[p4l1320t2443r1401b2519],
10	conjunction	NN	O	conjunction	prep_in	7	SENT_67	[p4l1432t2443r1920b2541],
11	with	IN	O	with	_	0	SENT_67	[p4l1945t2442r2134b2521],
12	the	DT	O	the	det	13	SENT_67	[p4l12t2570r145b2648],
13	authors	NNS	O	author	prep_with	7	SENT_67	[p4l182t2570r530b2649],
14	.	.	O	.	_	0	SENT_67	[p4l182t2570r530b2649],

1	The	DT	O	the	det	3	SENT_68	[p4l569t2570r730b2649],
2	corresponding	JJ	O	corresponding	amod	3	SENT_68	[p4l769t2570r1399b2671],
3	author	NN	O	author	nsubj	4	SENT_68	[p4l1433t2570r1716b2649],
4	Wrote	VBD	O	write	_	0	SENT_68	[p4l1746t2587r1993b2649],
5	all	PDT	O	all	predet	7	SENT_68	[p4l2031t2570r2135b2648],
6	the	DT	O	the	det	7	SENT_68	[p4l12t2697r143b2775],
7	drafts	NNS	O	draft	dobj	4	SENT_68	[p4l172t2696r419b2776],
8	of	IN	O	of	_	0	SENT_68	[p4l450t2696r549b2776],
9	the	DT	O	the	det	10	SENT_68	[p4l559t2697r689b2775],
10	manuscript	NN	O	manuscript	prep_of	7	SENT_68	[p4l718t2698r1220b2797],
11	.	.	O	.	_	0	SENT_68	[p4l718t2698r1220b2797],

1	All	PDT	O	all	predet	3	SENT_69	[p4l1250t2697r1373b2775],
2	the	DT	O	the	det	3	SENT_69	[p4l1401t2697r1532b2775],
3	authors	NNS	O	author	nsubj	4	SENT_69	[p4l1560t2697r1875b2777],
4	made	VBD	O	make	_	0	SENT_69	[p4l1906t2697r2134b2776],
5	the	DT	O	the	det	6	SENT_69	[p4l12t2825r145b2903],
6	decision	NN	O	decision	dobj	4	SENT_69	[p4l184t2825r536b2904],
7	to	TO	O	to	aux	8	SENT_69	[p4l574t2842r656b2904],
8	submit	VB	O	submit	infmod	6	SENT_69	[p4l697t2825r995b2905],
9	the	DT	O	the	det	10	SENT_69	[p4l1029t2825r1162b2903],
10	manuscript	NN	O	manuscript	dobj	8	SENT_69	[p4l1200t2826r1693b2925],
11	for	IN	O	for	_	0	SENT_69	[p4l1725t2824r1849b2904],
12	publication	NN	O	publication	prep_for	10	SENT_69	[p4l1882t2825r2133b2925, p4l12t2954r276b3032],
13	and	CC	O	and	_	0	SENT_69	[p4l311t2953r469b3032],
14	vouch	NN	O	vouch	conj_and	12	SENT_69	[p4l501t2953r753b3033],
15	for	IN	O	for	_	0	SENT_69	[p4l789t2952r912b3032],
16	the	DT	O	the	det	17	SENT_69	[p4l946t2953r1078b3031],
17	accuracy	NN	O	accuracy	prep_for	8	SENT_69	[p4l1114t2979r1485b3053],
18	and	CC	O	and	_	0	SENT_69	[p4l1516t2953r1674b3032],
19	completeness	NN	O	completeness	prep_for	8	SENT_69	[p4l1711t2953r2133b3053, p4l12t3107r196b3159],
20	of	IN	O	of	_	0	SENT_69	[p4l231t3080r331b3160],
21	the	DT	O	the	det	22	SENT_69	[p4l345t3081r478b3159],
22	data	NNS	O	datum	prep_of	17	SENT_69	[p4l510t3081r693b3160],
23	and	CC	O	and	_	0	SENT_69	[p4l723t3081r881b3160],
24	for	IN	O	for	_	0	SENT_69	[p4l912t3080r1036b3160],
25	the	DT	O	the	det	26	SENT_69	[p4l1066t3081r1198b3159],
26	fidelity	NN	O	fidelity	prep_for	8	SENT_69	[p4l1230t3080r1537b3181],
27	of	IN	O	of	_	0	SENT_69	[p4l1565t3080r1665b3160],
28	this	DT	O	this	det	29	SENT_69	[p4l1679t3081r1839b3159],
29	report	NN	O	report	prep_of	26	SENT_69	[p4l1872t3098r2139b3181],
30	to	TO	O	to	_	0	SENT_69	[p4l12t3226r94b3288],
31	the	DT	O	the	det	33	SENT_69	[p4l132t3210r264b3288],
32	study	NN	O	study	nn	33	SENT_69	[p4l302t3210r532b3309],
33	protocol	NN	O	protocol	prep_to	8	SENT_69	[p4l561t3210r945b3309],
34	.	.	O	.	_	0	SENT_69	[p4l561t3210r945b3309],

1	Editorial	NN	O	editorial	nn	2	SENT_70	[p4l986t3210r1359b3288],
2	support	NN	O	support	nsubjpass	4	SENT_70	[p4l1396t3227r1729b3309],
3	was	VBD	O	be	auxpass	4	SENT_70	[p4l1756t3236r1918b3289],
4	provided	VBN	O	provide	_	0	SENT_70	[p4l1954t3236r2133b3309, p4l7t3338r233b3417],
5	by	IN	O	by	_	0	SENT_70	[p4l264t3338r360b3437],
6	a	DT	O	a	det	8	SENT_70	[p4l386t3364r430b3416],
7	medical	JJ	O	medical	amod	8	SENT_70	[p4l459t3338r792b3416],
8	writer	NN	O	writer	agent	4	SENT_70	[p4l818t3339r1075b3417],
9	at	IN	O	at	_	0	SENT_70	[p4l1102t3355r1180b3416],
10	ACUMED	NNP	O	ACUMED	prep_at	8	SENT_70	[p4l1202t3344r1608b3416],
11	(	CD	NUMBER	(	num	10	SENT_70	[p4l1644t3344r1867b3428],
12	New	NNP	LOCATION	New	nn	14	SENT_70	[p4l1644t3344r1867b3428],
13	York	NNP	LOCATION	York	nn	14	SENT_70	[p4l1890t3338r2129b3433],
14	)	NN	O	)	tmod	4	SENT_70	[p4l1890t3338r2129b3433],
15	,	,	O	,	_	0	SENT_70	[p4l1890t3338r2129b3433],
16	who	WP	O	who	nsubjpass	18	SENT_70	[p4l7t3465r188b3545],
17	was	VBD	O	be	auxpass	18	SENT_70	[p4l216t3491r376b3545],
18	funded	VBN	O	fund	rcmod	14	SENT_70	[p4l408t3464r706b3545],
19	by	IN	O	by	_	0	SENT_70	[p4l738t3465r834b3565],
20	the	DT	O	the	det	21	SENT_70	[p4l860t3465r990b3543],
21	sponsor	NN	O	sponsor	agent	18	SENT_70	[p4l1023t3491r1376b3565],
22	.	.	O	.	_	0	SENT_70	[p4l1023t3491r1376b3565],

1	The	DT	O	the	det	2	SENT_71	[p4l1409t3465r1567b3543],
2	protocol	NN	O	protocol	nsubj	8	SENT_71	[p4l1596t3465r1950b3565],
3	and	CC	O	and	_	0	SENT_71	[p4l1979t3465r2134b3544],
4	statistical	JJ	O	statistical	amod	6	SENT_71	[p4l13t3594r418b3672],
5	analysis	NN	O	analysis	nn	6	SENT_71	[p4l449t3594r781b3694],
6	plan	NN	O	plan	conj_and	2	SENT_71	[p4l815t3594r1000b3694],
7	are	VBP	O	be	cop	8	SENT_71	[p4l1032t3620r1159b3672],
8	available	JJ	O	available	_	0	SENT_71	[p4l1191t3594r1554b3673],
9	at	IN	O	at	_	0	SENT_71	[p4l1586t3611r1664b3672],
10	N	NN	O	n	nn	11	SENT_71	[p4l1689t3602r1764b3673],
11	EJM.org	NN	O	ejm.org	prep_at	8	SENT_71	[p4l1766t3602r2124b3695],
12	.	.	O	.	_	0	SENT_71	[p4l1766t3602r2124b3695],

1	STUDY	NN	O	study	nn	2	SENT_72	[p5l12t111r268b161],
2	DESIGN	NN	O	design	nsubjpass	8	SENT_72	[p5l305t111r599b161],
3	AND	CC	O	and	_	0	SENT_72	[p5l638t112r807b160],
4	TREATMENT	NN	O	treatment	nn	5	SENT_72	[p5l839t112r1309b160],
5	Patients	NNS	O	patient	conj_and	2	SENT_72	[p5l11t211r350b288],
6	were	VBD	O	be	auxpass	8	SENT_72	[p5l390t236r592b289],
7	randomly	RB	O	randomly	advmod	8	SENT_72	[p5l635t210r1049b310],
8	assigned	VBN	O	assign	_	0	SENT_72	[p5l1087t210r1483b311],
9	,	,	O	,	_	0	SENT_72	[p5l1087t210r1483b311],
10	in	IN	O	in	_	0	SENT_72	[p5l1530t211r1614b288],
11	a	DT	O	a	det	13	SENT_72	[p5l1656t236r1700b288],
12	1:1	CD	NUMBER	1:1	num	13	SENT_72	[p5l1744t216r1866b289],
13	ratio	NN	O	ratio	prep_in	8	SENT_72	[p5l1909t211r2128b306],
14	,	,	O	,	_	0	SENT_72	[p5l1909t211r2128b306],
15	to	TO	O	to	aux	16	SENT_72	[p5l12t355r94b417],
16	receive	VB	O	receive	xcomp	8	SENT_72	[p5l132t339r421b417],
17	oral	JJ	O	oral	amod	19	SENT_72	[p5l459t338r624b417],
18	crizotinib	NN	O	crizotinib	nn	19	SENT_72	[p5l662t338r1082b417],
19	(	NN	O	(	dobj	16	SENT_72	[p5l1125t344r1304b429],
20	250	CD	NUMBER	250	num	21	SENT_72	[p5l1125t344r1304b429],
21	mg	NN	O	mg	npadvmod	22	SENT_72	[p5l1342t364r1480b439],
22	twice	RB	O	twice	advmod	16	SENT_72	[p5l1515t339r1742b417],
23	daily	JJ	SET	daily	amod	24	SENT_72	[p5l1779t338r2009b438],
24	)	NN	O	)	pobj	22	SENT_72	[p5l1779t338r2009b438],
25	in	IN	O	in	_	0	SENT_72	[p5l2051t339r2134b416],
26	a	DT	O	a	det	28	SENT_72	[p5l11t492r56b543],
27	3-week	JJ	DURATION	3-week	amod	28	SENT_72	[p5l89t466r388b545],
28	cycle	NN	O	cycle	prep_in	16	SENT_72	[p5l418t466r616b565],
29	or	CC	O	or	_	0	SENT_72	[p5l651t492r739b544],
30	intravenous	JJ	O	intravenous	amod	31	SENT_72	[p5l768t467r1258b545],
31	chemotherapy	NN	O	chemotherapy	prep_in	16	SENT_72	[p5l1294t466r1893b565],
32	comprising	VBG	O	comprise	partmod	28	SENT_72	[p5l1923t492r2133b544, p5l11t595r310b695],
33	either	CC	O	either	dep	8	SENT_72	[p5l337t594r579b672],
34	pemetrexed	VBN	O	pemetrex	conj	8	SENT_72	[p5l604t594r1096b694],
35	(	NN	O	(	nn	37	SENT_72	[p5l1130t600r1309b685],
36	500	CD	NUMBER	500	num	37	SENT_72	[p5l1130t600r1309b685],
37	mg	NN	O	mg	dobj	34	SENT_72	[p5l1338t620r1476b695],
38	per	IN	O	per	_	0	SENT_72	[p5l1501t620r1639b694],
39	square	NN	O	square	nn	40	SENT_72	[p5l1667t620r1943b694],
40	meter	NN	O	meter	prep_per	37	SENT_72	[p5l1973t620r2133b672, p5l12t739r125b800],
41	of	IN	O	of	_	0	SENT_72	[p5l155t721r254b801],
42	body	NN	O	body	nn	45	SENT_72	[p5l271t721r821b822],
43	—	CD	NUMBER	—	num	45	SENT_72	[p5l271t721r821b822],
44	surface	NN	O	surface	nn	45	SENT_72	[p5l271t721r821b822],
45	area	NN	O	area	prep_of	40	SENT_72	[p5l855t729r1060b813],
46	)	CD	NUMBER	)	dep	45	SENT_72	[p5l855t729r1060b813],
47	or	CC	O	or	_	0	SENT_72	[p5l1100t748r1189b801],
48	docetaxel	NN	O	docetaxel	conj_or	45	SENT_72	[p5l1221t722r1627b801],
49	(	CD	NUMBER	(	number	50	SENT_72	[p5l1665t729r1791b813],
50	75	CD	NUMBER	75	num	51	SENT_72	[p5l1665t729r1791b813],
51	mg	NN	O	mg	dep	48	SENT_72	[p5l1828t748r1967b823],
52	per	IN	O	per	_	0	SENT_72	[p5l1997t748r2137b822],
53	square	NN	O	square	nn	54	SENT_72	[p5l13t876r296b949],
54	meter	NN	O	meter	prep_per	37	SENT_72	[p5l338t857r609b940],
55	)	CD	NUMBER	)	num	54	SENT_72	[p5l338t857r609b940],
56	every	DT	SET	every	det	58	SENT_72	[p5l657t876r878b949],
57	3	CD	SET	3	num	58	SENT_72	[p5l917t856r960b929],
58	weeks	NNS	NUMBER	week	tmod	34	SENT_72	[p5l1002t850r1288b929],
59	.	.	O	.	_	0	SENT_72	[p5l1002t850r1288b929],

1	Patients	NNS	O	patient	nsubj	8	SENT_73	[p5l1334t851r1674b928],
2	who	WP	O	who	nsubjpass	5	SENT_73	[p5l1713t850r1896b929],
3	were	VBD	O	be	auxpass	5	SENT_73	[p5l1935t876r2134b929],
4	randomly	RB	O	randomly	advmod	5	SENT_73	[p5l12t978r412b1078],
5	assigned	VBN	O	assign	rcmod	1	SENT_73	[p5l430t978r789b1079],
6	to	TO	O	to	_	0	SENT_73	[p5l812t995r892b1057],
7	chemotherapy	NN	O	chemotherapy	prep_to	5	SENT_73	[p5l917t978r1504b1078],
8	received	VBD	O	receive	_	0	SENT_73	[p5l1523t978r1853b1057],
9	peme	JJ	O	peme	amod	10	SENT_73	[p5l1876t1004r2133b1078],
10	—	NN	O	—	dobj	8	SENT_73	[p5l1876t1004r2133b1078],
11	trexed	VBN	O	trex	partmod	10	SENT_73	[p5l12t1106r265b1185],
12	unless	IN	O	unless	mark	17	SENT_73	[p5l309t1106r580b1185],
13	their	PRP$	O	they	poss	16	SENT_73	[p5l628t1106r832b1184],
14	prior	JJ	O	prior	amod	16	SENT_73	[p5l873t1107r1086b1206],
15	chemotherapy	NN	O	chemotherapy	nn	16	SENT_73	[p5l1129t1106r1740b1206],
16	regimen	NN	O	regimen	nsubj	17	SENT_73	[p5l1781t1107r2134b1207],
17	contained	VBD	O	contain	dep	11	SENT_73	[p5l12t1234r430b1312],
18	pemetrexed	JJ	O	pemetrexed	acomp	17	SENT_73	[p5l469t1234r962b1333],
19	or	CC	O	or	_	0	SENT_73	[p5l1003t1260r1091b1312],
20	unless	IN	O	unless	mark	23	SENT_73	[p5l1128t1234r1394b1313],
21	their	PRP$	O	they	poss	22	SENT_73	[p5l1437t1234r1637b1312],
22	tumor	NN	O	tumor	nsubj	23	SENT_73	[p5l1676t1251r1939b1313],
23	had	VBD	O	have	dep	11	SENT_73	[p5l1978t1234r2134b1312],
24	predominantly	RB	O	predominantly	advmod	25	SENT_73	[p5l11t1362r639b1462],
25	squamous	JJ	O	squamous	amod	29	SENT_73	[p5l672t1362r1283b1462],
26	—	NN	O	—	nn	29	SENT_73	[p5l672t1362r1283b1462],
27	cell	NN	O	cell	nn	29	SENT_73	[p5l672t1362r1283b1462],
28	histologic	JJ	O	histologic	amod	29	SENT_73	[p5l1319t1362r1734b1463],
29	features	NNS	O	feature	dobj	23	SENT_73	[p5l1770t1361r2128b1441],
30	.	.	O	.	_	0	SENT_73	[p5l1770t1361r2128b1441],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_74	[p5l11t1491r342b1568],
2	were	VBD	O	be	auxpass	3	SENT_74	[p5l367t1516r565b1569],
3	stratified	VBN	O	stratify	_	0	SENT_74	[p5l594t1489r978b1569],
4	according	VBG	O	accord	_	0	SENT_74	[p5l1004t1490r1422b1591],
5	to	TO	O	to	prepc_according_to	3	SENT_74	[p5l1446t1507r1526b1569],
6	ECOG	NNP	O	ECOG	nn	8	SENT_74	[p5l1553t1496r1817b1569],
7	performance	NN	O	performance	nn	8	SENT_74	[p5l1843t1489r2133b1590, p5l12t1644r286b1696],
8	status	NN	O	status	pobj	3	SENT_74	[p5l316t1635r557b1697],
9	(	CD	NUMBER	(	num	10	SENT_74	[p5l594t1624r665b1708],
10	O	NN	O	o	dep	8	SENT_74	[p5l594t1624r665b1708],
11	or	CC	O	or	_	0	SENT_74	[p5l696t1644r782b1696],
12	1	CD	NUMBER	1	pobj	3	SENT_74	[p5l812t1624r856b1695],
13	vs.	CC	O	vs.	prep	12	SENT_74	[p5l881t1644r986b1697],
14	2	CD	NUMBER	2	num	15	SENT_74	[p5l1021t1624r1115b1713],
15	)	NN	O	)	dep	13	SENT_74	[p5l1021t1624r1115b1713],
16	,	,	O	,	_	0	SENT_74	[p5l1021t1624r1115b1713],
17	the	DT	O	the	det	18	SENT_74	[p5l1151t1618r1279b1696],
18	presence	NN	O	presence	pobj	3	SENT_74	[p5l1307t1644r1667b1717],
19	or	CC	O	or	_	0	SENT_74	[p5l1698t1644r1784b1696],
20	absence	NN	O	absence	conj_or	18	SENT_74	[p5l1810t1618r2134b1696],
21	of	IN	O	of	_	0	SENT_74	[p5l12t1744r113b1824],
22	brain	NN	O	brain	nn	23	SENT_74	[p5l123t1745r349b1824],
23	metastases	NNS	O	metastase	prep_of	18	SENT_74	[p5l377t1762r874b1841],
24	,	,	O	,	_	0	SENT_74	[p5l377t1762r874b1841],
25	and	CC	O	and	cc	26	SENT_74	[p5l907t1745r1065b1824],
26	prior	RB	O	prior	advmod	23	SENT_74	[p5l1091t1746r1305b1845],
27	or	CC	O	or	_	0	SENT_74	[p5l1331t1771r1419b1824],
28	no	DT	O	no	det	30	SENT_74	[p5l1445t1771r1550b1824],
29	prior	JJ	O	prior	amod	30	SENT_74	[p5l1578t1746r1792b1845],
30	therapy	NN	O	therapy	pobj	3	SENT_74	[p5l1818t1745r2139b1845],
31	with	IN	O	with	_	0	SENT_74	[p5l7t1874r203b1953],
32	epidermal	JJ	O	epidermal	amod	35	SENT_74	[p5l257t1874r689b1974],
33	growth	NN	O	growth	nn	35	SENT_74	[p5l742t1874r1056b1975],
34	factor	NN	O	factor	nn	35	SENT_74	[p5l1110t1873r1360b1953],
35	receptor	NN	O	receptor	prep_with	30	SENT_74	[p5l1411t1891r1767b1974],
36	(	CD	NUMBER	(	num	40	SENT_74	[p5l1823t1880r2129b1965],
37	EGFR	NN	ORGANIZATION	egfr	nn	40	SENT_74	[p5l1823t1880r2129b1965],
38	)	NN	O	)	nn	40	SENT_74	[p5l1823t1880r2129b1965],
39	kinase	NN	O	kinase	nn	40	SENT_74	[p5l12t2003r290b2082],
40	inhibitors	NNS	O	inhibitor	dep	30	SENT_74	[p5l324t2003r771b2082],
41	.	.	O	.	_	0	SENT_74	[p5l324t2003r771b2082],

1	The	DT	O	the	det	4	SENT_75	[p5l137t2131r298b2209],
2	primary	JJ	O	primary	amod	4	SENT_75	[p5l346t2132r696b2231],
3	end	NN	O	end	nn	4	SENT_75	[p5l742t2131r895b2210],
4	point	NN	O	point	nsubj	8	SENT_75	[p5l943t2132r1173b2231],
5	was	VBD	O	be	cop	8	SENT_75	[p5l1213t2157r1376b2210],
6	progression	NN	O	progression	npadvmod	8	SENT_75	[p5l1426t2130r2134b2232],
7	—	CD	NUMBER	—	num	6	SENT_75	[p5l1426t2130r2134b2232],
8	free	JJ	O	free	_	0	SENT_75	[p5l1426t2130r2134b2232],

1	2386	CD	DATE	2386	num	4	SENT_76	[p5l149t2289r226b2313],
2	N	NN	O	n	nn	4	SENT_76	[p5l964t2300r978b2315],
3	ENGLJ	NN	O	englj	nn	4	SENT_76	[p5l993t2300r1071b2322],
4	MED	NN	O	med	_	0	SENT_76	[p5l1085t2300r1137b2315],
5	368	CD	NUMBER	368	num	7	SENT_76	[p5l1147t2294r1226b2322],
6	;	:	O	;	_	0	SENT_76	[p5l1147t2294r1226b2322],
7	25	CD	NUMBER	25	dep	4	SENT_76	[p5l1147t2294r1226b2322],
8	NEjM	NNP	O	NEjM	nn	10	SENT_76	[p5l1262t2300r1386b2322],
9	,	,	O	,	_	0	SENT_76	[p5l1262t2300r1386b2322],
10	ORG	NNP	O	ORG	dep	7	SENT_76	[p5l1262t2300r1386b2322],
11	JUNE20	NN	O	june20	dep	4	SENT_76	[p5l1417t2300r1595b2322],
12	,2013	CD	NUMBER	,2013	num	11	SENT_76	[p5l1417t2300r1595b2322],

1	The	DT	O	the	det	4	SENT_77	[p5l936t2333r987b2357],
2	New	NNP	O	New	nn	4	SENT_77	[p5l996t2334r1058b2357],
3	England	NNP	O	England	nn	4	SENT_77	[p5l1067t2333r1178b2364],
4	Journal	NNP	O	Journal	_	0	SENT_77	[p5l1187t2333r1284b2357],
5	of	IN	O	of	_	0	SENT_77	[p5l1294t2333r1323b2357],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_77	[p5l1330t2333r1455b2357],

1	CRIZOTINIB	NNP	O	CRIZOTINIB	_	0	SENT_78	[p5l696t2521r899b2540],
2	FOR	IN	O	for	_	0	SENT_78	[p5l913t2521r977b2540],
3	ALK-POSITIVE	NNP	O	ALK-POSITIVE	nn	5	SENT_78	[p5l987t2521r1210b2540],
4	LUNG	NN	O	lung	nn	5	SENT_78	[p5l1225t2521r1316b2540],
5	CANCER	NNP	O	CANCER	prep_for	1	SENT_78	[p5l1330t2521r1464b2540],

1	survival	NN	O	survival	_	0	SENT_79	[p5l12t2734r367b2830],
2	,	,	O	,	_	0	SENT_79	[p5l12t2734r367b2830],
3	as	IN	O	as	mark	4	SENT_79	[p5l422t2760r507b2812],
4	assessed	VBN	O	assess	dep	1	SENT_79	[p5l559t2734r927b2813],
5	by	IN	O	by	_	0	SENT_79	[p5l978t2734r1075b2834],
6	independent	JJ	O	independent	amod	8	SENT_79	[p5l1120t2734r1658b2834],
7	radiologic	JJ	O	radiologic	amod	8	SENT_79	[p5l1703t2734r2134b2835],
8	review	NN	O	review	prep_by	4	SENT_79	[p5l11t2863r291b2941],
9	.	.	O	.	_	0	SENT_79	[p5l11t2863r291b2941],

1	Secondary	JJ	O	secondary	amod	3	SENT_80	[p5l336t2862r764b2961],
2	end	NN	O	end	nn	3	SENT_80	[p5l797t2862r945b2940],
3	points	NNS	O	point	nsubj	4	SENT_80	[p5l981t2863r1239b2961],
4	included	VBD	O	include	_	0	SENT_80	[p5l1277t2862r1629b2941],
5	overall	JJ	O	overall	amod	6	SENT_80	[p5l1666t2862r1938b2941],
6	survival	NN	O	survival	nsubj	19	SENT_80	[p5l1976t2888r2132b2941, p5l7t2989r224b3085],
7	,	,	O	,	_	0	SENT_80	[p5l1976t2888r2132b2941, p5l7t2989r224b3085],
8	response	NN	O	response	nn	9	SENT_80	[p5l267t3015r647b3089],
9	rate	NN	O	rate	appos	6	SENT_80	[p5l684t3006r844b3067],
10	(	CD	NUMBER	(	num	11	SENT_80	[p5l886t2996r1072b3080],
11	rate	NN	O	rate	dep	9	SENT_80	[p5l886t2996r1072b3080],
12	of	IN	O	of	_	0	SENT_80	[p5l1110t2988r1209b3068],
13	partial	JJ	O	partial	amod	16	SENT_80	[p5l1226t2989r1514b3089],
14	and	CC	O	and	_	0	SENT_80	[p5l1549t2989r1707b3068],
15	complete	JJ	O	complete	conj_and	13	SENT_80	[p5l1744t2989r2133b3089],
16	responses	NNS	O	response	prep_of	11	SENT_80	[p5l11t3124r474b3217],
17	)	RB	O	)	advmod	16	SENT_80	[p5l11t3124r474b3217],
18	,	,	O	,	_	0	SENT_80	[p5l11t3124r474b3217],
19	safety	NN	O	safety	xcomp	4	SENT_80	[p5l511t3116r771b3217],
20	,	,	O	,	_	0	SENT_80	[p5l511t3116r771b3217],
21	and	CC	O	and	_	0	SENT_80	[p5l805t3117r961b3196],
22	patient	NN	O	patient	nsubj	24	SENT_80	[p5l990t3117r1670b3217],
23	—	RB	O	—	advmod	24	SENT_80	[p5l990t3117r1670b3217],
24	reported	VBD	O	report	conj_and	4	SENT_80	[p5l990t3117r1670b3217],
25	outcomes	NNS	O	outcome	dobj	24	SENT_80	[p5l1700t3134r2128b3197],
26	.	.	O	.	_	0	SENT_80	[p5l1700t3134r2128b3197],

1	Treatment	NN	O	treatment	nsubjpass	3	SENT_81	[p5l7t3252r456b3324],
2	was	VBD	O	be	auxpass	3	SENT_81	[p5l497t3272r660b3325],
3	continued	VBN	O	continue	_	0	SENT_81	[p5l714t3246r1142b3325],
4	until	IN	O	until	mark	7	SENT_81	[p5l1193t3246r1396b3325],
5	RECIST	NNP	O	RECIST	nsubj	7	SENT_81	[p5l1445t3245r2133b3330],
6	—	RB	O	—	advmod	7	SENT_81	[p5l1445t3245r2133b3330],
7	defined	VBD	O	define	advcl	3	SENT_81	[p5l1445t3245r2133b3330],
8	disease	NN	O	disease	nn	9	SENT_81	[p5l12t3374r302b3453],
9	progression	NN	O	progression	nsubjpass	11	SENT_81	[p5l337t3375r816b3475],
10	was	VBD	O	be	auxpass	11	SENT_81	[p5l847t3400r1003b3453],
11	documented	VBN	O	document	ccomp	7	SENT_81	[p5l1041t3374r1565b3470],
12	,	,	O	,	_	0	SENT_81	[p5l1041t3374r1565b3470],
13	unacceptable	JJ	O	unacceptable	amod	14	SENT_81	[p5l1606t3374r2133b3474],
14	toxic	JJ	O	toxic	amod	15	SENT_81	[p5l12t3502r208b3580],
15	effects	NNS	O	effect	nsubj	16	SENT_81	[p5l244t3500r512b3579],
16	developed	VBD	O	develop	ccomp	3	SENT_81	[p5l550t3501r980b3601],
17	,	,	O	,	_	0	SENT_81	[p5l550t3501r980b3601],
18	the	DT	O	the	det	19	SENT_81	[p5l1021t3501r1150b3579],
19	patient	NN	O	patient	nsubj	20	SENT_81	[p5l1183t3502r1472b3601],
20	withdrew	VBD	O	withdraw	ccomp	3	SENT_81	[p5l1498t3501r1898b3581],
21	from	IN	O	from	_	0	SENT_81	[p5l1930t3500r2133b3580],
22	the	DT	O	the	det	23	SENT_81	[p5l12t3630r144b3708],
23	study	NN	O	study	prep_from	20	SENT_81	[p5l208t3630r451b3729],
24	,	,	O	,	_	0	SENT_81	[p5l208t3630r451b3729],
25	or	CC	O	or	_	0	SENT_81	[p5l520t3656r608b3708],
26	the	DT	O	the	det	27	SENT_81	[p5l668t3630r801b3708],
27	patient	NN	O	patient	nsubj	28	SENT_81	[p5l862t3631r1164b3729],
28	died	VBD	O	die	conj_or	3	SENT_81	[p5l1222t3630r1427b3708],
29	.	.	O	.	_	0	SENT_81	[p5l1222t3630r1427b3708],

1	Patients	NNS	O	patient	nsubj	3	SENT_82	[p5l1494t3631r1834b3708],
2	could	MD	O	could	aux	3	SENT_82	[p5l1899t3630r2133b3709],
3	continue	VB	O	continue	_	0	SENT_82	[p6l12t22r385b100],
4	treatment	NN	O	treatment	dobj	3	SENT_82	[p6l425t38r848b99],
5	beyond	IN	O	beyond	_	0	SENT_82	[p6l883t21r1190b121],
6	RECIST	NNP	O	RECIST	prep_beyond	3	SENT_82	[p6l1228t20r1916b105],
7	—	CD	NUMBER	—	num	6	SENT_82	[p6l1228t20r1916b105],
8	def1ned	VBN	O	def1ne	partmod	6	SENT_82	[p6l1228t20r1916b105],
9	progression	NN	O	progression	dobj	8	SENT_82	[p6l1953t47r2132b121, p6l11t151r373b251],
10	at	IN	O	at	_	0	SENT_82	[p6l436t167r514b228],
11	the	DT	O	the	det	12	SENT_82	[p6l573t150r706b228],
12	discretion	NN	O	discretion	prep_at	8	SENT_82	[p6l769t150r1198b229],
13	of	IN	O	of	_	0	SENT_82	[p6l1262t149r1362b229],
14	the	DT	O	the	det	15	SENT_82	[p6l1406t150r1539b228],
15	investigator	NN	O	investigator	prep_of	12	SENT_82	[p6l1601t151r2128b251],
16	.	.	O	.	_	0	SENT_82	[p6l1601t151r2128b251],

1	Patients	NNS	O	patient	nsubjpass	10	SENT_83	[p6l9t279r341b356],
2	in	IN	O	in	_	0	SENT_83	[p6l376t279r458b356],
3	the	DT	O	the	det	5	SENT_83	[p6l492t278r622b356],
4	chemotherapy	NN	O	chemotherapy	nn	5	SENT_83	[p6l656t278r1255b378],
5	group	NN	O	group	prep_in	1	SENT_83	[p6l1283t304r1531b379],
6	with	IN	O	with	_	0	SENT_83	[p6l1561t278r1753b357],
7	RECISTdefined	VBN	O	recistdefine	prepc_with	5	SENT_83	[p6l1784t284r2132b361, p6l12t405r338b485],
8	progression	NN	O	progression	dobj	7	SENT_83	[p6l382t407r893b507],
9	were	VBD	O	be	auxpass	10	SENT_83	[p6l935t432r1137b485],
10	allowed	VBN	O	allow	_	0	SENT_83	[p6l1182t406r1516b485],
11	to	TO	O	to	aux	12	SENT_83	[p6l1562t423r1644b485],
12	cross	VB	O	cross	xcomp	10	SENT_83	[p6l1692t432r1910b485],
13	over	IN	O	over	acomp	12	SENT_83	[p6l1958t432r2136b485],
14	to	TO	O	to	aux	15	SENT_83	[p6l12t550r93b612],
15	receive	VB	O	receive	xcomp	13	SENT_83	[p6l140t534r429b612],
16	crizotinib	NN	O	crizotinib	dobj	15	SENT_83	[p6l474t533r894b612],
17	as	IN	O	as	_	0	SENT_83	[p6l940t559r1026b611],
18	part	NN	O	part	prep_as	15	SENT_83	[p6l1071t550r1251b633],
19	of	IN	O	of	_	0	SENT_83	[p6l1292t532r1391b612],
20	a	DT	O	a	det	22	SENT_83	[p6l1418t559r1462b611],
21	separate	JJ	O	separate	amod	22	SENT_83	[p6l1507t550r1862b633],
22	study	NN	O	study	prep_of	18	SENT_83	[p6l1908t533r2138b633],
23	(	CD	NUMBER	(	num	24	SENT_83	[p6l16t662r803b763],
24	ClinicalTrials	NNS	O	clinicaltrial	dobj	12	SENT_83	[p6l16t662r803b763],
25	.	.	O	.	_	0	SENT_83	[p6l16t662r803b763],

1	goV	NN	O	gov	nn	2	SENT_84	[p6l16t662r803b763],
2	number	NN	O	number	_	0	SENT_84	[p6l839t662r1194b758],
3	,	,	O	,	_	0	SENT_84	[p6l839t662r1194b758],
4	NCTOO932451	NN	O	nctoo932451	nn	5	SENT_84	[p6l1237t668r1894b753],
5	)	NN	O	)	appos	2	SENT_84	[p6l1237t668r1894b753],
6	.	.	O	.	_	0	SENT_84	[p6l1237t668r1894b753],

1	ASSESSMENTS	NNS	O	assessment	nn	2	SENT_85	[p6l9t937r575b987],
2	Patients	NNS	O	patient	nsubj	3	SENT_85	[p6l9t1037r349b1114],
3	underwent	VBD	O	undergo	_	0	SENT_85	[p6l391t1036r856b1115],
4	baseline	NN	O	baseline	nn	6	SENT_85	[p6l893t1036r1244b1115],
5	tumor	NN	O	tumor	nn	6	SENT_85	[p6l1286t1053r1554b1115],
6	imaging	NN	O	imaging	dobj	3	SENT_85	[p6l1591t1037r1972b1137],
7	,	,	O	,	_	0	SENT_85	[p6l1591t1037r1972b1137],
8	including	VBG	O	include	_	0	SENT_85	[p6l2017t1037r2132b1114, p6l12t1164r334b1265],
9	brain	NN	O	brain	nn	12	SENT_85	[p6l366t1164r591b1243],
10	and	CC	O	and	_	0	SENT_85	[p6l625t1164r783b1243],
11	bone	NN	O	bone	nn	12	SENT_85	[p6l818t1164r1025b1243],
12	scanning	NN	O	scanning	prep_including	6	SENT_85	[p6l1062t1165r1477b1265],
13	.	.	O	.	_	0	SENT_85	[p6l1062t1165r1477b1265],

1	Tumor	NN	O	tumor	nsubj	2	SENT_86	[p6l1513t1170r1803b1243],
2	assess	VB	O	assess	_	0	SENT_86	[p6l1834t1190r2132b1242],
3	—	JJ	O	—	amod	4	SENT_86	[p6l1834t1190r2132b1242],
4	ments	NNS	O	ment	nsubjpass	6	SENT_86	[p6l11t1308r263b1369],
5	were	VBD	O	be	auxpass	6	SENT_86	[p6l288t1317r484b1371],
6	performed	VBN	O	perform	ccomp	2	SENT_86	[p6l511t1290r950b1391],
7	every	DT	SET	every	det	9	SENT_86	[p6l979t1317r1191b1391],
8	6	CD	SET	6	num	9	SENT_86	[p6l1215t1297r1262b1370],
9	weeks	NNS	NUMBER	week	tmod	6	SENT_86	[p6l1287t1291r1540b1371],
10	until	IN	O	until	_	0	SENT_86	[p6l1570t1291r1764b1371],
11	RECISTdefmed	NN	O	recistdefmed	nn	13	SENT_86	[p6l1791t1297r2132b1375, p6l12t1419r332b1499],
12	disease	NN	O	disease	nn	13	SENT_86	[p6l368t1420r671b1499],
13	progression	NN	O	progression	prep_until	6	SENT_86	[p6l706t1421r1228b1521],
14	.	.	O	.	_	0	SENT_86	[p6l706t1421r1228b1521],

1	RECIST	NNP	LOCATION	RECIST	nsubjpass	7	SENT_87	[p6l1268t1426r1609b1516],
2	,	,	O	,	_	0	SENT_87	[p6l1268t1426r1609b1516],
3	version	NN	O	version	appos	1	SENT_87	[p6l1646t1421r1947b1499],
4	1.1	CD	NUMBER	1.1	num	3	SENT_87	[p6l1987t1426r2128b1516],
5	,	,	O	,	_	0	SENT_87	[p6l1987t1426r2128b1516],
6	was	VBD	O	be	auxpass	7	SENT_87	[p6l7t1574r165b1627],
7	used	VBN	O	use	_	0	SENT_87	[p6l196t1548r386b1627],
8	to	TO	O	to	aux	9	SENT_87	[p6l416t1565r495b1626],
9	assess	VB	O	assess	xcomp	7	SENT_87	[p6l524t1574r777b1626],
10	tumor	NN	O	tumor	nn	11	SENT_87	[p6l809t1564r1069b1627],
11	responses	NNS	O	response	dobj	9	SENT_87	[p6l1094t1574r1523b1647],
12	;	:	O	;	_	0	SENT_87	[p6l1094t1574r1523b1647],
13	all	DT	O	all	det	14	SENT_87	[p6l1555t1548r1656b1625],
14	scans	NNS	O	scan	nsubj	16	SENT_87	[p6l1685t1574r1911b1626],
15	were	VBD	O	be	cop	16	SENT_87	[p6l1938t1574r2133b1627],
16	subject	JJ	O	subject	parataxis	7	SENT_87	[p6l12t1676r310b1775],
17	to	TO	O	to	_	0	SENT_87	[p6l341t1693r422b1754],
18	central	JJ	O	central	amod	19	SENT_87	[p6l459t1676r754b1754],
19	review	NN	O	review	prep_to	16	SENT_87	[p6l789t1677r1069b1755],
20	by	IN	O	by	_	0	SENT_87	[p6l1101t1676r1198b1775],
21	independent	JJ	O	independent	amod	22	SENT_87	[p6l1228t1676r1767b1775],
22	radiologists	NNS	O	radiologist	prep_by	16	SENT_87	[p6l1796t1676r2132b1754, p6l11t1805r206b1905],
23	who	WP	O	who	nsubj	25	SENT_87	[p6l229t1804r409b1883],
24	were	VBD	O	be	cop	25	SENT_87	[p6l431t1830r630b1883],
25	unaware	JJ	O	unaware	rcmod	22	SENT_87	[p6l655t1830r1014b1883],
26	of	IN	O	of	_	0	SENT_87	[p6l1040t1803r1139b1883],
27	the	DT	O	the	det	29	SENT_87	[p6l1146t1804r1276b1882],
28	group	NN	O	group	nn	29	SENT_87	[p6l1302t1830r1550b1905],
29	assignments	NNS	O	assignment	prep_of	25	SENT_87	[p6l1575t1805r2127b1905],
30	.	.	O	.	_	0	SENT_87	[p6l1575t1805r2127b1905],

1	Adverse	JJ	O	adverse	amod	2	SENT_88	[p6l136t1932r459b2011],
2	events	NNS	O	event	_	0	SENT_88	[p6l492t1949r767b2028],
3	,	,	O	,	_	0	SENT_88	[p6l492t1949r767b2028],
4	which	WDT	O	which	nsubjpass	8	SENT_88	[p6l801t1932r1055b2011],
5	were	VBD	O	be	auxpass	6	SENT_88	[p6l1084t1958r1279b2011],
6	classified	VBN	O	classify	dep	2	SENT_88	[p6l1312t1931r1698b2011],
7	and	CC	O	and	_	0	SENT_88	[p6l1730t1932r1884b2011],
8	graded	VBN	O	grade	dep	2	SENT_88	[p6l1916t1932r2132b2033, p6l12t2060r106b2139],
9	according	VBG	O	accord	_	0	SENT_88	[p6l137t2060r546b2161],
10	to	TO	O	to	prepc_according_to	6	SENT_88	[p6l574t2077r654b2139],
11	the	DT	O	the	det	14	SENT_88	[p6l687t2060r816b2138],
12	Common	JJ	O	common	amod	14	SENT_88	[p6l847t2066r1238b2139],
13	Terminology	NN	O	terminology	nn	14	SENT_88	[p6l1266t2060r1801b2161],
14	Criteria	NNS	O	criterion	pobj	6	SENT_88	[p6l1828t2061r2135b2139],
15	for	IN	O	for	_	0	SENT_88	[p6l11t2186r136b2266],
16	Adverse	JJ	O	adverse	amod	17	SENT_88	[p6l194t2187r535b2267],
17	Events	NNS	O	event	prep_for	14	SENT_88	[p6l598t2195r902b2283],
18	,	,	O	,	_	0	SENT_88	[p6l598t2195r902b2283],
19	version	NN	O	version	appos	17	SENT_88	[p6l967t2188r1282b2267],
20	4.0	CD	NUMBER	4.0	number	21	SENT_88	[p6l1344t2193r1473b2266],
21	(	CD	NUMBER	(	num	22	SENT_88	[p6l1543t2187r2134b2287],
22	http://evs.nci	NNS	O	http://evs.nci	dep	19	SENT_88	[p6l1543t2187r2134b2287],
23	.	.	O	.	_	0	SENT_88	[p6l15t2315r2123b2417],

1	nih	NN	O	nih	_	0	SENT_89	[p6l15t2315r2123b2417],
2	.	.	O	.	_	0	SENT_89	[p6l15t2315r2123b2417],

1	gov/ftp1/CTCAE	NN	O	gov/ftp1/ctcae	_	0	SENT_90	[p6l15t2315r2123b2417],
2	/	:	O	/	punct	3	SENT_90	[p6l15t2315r2123b2417],
3	CTCAE_4	NN	O	ctcae_4	dep	1	SENT_90	[p6l15t2315r2123b2417],
4	.03	CD	NUMBER	.03	number	5	SENT_90	[p6l15t2315r2123b2417],
5	_	CD	NUMBER	_	dep	3	SENT_90	[p6l15t2315r2123b2417],
6	2010	CD	DATE	2010	dep	5	SENT_90	[p6l15t2315r2123b2417],
7	.	.	O	.	_	0	SENT_90	[p6l15t2315r2123b2417],

1	—	NN	O	—	_	0	SENT_91	[p6l15t2315r2123b2417],
2	.	.	O	.	_	0	SENT_91	[p6l15t2315r2123b2417],

1	O6-14	CD	NUMBER	o6-14	num	3	SENT_92	[p6l15t2315r2123b2417],
2	_	CD	NUMBER	_	num	3	SENT_92	[p6l15t2315r2123b2417],
3	QuickReference_8	NN	O	quickreference_8	_	0	SENT_92	[p6l11t2442r1240b2543],
4	.5	CD	NUMBER	.5	num	5	SENT_92	[p6l11t2442r1240b2543],
5	X11	NN	O	x11	dep	3	SENT_92	[p6l11t2442r1240b2543],
6	.	.	O	.	_	0	SENT_92	[p6l11t2442r1240b2543],

1	pdf	NN	O	pdf	nn	2	SENT_93	[p6l11t2442r1240b2543],
2	)	NN	O	)	nsubjpass	5	SENT_93	[p6l11t2442r1240b2543],
3	,	,	O	,	_	0	SENT_93	[p6l11t2442r1240b2543],
4	were	VBD	O	be	auxpass	5	SENT_93	[p6l1283t2469r1481b2523],
5	assessed	VBN	O	assess	_	0	SENT_93	[p6l1523t2443r1884b2522],
6	from	IN	O	from	_	0	SENT_93	[p6l1926t2442r2133b2522],
7	the	DT	O	the	det	8	SENT_93	[p6l12t2571r144b2649],
8	time	NN	O	time	prep_from	5	SENT_93	[p6l192t2572r385b2649],
9	the	DT	O	the	det	10	SENT_93	[p6l433t2571r566b2649],
10	patient	NN	O	patient	nsubj	11	SENT_93	[p6l612t2572r914b2671],
11	provided	VBD	O	provide	rcmod	8	SENT_93	[p6l954t2571r1329b2671],
12	written	VBN	O	write	amod	14	SENT_93	[p6l1371t2572r1685b2651],
13	informed	VBN	O	inform	amod	14	SENT_93	[p6l1732t2570r2134b2650],
14	consent	NN	O	consent	dobj	11	SENT_93	[p6l12t2716r346b2778],
15	until	IN	O	until	_	0	SENT_93	[p6l382t2699r585b2778],
16	at	IN	DURATION	at	quantmod	18	SENT_93	[p6l624t2716r702b2777],
17	least	JJS	DURATION	least	mwe	16	SENT_93	[p6l737t2699r936b2777],
18	28	CD	DURATION	28	num	19	SENT_93	[p6l970t2705r1070b2778],
19	days	NNS	NUMBER	day	prep_until	11	SENT_93	[p6l1112t2699r1297b2799],
20	after	IN	O	after	mark	28	SENT_93	[p6l1338t2698r1541b2777],
21	the	DT	O	the	det	23	SENT_93	[p6l1578t2699r1711b2777],
22	last	JJ	O	last	amod	23	SENT_93	[p6l1750t2699r1903b2777],
23	dose	NN	O	dose	nsubjpass	28	SENT_93	[p6l1939t2699r2133b2778],
24	of	IN	O	of	_	0	SENT_93	[p6l12t2827r112b2907],
25	study	NN	O	study	nn	26	SENT_93	[p6l127t2828r357b2928],
26	drug	NN	O	drug	prep_of	23	SENT_93	[p6l385t2828r589b2929],
27	was	VBD	O	be	auxpass	28	SENT_93	[p6l613t2854r776b2907],
28	administered	VBN	O	administer	advcl	11	SENT_93	[p6l809t2828r1403b2907],
29	.	.	O	.	_	0	SENT_93	[p6l809t2828r1403b2907],

1	Patient	NN	O	patient	nsubj	3	SENT_94	[p6l1439t2828r2133b2928],
2	—	CD	NUMBER	—	num	1	SENT_94	[p6l1439t2828r2133b2928],
3	reported	VBD	O	report	_	0	SENT_94	[p6l1439t2828r2133b2928],
4	symptoms	NNS	O	symptom	dobj	3	SENT_94	[p6l12t2973r471b3056],
5	,	,	O	,	_	0	SENT_94	[p6l12t2973r471b3056],
6	functioning	VBG	O	function	partmod	3	SENT_94	[p6l512t2955r1032b3057],
7	,	,	O	,	_	0	SENT_94	[p6l512t2955r1032b3057],
8	and	CC	O	and	_	0	SENT_94	[p6l1072t2956r1228b3035],
9	global	JJ	O	global	amod	10	SENT_94	[p6l1263t2956r1525b3057],
10	quality	NN	O	quality	nsubjpass	14	SENT_94	[p6l1561t2956r1853b3056],
11	of	IN	O	of	_	0	SENT_94	[p6l1885t2955r1984b3035],
12	life	NN	O	life	prep_of	10	SENT_94	[p6l2000t2955r2133b3034],
13	were	VBD	O	be	auxpass	14	SENT_94	[p6l7t3109r205b3163],
14	assessed	VBN	O	assess	conj_and	14	SENT_94	[p6l239t3083r599b3162],
15	at	IN	O	at	_	0	SENT_94	[p6l633t3100r711b3161],
16	baseline	NN	O	baseline	prep_at	14	SENT_94	[p6l741t3083r1107b3179],
17	,	,	O	,	_	0	SENT_94	[p6l741t3083r1107b3179],
18	on	IN	O	on	_	0	SENT_94	[p6l1147t3109r1252b3162],
19	day	NN	DURATION	day	prep_on	14	SENT_94	[p6l1288t3083r1432b3183],
20	1	CD	NUMBER	1	num	19	SENT_94	[p6l1464t3089r1509b3161],
21	of	IN	O	of	_	0	SENT_94	[p6l1544t3082r1643b3162],
22	every	DT	O	every	det	23	SENT_94	[p6l1660t3109r1876b3183],
23	cycle	NN	O	cycle	prep_of	19	SENT_94	[p6l1907t3083r2128b3183],
24	,	,	O	,	_	0	SENT_94	[p6l1907t3083r2128b3183],
25	and	CC	O	and	_	0	SENT_94	[p6l11t3212r168b3291],
26	at	IN	O	at	_	0	SENT_94	[p6l219t3229r298b3290],
27	the	DT	O	the	det	28	SENT_94	[p6l345t3212r477b3291],
28	end	NN	O	end	prep_at	14	SENT_94	[p6l530t3212r683b3291],
29	of	IN	O	of	_	0	SENT_94	[p6l735t3211r835b3291],
30	treatment	NN	O	treatment	prep_of	28	SENT_94	[p6l868t3229r1292b3290],
31	with	IN	O	with	_	0	SENT_94	[p6l1334t3212r1529b3291],
32	the	DT	O	the	det	33	SENT_94	[p6l1582t3212r1714b3291],
33	use	NN	O	use	prep_with	30	SENT_94	[p6l1765t3238r1906b3291],
34	of	IN	O	of	_	0	SENT_94	[p6l1958t3211r2058b3291],
35	a	DT	O	a	prep_of	33	SENT_94	[p6l2091t3238r2135b3290],
36	validated	VBN	O	validate	partmod	35	SENT_94	[p6l7t3340r396b3419],
37	questionnaire	NN	O	questionnaire	dobj	36	SENT_94	[p6l431t3341r1047b3440],
38	,	,	O	,	_	0	SENT_94	[p6l431t3341r1047b3440],
39	the	DT	O	the	det	41	SENT_94	[p6l1088t3340r1221b3419],
40	European	NNP	ORGANIZATION	European	nn	41	SENT_94	[p6l1254t3348r1667b3440],
41	Organization	NNP	ORGANIZATION	Organization	conj_and	37	SENT_94	[p6l1702t3341r2132b3441, p6l12t3468r177b3546],
42	for	IN	ORGANIZATION	for	_	0	SENT_94	[p6l218t3466r339b3546],
43	Research	NNP	ORGANIZATION	Research	prep_for	41	SENT_94	[p6l376t3467r759b3551],
44	and	CC	O	and	_	0	SENT_94	[p6l799t3467r955b3546],
45	Treatment	NN	O	treatment	conj_and	37	SENT_94	[p6l991t3473r1432b3545],
46	of	IN	O	of	_	0	SENT_94	[p6l1468t3466r1567b3546],
47	Cancer	NNP	O	Cancer	nn	49	SENT_94	[p6l1589t3473r1883b3546],
48	quality	NN	O	quality	nn	49	SENT_94	[p6l1921t3467r2132b3567, p6l11t3594r398b3695],
49	—	NN	O	—	prep_of	45	SENT_94	[p6l1921t3467r2132b3567, p6l11t3594r398b3695],
50	of	IN	O	of	_	0	SENT_94	[p6l1921t3467r2132b3567, p6l11t3594r398b3695],
51	—	CD	NUMBER	—	num	53	SENT_94	[p6l1921t3467r2132b3567, p6l11t3594r398b3695],
52	life	NN	O	life	nn	53	SENT_94	[p6l1921t3467r2132b3567, p6l11t3594r398b3695],
53	questionnaire	NN	O	questionnaire	prep_of	49	SENT_94	[p6l435t3596r1029b3695],
54	(	CD	NUMBER	(	num	55	SENT_94	[p6l1070t3601r1601b3694],
55	QLQ	NN	O	qlq	dep	45	SENT_94	[p6l1070t3601r1601b3694],
56	.	.	O	.	_	0	SENT_94	[p6l1070t3601r1601b3694],

1	—	NN	O	—	_	0	SENT_95	[p6l1070t3601r1601b3694],
2	.	.	O	.	_	0	SENT_95	[p6l1070t3601r1601b3694],

1	C30	NN	O	c30	nn	2	SENT_96	[p6l1070t3601r1601b3694],
2	)	NN	O	)	_	0	SENT_96	[p6l1070t3601r1601b3694],
3	2	CD	NUMBER	2	num	4	SENT_96	[p6l1070t3601r1601b3694],
4	°	NN	O	°	dep	2	SENT_96	[p6l1070t3601r1601b3694],
5	and	CC	O	and	_	0	SENT_96	[p6l1637t3595r1795b3674],
6	its	PRP$	O	its	poss	7	SENT_96	[p6l1831t3596r1929b3673],
7	corresponding	JJ	O	corresponding	dep	2	SENT_96	[p6l1969t3621r2132b3674, p7l11t22r502b123],

1	module	NN	O	module	_	0	SENT_97	[p7l522t22r844b101],
2	for	IN	O	for	_	0	SENT_97	[p7l867t21r990b101],
3	lung	NN	O	lung	nn	4	SENT_97	[p7l1009t22r1203b123],
4	cancer	NN	O	cancer	prep_for	1	SENT_97	[p7l1223t48r1504b100],
5	(	CD	NUMBER	(	num	6	SENT_97	[p7l1529t27r2134b120],
6	QLQ	NN	O	qlq	dep	4	SENT_97	[p7l1529t27r2134b120],
7	.	.	O	.	_	0	SENT_97	[p7l1529t27r2134b120],

1	—	NN	O	—	_	0	SENT_98	[p7l1529t27r2134b120],
2	.	.	O	.	_	0	SENT_98	[p7l1529t27r2134b120],

1	LC13	NN	O	lc13	nsubj	8	SENT_99	[p7l1529t27r2134b120],
2	)	CD	NUMBER	)	number	3	SENT_99	[p7l1529t27r2134b120],
3	.21	CD	NUMBER	.21	num	4	SENT_99	[p7l1529t27r2134b120],
4	Scores	NNS	O	score	dep	1	SENT_99	[p7l13t156r284b229],
5	on	IN	O	on	_	0	SENT_99	[p7l329t176r435b229],
6	these	DT	O	these	det	7	SENT_99	[p7l478t150r701b229],
7	questionnaires	NNS	O	questionnaire	prep_on	1	SENT_99	[p7l745t151r1380b250],
8	range	VBP	O	range	_	0	SENT_99	[p7l1424t176r1664b251],
9	from	IN	O	from	_	0	SENT_99	[p7l1707t149r1917b229],
10	o	NN	O	o	prep_from	8	SENT_99	[p7l1960t156r2006b229],
11	to	TO	O	to	_	0	SENT_99	[p7l2050t167r2132b229],
12	100	CD	NUMBER	100	prep_to	8	SENT_99	[p7l15t284r185b357],
13	.	.	O	.	_	0	SENT_99	[p7l15t284r185b357],

1	For	IN	O	for	_	0	SENT_100	[p7l222t286r364b357],
2	symptoms	NNS	O	symptom	prep_for	6	SENT_100	[p7l396t295r864b378],
3	,	,	O	,	_	0	SENT_100	[p7l396t295r864b378],
4	higher	JJR	O	higher	amod	5	SENT_100	[p7l902t278r1183b379],
5	scores	NNS	O	score	nsubj	6	SENT_100	[p7l1214t304r1478b357],
6	indicate	VBP	O	indicate	_	0	SENT_100	[p7l1512t278r1853b357],
7	greater	JJR	O	greater	amod	8	SENT_100	[p7l1886t295r2132b379, p7l12t432r92b484],
8	severity	NN	O	severity	dobj	6	SENT_100	[p7l149t407r474b506],
9	of	IN	O	of	_	0	SENT_100	[p7l528t405r628b485],
10	symptoms	NNS	O	symptom	prep_of	8	SENT_100	[p7l669t423r1136b506],
11	;	:	O	;	_	0	SENT_100	[p7l669t423r1136b506],
12	for	IN	O	for	_	0	SENT_100	[p7l1197t405r1320b485],
13	global	JJ	O	global	amod	14	SENT_100	[p7l1375t406r1642b507],
14	quality	NN	O	quality	prep_for	20	SENT_100	[p7l1700t406r1999b506],
15	of	IN	O	of	_	0	SENT_100	[p7l2052t405r2152b485],
16	life	NN	O	life	prep_of	14	SENT_100	[p7l10t533r169b630],
17	,	,	O	,	_	0	SENT_100	[p7l10t533r169b630],
18	higher	JJR	O	higher	amod	19	SENT_100	[p7l218t534r499b635],
19	scores	NNS	O	score	nsubj	20	SENT_100	[p7l541t560r804b613],
20	indicate	VBP	O	indicate	parataxis	6	SENT_100	[p7l850t534r1191b613],
21	better	JJR	O	better	amod	23	SENT_100	[p7l1236t534r1488b613],
22	global	JJ	O	global	amod	23	SENT_100	[p7l1528t534r1795b635],
23	quality	NN	O	quality	dobj	20	SENT_100	[p7l1840t534r2137b634],
24	of	IN	O	of	_	0	SENT_100	[p7l12t661r112b741],
25	life	NN	O	life	prep_of	23	SENT_100	[p7l132t661r291b741],
26	.	.	O	.	_	0	SENT_100	[p7l132t661r291b741],

1	STATISTICAL	JJ	O	statistical	amod	2	SENT_101	[p7l11t935r500b985],
2	ANALYSIS	NN	O	analysis	nsubj	58	SENT_101	[p7l530t935r905b985],
3	We	PRP	O	we	nsubj	4	SENT_101	[p7l7t1042r140b1113],
4	estimated	VBD	O	estimate	rcmod	2	SENT_101	[p7l170t1034r591b1113],
5	that	IN	O	that	complm	19	SENT_101	[p7l621t1034r793b1112],
6	with	IN	O	with	_	0	SENT_101	[p7l813t1034r1008b1113],
7	a	DT	O	a	det	8	SENT_101	[p7l1036t1060r1080b1112],
8	total	NN	O	total	prep_with	19	SENT_101	[p7l1108t1034r1305b1113],
9	of	IN	O	of	_	0	SENT_101	[p7l1334t1033r1434b1113],
10	217	CD	NUMBER	217	num	12	SENT_101	[p7l1445t1040r1594b1112],
11	progression	NN	O	progression	nn	12	SENT_101	[p7l1622t1035r2133b1135],
12	events	NNS	O	event	prep_of	8	SENT_101	[p7l12t1178r275b1241],
13	or	CC	O	or	_	0	SENT_101	[p7l309t1188r398b1240],
14	deaths	NNS	O	death	conj_or	12	SENT_101	[p7l426t1162r730b1257],
15	,	,	O	,	_	0	SENT_101	[p7l426t1162r730b1257],
16	the	DT	O	the	det	17	SENT_101	[p7l767t1162r899b1240],
17	study	NN	O	study	nsubj	19	SENT_101	[p7l932t1162r1161b1261],
18	would	MD	O	would	aux	19	SENT_101	[p7l1183t1162r1449b1241],
19	have	VB	O	have	ccomp	4	SENT_101	[p7l1480t1162r1669b1241],
20	90	CD	PERCENT	90	number	21	SENT_101	[p7l1700t1167r1890b1241],
21	%	NN	PERCENT	%	amod	22	SENT_101	[p7l1700t1167r1890b1241],
22	power	NN	O	power	dobj	19	SENT_101	[p7l1918t1188r2132b1261, p7l12t1316r92b1368],
23	to	TO	O	to	aux	24	SENT_101	[p7l131t1307r212b1369],
24	detect	VB	O	detect	infmod	22	SENT_101	[p7l256t1290r514b1369],
25	a	DT	O	a	det	28	SENT_101	[p7l550t1316r594b1368],
26	56	CD	PERCENT	56	number	27	SENT_101	[p7l636t1295r817b1369],
27	%	NN	PERCENT	%	amod	28	SENT_101	[p7l636t1295r817b1369],
28	improvement	NN	O	improvement	dobj	24	SENT_101	[p7l857t1291r1431b1390],
29	in	IN	O	in	_	0	SENT_101	[p7l1466t1291r1550b1368],
30	progressionfree	JJ	O	progressionfree	amod	31	SENT_101	[p7l1589t1291r2132b1391, p7l11t1416r167b1495],
31	survival	NN	O	survival	prep_in	28	SENT_101	[p7l198t1417r514b1497],
32	with	IN	O	with	_	0	SENT_101	[p7l540t1417r728b1497],
33	crizotinib	NN	O	crizotinib	prep_with	31	SENT_101	[p7l759t1417r1160b1496],
34	as	IN	O	as	prep	24	SENT_101	[p7l1190t1443r1274b1495],
35	compared	VBN	O	compare	_	0	SENT_101	[p7l1306t1417r1718b1517],
36	with	IN	O	with	prepc_compared_with	24	SENT_101	[p7l1743t1417r1932b1497],
37	chemotherapy	NN	O	chemotherapy	pobj	24	SENT_101	[p7l1962t1417r2132b1495, p7l11t1546r457b1646],
38	(	CD	NUMBER	(	num	37	SENT_101	[p7l488t1547r659b1642],
39	i.e.	FW	O	i.e.	amod	37	SENT_101	[p7l488t1547r659b1642],
40	,	,	O	,	_	0	SENT_101	[p7l488t1547r659b1642],
41	median	JJ	O	median	amod	42	SENT_101	[p7l700t1546r1023b1625],
42	progression	NN	O	progression	dep	39	SENT_101	[p7l1057t1545r1765b1647],
43	—	CD	NUMBER	—	num	45	SENT_101	[p7l1057t1545r1765b1647],
44	free	JJ	O	free	amod	45	SENT_101	[p7l1057t1545r1765b1647],
45	survival	NN	O	survival	dep	42	SENT_101	[p7l1802t1546r2134b1625],
46	of	IN	O	of	_	0	SENT_101	[p7l12t1672r112b1752],
47	7.0	CD	DURATION	7.0	num	48	SENT_101	[p7l132t1679r246b1752],
48	months	NNS	NUMBER	month	prep_of	45	SENT_101	[p7l285t1673r612b1752],
49	vs.	CC	O	vs.	prep	48	SENT_101	[p7l648t1699r757b1752],
50	4.5	CD	DURATION	4.5	num	51	SENT_101	[p7l798t1680r923b1752],
51	months	NNS	NUMBER	month	dep	49	SENT_101	[p7l964t1673r1341b1769],
52	)	RB	O	)	advmod	24	SENT_101	[p7l964t1673r1341b1769],
53	,	,	O	,	_	0	SENT_101	[p7l964t1673r1341b1769],
54	at	IN	O	at	_	0	SENT_101	[p7l1384t1690r1463b1751],
55	a	DT	O	a	det	57	SENT_101	[p7l1495t1699r1540b1751],
56	one	CD	NUMBER	one	num	57	SENT_101	[p7l1577t1673r1990b1752],
57	—	NN	O	—	prep_at	24	SENT_101	[p7l1577t1673r1990b1752],
58	sided	VBD	O	side	_	0	SENT_101	[p7l1577t1673r1990b1752],
59	alpha	NN	O	alpha	amod	60	SENT_101	[p7l2027t1673r2132b1751, p7l9t1802r169b1902],
60	level	NN	O	level	dobj	58	SENT_101	[p7l207t1802r395b1881],
61	of	IN	O	of	_	0	SENT_101	[p7l436t1801r536b1881],
62	0.025	CD	NUMBER	0.025	prep_of	60	SENT_101	[p7l559t1808r807b1881],
63	.	.	O	.	_	0	SENT_101	[p7l559t1808r807b1881],

1	Progression	NN	O	progression	npadvmod	3	SENT_102	[p7l852t1801r1560b1903],
2	—	CD	NUMBER	—	num	1	SENT_102	[p7l852t1801r1560b1903],
3	free	JJ	O	free	amod	4	SENT_102	[p7l852t1801r1560b1903],
4	survival	NN	O	survival	nsubjpass	6	SENT_102	[p7l1602t1802r1933b1881],
5	was	VBD	O	be	auxpass	6	SENT_102	[p7l1969t1828r2131b1881],
6	defined	VBN	O	define	_	0	SENT_102	[p7l12t1928r338b2008],
7	as	IN	O	as	_	0	SENT_102	[p7l376t1955r461b2007],
8	the	DT	O	the	det	9	SENT_102	[p7l502t1929r635b2007],
9	time	NN	O	time	prep_as	6	SENT_102	[p7l674t1930r867b2007],
10	from	IN	O	from	_	0	SENT_102	[p7l906t1928r1116b2008],
11	randomization	NN	O	randomization	prep_from	9	SENT_102	[p7l1155t1929r1795b2008],
12	to	TO	O	to	_	0	SENT_102	[p7l1834t1946r1915b2008],
13	progression	NN	O	progression	prep_to	6	SENT_102	[p7l1953t1955r2132b2029, p7l11t2059r373b2159],
14	of	IN	O	of	_	0	SENT_102	[p7l411t2057r510b2137],
15	the	DT	O	the	det	16	SENT_102	[p7l529t2058r662b2136],
16	disease	NN	O	disease	prep_of	13	SENT_102	[p7l700t2058r1033b2154],
17	,	,	O	,	_	0	SENT_102	[p7l700t2058r1033b2154],
18	as	IN	O	as	mark	19	SENT_102	[p7l1075t2084r1160b2136],
19	assessed	VBN	O	assess	dep	16	SENT_102	[p7l1199t2058r1567b2137],
20	by	IN	O	by	_	0	SENT_102	[p7l1604t2058r1701b2158],
21	means	NNS	O	means	_	0	SENT_102	[p7l1733t2084r2012b2136],
22	of	IN	O	of	_	0	SENT_102	[p7l2052t2057r2152b2137],
23	independent	JJ	O	independent	amod	25	SENT_102	[p7l11t2186r549b2286],
24	radiologic	JJ	O	radiologic	amod	25	SENT_102	[p7l588t2186r1019b2287],
25	review	NN	O	review	prep_by_means_of	19	SENT_102	[p7l1063t2187r1356b2282],
26	,	,	O	,	_	0	SENT_102	[p7l1063t2187r1356b2282],
27	or	CC	O	or	_	0	SENT_102	[p7l1407t2212r1496b2265],
28	to	TO	O	to	_	0	SENT_102	[p7l1538t2203r1619b2265],
29	death	NN	O	death	prep_to	6	SENT_102	[p7l1666t2186r1926b2265],
30	.	.	O	.	_	0	SENT_102	[p7l1666t2186r1926b2265],

1	The	DT	O	the	det	3	SENT_103	[p7l1972t2186r2133b2264],
2	prespeciﬁed	JJ	O	prespeciﬁed	amod	3	SENT_103	[p7l9t2313r539b2414],
3	number	NN	O	number	nsubjpass	10	SENT_103	[p7l602t2314r940b2393],
4	of	IN	O	of	_	0	SENT_103	[p7l1000t2313r1100b2393],
5	progression	NN	O	progression	nn	6	SENT_103	[p7l1143t2315r1654b2415],
6	events	NNS	O	event	prep_of	3	SENT_103	[p7l1718t2331r1982b2393],
7	or	CC	O	or	_	0	SENT_103	[p7l2047t2340r2136b2393],
8	deaths	NNS	O	death	prep_of	3	SENT_103	[p7l12t2441r291b2520],
9	was	VBD	O	be	auxpass	10	SENT_103	[p7l334t2467r497b2520],
10	reached	VBN	O	reach	_	0	SENT_103	[p7l545t2441r877b2520],
11	in	IN	O	in	_	0	SENT_103	[p7l922t2442r1005b2519],
12	March	NNP	DATE	March	prep_in	10	SENT_103	[p7l1048t2441r1324b2519],
13	2012	CD	DATE	2012	num	12	SENT_103	[p7l1370t2447r1598b2537],
14	;	:	O	;	_	0	SENT_103	[p7l1370t2447r1598b2537],
15	the	DT	O	the	det	16	SENT_103	[p7l1648t2441r1781b2519],
16	date	NN	O	date	nsubj	20	SENT_103	[p7l1827t2441r2005b2520],
17	of	IN	O	of	_	0	SENT_103	[p7l2052t2440r2152b2520],
18	data	NNS	O	datum	nn	19	SENT_103	[p7l12t2569r191b2648],
19	cutoff	NN	O	cutoff	prep_of	16	SENT_103	[p7l223t2568r490b2649],
20	was	VBD	O	be	parataxis	10	SENT_103	[p7l499t2595r660b2649],
21	March	NNP	DATE	March	tmod	20	SENT_103	[p7l692t2569r963b2647],
22	30	CD	DATE	30	num	21	SENT_103	[p7l996t2575r1115b2665],
23	,	,	DATE	,	_	0	SENT_103	[p7l996t2575r1115b2665],
24	2012	CD	DATE	2012	num	21	SENT_103	[p7l1153t2575r1377b2648],
25	.	.	O	.	_	0	SENT_103	[p7l1153t2575r1377b2648],

1	One	CD	NUMBER	one	num	4	SENT_104	[p7l1415t2575r1585b2648],
2	prespeciﬁed	JJ	O	prespeciﬁed	amod	4	SENT_104	[p7l1616t2568r2133b2669],
3	interim	JJ	O	interim	amod	4	SENT_104	[p7l11t2698r322b2775],
4	analysis	NN	O	analysis	nsubjpass	9	SENT_104	[p7l353t2697r685b2797],
5	of	IN	O	of	_	0	SENT_104	[p7l719t2696r818b2776],
6	overall	JJ	O	overall	amod	7	SENT_104	[p7l831t2697r1110b2777],
7	survival	NN	O	survival	prep_of	4	SENT_104	[p7l1143t2697r1467b2777],
8	was	VBD	O	be	auxpass	9	SENT_104	[p7l1493t2723r1653b2777],
9	performed	VBN	O	perform	_	0	SENT_104	[p7l1685t2696r2133b2797],
10	at	IN	O	at	_	0	SENT_104	[p7l11t2843r89b2904],
11	the	DT	O	the	det	12	SENT_104	[p7l129t2826r261b2904],
12	time	NN	O	time	prep_at	9	SENT_104	[p7l306t2827r499b2905],
13	of	IN	O	of	_	0	SENT_104	[p7l545t2825r644b2905],
14	the	DT	O	the	det	16	SENT_104	[p7l671t2826r804b2904],
15	final	JJ	O	final	amod	16	SENT_104	[p7l848t2825r1052b2904],
16	analysis	NN	O	analysis	prep_of	12	SENT_104	[p7l1095t2826r1435b2926],
17	of	IN	O	of	_	0	SENT_104	[p7l1482t2825r1582b2905],
18	progressionfree	JJ	O	progressionfree	amod	19	SENT_104	[p7l1606t2827r2132b2927, p7l11t2952r167b3031],
19	survival	NN	O	survival	prep_of	16	SENT_104	[p7l200t2953r537b3033],
20	.	.	O	.	_	0	SENT_104	[p7l200t2953r537b3033],

1	For	IN	O	for	_	0	SENT_105	[p7l574t2961r713b3032],
2	the	DT	O	the	det	5	SENT_105	[p7l742t2953r870b3031],
3	final	JJ	O	final	amod	5	SENT_105	[p7l903t2952r1098b3031],
4	survival	NN	O	survival	nn	5	SENT_105	[p7l1132t2953r1448b3033],
5	analysis	NN	O	analysis	prep_for	8	SENT_105	[p7l1480t2953r1826b3053],
6	,	,	O	,	_	0	SENT_105	[p7l1480t2953r1826b3053],
7	We	PRP	O	we	nsubj	8	SENT_105	[p7l1860t2979r1978b3033],
8	estimate	VBP	O	estimate	_	0	SENT_105	[p7l2015t2979r2132b3031, p7l12t3082r287b3159],
9	that	IN	O	that	complm	14	SENT_105	[p7l337t3081r509b3159],
10	241	CD	NUMBER	241	num	11	SENT_105	[p7l554t3087r698b3160],
11	events	NNS	O	event	nsubjpass	14	SENT_105	[p7l750t3098r1012b3161],
12	Will	MD	O	will	aux	14	SENT_105	[p7l1059t3081r1224b3161],
13	be	VB	O	be	auxpass	14	SENT_105	[p7l1274t3081r1370b3160],
14	required	VBN	O	require	ccomp	8	SENT_105	[p7l1420t3081r1781b3181],
15	for	IN	O	for	_	0	SENT_105	[p7l1831t3080r1954b3160],
16	the	DT	O	the	det	17	SENT_105	[p7l2001t3081r2133b3159],
17	study	NN	O	study	prep_for	14	SENT_105	[p7l12t3210r242b3309],
18	to	TO	O	to	aux	19	SENT_105	[p7l266t3226r348b3288],
19	have	VB	O	have	xcomp	14	SENT_105	[p7l377t3210r567b3289],
20	80	CD	PERCENT	80	number	21	SENT_105	[p7l596t3215r784b3289],
21	%	NN	PERCENT	%	amod	22	SENT_105	[p7l596t3215r784b3289],
22	power	NN	O	power	dobj	19	SENT_105	[p7l810t3236r1078b3309],
23	to	TO	O	to	aux	24	SENT_105	[p7l1103t3226r1185b3288],
24	detect	VB	O	detect	infmod	22	SENT_105	[p7l1215t3210r1474b3288],
25	a	DT	O	a	det	28	SENT_105	[p7l1496t3236r1540b3287],
26	44	CD	PERCENT	44	number	27	SENT_105	[p7l1565t3215r1754b3289],
27	%	NN	PERCENT	%	amod	28	SENT_105	[p7l1565t3215r1754b3289],
28	increase	NN	O	increase	dobj	24	SENT_105	[p7l1780t3211r2133b3288],
29	in	IN	O	in	_	0	SENT_105	[p7l11t3338r94b3415],
30	overall	JJ	O	overall	amod	31	SENT_105	[p7l137t3337r422b3416],
31	survival	NN	O	survival	prep_in	28	SENT_105	[p7l466t3337r821b3433],
32	;	:	O	;	_	0	SENT_105	[p7l466t3337r821b3433],
33	this	DT	O	this	det	34	SENT_105	[p7l869t3337r1029b3415],
34	number	NN	O	number	nsubjpass	39	SENT_105	[p7l1074t3337r1412b3416],
35	of	IN	O	of	_	0	SENT_105	[p7l1452t3336r1552b3416],
36	events	NNS	O	event	prep_of	34	SENT_105	[p7l1577t3354r1840b3416],
37	is	VBZ	O	be	auxpass	39	SENT_105	[p7l1885t3338r1951b3415],
38	not	RB	O	not	neg	39	SENT_105	[p7l1996t3354r2138b3416],
39	projected	VBN	O	project	parataxis	8	SENT_105	[p7l9t3465r407b3565],
40	to	TO	O	to	aux	41	SENT_105	[p7l438t3482r519b3544],
41	occur	VB	O	occur	xcomp	39	SENT_105	[p7l554t3491r792b3545],
42	until	IN	O	until	_	0	SENT_105	[p7l821t3465r1024b3545],
43	21	CD	DURATION	21	num	44	SENT_105	[p7l1054t3471r1154b3543],
44	months	NNS	NUMBER	month	prep_until	41	SENT_105	[p7l1186t3465r1512b3544],
45	after	IN	O	after	_	0	SENT_105	[p7l1545t3464r1747b3543],
46	the	DT	O	the	det	47	SENT_105	[p7l1776t3465r1908b3543],
47	time	NN	O	time	prep_after	41	SENT_105	[p7l1940t3466r2133b3543],
48	of	IN	O	of	_	0	SENT_105	[p7l12t3593r112b3673],
49	data	NNS	O	datum	nn	50	SENT_105	[p7l129t3594r312b3673],
50	cutoff	NN	O	cutoff	prep_of	47	SENT_105	[p7l345t3593r621b3673],
51	.	.	O	.	_	0	SENT_105	[p7l345t3593r621b3673],

1	Efficacy	NN	O	efficacy	nn	3	SENT_106	[p8l139t30r487b131],
2	end	NN	O	end	nn	3	SENT_106	[p8l528t31r682b110],
3	points	NNS	O	point	nsubjpass	5	SENT_106	[p8l725t32r995b131],
4	were	VBD	O	be	auxpass	5	SENT_106	[p8l1038t57r1240b111],
5	analyzed	VBN	O	analyze	_	0	SENT_106	[p8l1285t31r1665b131],
6	mainly	RB	O	mainly	advmod	5	SENT_106	[p8l1710t31r2010b131],
7	in	IN	O	in	_	0	SENT_106	[p8l2050t32r2133b109],
8	the	DT	O	the	det	9	SENT_106	[p8l12t160r144b238],
9	intention	NN	O	intention	prep_in	5	SENT_106	[p8l201t161r952b238],
10	—	CD	NUMBER	—	num	9	SENT_106	[p8l201t161r952b238],
11	to	TO	O	to	_	0	SENT_106	[p8l201t161r952b238],
12	—	CD	NUMBER	—	num	14	SENT_106	[p8l201t161r952b238],
13	treat	NN	O	treat	nn	14	SENT_106	[p8l201t161r952b238],
14	population	NN	O	population	prep_to	5	SENT_106	[p8l1003t160r1497b259],
15	.	.	O	.	_	0	SENT_106	[p8l1003t160r1497b259],

1	We	PRP	O	we	nsubj	2	SENT_107	[p8l1556t167r1689b238],
2	used	VBD	O	use	_	0	SENT_107	[p8l1746t160r1943b239],
3	the	DT	O	the	det	4	SENT_107	[p8l2001t160r2133b238],
4	Kaplan	NNP	PERSON	Kaplan	dobj	2	SENT_107	[p8l11t288r613b388],
5	.	.	O	.	_	0	SENT_107	[p8l11t288r613b388],

1	—	NN	O	—	_	0	SENT_108	[p8l11t288r613b388],
2	.	.	O	.	_	0	SENT_108	[p8l11t288r613b388],

1	Meier	JJR	PERSON	meier	amod	2	SENT_109	[p8l11t288r613b388],
2	method	NN	O	method	dep	13	SENT_109	[p8l661t288r992b367],
3	to	TO	O	to	aux	4	SENT_109	[p8l1042t305r1124b367],
4	estimate	VB	O	estimate	infmod	2	SENT_109	[p8l1176t289r1541b367],
5	progressionfree	JJ	O	progressionfree	amod	6	SENT_109	[p8l1589t289r2132b389, p8l11t414r170b493],
6	survival	NN	O	survival	dobj	4	SENT_109	[p8l210t415r534b494],
7	and	CC	O	and	_	0	SENT_109	[p8l572t415r727b494],
8	overall	JJ	O	overall	amod	9	SENT_109	[p8l767t415r1045b494],
9	survival	NN	O	survival	dobj	4	SENT_109	[p8l1085t415r1430b511],
10	,	,	O	,	_	0	SENT_109	[p8l1085t415r1430b511],
11	one	CD	NUMBER	one	num	12	SENT_109	[p8l1475t415r1880b494],
12	—	NN	O	—	nsubj	13	SENT_109	[p8l1475t415r1880b494],
13	sided	VBD	O	side	_	0	SENT_109	[p8l1475t415r1880b494],
14	stratified	VBN	O	stratify	amod	15	SENT_109	[p8l1920t432r2132b493, p8l11t543r202b623],
15	log	NN	O	log	dobj	13	SENT_109	[p8l252t544r621b645],
16	—	CD	NUMBER	—	num	18	SENT_109	[p8l252t544r621b645],
17	rank	NN	O	rank	nn	18	SENT_109	[p8l252t544r621b645],
18	tests	NNS	O	test	nsubj	20	SENT_109	[p8l670t561r863b622],
19	to	TO	O	to	aux	20	SENT_109	[p8l917t561r999b623],
20	compare	VB	O	compare	infmod	15	SENT_109	[p8l1053t570r1422b644],
21	survival	NN	O	survival	nn	22	SENT_109	[p8l1476t544r1808b623],
22	curves	NNS	O	curve	dobj	20	SENT_109	[p8l1860t570r2130b623],
23	between	IN	O	between	_	0	SENT_109	[p8l12t672r357b751],
24	the	DT	O	the	det	26	SENT_109	[p8l387t672r515b750],
25	two	CD	NUMBER	two	num	26	SENT_109	[p8l546t689r700b751],
26	groups	NNS	O	group	prep_between	22	SENT_109	[p8l730t698r1038b773],
27	,	,	O	,	_	0	SENT_109	[p8l730t698r1038b773],
28	and	CC	O	and	_	0	SENT_109	[p8l1072t672r1226b751],
29	stratified	JJ	O	stratified	dep	30	SENT_109	[p8l1258t671r1632b751],
30	Cox	NN	PERSON	cox	amod	32	SENT_109	[p8l1662t678r1821b751],
31	regression	NN	O	regression	nn	32	SENT_109	[p8l1849t698r2132b773, p8l12t801r188b878],
32	models	NNS	O	model	nsubj	34	SENT_109	[p8l222t800r531b878],
33	to	TO	O	to	aux	34	SENT_109	[p8l569t817r651b878],
34	estimate	VB	O	estimate	conj_and	13	SENT_109	[p8l688t801r1052b878],
35	hazard	NN	O	hazard	nn	36	SENT_109	[p8l1088t800r1384b878],
36	ratios	NNS	O	ratio	dobj	34	SENT_109	[p8l1418t801r1684b878],
37	.	.	O	.	_	0	SENT_109	[p8l1418t801r1684b878],

1	Response	NN	O	response	nn	2	SENT_110	[p8l1723t806r2133b899],
2	rates	NNS	O	rate	nsubj	24	SENT_110	[p8l11t944r209b1005],
3	as	IN	O	as	mark	12	SENT_110	[p8l247t953r331b1005],
4	assessed	VBN	O	assess	csubjpass	12	SENT_110	[p8l369t927r730b1006],
5	by	IN	O	by	_	0	SENT_110	[p8l767t927r863b1027],
6	means	NNS	O	means	_	0	SENT_110	[p8l894t953r1169b1005],
7	of	IN	O	of	_	0	SENT_110	[p8l1208t926r1307b1006],
8	independent	JJ	O	independent	amod	10	SENT_110	[p8l1324t927r1852b1027],
9	radiologic	JJ	O	radiologic	amod	10	SENT_110	[p8l1883t927r2132b1006, p8l10t1056r213b1157],
10	review	NN	O	review	prep_by_means_of	4	SENT_110	[p8l261t1057r541b1135],
11	were	VBD	O	be	auxpass	12	SENT_110	[p8l584t1082r786b1135],
12	compared	VBN	O	compare	dep	2	SENT_110	[p8l838t1056r1264b1156],
13	between	IN	O	between	_	0	SENT_110	[p8l1316t1056r1673b1135],
14	the	DT	O	the	det	16	SENT_110	[p8l1725t1056r1857b1134],
15	treatment	NN	O	treatment	nn	16	SENT_110	[p8l1909t1073r2132b1135, p8l11t1201r229b1263],
16	groups	NNS	O	group	prep_between	12	SENT_110	[p8l253t1210r544b1285],
17	with	IN	O	with	_	0	SENT_110	[p8l571t1184r763b1263],
18	the	DT	O	the	det	19	SENT_110	[p8l793t1184r924b1262],
19	use	NN	O	use	prep_with	12	SENT_110	[p8l954t1210r1092b1263],
20	of	IN	O	of	_	0	SENT_110	[p8l1123t1183r1222b1263],
21	a	DT	O	a	det	23	SENT_110	[p8l1232t1210r1277b1262],
22	two	CD	NUMBER	two	num	23	SENT_110	[p8l1306t1184r1718b1263],
23	—	NN	O	—	prep_of	19	SENT_110	[p8l1306t1184r1718b1263],
24	sided	VBD	O	side	_	0	SENT_110	[p8l1306t1184r1718b1263],
25	stratiﬁed	JJ	O	stratiﬁed	amod	26	SENT_110	[p8l1749t1183r2133b1263],
26	Cochran	NNP	PERSON	Cochran	dobj	24	SENT_110	[p8l11t1312r1156b1391],
27	.	.	O	.	_	0	SENT_110	[p8l11t1312r1156b1391],

1	—	NN	O	—	_	0	SENT_111	[p8l11t1312r1156b1391],
2	.	.	O	.	_	0	SENT_111	[p8l11t1312r1156b1391],

1	Mantel	NNP	O	Mantel	_	0	SENT_112	[p8l11t1312r1156b1391],
2	.	.	O	.	_	0	SENT_112	[p8l11t1312r1156b1391],

1	—	NN	O	—	_	0	SENT_113	[p8l11t1312r1156b1391],
2	.	.	O	.	_	0	SENT_113	[p8l11t1312r1156b1391],

1	Haenszel	NNP	PERSON	Haenszel	nsubj	2	SENT_114	[p8l11t1312r1156b1391],
2	test	NN	O	test	_	0	SENT_114	[p8l1200t1329r1370b1391],
3	.	.	O	.	_	0	SENT_114	[p8l1200t1329r1370b1391],

1	We	PRP	O	we	nsubj	2	SENT_115	[p8l1416t1320r1548b1391],
2	evaluated	VBD	O	evaluate	_	0	SENT_115	[p8l1592t1312r1986b1391],
3	efficacy	NN	O	efficacy	dobj	2	SENT_115	[p8l2031t1311r2132b1391, p8l11t1438r259b1539],

1	end	NN	O	end	nn	2	SENT_116	[p8l298t1439r451b1518],
2	points	NNS	O	point	nsubj	12	SENT_116	[p8l496t1440r765b1539],
3	for	IN	O	for	_	0	SENT_116	[p8l813t1438r936b1518],
4	pemetrexed	JJ	O	pemetrexed	prep_for	2	SENT_116	[p8l977t1439r1479b1539],
5	and	CC	O	and	_	0	SENT_116	[p8l1524t1439r1682b1518],
6	docetaxel	NN	O	docetaxel	conj_and	4	SENT_116	[p8l1729t1439r2134b1518],
7	separately	RB	O	separately	advmod	12	SENT_116	[p8l12t1568r425b1667],
8	in	IN	O	in	_	0	SENT_116	[p8l463t1569r545b1645],
9	the	DT	O	the	det	11	SENT_116	[p8l589t1568r718b1646],
10	as	IN	O	as	amod	11	SENT_116	[p8l760t1568r1164b1646],
11	—	NN	O	—	prep_in	7	SENT_116	[p8l760t1568r1164b1646],
12	treated	VBN	O	treat	_	0	SENT_116	[p8l760t1568r1164b1646],
13	population	NN	O	population	dobj	12	SENT_116	[p8l1206t1568r1679b1667],
14	,	,	O	,	_	0	SENT_116	[p8l1206t1568r1679b1667],
15	which	WDT	O	which	nsubj	16	SENT_116	[p8l1724t1568r1978b1647],
16	included	VBD	O	include	rcmod	13	SENT_116	[p8l2022t1569r2132b1645, p8l12t1695r279b1775],
17	patients	NNS	O	patient	dobj	16	SENT_116	[p8l310t1696r652b1795],
18	who	WP	O	who	nsubj	19	SENT_116	[p8l687t1695r870b1775],
19	received	VBD	O	receive	rcmod	17	SENT_116	[p8l908t1695r1253b1775],
20	at	IN	O	at	quantmod	22	SENT_116	[p8l1289t1712r1368b1773],
21	least	JJS	O	least	mwe	20	SENT_116	[p8l1399t1695r1598b1773],
22	one	CD	NUMBER	one	num	23	SENT_116	[p8l1631t1721r1782b1774],
23	dose	NN	O	dose	dobj	19	SENT_116	[p8l1820t1695r2014b1774],
24	of	IN	O	of	_	0	SENT_116	[p8l2052t1694r2152b1774],
25	study	NN	O	study	nn	26	SENT_116	[p8l12t1824r242b1923],
26	medication	NN	O	medication	prep_of	23	SENT_116	[p8l277t1824r782b1902],
27	.	.	O	.	_	0	SENT_116	[p8l277t1824r782b1902],

1	Patient	NN	O	patient	nsubj	3	SENT_117	[p8l138t1952r833b2051],
2	—	CD	NUMBER	—	num	1	SENT_117	[p8l138t1952r833b2051],
3	reported	VBD	O	report	_	0	SENT_117	[p8l138t1952r833b2051],
4	outcomes	NNS	O	outcome	nsubjpass	6	SENT_117	[p8l884t1969r1296b2031],
5	were	VBD	O	be	auxpass	6	SENT_117	[p8l1344t1978r1546b2031],
6	evaluated	VBN	O	evaluate	ccomp	3	SENT_117	[p8l1598t1952r2000b2031],
7	in	IN	O	in	_	0	SENT_117	[p8l2050t1953r2133b2029],
8	all	DT	O	all	det	10	SENT_117	[p8l11t2080r113b2157],
9	treated	JJ	O	treated	amod	10	SENT_117	[p8l147t2080r438b2158],
10	patients	NNS	O	patient	prep_in	6	SENT_117	[p8l471t2081r805b2179],
11	who	WP	O	who	nsubj	13	SENT_117	[p8l836t2080r1017b2159],
12	had	VBD	O	have	aux	13	SENT_117	[p8l1053t2080r1207b2158],
13	completed	VBN	O	complete	rcmod	10	SENT_117	[p8l1241t2080r1678b2179],
14	a	DT	O	a	det	16	SENT_117	[p8l1711t2106r1755b2157],
15	baseline	NN	O	baseline	nn	16	SENT_117	[p8l1788t2080r2133b2158],
16	assessment	NN	O	assessment	tmod	13	SENT_117	[p8l11t2224r501b2286],
17	and	CC	O	and	_	0	SENT_117	[p8l528t2208r686b2286],
18	at	IN	O	at	advmod	16	SENT_117	[p8l718t2224r797b2286],
19	least	JJS	O	least	pobj	18	SENT_117	[p8l823t2208r1022b2286],
20	one	CD	NUMBER	one	num	22	SENT_117	[p8l1050t2234r1202b2286],
21	post-baseline	JJ	O	post-baseline	amod	22	SENT_117	[p8l1233t2208r1801b2307],
22	assessment	NN	O	assessment	tmod	13	SENT_117	[p8l1833t2234r2132b2286, p8l11t2353r243b2415],
23	.	.	O	.	_	0	SENT_117	[p8l1833t2234r2132b2286, p8l11t2353r243b2415],

1	Repeated	JJ	O	repeated	amod	3	SENT_118	[p8l290t2336r1092b2436],
2	—	NN	O	—	nn	3	SENT_118	[p8l290t2336r1092b2436],
3	measures	NNS	O	measure	nsubj	4	SENT_118	[p8l290t2336r1092b2436],
4	miXed	VBN	O	mix	_	0	SENT_118	[p8l1135t2335r1695b2415],
5	—	CD	NUMBER	—	num	6	SENT_118	[p8l1135t2335r1695b2415],
6	effects	NNS	O	effect	dobj	4	SENT_118	[p8l1135t2335r1695b2415],
7	modeling	NN	O	modeling	nsubjpass	9	SENT_118	[p8l1739t2336r2137b2437],
8	was	VBD	O	be	auxpass	9	SENT_118	[p8l7t2490r169b2543],
9	performed	VBN	O	perform	rcmod	6	SENT_118	[p8l209t2463r665b2564],
10	to	TO	O	to	aux	11	SENT_118	[p8l705t2481r786b2543],
11	compare	VB	O	compare	xcomp	9	SENT_118	[p8l827t2490r1197b2564],
12	the	DT	O	the	det	14	SENT_118	[p8l1236t2464r1369b2542],
13	two	CD	NUMBER	two	num	14	SENT_118	[p8l1409t2481r1566b2543],
14	groups	NNS	O	group	dobj	11	SENT_118	[p8l1606t2490r1902b2565],
15	with	IN	O	with	_	0	SENT_118	[p8l1938t2464r2133b2543],
16	respect	NN	O	respect	prep_with	14	SENT_118	[p8l11t2609r313b2692],
17	to	TO	O	to	_	0	SENT_118	[p8l340t2609r420b2671],
18	the	DT	O	the	det	20	SENT_118	[p8l453t2592r584b2670],
19	overall	JJ	O	overall	amod	20	SENT_118	[p8l616t2592r895b2671],
20	change	NN	O	change	prep_to	11	SENT_118	[p8l926t2592r1225b2693],
21	from	IN	O	from	_	0	SENT_118	[p8l1257t2591r1464b2671],
22	baseline	NN	O	baseline	nn	23	SENT_118	[p8l1496t2592r1840b2671],
23	scores	NNS	O	score	prep_from	11	SENT_118	[p8l1873t2618r2130b2671],
24	on	IN	O	on	_	0	SENT_118	[p8l12t2746r118b2799],
25	the	DT	O	the	det	26	SENT_118	[p8l153t2720r285b2798],
26	QLQ	NNP	O	QLQ	prep_on	23	SENT_118	[p8l320t2726r720b2818],
27	.	.	O	.	_	0	SENT_118	[p8l320t2726r720b2818],

1	—	NN	O	—	_	0	SENT_119	[p8l320t2726r720b2818],
2	.	.	O	.	_	0	SENT_119	[p8l320t2726r720b2818],

1	C3O	NN	O	c3o	_	0	SENT_120	[p8l320t2726r720b2818],
2	and	CC	O	and	_	0	SENT_120	[p8l755t2720r913b2799],
3	QLQ	NN	O	qlq	conj_and	1	SENT_120	[p8l947t2726r1394b2818],
4	.	.	O	.	_	0	SENT_120	[p8l947t2726r1394b2818],

1	—	NN	O	—	_	0	SENT_121	[p8l947t2726r1394b2818],
2	.	.	O	.	_	0	SENT_121	[p8l947t2726r1394b2818],

1	LC13	NN	O	lc13	nn	2	SENT_122	[p8l947t2726r1394b2818],
2	scales	NNS	O	scale	_	0	SENT_122	[p8l1433t2720r1708b2799],
3	.	.	O	.	_	0	SENT_122	[p8l1433t2720r1708b2799],

1	The	DT	O	the	det	2	SENT_123	[p8l1745t2720r1906b2798],
2	time	NN	O	time	nsubjpass	6	SENT_123	[p8l1940t2721r2134b2798],
3	to	TO	O	to	_	0	SENT_123	[p8l12t2865r91b2927],
4	deterioration	NN	O	deterioration	prep_to	2	SENT_123	[p8l140t2848r671b2927],
5	was	VBD	O	be	auxpass	6	SENT_123	[p8l713t2874r871b2927],
6	calculated	VBN	O	calculate	_	0	SENT_123	[p8l921t2848r1337b2927],
7	as	IN	O	as	_	0	SENT_123	[p8l1383t2874r1466b2926],
8	the	DT	O	the	det	9	SENT_123	[p8l1516t2848r1644b2927],
9	time	NN	O	time	prep_as	6	SENT_123	[p8l1692t2849r1878b2927],
10	from	IN	O	from	_	0	SENT_123	[p8l1925t2847r2133b2927],
11	randomization	NN	O	randomization	prep_from	9	SENT_123	[p8l11t2975r651b3054],
12	to	TO	O	to	_	0	SENT_123	[p8l693t2992r774b3054],
13	the	DT	O	the	det	15	SENT_123	[p8l817t2975r950b3053],
14	first	JJ	ORDINAL	first	amod	15	SENT_123	[p8l990t2974r1174b3053],
15	increase	NN	O	increase	prep_to	6	SENT_123	[p8l1209t2976r1561b3053],
16	of	IN	O	of	_	0	SENT_123	[p8l1603t2974r1703b3054],
17	10	CD	NUMBER	10	num	18	SENT_123	[p8l1729t2981r1822b3054],
18	points	NNS	O	point	prep_of	15	SENT_123	[p8l1862t2976r2131b3075],
19	or	CC	O	or	_	0	SENT_123	[p8l12t3130r100b3183],
20	more	JJR	O	more	amod	21	SENT_123	[p8l147t3130r366b3183],
21	(	NN	O	(	conj_or	18	SENT_123	[p8l421t3104r890b3205],
22	indicating	VBG	O	indicate	xcomp	6	SENT_123	[p8l421t3104r890b3205],
23	worsening	VBG	O	worsen	amod	24	SENT_123	[p8l932t3105r1389b3205],
24	condition	NN	O	condition	dobj	22	SENT_123	[p8l1436t3104r1872b3195],
25	)	CD	NUMBER	)	npadvmod	22	SENT_123	[p8l1436t3104r1872b3195],
26	from	IN	O	from	_	0	SENT_123	[p8l1926t3103r2134b3183],
27	baseline	NN	O	baseline	prep_from	22	SENT_123	[p8l12t3231r356b3310],
28	in	IN	O	in	_	0	SENT_123	[p8l404t3232r486b3309],
29	scores	NNS	O	score	prep_in	22	SENT_123	[p8l536t3257r794b3310],
30	for	IN	O	for	_	0	SENT_123	[p8l845t3230r966b3310],
31	a	DT	O	a	det	34	SENT_123	[p8l1010t3257r1055b3309],
32	composite	JJ	O	composite	amod	34	SENT_123	[p8l1103t3232r1535b3331],
33	end	NN	O	end	nn	34	SENT_123	[p8l1584t3231r1735b3310],
34	point	NN	O	point	prep_for	29	SENT_123	[p8l1782t3232r2008b3331],
35	of	IN	O	of	_	0	SENT_123	[p8l2052t3230r2152b3310],
36	chest	NN	O	chest	nn	37	SENT_123	[p8l12t3360r234b3438],
37	pain	NN	O	pain	prep_of	34	SENT_123	[p8l265t3361r478b3460],
38	,	,	O	,	_	0	SENT_123	[p8l265t3361r478b3460],
39	dyspnea	NN	O	dyspnea	conj_or	37	SENT_123	[p8l520t3360r888b3460],
40	,	,	O	,	_	0	SENT_123	[p8l520t3360r888b3460],
41	or	CC	O	or	_	0	SENT_123	[p8l931t3386r1020b3439],
42	cough	NN	O	cough	conj_or	37	SENT_123	[p8l1053t3360r1338b3461],
43	.	.	O	.	_	0	SENT_123	[p8l1053t3360r1338b3461],

1	The	DT	O	the	det	2	SENT_124	[p8l1377t3360r1537b3438],
2	time	NN	O	time	nsubjpass	6	SENT_124	[p8l1574t3361r1766b3438],
3	to	TO	O	to	_	0	SENT_124	[p8l1804t3377r1885b3439],
4	deterioration	NN	O	deterioration	prep_to	2	SENT_124	[p8l1923t3360r2132b3439, p8l11t3489r387b3567],
5	was	VBD	O	be	auxpass	6	SENT_124	[p8l426t3514r589b3567],
6	estimated	VBN	O	estimate	_	0	SENT_124	[p8l634t3488r1056b3567],
7	with	IN	O	with	_	0	SENT_124	[p8l1094t3488r1289b3567],
8	the	DT	O	the	det	9	SENT_124	[p8l1333t3488r1466b3566],
9	use	NN	O	use	prep_with	6	SENT_124	[p8l1509t3514r1649b3567],
10	of	IN	O	of	_	0	SENT_124	[p8l1693t3487r1793b3567],
11	the	DT	O	the	det	12	SENT_124	[p8l1818t3488r1951b3566],
12	Kaplan	NNP	PERSON	Kaplan	prep_of	9	SENT_124	[p8l1993t3496r2132b3568, p8l9t3616r478b3715],
13	.	.	O	.	_	0	SENT_124	[p8l1993t3496r2132b3568, p8l9t3616r478b3715],

1	—	NN	O	—	_	0	SENT_125	[p8l1993t3496r2132b3568, p8l9t3616r478b3715],
2	.	.	O	.	_	0	SENT_125	[p8l1993t3496r2132b3568, p8l9t3616r478b3715],

1	Meier	NNP	PERSON	Meier	_	0	SENT_126	[p8l1993t3496r2132b3568, p8l9t3616r478b3715],

1	method	NN	O	method	nsubjpass	4	SENT_127	[p8l529t3616r850b3694],
2	and	CC	O	and	advmod	4	SENT_127	[p8l904t3616r1057b3694],
3	was	VBD	O	be	auxpass	4	SENT_127	[p8l1107t3642r1265b3695],
4	compared	VBN	O	compare	_	0	SENT_127	[p8l1322t3616r1734b3715],
5	between	IN	O	between	_	0	SENT_127	[p8l1788t3616r2133b3695],
6	the	DT	O	the	det	8	SENT_127	[p9l12t22r142b101],
7	two	CD	NUMBER	two	num	8	SENT_127	[p9l190t39r347b101],
8	groups	NNS	O	group	prep_between	4	SENT_127	[p9l395t48r691b123],
9	with	IN	O	with	_	0	SENT_127	[p9l735t22r930b101],
10	the	DT	O	the	det	11	SENT_127	[p9l977t22r1110b100],
11	use	NN	O	use	prep_with	4	SENT_127	[p9l1157t48r1297b101],
12	of	IN	O	of	_	0	SENT_127	[p9l1346t21r1445b101],
13	an	DT	O	a	det	15	SENT_127	[p9l1473t48r1576b100],
14	unstratified	JJ	O	unstratified	amod	15	SENT_127	[p9l1623t21r2133b101],
15	log	NN	O	log	prep_of	11	SENT_127	[p9l10t150r380b251],
16	—	CD	NUMBER	—	num	17	SENT_127	[p9l10t150r380b251],
17	ranl	NN	O	ranl	dep	15	SENT_127	[p9l10t150r380b251],
18	<	JJR	O	<	amod	19	SENT_127	[p9l10t150r380b251],
19	test	NN	O	test	dep	17	SENT_127	[p9l415t167r590b229],
20	.	.	O	.	_	0	SENT_127	[p9l415t167r590b229],

1	RESULTS	NNS	O	result	_	0	SENT_128	[p9l835t447r1310b505],

1	PATIENTS	NNS	O	patient	nsubjpass	15	SENT_129	[p9l16t680r383b730],
2	From	IN	O	from	_	0	SENT_129	[p9l9t786r233b858],
3	February	NNP	DATE	February	prep_from	15	SENT_129	[p9l264t779r643b879],
4	2010	CD	DATE	2010	num	3	SENT_129	[p9l670t785r866b858],
5	through	IN	O	through	_	0	SENT_129	[p9l901t779r1243b880],
6	February	NNP	DATE	February	prep_through	15	SENT_129	[p9l1273t779r1652b879],
7	2012	CD	DATE	2012	num	6	SENT_129	[p9l1680t785r1903b875],
8	,	,	O	,	_	0	SENT_129	[p9l1680t785r1903b875],
9	a	DT	O	a	det	10	SENT_129	[p9l1941t805r1986b857],
10	total	NN	O	total	nsubjpass	15	SENT_129	[p9l2017t796r2132b858, p9l12t906r118b984],
11	of	IN	O	of	_	0	SENT_129	[p9l153t905r252b985],
12	4967	CD	DATE	4967	num	13	SENT_129	[p9l269t912r473b985],
13	patients	NNS	O	patient	prep_of	10	SENT_129	[p9l508t907r850b1006],
14	were	VBD	O	be	auxpass	15	SENT_129	[p9l884t932r1085b986],
15	screened	VBN	O	screen	_	0	SENT_129	[p9l1124t906r1519b1002],
16	,	,	O	,	_	0	SENT_129	[p9l1124t906r1519b1002],
17	of	IN	O	of	_	0	SENT_129	[p9l1561t905r1662b985],
18	whom	WP	O	whom	dobj	20	SENT_129	[p9l1675t906r1946b986],
19	347	CD	NUMBER	347	nsubj	20	SENT_129	[p9l1983t912r2132b985],
20	underwent	VBD	O	undergo	prepc_of	15	SENT_129	[p9l11t1036r459b1115],
21	randomization	NN	O	randomization	nn	22	SENT_129	[p9l484t1036r1098b1115],
22	—	NN	O	—	dobj	20	SENT_129	[p9l1125t1081r1233b1089],
23	173	CD	NUMBER	173	num	22	SENT_129	[p9l1263t1042r1401b1115],
24	to	TO	O	to	_	0	SENT_129	[p9l1436t1053r1515b1115],
25	crizotinib	JJ	O	crizotinib	prep_to	20	SENT_129	[p9l1548t1036r1948b1115],
26	and	CC	O	and	_	0	SENT_129	[p9l1980t1036r2133b1115],
27	174	CD	NUMBER	174	conj_and	25	SENT_129	[p9l15t1170r150b1243],
28	to	TO	O	to	_	0	SENT_129	[p9l181t1181r260b1243],
29	chemotherapy	NN	O	chemotherapy	nn	31	SENT_129	[p9l293t1164r880b1264],
30	(	CD	NUMBER	(	num	31	SENT_129	[p9l911t1165r1082b1265],
31	Fig	NN	O	fig	prep_to	20	SENT_129	[p9l911t1165r1082b1265],
32	.	.	O	.	_	0	SENT_129	[p9l911t1165r1082b1265],

1	S1	NN	O	s1	_	0	SENT_130	[p9l1120t1170r1213b1243],
2	in	IN	O	in	_	0	SENT_130	[p9l1244t1165r1324b1242],
3	the	DT	O	the	det	6	SENT_130	[p9l1356t1164r1484b1242],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_130	[p9l1517t1164r2138b1264],
5	Appendix	NNP	O	Appendix	nn	6	SENT_130	[p9l7t1292r473b1391],
6	)	NN	O	)	prep_in	1	SENT_130	[p9l7t1292r473b1391],
7	.	.	O	.	_	0	SENT_130	[p9l7t1292r473b1391],

1	The	DT	O	the	det	3	SENT_131	[p9l507t1292r668b1370],
2	347	CD	NUMBER	347	num	3	SENT_131	[p9l701t1298r850b1371],
3	patients	NNS	O	patient	_	0	SENT_131	[p9l881t1293r1222b1391],
4	who	WP	O	who	nsubj	5	SENT_131	[p9l1252t1292r1435b1371],
5	underwent	VBD	O	undergo	dep	3	SENT_131	[p9l1468t1292r1933b1371],
6	ranN	NNP	O	ranN	dobj	5	SENT_131	[p9l1960t1318r2132b1370, p9l571t1460r585b1475],

1	ENGLJ	NNP	MISC	ENGLJ	nn	2	SENT_132	[p9l600t1460r678b1482],
2	MED	NNP	MISC	MED	_	0	SENT_132	[p9l692t1460r744b1475],
3	368	CD	NUMBER	368	num	2	SENT_132	[p9l755t1454r834b1482],
4	;	:	O	;	_	0	SENT_132	[p9l755t1454r834b1482],
5	25	CD	NUMBER	25	num	7	SENT_132	[p9l755t1454r834b1482],
6	NEjM.ORG	NN	O	nejm.org	nn	7	SENT_132	[p9l869t1460r993b1482],
7	JUNE	NN	DATE	june	dep	2	SENT_132	[p9l1024t1460r1088b1482],
8	20	CD	DATE	20	dep	7	SENT_132	[p9l1099t1460r1136b1480],
9	,	,	DATE	,	_	0	SENT_132	[p9l1099t1460r1136b1480],
10	2013	CD	DATE	2013	num	11	SENT_132	[p9l1147t1460r1202b1482],
11	2337	CD	DATE	2337	appos	8	SENT_132	[p9l1939t1450r2016b1473],

1	The	DT	O	the	det	4	SENT_133	[p9l702t1493r753b1517],
2	New	NNP	O	New	nn	4	SENT_133	[p9l762t1494r824b1517],
3	England	NNP	O	England	nn	4	SENT_133	[p9l833t1493r944b1524],
4	Journal	NNP	O	Journal	_	0	SENT_133	[p9l952t1493r1050b1517],
5	of	IN	O	of	_	0	SENT_133	[p9l1059t1493r1088b1517],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_133	[p9l1095t1493r1220b1517],

1	The	DT	O	the	det	4	SENT_134	[p9l673t1681r719b1702],
2	NEW	NNP	O	NEW	nn	4	SENT_134	[p9l737t1683r822b1702],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_134	[p9l841t1683r1030b1702],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_134	[p9l1049t1683r1228b1709],
5	of	IN	O	of	_	0	SENT_134	[p9l1248t1681r1276b1708],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_134	[p9l1288t1683r1487b1702],

1	domization	NN	O	domization	nsubj	2	SENT_135	[p9l565t1854r927b1913],
2	comprised	VBD	O	comprise	_	0	SENT_135	[p9l954t1854r1284b1928],
3	the	DT	O	the	det	7	SENT_135	[p9l1311t1854r1408b1912],
4	intention	NN	O	intention	nn	7	SENT_135	[p9l1435t1855r1982b1913],
5	—	CD	NUMBER	—	num	7	SENT_135	[p9l1435t1855r1982b1913],
6	to-treat	JJ	O	to-treat	amod	7	SENT_135	[p9l1435t1855r1982b1913],
7	population	NN	O	population	dobj	2	SENT_135	[p9l2004t1873r2148b1928, p9l564t1949r803b2008],
8	.	.	O	.	_	0	SENT_135	[p9l2004t1873r2148b1928, p9l564t1949r803b2008],

1	A	DT	O	a	det	2	SENT_136	[p9l835t1955r884b2006],
2	total	NN	O	total	nsubj	14	SENT_136	[p9l913t1949r1060b2008],
3	of	IN	O	of	_	0	SENT_136	[p9l1091t1948r1166b2008],
4	99	CD	NUMBER	99	num	5	SENT_136	[p9l1184t1953r1258b2008],
5	patients	NNS	O	patient	prep_of	2	SENT_136	[p9l1289t1950r1544b2023],
6	(	IN	O	(	_	0	SENT_136	[p9l1581t1953r1757b2017],
7	57	CD	PERCENT	57	num	8	SENT_136	[p9l1581t1953r1757b2017],
8	%	NN	PERCENT	%	prep_(	14	SENT_136	[p9l1581t1953r1757b2017],
9	)	CD	NUMBER	)	nsubj	14	SENT_136	[p9l1581t1953r1757b2017],
10	in	IN	O	in	_	0	SENT_136	[p9l1792t1950r1854b2007],
11	the	DT	O	the	det	13	SENT_136	[p9l1886t1949r1985b2007],
12	chemotherapy	NN	O	chemotherapy	nn	13	SENT_136	[p9l2017t1949r2148b2007, p9l564t2044r910b2118],
13	group	NN	O	group	prep_in	9	SENT_136	[p9l949t2063r1137b2119],
14	received	VBD	O	receive	_	0	SENT_136	[p9l1180t2044r1438b2103],
15	pemetrexed	JJ	O	pemetrexed	acomp	14	SENT_136	[p9l1478t2044r1870b2118],
16	,	,	O	,	_	0	SENT_136	[p9l1478t2044r1870b2118],
17	and	CC	O	and	_	0	SENT_136	[p9l1916t2044r2034b2103],
18	72	CD	PERCENT	72	number	19	SENT_136	[p9l2076t2048r2148b2102],
19	(	CD	PERCENT	(	conj_and	14	SENT_136	[p9l568t2143r731b2207],
20	41	CD	PERCENT	41	num	21	SENT_136	[p9l568t2143r731b2207],
21	%	NN	PERCENT	%	dep	19	SENT_136	[p9l568t2143r731b2207],
22	)	CD	NUMBER	)	dep	19	SENT_136	[p9l568t2143r731b2207],
23	received	VBD	O	receive	dep	14	SENT_136	[p9l758t2139r1011b2198],
24	docetaxel	NN	O	docetaxel	dobj	23	SENT_136	[p9l1034t2139r1347b2198],
25	.	.	O	.	_	0	SENT_136	[p9l1034t2139r1347b2198],

1	Three	CD	NUMBER	three	num	2	SENT_137	[p9l1371t2139r1553b2197],
2	patients	NNS	O	patient	nsubj	23	SENT_137	[p9l1575t2140r1824b2213],
3	who	WP	O	who	nsubjpass	6	SENT_137	[p9l1845t2139r1980b2198],
4	were	VBD	O	be	auxpass	6	SENT_137	[p9l2001t2158r2149b2198],
5	randomly	RB	O	randomly	advmod	6	SENT_137	[p9l565t2234r874b2308],
6	assigned	VBN	O	assign	rcmod	2	SENT_137	[p9l909t2234r1189b2309],
7	to	TO	O	to	_	0	SENT_137	[p9l1228t2246r1289b2293],
8	the	DT	O	the	det	10	SENT_137	[p9l1329t2234r1429b2292],
9	chemotherapy	NN	O	chemotherapy	nn	10	SENT_137	[p9l1469t2234r1925b2308],
10	group	NN	O	group	prep_to	6	SENT_137	[p9l1960t2253r2148b2309],
11	and	CC	O	and	_	0	SENT_137	[p9l564t2329r679b2388],
12	1	CD	NUMBER	1	prep_to	6	SENT_137	[p9l702t2333r735b2387],
13	who	WP	O	who	nsubjpass	16	SENT_137	[p9l753t2329r886b2388],
14	was	VBD	O	be	auxpass	16	SENT_137	[p9l905t2348r1023b2388],
15	randomly	RB	O	randomly	advmod	16	SENT_137	[p9l1045t2329r1344b2403],
16	assigned	VBN	O	assign	rcmod	12	SENT_137	[p9l1361t2329r1629b2404],
17	to	TO	O	to	_	0	SENT_137	[p9l1650t2341r1709b2388],
18	the	DT	O	the	det	20	SENT_137	[p9l1731t2329r1827b2387],
19	crizotinib	JJ	O	crizotinib	amod	20	SENT_137	[p9l1849t2329r2148b2388],
20	group	NN	O	group	prep_to	16	SENT_137	[p9l564t2443r746b2499],
21	did	VBD	O	do	aux	23	SENT_137	[p9l770t2424r867b2483],
22	not	RB	O	not	neg	23	SENT_137	[p9l888t2436r991b2483],
23	receive	VB	O	receive	_	0	SENT_137	[p9l1009t2425r1215b2483],
24	the	DT	O	the	det	27	SENT_137	[p9l1237t2424r1333b2482],
25	assigned	VBN	O	assign	amod	27	SENT_137	[p9l1354t2424r1622b2499],
26	study	NN	O	study	nn	27	SENT_137	[p9l1644t2424r1810b2498],
27	treatment	NN	O	treatment	dobj	23	SENT_137	[p9l1828t2436r2145b2483],
28	.	.	O	.	_	0	SENT_137	[p9l1828t2436r2145b2483],

1	Table	NNP	O	Table	_	0	SENT_138	[p10l60t101r202b149],
2	1	CD	NUMBER	1	dep	1	SENT_138	[p10l222t105r263b149],
3	.	.	O	.	_	0	SENT_138	[p10l222t105r263b149],

1	Baseline	NN	O	baseline	nn	3	SENT_139	[p10l286t101r503b149],
2	Clinical	JJ	O	clinical	amod	3	SENT_139	[p10l520t101r711b149],
3	Characteristics	NNS	O	characteristic	_	0	SENT_139	[p10l731t101r1121b149],
4	of	IN	O	of	_	0	SENT_139	[p10l1140t100r1200b149],
5	Patients	NNS	O	patient	prep_of	3	SENT_139	[p10l1210t102r1418b149],
6	in	IN	O	in	_	0	SENT_139	[p10l1439t102r1482b148],
7	the	DT	O	the	det	9	SENT_139	[p10l1501t101r1585b149],
8	Intention-to-Treat	NNP	O	Intention-to-Treat	nn	9	SENT_139	[p10l1606t102r2069b149],
9	Population	NNP	O	Population	prep_in	5	SENT_139	[p10l65t181r394b244],
10	!	.	O	!	_	0	SENT_139	[p10l65t181r394b244],
11	"	''	O	"	punct	3	SENT_139	[p10l65t181r394b244],

1	Crizotinib	NNP	O	Crizotinib	nn	2	SENT_140	[p10l1277t324r1532b373],
2	Chemotherapy	NNP	O	Chemotherapy	_	0	SENT_140	[p10l1679t324r2067b387],

1	Characteristic	JJ	O	characteristic	amod	3	SENT_141	[p10l61t397r424b445],
2	(	NN	O	(	nn	3	SENT_141	[p10l1292t401r1349b460],
3	N	NN	O	n	_	0	SENT_141	[p10l1292t401r1349b460],
4	=	JJ	O	=	quantmod	6	SENT_141	[p10l1365t421r1397b437],
5	173	CD	NUMBER	173	number	6	SENT_141	[p10l1411t400r1518b460],
6	)	CD	NUMBER	)	num	8	SENT_141	[p10l1411t400r1518b460],
7	(	NN	O	(	nn	8	SENT_141	[p10l1760t401r1817b460],
8	N	NN	O	n	npadvmod	9	SENT_141	[p10l1760t401r1817b460],
9	=	JJ	O	=	amod	3	SENT_141	[p10l1832t421r1865b437],
10	174	CD	NUMBER	174	number	11	SENT_141	[p10l1879t401r1986b460],
11	)	CD	NUMBER	)	dep	3	SENT_141	[p10l1879t401r1986b460],
12	Age	NNP	O	Age	nn	14	SENT_141	[p10l60t511r158b571],
13	—	CD	NUMBER	—	num	14	SENT_141	[p10l175t537r239b542],
14	yr	NN	DURATION	yr	dep	11	SENT_141	[p10l255t525r302b571],

1	Median	JJ	O	median	amod	2	SENT_142	[p10l130t618r321b667],
2	51	CD	NUMBER	51	_	0	SENT_142	[p10l1376t623r1432b667],
3	49	CD	NUMBER	49	dep	2	SENT_142	[p10l1842t623r1902b667],
4	Range	NNP	O	Range	dep	2	SENT_142	[p10l130t734r287b793],

1	Age	NNP	O	Age	nn	2	SENT_143	[p10l60t844r158b904],
2	distribution	NN	O	distribution	_	0	SENT_143	[p10l177t841r480b889],
3	—	CD	NUMBER	—	num	4	SENT_143	[p10l500t871r565b875],
4	no.	NN	O	no.	dep	2	SENT_143	[p10l584t858r660b889],
5	(	CD	PERCENT	(	num	6	SENT_143	[p10l687t843r773b904],
6	%	NN	PERCENT	%	dep	4	SENT_143	[p10l687t843r773b904],
7	)	CD	NUMBER	)	dep	2	SENT_143	[p10l687t843r773b904],

1	<	JJR	O	<	_	0	SENT_144	[p10l126t956r218b1000],
2	65	CD	DURATION	65	num	3	SENT_144	[p10l126t956r218b1000],
3	yr	NN	DURATION	yr	dep	1	SENT_144	[p10l238t969r286b1015],
4	265	CD	DURATION	265	num	5	SENT_144	[p10l126t1067r218b1111],
5	yr	NN	DURATION	yr	dep	1	SENT_144	[p10l238t1080r286b1126],

1	Male	JJ	O	male	amod	4	SENT_145	[p10l66t1174r189b1222],
2	sex	NN	O	sex	nn	4	SENT_145	[p10l210t1191r290b1222],
3	—	JJ	O	—	amod	4	SENT_145	[p10l306t1204r371b1208],
4	no.	NN	O	no.	dep	10	SENT_145	[p10l390t1191r467b1222],
5	(	CD	PERCENT	(	num	6	SENT_145	[p10l493t1176r579b1237],
6	%	NN	PERCENT	%	dep	4	SENT_145	[p10l493t1176r579b1237],
7	)	CD	NUMBER	)	num	8	SENT_145	[p10l493t1176r579b1237],
8	Race	NN	O	race	dep	10	SENT_145	[p10l66t1289r184b1333],
9	—	CD	NUMBER	—	num	10	SENT_145	[p10l200t1315r265b1319],
10	no.	NN	O	no.	dep	13	SENT_145	[p10l285t1302r361b1333],
11	(	CD	PERCENT	(	num	12	SENT_145	[p10l388t1287r515b1348],
12	%	NN	PERCENT	%	dep	10	SENT_145	[p10l388t1287r515b1348],
13	)	NN	O	)	_	0	SENT_145	[p10l388t1287r515b1348],
14	'	''	O	'	_	0	SENT_145	[p10l388t1287r515b1348],
15	i	FW	O	i	nn	16	SENT_145	[p10l388t1287r515b1348],
16	‘	FW	O	‘	dep	13	SENT_145	[p10l388t1287r515b1348],

1	White	JJ	MISC	white	amod	2	SENT_146	[p10l124t1396r277b1444],
2	Asian	JJ	MISC	asian	amod	4	SENT_146	[p10l124t1510r267b1555],
3	Other	JJ	O	other	amod	4	SENT_146	[p10l126t1618r279b1666],
4	24-85	NN	O	24-85	_	0	SENT_146	[p10l1796t733r1946b778],

1	Smoking	NN	O	smoking	nn	2	SENT_147	[p10l63t1729r294b1793],
2	status	NN	O	status	_	0	SENT_147	[p10l313t1738r468b1777],
3	—	CD	NUMBER	—	num	4	SENT_147	[p10l487t1759r551b1763],
4	no.	NN	O	no.	dep	2	SENT_147	[p10l571t1746r647b1777],
5	(	CD	PERCENT	(	num	6	SENT_147	[p10l674t1731r801b1792],
6	%	NN	PERCENT	%	rcmod	4	SENT_147	[p10l674t1731r801b1792],
7	)	CD	NUMBER	)	dep	6	SENT_147	[p10l674t1731r801b1792],
8	:	:	O	:	_	0	SENT_147	[p10l674t1731r801b1792],
9	i	FW	O	i	dep	6	SENT_147	[p10l674t1731r801b1792],
10	:	:	O	:	_	0	SENT_147	[p10l674t1731r801b1792],

1	Never	RB	O	never	neg	2	SENT_148	[p10l130t1844r283b1888],
2	smoked	VBN	O	smoke	_	0	SENT_148	[p10l301t1840r504b1888],
3	111	CD	NUMBER	111	number	4	SENT_148	[p10l1769t1844r1855b1887],
4	(	CD	NUMBER	(	dobj	2	SENT_148	[p10l1882t1844r1978b1903],
5	64	CD	NUMBER	64	num	6	SENT_148	[p10l1882t1844r1978b1903],
6	)	NN	O	)	dep	4	SENT_148	[p10l1882t1844r1978b1903],
7	Former	JJ	O	former	amod	8	SENT_148	[p10l130t1955r319b1999],
8	smoker	NN	O	smoker	dep	14	SENT_148	[p10l337t1951r532b1999],
9	54	CD	NUMBER	54	dep	8	SENT_148	[p10l1798t1955r1857b1999],
10	(	NN	O	(	dep	14	SENT_148	[p10l1882t1955r1978b2014],
11	31	CD	NUMBER	31	num	10	SENT_148	[p10l1882t1955r1978b2014],
12	)	CD	NUMBER	)	num	14	SENT_148	[p10l1882t1955r1978b2014],
13	Current	JJ	DATE	current	amod	14	SENT_148	[p10l126t2066r324b2110],
14	smoker	NN	O	smoker	dep	18	SENT_148	[p10l344t2062r538b2110],
15	9	CD	NUMBER	9	num	16	SENT_148	[p10l1830t2066r1856b2110],
16	(	NN	O	(	dep	14	SENT_148	[p10l1882t2066r1945b2125],
17	5	CD	NUMBER	5	num	18	SENT_148	[p10l1882t2066r1945b2125],
18	)	NN	O	)	dep	4	SENT_148	[p10l1882t2066r1945b2125],

1	Tumor	NN	O	tumor	nn	3	SENT_149	[p10l59t2178r239b2221],
2	histologic	JJ	O	histologic	amod	3	SENT_149	[p10l258t2173r513b2237],
3	type	NN	O	type	_	0	SENT_149	[p10l529t2182r637b2237],
4	—	CD	NUMBER	—	num	5	SENT_149	[p10l653t2203r718b2207],
5	no.	NN	O	no.	dep	3	SENT_149	[p10l738t2190r814b2221],
6	(	CD	PERCENT	(	num	7	SENT_149	[p10l841t2173r957b2236],
7	%	NN	PERCENT	%	dep	5	SENT_149	[p10l841t2173r957b2236],
8	)	CD	NUMBER	)	num	9	SENT_149	[p10l841t2173r957b2236],
9	§	NN	O	§	dep	3	SENT_149	[p10l841t2173r957b2236],

1	Adenocarcinoma	NN	O	adenocarcinoma	nn	3	SENT_150	[p10l124t2284r572b2332],
2	164	CD	NUMBER	164	num	3	SENT_150	[p10l1769t2288r1857b2332],
3	(	NN	O	(	_	0	SENT_150	[p10l1882t2288r1978b2347],
4	94	CD	NUMBER	94	number	5	SENT_150	[p10l1882t2288r1978b2347],
5	)	CD	NUMBER	)	num	6	SENT_150	[p10l1882t2288r1978b2347],
6	Non-adenocarcinoma	NN	O	non-adenocarcinoma	dep	3	SENT_150	[p10l130t2395r700b2443],
7	7	CD	NUMBER	7	num	8	SENT_150	[p10l1833t2399r1857b2443],
8	(	NN	O	(	dep	6	SENT_150	[p10l1882t2399r1945b2458],
9	4	CD	NUMBER	4	num	10	SENT_150	[p10l1882t2399r1945b2458],
10	)	NN	O	)	dep	3	SENT_150	[p10l1882t2399r1945b2458],

1	ECOG	NN	ORGANIZATION	ecog	nn	3	SENT_151	[p10l66t2510r222b2555],
2	performance	NN	O	performance	nn	3	SENT_151	[p10l247t2505r579b2569],
3	status	NN	O	status	_	0	SENT_151	[p10l600t2516r755b2555],
4	—	CD	NUMBER	—	num	5	SENT_151	[p10l773t2536r838b2540],
5	no.	NN	O	no.	dep	3	SENT_151	[p10l858t2523r934b2554],
6	(	CD	PERCENT	(	num	7	SENT_151	[p10l961t2506r1088b2569],
7	%	NN	PERCENT	%	dep	5	SENT_151	[p10l961t2506r1088b2569],
8	)	CD	NUMBER	)	number	9	SENT_151	[p10l961t2506r1088b2569],
9	1	CD	NUMBER	1	num	7	SENT_151	[p10l961t2506r1088b2569],
10	]	NN	O	]	dep	3	SENT_151	[p10l961t2506r1088b2569],

1	Extent	NN	O	extent	nn	2	SENT_152	[p10l66t2955r223b2999],
2	ofdisease	NN	O	ofdisease	_	0	SENT_152	[p10l242t2950r503b2999],
3	—	CD	NUMBER	—	num	4	SENT_152	[p10l520t2980r585b2984],
4	no.	NN	O	no.	dep	2	SENT_152	[p10l605t2967r680b2999],
5	(	CD	PERCENT	(	num	6	SENT_152	[p10l708t2953r793b3013],
6	%	NN	PERCENT	%	dep	4	SENT_152	[p10l708t2953r793b3013],
7	)	CD	NUMBER	)	dep	2	SENT_152	[p10l708t2953r793b3013],

1	Locally	RB	O	locally	advmod	2	SENT_153	[p10l130t3061r305b3125],
2	advanced	VBN	O	advance	_	0	SENT_153	[p10l324t3061r568b3109],
3	16	CD	NUMBER	16	number	4	SENT_153	[p10l1801t3065r1857b3109],
4	(	CD	NUMBER	(	num	5	SENT_153	[p10l1882t3065r1945b3124],
5	9	CD	NUMBER	9	dobj	2	SENT_153	[p10l1882t3065r1945b3124],
6	)	NN	O	)	dep	12	SENT_153	[p10l1882t3065r1945b3124],
7	Metastatic	JJ	O	metastatic	amod	8	SENT_153	[p10l130t3177r403b3220],
8	158	CD	NUMBER	158	dep	6	SENT_153	[p10l1769t3176r1856b3221],
9	(	NN	O	(	dep	12	SENT_153	[p10l1882t3176r1978b3236],
10	91	CD	NUMBER	91	num	9	SENT_153	[p10l1882t3176r1978b3236],
11	)	CD	NUMBER	)	num	12	SENT_153	[p10l1882t3176r1978b3236],
12	Presence	NN	O	presence	dep	5	SENT_153	[p10l66t3288r297b3332],
13	of	IN	O	of	_	0	SENT_153	[p10l317t3283r374b3332],
14	brain	NN	O	brain	nn	15	SENT_153	[p10l386t3283r513b3332],
15	metastases	NNS	O	metastase	prep_of	12	SENT_153	[p10l538t3292r831b3332],
16	—	VBP	O	—	dep	2	SENT_153	[p10l849t3313r914b3318],
17	no.	RB	O	no.	advmod	16	SENT_153	[p10l934t3300r1010b3332],
18	(	CD	PERCENT	(	num	19	SENT_153	[p10l1037t3286r1123b3346],
19	%	NN	PERCENT	%	dep	17	SENT_153	[p10l1037t3286r1123b3346],
20	)	CD	NUMBER	)	dep	17	SENT_153	[p10l1037t3286r1123b3346],
21	60	CD	NUMBER	60	num	24	SENT_153	[p10l1799t3286r1858b3332],
22	(	NN	O	(	nn	24	SENT_153	[p10l1882t3287r1978b3346],
23	34	CD	NUMBER	34	num	24	SENT_153	[p10l1882t3287r1978b3346],
24	)	NN	O	)	nsubj	2	SENT_153	[p10l1882t3287r1978b3346],

1	*	NN	O	*	_	0	SENT_154	[p10l10t3451r39b3479],
2	‘	CD	NUMBER	‘	num	1	SENT_154	[p10l10t3451r39b3479],
3	There	EX	O	there	expl	4	SENT_154	[p10l57t3447r205b3495],
4	were	VBD	O	be	rcmod	1	SENT_154	[p10l225t3464r347b3495],
5	no	DT	O	no	det	7	SENT_154	[p10l373t3464r434b3495],
6	significant	JJ	O	significant	amod	7	SENT_154	[p10l458t3446r729b3510],
7	differences	NNS	O	difference	nsubj	4	SENT_154	[p10l750t3446r1035b3495],
8	between	IN	O	between	_	0	SENT_154	[p10l1061t3447r1273b3495],
9	the	DT	O	the	det	10	SENT_154	[p10l1296t3447r1378b3495],
10	groups	NNS	O	group	prep_between	7	SENT_154	[p10l1401t3464r1581b3510],
11	in	IN	O	in	_	0	SENT_154	[p10l1607t3451r1648b3494],
12	any	DT	O	any	det	14	SENT_154	[p10l1674t3464r1762b3510],
13	ofthe	NN	O	ofthe	nn	14	SENT_154	[p10l1783t3446r1932b3495],
14	baseline	NN	O	baseline	prep_in	10	SENT_154	[p10l1957t3447r2090b3495, p10l61t3520r151b3567],

1	characteristics	NNS	O	characteristic	nsubj	2	SENT_155	[p10l173t3520r550b3567],
2	listed	VBN	O	list	_	0	SENT_155	[p10l576t3520r711b3567],
3	here	RB	O	here	advmod	2	SENT_155	[p10l738t3520r862b3567],
4	.	.	O	.	_	0	SENT_155	[p10l738t3520r862b3567],

1	1	CD	NUMBER	1	dep	5	SENT_156	[p11l12t23r42b82],
2	'	''	O	'	_	0	SENT_156	[p11l12t23r42b82],
3	Race	NN	O	race	nsubjpass	5	SENT_156	[p11l63t23r181b67],
4	was	VBD	O	be	auxpass	5	SENT_156	[p11l201t35r299b67],
5	reported	VBN	O	report	_	0	SENT_156	[p11l326t19r543b82],
6	by	IN	O	by	_	0	SENT_156	[p11l570t19r624b82],
7	the	DT	O	the	det	8	SENT_156	[p11l643t19r725b67],
8	investigators	NNS	O	investigator	agent	5	SENT_156	[p11l749t23r1098b82],
9	.	.	O	.	_	0	SENT_156	[p11l749t23r1098b82],

1	:	:	O	:	_	0	SENT_157	[p11l12t95r42b154],
2	i	FW	O	i	nsubj	6	SENT_157	[p11l12t95r42b154],
3	:	:	O	:	_	0	SENT_157	[p11l12t95r42b154],
4	Data	NNS	O	datum	dep	2	SENT_157	[p11l63t95r180b139],
5	were	VBD	O	be	aux	6	SENT_157	[p11l201t107r323b139],
6	missing	VBG	O	miss	_	0	SENT_157	[p11l348t95r553b154],
7	for	IN	O	for	_	0	SENT_157	[p11l573t90r646b139],
8	one	CD	NUMBER	one	num	9	SENT_157	[p11l666t107r761b139],
9	patient	NN	O	patient	prep_for	6	SENT_157	[p11l786t95r965b154],
10	in	IN	O	in	_	0	SENT_157	[p11l989t95r1030b138],
11	the	DT	O	the	det	13	SENT_157	[p11l1053t91r1135b139],
12	crizotinib	JJ	O	crizotinib	amod	13	SENT_157	[p11l1157t91r1402b139],
13	group	NN	O	group	prep_in	9	SENT_157	[p11l1426t107r1592b154],
14	.	.	O	.	_	0	SENT_157	[p11l1426t107r1592b154],

1	§	NNP	O	§	nn	2	SENT_158	[p11l11t162r31b226],
2	Data	NNP	O	Data	nsubj	4	SENT_158	[p11l63t167r180b211],
3	were	VBD	O	be	aux	4	SENT_158	[p11l201t179r323b211],
4	missing	VBG	O	miss	_	0	SENT_158	[p11l348t167r553b226],
5	for	IN	O	for	_	0	SENT_158	[p11l573t162r646b211],
6	seven	CD	NUMBER	seven	num	7	SENT_158	[p11l667t179r811b211],
7	patients	NNS	O	patient	prep_for	4	SENT_158	[p11l839t167r1060b226],
8	:	:	O	:	_	0	SENT_158	[p11l839t167r1060b226],
9	four	CD	NUMBER	four	dep	7	SENT_158	[p11l1084t162r1191b211],
10	in	IN	O	in	_	0	SENT_158	[p11l1213t167r1255b210],
11	the	DT	O	the	det	13	SENT_158	[p11l1278t163r1359b211],
12	crizotinib	JJ	O	crizotinib	amod	13	SENT_158	[p11l1382t163r1627b211],
13	group	NN	O	group	prep_in	9	SENT_158	[p11l1650t179r1803b226],
14	and	CC	O	and	_	0	SENT_158	[p11l1826t163r1918b211],
15	three	CD	NUMBER	three	prep_for	4	SENT_158	[p11l1941t163r2074b211],
16	in	IN	O	in	_	0	SENT_158	[p11l2099t167r2140b210],
17	the	DT	O	the	det	19	SENT_158	[p11l57t235r139b283],
18	chemotherapy	NN	O	chemotherapy	nn	19	SENT_158	[p11l161t235r537b298],
19	group	NN	O	group	prep_in	15	SENT_158	[p11l558t251r725b298],
20	.	.	O	.	_	0	SENT_158	[p11l558t251r725b298],

1	1	CD	NUMBER	1	number	2	SENT_159	[p11l12t306r125b369],
2	]	CD	NUMBER	]	nsubj	47	SENT_159	[p11l12t306r125b369],
3	An	DT	O	a	det	13	SENT_159	[p11l12t306r125b369],
4	Eastern	NNP	ORGANIZATION	Eastern	nn	13	SENT_159	[p11l154t311r343b355],
5	Cooperative	NNP	ORGANIZATION	Cooperative	nn	13	SENT_159	[p11l368t310r682b370],
6	Oncology	NNP	ORGANIZATION	Oncology	nn	13	SENT_159	[p11l705t307r956b370],
7	Group	NNP	ORGANIZATION	Group	nn	13	SENT_159	[p11l977t310r1143b370],
8	(	CD	NUMBER	(	num	13	SENT_159	[p11l1171t310r1370b370],
9	ECOG	NNP	O	ECOG	nn	13	SENT_159	[p11l1171t310r1370b370],
10	)	CD	NUMBER	)	num	13	SENT_159	[p11l1171t310r1370b370],
11	performance	NN	O	performance	nn	13	SENT_159	[p11l1401t306r1732b370],
12	status	NN	O	status	nn	13	SENT_159	[p11l1756t316r1911b355],
13	ofO	NN	O	ofo	nsubj	14	SENT_159	[p11l1935t306r2033b355],
14	indicates	VBZ	O	indicate	rcmod	2	SENT_159	[p11l2056t311r2118b354, p11l59t379r241b427],
15	that	IN	O	that	complm	20	SENT_159	[p11l263t379r366b427],
16	the	DT	O	the	det	17	SENT_159	[p11l385t379r467b427],
17	patient	NN	O	patient	nsubj	20	SENT_159	[p11l492t383r672b442],
18	is	VBZ	O	be	cop	20	SENT_159	[p11l695t383r731b427],
19	fully	RB	O	fully	advmod	20	SENT_159	[p11l754t378r862b442],
20	active	JJ	O	active	ccomp	14	SENT_159	[p11l883t383r1045b435],
21	,	,	O	,	_	0	SENT_159	[p11l883t383r1045b435],
22	1	CD	NUMBER	1	nsubj	47	SENT_159	[p11l1073t383r1094b426],
23	that	IN	O	that	complm	27	SENT_159	[p11l1117t379r1221b427],
24	the	DT	O	the	det	25	SENT_159	[p11l1240t379r1322b427],
25	patient	NN	O	patient	nsubj	27	SENT_159	[p11l1347t383r1526b442],
26	is	VBZ	O	be	cop	27	SENT_159	[p11l1550t383r1586b427],
27	ambulatory	JJ	O	ambulatory	dep	22	SENT_159	[p11l1610t379r1908b442],
28	but	CC	O	but	_	0	SENT_159	[p11l1931t379r2013b427],
29	restricted	JJ	O	restricted	conj_but	27	SENT_159	[p11l2037t395r2099b427, p11l60t451r251b499],
30	in	IN	O	in	_	0	SENT_159	[p11l278t455r319b498],
31	strenuous	JJ	O	strenuous	amod	32	SENT_159	[p11l345t460r606b499],
32	activity	NN	O	activity	prep_in	27	SENT_159	[p11l630t455r824b514],
33	,	,	O	,	_	0	SENT_159	[p11l630t455r824b514],
34	and	CC	O	and	_	0	SENT_159	[p11l849t451r941b499],
35	2	CD	NUMBER	2	nsubj	47	SENT_159	[p11l966t455r993b498],
36	that	IN	O	that	complm	40	SENT_159	[p11l1014t451r1117b499],
37	the	DT	O	the	det	38	SENT_159	[p11l1137t451r1218b499],
38	patient	NN	O	patient	nsubj	42	SENT_159	[p11l1243t455r1423b514],
39	is	VBZ	O	be	cop	40	SENT_159	[p11l1446t455r1483b499],
40	ambulatory	JJ	O	ambulatory	dep	35	SENT_159	[p11l1507t451r1804b514],
41	and	CC	O	and	_	0	SENT_159	[p11l1826t451r1918b499],
42	capable	JJ	O	capable	dep	35	SENT_159	[p11l1943t451r2142b514],
43	of	IN	O	of	_	0	SENT_159	[p11l59t522r116b571],
44	self-care	NN	O	self-care	prep_of	2	SENT_159	[p11l130t522r345b571],
45	but	CC	O	but	advmod	47	SENT_159	[p11l370t523r452b571],
46	is	VBZ	O	be	cop	47	SENT_159	[p11l475t527r512b571],
47	unable	JJ	O	unable	_	0	SENT_159	[p11l538t523r711b571],
48	to	TO	O	to	aux	49	SENT_159	[p11l731t532r782b571],
49	work	VB	O	work	xcomp	47	SENT_159	[p11l802t523r942b571],
50	.	.	O	.	_	0	SENT_159	[p11l802t523r942b571],

1	Data	NNS	O	datum	nsubj	3	SENT_160	[p11l971t527r1087b571],
2	were	VBD	O	be	aux	3	SENT_160	[p11l1109t539r1231b571],
3	missing	VBG	O	miss	_	0	SENT_160	[p11l1256t527r1461b586],
4	for	IN	O	for	_	0	SENT_160	[p11l1480t522r1553b571],
5	one	CD	NUMBER	one	num	6	SENT_160	[p11l1573t539r1668b571],
6	patient	NN	O	patient	prep_for	3	SENT_160	[p11l1693t527r1873b586],
7	in	IN	O	in	_	0	SENT_160	[p11l1896t527r1937b570],
8	the	DT	O	the	det	10	SENT_160	[p11l1961t523r2042b571],
9	crizotinib	JJ	O	crizotinib	amod	10	SENT_160	[p11l59t595r304b643],
10	group	NN	O	group	prep_in	6	SENT_160	[p11l327t611r494b658],
11	.	.	O	.	_	0	SENT_160	[p11l327t611r494b658],

1	At	IN	O	at	_	0	SENT_161	[p11l8t914r109b984],
2	the	DT	O	the	det	3	SENT_161	[p11l141t906r274b984],
3	time	NN	O	time	prep_at	18	SENT_161	[p11l312t907r506b984],
4	of	IN	O	of	_	0	SENT_161	[p11l543t905r644b985],
5	data	NNS	O	datum	nn	6	SENT_161	[p11l663t906r847b985],
6	cutoff	NN	O	cutoff	prep_of	3	SENT_161	[p11l883t905r1160b1002],
7	,	,	O	,	_	0	SENT_161	[p11l883t905r1160b1002],
8	the	DT	O	the	det	9	SENT_161	[p11l1204t906r1337b984],
9	median	NN	O	median	nsubj	18	SENT_161	[p11l1374t906r1699b985],
10	follow	VB	O	follow	dep	9	SENT_161	[p11l1736t905r2147b1006],
11	—	RB	O	—	advmod	10	SENT_161	[p11l1736t905r2147b1006],
12	up	RP	O	up	prep	10	SENT_161	[p11l1736t905r2147b1006],
13	for	IN	O	for	_	0	SENT_161	[p11l12t1034r136b1114],
14	overall	JJ	O	overall	amod	15	SENT_161	[p11l165t1035r452b1114],
15	survival	NN	O	survival	prep_for	12	SENT_161	[p11l484t1035r818b1114],
16	was	VBD	O	be	cop	18	SENT_161	[p11l843t1061r1007b1114],
17	12.2	CD	DURATION	12.2	num	18	SENT_161	[p11l1044t1041r1223b1114],
18	months	NNS	NUMBER	month	_	0	SENT_161	[p11l1255t1035r1584b1114],
19	in	IN	O	in	_	0	SENT_161	[p11l1617t1036r1700b1113],
20	the	DT	O	the	det	21	SENT_161	[p11l1732t1035r1865b1113],
21	crizotinib	NN	O	crizotinib	prep_in	18	SENT_161	[p11l1897t1036r2147b1114, p11l12t1163r215b1242],

1	group	NN	O	group	_	0	SENT_162	[p11l251t1189r506b1264],
2	and	CC	O	and	cc	3	SENT_162	[p11l541t1163r700b1242],
3	12.1	CD	DURATION	12.1	num	4	SENT_162	[p11l738t1169r915b1242],
4	months	NNS	NUMBER	month	dep	1	SENT_162	[p11l951t1163r1280b1242],
5	in	IN	O	in	_	0	SENT_162	[p11l1316t1164r1400b1241],
6	the	DT	O	the	det	7	SENT_162	[p11l1435t1163r1569b1241],
7	chemothera	NN	O	chemothera	prep_in	4	SENT_162	[p11l1604t1163r2147b1242],
8	—	CD	NUMBER	—	num	10	SENT_162	[p11l1604t1163r2147b1242],
9	py	NN	O	py	nn	10	SENT_162	[p11l11t1290r111b1364],
10	group	NN	O	group	dep	4	SENT_162	[p11l141t1290r418b1365],
11	.	.	O	.	_	0	SENT_162	[p11l141t1290r418b1365],

1	The	DT	O	the	det	3	SENT_163	[p11l138t1391r300b1469],
2	baseline	NN	O	baseline	nn	3	SENT_163	[p11l362t1391r716b1470],
3	characteristics	NNS	O	characteristic	nsubj	9	SENT_163	[p11l777t1391r1403b1469],
4	of	IN	O	of	_	0	SENT_163	[p11l1466t1390r1566b1470],
5	the	DT	O	the	det	6	SENT_163	[p11l1609t1391r1743b1469],
6	patients	NNS	O	patient	prep_of	3	SENT_163	[p11l1802t1392r2145b1491],
7	were	VBD	O	be	cop	9	SENT_163	[p11l8t1546r207b1599],
8	well	RB	O	well	advmod	9	SENT_163	[p11l236t1520r411b1599],
9	balanced	JJ	O	balanced	dep	15	SENT_163	[p11l444t1520r824b1599],
10	between	IN	O	between	_	0	SENT_163	[p11l856t1520r1211b1599],
11	the	DT	O	the	det	14	SENT_163	[p11l1243t1520r1374b1598],
12	two	CD	NUMBER	two	num	14	SENT_163	[p11l1408t1537r1564b1599],
13	study	NN	O	study	nn	14	SENT_163	[p11l1600t1520r1826b1620],
14	groups	NNS	O	group	prep_between	9	SENT_163	[p11l1854t1546r2146b1621],
15	(	VBP	O	(	_	0	SENT_163	[p11l17t1648r276b1740],
16	Table	NNP	O	Table	dobj	15	SENT_163	[p11l17t1648r276b1740],
17	1	CD	NUMBER	1	num	16	SENT_163	[p11l320t1654r415b1740],
18	)	CD	NUMBER	)	nsubj	15	SENT_163	[p11l320t1654r415b1740],
19	.	.	O	.	_	0	SENT_163	[p11l320t1654r415b1740],

1	The	DT	O	the	det	2	SENT_164	[p11l458t1648r619b1727],
2	majority	NN	O	majority	nsubj	6	SENT_164	[p11l659t1649r1023b1749],
3	of	IN	O	of	_	0	SENT_164	[p11l1059t1647r1159b1728],
4	patients	NNS	O	patient	prep_of	2	SENT_164	[p11l1179t1649r1522b1749],
5	were	VBD	O	be	cop	6	SENT_164	[p11l1560t1674r1763b1728],
6	younger	JJR	O	younger	ccomp	15	SENT_164	[p11l1799t1674r2151b1750],
7	than	IN	O	than	_	0	SENT_164	[p11l12t1777r210b1856],
8	65	CD	DURATION	65	num	9	SENT_164	[p11l245t1784r339b1857],
9	years	NNS	NUMBER	year	prep_than	6	SENT_164	[p11l372t1803r592b1878],
10	of	IN	O	of	_	0	SENT_164	[p11l629t1776r729b1857],
11	age	NN	O	age	prep_of	9	SENT_164	[p11l743t1804r911b1879],
12	,	,	O	,	_	0	SENT_164	[p11l743t1804r911b1879],
13	had	VBD	O	have	aux	15	SENT_164	[p11l950t1777r1107b1857],
14	never	RB	O	never	neg	15	SENT_164	[p11l1140t1803r1372b1857],
15	smoked	VBN	O	smoke	_	0	SENT_164	[p11l1403t1777r1761b1874],
16	,	,	O	,	_	0	SENT_164	[p11l1403t1777r1761b1874],
17	and	CC	O	and	_	0	SENT_164	[p11l1799t1777r1957b1857],
18	had	VBD	O	have	conj_and	15	SENT_164	[p11l1991t1777r2148b1857],
19	adenocarcinoma	NN	O	adenocarcinoma	dobj	18	SENT_164	[p11l11t1906r731b1986],
20	of	IN	O	of	_	0	SENT_164	[p11l787t1905r887b1986],
21	the	DT	O	the	det	22	SENT_164	[p11l926t1906r1060b1985],
22	lung	NN	O	lung	prep_of	19	SENT_164	[p11l1116t1906r1310b2008],
23	—	NN	O	—	nn	24	SENT_164	[p11l1360t1952r1468b1960],
24	characteristics	NNS	O	characteristic	dobj	15	SENT_164	[p11l1521t1906r2146b1985],
25	that	WDT	O	that	nsubj	27	SENT_164	[p11l12t2034r186b2112],
26	were	VBD	O	be	cop	27	SENT_164	[p11l217t2060r420b2114],
27	consistent	JJ	O	consistent	rcmod	24	SENT_164	[p11l463t2035r904b2113],
28	with	IN	O	with	_	0	SENT_164	[p11l935t2034r1132b2114],
29	those	DT	O	those	prep_with	27	SENT_164	[p11l1173t2034r1406b2113],
30	of	IN	O	of	_	0	SENT_164	[p11l1448t2033r1548b2113],
31	patients	NNS	O	patient	prep_of	29	SENT_164	[p11l1569t2035r1913b2134],
32	with	IN	O	with	_	0	SENT_164	[p11l1952t2034r2148b2114],
33	ALK	NN	O	alk	prep_with	27	SENT_164	[p11l6t2164r536b2263],
34	—	CD	NUMBER	—	num	37	SENT_164	[p11l6t2164r536b2263],
35	positive	JJ	O	positive	amod	37	SENT_164	[p11l6t2164r536b2263],
36	non	JJ	O	non	amod	37	SENT_164	[p11l577t2163r1224b2242],
37	—	NN	O	—	nsubj	18	SENT_164	[p11l577t2163r1224b2242],
38	small	JJ	O	small	amod	42	SENT_164	[p11l577t2163r1224b2242],
39	—	NN	O	—	nn	42	SENT_164	[p11l577t2163r1224b2242],
40	cell	NN	O	cell	nn	42	SENT_164	[p11l577t2163r1224b2242],
41	lung	NN	O	lung	nn	42	SENT_164	[p11l1262t2163r1456b2264],
42	cancer	NN	O	cancer	dep	51	SENT_164	[p11l1495t2189r1777b2241],
43	in	IN	O	in	_	0	SENT_164	[p11l1814t2164r1897b2241],
44	prior	JJ	O	prior	amod	45	SENT_164	[p11l1936t2164r2151b2263],
45	studies	NNS	O	study	prep_in	42	SENT_164	[p11l14t2291r516b2370],
46	.22	CD	NUMBER	.22	dep	51	SENT_164	[p11l14t2291r516b2370],
47	»	CD	NUMBER	»	number	48	SENT_164	[p11l14t2291r516b2370],
48	23	CD	NUMBER	23	num	51	SENT_164	[p11l14t2291r516b2370],
49	The	DT	O	the	det	51	SENT_164	[p11l569t2291r731b2369],
50	baseline	NN	O	baseline	nn	51	SENT_164	[p11l786t2291r1140b2370],
51	characteristics	NNS	O	characteristic	dep	62	SENT_164	[p11l1195t2291r1821b2369],
52	of	IN	O	of	_	0	SENT_164	[p11l1878t2290r1978b2370],
53	the	DT	O	the	det	54	SENT_164	[p11l2014t2291r2148b2369],
54	patients	NNS	O	patient	prep_of	51	SENT_164	[p11l11t2420r354b2520],
55	according	VBG	O	accord	_	0	SENT_164	[p11l401t2419r831b2521],
56	to	TO	O	to	prepc_according_to	62	SENT_164	[p11l873t2436r955b2499],
57	the	DT	O	the	det	58	SENT_164	[p11l1003t2419r1136b2498],
58	type	NN	O	type	pobj	62	SENT_164	[p11l1182t2436r1364b2520],
59	of	IN	O	of	_	0	SENT_164	[p11l1410t2418r1511b2499],
60	chemotherapy	NN	O	chemotherapy	prep_of	58	SENT_164	[p11l1539t2419r2153b2520],
61	they	PRP	O	they	nsubj	62	SENT_164	[p11l12t2548r197b2648],
62	received	VBD	O	receive	dep	15	SENT_164	[p11l233t2548r581b2627],
63	are	VBP	O	be	auxpass	64	SENT_164	[p11l622t2574r752b2626],
64	shown	VBN	O	show	ccomp	62	SENT_164	[p11l795t2548r1078b2628],
65	in	IN	O	in	_	0	SENT_164	[p11l1120t2549r1203b2626],
66	Table	NNP	O	Table	nn	67	SENT_164	[p11l1242t2548r1473b2627],
67	S1	NN	O	s1	prep_in	64	SENT_164	[p11l1517t2554r1613b2627],
68	in	IN	O	in	_	0	SENT_164	[p11l1654t2549r1738b2626],
69	the	DT	O	the	det	71	SENT_164	[p11l1780t2548r1914b2626],
70	Supplementary	NNP	O	Supplementary	nn	71	SENT_164	[p11l1958t2554r2147b2648, p11l11t2677r504b2777],
71	Appendix	NNP	O	Appendix	prep_in	64	SENT_164	[p11l535t2677r977b2777],
72	.	.	O	.	_	0	SENT_164	[p11l535t2677r977b2777],

1	EFFICACY	NN	O	efficacy	_	0	SENT_165	[p11l17t2953r388b3004],

1	Among	IN	O	among	_	0	SENT_166	[p11l8t3061r331b3154],
2	the	DT	O	the	det	4	SENT_166	[p11l365t3053r498b3131],
3	347	CD	NUMBER	347	num	4	SENT_166	[p11l537t3059r687b3132],
4	patients	NNS	O	patient	prep_among	15	SENT_166	[p11l724t3054r1068b3153],
5	in	IN	O	in	_	0	SENT_166	[p11l1107t3054r1190b3131],
6	the	DT	O	the	det	7	SENT_166	[p11l1227t3053r1361b3131],
7	intention	NN	O	intention	prep_in	4	SENT_166	[p11l1398t3054r2153b3132],
8	—	CD	NUMBER	—	number	10	SENT_166	[p11l1398t3054r2153b3132],
9	to	TO	O	to	dep	10	SENT_166	[p11l1398t3054r2153b3132],
10	—	CD	NUMBER	—	num	12	SENT_166	[p11l1398t3054r2153b3132],
11	treat	NN	O	treat	nn	12	SENT_166	[p11l1398t3054r2153b3132],
12	population	NN	O	population	dep	7	SENT_166	[p11l11t3181r508b3281],
13	,	,	O	,	_	0	SENT_166	[p11l11t3181r508b3281],
14	227	CD	NUMBER	227	nsubj	19	SENT_166	[p11l551t3187r704b3259],
15	had	VBD	O	have	_	0	SENT_166	[p11l743t3181r901b3260],
16	disease	NN	O	disease	nn	17	SENT_166	[p11l939t3181r1251b3260],
17	progression	NN	O	progression	dobj	15	SENT_166	[p11l1287t3182r1802b3282],
18	or	CC	O	or	_	0	SENT_166	[p11l1840t3207r1930b3260],
19	died	VBD	O	die	conj_or	15	SENT_166	[p11l1965t3181r2148b3260],
20	by	IN	O	by	_	0	SENT_166	[p11l13t3309r110b3410],
21	the	DT	O	the	det	22	SENT_166	[p11l146t3309r280b3388],
22	time	NN	O	time	prep_by	19	SENT_166	[p11l320t3310r514b3388],
23	of	IN	O	of	_	0	SENT_166	[p11l554t3308r655b3389],
24	data	NNS	O	datum	nn	25	SENT_166	[p11l677t3309r860b3389],
25	cutoff	NN	O	cutoff	prep_of	22	SENT_166	[p11l899t3308r1177b3389],
26	.	.	O	.	_	0	SENT_166	[p11l899t3308r1177b3389],

1	The	DT	O	the	det	6	SENT_167	[p11l1218t3309r1380b3388],
2	median	JJ	O	median	amod	6	SENT_167	[p11l1420t3309r1745b3389],
3	progression	NN	O	progression	nn	6	SENT_167	[p11l1783t3335r2147b3411, p11l14t3436r389b3516],
4	—	CD	NUMBER	—	num	6	SENT_167	[p11l1783t3335r2147b3411, p11l14t3436r389b3516],
5	free	JJ	O	free	amod	6	SENT_167	[p11l1783t3335r2147b3411, p11l14t3436r389b3516],
6	survival	NN	O	survival	nsubj	17	SENT_167	[p11l426t3437r782b3533],
7	,	,	O	,	_	0	SENT_167	[p11l426t3437r782b3533],
8	as	IN	O	as	mark	9	SENT_167	[p11l824t3463r910b3515],
9	determined	VBN	O	determine	dep	6	SENT_167	[p11l949t3437r1446b3516],
10	by	IN	O	by	_	0	SENT_167	[p11l1483t3437r1581b3537],
11	independent	JJ	O	independent	amod	13	SENT_167	[p11l1611t3437r2153b3537],
12	radiologic	JJ	O	radiologic	amod	13	SENT_167	[p11l12t3566r446b3667],
13	review	NN	O	review	prep_by	9	SENT_167	[p11l476t3567r771b3662],
14	,	,	O	,	_	0	SENT_167	[p11l476t3567r771b3662],
15	was	VBD	O	be	cop	17	SENT_167	[p11l803t3592r966b3645],
16	7.7	CD	DURATION	7.7	num	17	SENT_167	[p11l1000t3574r1113b3645],
17	months	NNS	NUMBER	month	_	0	SENT_167	[p11l1145t3566r1474b3645],
18	(	VBP	O	(	rcmod	17	SENT_167	[p11l1512t3571r1724b3657],
19	95	CD	PERCENT	95	number	20	SENT_167	[p11l1512t3571r1724b3657],
20	%	NN	PERCENT	%	amod	21	SENT_167	[p11l1512t3571r1724b3657],
21	CI	NN	O	ci	dobj	18	SENT_167	[p11l1753t3572r1869b3662],
22	,	,	O	,	_	0	SENT_167	[p11l1753t3572r1869b3662],
23	6.0	CD	NUMBER	6.0	number	26	SENT_167	[p11l1906t3572r2033b3645],
24	to	TO	O	to	dep	26	SENT_167	[p11l2065t3583r2147b3645],
25	8.8	CD	NUMBER	8.8	number	26	SENT_167	[p11l13t3700r169b3785],
26	)	CD	NUMBER	)	appos	21	SENT_167	[p11l13t3700r169b3785],
27	in	IN	O	in	_	0	SENT_167	[p11l223t3695r306b3772],
28	the	DT	O	the	det	30	SENT_167	[p11l355t3694r489b3772],
29	crizotinib	JJ	O	crizotinib	amod	30	SENT_167	[p11l538t3694r961b3773],
30	group	NN	O	group	prep_in	26	SENT_167	[p11l1011t3720r1287b3795],
31	,	,	O	,	_	0	SENT_167	[p11l1011t3720r1287b3795],
32	as	IN	O	as	_	0	SENT_167	[p11l1341t3720r1427b3772],
33	compared	VBN	O	compare	prepc_as	18	SENT_167	[p11l1478t3694r1908b3794],
34	with	IN	O	with	pcomp	33	SENT_167	[p11l1952t3694r2148b3773],

1	3.0	CD	DURATION	3.0	num	2	SENT_168	[p12l13t26r138b99],
2	months	NNS	DURATION	month	nsubj	3	SENT_168	[p12l187t20r516b99],
3	(	VBP	O	(	_	0	SENT_168	[p12l571t25r783b111],
4	95	CD	PERCENT	95	number	5	SENT_168	[p12l571t25r783b111],
5	%	NN	PERCENT	%	amod	6	SENT_168	[p12l571t25r783b111],
6	CI	NN	O	ci	dobj	3	SENT_168	[p12l830t26r946b116],
7	,	,	O	,	_	0	SENT_168	[p12l830t26r946b116],
8	2.6	CD	NUMBER	2.6	number	11	SENT_168	[p12l999t26r1127b99],
9	to	TO	O	to	dep	11	SENT_168	[p12l1177t37r1258b99],
10	4.3	CD	NUMBER	4.3	number	11	SENT_168	[p12l1305t26r1460b111],
11	)	CD	NUMBER	)	appos	6	SENT_168	[p12l1305t26r1460b111],
12	in	IN	O	in	_	0	SENT_168	[p12l1513t21r1596b98],
13	the	DT	O	the	det	18	SENT_168	[p12l1644t20r1778b98],
14	chemotherapy	NN	O	chemotherapy	nn	18	SENT_168	[p12l1827t20r2147b99, p12l12t149r336b250],
15	group	NN	O	group	nn	18	SENT_168	[p12l370t175r624b251],
16	(	CD	NUMBER	(	num	18	SENT_168	[p12l669t149r997b241],
17	hazard	NN	O	hazard	nn	18	SENT_168	[p12l669t149r997b241],
18	ratio	NN	O	ratio	prep_in	11	SENT_168	[p12l1035t150r1233b229],
19	for	IN	O	for	_	0	SENT_168	[p12l1273t148r1397b229],
20	disease	NN	O	disease	nn	21	SENT_168	[p12l1434t149r1746b229],
21	progression	NN	O	progression	prep_for	18	SENT_168	[p12l1783t175r2147b251, p12l14t279r190b357],
22	or	CC	O	or	_	0	SENT_168	[p12l228t304r318b357],
23	death	NN	O	death	prep_for	18	SENT_168	[p12l353t278r592b357],
24	with	IN	O	with	_	0	SENT_168	[p12l625t278r821b357],
25	crizotinib	NN	O	crizotinib	prep_with	11	SENT_168	[p12l860t278r1304b374],
26	,	,	O	,	_	0	SENT_168	[p12l860t278r1304b374],
27	0.49	CD	NUMBER	0.49	appos	25	SENT_168	[p12l1348t284r1548b374],
28	;	:	O	;	_	0	SENT_168	[p12l1348t284r1548b374],
29	95	CD	PERCENT	95	number	30	SENT_168	[p12l1591t283r1775b357],
30	%	NN	PERCENT	%	amod	31	SENT_168	[p12l1591t283r1775b357],
31	CI	NN	O	ci	dep	11	SENT_168	[p12l1813t284r1928b374],
32	,	,	O	,	_	0	SENT_168	[p12l1813t284r1928b374],
33	0.37	CD	NUMBER	0.37	num	35	SENT_168	[p12l1971t284r2148b357],
34	to	TO	O	to	dep	35	SENT_168	[p12l12t424r94b486],
35	0.64	CD	NUMBER	0.64	appos	31	SENT_168	[p12l128t413r333b502],
36	;	:	O	;	_	0	SENT_168	[p12l128t413r333b502],
37	P	NN	O	p	dep	11	SENT_168	[p12l367t413r733b498],
38	<	JJR	O	<	dep	37	SENT_168	[p12l367t413r733b498],
39	0.001	CD	NUMBER	0.001	num	40	SENT_168	[p12l367t413r733b498],
40	)	NN	O	)	tmod	3	SENT_168	[p12l367t413r733b498],
41	(	CD	NUMBER	(	num	42	SENT_168	[p12l775t408r955b508],
42	Fig	NN	O	fig	dep	40	SENT_168	[p12l775t408r955b508],
43	.	.	O	.	_	0	SENT_168	[p12l775t408r955b508],

1	1A	NN	O	1a	_	0	SENT_169	[p12l996t413r1160b498],
2	)	NN	O	)	dep	1	SENT_169	[p12l996t413r1160b498],
3	.	.	O	.	_	0	SENT_169	[p12l996t413r1160b498],

1	In	IN	O	in	_	0	SENT_170	[p12l1196t415r1285b485],
2	subgroup	NN	O	subgroup	nn	3	SENT_170	[p12l1318t407r1724b508],
3	analyses	NNS	O	analysis	prep_in	6	SENT_170	[p12l1756t407r2142b507],
4	,	,	O	,	_	0	SENT_170	[p12l1756t407r2142b507],
5	there	EX	O	there	expl	6	SENT_170	[p12l12t535r231b614],
6	was	VBD	O	be	_	0	SENT_170	[p12l281t562r444b615],
7	significant	JJ	O	significant	amod	8	SENT_170	[p12l502t534r973b637],
8	improvement	NN	O	improvement	nsubj	6	SENT_170	[p12l1021t536r1599b636],
9	in	IN	O	in	_	0	SENT_170	[p12l1647t536r1730b613],
10	progression	NN	O	progression	npadvmod	12	SENT_170	[p12l1783t561r2147b637, p12l14t662r389b742],
11	—	CD	NUMBER	—	num	10	SENT_170	[p12l1783t561r2147b637, p12l14t662r389b742],
12	free	JJ	O	free	amod	13	SENT_170	[p12l1783t561r2147b637, p12l14t662r389b742],
13	survival	NN	O	survival	prep_in	8	SENT_170	[p12l448t663r782b743],
14	with	IN	O	with	_	0	SENT_170	[p12l835t663r1032b743],
15	crizotinib	NN	O	crizotinib	prep_with	13	SENT_170	[p12l1091t663r1513b742],
16	as	IN	O	as	prep	6	SENT_170	[p12l1573t689r1658b741],
17	compared	VBN	O	compare	prep	6	SENT_170	[p12l1719t663r2148b763],
18	with	IN	O	with	pcomp	17	SENT_170	[p12l7t791r204b871],
19	pemetrexed	JJ	O	pemetrexed	amod	22	SENT_170	[p12l252t791r757b891],
20	(	NN	O	(	nn	22	SENT_170	[p12l811t791r1138b882],
21	hazard	NN	O	hazard	nn	22	SENT_170	[p12l811t791r1138b882],
22	ratio	NN	O	ratio	pobj	18	SENT_170	[p12l1187t792r1386b870],
23	for	IN	O	for	_	0	SENT_170	[p12l1436t790r1560b870],
24	disease	NN	O	disease	nn	25	SENT_170	[p12l1607t791r1919b870],
25	progression	NN	O	progression	prep_for	22	SENT_170	[p12l1967t817r2147b891, p12l12t921r377b1021],
26	or	CC	O	or	_	0	SENT_170	[p12l432t946r521b999],
27	death	NN	O	death	conj_or	25	SENT_170	[p12l573t920r835b1016],
28	,	,	O	,	_	0	SENT_170	[p12l573t920r835b1016],
29	0.59	CD	NUMBER	0.59	conj_or	22	SENT_170	[p12l895t926r1095b1016],
30	;	:	O	;	_	0	SENT_170	[p12l895t926r1095b1016],
31	95	CD	PERCENT	95	number	32	SENT_170	[p12l1155t925r1339b999],
32	%	NN	PERCENT	%	amod	33	SENT_170	[p12l1155t925r1339b999],
33	CI	NN	O	ci	dep	29	SENT_170	[p12l1393t926r1509b1016],
34	,	,	O	,	_	0	SENT_170	[p12l1393t926r1509b1016],
35	0.43	CD	NUMBER	0.43	conj_or	22	SENT_170	[p12l1569t926r1741b999],
36	to	TO	O	to	_	0	SENT_170	[p12l1800t937r1881b999],
37	0.80	CD	NUMBER	0.80	prep_to	35	SENT_170	[p12l1937t926r2144b1015],
38	;	:	O	;	_	0	SENT_170	[p12l1937t926r2144b1015],
39	P	NN	O	p	nn	53	SENT_170	[p12l11t1054r377b1139],
40	<	JJR	O	<	nn	53	SENT_170	[p12l11t1054r377b1139],
41	0.001	CD	NUMBER	0.001	num	42	SENT_170	[p12l11t1054r377b1139],
42	)	NN	O	)	dep	40	SENT_170	[p12l11t1054r377b1139],
43	and	CC	O	and	_	0	SENT_170	[p12l426t1048r585b1127],
44	as	IN	O	as	mark	45	SENT_170	[p12l630t1074r715b1126],
45	compared	VBN	O	compare	nn	53	SENT_170	[p12l763t1048r1192b1148],
46	with	IN	O	with	pcomp	45	SENT_170	[p12l1233t1048r1429b1128],
47	docetaxel	NN	O	docetaxel	nn	50	SENT_170	[p12l1474t1048r1883b1127],
48	(	NN	O	(	nn	50	SENT_170	[p12l1932t1048r2147b1139, p12l11t1177r150b1257],
49	hazard	NN	O	hazard	nn	50	SENT_170	[p12l1932t1048r2147b1139, p12l11t1177r150b1257],
50	ratio	NN	O	ratio	pobj	46	SENT_170	[p12l191t1178r390b1257],
51	for	IN	O	for	_	0	SENT_170	[p12l432t1176r556b1257],
52	disease	NN	O	disease	prep_for	50	SENT_170	[p12l595t1177r907b1257],
53	progression	NN	O	progression	pobj	18	SENT_170	[p12l947t1178r1461b1279],
54	or	CC	O	or	_	0	SENT_170	[p12l1503t1203r1592b1257],
55	death	NN	O	death	pobj	18	SENT_170	[p12l1631t1177r1893b1274],
56	,	,	O	,	_	0	SENT_170	[p12l1631t1177r1893b1274],
57	0.30	CD	NUMBER	0.30	appos	55	SENT_170	[p12l1940t1184r2144b1273],
58	;	:	O	;	_	0	SENT_170	[p12l1940t1184r2144b1273],
59	95	CD	PERCENT	95	number	60	SENT_170	[p12l12t1312r197b1386],
60	%	NN	PERCENT	%	amod	61	SENT_170	[p12l12t1312r197b1386],
61	CI	NN	O	ci	dep	55	SENT_170	[p12l231t1313r346b1403],
62	,	,	O	,	_	0	SENT_170	[p12l231t1313r346b1403],
63	0.21	CD	NUMBER	0.21	num	65	SENT_170	[p12l386t1313r566b1386],
64	to	TO	O	to	dep	65	SENT_170	[p12l600t1323r683b1386],
65	0.43	CD	NUMBER	0.43	appos	61	SENT_170	[p12l718t1313r916b1402],
66	;	:	O	;	_	0	SENT_170	[p12l718t1313r916b1402],
67	P	NN	O	p	dep	68	SENT_170	[p12l952t1313r1319b1398],
68	<	JJR	O	<	dep	55	SENT_170	[p12l952t1313r1319b1398],
69	0.001	CD	NUMBER	0.001	num	70	SENT_170	[p12l952t1313r1319b1398],
70	)	NN	O	)	dep	68	SENT_170	[p12l952t1313r1319b1398],
71	(	CD	NUMBER	(	num	72	SENT_170	[p12l1364t1308r1544b1408],
72	Fig	NN	O	fig	dep	68	SENT_170	[p12l1364t1308r1544b1408],
73	.	.	O	.	_	0	SENT_170	[p12l1364t1308r1544b1408],

1	1B	NN	O	1b	_	0	SENT_171	[p12l1587t1313r1745b1398],
2	)	NN	O	)	dep	1	SENT_171	[p12l1587t1313r1745b1398],
3	.	.	O	.	_	0	SENT_171	[p12l1587t1313r1745b1398],

1	Progression-free	JJ	O	progression-free	amod	2	SENT_172	[p12l1783t1313r2147b1408, p12l14t1434r389b1515],
2	survival	NN	O	survival	nsubjpass	13	SENT_172	[p12l420t1435r754b1515],
3	was	VBD	O	be	auxpass	13	SENT_172	[p12l778t1462r941b1515],
4	longer	RBR	O	longer	advmod	13	SENT_172	[p12l972t1435r1248b1537],
5	with	IN	O	with	_	0	SENT_172	[p12l1270t1435r1467b1515],
6	crizotinib	NN	O	crizotinib	prep_with	4	SENT_172	[p12l1496t1435r1920b1515],
7	than	IN	O	than	advmod	13	SENT_172	[p12l1950t1435r2148b1514],
8	with	IN	O	with	_	0	SENT_172	[p12l7t1564r205b1644],
9	chemotherapy	NN	O	chemotherapy	prep_with	7	SENT_172	[p12l239t1564r854b1665],
10	in	IN	O	in	_	0	SENT_172	[p12l883t1565r967b1642],
11	patient	NN	O	patient	nn	12	SENT_172	[p12l999t1565r1303b1665],
12	subgroups	NNS	O	subgroup	prep_in	9	SENT_172	[p12l1334t1564r1783b1666],
13	defined	VBN	O	define	_	0	SENT_172	[p12l1820t1563r2148b1644],
14	according	VBG	O	accord	_	0	SENT_172	[p12l11t1693r441b1795],
15	to	TO	O	to	prepc_according_to	13	SENT_172	[p12l469t1710r551b1773],
16	baseline	NN	O	baseline	nn	17	SENT_172	[p12l585t1693r939b1773],
17	characteristics	NNS	O	characteristic	pobj	13	SENT_172	[p12l972t1693r1596b1772],
18	and	CC	O	and	_	0	SENT_172	[p12l1630t1693r1788b1773],
19	stratification	NN	O	stratification	nn	20	SENT_172	[p12l1822t1692r2147b1772, p12l13t1823r278b1902],
20	factors	NNS	O	factor	nsubj	21	SENT_172	[p12l316t1821r608b1902],
21	(	VBP	O	(	conj_and	13	SENT_172	[p12l654t1823r834b1924],
22	Fig	NN	O	fig	dobj	21	SENT_172	[p12l654t1823r834b1924],
23	.	.	O	.	_	0	SENT_172	[p12l654t1823r834b1924],

1	S2	NN	O	s2	_	0	SENT_173	[p12l881t1828r976b1902],
2	in	IN	O	in	_	0	SENT_173	[p12l1015t1823r1099b1900],
3	the	DT	O	the	det	6	SENT_173	[p12l1138t1822r1271b1901],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_173	[p12l1312t1822r1963b1923],
5	Appendix	NNP	O	Appendix	nn	6	SENT_173	[p12l1993t1830r2147b1923, p12l11t1951r358b2051],
6	)	NN	O	)	prep_in	1	SENT_173	[p12l1993t1830r2147b1923, p12l11t1951r358b2051],
7	.	.	O	.	_	0	SENT_173	[p12l1993t1830r2147b1923, p12l11t1951r358b2051],

1	In	IN	O	in	_	0	SENT_174	[p12l141t2088r230b2158],
2	the	DT	O	the	det	3	SENT_174	[p12l287t2080r420b2158],
3	intention	NN	O	intention	prep_in	25	SENT_174	[p12l477t2081r1233b2159],
4	—	CD	NUMBER	—	number	6	SENT_174	[p12l477t2081r1233b2159],
5	to	TO	O	to	dep	6	SENT_174	[p12l477t2081r1233b2159],
6	—	CD	NUMBER	—	num	8	SENT_174	[p12l477t2081r1233b2159],
7	treat	NN	O	treat	nn	8	SENT_174	[p12l477t2081r1233b2159],
8	population	NN	O	population	nsubj	25	SENT_174	[p12l1282t2080r1780b2180],
9	,	,	O	,	_	0	SENT_174	[p12l1282t2080r1780b2180],
10	the	DT	O	the	det	12	SENT_174	[p12l1843t2080r1976b2158],
11	response	NN	O	response	nn	12	SENT_174	[p12l2033t2106r2147b2158, p12l14t2234r310b2308],
12	rate	NN	O	rate	appos	8	SENT_174	[p12l345t2225r528b2304],
13	,	,	O	,	_	0	SENT_174	[p12l345t2225r528b2304],
14	as	IN	O	as	mark	15	SENT_174	[p12l568t2234r654b2286],
15	verified	VBN	O	verify	dep	8	SENT_174	[p12l686t2207r1016b2287],
16	by	IN	O	by	_	0	SENT_174	[p12l1051t2208r1148b2308],
17	means	NNS	O	means	_	0	SENT_174	[p12l1178t2234r1459b2286],
18	of	IN	O	of	_	0	SENT_174	[p12l1496t2207r1596b2287],
19	independent	JJ	O	independent	amod	21	SENT_174	[p12l1611t2208r2153b2308],
20	radiologic	JJ	O	radiologic	amod	21	SENT_174	[p12l12t2337r446b2439],
21	review	NN	O	review	prep_by_means_of	15	SENT_174	[p12l478t2338r773b2434],
22	,	,	O	,	_	0	SENT_174	[p12l478t2338r773b2434],
23	was	VBD	O	be	cop	25	SENT_174	[p12l808t2364r972b2417],
24	significantly	RB	O	significantly	advmod	25	SENT_174	[p12l1009t2336r1555b2439],
25	higher	JJR	O	higher	_	0	SENT_174	[p12l1584t2337r1866b2439],
26	in	IN	O	in	_	0	SENT_174	[p12l1896t2338r1980b2415],
27	the	DT	O	the	det	29	SENT_174	[p12l2014t2337r2148b2416],
28	crizotinib	JJ	O	crizotinib	amod	29	SENT_174	[p12l13t2466r426b2545],
29	group	NN	O	group	prep_in	25	SENT_174	[p12l458t2492r707b2567],
30	than	IN	O	than	dep	25	SENT_174	[p12l741t2466r935b2544],
31	in	IN	O	in	_	0	SENT_174	[p12l965t2467r1048b2544],
32	the	DT	O	the	det	34	SENT_174	[p12l1079t2466r1211b2544],
33	chemotherapy	NN	O	chemotherapy	nn	34	SENT_174	[p12l1243t2466r1845b2566],
34	group	NN	O	group	prep_in	25	SENT_174	[p12l1871t2492r2144b2567],
35	:	:	O	:	_	0	SENT_174	[p12l1871t2492r2144b2567],
36	65	CD	PERCENT	65	num	37	SENT_174	[p12l12t2599r196b2673],
37	%	NN	PERCENT	%	dep	34	SENT_174	[p12l12t2599r196b2673],
38	(	CD	PERCENT	(	num	41	SENT_174	[p12l242t2599r455b2685],
39	95	CD	PERCENT	95	number	40	SENT_174	[p12l242t2599r455b2685],
40	%	NN	PERCENT	%	amod	41	SENT_174	[p12l242t2599r455b2685],
41	CI	NN	O	ci	dep	37	SENT_174	[p12l496t2600r612b2690],
42	,	,	O	,	_	0	SENT_174	[p12l496t2600r612b2690],
43	58	CD	NUMBER	58	number	46	SENT_174	[p12l661t2600r758b2673],
44	to	TO	O	to	dep	46	SENT_174	[p12l803t2611r885b2673],
45	72	CD	NUMBER	72	number	46	SENT_174	[p12l929t2600r1054b2685],
46	)	CD	NUMBER	)	npadvmod	49	SENT_174	[p12l929t2600r1054b2685],
47	with	IN	O	with	_	0	SENT_174	[p12l1097t2594r1294b2673],
48	crizotinib	NN	O	crizotinib	prep_with	46	SENT_174	[p12l1336t2594r1760b2673],
49	as	IN	O	as	advmod	25	SENT_174	[p12l1802t2620r1888b2672],
50	compared	VBN	O	compare	_	0	SENT_174	[p12l1933t2620r2147b2673, p12l11t2723r255b2823],
51	With	IN	O	with	prepc_compared_with	25	SENT_174	[p12l289t2723r485b2802],
52	20	CD	PERCENT	20	number	53	SENT_174	[p12l524t2728r712b2802],
53	%	NN	PERCENT	%	amod	57	SENT_174	[p12l524t2728r712b2802],
54	(	CD	PERCENT	(	number	55	SENT_174	[p12l755t2728r968b2814],
55	95	CD	PERCENT	95	dep	56	SENT_174	[p12l755t2728r968b2814],
56	%	NN	PERCENT	%	dep	57	SENT_174	[p12l755t2728r968b2814],
57	CI	NN	O	ci	pobj	25	SENT_174	[p12l1005t2729r1121b2819],
58	,	,	O	,	_	0	SENT_174	[p12l1005t2729r1121b2819],
59	14	CD	NUMBER	14	number	62	SENT_174	[p12l1169t2729r1262b2802],
60	to	TO	O	to	dep	62	SENT_174	[p12l1301t2740r1383b2802],
61	26	CD	NUMBER	26	number	62	SENT_174	[p12l1423t2729r1551b2814],
62	)	CD	NUMBER	)	dep	67	SENT_174	[p12l1423t2729r1551b2814],
63	with	IN	O	with	_	0	SENT_174	[p12l1591t2723r1787b2802],
64	chemotherapy	NN	O	chemotherapy	prep_with	62	SENT_174	[p12l1826t2723r2147b2802, p12l12t2852r336b2952],
65	(	CD	NUMBER	(	num	66	SENT_174	[p12l402t2858r798b2943],
66	P	NN	O	p	dep	67	SENT_174	[p12l402t2858r798b2943],
67	<	JJR	O	<	dep	73	SENT_174	[p12l402t2858r798b2943],
68	0.001	CD	NUMBER	0.001	dep	67	SENT_174	[p12l402t2858r798b2943],
69	)	NN	O	)	nn	71	SENT_174	[p12l402t2858r798b2943],
70	(	CD	NUMBER	(	num	71	SENT_174	[p12l873t2852r1133b2943],
71	Table	NNP	O	Table	dep	68	SENT_174	[p12l873t2852r1133b2943],
72	2	CD	NUMBER	2	num	73	SENT_174	[p12l1199t2858r1299b2943],
73	)	CD	NUMBER	)	dep	25	SENT_174	[p12l1199t2858r1299b2943],
74	.	.	O	.	_	0	SENT_174	[p12l1199t2858r1299b2943],

1	In	IN	O	in	_	0	SENT_175	[p12l1369t2860r1458b2930],
2	the	DT	O	the	det	4	SENT_175	[p12l1524t2852r1657b2930],
3	as	IN	O	as	amod	4	SENT_175	[p12l1722t2852r2148b2931],
4	—	NN	O	—	prep_in	12	SENT_175	[p12l1722t2852r2148b2931],
5	treated	VBN	O	treat	partmod	4	SENT_175	[p12l1722t2852r2148b2931],
6	population	NN	O	population	dobj	5	SENT_175	[p12l11t2981r508b3081],
7	,	,	O	,	_	0	SENT_175	[p12l11t2981r508b3081],
8	the	DT	O	the	det	10	SENT_175	[p12l568t2981r701b3060],
9	response	NN	O	response	nn	10	SENT_175	[p12l755t3007r1138b3081],
10	rate	NN	O	rate	nsubj	12	SENT_175	[p12l1192t2998r1353b3059],
11	was	VBD	O	be	cop	12	SENT_175	[p12l1403t3007r1566b3060],
12	higher	JJR	O	higher	_	0	SENT_175	[p12l1622t2981r1905b3082],
13	with	IN	O	with	_	0	SENT_175	[p12l1952t2981r2148b3060],
14	crizotinib	NN	O	crizotinib	prep_with	12	SENT_175	[p12l13t3108r436b3187],
15	than	IN	O	than	prep	12	SENT_175	[p12l471t3108r668b3186],
16	with	IN	O	with	pcomp	15	SENT_175	[p12l697t3108r893b3187],
17	either	CC	O	either	dep	16	SENT_175	[p12l927t3108r1176b3186],
18	type	NN	O	type	conj	16	SENT_175	[p12l1206t3125r1388b3208],
19	of	IN	O	of	_	0	SENT_175	[p12l1422t3107r1523b3187],
20	chemotherapy	NN	O	chemotherapy	nn	22	SENT_175	[p12l1539t3108r2153b3208],
21	(	CD	NUMBER	(	num	22	SENT_175	[p12l17t3238r197b3338],
22	Fig	NN	O	fig	prep_of	12	SENT_175	[p12l17t3238r197b3338],
23	.	.	O	.	_	0	SENT_175	[p12l17t3238r197b3338],

1	S3	NN	O	s3	_	0	SENT_176	[p12l259t3243r352b3316],
2	in	IN	O	in	_	0	SENT_176	[p12l409t3238r493b3315],
3	the	DT	O	the	det	6	SENT_176	[p12l547t3237r681b3315],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_176	[p12l738t3237r1388b3337],
5	Appendix	NNP	O	Appendix	nn	6	SENT_176	[p12l1434t3237r1905b3337],
6	)	NNP	O	)	prep_in	1	SENT_176	[p12l1434t3237r1905b3337],
7	:	:	O	:	_	0	SENT_176	[p12l1434t3237r1905b3337],
8	66	CD	PERCENT	66	num	9	SENT_176	[p12l1963t3242r2149b3316],
9	%	NN	PERCENT	%	dep	1	SENT_176	[p12l1963t3242r2149b3316],
10	(	CD	PERCENT	(	num	13	SENT_176	[p12l17t3370r229b3456],
11	95	CD	PERCENT	95	number	12	SENT_176	[p12l17t3370r229b3456],
12	%	NN	PERCENT	%	amod	13	SENT_176	[p12l17t3370r229b3456],
13	CI	NN	O	ci	dep	9	SENT_176	[p12l269t3371r385b3461],
14	,	,	O	,	_	0	SENT_176	[p12l269t3371r385b3461],
15	58	CD	NUMBER	58	number	18	SENT_176	[p12l433t3371r529b3444],
16	to	TO	O	to	dep	18	SENT_176	[p12l572t3382r654b3444],
17	73	CD	NUMBER	73	number	18	SENT_176	[p12l697t3371r821b3456],
18	)	CD	NUMBER	)	appos	9	SENT_176	[p12l697t3371r821b3456],
19	with	IN	O	with	_	0	SENT_176	[p12l862t3365r1059b3444],
20	crizotinib	NN	O	crizotinib	prep_with	18	SENT_176	[p12l1099t3365r1544b3461],
21	,	,	O	,	_	0	SENT_176	[p12l1099t3365r1544b3461],
22	as	IN	O	as	mark	20	SENT_176	[p12l1590t3391r1676b3443],
23	compared	VBN	O	compare	_	0	SENT_176	[p12l1719t3365r2148b3465],
24	with	IN	O	with	_	0	SENT_176	[p12l7t3494r204b3573],
25	29	CD	NUMBER	29	num	26	SENT_176	[p12l255t3499r444b3573],
26	°	CD	NUMBER	°	prep_compared_with	20	SENT_176	[p12l255t3499r444b3573],
27	/	:	O	/	punct	28	SENT_176	[p12l255t3499r444b3573],
28	o	NN	O	o	dep	20	SENT_176	[p12l255t3499r444b3573],
29	(	CD	PERCENT	(	num	32	SENT_176	[p12l499t3499r711b3585],
30	95	CD	PERCENT	95	number	31	SENT_176	[p12l499t3499r711b3585],
31	%	NN	PERCENT	%	amod	32	SENT_176	[p12l499t3499r711b3585],
32	CI	NN	O	ci	dep	28	SENT_176	[p12l762t3500r877b3590],
33	,	,	O	,	_	0	SENT_176	[p12l762t3500r877b3590],
34	21	CD	NUMBER	21	number	37	SENT_176	[p12l934t3500r1034b3572],
35	to	TO	O	to	dep	37	SENT_176	[p12l1086t3511r1168b3573],
36	39	CD	NUMBER	39	number	37	SENT_176	[p12l1221t3500r1345b3585],
37	)	CD	NUMBER	)	appos	28	SENT_176	[p12l1221t3500r1345b3585],
38	with	IN	O	with	_	0	SENT_176	[p12l1397t3494r1594b3574],
39	pemetrexed	NN	O	pemetrexed	prep_with	37	SENT_176	[p12l1643t3494r2148b3594],
40	and	CC	O	and	_	0	SENT_176	[p12l11t3623r171b3702],
41	7	CD	PERCENT	7	number	42	SENT_176	[p12l207t3628r340b3703],
42	%	NN	PERCENT	%	amod	46	SENT_176	[p12l207t3628r340b3703],
43	(	CD	PERCENT	(	number	44	SENT_176	[p12l380t3628r593b3714],
44	95	CD	PERCENT	95	dep	45	SENT_176	[p12l380t3628r593b3714],
45	%	NN	PERCENT	%	dep	46	SENT_176	[p12l380t3628r593b3714],
46	CI	NN	O	ci	conj_and	39	SENT_176	[p12l628t3629r743b3718],
47	,	,	O	,	_	0	SENT_176	[p12l628t3629r743b3718],
48	2	CD	NUMBER	2	number	51	SENT_176	[p12l785t3629r832b3701],
49	to	TO	O	to	dep	51	SENT_176	[p12l869t3640r951b3702],
50	16	CD	NUMBER	16	number	51	SENT_176	[p12l992t3629r1115b3714],
51	)	CD	NUMBER	)	appos	28	SENT_176	[p12l992t3629r1115b3714],
52	with	IN	O	with	_	0	SENT_176	[p12l1151t3623r1347b3703],
53	docetaxel	NN	O	docetaxel	prep_with	51	SENT_176	[p12l1384t3623r1815b3702],
54	.	.	O	.	_	0	SENT_176	[p12l1384t3623r1815b3702],

1	All	PDT	O	all	_	0	SENT_177	[p12l1853t3623r1978b3701],
2	the	DT	O	the	dep	1	SENT_177	[p12l2014t3623r2148b3702],

1	2383	CD	DATE	2383	num	4	SENT_178	[p13l149t44r225b67],
2	N	NN	O	n	nn	4	SENT_178	[p13l964t54r978b69],
3	ENGLJ	NN	O	englj	nn	4	SENT_178	[p13l993t54r1071b76],
4	MED	NN	O	med	_	0	SENT_178	[p13l1085t54r1137b69],
5	368	CD	NUMBER	368	num	7	SENT_178	[p13l1147t48r1226b76],
6	;	:	O	;	_	0	SENT_178	[p13l1147t48r1226b76],
7	25	CD	NUMBER	25	dep	4	SENT_178	[p13l1147t48r1226b76],
8	NEjM	NNP	O	NEjM	nn	10	SENT_178	[p13l1262t54r1386b76],
9	,	,	O	,	_	0	SENT_178	[p13l1262t54r1386b76],
10	ORG	NNP	O	ORG	dep	7	SENT_178	[p13l1262t54r1386b76],
11	JUNE20	NN	O	june20	dep	4	SENT_178	[p13l1417t54r1595b76],
12	,2013	CD	NUMBER	,2013	num	11	SENT_178	[p13l1417t54r1595b76],

1	The	DT	O	the	det	4	SENT_179	[p13l936t87r987b111],
2	New	NNP	O	New	nn	4	SENT_179	[p13l996t88r1058b111],
3	England	NNP	O	England	nn	4	SENT_179	[p13l1067t87r1178b118],
4	Journal	NNP	O	Journal	_	0	SENT_179	[p13l1187t87r1284b111],
5	of	IN	O	of	_	0	SENT_179	[p13l1294t87r1323b111],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_179	[p13l1330t87r1455b111],

1	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	CD	NUMBER	iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii	num	2	SENT_180	[p13l696t275r1418b294],
2	ER	NN	O	er	_	0	SENT_180	[p13l1423t275r1464b294],

1	differences	NNS	O	difference	nsubj	15	SENT_181	[p13l12t488r487b568],
2	in	IN	O	in	_	0	SENT_181	[p13l527t490r611b567],
3	response	NN	O	response	nn	4	SENT_181	[p13l649t515r1030b589],
4	rates	NNS	O	rate	prep_in	1	SENT_181	[p13l1070t506r1272b567],
5	between	IN	O	between	_	0	SENT_181	[p13l1314t489r1672b569],
6	crizotinib	NN	O	crizotinib	prep_between	4	SENT_181	[p13l1712t489r2132b568],
7	and	CC	O	and	_	0	SENT_181	[p13l11t618r168b697],
8	each	DT	O	each	det	9	SENT_181	[p13l209t618r401b696],
9	type	NN	O	type	conj_and	4	SENT_181	[p13l441t635r622b718],
10	of	IN	O	of	_	0	SENT_181	[p13l663t617r763b697],
11	chemotherapy	NN	O	chemotherapy	prep_of	9	SENT_181	[p13l786t618r1396b718],
12	were	VBD	O	be	cop	15	SENT_181	[p13l1427t644r1629b697],
13	significant	JJ	O	significant	amod	15	SENT_181	[p13l1671t617r2139b719],
14	(	NN	O	(	nn	15	SENT_181	[p13l16t752r434b836],
15	P	NN	O	p	_	0	SENT_181	[p13l16t752r434b836],
16	<	JJR	O	<	dep	15	SENT_181	[p13l16t752r434b836],
17	0.001	CD	NUMBER	0.001	num	18	SENT_181	[p13l16t752r434b836],
18	)	NN	O	)	dep	16	SENT_181	[p13l16t752r434b836],
19	.	.	O	.	_	0	SENT_181	[p13l16t752r434b836],

1	At	IN	O	at	_	0	SENT_182	[p13l136t881r236b951],
2	the	DT	O	the	det	3	SENT_182	[p13l271t873r404b951],
3	time	NN	O	time	prep_at	11	SENT_182	[p13l444t874r637b951],
4	of	IN	O	of	_	0	SENT_182	[p13l679t872r778b952],
5	data	NNS	O	datum	nn	6	SENT_182	[p13l801t873r984b952],
6	cutoff	NN	O	cutoff	prep_of	3	SENT_182	[p13l1023t872r1298b969],
7	,	,	O	,	_	0	SENT_182	[p13l1023t872r1298b969],
8	96	CD	NUMBER	96	num	9	SENT_182	[p13l1345t879r1445b952],
9	deaths	NNS	O	death	nsubj	11	SENT_182	[p13l1487t873r1765b952],
10	had	VBD	O	have	aux	11	SENT_182	[p13l1808t873r1965b952],
11	occurred	VBN	O	occur	_	0	SENT_182	[p13l2005t899r2132b952, p13l12t1002r289b1081],
12	in	IN	O	in	_	0	SENT_182	[p13l324t1003r407b1079],
13	the	DT	O	the	det	14	SENT_182	[p13l444t1002r576b1080],
14	intention	NN	O	intention	prep_in	11	SENT_182	[p13l612t1003r1363b1080],
15	—	CD	NUMBER	—	number	17	SENT_182	[p13l612t1003r1363b1080],
16	to	TO	O	to	dep	17	SENT_182	[p13l612t1003r1363b1080],
17	—	CD	NUMBER	—	num	22	SENT_182	[p13l612t1003r1363b1080],
18	treat	NN	O	treat	nn	22	SENT_182	[p13l612t1003r1363b1080],
19	population	NN	O	population	nn	22	SENT_182	[p13l1392t1002r1863b1101],
20	—	CD	NUMBER	—	number	21	SENT_182	[p13l1895t1047r2003b1055],
21	49	CD	NUMBER	49	num	22	SENT_182	[p13l2033t1008r2132b1080],
22	(	NN	O	(	dep	14	SENT_182	[p13l16t1135r254b1221],
23	28	CD	PERCENT	28	number	24	SENT_182	[p13l16t1135r254b1221],
24	%	NN	PERCENT	%	amod	22	SENT_182	[p13l16t1135r254b1221],
25	)	CD	NUMBER	)	dep	14	SENT_182	[p13l16t1135r254b1221],
26	in	IN	O	in	_	0	SENT_182	[p13l309t1131r392b1208],
27	the	DT	O	the	det	29	SENT_182	[p13l442t1130r575b1208],
28	crizotinib	JJ	O	crizotinib	amod	29	SENT_182	[p13l626t1130r1046b1209],
29	group	NN	O	group	prep_in	25	SENT_182	[p13l1097t1156r1349b1231],
30	and	CC	O	and	_	0	SENT_182	[p13l1400t1130r1558b1209],
31	47	CD	PERCENT	47	number	32	SENT_182	[p13l1606t1136r1704b1209],
32	(	CD	PERCENT	(	conj_and	14	SENT_182	[p13l1760t1135r1996b1221],
33	27	CD	PERCENT	27	num	34	SENT_182	[p13l1760t1135r1996b1221],
34	%	NN	PERCENT	%	dep	32	SENT_182	[p13l1760t1135r1996b1221],
35	)	CD	NUMBER	)	tmod	11	SENT_182	[p13l1760t1135r1996b1221],
36	in	IN	O	in	_	0	SENT_182	[p13l2050t1131r2133b1208],
37	the	DT	O	the	det	39	SENT_182	[p13l12t1258r144b1336],
38	chemotherapy	NN	O	chemotherapy	nn	39	SENT_182	[p13l178t1258r789b1358],
39	group	NN	O	group	prep_in	35	SENT_182	[p13l816t1284r1069b1359],
40	—	CD	NUMBER	—	xcomp	11	SENT_182	[p13l1098t1297r1227b1306],
41	representing	VBG	O	represent	partmod	40	SENT_182	[p13l1255t1259r1801b1359],
42	40	CD	PERCENT	40	num	43	SENT_182	[p13l1828t1263r2019b1337],
43	%	NN	PERCENT	%	dobj	41	SENT_182	[p13l1828t1263r2019b1337],
44	of	IN	O	of	_	0	SENT_182	[p13l2052t1257r2152b1337],
45	the	DT	O	the	det	47	SENT_182	[p13l12t1385r144b1463],
46	total	JJ	O	total	amod	47	SENT_182	[p13l181t1385r378b1464],
47	number	NN	O	number	prep_of	43	SENT_182	[p13l414t1385r751b1464],
48	of	IN	O	of	_	0	SENT_182	[p13l786t1384r886b1464],
49	events	NNS	O	event	prep_of	47	SENT_182	[p13l905t1402r1168b1464],
50	required	VBN	O	require	partmod	49	SENT_182	[p13l1206t1385r1568b1485],
51	for	IN	O	for	_	0	SENT_182	[p13l1604t1384r1727b1464],
52	the	DT	O	the	det	54	SENT_182	[p13l1761t1385r1894b1463],
53	final	JJ	O	final	amod	54	SENT_182	[p13l1930t1384r2134b1463],
54	analysis	NN	O	analysis	prep_for	50	SENT_182	[p13l11t1513r350b1613],
55	of	IN	O	of	_	0	SENT_182	[p13l400t1512r501b1592],
56	overall	JJ	O	overall	amod	57	SENT_182	[p13l531t1513r816b1593],
57	survival	NN	O	survival	prep_of	54	SENT_182	[p13l864t1513r1218b1593],
58	.	.	O	.	_	0	SENT_182	[p13l864t1513r1218b1593],

1	The	DT	O	the	det	4	SENT_183	[p13l1268t1513r1429b1591],
2	median	JJ	O	median	amod	4	SENT_183	[p13l1477t1513r1800b1592],
3	overall	JJ	O	overall	amod	4	SENT_183	[p13l1849t1513r2134b1592],
4	survival	NN	O	survival	nsubj	7	SENT_183	[p13l12t1641r344b1720],
5	was	VBD	O	be	cop	7	SENT_183	[p13l388t1667r550b1720],
6	20.3	CD	DURATION	20.3	number	7	SENT_183	[p13l601t1647r776b1719],
7	months	NNS	NUMBER	month	dep	23	SENT_183	[p13l828t1641r1155b1719],
8	(	VBP	O	(	dep	7	SENT_183	[p13l1210t1646r1422b1731],
9	95	CD	PERCENT	95	number	10	SENT_183	[p13l1210t1646r1422b1731],
10	%	NN	PERCENT	%	amod	11	SENT_183	[p13l1210t1646r1422b1731],
11	CI	NN	O	ci	dobj	8	SENT_183	[p13l1470t1647r1585b1736],
12	,	,	O	,	_	0	SENT_183	[p13l1470t1647r1585b1736],
13	18.1	CD	NUMBER	18.1	appos	7	SENT_183	[p13l1642t1647r1815b1719],
14	to	TO	O	to	prep	13	SENT_183	[p13l1865t1657r1946b1719],
15	not	RB	O	not	pobj	14	SENT_183	[p13l1996t1657r2139b1719],
16	reached	VBN	O	reach	partmod	13	SENT_183	[p13l11t1768r356b1858],
17	)	NN	O	)	dobj	16	SENT_183	[p13l11t1768r356b1858],
18	with	IN	O	with	_	0	SENT_183	[p13l387t1768r576b1847],
19	crizotinib	NN	O	crizotinib	prep_with	16	SENT_183	[p13l607t1768r1008b1846],
20	and	CC	O	and	_	0	SENT_183	[p13l1039t1768r1193b1846],
21	22.8	CD	DURATION	22.8	num	22	SENT_183	[p13l1223t1774r1397b1846],
22	months	NNS	NUMBER	month	conj_and	19	SENT_183	[p13l1430t1768r1746b1846],
23	(	VBP	O	(	_	0	SENT_183	[p13l1783t1773r1987b1858],
24	95	CD	PERCENT	95	number	25	SENT_183	[p13l1783t1773r1987b1858],
25	%	NN	PERCENT	%	amod	26	SENT_183	[p13l1783t1773r1987b1858],
26	CI	NN	O	ci	dobj	23	SENT_183	[p13l2018t1774r2128b1863],
27	,	,	O	,	_	0	SENT_183	[p13l2018t1774r2128b1863],
28	18.6	CD	NUMBER	18.6	nsubj	31	SENT_183	[p13l15t1902r189b1974],
29	to	TO	O	to	prep	28	SENT_183	[p13l229t1913r310b1974],
30	not	RB	O	not	neg	31	SENT_183	[p13l350t1912r492b1974],
31	reached	VBN	O	reach	rcmod	26	SENT_183	[p13l525t1896r886b1986],
32	)	NN	O	)	dobj	31	SENT_183	[p13l525t1896r886b1986],
33	with	IN	O	with	_	0	SENT_183	[p13l925t1896r1120b1975],
34	chemotherapy	NN	O	chemotherapy	nn	37	SENT_183	[p13l1159t1896r1769b1995],
35	(	NN	O	(	nn	37	SENT_183	[p13l1808t1896r2133b1986],
36	hazard	NN	O	hazard	nn	37	SENT_183	[p13l1808t1896r2133b1986],
37	ratio	NN	O	ratio	prep_with	31	SENT_183	[p13l11t2025r208b2103],
38	for	IN	O	for	_	0	SENT_183	[p13l242t2023r365b2103],
39	death	NN	O	death	prep_for	37	SENT_183	[p13l395t2024r633b2103],
40	in	IN	O	in	_	0	SENT_183	[p13l665t2025r748b2102],
41	the	DT	O	the	det	43	SENT_183	[p13l781t2024r914b2102],
42	crizotinib	JJ	O	crizotinib	amod	43	SENT_183	[p13l947t2024r1368b2103],
43	group	NN	O	group	prep_in	31	SENT_183	[p13l1401t2050r1676b2125],
44	,	,	O	,	_	0	SENT_183	[p13l1401t2050r1676b2125],
45	1.02	CD	NUMBER	1.02	dep	31	SENT_183	[p13l1717t2030r1913b2119],
46	;	:	O	;	_	0	SENT_183	[p13l1717t2030r1913b2119],
47	95	CD	PERCENT	95	num	48	SENT_183	[p13l1950t2029r2134b2103],
48	%	NN	PERCENT	%	dep	45	SENT_183	[p13l1950t2029r2134b2103],
49	CI	NN	O	ci	nsubj	23	SENT_183	[p13l11t2158r126b2248],
50	,	,	O	,	_	0	SENT_183	[p13l11t2158r126b2248],
51	0.68	CD	NUMBER	0.68	number	53	SENT_183	[p13l172t2158r349b2231],
52	to	TO	O	to	dep	53	SENT_183	[p13l391t2169r473b2231],
53	1.54	CD	NUMBER	1.54	appos	49	SENT_183	[p13l518t2158r717b2248],
54	;	:	O	;	_	0	SENT_183	[p13l518t2158r717b2248],
55	P	NN	O	p	dep	53	SENT_183	[p13l759t2158r1104b2243],
56	=	JJ	O	=	advmod	60	SENT_183	[p13l759t2158r1104b2243],
57	0.54	CD	NUMBER	0.54	dep	56	SENT_183	[p13l759t2158r1104b2243],
58	)	CD	NUMBER	)	number	59	SENT_183	[p13l759t2158r1104b2243],
59	(	CD	NUMBER	(	num	60	SENT_183	[p13l1154t2153r1333b2253],
60	Fig	NN	O	fig	rcmod	55	SENT_183	[p13l1154t2153r1333b2253],
61	.	.	O	.	_	0	SENT_183	[p13l1154t2153r1333b2253],

1	S4	NN	O	s4	_	0	SENT_184	[p13l1381t2158r1479b2231],
2	in	IN	O	in	_	0	SENT_184	[p13l1518t2153r1601b2230],
3	the	DT	O	the	det	6	SENT_184	[p13l1642t2152r1774b2230],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_184	[p13l1817t2152r2132b2252, p13l11t2296r371b2379],
5	Appendix	NNP	O	Appendix	nn	6	SENT_184	[p13l429t2279r895b2379],
6	)	NN	O	)	prep_in	1	SENT_184	[p13l429t2279r895b2379],
7	.	.	O	.	_	0	SENT_184	[p13l429t2279r895b2379],

1	Of	IN	O	of	_	0	SENT_185	[p13l967t2278r1088b2358],
2	the	DT	O	the	det	4	SENT_185	[p13l1137t2279r1269b2357],
3	174	CD	NUMBER	174	num	4	SENT_185	[p13l1339t2285r1479b2358],
4	patients	NNS	O	patient	prep_of	35	SENT_185	[p13l1544t2280r1885b2379],
5	who	WP	O	who	nsubjpass	8	SENT_185	[p13l1949t2279r2132b2359],
6	were	VBD	O	be	auxpass	8	SENT_185	[p13l7t2434r208b2487],
7	randomly	RB	O	randomly	advmod	8	SENT_185	[p13l263t2408r678b2508],
8	assigned	VBN	O	assign	rcmod	4	SENT_185	[p13l728t2408r1102b2509],
9	to	TO	O	to	_	0	SENT_185	[p13l1156t2425r1238b2487],
10	chemotherapy	NN	O	chemotherapy	prep_to	8	SENT_185	[p13l1295t2408r1919b2508],
11	,	,	O	,	_	0	SENT_185	[p13l1295t2408r1919b2508],
12	112	CD	PERCENT	112	number	13	SENT_185	[p13l1983t2414r2132b2486],
13	(	CD	PERCENT	(	appos	10	SENT_185	[p13l16t2541r251b2626],
14	64	CD	PERCENT	64	num	15	SENT_185	[p13l16t2541r251b2626],
15	%	NN	PERCENT	%	dep	13	SENT_185	[p13l16t2541r251b2626],
16	)	CD	NUMBER	)	nsubj	35	SENT_185	[p13l16t2541r251b2626],
17	subsequently	RB	O	subsequently	advmod	18	SENT_185	[p13l319t2536r879b2635],
18	received	VBN	O	receive	partmod	16	SENT_185	[p13l936t2536r1281b2615],
19	crizotinib	NN	O	crizotinib	dobj	18	SENT_185	[p13l1342t2536r1763b2614],
20	outside	IN	O	outside	_	0	SENT_185	[p13l1825t2536r2133b2615],
21	the	DT	O	the	det	22	SENT_185	[p13l12t2664r144b2742],
22	study	NN	O	study	prep_outside	19	SENT_185	[p13l197t2664r444b2763],
23	;	:	O	;	_	0	SENT_185	[p13l197t2664r444b2763],
24	34	CD	NUMBER	34	num	25	SENT_185	[p13l501t2670r601b2743],
25	patients	NNS	O	patient	dep	19	SENT_185	[p13l650t2665r991b2763],
26	(	IN	O	(	_	0	SENT_185	[p13l1049t2669r1288b2754],
27	20	CD	PERCENT	20	number	28	SENT_185	[p13l1049t2669r1288b2754],
28	%	NN	PERCENT	%	amod	31	SENT_185	[p13l1049t2669r1288b2754],
29	)	CD	NUMBER	)	num	31	SENT_185	[p13l1049t2669r1288b2754],
30	discontinued	VBN	O	discontinue	amod	31	SENT_185	[p13l1345t2664r1904b2743],
31	chemotherapy	NN	O	chemotherapy	prep_(	25	SENT_185	[p13l1956t2664r2132b2742, p13l11t2792r474b2891],
32	but	CC	O	but	advmod	31	SENT_185	[p13l507t2792r647b2871],
33	did	VBD	O	do	aux	35	SENT_185	[p13l680t2792r814b2870],
34	not	RB	O	not	neg	35	SENT_185	[p13l850t2809r994b2870],
35	receive	VB	O	receive	_	0	SENT_185	[p13l1026t2793r1314b2871],
36	crizotinib	NN	O	crizotinib	dobj	35	SENT_185	[p13l1352t2792r1795b2887],
37	,	,	O	,	_	0	SENT_185	[p13l1352t2792r1795b2887],
38	including	VBG	O	include	_	0	SENT_185	[p13l1836t2792r2132b2871, p13l11t2921r150b3021],
39	13	CD	NUMBER	13	num	40	SENT_185	[p13l195t2926r290b2999],
40	patients	NNS	O	patient	prep_including	36	SENT_185	[p13l338t2921r679b3020],
41	who	WP	O	who	nsubj	42	SENT_185	[p13l723t2920r905b2999],
42	died	VBD	O	die	conj_or	42	SENT_185	[p13l952t2920r1135b2999],
43	either	CC	O	either	advmod	42	SENT_185	[p13l1181t2920r1427b2998],
44	while	IN	O	while	_	0	SENT_185	[p13l1466t2920r1701b2999],
45	receiving	VBG	O	receive	prepc_while	42	SENT_185	[p13l1747t2921r2137b3021],
46	chemotherapy	NN	O	chemotherapy	dobj	45	SENT_185	[p13l12t3048r623b3148],
47	or	CC	O	or	_	0	SENT_185	[p13l660t3074r749b3127],
48	before	IN	O	before	_	0	SENT_185	[p13l787t3047r1056b3127],
49	starting	VBG	O	start	prepc_before	42	SENT_185	[p13l1099t3049r1441b3149],
50	folloW	NNP	O	folloW	dobj	49	SENT_185	[p13l1479t3047r1887b3148],
51	—	CD	NUMBER	—	num	50	SENT_185	[p13l1479t3047r1887b3148],
52	up	IN	O	up	_	0	SENT_185	[p13l1479t3047r1887b3148],
53	therapy	NN	O	therapy	nn	56	SENT_185	[p13l1930t3048r2132b3126, p13l11t3202r156b3275],
54	(	CD	NUMBER	(	num	56	SENT_185	[p13l195t3176r454b3266],
55	Table	NNP	O	Table	nn	56	SENT_185	[p13l195t3176r454b3266],
56	S2	NN	O	s2	prep_up	50	SENT_185	[p13l496t3182r590b3254],
57	in	IN	O	in	_	0	SENT_185	[p13l630t3177r714b3253],
58	the	DT	O	the	det	61	SENT_185	[p13l754t3176r887b3254],
59	Supplementary	NNP	O	Supplementary	nn	61	SENT_185	[p13l928t3176r1574b3275],
60	Appendix	NNP	O	Appendix	nn	61	SENT_185	[p13l1606t3176r2072b3275],
61	)	NN	O	)	prep_in	49	SENT_185	[p13l1606t3176r2072b3275],
62	.	.	O	.	_	0	SENT_185	[p13l1606t3176r2072b3275],

1	A	DT	O	a	det	2	SENT_186	[p13l136t3311r202b3381],
2	total	NN	O	total	nsubj	17	SENT_186	[p13l242t3303r438b3382],
3	of	IN	O	of	_	0	SENT_186	[p13l480t3302r580b3382],
4	85	CD	NUMBER	85	num	5	SENT_186	[p13l604t3309r697b3382],
5	patients	NNS	O	patient	prep_of	2	SENT_186	[p13l741t3304r1083b3403],
6	(	IN	O	(	_	0	SENT_186	[p13l1132t3309r1365b3394],
7	49	CD	PERCENT	49	num	8	SENT_186	[p13l1132t3309r1365b3394],
8	%	NN	PERCENT	%	prep_(	17	SENT_186	[p13l1132t3309r1365b3394],
9	)	CD	NUMBER	)	nsubj	17	SENT_186	[p13l1132t3309r1365b3394],
10	in	IN	O	in	_	0	SENT_186	[p13l1411t3304r1494b3381],
11	the	DT	O	the	det	13	SENT_186	[p13l1537t3303r1669b3381],
12	crizotinib	JJ	O	crizotinib	amod	13	SENT_186	[p13l1712t3303r2132b3382],
13	group	NN	O	group	prep_in	9	SENT_186	[p13l11t3458r263b3533],
14	and	CC	O	and	_	0	SENT_186	[p13l302t3432r460b3511],
15	28	CD	NUMBER	28	num	16	SENT_186	[p13l499t3438r598b3511],
16	patients	NNS	O	patient	prep_in	9	SENT_186	[p13l637t3433r978b3532],
17	(	VBD	O	(	_	0	SENT_186	[p13l1024t3437r1254b3523],
18	16	CD	PERCENT	16	num	19	SENT_186	[p13l1024t3437r1254b3523],
19	%	NN	PERCENT	%	dobj	17	SENT_186	[p13l1024t3437r1254b3523],
20	)	CD	NUMBER	)	nsubj	27	SENT_186	[p13l1024t3437r1254b3523],
21	in	IN	O	in	_	0	SENT_186	[p13l1298t3433r1381b3510],
22	the	DT	O	the	det	24	SENT_186	[p13l1420t3432r1553b3510],
23	chemotherapy	NN	O	chemotherapy	nn	24	SENT_186	[p13l1592t3432r2132b3511, p13l9t3586r109b3660],
24	group	NN	O	group	prep_in	20	SENT_186	[p13l140t3586r393b3661],
25	were	VBD	O	be	aux	27	SENT_186	[p13l425t3586r627b3639],
26	still	RB	O	still	advmod	27	SENT_186	[p13l665t3560r826b3638],
27	receiving	VBG	O	receive	dep	17	SENT_186	[p13l861t3561r1251b3661],
28	the	DT	O	the	det	30	SENT_186	[p13l1284t3560r1416b3639],
29	study	NN	O	study	nn	30	SENT_186	[p13l1454t3560r1683b3660],
30	treatment	NN	O	treatment	dobj	27	SENT_186	[p13l1715t3577r2138b3638],
31	at	IN	O	at	_	0	SENT_186	[p13l11t3704r90b3765],
32	the	DT	O	the	det	33	SENT_186	[p13l129t3687r261b3765],
33	time	NN	O	time	prep_at	27	SENT_186	[p13l306t3688r499b3765],
34	of	IN	O	of	_	0	SENT_186	[p13l545t3686r644b3766],
35	data	NNS	O	datum	nn	36	SENT_186	[p13l671t3687r854b3766],
36	cutoff	NN	O	cutoff	prep_of	33	SENT_186	[p13l897t3686r1173b3766],
37	.	.	O	.	_	0	SENT_186	[p13l897t3686r1173b3766],

1	More	RBR	O	more	nsubj	33	SENT_187	[p13l1221t3695r1442b3766],
2	patients	NNS	O	patient	nsubj	12	SENT_187	[p13l1485t3688r1827b3787],
3	in	IN	O	in	_	0	SENT_187	[p13l1872t3688r1956b3765],
4	the	DT	O	the	det	6	SENT_187	[p13l2001t3687r2133b3765],
5	crizotinib	JJ	O	crizotinib	amod	6	SENT_187	[p14l12t21r422b100],
6	group	NN	O	group	prep_in	2	SENT_187	[p14l458t47r706b122],
7	than	IN	O	than	advmod	12	SENT_187	[p14l743t21r936b99],
8	in	IN	O	in	_	0	SENT_187	[p14l971t22r1053b99],
9	the	DT	O	the	det	11	SENT_187	[p14l1089t21r1219b99],
10	chemotherapy	NN	O	chemotherapy	nn	11	SENT_187	[p14l1255t21r1854b121],
11	group	NN	O	group	prep_in	7	SENT_187	[p14l1885t47r2132b122],
12	continued	VBD	O	continue	rcmod	1	SENT_187	[p14l12t148r432b227],
13	treatment	NN	O	treatment	dobj	12	SENT_187	[p14l468t165r883b226],
14	beyond	IN	O	beyond	_	0	SENT_187	[p14l914t148r1216b248],
15	RECIST	NNP	O	RECIST	prep_beyond	12	SENT_187	[p14l1249t147r1924b232],
16	—	CD	NUMBER	—	nsubj	33	SENT_187	[p14l1249t147r1924b232],
17	def1ned	VBN	O	def1ne	partmod	16	SENT_187	[p14l1249t147r1924b232],
18	progression	NN	O	progression	dobj	17	SENT_187	[p14l1957t174r2132b248, p14l11t278r366b378],
19	of	IN	O	of	_	0	SENT_187	[p14l404t276r503b356],
20	disease	NN	O	disease	nn	21	SENT_187	[p14l525t277r835b356],
21	(	NN	O	(	prep_of	18	SENT_187	[p14l880t283r1006b368],
22	58	CD	NUMBER	58	num	21	SENT_187	[p14l880t283r1006b368],
23	vs.	CC	O	vs.	prep	18	SENT_187	[p14l1044t303r1153b356],
24	17	CD	NUMBER	17	num	25	SENT_187	[p14l1201t283r1351b373],
25	)	NN	O	)	dep	23	SENT_187	[p14l1201t283r1351b373],
26	,	,	O	,	_	0	SENT_187	[p14l1201t283r1351b373],
27	and	CC	O	and	_	0	SENT_187	[p14l1396t277r1554b356],
28	the	DT	O	the	det	29	SENT_187	[p14l1594t277r1727b355],
29	duration	NN	O	duration	conj_and	18	SENT_187	[p14l1767t277r2133b356],
30	of	IN	O	of	_	0	SENT_187	[p14l12t404r112b484],
31	such	JJ	O	such	amod	32	SENT_187	[p14l136t405r330b484],
32	therapy	NN	O	therapy	prep_of	29	SENT_187	[p14l371t405r692b505],
33	was	VBD	O	be	_	0	SENT_187	[p14l724t431r887b484],
34	longer	RBR	O	longer	advmod	33	SENT_187	[p14l929t405r1204b506],
35	with	IN	O	with	_	0	SENT_187	[p14l1237t405r1432b484],
36	crizotinib	NN	O	crizotinib	prep_with	33	SENT_187	[p14l1475t405r1894b484],
37	than	IN	O	than	dep	33	SENT_187	[p14l1938t405r2134b483],
38	with	IN	O	with	_	0	SENT_187	[p14l7t533r202b612],
39	chemotherapy	NN	O	chemotherapy	nn	41	SENT_187	[p14l244t533r854b633],
40	(	CD	NUMBER	(	num	41	SENT_187	[p14l896t533r1268b629],
41	median	NN	O	median	prep_with	33	SENT_187	[p14l896t533r1268b629],
42	,	,	O	,	_	0	SENT_187	[p14l896t533r1268b629],
43	15.9	CD	DURATION	15.9	num	44	SENT_187	[p14l1318t539r1490b612],
44	Weeks	NNS	DURATION	week	tmod	45	SENT_187	[p14l1528t533r1789b612],
45	[	JJ	O	[	amod	46	SENT_187	[p14l1841t539r2128b634],
46	range	NN	O	range	appos	41	SENT_187	[p14l1841t539r2128b634],
47	,	,	O	,	_	0	SENT_187	[p14l1841t539r2128b634],
48	2.9	CD	NUMBER	2.9	number	51	SENT_187	[p14l11t667r136b740],
49	to	TO	O	to	dep	51	SENT_187	[p14l177t678r259b740],
50	73.4	CD	NUMBER	73.4	number	51	SENT_187	[p14l301t667r502b752],
51	]	CD	NUMBER	]	appos	41	SENT_187	[p14l301t667r502b752],
52	vs.	IN	O	vs.	_	0	SENT_187	[p14l547t687r656b740],
53	6.9	CD	DURATION	6.9	num	54	SENT_187	[p14l701t667r826b740],
54	weeks	NNS	NUMBER	week	tmod	55	SENT_187	[p14l862t661r1123b740],
55	[	JJ	O	[	amod	56	SENT_187	[p14l1174t667r1460b762],
56	range	NN	O	range	prep_vs.	51	SENT_187	[p14l1174t667r1460b762],
57	,	,	O	,	_	0	SENT_187	[p14l1174t667r1460b762],
58	6.0	CD	NUMBER	6.0	number	60	SENT_187	[p14l1506t667r1631b740],
59	to	TO	O	to	dep	60	SENT_187	[p14l1672t678r1754b740],
60	42.0	CD	NUMBER	42.0	appos	41	SENT_187	[p14l1793t667r2058b752],
61	]	CD	NUMBER	]	num	62	SENT_187	[p14l1793t667r2058b752],
62	)	NN	O	)	dep	60	SENT_187	[p14l1793t667r2058b752],
63	.	.	O	.	_	0	SENT_187	[p14l1793t667r2058b752],

1	SAFETY	NN	O	safety	nsubjpass	18	SENT_188	[p14l11t936r296b986],
2	AND	CC	O	and	_	0	SENT_188	[p14l326t937r495b985],
3	ADVERSE	JJ	O	adverse	amod	4	SENT_188	[p14l527t936r878b986],
4	EVENTS	NNS	O	event	conj_and	1	SENT_188	[p14l917t936r1211b986],
5	A	DT	O	a	det	6	SENT_188	[p14l7t1042r73b1112],
6	total	NN	O	total	dep	4	SENT_188	[p14l100t1034r297b1113],
7	of	IN	O	of	_	0	SENT_188	[p14l327t1033r427b1113],
8	343	CD	NUMBER	343	num	9	SENT_188	[p14l439t1040r585b1113],
9	patients	NNS	O	patient	prep_of	6	SENT_188	[p14l617t1035r958b1134],
10	(	IN	O	(	_	0	SENT_188	[p14l995t1034r1151b1125],
11	the	DT	O	the	det	13	SENT_188	[p14l995t1034r1151b1125],
12	as	IN	O	as	amod	13	SENT_188	[p14l1181t1034r1604b1113],
13	—	NN	O	—	prep_(	9	SENT_188	[p14l1181t1034r1604b1113],
14	treated	VBN	O	treat	partmod	1	SENT_188	[p14l1181t1034r1604b1113],
15	population	NN	O	population	dobj	14	SENT_188	[p14l1632t1034r2128b1134],
16	)	CD	NUMBER	)	num	15	SENT_188	[p14l1632t1034r2128b1134],
17	were	VBD	O	be	auxpass	18	SENT_188	[p14l7t1188r205b1242],
18	included	VBN	O	include	_	0	SENT_188	[p14l238t1162r598b1242],
19	in	IN	O	in	_	0	SENT_188	[p14l630t1163r713b1240],
20	the	DT	O	the	det	22	SENT_188	[p14l746t1162r877b1240],
21	safety	NN	O	safety	nn	22	SENT_188	[p14l912t1161r1160b1262],
22	analysis	NN	O	analysis	prep_in	18	SENT_188	[p14l1188t1162r1544b1262],
23	.	.	O	.	_	0	SENT_188	[p14l1188t1162r1544b1262],

1	This	DT	O	this	det	2	SENT_189	[p14l1579t1162r1764b1240],
2	analysis	NN	O	analysis	nsubjpass	5	SENT_189	[p14l1799t1162r2131b1262],
3	was	VBD	O	be	auxpass	5	SENT_189	[p14l7t1316r169b1370],
4	not	RB	O	not	neg	5	SENT_189	[p14l209t1307r351b1369],
5	adjusted	VBN	O	adjust	dep	24	SENT_189	[p14l383t1290r739b1390],
6	for	IN	O	for	_	0	SENT_189	[p14l776t1289r899b1369],
7	the	DT	O	the	det	8	SENT_189	[p14l934t1290r1067b1368],
8	fact	NN	O	fact	prep_for	5	SENT_189	[p14l1104t1289r1263b1368],
9	that	IN	O	that	complm	15	SENT_189	[p14l1295t1290r1468b1368],
10	patients	NNS	O	patient	nsubj	15	SENT_189	[p14l1499t1291r1840b1390],
11	in	IN	O	in	_	0	SENT_189	[p14l1880t1291r1963b1368],
12	the	DT	O	the	det	14	SENT_189	[p14l2001t1290r2133b1368],
13	crizotinib	JJ	O	crizotinib	amod	14	SENT_189	[p14l12t1419r432b1498],
14	group	NN	O	group	prep_in	10	SENT_189	[p14l468t1445r720b1520],
15	received	VBD	O	receive	ccomp	5	SENT_189	[p14l757t1419r1102b1498],
16	the	DT	O	the	det	18	SENT_189	[p14l1138t1419r1271b1497],
17	assigned	VBN	O	assign	amod	18	SENT_189	[p14l1306t1419r1679b1520],
18	treatment	NN	O	treatment	dobj	15	SENT_189	[p14l1715t1436r2139b1497],
19	for	IN	O	for	_	0	SENT_189	[p14l11t1546r134b1626],
20	a	DT	O	a	det	22	SENT_189	[p14l159t1573r203b1625],
21	longer	JJR	O	longer	amod	22	SENT_189	[p14l229t1547r504b1648],
22	duration	NN	O	duration	prep_for	18	SENT_189	[p14l530t1547r896b1626],
23	than	IN	O	than	advmod	24	SENT_189	[p14l924t1547r1120b1625],
24	did	VBD	O	do	_	0	SENT_189	[p14l1150t1547r1284b1626],
25	patients	NNS	O	patient	dobj	24	SENT_189	[p14l1311t1548r1652b1647],
26	in	IN	O	in	_	0	SENT_189	[p14l1682t1548r1765b1625],
27	the	DT	O	the	det	29	SENT_189	[p14l1794t1547r1926b1625],
28	chemotherapy	NN	O	chemotherapy	nn	29	SENT_189	[p14l1956t1547r2132b1625, p14l11t1675r465b1775],
29	group	NN	O	group	prep_in	24	SENT_189	[p14l487t1701r735b1776],
30	(	CD	NUMBER	(	num	31	SENT_189	[p14l767t1675r1131b1771],
31	median	NN	O	median	nsubj	24	SENT_189	[p14l767t1675r1131b1771],
32	,	,	O	,	_	0	SENT_189	[p14l767t1675r1131b1771],
33	31	CD	DURATION	31	num	34	SENT_189	[p14l1164t1681r1258b1754],
34	Weeks	NNS	DURATION	week	appos	31	SENT_189	[p14l1280t1675r1537b1754],
35	vs.	CC	O	vs.	_	0	SENT_189	[p14l1561t1701r1667b1754],
36	12	CD	DURATION	12	num	37	SENT_189	[p14l1703t1681r1799b1753],
37	weeks	NNS	NUMBER	week	appos	31	SENT_189	[p14l1821t1675r2127b1766],
38	)	CD	NUMBER	)	dep	37	SENT_189	[p14l1821t1675r2127b1766],
39	.	.	O	.	_	0	SENT_189	[p14l1821t1675r2127b1766],

1	The	DT	O	the	det	5	SENT_190	[p14l7t1804r168b1882],
2	most	RBS	O	most	advmod	3	SENT_190	[p14l198t1821r414b1883],
3	common	JJ	O	common	amod	5	SENT_190	[p14l440t1830r821b1883],
4	adverse	JJ	O	adverse	amod	5	SENT_190	[p14l850t1804r1165b1883],
5	events	NNS	O	event	nsubj	25	SENT_190	[p14l1196t1821r1459b1883],
6	with	IN	O	with	_	0	SENT_190	[p14l1486t1804r1681b1883],
7	crizotinib	NN	O	crizotinib	prep_with	5	SENT_190	[p14l1712t1804r2132b1883],
8	for	IN	O	for	_	0	SENT_190	[p14l11t1931r134b2011],
9	which	WDT	O	which	rel	17	SENT_190	[p14l170t1932r433b2011],
10	the	DT	O	the	det	11	SENT_190	[p14l476t1932r608b2010],
11	incidence	NN	O	incidence	nsubj	17	SENT_190	[p14l652t1932r1057b2011],
12	was	VBD	O	be	cop	17	SENT_190	[p14l1095t1958r1258b2011],
13	at	IN	O	at	quantmod	15	SENT_190	[p14l1303t1949r1382b2010],
14	least	JJS	O	least	mwe	13	SENT_190	[p14l1419t1932r1618b2010],
15	5	CD	PERCENT	5	num	16	SENT_190	[p14l1658t1937r1789b2011],
16	%	NN	PERCENT	%	npadvmod	17	SENT_190	[p14l1658t1937r1789b2011],
17	greater	JJR	O	greater	rcmod	7	SENT_190	[p14l1831t1949r2137b2033],
18	than	IN	O	than	_	0	SENT_190	[p14l12t2060r205b2137],
19	that	DT	O	that	prep_than	17	SENT_190	[p14l233t2060r402b2137],
20	observed	VBN	O	observe	partmod	19	SENT_190	[p14l426t2060r799b2139],
21	with	IN	O	with	_	0	SENT_190	[p14l822t2060r1015b2139],
22	chemotherapy	NN	O	chemotherapy	prep_with	20	SENT_190	[p14l1044t2060r1642b2159],
23	were	VBD	O	be	cop	25	SENT_190	[p14l1662t2086r1860b2139],
24	vision	NN	O	vision	nn	25	SENT_190	[p14l1884t2061r2134b2139],
25	disorder	NN	O	disorder	_	0	SENT_190	[p14l12t2187r354b2266],
26	(	CD	NUMBER	(	tmod	25	SENT_190	[p14l390t2194r623b2278],
27	most	RBS	O	most	advmod	28	SENT_190	[p14l390t2194r623b2278],
28	frequently	RB	O	frequently	advmod	26	SENT_190	[p14l652t2186r1083b2287],
29	,	,	O	,	_	0	SENT_190	[p14l652t2186r1083b2287],
30	visual	JJ	O	visual	amod	31	SENT_190	[p14l1117t2187r1358b2267],
31	impairment	NN	O	impairment	appos	25	SENT_190	[p14l1391t2188r1903b2287],
32	,	,	O	,	_	0	SENT_190	[p14l1391t2188r1903b2287],
33	photopsia	NN	O	photopsium	appos	31	SENT_190	[p14l1941t2187r2132b2287, p14l12t2317r280b2415],
34	,	,	O	,	_	0	SENT_190	[p14l1941t2187r2132b2287, p14l12t2317r280b2415],
35	or	CC	O	or	_	0	SENT_190	[p14l319t2342r408b2394],
36	blurred	VBD	O	blur	conj_or	25	SENT_190	[p14l442t2316r754b2395],
37	vision	NN	O	vision	nn	38	SENT_190	[p14l787t2317r1092b2411],
38	)	NN	O	)	dobj	36	SENT_190	[p14l787t2317r1092b2411],
39	,	,	O	,	_	0	SENT_190	[p14l787t2317r1092b2411],
40	diarrhea	NN	O	diarrhea	appos	38	SENT_190	[p14l1135t2316r1519b2411],
41	,	,	O	,	_	0	SENT_190	[p14l1135t2316r1519b2411],
42	nausea	NN	O	nausea	nn	49	SENT_190	[p14l1561t2342r1880b2411],
43	,	,	O	,	_	0	SENT_190	[p14l1561t2342r1880b2411],
44	vomiting	VBG	O	vomit	amod	49	SENT_190	[p14l1918t2342r2132b2395, p14l11t2445r220b2545],
45	,	,	O	,	_	0	SENT_190	[p14l1918t2342r2132b2395, p14l11t2445r220b2545],
46	constipation	NN	O	constipation	dep	49	SENT_190	[p14l263t2445r795b2544],
47	,	,	O	,	_	0	SENT_190	[p14l263t2445r795b2544],
48	elevated	JJ	O	elevated	amod	49	SENT_190	[p14l839t2444r1165b2523],
49	liver	NN	O	liver	appos	40	SENT_190	[p14l1200t2444r1376b2523],
50	aminotransferase	NN	O	aminotransferase	nn	51	SENT_190	[p14l1408t2443r2133b2523],
51	levels	NNS	O	level	nsubj	36	SENT_190	[p14l10t2572r259b2668],
52	,	,	O	,	_	0	SENT_190	[p14l10t2572r259b2668],
53	edema	NN	O	edema	nsubj	36	SENT_190	[p14l294t2572r591b2668],
54	,	,	O	,	_	0	SENT_190	[p14l294t2572r591b2668],
55	upper	JJ	O	upper	amod	57	SENT_190	[p14l626t2598r869b2672],
56	respiratory	JJ	O	respiratory	amod	57	SENT_190	[p14l895t2573r1355b2672],
57	infection	NN	O	infection	conj_and	51	SENT_190	[p14l1379t2571r1778b2668],
58	,	,	O	,	_	0	SENT_190	[p14l1379t2571r1778b2668],
59	dysgeu	NN	O	dysgeu	nn	61	SENT_190	[p14l1814t2572r2132b2673],
60	—	CD	NUMBER	—	num	61	SENT_190	[p14l1814t2572r2132b2673],
61	sia	NN	O	sium	conj_and	51	SENT_190	[p14l12t2700r146b2794],
62	,	,	O	,	_	0	SENT_190	[p14l12t2700r146b2794],
63	and	CC	O	and	_	0	SENT_190	[p14l199t2699r357b2777],
64	dizziness	NN	O	dizziness	nn	66	SENT_190	[p14l408t2699r805b2777],
65	(	CD	NUMBER	(	num	66	SENT_190	[p14l862t2699r1119b2789],
66	Table	NNP	O	Table	conj_and	51	SENT_190	[p14l862t2699r1119b2789],
67	3	CD	NUMBER	3	num	68	SENT_190	[p14l1170t2705r1267b2789],
68	)	NN	O	)	dep	66	SENT_190	[p14l1170t2705r1267b2789],
69	.	.	O	.	_	0	SENT_190	[p14l1170t2705r1267b2789],

1	These	DT	O	these	det	2	SENT_191	[p14l1319t2699r1570b2776],
2	events	NNS	O	event	nsubj	5	SENT_191	[p14l1621t2715r1884b2778],
3	were	VBD	O	be	cop	5	SENT_191	[p14l1931t2725r2133b2778],
4	mostly	RB	O	mostly	advmod	5	SENT_191	[p14l11t2827r297b2927],
5	grade	NN	O	grade	_	0	SENT_191	[p14l321t2827r555b2928],
6	1	CD	NUMBER	1	num	5	SENT_191	[p14l588t2833r632b2905],
7	or	CC	O	or	_	0	SENT_191	[p14l662t2853r750b2906],
8	2	CD	NUMBER	2	conj_or	5	SENT_191	[p14l776t2833r846b2923],
9	,	,	O	,	_	0	SENT_191	[p14l776t2833r846b2923],
10	with	IN	O	with	_	0	SENT_191	[p14l876t2827r1067b2906],
11	the	DT	O	the	det	12	SENT_191	[p14l1097t2827r1227b2905],
12	exception	NN	O	exception	prep_with	5	SENT_191	[p14l1257t2828r1659b2927],
13	of	IN	O	of	_	0	SENT_191	[p14l1689t2826r1787b2906],
14	elevated	JJ	O	elevated	amod	16	SENT_191	[p14l1799t2827r2133b2906],
15	aminotransferase	NN	O	aminotransferase	nn	16	SENT_191	[p14l11t2954r767b3034],
16	levels	NNS	O	level	prep_of	12	SENT_191	[p14l799t2955r1055b3051],
17	,	,	O	,	_	0	SENT_191	[p14l799t2955r1055b3051],
18	which	WDT	O	which	nsubj	20	SENT_191	[p14l1088t2955r1351b3034],
19	were	VBD	O	be	cop	20	SENT_191	[p14l1379t2981r1581b3034],
20	grade	NN	O	grade	rcmod	16	SENT_191	[p14l1614t2955r1852b3056],
21	3	CD	NUMBER	3	nsubj	27	SENT_191	[p14l1886t2961r1930b3034],
22	or	CC	O	or	_	0	SENT_191	[p14l1967t2981r2055b3034],
23	4	CD	NUMBER	4	nsubj	27	SENT_191	[p14l2083t2962r2133b3034],
24	in	IN	O	in	_	0	SENT_191	[p14l11t3084r94b3160],
25	27	CD	NUMBER	27	num	26	SENT_191	[p14l132t3089r230b3161],
26	patients	NNS	O	patient	prep_in	21	SENT_191	[p14l268t3084r609b3182],
27	(	VBD	O	(	rcmod	20	SENT_191	[p14l654t3088r910b3173],
28	16	CD	PERCENT	16	num	29	SENT_191	[p14l654t3088r910b3173],
29	%	NN	PERCENT	%	dobj	27	SENT_191	[p14l654t3088r910b3173],
30	)	CD	NUMBER	)	tmod	27	SENT_191	[p14l654t3088r910b3173],
31	.	.	O	.	_	0	SENT_191	[p14l654t3088r910b3173],

1	The	DT	O	the	det	3	SENT_192	[p14l950t3083r1111b3161],
2	most	RBS	O	most	advmod	3	SENT_192	[p14l1149t3099r1365b3161],
3	common	JJ	O	common	dep	5	SENT_192	[p14l1399t3109r1781b3161],
4	adverse	JJ	O	adverse	amod	5	SENT_192	[p14l1818t3083r2133b3162],
5	events	NNS	O	event	dep	8	SENT_192	[p14l12t3227r269b3289],
6	with	IN	O	with	_	0	SENT_192	[p14l297t3210r489b3290],
7	chemotherapy	NN	O	chemotherapy	prep_with	5	SENT_192	[p14l520t3210r1119b3310],
8	for	IN	O	for	dep	11	SENT_192	[p14l1144t3209r1265b3289],
9	which	WDT	O	which	pobj	8	SENT_192	[p14l1288t3210r1546b3290],
10	the	DT	O	the	det	11	SENT_192	[p14l1577t3210r1707b3288],
11	incidence	NN	O	incidence	_	0	SENT_192	[p14l1737t3210r2133b3289],

1	A	DT	O	a	det	3	SENT_193	[p15l53t157r96b205],
2	Progression-free	JJ	O	progression-free	amod	3	SENT_193	[p15l142t160r543b220],
3	Survival	NN	O	survival	_	0	SENT_193	[p15l560t161r755b206],

1	100	CD	NUMBER	100	num	3	SENT_194	[p15l451t255r528b295],
2	Hazard	NN	O	hazard	nn	3	SENT_194	[p15l1203t267r1365b309],
3	ratio	NN	O	ratio	_	0	SENT_194	[p15l1388t271r1488b309],
4	for	IN	O	for	_	0	SENT_194	[p15l1505t266r1569b309],
5	progression	NN	O	progression	prep_for	3	SENT_194	[p15l1588t271r1857b323],
6	or	CC	O	or	_	0	SENT_194	[p15l1877t282r1924b309],
7	death	NN	O	death	conj_or	5	SENT_194	[p15l1940t267r2065b309],
8	in	IN	O	in	_	0	SENT_194	[p15l1258t335r1294b373],
9	the	DT	O	the	det	11	SENT_194	[p15l1313t331r1384b373],
10	crizotinib	JJ	O	crizotinib	amod	11	SENT_194	[p15l1402t331r1617b373],
11	group	NN	O	group	prep_in	3	SENT_194	[p15l1636t346r1781b387],
12	,	,	O	,	_	0	SENT_194	[p15l1636t346r1781b387],
13	80	CD	NUMBER	80	number	14	SENT_194	[p15l476t419r528b459],
14	0.49	CD	NUMBER	0.49	num	15	SENT_194	[p15l1255t398r1350b438],
15	(	NN	O	(	appos	11	SENT_194	[p15l1373t398r1489b451],
16	95	CD	PERCENT	95	number	17	SENT_194	[p15l1373t398r1489b451],
17	%	NN	PERCENT	%	amod	18	SENT_194	[p15l1373t398r1489b451],
18	CI	NN	O	ci	dep	3	SENT_194	[p15l1507t399r1566b445],
19	,	,	O	,	_	0	SENT_194	[p15l1507t399r1566b445],
20	0.37-0	CD	NUMBER	0.37-0	num	22	SENT_194	[p15l1585t398r1828b451],
21	.64	CD	NUMBER	.64	num	22	SENT_194	[p15l1585t398r1828b451],
22	)	NN	O	)	appos	18	SENT_194	[p15l1585t398r1828b451],

1	P	NN	O	p	_	0	SENT_195	[p15l1203t466r1387b506],
2	<	JJR	O	<	dep	1	SENT_195	[p15l1203t466r1387b506],
3	0.001	CD	NUMBER	0.001	dep	1	SENT_195	[p15l1203t466r1387b506],

1	Crizotinib	NNP	O	Crizotinib	_	0	SENT_196	[p15l1162t701r1385b744],

1	Survival	NN	O	survival	_	0	SENT_197	[p15l329t643r374b838],
2	(	CD	PERCENT	(	num	3	SENT_197	[p15l332t541r389b620],
3	%	NN	PERCENT	%	dep	1	SENT_197	[p15l332t541r389b620],
4	)	CD	NUMBER	)	dep	1	SENT_197	[p15l332t541r389b620],

1	Chemotherapy	NN	O	chemotherapy	_	0	SENT_198	[p15l674t924r1012b979],

1	Probability	NN	O	probability	_	0	SENT_199	[p15l261t798r320b1058],
2	of	IN	O	of	_	0	SENT_199	[p15l260t726r306b782],
3	Progression-free	JJ	O	progression-free	prep_of	1	SENT_199	[p15l260t313r320b715],

1	No.	NN	O	no.	_	0	SENT_200	[p15l93t1343r177b1384],
2	at	IN	O	at	_	0	SENT_200	[p15l196t1346r242b1384],
3	Risk	NN	O	risk	nn	4	SENT_200	[p15l262t1339r361b1384],
4	Crizotinib	NN	O	crizotinib	prep_at	1	SENT_200	[p15l90t1410r313b1452],
5	173	CD	NUMBER	173	number	6	SENT_200	[p15l525t1413r599b1452],
6	93	CD	NUMBER	93	num	7	SENT_200	[p15l830t1413r879b1452],
7	Chemotherapy	NN	O	chemotherapy	dep	1	SENT_200	[p15l90t1474r428b1530],
8	174	CD	NUMBER	174	num	9	SENT_200	[p15l525t1478r602b1516],
9	49	CD	NUMBER	49	dep	7	SENT_200	[p15l829t1478r882b1517],

1	B	NN	O	b	_	0	SENT_201	[p15l58t1641r93b1690],
2	Progression-free	JJ	O	progression-free	amod	3	SENT_201	[p15l142t1644r543b1704],
3	Survival	NN	O	survival	dep	1	SENT_201	[p15l560t1645r754b1691],
4	with	IN	O	with	_	0	SENT_201	[p15l773t1645r877b1691],
5	Crizotinib	NNP	O	Crizotinib	prep_with	3	SENT_201	[p15l897t1645r1136b1691],
6	vs.	CC	O	vs.	_	0	SENT_201	[p15l1152t1660r1219b1691],
7	Pemetrexed	NNP	O	Pemetrexed	prep_with	3	SENT_201	[p15l1242t1645r1528b1691],
8	or	CC	O	or	_	0	SENT_201	[p15l1548t1660r1598b1691],
9	Docetaxel	NNP	O	Docetaxel	prep_with	3	SENT_201	[p15l1617t1645r1856b1691],

1	Hazard	NN	O	hazard	nn	2	SENT_202	[p15l1203t1768r1365b1810],
2	ratio	NN	O	ratio	dep	3	SENT_202	[p15l1388t1772r1488b1810],
3	for	IN	O	for	_	0	SENT_202	[p15l1505t1767r1569b1810],
4	progression	NN	O	progression	pobj	3	SENT_202	[p15l1587t1772r1857b1824],
5	or	CC	O	or	_	0	SENT_202	[p15l1877t1783r1924b1810],
6	death	NN	O	death	pobj	3	SENT_202	[p15l1940t1768r2079b1818],
7	,	,	O	,	_	0	SENT_202	[p15l1940t1768r2079b1818],

1	0.59	CD	PERCENT	0.59	num	2	SENT_203	[p15l1255t1835r1350b1875],
2	(	CD	PERCENT	(	_	0	SENT_203	[p15l1373t1834r1489b1888],
3	95	CD	PERCENT	95	number	4	SENT_203	[p15l1373t1834r1489b1888],
4	%	NN	PERCENT	%	amod	5	SENT_203	[p15l1373t1834r1489b1888],
5	CI	NN	O	ci	dep	2	SENT_203	[p15l1507t1836r1565b1882],
6	,	,	O	,	_	0	SENT_203	[p15l1507t1836r1565b1882],
7	0.43-0	CD	NUMBER	0.43-0	number	8	SENT_203	[p15l1585t1835r1828b1888],
8	.80	CD	NUMBER	.80	num	10	SENT_203	[p15l1585t1835r1828b1888],
9	)	CD	NUMBER	)	number	10	SENT_203	[p15l1585t1835r1828b1888],
10	30	CD	NUMBER	30	appos	5	SENT_203	[p15l476t1912r528b1952],
11	.	.	O	.	_	0	SENT_203	[p15l639t1940r640b1955],

1	CrlZ0l5l	NN	O	crlz0l5l	nn	4	SENT_204	[p15l782t1890r1005b1932],
2	“	CD	NUMBER	“	num	4	SENT_204	[p15l782t1890r1005b1932],
3	lb	NN	O	lb	nn	4	SENT_204	[p15l782t1890r1005b1932],
4	P	NN	O	p	_	0	SENT_204	[p15l1203t1903r1387b1943],
5	<	VBG	O	<	partmod	4	SENT_204	[p15l1203t1903r1387b1943],
6	0.001	CD	NUMBER	0.001	number	7	SENT_204	[p15l1203t1903r1387b1943],
7	(	CD	NUMBER	(	dobj	5	SENT_204	[p15l1413t1904r1487b1956],
8	vs.	IN	O	vs.	_	0	SENT_204	[p15l1413t1904r1487b1956],
9	pemetrexed	JJ	O	pemetrexed	amod	10	SENT_204	[p15l1509t1900r1791b1956],
10	)	NN	O	)	prep_vs.	7	SENT_204	[p15l1509t1900r1791b1956],

1	o	NN	O	o	nn	5	SENT_205	[p15l639t2016r640b2039],
2	8	CD	NUMBER	8	num	5	SENT_205	[p15l639t2016r640b2039],
3	*	NN	O	*	nn	5	SENT_205	[p15l639t2016r640b2039],
4	Hazard	NN	O	hazard	nn	5	SENT_205	[p15l1203t2003r1365b2046],
5	ratio	NN	O	ratio	dep	6	SENT_205	[p15l1388t2007r1488b2046],
6	for	IN	O	for	_	0	SENT_205	[p15l1505t2003r1569b2046],
7	progression	NN	O	progression	pobj	6	SENT_205	[p15l1587t2007r1857b2059],
8	or	CC	O	or	_	0	SENT_205	[p15l1877t2018r1924b2046],
9	death	NN	O	death	pobj	6	SENT_205	[p15l1940t2003r2079b2053],
10	,	,	O	,	_	0	SENT_205	[p15l1940t2003r2079b2053],

1	60	CD	NUMBER	60	num	3	SENT_206	[p15l476t2076r528b2116],
2	0.30	CD	NUMBER	0.30	num	3	SENT_206	[p15l1255t2071r1351b2110],
3	(	NN	O	(	_	0	SENT_206	[p15l1373t2070r1489b2123],
4	95	CD	PERCENT	95	number	5	SENT_206	[p15l1373t2070r1489b2123],
5	%	NN	PERCENT	%	amod	6	SENT_206	[p15l1373t2070r1489b2123],
6	CI	NN	O	ci	dep	3	SENT_206	[p15l1507t2071r1565b2117],
7	,	,	O	,	_	0	SENT_206	[p15l1507t2071r1565b2117],
8	0.21-0	CD	NUMBER	0.21-0	num	10	SENT_206	[p15l1585t2071r1828b2123],
9	.43	CD	NUMBER	.43	num	10	SENT_206	[p15l1585t2071r1828b2123],
10	)	NN	O	)	appos	6	SENT_206	[p15l1585t2071r1828b2123],

1	P	NN	O	p	_	0	SENT_207	[p15l1203t2139r1387b2178],
2	<	JJR	O	<	dep	1	SENT_207	[p15l1203t2139r1387b2178],
3	0.001	CD	NUMBER	0.001	num	4	SENT_207	[p15l1203t2139r1387b2178],
4	(	NN	O	(	dep	1	SENT_207	[p15l1413t2139r1487b2192],
5	vs.	CC	O	vs.	prep	4	SENT_207	[p15l1413t2139r1487b2192],
6	docetaxel	NN	O	docetaxel	nn	7	SENT_207	[p15l1506t2136r1736b2191],
7	)	NN	O	)	dep	5	SENT_207	[p15l1506t2136r1736b2191],

1	Survival	NN	O	survival	_	0	SENT_208	[p15l329t2136r374b2331],
2	(	CD	PERCENT	(	num	3	SENT_208	[p15l332t2034r389b2113],
3	%	NN	PERCENT	%	dep	1	SENT_208	[p15l332t2034r389b2113],
4	)	CD	NUMBER	)	dep	1	SENT_208	[p15l332t2034r389b2113],

1	Pemetrexed	VBN	O	pemetrex	_	0	SENT_209	[p15l1636t2363r1899b2405],

1	Probability	NN	O	probability	_	0	SENT_210	[p15l261t2291r320b2551],
2	of	IN	O	of	_	0	SENT_210	[p15l260t2219r306b2275],
3	Progression-free	JJ	O	progression-free	prep_of	1	SENT_210	[p15l260t1807r320b2208],

1	No.	NN	O	no.	_	0	SENT_211	[p15l93t2836r177b2877],
2	at	IN	O	at	_	0	SENT_211	[p15l196t2839r242b2877],
3	Risk	NN	O	risk	prep_at	1	SENT_211	[p15l262t2832r361b2877],
4	Crizoti	NNP	O	Crizoti	nn	7	SENT_211	[p15l90t2906r237b2946],
5	nib	NNP	O	nib	nn	7	SENT_211	[p15l246t2903r313b2946],
6	Pemetrexed	NNP	O	Pemetrexed	nn	7	SENT_211	[p15l93t2967r357b3009],
7	Docetaxel	NNP	O	Docetaxel	dep	1	SENT_211	[p15l94t3032r311b3074],

1	Figure	NNP	O	Figure	_	0	SENT_212	[p15l65t3176r228b3238],
2	1	CD	NUMBER	1	dep	1	SENT_212	[p15l251t3179r293b3223],
3	.	.	O	.	_	0	SENT_212	[p15l251t3179r293b3223],

1	Progression-free	JJ	O	progression-free	amod	2	SENT_213	[p15l319t3174r755b3238],
2	Survival	NN	O	survival	_	0	SENT_213	[p15l774t3175r1003b3223],
3	.	.	O	.	_	0	SENT_213	[p15l774t3175r1003b3223],

1	Panel	NN	O	panel	nn	2	SENT_214	[p15l66t3271r204b3319],
2	A	NN	O	a	nsubj	3	SENT_214	[p15l227t3274r264b3319],
3	shows	VBZ	O	show	_	0	SENT_214	[p15l286t3271r450b3319],
4	Kaplan	NNP	PERSON	Kaplan	dobj	3	SENT_214	[p15l478t3271r851b3334],
5	.	.	O	.	_	0	SENT_214	[p15l478t3271r851b3334],

1	—	NN	O	—	_	0	SENT_215	[p15l478t3271r851b3334],
2	.	.	O	.	_	0	SENT_215	[p15l478t3271r851b3334],

1	Meier	JJR	PERSON	meier	amod	2	SENT_216	[p15l478t3271r851b3334],
2	estimates	NNS	O	estimate	_	0	SENT_216	[p15l872t3276r1128b3319],
3	of	IN	O	of	_	0	SENT_216	[p15l1152t3270r1209b3319],
4	progression-free	JJ	O	progression-free	amod	5	SENT_216	[p15l1225t3270r1661b3335],
5	survival	NN	O	survival	prep_of	2	SENT_216	[p15l1685t3271r1885b3319],
6	in	IN	O	in	_	0	SENT_216	[p15l1912t3276r1954b3319],
7	the	DT	O	the	det	9	SENT_216	[p15l1977t3271r2060b3319],
8	intention-to-treat	JJ	O	intention-to-treat	amod	9	SENT_216	[p15l64t3356r524b3399],
9	population	NN	O	population	prep_in	2	SENT_216	[p15l547t3351r849b3414],
10	.	.	O	.	_	0	SENT_216	[p15l547t3351r849b3414],

1	The	DT	O	the	det	4	SENT_217	[p15l871t3351r970b3399],
2	median	JJ	O	median	amod	4	SENT_217	[p15l995t3351r1188b3399],
3	progression-free	JJ	O	progression-free	amod	4	SENT_217	[p15l1216t3351r1653b3415],
4	survival	NN	O	survival	nsubj	7	SENT_217	[p15l1676t3351r1877b3399],
5	was	VBD	O	be	cop	7	SENT_217	[p15l1900t3368r1999b3400],
6	7.7	CD	DURATION	7.7	num	7	SENT_217	[p15l65t3436r133b3480],
7	months	NNS	NUMBER	month	_	0	SENT_217	[p15l158t3432r359b3480],
8	with	IN	O	with	_	0	SENT_217	[p15l380t3432r490b3480],
9	crizotinib	NN	O	crizotinib	prep_with	7	SENT_217	[p15l515t3432r763b3480],
10	as	IN	O	as	prep	7	SENT_217	[p15l786t3448r839b3480],
11	compared	VBN	O	compare	_	0	SENT_217	[p15l863t3432r1128b3494],
12	with	IN	O	with	prepc_compared_with	7	SENT_217	[p15l1151t3432r1260b3480],
13	3.0	CD	DURATION	3.0	num	14	SENT_217	[p15l1287t3435r1362b3480],
14	months	NNS	NUMBER	month	pobj	7	SENT_217	[p15l1386t3432r1587b3480],
15	with	IN	O	with	_	0	SENT_217	[p15l1609t3432r1718b3480],
16	chemotherapy	NN	O	chemotherapy	prep_with	14	SENT_217	[p15l1743t3432r2083b3480, p15l65t3529r131b3575],
17	.	.	O	.	_	0	SENT_217	[p15l1743t3432r2083b3480, p15l65t3529r131b3575],

1	Panel	NN	O	panel	nn	2	SENT_218	[p15l160t3512r297b3560],
2	B	NN	O	b	nsubj	3	SENT_218	[p15l327t3516r354b3559],
3	shows	VBZ	O	show	_	0	SENT_218	[p15l379t3512r543b3560],
4	Kap	NNP	O	Kap	dobj	3	SENT_218	[p15l571t3512r944b3575],
5	|	CD	NUMBER	|	num	4	SENT_218	[p15l571t3512r944b3575],
6	an	DT	O	a	dep	4	SENT_218	[p15l571t3512r944b3575],
7	.	.	O	.	_	0	SENT_218	[p15l571t3512r944b3575],

1	—	NN	O	—	_	0	SENT_219	[p15l571t3512r944b3575],
2	.	.	O	.	_	0	SENT_219	[p15l571t3512r944b3575],

1	Meier	JJR	PERSON	meier	amod	2	SENT_220	[p15l571t3512r944b3575],
2	estimates	NNS	O	estimate	_	0	SENT_220	[p15l964t3516r1221b3560],
3	ofprogression-free	JJ	O	ofprogression-free	amod	4	SENT_220	[p15l1245t3511r1754b3576],
4	survival	NN	O	survival	dep	2	SENT_220	[p15l1778t3512r1978b3560],
5	in	IN	O	in	_	0	SENT_220	[p15l2005t3517r2047b3559],
6	the	DT	O	the	det	8	SENT_220	[p15l60t3592r144b3640],
7	as-treated	JJ	O	as-treated	amod	8	SENT_220	[p15l167t3592r428b3640],
8	population	NN	O	population	prep_in	4	SENT_220	[p15l456t3592r740b3655],
9	(	CD	NUMBER	(	num	8	SENT_220	[p15l771t3592r940b3655],
10	which	WDT	O	which	nsubj	11	SENT_220	[p15l771t3592r940b3655],
11	excluded	VBD	O	exclude	rcmod	8	SENT_220	[p15l965t3592r1198b3640],
12	four	CD	NUMBER	four	num	13	SENT_220	[p15l1221t3591r1331b3640],
13	patients	NNS	O	patient	dobj	11	SENT_220	[p15l1353t3597r1565b3655],
14	who	WP	O	who	nsubj	17	SENT_220	[p15l1586t3592r1697b3640],
15	did	VBD	O	do	aux	17	SENT_220	[p15l1719t3592r1798b3640],
16	not	RB	O	not	neg	17	SENT_220	[p15l1825t3601r1910b3640],
17	receive	VB	O	receive	rcmod	13	SENT_220	[p15l1933t3609r1998b3640, p15l62t3677r193b3721],
18	study	NN	O	study	nn	20	SENT_220	[p15l216t3672r359b3736],
19	treatment	NN	O	treatment	nn	20	SENT_220	[p15l378t3676r677b3736],
20	)	NN	O	)	dobj	17	SENT_220	[p15l378t3676r677b3736],
21	,	,	O	,	_	0	SENT_220	[p15l378t3676r677b3736],
22	according	VBG	O	accord	_	0	SENT_220	[p15l702t3672r962b3736],
23	to	TO	O	to	prepc_according_to	11	SENT_220	[p15l981t3681r1032b3720],
24	the	DT	O	the	det	25	SENT_220	[p15l1053t3672r1136b3720],
25	type	NN	O	type	pobj	11	SENT_220	[p15l1157t3681r1269b3736],
26	of	IN	O	of	_	0	SENT_220	[p15l1292t3672r1349b3720],
27	chemotherapy	NN	O	chemotherapy	prep_of	25	SENT_220	[p15l1362t3672r1756b3736],
28	.	.	O	.	_	0	SENT_220	[p15l1362t3672r1756b3736],

1	The	DT	O	the	det	4	SENT_221	[p15l1778t3672r1878b3721],
2	median	JJ	O	median	amod	4	SENT_221	[p15l1902t3672r2095b3720],
3	progression-free	JJ	O	progression-free	amod	4	SENT_221	[p15l65t3752r501b3816],
4	survival	NN	O	survival	nsubj	7	SENT_221	[p15l525t3753r726b3801],
5	was	VBD	O	be	cop	7	SENT_221	[p15l748t3770r847b3801],
6	7.7	CD	DURATION	7.7	num	7	SENT_221	[p15l874t3757r942b3801],
7	months	NNS	NUMBER	month	_	0	SENT_221	[p15l967t3753r1168b3801],
8	with	IN	O	with	_	0	SENT_221	[p15l1189t3753r1299b3801],
9	crizotinib	NN	O	crizotinib	prep_with	7	SENT_221	[p15l1324t3753r1586b3810],
10	,	,	O	,	_	0	SENT_221	[p15l1324t3753r1586b3810],
11	as	IN	O	as	_	0	SENT_221	[p15l1611t3770r1664b3801],
12	compared	VBN	O	compare	prepc_as	7	SENT_221	[p15l1688t3753r1953b3816],
13	with	IN	O	with	pcomp	12	SENT_221	[p15l1976t3753r2086b3801],

1	4.2	CD	DURATION	4.2	num	2	SENT_222	[p16l61t9r139b53],
2	months	NNS	DURATION	month	_	0	SENT_222	[p16l165t6r365b53],
3	with	IN	O	with	_	0	SENT_222	[p16l387t6r497b53],
4	pemetrexed	NN	O	pemetrexed	prep_with	2	SENT_222	[p16l525t6r835b68],
5	and	CC	O	and	_	0	SENT_222	[p16l861t6r954b53],
6	2.6	CD	DURATION	2.6	num	7	SENT_222	[p16l979t9r1055b53],
7	months	NNS	NUMBER	month	prep_with	2	SENT_222	[p16l1081t6r1281b53],
8	with	IN	O	with	_	0	SENT_222	[p16l1303t6r1413b53],
9	docetaxel	NN	O	docetaxel	prep_with	2	SENT_222	[p16l1438t6r1705b53],
10	.	.	O	.	_	0	SENT_222	[p16l1438t6r1705b53],

1	In	IN	O	in	_	0	SENT_223	[p16l1733t9r1776b52],
2	both	DT	O	both	det	3	SENT_223	[p16l1803t6r1918b53],
3	panels	NNS	O	panel	prep_in	11	SENT_223	[p16l1946t22r2059b68, p16l62t85r147b142],
4	,	,	O	,	_	0	SENT_223	[p16l1946t22r2059b68, p16l62t85r147b142],
5	tick	VB	O	tick	csubj	11	SENT_223	[p16l170t85r264b133],
6	marks	NNS	O	mark	dobj	5	SENT_223	[p16l287t85r446b133],
7	on	IN	O	on	_	0	SENT_223	[p16l470t102r532b133],
8	the	DT	O	the	det	10	SENT_223	[p16l556t85r639b133],
9	survival	NN	O	survival	nn	10	SENT_223	[p16l662t85r863b133],
10	curves	NNS	O	curve	prep_on	5	SENT_223	[p16l888t102r1059b133],
11	indicate	VBP	O	indicate	_	0	SENT_223	[p16l1085t85r1292b133],
12	censoring	NN	O	censoring	dobj	11	SENT_223	[p16l1314t90r1576b149],
13	of	IN	O	of	_	0	SENT_223	[p16l1597t85r1654b133],
14	data	NNS	O	datum	prep_of	12	SENT_223	[p16l1667t85r1796b133],
15	.	.	O	.	_	0	SENT_223	[p16l1667t85r1796b133],

1	was	VBD	O	be	cop	5	SENT_224	[p16l8t311r129b351],
2	at	IN	O	at	quantmod	5	SENT_224	[p16l160t304r219b350],
3	least	JJS	O	least	mwe	2	SENT_224	[p16l245t292r394b350],
4	5	CD	NUMBER	5	number	5	SENT_224	[p16l422t296r520b351],
5	°	CD	NUMBER	°	dep	7	SENT_224	[p16l422t296r520b351],
6	/	:	O	/	punct	7	SENT_224	[p16l422t296r520b351],
7	o	NN	O	o	_	0	SENT_224	[p16l422t296r520b351],
8	greater	JJR	O	greater	dep	7	SENT_224	[p16l549t304r777b367],
9	than	IN	O	than	mark	15	SENT_224	[p16l805t292r952b350],
10	that	DT	O	that	nsubj	15	SENT_224	[p16l983t292r1112b350],
11	observed	VBN	O	observe	partmod	10	SENT_224	[p16l1139t292r1423b351],
12	with	IN	O	with	_	0	SENT_224	[p16l1450t292r1596b351],
13	crizotinib	NN	O	crizotinib	prep_with	11	SENT_224	[p16l12t387r325b446],
14	were	VBD	O	be	cop	15	SENT_224	[p16l362t406r513b446],
15	fatigue	NN	O	fatigue	ccomp	8	SENT_224	[p16l552t386r791b462],
16	,	,	O	,	_	0	SENT_224	[p16l552t386r791b462],
17	alopecia	NN	O	alopecia	ccomp	8	SENT_224	[p16l834t387r1116b461],
18	,	,	O	,	_	0	SENT_224	[p16l834t387r1116b461],
19	dyspnea	NN	O	dyspnea	ccomp	8	SENT_224	[p16l1160t387r1435b461],
20	,	,	O	,	_	0	SENT_224	[p16l1160t387r1435b461],
21	and	CC	O	and	_	0	SENT_224	[p16l1478t387r1596b446],
22	rash	JJ	O	rash	amod	23	SENT_224	[p16l11t483r147b541],
23	(	NN	O	(	ccomp	8	SENT_224	[p16l176t483r369b550],
24	Table	NNP	O	Table	nn	26	SENT_224	[p16l176t483r369b550],
25	3	CD	NUMBER	3	num	26	SENT_224	[p16l396t487r469b550],
26	)	NN	O	)	dep	23	SENT_224	[p16l396t487r469b550],
27	.	.	O	.	_	0	SENT_224	[p16l396t487r469b550],

1	In	IN	O	in	_	0	SENT_225	[p16l106t583r173b635],
2	the	DT	O	the	det	4	SENT_225	[p16l204t577r303b635],
3	crizotinib	JJ	O	crizotinib	amod	4	SENT_225	[p16l335t577r649b636],
4	group	NN	O	group	prep_in	11	SENT_225	[p16l680t596r886b652],
5	,	,	O	,	_	0	SENT_225	[p16l680t596r886b652],
6	grade	NN	O	grade	nsubj	11	SENT_225	[p16l921t577r1099b652],
7	3	CD	NUMBER	3	num	6	SENT_225	[p16l1131t582r1163b636],
8	or	CC	O	or	_	0	SENT_225	[p16l1198t596r1264b636],
9	4	CD	NUMBER	4	num	10	SENT_225	[p16l1292t582r1329b636],
10	neutropenia	NN	O	neutropenia	conj_or	6	SENT_225	[p16l1360t589r1595b636, p16l10t673r191b746],
11	occurred	VBD	O	occur	_	0	SENT_225	[p16l224t672r512b731],
12	in	IN	O	in	_	0	SENT_225	[p16l545t673r608b730],
13	23	CD	NUMBER	23	num	14	SENT_225	[p16l641t676r715b731],
14	patients	NNS	O	patient	prep_in	11	SENT_225	[p16l750t673r1011b746],
15	(	IN	O	(	_	0	SENT_225	[p16l1050t676r1248b743],
16	13	CD	PERCENT	13	num	17	SENT_225	[p16l1050t676r1248b743],
17	%	NN	PERCENT	%	prep_(	11	SENT_225	[p16l1050t676r1248b743],
18	)	CD	NUMBER	)	tmod	11	SENT_225	[p16l1050t676r1248b743],
19	,	,	O	,	_	0	SENT_225	[p16l1050t676r1248b743],
20	including	VBG	O	include	_	0	SENT_225	[p16l1285t672r1598b747],
21	1	CD	NUMBER	1	num	22	SENT_225	[p16l14t771r47b824],
22	patient	NN	O	patient	prep_including	11	SENT_225	[p16l78t768r304b841],
23	who	WP	O	who	nsubj	24	SENT_225	[p16l327t767r464b826],
24	had	VBD	O	have	rcmod	22	SENT_225	[p16l495t767r612b826],
25	febrile	JJ	O	febrile	amod	29	SENT_225	[p16l643t766r846b826],
26	neutropenia	NN	O	neutropenia	dep	25	SENT_225	[p16l877t768r1266b841],
27	(	CD	NUMBER	(	num	26	SENT_225	[p16l1299t767r1492b835],
28	Table	NNP	O	Table	nn	29	SENT_225	[p16l1299t767r1492b835],
29	S3	NN	O	s3	dobj	24	SENT_225	[p16l1524t771r1593b826],
30	in	IN	O	in	_	0	SENT_225	[p16l11t863r73b920],
31	the	DT	O	the	det	34	SENT_225	[p16l104t862r204b920],
32	Supplementary	NNP	O	Supplementary	nn	34	SENT_225	[p16l237t862r720b936],
33	Appendix	NNP	O	Appendix	nn	34	SENT_225	[p16l745t862r1093b936],
34	)	NN	O	)	prep_in	29	SENT_225	[p16l745t862r1093b936],
35	.	.	O	.	_	0	SENT_225	[p16l745t862r1093b936],

1	In	IN	O	in	_	0	SENT_226	[p16l1127t868r1194b919],
2	the	DT	O	the	det	4	SENT_226	[p16l1226t862r1325b920],
3	chemotherapy	NN	O	chemotherapy	nn	4	SENT_226	[p16l1357t862r1595b921, p16l12t957r247b1031],
4	group	NN	O	group	prep_in	11	SENT_226	[p16l269t976r470b1032],
5	,	,	O	,	_	0	SENT_226	[p16l269t976r470b1032],
6	grade	NN	O	grade	nsubj	11	SENT_226	[p16l499t957r675b1032],
7	3	CD	NUMBER	3	num	6	SENT_226	[p16l701t962r733b1016],
8	or	CC	O	or	_	0	SENT_226	[p16l762t976r828b1016],
9	4	CD	NUMBER	4	num	10	SENT_226	[p16l850t962r887b1015],
10	neutropenia	NN	O	neutropenia	conj_or	6	SENT_226	[p16l912t958r1294b1031],
11	occurred	VBD	O	occur	_	0	SENT_226	[p16l1319t957r1596b1016],
12	in	IN	O	in	_	0	SENT_226	[p16l11t1053r73b1110],
13	33	CD	NUMBER	33	num	14	SENT_226	[p16l106t1056r176b1111],
14	patients	NNS	O	patient	prep_in	11	SENT_226	[p16l209t1053r464b1126],
15	(	CD	PERCENT	(	number	16	SENT_226	[p16l502t1056r696b1123],
16	19	CD	PERCENT	19	num	17	SENT_226	[p16l502t1056r696b1123],
17	%	NN	PERCENT	%	dobj	11	SENT_226	[p16l502t1056r696b1123],
18	)	CD	NUMBER	)	tmod	11	SENT_226	[p16l502t1056r696b1123],
19	,	,	O	,	_	0	SENT_226	[p16l502t1056r696b1123],
20	including	VBG	O	include	_	0	SENT_226	[p16l732t1052r1039b1127],
21	16	CD	NUMBER	16	num	22	SENT_226	[p16l1071t1056r1141b1111],
22	patients	NNS	O	patient	prep_including	11	SENT_226	[p16l1172t1053r1428b1126],
23	who	WP	O	who	nsubj	24	SENT_226	[p16l1458t1052r1595b1111],
24	had	VBD	O	have	rcmod	22	SENT_226	[p16l11t1147r128b1206],
25	febrile	JJ	O	febrile	amod	26	SENT_226	[p16l157t1146r361b1206],
26	neutropenia	NN	O	neutropenia	dobj	24	SENT_226	[p16l390t1148r796b1221],
27	.	.	O	.	_	0	SENT_226	[p16l390t1148r796b1221],

1	N	NN	O	n	nn	3	SENT_227	[p16l572t1306r585b1321],
2	ENGLJ	NN	O	englj	nn	3	SENT_227	[p16l600t1306r678b1328],
3	MED	NN	O	med	_	0	SENT_227	[p16l693t1306r745b1321],
4	368	CD	NUMBER	368	nsubj	8	SENT_227	[p16l755t1300r834b1328],
5	;	:	O	;	_	0	SENT_227	[p16l755t1300r834b1328],
6	25	CD	NUMBER	25	num	7	SENT_227	[p16l755t1300r834b1328],
7	NE	NNS	O	ne	dep	4	SENT_227	[p16l869t1306r993b1328],
8	)	VBP	O	)	rcmod	3	SENT_227	[p16l869t1306r993b1328],
9	M.ORG	NNP	O	M.ORG	nn	10	SENT_227	[p16l869t1306r993b1328],
10	JUNE	NNP	DATE	JUNE	dobj	8	SENT_227	[p16l1024t1306r1088b1328],
11	20	CD	DATE	20	num	10	SENT_227	[p16l1099t1306r1136b1326],
12	,	,	DATE	,	_	0	SENT_227	[p16l1099t1306r1136b1326],
13	2013	CD	DATE	2013	num	10	SENT_227	[p16l1147t1306r1202b1328],
14	2339	CD	DATE	2339	dep	10	SENT_227	[p16l1940t1296r2016b1319],

1	The	DT	O	the	det	4	SENT_228	[p16l702t1339r753b1363],
2	New	NNP	O	New	nn	4	SENT_228	[p16l762t1340r824b1363],
3	England	NNP	O	England	nn	4	SENT_228	[p16l833t1339r944b1370],
4	Joumal	NNP	O	Joumal	_	0	SENT_228	[p16l953t1339r1050b1363],
5	of	IN	O	of	_	0	SENT_228	[p16l1060t1339r1089b1363],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_228	[p16l1095t1339r1220b1363],

1	The	DT	O	the	det	4	SENT_229	[p16l673t1527r719b1548],
2	NEW	NNP	O	NEW	nn	4	SENT_229	[p16l737t1529r822b1548],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_229	[p16l841t1529r1030b1548],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_229	[p16l1049t1529r1228b1555],
5	of	IN	O	of	_	0	SENT_229	[p16l1248t1527r1276b1554],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_229	[p16l1288t1529r1487b1548],

1	Table	NNP	O	Table	_	0	SENT_230	[p16l59t1752r200b1799],
2	2	CD	NUMBER	2	dep	1	SENT_230	[p16l217t1756r261b1799],
3	.	.	O	.	_	0	SENT_230	[p16l217t1756r261b1799],

1	Summary	NN	O	summary	_	0	SENT_231	[p16l280t1755r533b1814],
2	of	IN	O	of	_	0	SENT_231	[p16l549t1751r609b1799],
3	Responses	NNS	O	response	prep_of	1	SENT_231	[p16l620t1756r897b1813],
4	in	IN	O	in	_	0	SENT_231	[p16l917t1752r961b1799],
5	the	DT	O	the	det	7	SENT_231	[p16l979t1751r1063b1800],
6	Intention-to-Treat	NNP	O	Intention-to-Treat	nn	7	SENT_231	[p16l1084t1752r1545b1800],
7	Population	NNP	O	Population	prep_in	1	SENT_231	[p16l1565t1751r1893b1813],
8	.	.	O	.	_	0	SENT_231	[p16l1565t1751r1893b1813],

1	‘	NN	O	‘	nsubj	2	SENT_232	[p16l1565t1751r1893b1813],
2	~	CD	NUMBER	~	_	0	SENT_232	[p16l1565t1751r1893b1813],
3	"	''	O	"	punct	2	SENT_232	[p16l1565t1751r1893b1813],

1	Crizotinib	NNP	O	Crizotinib	nn	2	SENT_233	[p16l1273t1895r1526b1944],
2	Chemotherapy	NNP	O	Chemotherapy	_	0	SENT_233	[p16l1662t1895r2048b1958],

1	Response	NN	O	response	dep	12	SENT_234	[p16l63t1972r314b2030],
2	(	CD	NUMBER	(	num	3	SENT_234	[p16l1286t1972r1344b2031],
3	N	NN	O	n	dep	1	SENT_234	[p16l1286t1972r1344b2031],
4	=	JJ	O	=	dep	12	SENT_234	[p16l1359t1991r1392b2008],
5	173	CD	NUMBER	173	number	6	SENT_234	[p16l1405t1971r1512b2031],
6	)	CD	NUMBER	)	num	12	SENT_234	[p16l1405t1971r1512b2031],
7	(	NN	O	(	nn	12	SENT_234	[p16l1742t1972r1799b2031],
8	N	NN	O	n	nn	12	SENT_234	[p16l1742t1972r1799b2031],
9	=	JJ	O	=	amod	12	SENT_234	[p16l1814t1991r1847b2008],
10	174	CD	NUMBER	174	number	11	SENT_234	[p16l1861t1972r1967b2031],
11	)	CD	NUMBER	)	dep	9	SENT_234	[p16l1861t1972r1967b2031],
12	Type	NN	O	type	dep	18	SENT_234	[p16l58t2082r181b2141],
13	of	IN	O	of	_	0	SENT_234	[p16l200t2077r257b2126],
14	response	NN	O	response	nn	16	SENT_234	[p16l270t2095r505b2140],
15	—	CD	NUMBER	—	num	16	SENT_234	[p16l521t2107r586b2112],
16	no.	NN	O	no.	prep_of	12	SENT_234	[p16l606t2095r681b2126],
17	(	CD	PERCENT	(	num	18	SENT_234	[p16l708t2080r793b2141],
18	%	NN	PERCENT	%	dep	19	SENT_234	[p16l708t2080r793b2141],
19	)	CD	NUMBER	)	_	0	SENT_234	[p16l708t2080r793b2141],

1	Complete	JJ	O	complete	amod	8	SENT_235	[p16l157t2188r408b2251],
2	response	NN	O	response	nn	8	SENT_235	[p16l430t2205r666b2251],
3	Partial	JJ	O	partial	amod	8	SENT_235	[p16l160t2299r318b2347],
4	response	NN	O	response	nn	8	SENT_235	[p16l342t2316r577b2361],
5	Stable	JJ	O	stable	amod	8	SENT_235	[p16l157t2409r315b2457],
6	disease	NN	O	disease	nn	8	SENT_235	[p16l335t2409r528b2457],
7	Progressive	JJ	O	progressive	amod	8	SENT_235	[p16l160t2524r458b2583],
8	disease	NN	O	disease	nsubjpass	12	SENT_235	[p16l477t2520r671b2568],
9	Could	MD	O	could	aux	12	SENT_235	[p16l157t2630r306b2678],
10	not	RB	O	not	neg	12	SENT_235	[p16l331t2639r413b2678],
11	be	VB	O	be	auxpass	12	SENT_235	[p16l434t2630r491b2678],
12	evaluated	VBN	O	evaluate	_	0	SENT_235	[p16l510t2630r794b2693],
13	'	''	O	'	_	0	SENT_235	[p16l510t2630r794b2693],
14	i	FW	O	i	dobj	12	SENT_235	[p16l510t2630r794b2693],
15	'	''	DATE	'	_	0	SENT_235	[p16l510t2630r794b2693],
16	17	CD	DATE	17	tmod	12	SENT_235	[p16l1316t2634r1372b2678],
17	(	CD	NUMBER	(	number	18	SENT_235	[p16l1397t2633r1492b2693],
18	10	CD	NUMBER	10	num	19	SENT_235	[p16l1397t2633r1492b2693],
19	)	NN	O	)	dobj	12	SENT_235	[p16l1397t2633r1492b2693],
20	17	CD	NUMBER	17	number	21	SENT_235	[p16l1760t2634r1816b2678],
21	(	CD	NUMBER	(	dep	19	SENT_235	[p16l1841t2633r1935b2693],
22	10	CD	NUMBER	10	num	23	SENT_235	[p16l1841t2633r1935b2693],
23	)	NN	O	)	dep	21	SENT_235	[p16l1841t2633r1935b2693],

1	Rate	NN	O	rate	_	0	SENT_236	[p16l64t2745r171b2789],
2	of	IN	O	of	_	0	SENT_236	[p16l188t2740r244b2789],
3	objective	JJ	O	objective	amod	4	SENT_236	[p16l252t2740r476b2804],
4	response	NN	O	response	prep_of	1	SENT_236	[p16l496t2757r724b2803],
5	—	CD	PERCENT	—	num	6	SENT_236	[p16l738t2770r803b2774],
6	%	NN	PERCENT	%	dep	1	SENT_236	[p16l818t2743r868b2791],
7	(	CD	PERCENT	(	num	12	SENT_236	[p16l891t2743r1019b2803],
8	95	CD	PERCENT	95	number	11	SENT_236	[p16l891t2743r1019b2803],
9	%	NN	PERCENT	%	dep	11	SENT_236	[p16l891t2743r1019b2803],
10	C	NN	O	c	dep	11	SENT_236	[p16l1037t2744r1146b2804],
11	|	JJ	O	|	amod	12	SENT_236	[p16l1037t2744r1146b2804],
12	)	NN	O	)	dep	6	SENT_236	[p16l1037t2744r1146b2804],
13	:	:	O	:	_	0	SENT_236	[p16l1037t2744r1146b2804],
14	i	FW	O	i	dep	6	SENT_236	[p16l1037t2744r1146b2804],
15	:	:	O	:	_	0	SENT_236	[p16l1037t2744r1146b2804],
16	65	CD	NUMBER	65	number	17	SENT_236	[p16l1261t2744r1317b2789],
17	(	CD	NUMBER	(	dep	14	SENT_236	[p16l1345t2743r1533b2803],
18	58-72	CD	NUMBER	58-72	dep	24	SENT_236	[p16l1345t2743r1533b2803],
19	)	CD	NUMBER	)	num	20	SENT_236	[p16l1345t2743r1533b2803],
20	20	CD	NUMBER	20	dep	18	SENT_236	[p16l1716t2743r1776b2789],
21	(	NN	O	(	dep	24	SENT_236	[p16l1800t2744r1988b2803],
22	14-26	CD	NUMBER	14-26	num	21	SENT_236	[p16l1800t2744r1988b2803],
23	)	CD	NUMBER	)	num	24	SENT_236	[p16l1800t2744r1988b2803],
24	Duration	NN	O	duration	dep	14	SENT_236	[p16l65t2855r290b2899],
25	of	IN	O	of	_	0	SENT_236	[p16l312t2851r369b2899],
26	response	NN	O	response	nn	29	SENT_236	[p16l381t2868r616b2913],
27	—	CD	NUMBER	—	num	29	SENT_236	[p16l633t2881r697b2885],
28	wk	NN	DURATION	wk	nn	29	SENT_236	[p16l712t2851r806b2914],
29	§	NN	O	§	prep_of	24	SENT_236	[p16l712t2851r806b2914],

1	Median	JJ	O	median	amod	2	SENT_237	[p16l160t2962r350b3009],
2	32.1	CD	NUMBER	32.1	_	0	SENT_237	[p16l1347t2966r1450b3009],
3	24.4	CD	NUMBER	24.4	num	5	SENT_237	[p16l1801t2966r1908b3009],
4	Rangeﬁ	NN	O	rangeﬁ	nn	5	SENT_237	[p16l160t3071r352b3135],
5	]	NN	O	]	dep	2	SENT_237	[p16l160t3071r352b3135],
6	2.1	CD	NUMBER	2.1	number	7	SENT_237	[p16l1290t3076r1508b3120],
7	—	CD	NUMBER	—	num	9	SENT_237	[p16l1290t3076r1508b3120],
8	72.4	CD	NUMBER	72.4	number	9	SENT_237	[p16l1290t3076r1508b3120],
9	3.0	CD	NUMBER	3.0	dep	5	SENT_237	[p16l1746t3075r1964b3120],
10	—	NN	O	—	dep	2	SENT_237	[p16l1746t3075r1964b3120],
11	43.6	CD	NUMBER	43.6	num	10	SENT_237	[p16l1746t3075r1964b3120],

1	Time	NNP	O	Time	_	0	SENT_238	[p16l58t3187r190b3230],
2	to	TO	O	to	_	0	SENT_238	[p16l208t3192r258b3230],
3	response	NN	O	response	nn	6	SENT_238	[p16l281t3199r516b3245],
4	—	NN	O	—	nn	6	SENT_238	[p16l532t3212r597b3216],
5	wkl	NN	O	wkl	nn	6	SENT_238	[p16l612t3178r703b3247],
6	|	NN	O	|	prep_to	1	SENT_238	[p16l612t3178r703b3247],

1	Median	JJ	MISC	median	amod	2	SENT_239	[p16l160t3293r350b3341],
2	Range	NNP	MISC	Range	_	0	SENT_239	[p16l160t3408r317b3466],

1	7	CD	NUMBER	7	num	4	SENT_240	[p16l9t3570r38b3598],
2	"	``	O	"	punct	4	SENT_240	[p16l9t3570r38b3598],
3	Tumor	NN	O	tumor	nn	4	SENT_240	[p16l55t3570r234b3614],
4	responses	NNS	O	response	nsubjpass	26	SENT_240	[p16l256t3583r518b3628],
5	were	VBD	O	be	auxpass	6	SENT_240	[p16l540t3583r662b3614],
6	assessed	VBN	O	assess	rcmod	4	SENT_240	[p16l684t3566r916b3614],
7	with	IN	O	with	_	0	SENT_240	[p16l938t3566r1045b3614],
8	the	DT	O	the	det	9	SENT_240	[p16l1069t3566r1150b3614],
9	use	NN	O	use	prep_with	6	SENT_240	[p16l1174t3583r1260b3614],
10	of	IN	O	of	_	0	SENT_240	[p16l1283t3565r1339b3614],
11	Response	NN	O	response	nn	13	SENT_240	[p16l1356t3570r1606b3628],
12	Evaluation	NN	O	evaluation	nn	13	SENT_240	[p16l1632t3566r1898b3614],
13	Criteria	NNS	O	criterion	prep_of	9	SENT_240	[p16l1924t3570r2111b3614],
14	in	IN	O	in	_	0	SENT_240	[p16l60t3643r100b3685],
15	Solid	JJ	O	solid	amod	16	SENT_240	[p16l126t3638r252b3686],
16	Tumors	NNS	O	tumor	prep_in	6	SENT_240	[p16l275t3643r478b3686],
17	(	VBP	O	(	_	0	SENT_240	[p16l507t3642r755b3701],
18	RECIST	NN	O	recist	dobj	17	SENT_240	[p16l507t3642r755b3701],
19	)	CD	NUMBER	)	num	18	SENT_240	[p16l507t3642r755b3701],
20	,	,	O	,	_	0	SENT_240	[p16l507t3642r755b3701],
21	version	NN	O	version	appos	18	SENT_240	[p16l778t3643r966b3686],
22	1.1	CD	NUMBER	1.1	num	21	SENT_240	[p16l994t3643r1080b3695],
23	,	,	O	,	_	0	SENT_240	[p16l994t3643r1080b3695],
24	and	CC	O	and	_	0	SENT_240	[p16l1105t3638r1197b3686],
25	were	VBD	O	be	auxpass	26	SENT_240	[p16l1219t3655r1341b3686],
26	confirmed	VBN	O	confirm	conj_and	17	SENT_240	[p16l1363t3638r1627b3686],
27	by	IN	O	by	_	0	SENT_240	[p16l1654t3638r1708b3701],
28	independent	JJ	O	independent	amod	30	SENT_240	[p16l1731t3638r2059b3700],
29	radiologic	JJ	O	radiologic	amod	30	SENT_240	[p17l60t19r316b82],
30	review	NN	O	review	agent	26	SENT_240	[p17l340t24r515b67],
31	.	.	O	.	_	0	SENT_240	[p17l340t24r515b67],

1	1	CD	NUMBER	1	number	2	SENT_241	[p17l11t95r40b153],
2	‘	CD	NUMBER	‘	num	3	SENT_241	[p17l11t95r40b153],
3	Responses	NNS	O	response	nsubj	15	SENT_241	[p17l61t95r338b152],
4	were	VBD	O	be	cop	5	SENT_241	[p17l359t107r481b138],
5	indeterminate	JJ	O	indeterminate	_	0	SENT_241	[p17l505t90r870b138],
6	in	IN	O	in	_	0	SENT_241	[p17l894t95r935b137],
7	13	CD	NUMBER	13	num	8	SENT_241	[p17l964t94r1016b138],
8	patients	NNS	O	patient	prep_in	5	SENT_241	[p17l1044t95r1249b152],
9	in	IN	O	in	_	0	SENT_241	[p17l1275t95r1316b137],
10	each	DT	O	each	det	11	SENT_241	[p17l1341t90r1456b138],
11	group	NN	O	group	prep_in	8	SENT_241	[p17l1482t107r1634b153],
12	and	CC	O	and	_	0	SENT_241	[p17l1657t90r1749b138],
13	were	VBD	O	be	cop	15	SENT_241	[p17l1771t107r1893b138],
14	not	RB	O	not	neg	15	SENT_241	[p17l1918t99r2001b138],
15	available	JJ	O	available	conj_and	5	SENT_241	[p17l58t161r282b209],
16	owing	VBG	O	owe	_	0	SENT_241	[p17l305t166r461b224],
17	to	TO	O	to	_	0	SENT_241	[p17l480t170r531b209],
18	early	JJ	O	early	amod	19	SENT_241	[p17l553t161r674b224],
19	death	NN	O	death	prep_owing_to	15	SENT_241	[p17l694t161r835b209],
20	in	IN	O	in	_	0	SENT_241	[p17l863t166r904b208],
21	4	CD	NUMBER	4	num	22	SENT_241	[p17l928t166r956b208],
22	patients	NNS	O	patient	prep_in	15	SENT_241	[p17l981t166r1186b223],
23	in	IN	O	in	_	0	SENT_241	[p17l1212t166r1252b208],
24	each	DT	O	each	det	25	SENT_241	[p17l1278t161r1393b209],
25	group	NN	O	group	prep_in	22	SENT_241	[p17l1419t178r1585b224],
26	.	.	O	.	_	0	SENT_241	[p17l1419t178r1585b224],

1	:	:	O	:	_	0	SENT_242	[p17l11t237r40b295],
2	i	FW	O	i	_	0	SENT_242	[p17l11t237r40b295],
3	:	:	O	:	_	0	SENT_242	[p17l11t237r40b295],
4	P	NN	O	p	dep	5	SENT_242	[p17l61t235r264b280],
5	<	JJR	O	<	dep	2	SENT_242	[p17l61t235r264b280],
6	0.001	CD	NUMBER	0.001	dep	5	SENT_242	[p17l61t235r264b280],
7	for	IN	O	for	_	0	SENT_242	[p17l288t232r361b280],
8	the	DT	O	the	det	9	SENT_242	[p17l379t232r460b280],
9	comparison	NN	O	comparison	prep_for	2	SENT_242	[p17l482t237r791b294],
10	between	IN	O	between	_	0	SENT_242	[p17l819t232r1030b280],
11	the	DT	O	the	det	13	SENT_242	[p17l1053t232r1134b280],
12	two	CD	NUMBER	two	num	13	SENT_242	[p17l1154t241r1247b280],
13	groups	NNS	O	group	prep_between	9	SENT_242	[p17l1270t249r1465b295],
14	.	.	O	.	_	0	SENT_242	[p17l1270t249r1465b295],

1	R3	NN	O	r3	nn	3	SENT_243	[p17l10t303r29b366],
2	The	DT	O	the	det	3	SENT_243	[p17l55t303r152b351],
3	duration	NN	O	duration	nsubjpass	7	SENT_243	[p17l174t303r392b351],
4	of	IN	O	of	_	0	SENT_243	[p17l417t303r474b351],
5	response	NN	O	response	prep_of	3	SENT_243	[p17l489t320r724b365],
6	was	VBD	O	be	auxpass	7	SENT_243	[p17l744t320r842b351],
7	calculated	VBN	O	calculate	_	0	SENT_243	[p17l865t303r1125b351],
8	from	IN	O	from	_	0	SENT_243	[p17l1148t303r1270b351],
9	the	DT	O	the	det	11	SENT_243	[p17l1293t303r1374b351],
10	date	NN	O	date	nn	11	SENT_243	[p17l1396t303r1506b351],
11	ofthe	NN	O	ofthe	prep_from	7	SENT_243	[p17l1529t303r1678b351],
12	first	RB	ORDINAL	first	advmod	13	SENT_243	[p17l1698t303r1800b351],
13	documentation	NN	O	documentation	rcmod	11	SENT_243	[p17l1821t303r2134b351, p17l56t379r154b422],
14	of	IN	O	of	_	0	SENT_243	[p17l179t374r236b422],
15	partial	JJ	O	partial	amod	18	SENT_243	[p17l252t374r410b436],
16	or	CC	O	or	_	0	SENT_243	[p17l434t391r488b422],
17	complete	JJ	O	complete	conj_or	15	SENT_243	[p17l508t374r749b436],
18	response	NN	O	response	prep_of	13	SENT_243	[p17l774t391r1009b436],
19	to	TO	O	to	_	0	SENT_243	[p17l1029t383r1080b422],
20	the	DT	O	the	det	21	SENT_243	[p17l1100t374r1182b422],
21	date	NN	O	date	prep_to	7	SENT_243	[p17l1204t374r1314b422],
22	of	IN	O	of	_	0	SENT_243	[p17l1336t374r1393b422],
23	RECIST-deﬁned	JJ	O	recist-deﬁned	amod	24	SENT_243	[p17l1410t374r1812b422],
24	progression	NN	O	progression	prep_of	21	SENT_243	[p17l1839t391r2052b437, p17l59t450r163b493],
25	or	CC	O	or	_	0	SENT_243	[p17l188t462r241b493],
26	death	NN	O	death	prep_of	21	SENT_243	[p17l261t445r419b501],
27	,	,	O	,	_	0	SENT_243	[p17l261t445r419b501],
28	with	IN	O	with	_	0	SENT_243	[p17l442t445r549b493],
29	the	DT	O	the	det	32	SENT_243	[p17l572t445r653b493],
30	use	NN	O	use	nn	32	SENT_243	[p17l678t462r764b493],
31	ofthe	NN	O	ofthe	nn	32	SENT_243	[p17l786t445r935b493],
32	Kaplan	NNP	PERSON	Kaplan	prep_with	7	SENT_243	[p17l961t445r1322b507],
33	.	.	O	.	_	0	SENT_243	[p17l961t445r1322b507],

1	—	NN	O	—	_	0	SENT_244	[p17l961t445r1322b507],
2	.	.	O	.	_	0	SENT_244	[p17l961t445r1322b507],

1	Meier	JJR	PERSON	meier	_	0	SENT_245	[p17l961t445r1322b507],
2	method	NN	O	method	dep	1	SENT_245	[p17l1345t445r1558b493],
3	.	.	O	.	_	0	SENT_245	[p17l1345t445r1558b493],

1	ﬁ	NN	O	ﬁ	nsubj	5	SENT_246	[p17l10t516r164b578],
2	]	CD	NUMBER	]	num	1	SENT_246	[p17l10t516r164b578],
3	This	DT	O	this	det	4	SENT_246	[p17l10t516r164b578],
4	range	NN	O	range	dep	1	SENT_246	[p17l191t533r333b579],
5	takes	VBZ	O	take	_	0	SENT_246	[p17l353t516r486b564],
6	into	IN	O	into	_	0	SENT_246	[p17l512t521r609b564],
7	account	NN	O	account	prep_into	5	SENT_246	[p17l633t525r839b564],
8	only	RB	O	only	advmod	9	SENT_246	[p17l860t516r967b579],
9	patients	NNS	O	patient	dobj	5	SENT_246	[p17l990t521r1195b578],
10	who	WP	O	who	nsubj	11	SENT_246	[p17l1217t516r1325b564],
11	had	VBD	O	have	rcmod	9	SENT_246	[p17l1350t516r1439b564],
12	subsequent	JJ	O	subsequent	amod	14	SENT_246	[p17l1465t516r1768b578],
13	disease	NN	O	disease	nn	14	SENT_246	[p17l1789t516r1983b564],
14	progression	NN	O	progression	dobj	11	SENT_246	[p17l2007t533r2108b578, p17l58t592r276b650],
15	or	CC	O	or	_	0	SENT_246	[p17l301t604r354b635],
16	who	WP	O	who	nsubj	17	SENT_246	[p17l372t587r480b635],
17	died	VBD	O	die	conj_or	14	SENT_246	[p17l502t587r626b635],
18	.	.	O	.	_	0	SENT_246	[p17l502t587r626b635],

1	|	NN	O	|	nsubjpass	8	SENT_247	[p17l16t654r27b722],
2	|	CD	NUMBER	|	num	1	SENT_247	[p17l16t654r27b722],
3	The	DT	O	the	det	4	SENT_247	[p17l55t658r152b706],
4	time	NN	O	time	tmod	1	SENT_247	[p17l172t663r289b706],
5	to	TO	O	to	_	0	SENT_247	[p17l309t667r360b706],
6	response	NN	O	response	prep_to	1	SENT_247	[p17l385t675r620b720],
7	was	VBD	O	be	auxpass	8	SENT_247	[p17l639t675r738b706],
8	calculated	VBN	O	calculate	_	0	SENT_247	[p17l761t658r1021b706],
9	from	IN	O	from	_	0	SENT_247	[p17l1044t658r1166b706],
10	the	DT	O	the	det	11	SENT_247	[p17l1189t658r1270b706],
11	date	NN	O	date	prep_from	8	SENT_247	[p17l1292t658r1403b706],
12	of	IN	O	of	_	0	SENT_247	[p17l1424t658r1481b706],
13	randomization	NN	O	randomization	prep_of	11	SENT_247	[p17l1497t658r1876b706],
14	to	TO	O	to	_	0	SENT_247	[p17l1899t667r1950b706],
15	the	DT	O	the	det	20	SENT_247	[p17l1971t658r2052b706],
16	date	NN	O	date	nn	20	SENT_247	[p17l58t729r167b777],
17	ofthe	NN	O	ofthe	nn	20	SENT_247	[p17l190t729r339b777],
18	first	JJ	ORDINAL	first	amod	20	SENT_247	[p17l359t729r461b777],
19	documentation	NN	O	documentation	nn	20	SENT_247	[p17l482t729r879b777],
20	ofa	NN	O	ofa	prep_to	8	SENT_247	[p17l905t729r999b777],
21	partial	JJ	O	partial	amod	24	SENT_247	[p17l1025t729r1182b791],
22	or	CC	O	or	_	0	SENT_247	[p17l1208t746r1261b777],
23	complete	JJ	O	complete	conj_or	21	SENT_247	[p17l1281t729r1522b791],
24	response	NN	O	response	dep	20	SENT_247	[p17l1547t746r1796b791],
25	.	.	O	.	_	0	SENT_247	[p17l1547t746r1796b791],

1	By	IN	O	by	_	0	SENT_248	[p17l656t977r733b1047],
2	the	DT	O	the	det	3	SENT_248	[p17l761t973r859b1031],
3	time	NN	O	time	prep_by	29	SENT_248	[p17l891t973r1034b1031],
4	of	IN	O	of	_	0	SENT_248	[p17l1066t972r1140b1031],
5	data	NNS	O	datum	nn	6	SENT_248	[p17l1158t973r1294b1031],
6	cutoff	NN	O	cutoff	prep_of	3	SENT_248	[p17l1324t972r1529b1043],
7	,	,	O	,	_	0	SENT_248	[p17l1324t972r1529b1043],
8	25	CD	NUMBER	25	num	9	SENT_248	[p17l1564t977r1636b1031],
9	patients	NNS	O	patient	conj_and	3	SENT_248	[p17l1669t973r1923b1047],
10	(	CD	PERCENT	(	number	11	SENT_248	[p17l1959t977r2134b1040],
11	15	CD	PERCENT	15	num	12	SENT_248	[p17l1959t977r2134b1040],
12	%	NN	PERCENT	%	dep	9	SENT_248	[p17l1959t977r2134b1040],
13	)	CD	NUMBER	)	dep	9	SENT_248	[p17l1959t977r2134b1040],
14	in	IN	O	in	_	0	SENT_248	[p17l560t1068r622b1125],
15	the	DT	O	the	det	17	SENT_248	[p17l647t1068r746b1126],
16	crizotinib	JJ	O	crizotinib	amod	17	SENT_248	[p17l772t1068r1083b1126],
17	group	NN	O	group	prep_in	13	SENT_248	[p17l1109t1086r1296b1142],
18	and	CC	O	and	_	0	SENT_248	[p17l1322t1067r1439b1126],
19	7	CD	PERCENT	7	num	20	SENT_248	[p17l1465t1073r1499b1126],
20	(	NN	PERCENT	(	prep_by	29	SENT_248	[p17l1528t1072r1661b1135],
21	4	CD	PERCENT	4	number	22	SENT_248	[p17l1528t1072r1661b1135],
22	%	NN	PERCENT	%	amod	20	SENT_248	[p17l1528t1072r1661b1135],
23	)	CD	NUMBER	)	nsubj	29	SENT_248	[p17l1528t1072r1661b1135],
24	in	IN	O	in	_	0	SENT_248	[p17l1689t1068r1751b1125],
25	the	DT	O	the	det	27	SENT_248	[p17l1776t1068r1875b1126],
26	chemotherapy	NN	O	chemotherapy	nn	27	SENT_248	[p17l1901t1068r2137b1126, p17l561t1163r800b1237],
27	group	NN	O	group	prep_in	23	SENT_248	[p17l832t1181r1020b1237],
28	had	VBD	O	have	aux	29	SENT_248	[p17l1056t1163r1173b1221],
29	died	VBN	O	die	_	0	SENT_248	[p17l1209t1163r1344b1221],
30	from	IN	O	from	_	0	SENT_248	[p17l1380t1162r1536b1221],
31	any	DT	O	any	det	32	SENT_248	[p17l1571t1181r1683b1237],
32	cause	NN	O	cause	prep_from	29	SENT_248	[p17l1716t1182r1889b1221],
33	during	IN	O	during	_	0	SENT_248	[p17l1926t1163r2140b1237],
34	the	DT	O	the	det	35	SENT_248	[p17l561t1258r660b1316],
35	course	NN	O	course	prep_during	29	SENT_248	[p17l691t1276r898b1316],
36	of	IN	O	of	_	0	SENT_248	[p17l930t1257r1004b1316],
37	the	DT	O	the	det	41	SENT_248	[p17l1021t1258r1119b1316],
38	study	NN	O	study	nn	41	SENT_248	[p17l1151t1257r1322b1332],
39	(	CD	NUMBER	(	num	41	SENT_248	[p17l1352t1257r1544b1325],
40	Table	NNP	O	Table	nn	41	SENT_248	[p17l1352t1257r1544b1325],
41	S4	NN	O	s4	prep_of	35	SENT_248	[p17l1576t1262r1649b1316],
42	in	IN	O	in	_	0	SENT_248	[p17l1679t1258r1741b1315],
43	the	DT	O	the	det	46	SENT_248	[p17l1771t1258r1870b1316],
44	Supplementary	NNP	O	Supplementary	nn	46	SENT_248	[p17l1903t1258r2137b1332, p17l561t1365r829b1427],
45	Appendix	NNP	O	Appendix	nn	46	SENT_248	[p17l851t1353r1197b1427],
46	)	NN	O	)	prep_in	41	SENT_248	[p17l851t1353r1197b1427],
47	.	.	O	.	_	0	SENT_248	[p17l851t1353r1197b1427],

1	The	DT	O	the	det	4	SENT_249	[p17l1228t1353r1347b1411],
2	most	RBS	O	most	advmod	3	SENT_249	[p17l1376t1365r1537b1411],
3	common	JJ	O	common	amod	4	SENT_249	[p17l1562t1371r1846b1411],
4	cause	NN	O	cause	nsubj	12	SENT_249	[p17l1875t1372r2048b1411],
5	of	IN	O	of	_	0	SENT_249	[p17l2078t1352r2152b1411],
6	death	NN	O	death	prep_of	4	SENT_249	[p17l561t1448r738b1506],
7	in	IN	O	in	_	0	SENT_249	[p17l774t1448r836b1505],
8	both	DT	O	both	det	9	SENT_249	[p17l873t1448r1020b1506],
9	groups	NNS	O	group	prep_in	6	SENT_249	[p17l1056t1466r1276b1522],
10	was	VBD	O	be	cop	12	SENT_249	[p17l1311t1467r1431b1507],
11	disease	NN	O	disease	nn	12	SENT_249	[p17l1470t1447r1701b1506],
12	progression	NN	O	progression	_	0	SENT_249	[p17l1737t1448r2134b1522],
13	,	,	O	,	_	0	SENT_249	[p17l1737t1448r2134b1522],
14	which	WDT	O	which	nsubjpass	16	SENT_249	[p17l557t1542r753b1601],
15	was	VBD	O	be	auxpass	16	SENT_249	[p17l782t1562r903b1601],
16	reported	VBN	O	report	rcmod	12	SENT_249	[p17l937t1542r1209b1617],
17	in	IN	O	in	_	0	SENT_249	[p17l1241t1543r1303b1600],
18	14	CD	NUMBER	14	num	19	SENT_249	[p17l1338t1547r1407b1601],
19	patients	NNS	O	patient	prep_in	16	SENT_249	[p17l1439t1543r1692b1617],
20	in	IN	O	in	_	0	SENT_249	[p17l1726t1543r1788b1600],
21	the	DT	O	the	det	23	SENT_249	[p17l1821t1543r1919b1601],
22	crizotinib	JJ	O	crizotinib	amod	23	SENT_249	[p17l1953t1543r2137b1601, p17l561t1638r711b1696],
23	group	NN	O	group	prep_in	19	SENT_249	[p17l750t1656r937b1712],
24	and	CC	O	and	_	0	SENT_249	[p17l976t1637r1093b1696],
25	3	CD	NUMBER	3	prep_in	16	SENT_249	[p17l1131t1642r1164b1696],
26	in	IN	O	in	_	0	SENT_249	[p17l1204t1638r1266b1695],
27	the	DT	O	the	det	29	SENT_249	[p17l1304t1637r1403b1696],
28	chemotherapy	NN	O	chemotherapy	nn	29	SENT_249	[p17l1442t1638r1895b1712],
29	group	NN	O	group	prep_in	25	SENT_249	[p17l1930t1656r2134b1712],
30	.	.	O	.	_	0	SENT_249	[p17l1930t1656r2134b1712],

1	Treatment-related	JJ	O	treatment-related	amod	2	SENT_250	[p17l558t1733r1129b1791],
2	deaths	NNS	O	death	nsubj	3	SENT_250	[p17l1163t1733r1370b1791],
3	occurred	VBD	O	occur	conj_and	3	SENT_250	[p17l1405t1733r1687b1791],
4	in	IN	O	in	_	0	SENT_250	[p17l1719t1733r1781b1790],
5	3	CD	NUMBER	3	num	6	SENT_250	[p17l1815t1737r1848b1791],
6	patients	NNS	O	patient	prep_in	3	SENT_250	[p17l1882t1733r2136b1807],
7	in	IN	O	in	_	0	SENT_250	[p17l560t1828r622b1885],
8	the	DT	O	the	det	11	SENT_250	[p17l660t1827r759b1886],
9	crizotinib	JJ	O	crizotinib	amod	11	SENT_250	[p17l797t1828r1109b1886],
10	group	NN	O	group	nn	11	SENT_250	[p17l1147t1846r1335b1902],
11	(	NN	O	(	prep_in	6	SENT_250	[p17l1377t1828r1539b1895],
12	with	IN	O	with	_	0	SENT_250	[p17l1377t1828r1539b1895],
13	the	DT	O	the	det	14	SENT_250	[p17l1577t1828r1675b1886],
14	death	NN	O	death	prep_with	3	SENT_250	[p17l1714t1828r1890b1886],
15	due	JJ	O	due	amod	14	SENT_250	[p17l1928t1828r2038b1886],
16	to	TO	O	to	_	0	SENT_250	[p17l2077t1839r2137b1886],
17	ventricular	JJ	O	ventricular	amod	18	SENT_250	[p17l557t1923r907b1981],
18	arrhythmia	NN	O	arrhythmium	prep_to	15	SENT_250	[p17l933t1923r1296b1997],
19	in	IN	O	in	_	0	SENT_250	[p17l1324t1923r1386b1980],
20	1	CD	NUMBER	1	num	21	SENT_250	[p17l1418t1927r1451b1980],
21	patient	NN	O	patient	prep_in	18	SENT_250	[p17l1479t1923r1704b1997],
22	and	CC	O	and	_	0	SENT_250	[p17l1728t1923r1846b1981],
23	to	TO	O	to	_	0	SENT_250	[p17l1875t1935r1936b1981],
24	interstitial	JJ	O	interstitial	amod	26	SENT_250	[p17l1965t1923r2137b1981, p17l562t2018r738b2076],
25	lung	NN	O	lung	nn	26	SENT_250	[p17l764t2018r905b2092],
26	disease	NN	O	disease	prep_to	3	SENT_250	[p17l931t2018r1156b2076],
27	or	CC	O	or	_	0	SENT_250	[p17l1184t2036r1249b2076],
28	pneumonitis	NN	O	pneumonitis	conj_or	26	SENT_250	[p17l1273t2018r1671b2092],
29	in	IN	O	in	_	0	SENT_250	[p17l1699t2018r1760b2075],
30	2	CD	NUMBER	2	num	31	SENT_250	[p17l1788t2022r1823b2075],
31	patients	NNS	O	patient	prep_in	26	SENT_250	[p17l1849t2018r2134b2092],
32	)	RB	O	)	advmod	26	SENT_250	[p17l1849t2018r2134b2092],
33	,	,	O	,	_	0	SENT_250	[p17l1849t2018r2134b2092],
34	and	CC	O	and	_	0	SENT_250	[p17l560t2112r678b2171],
35	in	IN	O	in	_	0	SENT_250	[p17l726t2113r788b2170],
36	1	CD	NUMBER	1	num	37	SENT_250	[p17l840t2117r873b2170],
37	patient	NN	O	patient	prep_in	26	SENT_250	[p17l921t2113r1145b2187],
38	in	IN	O	in	_	0	SENT_250	[p17l1190t2113r1252b2170],
39	the	DT	O	the	det	41	SENT_250	[p17l1302t2113r1400b2171],
40	chemotherapy	NN	O	chemotherapy	nn	41	SENT_250	[p17l1450t2113r1904b2187],
41	group	NN	O	group	prep_in	37	SENT_250	[p17l1949t2131r2137b2187],
42	(	CD	NUMBER	(	dep	3	SENT_250	[p17l564t2207r726b2275],
43	with	IN	O	with	_	0	SENT_250	[p17l564t2207r726b2275],
44	the	DT	O	the	det	45	SENT_250	[p17l751t2208r849b2266],
45	death	NN	O	death	prep_with	3	SENT_250	[p17l874t2207r1051b2266],
46	due	JJ	O	due	_	0	SENT_250	[p17l1076t2208r1186b2266],
47	to	TO	O	to	_	0	SENT_250	[p17l1212t2220r1272b2266],
48	sepsis	NN	O	sepsis	nn	49	SENT_250	[p17l1299t2208r1524b2282],
49	)	NN	O	)	prep_due_to	45	SENT_250	[p17l1299t2208r1524b2282],
50	.	.	O	.	_	0	SENT_250	[p17l1299t2208r1524b2282],

1	In	IN	O	in	_	0	SENT_251	[p17l1552t2213r1618b2265],
2	addition	NN	O	addition	prep_in	18	SENT_251	[p17l1642t2208r1924b2279],
3	,	,	O	,	_	0	SENT_251	[p17l1642t2208r1924b2279],
4	in	IN	O	in	_	0	SENT_251	[p17l1952t2208r2014b2265],
5	the	DT	O	the	det	7	SENT_251	[p17l2039t2208r2138b2266],
6	crizotinib	JJ	O	crizotinib	amod	7	SENT_251	[p17l561t2303r873b2361],
7	group	NN	O	group	prep_in	18	SENT_251	[p17l921t2321r1125b2377],
8	,	,	O	,	_	0	SENT_251	[p17l921t2321r1125b2377],
9	hepatic	JJ	O	hepatic	amod	10	SENT_251	[p17l1175t2303r1406b2377],
10	dysfunction	NN	O	dysfunction	nsubj	18	SENT_251	[p17l1453t2302r1830b2377],
11	meeting	VBG	O	meet	partmod	10	SENT_251	[p17l1877t2303r2141b2377],
12	the	DT	O	the	det	13	SENT_251	[p17l561t2398r660b2456],
13	criteria	NNS	O	criterion	dobj	11	SENT_251	[p17l691t2398r917b2456],
14	for	IN	O	for	_	0	SENT_251	[p17l946t2397r1038b2456],
15	Hy	NN	PERSON	hy	poss	17	SENT_251	[p17l1066t2402r1200b2472],
16	’s	POS	O	’s	_	0	SENT_251	[p17l1066t2402r1200b2472],
17	law	NN	O	law	prep_for	13	SENT_251	[p17l1232t2398r1343b2457],
18	(	VBD	O	(	_	0	SENT_251	[p17l1375t2402r1426b2465],
19	a	DT	O	a	det	22	SENT_251	[p17l1375t2402r1426b2465],
20	serum	NN	O	serum	nn	22	SENT_251	[p17l1457t2417r1656b2456],
21	bilirubin	NN	O	bilirubin	nn	22	SENT_251	[p17l1687t2397r1967b2456],
22	level	NN	O	level	dobj	18	SENT_251	[p17l1997t2397r2138b2456],
23	23	CD	NUMBER	23	num	24	SENT_251	[p17l560t2497r638b2551],
24	times	NNS	O	time	tmod	18	SENT_251	[p17l669t2493r844b2551],
25	the	DT	O	the	det	27	SENT_251	[p17l874t2493r973b2551],
26	upper	JJ	O	upper	amod	27	SENT_251	[p17l1002t2512r1185b2567],
27	limit	NN	O	limit	dep	18	SENT_251	[p17l1211t2493r1366b2551],
28	of	IN	O	of	_	0	SENT_251	[p17l1392t2492r1466b2551],
29	the	DT	O	the	det	31	SENT_251	[p17l1481t2493r1579b2551],
30	normal	JJ	O	normal	amod	31	SENT_251	[p17l1608t2493r1841b2551],
31	range	NN	O	range	prep_of	27	SENT_251	[p17l1869t2511r2048b2567],
32	in	IN	O	in	_	0	SENT_251	[p17l2076t2493r2138b2550],
33	the	DT	O	the	det	34	SENT_251	[p17l561t2588r660b2646],
34	absence	NN	O	absence	prep_in	31	SENT_251	[p17l702t2588r952b2646],
35	of	IN	O	of	_	0	SENT_251	[p17l995t2587r1069b2646],
36	biliary	JJ	O	biliary	amod	37	SENT_251	[p17l1098t2588r1306b2662],
37	obstruction	NN	O	obstruction	prep_of	34	SENT_251	[p17l1345t2588r1715b2646],
38	or	CC	O	or	_	0	SENT_251	[p17l1758t2606r1823b2646],
39	Gilbert	NNP	PERSON	Gilbert	poss	43	SENT_251	[p17l1863t2588r2136b2646],
40	’s	POS	O	’s	_	0	SENT_251	[p17l1863t2588r2136b2646],
41	syndrome	NN	O	syndrome	nn	43	SENT_251	[p17l562t2683r953b2757],
42	)	CD	NUMBER	)	num	43	SENT_251	[p17l562t2683r953b2757],
43	“	NN	O	“	prep_of	27	SENT_251	[p17l562t2683r953b2757],
44	developed	VBN	O	develop	partmod	43	SENT_251	[p17l985t2682r1302b2757],
45	in	IN	O	in	_	0	SENT_251	[p17l1333t2683r1395b2740],
46	1	CD	NUMBER	1	num	47	SENT_251	[p17l1429t2687r1462b2740],
47	patient	NN	O	patient	prep_in	44	SENT_251	[p17l1493t2683r1733b2757],
48	,	,	O	,	_	0	SENT_251	[p17l1493t2683r1733b2757],
49	who	WP	O	who	nsubj	51	SENT_251	[p17l1766t2683r1902b2742],
50	subsequently	RB	O	subsequently	advmod	51	SENT_251	[p17l1936t2683r2137b2741, p17l561t2778r798b2852],
51	died	VBD	O	die	rcmod	47	SENT_251	[p17l842t2777r977b2836],
52	of	IN	O	of	_	0	SENT_251	[p17l1024t2777r1099b2836],
53	hepatic	JJ	O	hepatic	amod	54	SENT_251	[p17l1131t2778r1362b2852],
54	failure	NN	O	failure	prep_of	51	SENT_251	[p17l1409t2777r1615b2836],
55	after	IN	O	after	mark	58	SENT_251	[p17l1662t2777r1812b2836],
56	the	DT	O	the	det	57	SENT_251	[p17l1857t2778r1956b2836],
57	data	NNS	O	datum	nsubj	58	SENT_251	[p17l2003t2777r2139b2836],
58	cutoff	VBP	O	cutoff	advcl	51	SENT_251	[p17l561t2872r763b2931],
59	date	NN	O	date	dobj	58	SENT_251	[p17l779t2872r928b2930],
60	.	.	O	.	_	0	SENT_251	[p17l779t2872r928b2930],

1	Overall	RB	O	overall	advmod	10	SENT_252	[p17l140t3125r470b3221],
2	,	,	O	,	_	0	SENT_252	[p17l140t3125r470b3221],
3	more	JJR	O	more	amod	5	SENT_252	[p17l541t3151r761b3204],
4	adverse	JJ	O	adverse	amod	5	SENT_252	[p17l827t3125r1142b3204],
5	events	NNS	O	event	nsubjpass	10	SENT_252	[p17l1209t3142r1472b3205],
6	of	IN	O	of	_	0	SENT_252	[p17l1541t3124r1641b3204],
7	any	DT	O	any	det	8	SENT_252	[p17l1688t3151r1838b3225],
8	cause	NN	O	cause	prep_of	5	SENT_252	[p17l1900t3151r2134b3205],
9	were	VBD	O	be	auxpass	10	SENT_252	[p17l6t3280r208b3333],
10	reported	VBN	O	report	_	0	SENT_252	[p17l240t3254r606b3354],
11	in	IN	O	in	_	0	SENT_252	[p17l638t3255r721b3332],
12	the	DT	O	the	det	14	SENT_252	[p17l753t3254r886b3332],
13	crizotinib	JJ	O	crizotinib	amod	14	SENT_252	[p17l919t3254r1339b3333],
14	group	NN	O	group	prep_in	10	SENT_252	[p17l1372t3280r1624b3355],
15	than	IN	O	than	prep	10	SENT_252	[p17l1658t3254r1854b3332],
16	in	IN	O	in	pcomp	15	SENT_252	[p17l1886t3255r1969b3332],
17	the	DT	O	the	det	19	SENT_252	[p17l2002t3254r2134b3332],
18	chemotherapy	NN	O	chemotherapy	nn	19	SENT_252	[p17l11t3382r623b3482],
19	group	NN	O	group	pobj	16	SENT_252	[p17l665t3408r940b3483],
20	.	.	O	.	_	0	SENT_252	[p17l665t3408r940b3483],

1	This	DT	O	this	det	2	SENT_253	[p17l990t3382r1178b3460],
2	increase	NN	O	increase	nsubj	9	SENT_253	[p17l1228t3383r1579b3460],
3	in	IN	O	in	_	0	SENT_253	[p17l1627t3383r1710b3460],
4	all-cause	JJ	O	all-cause	amod	6	SENT_253	[p17l1758t3382r2134b3461],
5	adverse	JJ	O	adverse	amod	6	SENT_253	[p17l10t3509r325b3589],
6	events	NNS	O	event	prep_in	2	SENT_253	[p17l389t3526r653b3588],
7	was	VBD	O	be	cop	9	SENT_253	[p17l714t3535r876b3588],
8	still	RB	O	still	advmod	9	SENT_253	[p17l943t3509r1104b3587],
9	apparent	JJ	O	apparent	_	0	SENT_253	[p17l1167t3526r1547b3609],
10	after	IN	O	after	_	0	SENT_253	[p17l1605t3508r1807b3587],
11	events	NNS	O	event	prep_after	9	SENT_253	[p17l1868t3526r2131b3589],
12	that	WDT	O	that	nsubj	13	SENT_253	[p17l11t3637r184b3715],
13	occurred	VBD	O	occur	rcmod	11	SENT_253	[p17l219t3637r598b3717],
14	after	IN	O	after	_	0	SENT_253	[p17l637t3636r840b3715],
15	RECIST-deﬁned	JJ	O	recist-deﬁned	amod	17	SENT_253	[p17l875t3636r1564b3721],
16	disease	NN	O	disease	nn	17	SENT_253	[p17l1605t3637r1915b3716],
17	progression	NN	O	progression	prep_after	13	SENT_253	[p17l1954t3663r2132b3737, p18l11t22r374b122],

1	were	VBD	O	be	auxpass	2	SENT_254	[p18l411t47r613b100],
2	excluded	VBN	O	exclude	_	0	SENT_254	[p18l656t21r1028b100],
3	(	RB	O	(	advmod	2	SENT_254	[p18l1075t21r1333b112],
4	Table	NNP	O	Table	nn	5	SENT_254	[p18l1075t21r1333b112],
5	S5	NNP	O	S5	nsubjpass	2	SENT_254	[p18l1378t27r1469b100],
6	in	IN	O	in	_	0	SENT_254	[p18l1514t22r1597b99],
7	the	DT	O	the	det	12	SENT_254	[p18l1639t21r1772b99],
8	Supple	NNP	O	Supple	nn	12	SENT_254	[p18l1817t21r2132b121],
9	—	NN	O	—	nn	12	SENT_254	[p18l1817t21r2132b121],
10	mentary	JJ	O	mentary	amod	12	SENT_254	[p18l11t165r371b248],
11	Appendix	NN	O	appendix	nn	12	SENT_254	[p18l406t148r872b248],
12	)	NN	O	)	prep_in	2	SENT_254	[p18l406t148r872b248],
13	.	.	O	.	_	0	SENT_254	[p18l406t148r872b248],

1	The	DT	O	the	det	2	SENT_255	[p18l917t148r1078b226],
2	incidence	NN	O	incidence	nsubj	17	SENT_255	[p18l1121t148r1526b227],
3	of	IN	O	of	_	0	SENT_255	[p18l1570t147r1669b227],
4	treatmentrelated	JJ	O	treatmentrelated	amod	5	SENT_255	[p18l1695t165r2133b226, p18l11t277r296b356],
5	grade	NN	O	grade	prep_of	2	SENT_255	[p18l330t277r564b378],
6	3	CD	NUMBER	3	num	10	SENT_255	[p18l599t283r643b356],
7	or	CC	O	or	_	0	SENT_255	[p18l681t303r769b356],
8	4	CD	NUMBER	4	num	10	SENT_255	[p18l798t283r848b356],
9	adverse	JJ	O	adverse	amod	10	SENT_255	[p18l882t277r1189b356],
10	events	NNS	O	event	nsubj	12	SENT_255	[p18l1225t294r1482b356],
11	was	VBD	O	be	cop	12	SENT_255	[p18l1515t303r1675b356],
12	similar	JJ	O	similar	rcmod	5	SENT_255	[p18l1713t277r2018b355],
13	in	IN	O	in	_	0	SENT_255	[p18l2050t278r2134b355],
14	the	DT	O	the	det	16	SENT_255	[p18l11t405r140b483],
15	two	CD	NUMBER	two	num	16	SENT_255	[p18l170t422r324b484],
16	groups	NNS	O	group	prep_in	12	SENT_255	[p18l354t431r639b506],
17	(	VBP	O	(	_	0	SENT_255	[p18l677t410r881b496],
18	33	CD	PERCENT	33	num	19	SENT_255	[p18l677t410r881b496],
19	%	NN	PERCENT	%	dobj	17	SENT_255	[p18l677t410r881b496],
20	with	IN	O	with	_	0	SENT_255	[p18l906t405r1094b484],
21	crizotinib	NN	O	crizotinib	prep_with	17	SENT_255	[p18l1125t405r1526b484],
22	and	CC	O	and	_	0	SENT_255	[p18l1557t405r1711b484],
23	32	CD	PERCENT	32	num	24	SENT_255	[p18l1741t410r1920b484],
24	%	NN	PERCENT	%	nsubj	38	SENT_255	[p18l1741t410r1920b484],
25	with	IN	O	with	_	0	SENT_255	[p18l1945t405r2134b484],
26	chemotherapy	NN	O	chemotherapy	nn	27	SENT_255	[p18l11t532r641b632],
27	)	NN	O	)	prep_with	24	SENT_255	[p18l11t532r641b632],
28	,	,	O	,	_	0	SENT_255	[p18l11t532r641b632],
29	as	RB	O	as	advmod	32	SENT_255	[p18l678t558r761b610],
30	was	VBD	O	be	cop	32	SENT_255	[p18l792t558r950b612],
31	the	DT	O	the	det	32	SENT_255	[p18l985t532r1113b610],
32	incidence	NN	O	incidence	dep	27	SENT_255	[p18l1145t532r1533b611],
33	of	IN	O	of	_	0	SENT_255	[p18l1566t531r1666b611],
34	treatmentrelated	JJ	O	treatmentrelated	amod	37	SENT_255	[p18l1685t549r2132b610, p18l11t661r303b739],
35	serious	JJ	O	serious	amod	37	SENT_255	[p18l348t662r650b740],
36	adverse	JJ	O	adverse	amod	37	SENT_255	[p18l695t661r1010b740],
37	events	NNS	O	event	prep_of	32	SENT_255	[p18l1055t678r1318b740],
38	(	VBP	O	(	conj_and	17	SENT_255	[p18l1370t666r1584b751],
39	12	CD	PERCENT	12	num	40	SENT_255	[p18l1370t666r1584b751],
40	%	NN	PERCENT	%	dobj	38	SENT_255	[p18l1370t666r1584b751],
41	and	CC	O	and	_	0	SENT_255	[p18l1627t661r1784b739],
42	14	CD	PERCENT	14	num	43	SENT_255	[p18l1832t666r2007b740],
43	%	NN	PERCENT	%	dobj	38	SENT_255	[p18l1832t666r2007b740],
44	in	IN	O	in	_	0	SENT_255	[p18l2051t662r2134b738],
45	the	DT	O	the	det	47	SENT_255	[p18l11t789r144b867],
46	two	CD	NUMBER	two	num	47	SENT_255	[p18l191t806r348b868],
47	groups	NNS	O	group	prep_in	43	SENT_255	[p18l397t815r716b890],
48	,	,	O	,	_	0	SENT_255	[p18l397t815r716b890],
49	respectively	RB	O	respectively	advmod	50	SENT_255	[p18l768t789r1317b889],
50	)	CD	NUMBER	)	rcmod	43	SENT_255	[p18l768t789r1317b889],
51	.	.	O	.	_	0	SENT_255	[p18l768t789r1317b889],

1	Treatment	NN	O	treatment	nn	5	SENT_256	[p18l1365t789r2134b868],
2	—	NN	O	—	nn	5	SENT_256	[p18l1365t789r2134b868],
3	related	JJ	O	related	amod	5	SENT_256	[p18l1365t789r2134b868],
4	adverse	JJ	O	adverse	amod	5	SENT_256	[p18l10t917r325b996],
5	events	NNS	O	event	nsubj	14	SENT_256	[p18l368t934r627b996],
6	leading	VBG	O	lead	partmod	5	SENT_256	[p18l669t917r982b1018],
7	to	TO	O	to	_	0	SENT_256	[p18l1020t934r1100b996],
8	permanent	JJ	O	permanent	amod	9	SENT_256	[p18l1141t934r1607b1017],
9	discontinuation	NN	O	discontinuation	prep_to	6	SENT_256	[p18l1644t917r2132b996, p18l10t1046r227b1124],
10	of	IN	O	of	_	0	SENT_256	[p18l267t1044r367b1124],
11	the	DT	O	the	det	13	SENT_256	[p18l388t1045r520b1123],
12	study	NN	O	study	nn	13	SENT_256	[p18l561t1045r791b1145],
13	drug	NN	O	drug	prep_of	9	SENT_256	[p18l825t1045r1029b1146],
14	occurred	VBD	O	occur	_	0	SENT_256	[p18l1066t1045r1445b1124],
15	in	IN	O	in	_	0	SENT_256	[p18l1482t1046r1565b1123],
16	6	CD	PERCENT	6	number	20	SENT_256	[p18l1605t1050r1734b1124],
17	%	NN	PERCENT	%	dep	20	SENT_256	[p18l1605t1050r1734b1124],
18	and	CC	O	and	_	0	SENT_256	[p18l1767t1045r1921b1124],
19	10	CD	PERCENT	10	prep_in	14	SENT_256	[p18l1958t1051r2135b1124],
20	%	NN	PERCENT	%	prep_in	14	SENT_256	[p18l1958t1051r2135b1124],
21	of	IN	O	of	_	0	SENT_256	[p18l11t1172r109b1252],
22	patients	NNS	O	patient	prep_of	20	SENT_256	[p18l125t1174r451b1273],
23	in	IN	O	in	_	0	SENT_256	[p18l488t1174r569b1251],
24	the	DT	O	the	det	26	SENT_256	[p18l605t1173r733b1251],
25	two	CD	NUMBER	two	num	26	SENT_256	[p18l769t1190r922b1252],
26	groups	NNS	O	group	prep_in	22	SENT_256	[p18l958t1199r1265b1274],
27	,	,	O	,	_	0	SENT_256	[p18l958t1199r1265b1274],
28	respectively	RB	O	respectively	advmod	14	SENT_256	[p18l1306t1173r1795b1273],
29	.	.	O	.	_	0	SENT_256	[p18l1306t1173r1795b1273],

1	PATIENT-REPORTED	JJ	O	patient-reported	amod	2	SENT_257	[p18l16t1448r787b1498],
2	OUTCOMES	NNS	O	outcome	_	0	SENT_257	[p18l822t1448r1271b1498],
3	Baseline	NN	O	baseline	nn	4	SENT_257	[p18l10t1547r370b1625],
4	scores	NNS	O	score	dep	2	SENT_257	[p18l412t1573r676b1626],
5	on	IN	O	on	_	0	SENT_257	[p18l720t1573r826b1626],
6	the	DT	O	the	det	7	SENT_257	[p18l868t1547r1001b1625],
7	QLQ-C30	NN	O	qlq-c30	prep_on	4	SENT_257	[p18l1042t1553r1442b1645],
8	and	CC	O	and	_	0	SENT_257	[p18l1484t1547r1642b1626],
9	QLQ	NN	O	qlq	prep_on	4	SENT_257	[p18l1683t1553r2130b1645],
10	.	.	O	.	_	0	SENT_257	[p18l1683t1553r2130b1645],

1	—	NN	O	—	_	0	SENT_258	[p18l1683t1553r2130b1645],
2	.	.	O	.	_	0	SENT_258	[p18l1683t1553r2130b1645],

1	LC13	NN	O	lc13	nsubjpass	3	SENT_259	[p18l1683t1553r2130b1645],
2	are	VBP	O	be	auxpass	3	SENT_259	[p18l10t1701r139b1753],
3	summarized	VBN	O	summarize	_	0	SENT_259	[p18l186t1675r729b1754],
4	in	IN	O	in	_	0	SENT_259	[p18l774t1676r857b1752],
5	Table	NNP	O	Table	nn	6	SENT_259	[p18l899t1675r1129b1753],
6	S6	NN	O	s6	prep_in	3	SENT_259	[p18l1177t1681r1273b1753],
7	in	IN	O	in	_	0	SENT_259	[p18l1319t1676r1402b1752],
8	the	DT	O	the	det	10	SENT_259	[p18l1448t1675r1581b1753],
9	Supplementary	NNP	O	Supplementary	nn	10	SENT_259	[p18l1629t1675r2133b1774, p18l11t1820r182b1903],
10	Appendix	NNP	O	Appendix	prep_in	3	SENT_259	[p18l212t1803r650b1903],
11	.	.	O	.	_	0	SENT_259	[p18l212t1803r650b1903],

1	There	EX	O	there	expl	2	SENT_260	[p18l691t1803r935b1881],
2	was	VBD	O	be	_	0	SENT_260	[p18l970t1829r1132b1882],
3	a	DT	O	a	det	7	SENT_260	[p18l1172t1829r1216b1881],
4	significantly	RB	O	significantly	advmod	5	SENT_260	[p18l1255t1802r1798b1904],
5	greater	JJR	O	greater	amod	7	SENT_260	[p18l1832t1820r2137b1904],
6	overall	JJ	O	overall	amod	7	SENT_260	[p18l11t1930r297b2010],
7	reduction	NN	O	reduction	nsubj	2	SENT_260	[p18l330t1930r739b2009],
8	from	IN	O	from	_	0	SENT_260	[p18l773t1929r983b2009],
9	baseline	NN	O	baseline	prep_from	7	SENT_260	[p18l1018t1930r1370b2009],
10	in	IN	O	in	_	0	SENT_260	[p18l1403t1931r1486b2008],
11	the	DT	O	the	det	12	SENT_260	[p18l1521t1930r1654b2008],
12	symptoms	NNS	O	symptom	prep_in	9	SENT_260	[p18l1689t1947r2131b2030],
13	of	IN	O	of	_	0	SENT_260	[p18l11t2058r112b2138],
14	alopecia	NN	O	alopecia	nn	23	SENT_260	[p18l131t2059r508b2159],
15	,	,	O	,	_	0	SENT_260	[p18l131t2059r508b2159],
16	cough	NN	O	cough	dep	23	SENT_260	[p18l553t2059r837b2160],
17	,	,	O	,	_	0	SENT_260	[p18l553t2059r837b2160],
18	dyspnea	NN	O	dyspnea	dep	23	SENT_260	[p18l882t2059r1251b2159],
19	,	,	O	,	_	0	SENT_260	[p18l882t2059r1251b2159],
20	fatigue	NN	O	fatigue	dep	23	SENT_260	[p18l1295t2058r1615b2160],
21	,	,	O	,	_	0	SENT_260	[p18l1295t2058r1615b2160],
22	chest	NN	O	chest	dep	23	SENT_260	[p18l1660t2059r1883b2137],
23	pain	NN	O	pain	prep_of	12	SENT_260	[p18l1915t2060r2129b2159],
24	,	,	O	,	_	0	SENT_260	[p18l1915t2060r2129b2159],
25	arm	NN	O	arm	conj_and	7	SENT_260	[p18l10t2212r183b2264],
26	or	CC	O	or	_	0	SENT_260	[p18l219t2212r308b2265],
27	shoulder	NN	O	shoulder	nn	28	SENT_260	[p18l341t2186r715b2266],
28	pain	NN	O	pain	conj_or	25	SENT_260	[p18l746t2187r960b2286],
29	,	,	O	,	_	0	SENT_260	[p18l746t2187r960b2286],
30	and	CC	O	and	_	0	SENT_260	[p18l1000t2186r1158b2265],
31	pain	NN	O	pain	conj_and	7	SENT_260	[p18l1192t2187r1383b2286],
32	in	IN	O	in	_	0	SENT_260	[p18l1417t2187r1500b2264],
33	other	JJ	O	other	amod	34	SENT_260	[p18l1537t2186r1765b2265],
34	parts	NNS	O	part	prep_in	31	SENT_260	[p18l1795t2203r2014b2286],
35	of	IN	O	of	_	0	SENT_260	[p18l2053t2185r2153b2265],
36	the	DT	O	the	det	37	SENT_260	[p18l11t2315r144b2393],
37	body	NN	O	body	prep_of	34	SENT_260	[p18l175t2315r384b2414],
38	with	IN	O	with	_	0	SENT_260	[p18l404t2315r599b2394],
39	crizotinib	NN	O	crizotinib	prep_with	37	SENT_260	[p18l629t2315r1050b2393],
40	than	IN	O	than	dep	2	SENT_260	[p18l1081t2315r1277b2392],
41	with	IN	O	with	_	0	SENT_260	[p18l1303t2315r1498b2394],
42	chemotherapy	NN	O	chemotherapy	prep_with	2	SENT_260	[p18l1527t2315r2139b2414],
43	(	CD	NUMBER	(	num	44	SENT_260	[p18l16t2448r376b2533],
44	P	NN	O	p	npadvmod	45	SENT_260	[p18l16t2448r376b2533],
45	<	JJR	O	<	amod	42	SENT_260	[p18l16t2448r376b2533],
46	0.001	CD	NUMBER	0.001	dep	45	SENT_260	[p18l16t2448r376b2533],
47	for	IN	O	for	dep	46	SENT_260	[p18l412t2441r533b2521],
48	all	DT	O	all	det	49	SENT_260	[p18l566t2442r668b2520],
49	comparisons	NNS	O	comparison	pobj	47	SENT_260	[p18l704t2443r1268b2542],
50	,	,	O	,	_	0	SENT_260	[p18l704t2443r1268b2542],
51	without	IN	O	without	_	0	SENT_260	[p18l1304t2442r1637b2522],
52	adjustment	NN	O	adjustment	prep_without	2	SENT_260	[p18l1667t2442r2139b2542],
53	for	IN	O	for	_	0	SENT_260	[p18l11t2570r134b2650],
54	multiple	JJ	O	multiple	amod	58	SENT_260	[p18l184t2571r539b2671],
55	testing	NN	O	testing	nn	58	SENT_260	[p18l593t2572r917b2672],
56	)	NN	O	)	nn	58	SENT_260	[p18l593t2572r917b2672],
57	(	CD	NUMBER	(	num	58	SENT_260	[p18l980t2572r1160b2672],
58	Fig	NN	O	fig	prep_for	52	SENT_260	[p18l980t2572r1160b2672],
59	.	.	O	.	_	0	SENT_260	[p18l980t2572r1160b2672],

1	2A	NN	O	2a	_	0	SENT_261	[p18l1218t2577r1384b2662],
2	)	NN	O	)	dep	1	SENT_261	[p18l1218t2577r1384b2662],
3	.	.	O	.	_	0	SENT_261	[p18l1218t2577r1384b2662],

1	Patients	NNS	O	patient	nsubj	6	SENT_262	[p18l1441t2572r1780b2649],
2	treated	VBN	O	treat	partmod	1	SENT_262	[p18l1835t2571r2134b2650],
3	with	IN	O	with	_	0	SENT_262	[p18l6t2699r202b2778],
4	crizotinib	NN	O	crizotinib	prep_with	2	SENT_262	[p18l252t2699r672b2778],
5	also	RB	O	also	advmod	6	SENT_262	[p18l722t2699r894b2778],
6	had	VBD	O	have	_	0	SENT_262	[p18l945t2699r1101b2778],
7	a	DT	O	a	det	10	SENT_262	[p18l1150t2725r1194b2777],
8	significantly	RB	O	significantly	advmod	9	SENT_262	[p18l1244t2698r1787b2800],
9	greater	JJR	O	greater	amod	10	SENT_262	[p18l1832t2716r2137b2800],
10	delay	NN	O	delay	dobj	6	SENT_262	[p18l11t2827r232b2927],
11	in	IN	O	in	_	0	SENT_262	[p18l256t2828r339b2905],
12	the	DT	O	the	det	13	SENT_262	[p18l369t2827r502b2905],
13	Worsening	NNP	O	Worsening	prep_in	10	SENT_262	[p18l526t2828r984b2928],
14	of	IN	O	of	_	0	SENT_262	[p18l1011t2826r1111b2906],
15	symptoms	NNS	O	symptom	prep_of	13	SENT_262	[p18l1122t2844r1589b2927],
16	.	.	O	.	_	0	SENT_262	[p18l1122t2844r1589b2927],

1	The	DT	O	the	det	3	SENT_263	[p18l1621t2827r1782b2905],
2	median	JJ	O	median	amod	3	SENT_263	[p18l1811t2827r2134b2906],
3	time	NN	O	time	nsubj	27	SENT_263	[p18l11t2956r205b3033],
4	to	TO	O	to	_	0	SENT_263	[p18l237t2972r318b3033],
5	deterioration	NN	O	deterioration	prep_to	3	SENT_263	[p18l353t2955r910b3033],
6	with	IN	O	with	_	0	SENT_263	[p18l939t2955r1134b3034],
7	respect	NN	O	respect	prep_with	5	SENT_263	[p18l1166t2972r1474b3054],
8	to	TO	O	to	_	0	SENT_263	[p18l1502t2971r1583b3033],
9	a	DT	O	a	det	12	SENT_263	[p18l1616t2981r1661b3032],
10	composite	JJ	O	composite	amod	12	SENT_263	[p18l1692t2956r2134b3054],
11	end	NN	O	end	nn	12	SENT_263	[p18l11t3083r165b3162],
12	point	NN	O	point	prep_to	3	SENT_263	[p18l196t3084r426b3183],
13	of	IN	O	of	_	0	SENT_263	[p18l455t3082r555b3162],
14	three	CD	NUMBER	three	num	15	SENT_263	[p18l570t3083r789b3161],
15	symptoms	NNS	O	symptom	npadvmod	16	SENT_263	[p18l825t3100r1267b3183],
16	—	JJ	O	—	amod	17	SENT_263	[p18l1299t3128r1406b3136],
17	cough	NN	O	cough	prep_of	12	SENT_263	[p18l1436t3083r1721b3184],
18	,	,	O	,	_	0	SENT_263	[p18l1436t3083r1721b3184],
19	dyspnea	NN	O	dyspnea	conj_or	17	SENT_263	[p18l1760t3083r2129b3183],
20	,	,	O	,	_	0	SENT_263	[p18l1760t3083r2129b3183],
21	or	CC	O	or	_	0	SENT_263	[p18l11t3237r100b3289],
22	chest	NN	O	chest	nn	24	SENT_263	[p18l132t3211r356b3289],
23	pain	NN	O	pain	nn	24	SENT_263	[p18l383t3212r574b3310],
24	—	NN	O	—	conj_or	17	SENT_263	[p18l604t3256r712b3264],
25	was	VBD	O	be	cop	27	SENT_263	[p18l737t3237r900b3290],
26	5.6	CD	DURATION	5.6	num	27	SENT_263	[p18l939t3217r1061b3289],
27	months	NNS	NUMBER	month	_	0	SENT_263	[p18l1096t3211r1423b3289],
28	with	IN	O	with	_	0	SENT_263	[p18l1455t3211r1650b3290],
29	crizotinib	NN	O	crizotinib	prep_with	27	SENT_263	[p18l1686t3211r2128b3306],
30	,	,	O	,	_	0	SENT_263	[p18l1686t3211r2128b3306],
31	as	IN	O	as	_	0	SENT_263	[p18l10t3365r95b3416],
32	compared	VBN	O	compare	prepc_as	27	SENT_263	[p18l137t3339r564b3438],
33	with	IN	O	with	pcomp	32	SENT_263	[p18l598t3339r793b3418],
34	1.4	CD	DURATION	1.4	num	35	SENT_263	[p18l834t3345r957b3417],
35	months	NNS	NUMBER	month	pobj	33	SENT_263	[p18l995t3339r1322b3417],
36	with	IN	O	with	_	0	SENT_263	[p18l1359t3339r1554b3418],
37	chemotherapy	NN	O	chemotherapy	nn	40	SENT_263	[p18l1593t3339r2133b3417, p18l10t3493r109b3566],
38	(	NN	O	(	nn	40	SENT_263	[p18l159t3467r485b3557],
39	hazard	NN	O	hazard	nn	40	SENT_263	[p18l159t3467r485b3557],
40	ratio	NN	O	ratio	prep_with	35	SENT_263	[p18l535t3468r732b3545],
41	With	IN	O	with	_	0	SENT_263	[p18l779t3467r974b3546],
42	crizotinib	NN	O	crizotinib	prep_with	40	SENT_263	[p18l1025t3467r1468b3562],
43	,	,	O	,	_	0	SENT_263	[p18l1025t3467r1468b3562],
44	0.54	CD	NUMBER	0.54	appos	42	SENT_263	[p18l1524t3473r1726b3562],
45	;	:	O	;	_	0	SENT_263	[p18l1524t3473r1726b3562],
46	95	CD	PERCENT	95	number	47	SENT_263	[p18l1780t3472r1964b3546],
47	%	NN	PERCENT	%	amod	48	SENT_263	[p18l1780t3472r1964b3546],
48	CI	NN	O	ci	dep	42	SENT_263	[p18l2013t3473r2129b3562],
49	,	,	O	,	_	0	SENT_263	[p18l2013t3473r2129b3562],
50	0.40	CD	NUMBER	0.40	num	52	SENT_263	[p18l11t3601r189b3673],
51	to	TO	O	to	dep	52	SENT_263	[p18l225t3611r306b3673],
52	0.71	CD	NUMBER	0.71	appos	48	SENT_263	[p18l343t3601r541b3690],
53	;	:	O	;	_	0	SENT_263	[p18l343t3601r541b3690],
54	P	NN	O	p	dep	42	SENT_263	[p18l579t3601r943b3685],
55	<	JJR	O	<	dep	54	SENT_263	[p18l579t3601r943b3685],
56	0.001	CD	NUMBER	0.001	num	57	SENT_263	[p18l579t3601r943b3685],
57	)	NN	O	)	dep	42	SENT_263	[p18l579t3601r943b3685],
58	(	CD	NUMBER	(	num	59	SENT_263	[p18l988t3596r1167b3695],
59	Fig	NN	O	fig	dep	57	SENT_263	[p18l988t3596r1167b3695],
60	.	.	O	.	_	0	SENT_263	[p18l988t3596r1167b3695],

1	2B	NN	O	2b	_	0	SENT_264	[p18l1207t3601r1367b3685],
2	)	NN	O	)	dep	1	SENT_264	[p18l1207t3601r1367b3685],
3	.	.	O	.	_	0	SENT_264	[p18l1207t3601r1367b3685],

1	There	EX	O	there	expl	2	SENT_265	[p19l136t21r381b99],
2	was	VBD	O	be	_	0	SENT_265	[p19l419t47r581b100],
3	also	RB	O	also	advmod	2	SENT_265	[p19l624t21r796b100],
4	a	DT	O	a	det	8	SENT_265	[p19l838t47r882b99],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_265	[p19l924t20r1467b122],
6	greater	JJR	O	greater	amod	8	SENT_265	[p19l1504t38r1809b122],
7	overall	JJ	O	overall	amod	8	SENT_265	[p19l1848t21r2134b100],
8	improvement	NN	O	improvement	nsubj	2	SENT_265	[p19l10t150r584b249],
9	from	IN	O	from	_	0	SENT_265	[p19l624t148r833b228],
10	baseline	NN	O	baseline	prep_from	8	SENT_265	[p19l879t149r1231b228],
11	in	IN	O	in	_	0	SENT_265	[p19l1274t150r1358b227],
12	global	JJ	O	global	amod	13	SENT_265	[p19l1402t149r1669b250],
13	quality	NN	O	quality	prep_in	10	SENT_265	[p19l1714t149r2012b249],
14	of	IN	O	of	_	0	SENT_265	[p19l2052t148r2152b228],
15	life	NN	O	life	prep_of	13	SENT_265	[p19l10t276r143b355],
16	among	IN	O	among	_	0	SENT_265	[p19l179t303r474b378],
17	patients	NNS	O	patient	prep_among	8	SENT_265	[p19l505t278r840b377],
18	who	WP	O	who	nsubj	19	SENT_265	[p19l873t277r1054b356],
19	received	VBD	O	receive	rcmod	17	SENT_265	[p19l1092t277r1430b356],
20	crizotinib	NN	O	crizotinib	nn	21	SENT_265	[p19l1467t277r1877b356],
21	treatment	NN	O	treatment	dobj	19	SENT_265	[p19l1915t294r2133b355, p19l11t422r228b483],
22	than	IN	O	than	dep	19	SENT_265	[p19l279t405r474b483],
23	among	IN	O	among	_	0	SENT_265	[p19l531t431r831b506],
24	those	DT	O	those	prep_among	19	SENT_265	[p19l885t405r1116b484],
25	who	WP	O	who	dep	26	SENT_265	[p19l1170t405r1352b484],
26	received	VBD	O	receive	rcmod	24	SENT_265	[p19l1411t405r1757b484],
27	chemotherapy	NN	O	chemotherapy	nsubj	30	SENT_265	[p19l1814t405r2132b484, p19l11t533r333b633],
28	(	CD	NUMBER	(	num	29	SENT_265	[p19l374t539r767b624],
29	P	NN	O	p	npadvmod	30	SENT_265	[p19l374t539r767b624],
30	<	JJR	O	<	xcomp	26	SENT_265	[p19l374t539r767b624],
31	0.001	CD	NUMBER	0.001	num	34	SENT_265	[p19l374t539r767b624],
32	)	NN	O	)	nn	34	SENT_265	[p19l374t539r767b624],
33	(	CD	NUMBER	(	num	34	SENT_265	[p19l818t534r997b634],
34	Fig	NN	O	fig	nsubj	26	SENT_265	[p19l818t534r997b634],
35	.	.	O	.	_	0	SENT_265	[p19l818t534r997b634],

1	2A	NN	O	2a	_	0	SENT_266	[p19l1044t539r1210b624],
2	)	NN	O	)	dep	1	SENT_266	[p19l1044t539r1210b624],
3	.	.	O	.	_	0	SENT_266	[p19l1044t539r1210b624],

1	In	IN	O	in	_	0	SENT_267	[p19l1255t541r1344b611],
2	particular	JJ	O	particular	prep_in	28	SENT_267	[p19l1384t533r1831b633],
3	,	,	O	,	_	0	SENT_267	[p19l1384t533r1831b633],
4	in	IN	O	in	_	0	SENT_267	[p19l1877t534r1960b611],
5	the	DT	O	the	det	7	SENT_267	[p19l2001t533r2134b611],
6	crizotinib	JJ	O	crizotinib	amod	7	SENT_267	[p19l11t661r432b740],
7	group	NN	O	group	prep_in	28	SENT_267	[p19l491t687r744b762],
8	a	DT	O	a	det	19	SENT_267	[p19l803t687r847b739],
9	statistically	RB	O	statistically	advmod	10	SENT_267	[p19l906t661r1400b761],
10	significant	JJ	O	significant	amod	19	SENT_267	[p19l1455t660r1923b762],
11	and	CC	O	and	_	0	SENT_267	[p19l1976t661r2134b740],
12	clinically	RB	O	clinically	advmod	13	SENT_267	[p19l11t789r402b889],
13	meaningful	JJ	O	meaningful	amod	14	SENT_267	[p19l458t788r964b890],
14	(	NN	O	(	conj_and	10	SENT_267	[p19l1029t790r1500b889],
15	210	CD	NUMBER	210	number	16	SENT_267	[p19l1029t790r1500b889],
16	—	CD	NUMBER	—	dep	17	SENT_267	[p19l1029t790r1500b889],
17	point	NN	O	point	dep	18	SENT_267	[p19l1029t790r1500b889],
18	)	NN	O	)	dep	10	SENT_267	[p19l1029t790r1500b889],
19	improvement	NN	O	improvement	nsubjpass	28	SENT_267	[p19l1565t790r2139b889],
20	from	IN	O	from	_	0	SENT_267	[p19l11t916r215b996],
21	baseline	NN	O	baseline	prep_from	19	SENT_267	[p19l245t917r581b996],
22	in	IN	O	in	_	0	SENT_267	[p19l610t918r691b995],
23	global	JJ	O	global	amod	24	SENT_267	[p19l720t917r976b1018],
24	quality	NN	O	quality	prep_in	21	SENT_267	[p19l1006t917r1291b1017],
25	of	IN	O	of	_	0	SENT_267	[p19l1317t916r1414b996],
26	life	NN	O	life	prep_of	24	SENT_267	[p19l1424t916r1553b995],
27	was	VBD	O	be	auxpass	28	SENT_267	[p19l1578t943r1736b996],
28	observed	VBN	O	observe	_	0	SENT_267	[p19l1768t917r2134b996],
29	in	IN	O	in	_	0	SENT_267	[p19l10t1046r93b1123],
30	cycle	NN	O	cycle	prep_in	28	SENT_267	[p19l126t1045r325b1145],
31	4	CD	NUMBER	4	num	30	SENT_267	[p19l357t1051r427b1141],
32	,	,	O	,	_	0	SENT_267	[p19l357t1051r427b1141],
33	and	CC	O	and	_	0	SENT_267	[p19l465t1045r621b1124],
34	a	DT	O	a	det	37	SENT_267	[p19l653t1071r698b1123],
35	statistically	RB	O	statistically	advmod	36	SENT_267	[p19l731t1045r1211b1145],
36	significant	JJ	O	significant	amod	37	SENT_267	[p19l1241t1044r1699b1146],
37	(	NN	O	(	conj_and	30	SENT_267	[p19l1731t1045r2134b1146],
38	although	IN	O	although	mark	53	SENT_267	[p19l1731t1045r2134b1146],
39	<	JJR	O	<	nsubjpass	53	SENT_267	[p19l13t1174r454b1273],
40	10	CD	NUMBER	10	num	42	SENT_267	[p19l13t1174r454b1273],
41	—	NN	O	—	nn	42	SENT_267	[p19l13t1174r454b1273],
42	point	NN	O	point	dep	39	SENT_267	[p19l13t1174r454b1273],
43	)	CD	NUMBER	)	num	44	SENT_267	[p19l13t1174r454b1273],
44	improvement	NN	O	improvement	dep	39	SENT_267	[p19l497t1174r1072b1273],
45	from	IN	O	from	_	0	SENT_267	[p19l1105t1172r1316b1252],
46	baseline	NN	O	baseline	prep_from	44	SENT_267	[p19l1355t1173r1707b1252],
47	in	IN	O	in	_	0	SENT_267	[p19l1745t1174r1829b1251],
48	global	JJ	O	global	amod	49	SENT_267	[p19l1868t1173r2135b1274],
49	quality	NN	O	quality	prep_in	46	SENT_267	[p19l11t1301r310b1401],
50	of	IN	O	of	_	0	SENT_267	[p19l349t1300r449b1380],
51	life	NN	O	life	prep_of	49	SENT_267	[p19l472t1300r608b1379],
52	Was	VBD	O	be	auxpass	53	SENT_267	[p19l646t1327r809b1380],
53	observed	VBN	O	observe	advcl	28	SENT_267	[p19l855t1301r1236b1380],
54	in	IN	O	in	_	0	SENT_267	[p19l1277t1302r1361b1379],
55	cycles	NNS	O	cycle	prep_in	53	SENT_267	[p19l1404t1301r1650b1401],
56	2	CD	NUMBER	2	dep	55	SENT_267	[p19l1695t1307r1742b1379],
57	through	IN	O	through	_	0	SENT_267	[p19l1785t1301r2134b1402],
58	12	CD	NUMBER	12	prep_through	53	SENT_267	[p19l14t1435r112b1506],
59	and	CC	O	and	_	0	SENT_267	[p19l152t1429r309b1507],
60	cycle	NN	O	cycle	prep_through	53	SENT_267	[p19l349t1429r552b1528],
61	14	CD	NUMBER	14	num	60	SENT_267	[p19l594t1435r708b1507],
62	.	.	O	.	_	0	SENT_267	[p19l594t1435r708b1507],

1	In	IN	O	in	_	0	SENT_268	[p19l752t1436r841b1506],
2	contrast	NN	O	contrast	prep_in	20	SENT_268	[p19l881t1445r1254b1524],
3	,	,	O	,	_	0	SENT_268	[p19l881t1445r1254b1524],
4	in	IN	O	in	_	0	SENT_268	[p19l1297t1430r1381b1506],
5	the	DT	O	the	det	7	SENT_268	[p19l1420t1429r1553b1507],
6	chemotherapy	NN	O	chemotherapy	nn	7	SENT_268	[p19l1593t1429r2133b1507, p19l10t1583r109b1657],
7	group	NN	O	group	prep_in	20	SENT_268	[p19l137t1583r411b1658],
8	,	,	O	,	_	0	SENT_268	[p19l137t1583r411b1658],
9	no	DT	O	no	det	11	SENT_268	[p19l450t1583r555b1636],
10	significant	JJ	O	significant	amod	11	SENT_268	[p19l590t1556r1058b1658],
11	change	NN	O	change	nsubjpass	20	SENT_268	[p19l1086t1557r1391b1658],
12	from	IN	O	from	_	0	SENT_268	[p19l1424t1556r1633b1636],
13	baseline	NN	O	baseline	prep_from	11	SENT_268	[p19l1667t1557r2019b1636],
14	in	IN	O	in	_	0	SENT_268	[p19l2051t1558r2134b1635],
15	global	JJ	O	global	amod	16	SENT_268	[p19l11t1685r278b1786],
16	quality	NN	O	quality	prep_in	13	SENT_268	[p19l327t1685r626b1785],
17	of	IN	O	of	_	0	SENT_268	[p19l670t1684r770b1764],
18	life	NN	O	life	prep_of	16	SENT_268	[p19l799t1684r935b1763],
19	was	VBD	O	be	auxpass	20	SENT_268	[p19l980t1711r1143b1764],
20	observed	VBN	O	observe	_	0	SENT_268	[p19l1195t1685r1575b1764],
21	at	IN	O	at	_	0	SENT_268	[p19l1624t1702r1703b1763],
22	any	DT	O	any	det	24	SENT_268	[p19l1746t1711r1896b1785],
23	time	NN	O	time	nn	24	SENT_268	[p19l1941t1686r2134b1763],
24	point	NN	O	point	prep_at	20	SENT_268	[p19l10t1814r260b1913],
25	.	.	O	.	_	0	SENT_268	[p19l10t1814r260b1913],

1	Similarly	RB	O	similarly	advmod	18	SENT_269	[p19l304t1813r703b1913],
2	,	,	O	,	_	0	SENT_269	[p19l304t1813r703b1913],
3	in	IN	O	in	_	0	SENT_269	[p19l744t1814r828b1891],
4	all	DT	O	all	det	5	SENT_269	[p19l863t1813r967b1891],
5	domains	NNS	O	domain	nsubj	6	SENT_269	[p19l1004t1813r1376b1892],
6	measuring	VBG	O	measure	prepc_in	18	SENT_269	[p19l1414t1814r1876b1914],
7	functioning	VBG	O	function	dobj	6	SENT_269	[p19l1909t1812r2133b1892, p19l11t1942r345b2042],
8	,	,	O	,	_	0	SENT_269	[p19l1909t1812r2133b1892, p19l11t1942r345b2042],
9	except	IN	O	except	_	0	SENT_269	[p19l385t1958r658b2041],
10	for	IN	O	for	_	0	SENT_269	[p19l686t1940r809b2020],
11	the	DT	O	the	det	12	SENT_269	[p19l839t1941r973b2019],
12	domain	NN	O	domain	prep_except_for	18	SENT_269	[p19l1007t1941r1336b2020],
13	measuring	VBG	O	measure	partmod	12	SENT_269	[p19l1370t1942r1832b2042],
14	cognitive	JJ	O	cognitive	amod	15	SENT_269	[p19l1862t1942r2133b2042, p19l11t2070r155b2148],
15	functioning	NN	O	functioning	dobj	13	SENT_269	[p19l192t2068r711b2170],
16	,	,	O	,	_	0	SENT_269	[p19l192t2068r711b2170],
17	there	EX	O	there	expl	18	SENT_269	[p19l753t2069r965b2147],
18	was	VBD	O	be	_	0	SENT_269	[p19l998t2095r1158b2148],
19	a	DT	O	a	det	23	SENT_269	[p19l1196t2095r1240b2147],
20	significantly	RB	O	significantly	advmod	21	SENT_269	[p19l1277t2068r1806b2170],
21	greater	JJR	O	greater	amod	23	SENT_269	[p19l1838t2086r2136b2170],
22	overall	JJ	O	overall	amod	23	SENT_269	[p19l11t2197r284b2276],
23	improvement	NN	O	improvement	nsubj	18	SENT_269	[p19l313t2198r865b2297],
24	from	IN	O	from	_	0	SENT_269	[p19l889t2196r1093b2276],
25	baseline	NN	O	baseline	prep_from	18	SENT_269	[p19l1123t2197r1460b2276],
26	among	IN	O	among	_	0	SENT_269	[p19l1490t2223r1780b2298],
27	patients	NNS	O	patient	prep_among	25	SENT_269	[p19l1806t2198r2131b2297],

1	2390	CD	DATE	2390	num	4	SENT_270	[p19l149t2373r226b2396],
2	N	NN	O	n	nn	4	SENT_270	[p19l964t2383r978b2398],
3	ENGLJ	NN	O	englj	nn	4	SENT_270	[p19l993t2383r1071b2405],
4	MED	NN	O	med	_	0	SENT_270	[p19l1085t2383r1137b2398],
5	368	CD	NUMBER	368	num	7	SENT_270	[p19l1147t2377r1226b2405],
6	;	:	O	;	_	0	SENT_270	[p19l1147t2377r1226b2405],
7	25	CD	NUMBER	25	dep	4	SENT_270	[p19l1147t2377r1226b2405],
8	NEjM	NNP	O	NEjM	nn	10	SENT_270	[p19l1262t2383r1386b2405],
9	,	,	O	,	_	0	SENT_270	[p19l1262t2383r1386b2405],
10	ORG	NNP	O	ORG	dep	7	SENT_270	[p19l1262t2383r1386b2405],
11	JUNE20	NN	O	june20	dep	4	SENT_270	[p19l1417t2383r1595b2405],
12	,2013	CD	NUMBER	,2013	num	11	SENT_270	[p19l1417t2383r1595b2405],

1	The	DT	O	the	det	4	SENT_271	[p19l936t2416r987b2440],
2	New	NNP	O	New	nn	4	SENT_271	[p19l996t2417r1058b2440],
3	England	NNP	O	England	nn	4	SENT_271	[p19l1067t2416r1178b2447],
4	Journal	NNP	O	Journal	_	0	SENT_271	[p19l1187t2416r1284b2440],
5	of	IN	O	of	_	0	SENT_271	[p19l1294t2416r1323b2440],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_271	[p19l1330t2416r1455b2440],

1	CRIZOTINIB	NNP	O	CRIZOTINIB	_	0	SENT_272	[p19l696t2604r899b2623],
2	FOR	IN	O	for	_	0	SENT_272	[p19l913t2604r978b2623],
3	ALK-POSITIVE	NNP	O	ALK-POSITIVE	nn	5	SENT_272	[p19l987t2604r1210b2623],
4	LUNG	NN	O	lung	nn	5	SENT_272	[p19l1225t2604r1316b2623],
5	CANCER	NNP	O	CANCER	prep_for	1	SENT_272	[p19l1330t2604r1464b2623],

1	in	IN	O	in	_	0	SENT_273	[p19l13t2819r97b2896],
2	the	DT	O	the	det	4	SENT_273	[p19l142t2818r276b2896],
3	crizotinib	JJ	O	crizotinib	amod	4	SENT_273	[p19l322t2818r744b2897],
4	group	NN	O	group	prep_in	6	SENT_273	[p19l790t2844r1043b2919],
5	than	IN	O	than	dep	6	SENT_273	[p19l1091t2818r1287b2896],
6	among	IN	O	among	_	0	SENT_273	[p19l1332t2844r1633b2919],
7	patients	NNS	O	patient	pobj	6	SENT_273	[p19l1673t2819r2017b2918],
8	in	IN	O	in	_	0	SENT_273	[p19l2063t2819r2147b2896],
9	the	DT	O	the	det	13	SENT_273	[p19l14t2946r147b3024],
10	chemotherapy	NN	O	chemotherapy	nn	13	SENT_273	[p19l192t2946r806b3046],
11	group	NN	O	group	nn	13	SENT_273	[p19l846t2972r1099b3047],
12	(	CD	NUMBER	(	num	13	SENT_273	[p19l1149t2947r1330b3047],
13	Fig	NN	O	fig	prep_in	7	SENT_273	[p19l1149t2947r1330b3047],
14	.	.	O	.	_	0	SENT_273	[p19l1149t2947r1330b3047],

1	S5	NN	O	s5	_	0	SENT_274	[p19l1382t2952r1474b3025],
2	in	IN	O	in	_	0	SENT_274	[p19l1520t2947r1605b3024],
3	the	DT	O	the	det	6	SENT_274	[p19l1649t2946r1782b3024],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_274	[p19l1829t2946r2145b3046, p19l13t3091r375b3174],
5	Appendix	NNP	O	Appendix	nn	6	SENT_274	[p19l407t3074r876b3174],
6	)	NN	O	)	prep_in	1	SENT_274	[p19l407t3074r876b3174],
7	.	.	O	.	_	0	SENT_274	[p19l407t3074r876b3174],

1	DISCUSSION	NN	O	discussion	_	0	SENT_275	[p19l739t3371r1421b3431],

1	We	PRP	O	we	nsubj	2	SENT_276	[p19l10t3598r142b3668],
2	conducted	VBD	O	conduct	_	0	SENT_276	[p19l174t3590r609b3669],
3	a	DT	O	a	det	4	SENT_276	[p19l640t3616r684b3668],
4	prospective	JJ	O	prospective	nsubj	8	SENT_276	[p19l712t3591r1215b3690],
5	,	,	O	,	_	0	SENT_276	[p19l712t3591r1215b3690],
6	randomized	VBN	O	randomize	partmod	4	SENT_276	[p19l1252t3590r1787b3686],
7	,	,	O	,	_	0	SENT_276	[p19l1252t3590r1787b3686],
8	phase	NN	O	phase	xcomp	2	SENT_276	[p19l1822t3590r2068b3690],
9	3	CD	NUMBER	3	num	8	SENT_276	[p19l2100t3596r2144b3669],

1	trial	NN	O	trial	nsubj	2	SENT_277	[p20l14t21r193b99],
2	comparing	VBG	O	compare	_	0	SENT_277	[p20l226t22r698b122],
3	crizotinib	NN	O	crizotinib	nn	4	SENT_277	[p20l729t21r1152b100],
4	therapy	NN	O	therapy	dobj	2	SENT_277	[p20l1187t21r1510b121],
5	with	IN	O	with	_	0	SENT_277	[p20l1535t21r1731b100],
6	standard	JJ	O	standard	amod	7	SENT_277	[p20l1766t21r2147b100],
7	chemotherapy	NN	O	chemotherapy	prep_with	2	SENT_277	[p20l15t149r617b249],
8	in	IN	O	in	_	0	SENT_277	[p20l645t150r728b227],
9	patients	NNS	O	patient	prep_in	7	SENT_277	[p20l760t150r1095b249],
10	with	IN	O	with	_	0	SENT_277	[p20l1127t149r1320b229],
11	advanced	JJ	O	advanced	amod	12	SENT_277	[p20l1354t149r1744b228],
12	ALK	NNP	O	ALK	prep_with	9	SENT_277	[p20l1771t155r2145b249, p20l13t279r180b357],
13	—	CD	NUMBER	—	num	12	SENT_277	[p20l1771t155r2145b249, p20l13t279r180b357],
14	positive	JJ	O	positive	amod	16	SENT_277	[p20l1771t155r2145b249, p20l13t279r180b357],
15	non	JJ	O	non	amod	16	SENT_277	[p20l209t278r827b357],
16	—	NN	O	—	tmod	2	SENT_277	[p20l209t278r827b357],
17	small	JJ	O	small	amod	21	SENT_277	[p20l209t278r827b357],
18	—	NN	O	—	nn	21	SENT_277	[p20l209t278r827b357],
19	cell	NN	O	cell	nn	21	SENT_277	[p20l209t278r827b357],
20	lung	NN	O	lung	nn	21	SENT_277	[p20l854t278r1042b379],
21	cancer	NN	O	cancer	dep	16	SENT_277	[p20l1067t304r1354b357],
22	.	.	O	.	_	0	SENT_277	[p20l1067t304r1354b357],

1	As	IN	O	as	_	0	SENT_278	[p20l1385t286r1489b356],
2	compared	VBN	O	compare	prepc_as	13	SENT_278	[p20l1520t278r1934b378],
3	with	IN	O	with	pcomp	2	SENT_278	[p20l1957t278r2147b357],
4	standard	JJ	O	standard	amod	8	SENT_278	[p20l15t406r381b485],
5	second	JJ	ORDINAL	second	amod	8	SENT_278	[p20l406t406r877b485],
6	—	NN	O	—	nn	8	SENT_278	[p20l406t406r877b485],
7	line	NN	O	line	nn	8	SENT_278	[p20l406t406r877b485],
8	chemotherapy	NN	O	chemotherapy	pobj	3	SENT_278	[p20l903t406r1504b506],
9	,	,	O	,	_	0	SENT_278	[p20l903t406r1504b506],
10	treatment	NN	O	treatment	nsubj	13	SENT_278	[p20l1534t423r1943b484],
11	with	IN	O	with	_	0	SENT_278	[p20l1957t406r2147b485],
12	crizotinib	NN	O	crizotinib	prep_with	10	SENT_278	[p20l15t535r427b614],
13	resulted	VBD	O	result	_	0	SENT_278	[p20l458t535r795b614],
14	in	IN	O	in	_	0	SENT_278	[p20l824t536r906b613],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_278	[p20l938t534r1470b636],
16	longer	JJR	O	longer	amod	17	SENT_278	[p20l1494t535r1765b636],
17	progression	NN	O	progression	prep_in	13	SENT_278	[p20l1791t561r2145b636, p20l15t662r383b742],
18	—	CD	NUMBER	—	num	20	SENT_278	[p20l1791t561r2145b636, p20l15t662r383b742],
19	free	JJ	O	free	amod	20	SENT_278	[p20l1791t561r2145b636, p20l15t662r383b742],
20	survival	NN	O	survival	dobj	13	SENT_278	[p20l435t663r790b759],
21	,	,	O	,	_	0	SENT_278	[p20l435t663r790b759],
22	significantly	RB	O	significantly	dep	25	SENT_278	[p20l846t662r1392b764],
23	higher	JJR	O	higher	amod	25	SENT_278	[p20l1436t663r1719b764],
24	response	NN	O	response	nn	25	SENT_278	[p20l1764t689r2147b763],
25	rates	NNS	O	rate	dep	13	SENT_278	[p20l13t808r242b887],
26	,	,	O	,	_	0	SENT_278	[p20l13t808r242b887],
27	a	DT	O	a	det	29	SENT_278	[p20l278t817r322b869],
28	significant	JJ	O	significant	amod	29	SENT_278	[p20l354t790r824b892],
29	reduction	NN	O	reduction	dep	13	SENT_278	[p20l851t791r1261b870],
30	in	IN	O	in	_	0	SENT_278	[p20l1292t792r1376b869],
31	symptoms	NNS	O	symptom	prep_in	29	SENT_278	[p20l1409t808r1878b891],
32	,	,	O	,	_	0	SENT_278	[p20l1409t808r1878b891],
33	and	CC	O	and	_	0	SENT_278	[p20l1915t791r2073b870],
34	a	DT	O	a	det	36	SENT_278	[p20l2104t817r2148b869],
35	signiﬁcant	JJ	O	signiﬁcant	amod	36	SENT_278	[p20l15t918r486b1020],
36	improvement	NN	O	improvement	conj_and	25	SENT_278	[p20l514t920r1090b1019],
37	in	IN	O	in	_	0	SENT_278	[p20l1118t920r1202b997],
38	global	JJ	O	global	amod	39	SENT_278	[p20l1235t919r1504b1020],
39	quality	NN	O	quality	prep_in	13	SENT_278	[p20l1538t919r1837b1019],
40	of	IN	O	of	_	0	SENT_278	[p20l1867t918r1968b998],
41	life	NN	O	life	prep_of	39	SENT_278	[p20l1982t918r2141b998],
42	.	.	O	.	_	0	SENT_278	[p20l1982t918r2141b998],

1	In	IN	O	in	_	0	SENT_279	[p20l12t1054r102b1124],
2	this	DT	O	this	det	3	SENT_279	[p20l140t1046r300b1124],
3	study	NN	O	study	prep_in	8	SENT_279	[p20l342t1046r586b1146],
4	,	,	O	,	_	0	SENT_279	[p20l342t1046r586b1146],
5	crizotinib	NN	O	crizotinib	nsubj	8	SENT_279	[p20l631t1046r1052b1125],
6	was	VBD	O	be	cop	8	SENT_279	[p20l1088t1072r1251b1126],
7	more	RBR	O	more	advmod	8	SENT_279	[p20l1292t1072r1512b1125],
8	effective	JJ	O	effective	_	0	SENT_279	[p20l1551t1045r1911b1126],
9	than	IN	O	than	_	0	SENT_279	[p20l1949t1046r2147b1124],
10	either	CC	O	either	preconj	11	SENT_279	[p20l15t1175r263b1253],
11	pemetrexed	JJ	O	pemetrexed	prep_than	8	SENT_279	[p20l293t1175r797b1275],
12	or	CC	O	or	_	0	SENT_279	[p20l833t1201r922b1254],
13	docetaxel	NN	O	docetaxel	prep_than	8	SENT_279	[p20l955t1175r1385b1254],
14	.	.	O	.	_	0	SENT_279	[p20l955t1175r1385b1254],

1	The	DT	O	the	dep	110	SENT_280	[p20l140t1303r297b1381],
2	efficacy	NN	O	efficacy	dep	110	SENT_280	[p20l327t1302r650b1403],
3	of	IN	O	of	dep	110	SENT_280	[p20l676t1302r775b1382],
4	second	JJ	ORDINAL	second	dep	110	SENT_280	[p20l787t1303r1258b1382],
5	—	NN	O	—	dep	110	SENT_280	[p20l787t1303r1258b1382],
6	line	NN	O	line	dep	110	SENT_280	[p20l787t1303r1258b1382],
7	docetaxel	NN	O	docetaxel	dep	110	SENT_280	[p20l1288t1303r1679b1382],
8	in	IN	O	in	dep	110	SENT_280	[p20l1708t1304r1789b1381],
9	patients	NNS	O	patient	dep	110	SENT_280	[p20l1817t1304r2145b1403],
10	with	IN	O	with	dep	110	SENT_280	[p20l9t1432r202b1511],
11	ALK	NN	O	alk	dep	110	SENT_280	[p20l232t1433r750b1532],
12	—	CD	NUMBER	—	dep	110	SENT_280	[p20l232t1433r750b1532],
13	positive	JJ	O	positive	dep	110	SENT_280	[p20l232t1433r750b1532],
14	non	JJ	O	non	dep	110	SENT_280	[p20l786t1432r1418b1511],
15	—	NN	O	—	dep	110	SENT_280	[p20l786t1432r1418b1511],
16	small	JJ	O	small	dep	110	SENT_280	[p20l786t1432r1418b1511],
17	—	NN	O	—	dep	110	SENT_280	[p20l786t1432r1418b1511],
18	cell	NN	O	cell	dep	110	SENT_280	[p20l786t1432r1418b1511],
19	lung	NN	O	lung	dep	110	SENT_280	[p20l1453t1432r1644b1533],
20	cancer	NN	O	cancer	dep	110	SENT_280	[p20l1678t1458r1955b1510],
21	was	VBD	O	be	dep	110	SENT_280	[p20l1984t1458r2145b1511],
22	modest	JJ	O	modest	dep	110	SENT_280	[p20l13t1560r353b1656],
23	,	,	O	,	_	0	SENT_280	[p20l13t1560r353b1656],
24	a	DT	O	a	dep	110	SENT_280	[p20l401t1586r445b1638],
25	finding	NN	O	finding	dep	110	SENT_280	[p20l486t1559r812b1661],
26	that	WDT	O	that	dep	110	SENT_280	[p20l851t1560r1025b1638],
27	was	VBD	O	be	dep	110	SENT_280	[p20l1057t1586r1221b1639],
28	consistent	JJ	O	consistent	dep	110	SENT_280	[p20l1266t1561r1707b1639],
29	with	IN	O	with	dep	110	SENT_280	[p20l1739t1560r1936b1639],
30	that	DT	O	that	dep	110	SENT_280	[p20l1979t1560r2152b1638],
31	in	IN	O	in	dep	110	SENT_280	[p20l13t1689r97b1766],
32	previous	JJ	O	previous	dep	110	SENT_280	[p20l130t1689r493b1788],
33	studies	NNS	O	study	dep	110	SENT_280	[p20l532t1688r833b1767],
34	involving	VBG	O	involve	dep	110	SENT_280	[p20l868t1688r1267b1789],
35	the	DT	O	the	dep	110	SENT_280	[p20l1298t1688r1431b1766],
36	general	JJ	O	general	dep	110	SENT_280	[p20l1466t1688r1784b1789],
37	population	NN	O	population	dep	110	SENT_280	[p20l1817t1688r2145b1788, p20l14t1817r185b1895],
38	of	IN	O	of	dep	110	SENT_280	[p20l239t1815r339b1895],
39	patients	NNS	O	patient	dep	110	SENT_280	[p20l374t1817r717b1916],
40	with	IN	O	with	dep	110	SENT_280	[p20l769t1816r965b1895],
41	non	JJ	O	non	dep	110	SENT_280	[p20l1020t1816r1666b1895],
42	—	JJ	O	—	dep	110	SENT_280	[p20l1020t1816r1666b1895],
43	small	JJ	O	small	dep	110	SENT_280	[p20l1020t1816r1666b1895],
44	—	NN	O	—	dep	110	SENT_280	[p20l1020t1816r1666b1895],
45	cell	NN	O	cell	dep	110	SENT_280	[p20l1020t1816r1666b1895],
46	lung	NN	O	lung	dep	110	SENT_280	[p20l1718t1816r1912b1917],
47	cancer	NN	O	cancer	dep	110	SENT_280	[p20l1964t1842r2145b1894, p20l15t1949r331b2023],
48	.13	CD	NUMBER	.13	dep	110	SENT_280	[p20l1964t1842r2145b1894, p20l15t1949r331b2023],
49	’15	CD	NUMBER	’15	dep	110	SENT_280	[p20l1964t1842r2145b1894, p20l15t1949r331b2023],
50	In	IN	O	in	dep	110	SENT_280	[p20l378t1952r467b2022],
51	contrast	NN	O	contrast	dep	110	SENT_280	[p20l513t1961r888b2040],
52	,	,	O	,	_	0	SENT_280	[p20l513t1961r888b2040],
53	the	DT	O	the	dep	110	SENT_280	[p20l939t1944r1072b2022],
54	response	NN	O	response	dep	110	SENT_280	[p20l1117t1970r1500b2044],
55	rate	NN	O	rate	dep	110	SENT_280	[p20l1545t1961r1706b2022],
56	to	TO	O	to	dep	110	SENT_280	[p20l1751t1961r1833b2023],
57	peme	VB	O	peme	dep	110	SENT_280	[p20l1878t1970r2145b2044],
58	—	NN	O	—	dep	110	SENT_280	[p20l1878t1970r2145b2044],
59	trexed	VBN	O	trex	dep	110	SENT_280	[p20l14t2073r279b2152],
60	was	VBD	O	be	dep	110	SENT_280	[p20l339t2099r501b2152],
61	higher	JJR	O	higher	dep	110	SENT_280	[p20l567t2073r850b2174],
62	than	IN	O	than	dep	110	SENT_280	[p20l911t2073r1108b2151],
63	expected	VBN	O	expect	dep	110	SENT_280	[p20l1173t2073r1550b2173],
64	—	NN	O	—	dep	110	SENT_280	[p20l1611t2118r1719b2126],
65	29	CD	PERCENT	29	dep	110	SENT_280	[p20l1778t2078r1990b2169],
66	%	NN	PERCENT	%	dep	110	SENT_280	[p20l1778t2078r1990b2169],
67	,	,	O	,	_	0	SENT_280	[p20l1778t2078r1990b2169],
68	as	IN	O	as	dep	110	SENT_280	[p20l2059t2099r2145b2151],
69	compared	VBN	O	compare	dep	110	SENT_280	[p20l15t2201r443b2301],
70	with	IN	O	with	dep	110	SENT_280	[p20l478t2201r674b2280],
71	12.8	CD	PERCENT	12.8	dep	110	SENT_280	[p20l716t2206r984b2280],
72	%	NN	PERCENT	%	dep	110	SENT_280	[p20l716t2206r984b2280],
73	in	IN	O	in	dep	110	SENT_280	[p20l1022t2202r1106b2279],
74	the	DT	O	the	dep	110	SENT_280	[p20l1145t2201r1279b2279],
75	general	JJ	O	general	dep	110	SENT_280	[p20l1318t2201r1637b2302],
76	population	NN	O	population	dep	110	SENT_280	[p20l1674t2201r2148b2301],
77	of	IN	O	of	dep	110	SENT_280	[p20l15t2328r115b2408],
78	patients	NNS	O	patient	dep	110	SENT_280	[p20l140t2330r483b2429],
79	with	IN	O	with	dep	110	SENT_280	[p20l526t2329r723b2408],
80	lung	NN	O	lung	dep	110	SENT_280	[p20l767t2329r960b2430],
81	adenocarcinoma	NN	O	adenocarcinoma	dep	110	SENT_280	[p20l1002t2329r1720b2408],
82	who	WP	O	who	dep	110	SENT_280	[p20l1760t2329r1943b2408],
83	had	VBD	O	have	dep	110	SENT_280	[p20l1990t2329r2148b2408],
84	previously	RB	DATE	previously	dep	110	SENT_280	[p20l12t2457r454b2557],
85	been	VBN	O	be	dep	110	SENT_280	[p20l506t2457r708b2536],
86	treated	VBN	O	treat	dep	110	SENT_280	[p20l764t2457r1064b2536],
87	with	IN	O	with	dep	110	SENT_280	[p20l1114t2457r1311b2536],
88	chemotherapy13v25	CD	NUMBER	chemotherapy13v25	dep	110	SENT_280	[p20l1367t2457r2144b2557],
89	—	CD	NUMBER	—	dep	110	SENT_280	[p20l10t2631r118b2639],
90	though	IN	O	though	dep	110	SENT_280	[p20l158t2586r468b2687],
91	the	DT	O	the	dep	110	SENT_280	[p20l512t2586r645b2664],
92	median	JJ	O	median	dep	110	SENT_280	[p20l689t2586r1015b2665],
93	progression	NN	O	progression	dep	110	SENT_280	[p20l1057t2585r1768b2687],
94	—	CD	NUMBER	—	dep	110	SENT_280	[p20l1057t2585r1768b2687],
95	free	JJ	O	free	dep	110	SENT_280	[p20l1057t2585r1768b2687],
96	survival	NN	O	survival	dep	110	SENT_280	[p20l1814t2586r2148b2665],
97	among	IN	O	among	dep	110	SENT_280	[p20l13t2740r315b2815],
98	patients	NNS	O	patient	dep	110	SENT_280	[p20l344t2715r688b2814],
99	in	IN	O	in	dep	110	SENT_280	[p20l724t2715r807b2792],
100	our	PRP$	O	we	dep	110	SENT_280	[p20l842t2740r989b2793],
101	study	NN	O	study	dep	110	SENT_280	[p20l1022t2714r1253b2814],
102	Who	WP	O	who	dep	110	SENT_280	[p20l1279t2714r1462b2793],
103	received	VBD	O	receive	dep	110	SENT_280	[p20l1498t2714r1846b2793],
104	peme	NN	O	peme	dep	110	SENT_280	[p20l1878t2740r2145b2814],
105	—	NN	O	—	dep	110	SENT_280	[p20l1878t2740r2145b2814],
106	trexed	VBD	O	trex	dep	110	SENT_280	[p20l14t2842r279b2921],
107	was	VBD	O	be	dep	110	SENT_280	[p20l313t2868r475b2921],
108	only	RB	O	only	dep	110	SENT_280	[p20l516t2842r701b2942],
109	4.2	CD	DURATION	4.2	dep	110	SENT_280	[p20l733t2848r862b2921],
110	months	NNS	NUMBER	month	_	0	SENT_280	[p20l900t2842r1253b2921],
111	.	.	O	.	_	0	SENT_280	[p20l900t2842r1253b2921],

1	Thus	RB	O	thus	advmod	16	SENT_281	[p20l1293t2842r1531b2938],
2	,	,	O	,	_	0	SENT_281	[p20l1293t2842r1531b2938],
3	patients	NNS	O	patient	nsubj	16	SENT_281	[p20l1572t2843r1916b2942],
4	with	IN	O	with	_	0	SENT_281	[p20l1951t2842r2147b2922],
5	ALK	NN	O	alk	npadvmod	7	SENT_281	[p20l7t2972r525b3071],
6	—	CD	NUMBER	—	num	5	SENT_281	[p20l7t2972r525b3071],
7	positive	JJ	O	positive	amod	9	SENT_281	[p20l7t2972r525b3071],
8	non	JJ	O	non	amod	9	SENT_281	[p20l559t2971r1191b3050],
9	—	NN	O	—	prep_with	3	SENT_281	[p20l559t2971r1191b3050],
10	small	JJ	O	small	amod	14	SENT_281	[p20l559t2971r1191b3050],
11	—	NN	O	—	nn	14	SENT_281	[p20l559t2971r1191b3050],
12	cell	NN	O	cell	nn	14	SENT_281	[p20l559t2971r1191b3050],
13	lung	NN	O	lung	nn	14	SENT_281	[p20l1223t2971r1414b3072],
14	cancer	NN	O	cancer	dep	9	SENT_281	[p20l1445t2997r1721b3049],
15	may	MD	O	may	aux	16	SENT_281	[p20l1752t2997r1930b3071],
16	have	VB	O	have	_	0	SENT_281	[p20l1960t2971r2147b3050],
17	a	DT	O	a	det	20	SENT_281	[p20l13t3125r58b3177],
18	higher	JJR	O	higher	amod	20	SENT_281	[p20l118t3099r401b3200],
19	response	NN	O	response	nn	20	SENT_281	[p20l461t3125r843b3199],
20	rate	NN	O	rate	dobj	16	SENT_281	[p20l906t3116r1066b3177],
21	with	IN	O	with	_	0	SENT_281	[p20l1125t3099r1321b3178],
22	pemetrexed	JJ	O	pemetrexed	prep_with	16	SENT_281	[p20l1382t3099r1886b3199],
23	than	IN	O	than	mark	24	SENT_281	[p20l1949t3099r2147b3177],
24	does	VBZ	O	do	advcl	16	SENT_281	[p20l15t3227r208b3306],
25	the	DT	O	the	det	27	SENT_281	[p20l247t3227r380b3305],
26	general	JJ	O	general	amod	27	SENT_281	[p20l415t3227r733b3328],
27	population	NN	O	population	dobj	24	SENT_281	[p20l767t3227r1240b3327],
28	With	IN	O	with	_	0	SENT_281	[p20l1271t3227r1467b3306],
29	non	JJ	O	non	amod	35	SENT_281	[p20l1502t3227r2148b3306],
30	—	JJ	O	—	amod	35	SENT_281	[p20l1502t3227r2148b3306],
31	small	JJ	O	small	amod	35	SENT_281	[p20l1502t3227r2148b3306],
32	—	NN	O	—	nn	35	SENT_281	[p20l1502t3227r2148b3306],
33	cell	NN	O	cell	nn	35	SENT_281	[p20l1502t3227r2148b3306],
34	lung	NN	O	lung	nn	35	SENT_281	[p20l12t3355r207b3456],
35	cancer	NN	O	cancer	prep_with	27	SENT_281	[p20l240t3381r540b3434],
36	.	.	O	.	_	0	SENT_281	[p20l240t3381r540b3434],

1	However	RB	O	however	advmod	8	SENT_282	[p20l581t3363r977b3451],
2	,	,	O	,	_	0	SENT_282	[p20l581t3363r977b3451],
3	the	DT	O	the	det	4	SENT_282	[p20l1019t3355r1152b3433],
4	benefit	NN	O	benefit	nsubj	8	SENT_282	[p20l1189t3354r1496b3434],
5	of	IN	O	of	_	0	SENT_282	[p20l1527t3354r1627b3434],
6	pemetrexed	JJ	O	pemetrexed	prep_of	4	SENT_282	[p20l1643t3355r2148b3455],
7	is	VBZ	O	be	cop	8	SENT_282	[p20l13t3484r78b3561],
8	less	JJR	O	less	_	0	SENT_282	[p20l111t3483r264b3561],
9	than	IN	O	than	_	0	SENT_282	[p20l297t3483r491b3561],
10	that	DT	O	that	prep_than	8	SENT_282	[p20l523t3483r693b3561],
11	originally	RB	O	originally	advmod	12	SENT_282	[p20l720t3483r1129b3584],
12	suggested	VBN	O	suggest	partmod	10	SENT_282	[p20l1157t3483r1577b3584],
13	in	IN	O	in	_	0	SENT_282	[p20l1608t3484r1690b3561],
14	retrospective	JJ	O	retrospective	amod	15	SENT_282	[p20l1722t3500r2145b3583, p20l14t3612r159b3690],
15	studies15	NN	O	studies15	prep_in	12	SENT_282	[p20l204t3611r672b3690],
16	’17	CD	NUMBER	’17	dep	15	SENT_282	[p20l204t3611r672b3690],
17	and	CC	O	and	_	0	SENT_282	[p20l717t3611r899b3707],
18	,	,	O	,	_	0	SENT_282	[p20l717t3611r899b3707],
19	importantly	RB	O	importantly	advmod	8	SENT_282	[p20l950t3611r1481b3711],
20	,	,	O	,	_	0	SENT_282	[p20l950t3611r1481b3711],
21	less	JJR	O	less	advmod	8	SENT_282	[p20l1532t3611r1688b3689],
22	than	IN	O	than	_	0	SENT_282	[p20l1736t3611r1933b3689],
23	that	DT	O	that	conj_and	10	SENT_282	[p20l1979t3611r2152b3689],
24	of	IN	O	of	_	0	SENT_282	[p21l15t20r115b100],
25	crizotinib	NN	O	crizotinib	prep_of	23	SENT_282	[p21l133t21r578b117],
26	,	,	O	,	_	0	SENT_282	[p21l133t21r578b117],
27	as	IN	O	as	mark	28	SENT_282	[p21l619t47r705b99],
28	shown	VBN	O	show	dep	25	SENT_282	[p21l743t21r1027b100],
29	in	IN	O	in	_	0	SENT_282	[p21l1062t22r1146b99],
30	this	DT	O	this	det	32	SENT_282	[p21l1182t21r1343b99],
31	randomized	JJ	O	randomized	amod	32	SENT_282	[p21l1380t21r1904b100],
32	trial	NN	O	trial	prep_in	28	SENT_282	[p21l1940t21r2141b100],
33	.	.	O	.	_	0	SENT_282	[p21l1940t21r2141b100],

1	In	IN	O	in	_	0	SENT_283	[p21l142t157r230b227],
2	a	DT	O	a	det	5	SENT_283	[p21l269t175r313b227],
3	prespecified	JJ	O	prespecified	amod	5	SENT_283	[p21l350t148r870b249],
4	interim	NN	O	interim	nn	5	SENT_283	[p21l909t150r1222b227],
5	analysis	NN	O	analysis	prep_in	10	SENT_283	[p21l1262t149r1619b249],
6	,	,	O	,	_	0	SENT_283	[p21l1262t149r1619b249],
7	overall	JJ	O	overall	amod	8	SENT_283	[p21l1665t149r1945b229],
8	survival	NN	O	survival	nsubjpass	10	SENT_283	[p21l1986t175r2145b229, p21l9t279r201b358],
9	was	VBD	O	be	auxpass	10	SENT_283	[p21l240t305r404b358],
10	shown	VBN	O	show	_	0	SENT_283	[p21l454t279r737b358],
11	to	TO	O	to	aux	13	SENT_283	[p21l785t296r867b358],
12	be	VB	O	be	cop	13	SENT_283	[p21l916t279r1012b358],
13	similar	JJ	O	similar	xcomp	10	SENT_283	[p21l1061t279r1368b357],
14	in	IN	O	in	_	0	SENT_283	[p21l1411t280r1495b357],
15	the	DT	O	the	det	19	SENT_283	[p21l1542t279r1675b358],
16	crizotinib	NN	O	crizotinib	nn	19	SENT_283	[p21l1723t279r2145b358],
17	and	CC	O	and	_	0	SENT_283	[p21l13t407r172b486],
18	chemotherapy	NN	O	chemotherapy	nn	19	SENT_283	[p21l206t407r820b507],
19	groups	NNS	O	group	prep_in	13	SENT_283	[p21l848t433r1170b508],
20	.	.	O	.	_	0	SENT_283	[p21l848t433r1170b508],

1	This	DT	O	this	det	2	SENT_284	[p21l1205t407r1395b485],
2	analysis	NN	O	analysis	nsubj	4	SENT_284	[p21l1429t407r1771b507],
3	was	VBD	O	be	cop	4	SENT_284	[p21l1802t433r1965b486],
4	immature	JJ	O	immature	_	0	SENT_284	[p21l2001t408r2145b485, p21l13t551r345b630],
5	,	,	O	,	_	0	SENT_284	[p21l2001t408r2145b485, p21l13t551r345b630],
6	and	CC	O	and	_	0	SENT_284	[p21l383t534r541b613],
7	it	PRP	O	it	nsubj	9	SENT_284	[p21l574t535r633b612],
8	is	VBZ	O	be	cop	9	SENT_284	[p21l660t535r727b612],
9	likely	JJ	O	likely	conj_and	4	SENT_284	[p21l761t534r994b634],
10	that	IN	O	that	complm	13	SENT_284	[p21l1023t534r1196b612],
11	it	PRP	O	it	nsubjpass	13	SENT_284	[p21l1223t535r1283b612],
12	was	VBD	O	be	auxpass	13	SENT_284	[p21l1306t560r1470b614],
13	confounded	VBN	O	confound	ccomp	9	SENT_284	[p21l1506t533r2021b613],
14	by	IN	O	by	_	0	SENT_284	[p21l2054t534r2152b634],
15	the	DT	O	the	det	18	SENT_284	[p21l14t663r147b741],
16	high	JJ	O	high	amod	18	SENT_284	[p21l202t663r398b764],
17	crossover	NN	O	crossover	nn	18	SENT_284	[p21l453t689r859b742],
18	rate	NN	O	rate	agent	13	SENT_284	[p21l910t680r1071b741],
19	among	IN	O	among	_	0	SENT_284	[p21l1125t689r1426b764],
20	patients	NNS	O	patient	prep_among	18	SENT_284	[p21l1476t664r1819b763],
21	in	IN	O	in	_	0	SENT_284	[p21l1875t664r1959b741],
22	the	DT	O	the	det	24	SENT_284	[p21l2014t663r2147b741],
23	chemotherapy	NN	O	chemotherapy	nn	24	SENT_284	[p21l15t791r628b891],
24	group	NN	O	group	prep_in	20	SENT_284	[p21l697t817r973b892],
25	.	.	O	.	_	0	SENT_284	[p21l697t817r973b892],

1	Crossover	NNP	O	Crossover	nsubj	4	SENT_285	[p21l1053t797r1478b870],
2	has	VBZ	O	have	aux	4	SENT_285	[p21l1549t791r1693b869],
3	similarly	RB	O	similarly	advmod	4	SENT_285	[p21l1771t791r2152b891],
4	complicated	VBN	O	complicate	_	0	SENT_285	[p21l15t918r540b1018],
5	the	DT	O	the	det	6	SENT_285	[p21l598t918r731b996],
6	analysis	NN	O	analysis	dobj	4	SENT_285	[p21l788t918r1129b1018],
7	of	IN	O	of	_	0	SENT_285	[p21l1189t917r1290b997],
8	overall	JJ	O	overall	amod	9	SENT_285	[p21l1329t918r1616b997],
9	survival	NN	O	survival	prep_of	6	SENT_285	[p21l1674t918r2008b997],
10	in	IN	O	in	_	0	SENT_285	[p21l2063t919r2148b996],
11	other	JJ	O	other	prep_in	4	SENT_285	[p21l15t1046r243b1125],
12	randomized	VBN	O	randomize	partmod	11	SENT_285	[p21l284t1046r831b1142],
13	,	,	O	,	_	0	SENT_285	[p21l284t1046r831b1142],
14	phase	NN	O	phase	dep	32	SENT_285	[p21l879t1046r1130b1146],
15	3	CD	NUMBER	3	num	16	SENT_285	[p21l1176t1052r1220b1125],
16	studies	NNS	O	study	dep	14	SENT_285	[p21l1269t1046r1571b1126],
17	of	IN	O	of	_	0	SENT_285	[p21l1618t1045r1718b1125],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_285	[p21l1743t1052r2000b1130],
19	kinase	NN	O	kinase	nn	20	SENT_285	[p21l2034t1046r2145b1126, p21l13t1201r207b1253],
20	inhibitors	NNS	O	inhibitor	prep_of	16	SENT_285	[p21l244t1175r667b1254],
21	in	IN	O	in	_	0	SENT_285	[p21l707t1176r790b1253],
22	patients	NNS	O	patient	prep_in	20	SENT_285	[p21l826t1176r1170b1275],
23	with	IN	O	with	_	0	SENT_285	[p21l1205t1175r1401b1254],
24	advanced	JJ	O	advanced	amod	25	SENT_285	[p21l1438t1175r1837b1254],
25	EGFRmutant	NN	O	egfrmutant	prep_with	22	SENT_285	[p21l1873t1181r2145b1259, p21l13t1321r329b1383],
26	non	JJ	O	non	dep	32	SENT_285	[p21l371t1304r1016b1383],
27	—	CD	NUMBER	—	num	32	SENT_285	[p21l371t1304r1016b1383],
28	small	JJ	O	small	amod	32	SENT_285	[p21l371t1304r1016b1383],
29	—	JJ	O	—	amod	32	SENT_285	[p21l371t1304r1016b1383],
30	cell	NN	O	cell	nn	32	SENT_285	[p21l371t1304r1016b1383],
31	lung	NN	O	lung	nn	32	SENT_285	[p21l1062t1304r1256b1405],
32	cancer	NN	O	cancer	dep	61	SENT_285	[p21l1301t1308r1777b1383],
33	.26	CD	NUMBER	.26	number	34	SENT_285	[p21l1301t1308r1777b1383],
34	‘	CD	NUMBER	‘	dep	32	SENT_285	[p21l1301t1308r1777b1383],
35	28	CD	NUMBER	28	dep	34	SENT_285	[p21l1301t1308r1777b1383],
36	Despite	IN	O	despite	_	0	SENT_285	[p21l1825t1305r2147b1404],
37	these	DT	O	these	det	38	SENT_285	[p21l14t1432r238b1510],
38	limitations	NNS	O	limitation	prep_despite	61	SENT_285	[p21l303t1432r802b1528],
39	,	,	O	,	_	0	SENT_285	[p21l303t1432r802b1528],
40	the	DT	O	the	det	43	SENT_285	[p21l873t1432r1006b1510],
41	median	JJ	O	median	amod	43	SENT_285	[p21l1071t1432r1396b1511],
42	overall	JJ	O	overall	amod	43	SENT_285	[p21l1462t1432r1748b1511],
43	survival	NN	O	survival	nsubj	61	SENT_285	[p21l1814t1432r2148b1511],
44	among	IN	O	among	_	0	SENT_285	[p21l13t1587r314b1662],
45	patients	NNS	O	patient	prep_among	43	SENT_285	[p21l348t1562r692b1661],
46	in	IN	O	in	_	0	SENT_285	[p21l732t1562r815b1639],
47	this	DT	O	this	det	48	SENT_285	[p21l855t1561r1015b1639],
48	study	NN	O	study	prep_in	45	SENT_285	[p21l1057t1561r1288b1661],
49	from	IN	O	from	_	0	SENT_285	[p21l1323t1560r1534b1640],
50	the	DT	O	the	det	51	SENT_285	[p21l1573t1561r1706b1639],
51	time	NN	O	time	prep_from	48	SENT_285	[p21l1746t1562r1939b1639],
52	that	WDT	O	that	dobj	58	SENT_285	[p21l1979t1561r2152b1639],
53	second	JJ	ORDINAL	second	amod	56	SENT_285	[p21l15t1689r497b1768],
54	—	NN	O	—	nn	56	SENT_285	[p21l15t1689r497b1768],
55	line	NN	O	line	nn	56	SENT_285	[p21l15t1689r497b1768],
56	therapy	NN	O	therapy	nsubjpass	58	SENT_285	[p21l536t1689r853b1789],
57	was	VBD	O	be	auxpass	58	SENT_285	[p21l882t1715r1043b1768],
58	initiated	VBN	O	initiate	rcmod	51	SENT_285	[p21l1083t1689r1436b1768],
59	was	VBD	O	be	cop	61	SENT_285	[p21l1469t1715r1631b1769],
60	remarkably	RB	O	remarkably	advmod	61	SENT_285	[p21l1671t1689r2152b1789],
61	high	JJ	O	high	parataxis	12	SENT_285	[p21l13t1818r231b1919],
62	,	,	O	,	_	0	SENT_285	[p21l13t1818r231b1919],
63	at	IN	O	at	_	0	SENT_285	[p21l275t1835r354b1896],
64	longer	JJR	O	longer	prep_at	12	SENT_285	[p21l386t1818r662b1919],
65	than	IN	O	than	_	0	SENT_285	[p21l698t1818r895b1896],
66	20	CD	DURATION	20	num	67	SENT_285	[p21l933t1824r1033b1897],
67	months	NNS	NUMBER	month	prep_than	64	SENT_285	[p21l1073t1818r1426b1914],
68	,	,	O	,	_	0	SENT_285	[p21l1073t1818r1426b1914],
69	suggesting	VBG	O	suggest	xcomp	12	SENT_285	[p21l1471t1819r1944b1919],
70	that	IN	O	that	_	0	SENT_285	[p21l1979t1818r2153b1896],
71	the	DT	O	the	det	72	SENT_285	[p21l14t1946r147b2024],
72	addition	NN	O	addition	prep_that	69	SENT_285	[p21l195t1946r553b2025],
73	of	IN	O	of	_	0	SENT_285	[p21l601t1945r701b2025],
74	crizotinib	NN	O	crizotinib	prep_of	72	SENT_285	[p21l731t1946r1153b2025],
75	either	CC	O	either	dep	69	SENT_285	[p21l1203t1946r1450b2024],
76	before	IN	O	before	conj	69	SENT_285	[p21l1496t1945r1766b2025],
77	or	CC	O	or	_	0	SENT_285	[p21l1814t1972r1903b2025],
78	after	IN	O	after	conj	69	SENT_285	[p21l1947t1945r2150b2024],

1	Table	NNP	O	Table	_	0	SENT_286	[p22l60t132r203b180],
2	3	CD	NUMBER	3	dep	1	SENT_286	[p22l220t136r263b180],
3	.	.	O	.	_	0	SENT_286	[p22l220t136r263b180],

1	Adverse	JJ	O	adverse	nsubj	2	SENT_287	[p22l281t132r493b180],
2	Events	NNS	O	event	_	0	SENT_287	[p22l514t136r684b180],
3	of	IN	O	of	_	0	SENT_287	[p22l702t131r763b180],
4	Any	DT	O	any	det	5	SENT_287	[p22l768t136r869b195],
5	Cause	NN	O	cause	prep_of	2	SENT_287	[p22l885t135r1094b180],
6	.	.	O	.	_	0	SENT_287	[p22l885t135r1094b180],
7	"	''	O	"	punct	2	SENT_287	[p22l885t135r1094b180],
8	"	''	O	"	punct	2	SENT_287	[p22l885t135r1094b180],

1	Crizotinib	NNP	O	Crizotinib	nn	2	SENT_288	[p22l1012t276r1267b325],
2	Chemotherapy	NNP	O	Chemotherapy	_	0	SENT_288	[p22l1625t276r2013b340],

1	Adverse	JJ	O	adverse	amod	4	SENT_289	[p22l60t349r271b397],
2	Event	NN	O	event	nn	4	SENT_289	[p22l295t353r440b397],
3	(	NN	O	(	nn	4	SENT_289	[p22l1026t353r1084b412],
4	N	NN	O	n	_	0	SENT_289	[p22l1026t353r1084b412],
5	=	JJ	O	=	dep	4	SENT_289	[p22l1099t373r1132b389],
6	172	CD	NUMBER	172	number	7	SENT_289	[p22l1145t353r1253b412],
7	)	CD	NUMBER	)	num	12	SENT_289	[p22l1145t353r1253b412],
8	(	NN	O	(	nn	12	SENT_289	[p22l1705t353r1763b412],
9	N	NN	O	n	nn	12	SENT_289	[p22l1705t353r1763b412],
10	=	JJ	O	=	amod	12	SENT_289	[p22l1778t373r1811b389],
11	171	CD	NUMBER	171	num	12	SENT_289	[p22l1824t353r1932b412],
12	)	NN	O	)	dep	5	SENT_289	[p22l1824t353r1932b412],

1	Any	DT	O	any	det	2	SENT_290	[p22l905t495r1003b555],
2	Grade	NNP	O	Grade	_	0	SENT_290	[p22l1202t492r1360b540],
3	3	CD	NUMBER	3	num	2	SENT_290	[p22l1379t496r1403b540],
4	Any	DT	O	any	det	7	SENT_290	[p22l1608t495r1706b555],
5	Grade	NNP	O	Grade	nn	7	SENT_290	[p22l1861t492r2018b540],
6	3	CD	NUMBER	3	num	7	SENT_290	[p22l2039t496r2062b540],
7	Grade	NNP	O	Grade	dep	2	SENT_290	[p22l876t564r1034b613],
8	or	CC	O	or	_	0	SENT_290	[p22l1255t581r1308b613],
9	4	CD	NUMBER	4	num	10	SENT_290	[p22l1324t569r1353b612],
10	Grade	NNP	O	Grade	dep	2	SENT_290	[p22l1579t564r1736b613],
11	or	CC	O	or	_	0	SENT_290	[p22l1914t581r1967b612],
12	4	CD	NUMBER	4	conj_or	10	SENT_290	[p22l1983t569r2012b612],

1	no.	NN	O	no.	dep	6	SENT_291	[p22l1234t693r1304b724],
2	of	IN	O	of	_	0	SENT_291	[p22l1328t675r1386b740],
3	patients	NNS	O	patient	prep_of	1	SENT_291	[p22l1388t678r1588b739],
4	(	CD	PERCENT	(	num	5	SENT_291	[p22l1611t678r1698b739],
5	%	NN	PERCENT	%	dep	6	SENT_291	[p22l1611t678r1698b739],
6	)	CD	NUMBER	)	dep	28	SENT_291	[p22l1611t678r1698b739],
7	Vision	NNP	O	Vision	nn	8	SENT_291	[p22l60t791r222b835],
8	disorder	NNP	O	disorder	dep	6	SENT_291	[p22l244t787r533b850],
9	'	POS	O	'	_	0	SENT_291	[p22l244t787r533b850],
10	i	FW	O	i	dep	8	SENT_291	[p22l244t787r533b850],
11	'	''	O	'	_	0	SENT_291	[p22l244t787r533b850],
12	:	:	O	:	_	0	SENT_291	[p22l244t787r533b850],
13	i	FW	O	i	dep	8	SENT_291	[p22l244t787r533b850],
14	:	:	O	:	_	0	SENT_291	[p22l244t787r533b850],
15	103	CD	NUMBER	103	number	16	SENT_291	[p22l846t790r930b835],
16	(	CD	NUMBER	(	dep	13	SENT_291	[p22l959t790r1054b850],
17	60	CD	NUMBER	60	num	18	SENT_291	[p22l959t790r1054b850],
18	)	NN	O	)	dep	16	SENT_291	[p22l959t790r1054b850],
19	16	CD	NUMBER	16	dep	16	SENT_291	[p22l1584t791r1640b835],
20	(	CD	NUMBER	(	number	21	SENT_291	[p22l1665t791r1728b850],
21	9	CD	NUMBER	9	num	25	SENT_291	[p22l1665t791r1728b850],
22	)	NN	O	)	nn	25	SENT_291	[p22l1665t791r1728b850],
23	Diarrhea	NN	O	diarrhea	nn	25	SENT_291	[p22l66t898r287b946],
24	103	CD	NUMBER	103	num	25	SENT_291	[p22l846t901r930b946],
25	(	NN	O	(	dep	8	SENT_291	[p22l959t901r1054b961],
26	60	CD	NUMBER	60	number	27	SENT_291	[p22l959t901r1054b961],
27	)	CD	NUMBER	)	num	25	SENT_291	[p22l959t901r1054b961],
28	Nausea	NN	O	nausea	dep	31	SENT_291	[p22l66t1009r286b1072],
29	§	CD	NUMBER	§	num	28	SENT_291	[p22l66t1009r286b1072],
30	55	CD	NUMBER	55	num	31	SENT_291	[p22l977t1013r1054b1072],
31	)	NN	O	)	_	0	SENT_291	[p22l977t1013r1054b1072],

1	Constipation	NN	O	constipation	_	0	SENT_292	[p22l63t1235r397b1294],
2	42	CD	NUMBER	42	number	3	SENT_292	[p22l975t1235r1054b1294],
3	)	CD	NUMBER	)	dep	1	SENT_292	[p22l975t1235r1054b1294],
4	Elevated	JJ	O	elevated	amod	5	SENT_292	[p22l67t1342r279b1390],
5	aminotransferase	NN	O	aminotransferase	dep	3	SENT_292	[p22l302t1342r761b1390],
6	38	CD	NUMBER	38	num	7	SENT_292	[p22l977t1345r1054b1405],
7	)	NN	O	)	dep	1	SENT_292	[p22l977t1345r1054b1405],

1	|	NN	O	|	_	0	SENT_293	[p22l161t1414r338b1478],
2	eve	NN	O	eve	nn	3	SENT_293	[p22l161t1414r338b1478],
3	|	NN	O	|	dep	1	SENT_293	[p22l161t1414r338b1478],
4	s	NNS	O	s	dep	3	SENT_293	[p22l161t1414r338b1478],
5	'	POS	O	'	_	0	SENT_293	[p22l161t1414r338b1478],
6	i	FW	O	i	dep	4	SENT_293	[p22l161t1414r338b1478],
7	'	''	O	'	_	0	SENT_293	[p22l161t1414r338b1478],

1	Edema'i	NNP	O	Edema'i	dep	7	SENT_294	[p22l67t1525r277b1589],
2	‘	CD	NUMBER	‘	num	1	SENT_294	[p22l67t1525r277b1589],
3	54	CD	NUMBER	54	dep	1	SENT_294	[p22l875t1530r933b1573],
4	(	NN	O	(	dep	7	SENT_294	[p22l959t1529r1054b1589],
5	31	CD	NUMBER	31	num	4	SENT_294	[p22l959t1529r1054b1589],
6	)	CD	NUMBER	)	num	7	SENT_294	[p22l959t1529r1054b1589],
7	Fatigue	NNP	O	Fatigue	dep	11	SENT_294	[p22l67t1640r255b1700],
8	46	CD	NUMBER	46	num	7	SENT_294	[p22l873t1640r934b1685],
9	(	CD	NUMBER	(	dep	7	SENT_294	[p22l959t1640r1054b1699],
10	27	CD	NUMBER	27	num	11	SENT_294	[p22l959t1640r1054b1699],
11	)	NN	O	)	_	0	SENT_294	[p22l959t1640r1054b1699],

1	Vomiting	VBG	O	vomit	_	0	SENT_295	[p22l60t1119r327b1183],
2	§	CD	NUMBER	§	number	3	SENT_295	[p22l60t1119r327b1183],
3	80	CD	NUMBER	80	num	4	SENT_295	[p22l874t1123r935b1169],
4	(	NN	O	(	dobj	1	SENT_295	[p22l959t1124r973b1183],
5	7	CD	NUMBER	7	num	6	SENT_295	[p22l1011t1124r1054b1183],
6	)	NN	O	)	dep	4	SENT_295	[p22l1011t1124r1054b1183],

1	Upper	NNP	O	Upper	nn	3	SENT_296	[p22l66t1752r226b1810],
2	respiratory	JJ	O	respiratory	amod	3	SENT_296	[p22l246t1752r525b1811],
3	infec	NN	O	infec	_	0	SENT_296	[p22l546t1747r684b1796],
4	-	:	O	-	_	0	SENT_296	[p22l546t1747r684b1796],
5	44	CD	NUMBER	44	number	6	SENT_296	[p22l873t1752r933b1795],
6	(	CD	NUMBER	(	dep	3	SENT_296	[p22l959t1751r1054b1810],
7	26	CD	NUMBER	26	num	8	SENT_296	[p22l959t1751r1054b1810],
8	)	NN	O	)	dep	6	SENT_296	[p22l959t1751r1054b1810],

1	tion	NN	O	tion	_	0	SENT_297	[p22l157t1824r294b1883],
2	'	''	O	'	_	0	SENT_297	[p22l157t1824r294b1883],
3	i	FW	O	i	rcmod	1	SENT_297	[p22l157t1824r294b1883],
4	'	''	O	'	_	0	SENT_297	[p22l157t1824r294b1883],
5	Dysgeusia	NNP	O	Dysgeusia	dep	6	SENT_297	[p22l67t1935r330b1994],
6	Dizziness	NNP	O	Dizziness	dep	3	SENT_297	[p22l67t2046r352b2105],
7	)	CD	NUMBER	)	number	8	SENT_297	[p22l67t2046r352b2105],
8	‘	CD	NUMBER	‘	num	6	SENT_297	[p22l67t2046r352b2105],
9	Dyspnea'i	NN	O	dyspnea'us	dep	3	SENT_297	[p22l67t2148r347b2217],
10	'	''	O	'	_	0	SENT_297	[p22l67t2148r347b2217],
11	|	CD	NUMBER	|	number	12	SENT_297	[p22l67t2148r347b2217],
12	|	CD	NUMBER	|	dep	1	SENT_297	[p22l67t2148r347b2217],
13	Rash	NNP	O	Rash	dep	12	SENT_297	[p22l67t2264r186b2312],

1	Alopecia	NNP	PERSON	Alopecia	_	0	SENT_298	[p22l60t2375r285b2437],

1	7	CD	NUMBER	7	dep	7	SENT_299	[p22l11t2543r39b2571],
2	'	''	O	'	_	0	SENT_299	[p22l11t2543r39b2571],
3	‘	CD	NUMBER	‘	num	5	SENT_299	[p22l11t2543r39b2571],
4	Adverse	JJ	O	adverse	amod	5	SENT_299	[p22l58t2538r267b2587],
5	events	NNS	O	event	nsubjpass	7	SENT_299	[p22l289t2548r456b2587],
6	are	VBP	O	be	auxpass	7	SENT_299	[p22l480t2555r557b2587],
7	listed	VBN	O	list	_	0	SENT_299	[p22l582t2538r717b2587],
8	here	RB	O	here	advmod	11	SENT_299	[p22l744t2538r853b2587],
9	ifthey	NN	O	ifthey	nsubjpass	11	SENT_299	[p22l878t2538r1034b2601],
10	were	VBD	O	be	auxpass	11	SENT_299	[p22l1053t2555r1175b2587],
11	reported	VBN	O	report	dep	7	SENT_299	[p22l1200t2538r1417b2601],
12	in	IN	O	in	_	0	SENT_299	[p22l1444t2543r1486b2586],
13	15	CD	PERCENT	15	number	14	SENT_299	[p22l1514t2541r1625b2589],
14	%	NN	PERCENT	%	prep_in	11	SENT_299	[p22l1514t2541r1625b2589],
15	or	CC	O	or	_	0	SENT_299	[p22l1647t2555r1700b2587],
16	more	JJR	O	more	conj_or	14	SENT_299	[p22l1723t2555r1856b2587],
17	of	IN	O	of	_	0	SENT_299	[p22l1879t2538r1936b2587],
18	patients	NNS	O	patient	prep_of	14	SENT_299	[p22l1951t2555r2027b2601, p22l58t2616r203b2660],
19	in	IN	O	in	prep	11	SENT_299	[p22l229t2616r270b2659],
20	either	CC	O	either	dep	19	SENT_299	[p22l295t2611r444b2660],
21	treatment	NN	O	treatment	nn	22	SENT_299	[p22l463t2620r723b2660],
22	group	NN	O	group	conj	19	SENT_299	[p22l744t2628r897b2675],
23	and	CC	O	and	_	0	SENT_299	[p22l920t2611r1012b2660],
24	ifthere	NN	O	ifthere	nsubj	31	SENT_299	[p22l1039t2610r1220b2660],
25	was	VBD	O	be	cop	31	SENT_299	[p22l1241t2628r1339b2660],
26	at	IN	O	at	advmod	31	SENT_299	[p22l1363t2620r1409b2660],
27	least	JJS	O	least	pobj	26	SENT_299	[p22l1433t2611r1551b2660],
28	a	DT	O	a	det	31	SENT_299	[p22l1573t2628r1598b2659],
29	5	CD	PERCENT	5	number	30	SENT_299	[p22l1622t2613r1703b2662],
30	%	NN	PERCENT	%	amod	31	SENT_299	[p22l1622t2613r1703b2662],
31	difference	NN	O	difference	conj_and	11	SENT_299	[p22l1725t2610r1983b2660],
32	between	IN	O	between	_	0	SENT_299	[p22l2008t2611r2082b2660, p22l58t2692r210b2732],
33	the	DT	O	the	det	35	SENT_299	[p22l233t2683r315b2732],
34	two	CD	NUMBER	two	num	35	SENT_299	[p22l335t2692r429b2732],
35	groups	NNS	O	group	prep_between	31	SENT_299	[p22l452t2700r648b2747],
36	.	.	O	.	_	0	SENT_299	[p22l452t2700r648b2747],

1	1	CD	NUMBER	1	dep	5	SENT_300	[p22l13t2759r42b2819],
2	'	''	O	'	_	0	SENT_300	[p22l13t2759r42b2819],
3	This	DT	O	this	det	4	SENT_300	[p22l57t2755r167b2804],
4	item	NN	O	item	nsubj	5	SENT_300	[p22l193t2760r304b2804],
5	comprised	VBD	O	comprise	_	0	SENT_300	[p22l329t2755r604b2818],
6	a	DT	O	a	det	7	SENT_300	[p22l630t2772r654b2803],
7	cluster	NN	O	cluster	dobj	5	SENT_300	[p22l677t2755r854b2804],
8	of	IN	O	of	_	0	SENT_300	[p22l874t2754r931b2804],
9	adverse	JJ	O	adverse	amod	10	SENT_300	[p22l945t2755r1144b2804],
10	events	NNS	O	event	prep_of	7	SENT_300	[p22l1166t2764r1332b2804],
11	that	WDT	O	that	nsubj	13	SENT_300	[p22l1354t2755r1457b2804],
12	may	MD	O	may	aux	13	SENT_300	[p22l1481t2772r1586b2818],
13	represent	VB	O	represent	rcmod	7	SENT_300	[p22l1610t2764r1856b2818],
14	similar	JJ	O	similar	amod	16	SENT_300	[p22l1878t2755r2057b2804],
15	clinical	JJ	O	clinical	amod	16	SENT_300	[p22l60t2827r237b2876],
16	symptoms	NNS	O	symptom	dobj	13	SENT_300	[p22l263t2836r537b2891],
17	or	CC	O	or	_	0	SENT_300	[p22l561t2844r614b2876],
18	syndromes	NNS	O	syndrome	dobj	13	SENT_300	[p22l636t2827r937b2891],
19	.	.	O	.	_	0	SENT_300	[p22l636t2827r937b2891],

1	:	:	O	:	_	0	SENT_301	[p22l13t2903r42b2963],
2	i	FW	O	i	nsubj	22	SENT_301	[p22l13t2903r42b2963],
3	:	:	O	:	_	0	SENT_301	[p22l13t2903r42b2963],
4	The	DT	O	the	det	5	SENT_301	[p22l57t2899r155b2948],
5	category	NN	O	category	dep	2	SENT_301	[p22l177t2908r399b2963],
6	of	IN	O	of	_	0	SENT_301	[p22l421t2898r478b2948],
7	vision	NN	O	vision	nn	8	SENT_301	[p22l490t2904r644b2948],
8	disorder	NN	O	disorder	prep_of	5	SENT_301	[p22l669t2899r890b2948],
9	included	VBD	O	include	rcmod	8	SENT_301	[p22l913t2899r1134b2948],
10	(	CD	NUMBER	(	dobj	9	SENT_301	[p22l1165t2903r1227b2962],
11	in	IN	O	in	_	0	SENT_301	[p22l1165t2903r1227b2962],
12	descending	VBG	O	descend	amod	13	SENT_301	[p22l1252t2899r1556b2963],
13	order	NN	O	order	prep_in	9	SENT_301	[p22l1578t2899r1719b2948],
14	of	IN	O	of	_	0	SENT_301	[p22l1739t2898r1797b2948],
15	frequency	NN	O	frequency	nn	20	SENT_301	[p22l1809t2898r2083b2963],
16	)	CD	NUMBER	)	num	20	SENT_301	[p22l1809t2898r2083b2963],
17	visual	JJ	O	visual	amod	20	SENT_301	[p22l58t2971r206b3020],
18	impairment	NN	O	impairment	nn	20	SENT_301	[p22l233t2976r553b3034],
19	,	,	O	,	_	0	SENT_301	[p22l233t2976r553b3034],
20	photopsia	NN	O	photopsium	prep_of	13	SENT_301	[p22l580t2971r854b3034],
21	,	,	O	,	_	0	SENT_301	[p22l580t2971r854b3034],
22	blurred	VBD	O	blur	_	0	SENT_301	[p22l881t2971r1064b3020],
23	vision	NN	O	vision	dobj	22	SENT_301	[p22l1087t2976r1256b3028],
24	,	,	O	,	_	0	SENT_301	[p22l1087t2976r1256b3028],
25	vitreous	JJ	O	vitreous	amod	26	SENT_301	[p22l1279t2976r1488b3020],
26	ﬂoaters	NNS	O	ﬂoaters	conj_or	23	SENT_301	[p22l1511t2970r1720b3028],
27	,	,	O	,	_	0	SENT_301	[p22l1511t2970r1720b3028],
28	halo	NN	O	halo	nn	29	SENT_301	[p22l1747t2971r1854b3020],
29	vision	NN	O	vision	conj_or	23	SENT_301	[p22l1875t2976r2028b3020],
30	or	CC	O	or	_	0	SENT_301	[p22l2053t2988r2106b3019],
31	photophobia	NN	O	photophobia	conj_or	23	SENT_301	[p22l62t3043r410b3106],
32	,	,	O	,	_	0	SENT_301	[p22l62t3043r410b3106],
33	chromatopsia	NN	O	chromatopsium	conj_or	23	SENT_301	[p22l435t3043r797b3106],
34	or	CC	O	or	_	0	SENT_301	[p22l820t3060r873b3092],
35	diplopia	NN	O	diplopium	conj_or	23	SENT_301	[p22l894t3043r1119b3106],
36	,	,	O	,	_	0	SENT_301	[p22l894t3043r1119b3106],
37	and	CC	O	and	_	0	SENT_301	[p22l1144t3043r1236b3092],
38	reduced	VBD	O	reduce	conj_and	22	SENT_301	[p22l1264t3043r1468b3092],
39	visual	JJ	O	visual	amod	40	SENT_301	[p22l1492t3043r1640b3092],
40	acuity	NN	O	acuity	dobj	38	SENT_301	[p22l1666t3048r1830b3106],
41	.	.	O	.	_	0	SENT_301	[p22l1666t3048r1830b3106],

1	§	NN	O	§	nn	3	SENT_302	[p22l12t3115r31b3178],
2	The	DT	O	the	det	3	SENT_302	[p22l57t3115r154b3164],
3	use	NN	O	use	nsubj	9	SENT_302	[p22l179t3132r265b3164],
4	of	IN	O	of	_	0	SENT_302	[p22l287t3114r345b3164],
5	antiemetic	JJ	O	antiemetic	amod	6	SENT_302	[p22l358t3120r634b3164],
6	agents	NNS	O	agent	prep_of	3	SENT_302	[p22l656t3124r826b3179],
7	was	VBD	O	be	cop	9	SENT_302	[p22l848t3132r946b3164],
8	significantly	RB	O	significantly	advmod	9	SENT_302	[p22l971t3114r1283b3179],
9	higher	JJR	O	higher	_	0	SENT_302	[p22l1307t3115r1471b3179],
10	in	IN	O	in	_	0	SENT_302	[p22l1493t3119r1534b3163],
11	the	DT	O	the	det	13	SENT_302	[p22l1558t3115r1639b3164],
12	chemotherapy	NN	O	chemotherapy	nn	13	SENT_302	[p22l1662t3115r2038b3179],
13	group	NN	O	group	prep_in	9	SENT_302	[p22l60t3204r212b3251],
14	than	IN	O	than	dep	9	SENT_302	[p22l233t3187r347b3236],
15	in	IN	O	in	_	0	SENT_302	[p22l375t3192r416b3235],
16	the	DT	O	the	det	18	SENT_302	[p22l439t3187r521b3236],
17	crizotinib	JJ	O	crizotinib	amod	18	SENT_302	[p22l543t3187r788b3236],
18	group	NN	O	group	prep_in	9	SENT_302	[p22l811t3204r964b3251],
19	(	CD	PERCENT	(	number	20	SENT_302	[p22l992t3189r1124b3250],
20	67	CD	PERCENT	67	dep	21	SENT_302	[p22l992t3189r1124b3250],
21	%	NN	PERCENT	%	dep	18	SENT_302	[p22l992t3189r1124b3250],
22	vs.	CC	O	vs.	prep	18	SENT_302	[p22l1145t3204r1213b3236],
23	20	CD	PERCENT	20	num	24	SENT_302	[p22l1238t3189r1389b3250],
24	%	NN	PERCENT	%	dep	22	SENT_302	[p22l1238t3189r1389b3250],
25	)	CD	NUMBER	)	dep	18	SENT_302	[p22l1238t3189r1389b3250],
26	.	.	O	.	_	0	SENT_302	[p22l1238t3189r1389b3250],

1	1	CD	NUMBER	1	num	2	SENT_303	[p22l12t3259r43b3321],
2	]	CD	NUMBER	]	nsubj	6	SENT_303	[p22l12t3259r43b3321],
3	Included	VBN	O	include	partmod	2	SENT_303	[p22l64t3259r284b3308],
4	is	VBZ	O	be	cop	6	SENT_303	[p22l311t3264r348b3308],
5	one	CD	NUMBER	one	num	6	SENT_303	[p22l372t3276r467b3308],
6	case	NN	O	case	dep	15	SENT_303	[p22l489t3276r602b3308],
7	that	WDT	O	that	nsubj	8	SENT_303	[p22l622t3259r725b3308],
8	met	VBD	O	meet	rcmod	6	SENT_303	[p22l749t3268r847b3308],
9	the	DT	O	the	det	10	SENT_303	[p22l867t3259r948b3308],
10	criteria	NNS	O	criterion	dobj	8	SENT_303	[p22l971t3264r1149b3308],
11	for	IN	O	for	_	0	SENT_303	[p22l1171t3258r1244b3308],
12	Hy	NN	PERSON	hy	poss	14	SENT_303	[p22l1268t3263r1378b3323],
13	’s	POS	O	’s	_	0	SENT_303	[p22l1268t3263r1378b3323],
14	law	NN	O	law	prep_for	8	SENT_303	[p22l1404t3259r1488b3308],
15	(	VBD	O	(	_	0	SENT_303	[p22l1514t3263r1557b3322],
16	a	DT	O	a	det	21	SENT_303	[p22l1514t3263r1557b3322],
17	serum	NN	O	serum	nn	21	SENT_303	[p22l1581t3276r1742b3308],
18	bilirubin	NN	O	bilirubin	nn	21	SENT_303	[p22l1769t3259r1982b3308],
19	level	NN	O	level	nn	21	SENT_303	[p22l2009t3259r2119b3308],
20	of23	NN	O	of23	nn	21	SENT_303	[p22l60t3330r189b3380],
21	times	NNS	O	time	nsubj	27	SENT_303	[p22l213t3336r358b3380],
22	the	DT	O	the	det	25	SENT_303	[p22l379t3331r461b3380],
23	upper	JJ	O	upper	amod	25	SENT_303	[p22l486t3348r637b3394],
24	limit	NN	O	limit	nn	25	SENT_303	[p22l660t3331r775b3380],
25	ofthe	NN	O	ofthe	dep	21	SENT_303	[p22l796t3330r946b3380],
26	normal	JJ	O	normal	dep	27	SENT_303	[p22l971t3331r1152b3380],
27	range	NN	O	range	xcomp	15	SENT_303	[p22l1180t3348r1322b3395],
28	in	IN	O	in	_	0	SENT_303	[p22l1347t3336r1388b3379],
29	the	DT	O	the	det	30	SENT_303	[p22l1411t3331r1493b3380],
30	absence	NN	O	absence	prep_in	27	SENT_303	[p22l1516t3331r1727b3380],
31	of	IN	O	of	_	0	SENT_303	[p22l1749t3330r1807b3380],
32	biliary	JJ	O	biliary	amod	33	SENT_303	[p22l1822t3331r1976b3394],
33	obstruction	NN	O	obstruction	poss	40	SENT_303	[p22l1996t3331r2077b3380, p22l61t3408r290b3452],
34	or	CC	O	or	_	0	SENT_303	[p22l316t3420r369b3452],
35	Gi	NN	O	gi	nn	37	SENT_303	[p22l389t3403r610b3452],
36	|	CD	NUMBER	|	num	37	SENT_303	[p22l389t3403r610b3452],
37	bert	NN	O	bert	conj_or	33	SENT_303	[p22l389t3403r610b3452],
38	’s	POS	O	’s	_	0	SENT_303	[p22l389t3403r610b3452],
39	syndrome	NN	O	syndrome	nn	40	SENT_303	[p22l635t3403r931b3467],
40	)	NN	O	)	prep_of	30	SENT_303	[p22l635t3403r931b3467],
41	,	,	O	,	_	0	SENT_303	[p22l635t3403r931b3467],
42	with	IN	O	with	_	0	SENT_303	[p22l954t3403r1061b3452],
43	grade	NN	O	grade	prep_with	27	SENT_303	[p22l1087t3403r1231b3467],
44	5	CD	NUMBER	5	num	46	SENT_303	[p22l1254t3407r1278b3452],
45	hepatic	JJ	O	hepatic	amod	46	SENT_303	[p22l1305t3403r1494b3466],
46	failure	NN	O	failure	nsubj	15	SENT_303	[p22l1514t3402r1677b3452],
47	occurring	VBG	O	occur	dep	15	SENT_303	[p22l1699t3408r1948b3467],
48	after	IN	O	after	mark	51	SENT_303	[p22l1970t3402r2087b3452],
49	the	DT	O	the	det	50	SENT_303	[p22l58t3475r139b3523],
50	data	NNS	O	datum	nsubj	51	SENT_303	[p22l162t3475r271b3523],
51	cutoff	VBP	O	cutoff	advcl	47	SENT_303	[p22l295t3474r453b3523],
52	date	NN	O	date	dobj	51	SENT_303	[p22l466t3475r590b3523],
53	.	.	O	.	_	0	SENT_303	[p22l466t3475r590b3523],

1	ll	NN	O	ll	nn	3	SENT_304	[p22l18t3541r29b3610],
2	One	CD	NUMBER	one	num	3	SENT_304	[p22l60t3549r169b3594],
3	case	NN	O	case	nsubjpass	9	SENT_304	[p22l191t3563r305b3594],
4	of	IN	O	of	_	0	SENT_304	[p22l327t3545r384b3594],
5	grade	NN	O	grade	nn	7	SENT_304	[p22l397t3546r542b3609],
6	5	CD	NUMBER	5	num	7	SENT_304	[p22l565t3550r588b3594],
7	dyspnea	NN	O	dyspnea	prep_of	3	SENT_304	[p22l614t3546r828b3609],
8	was	VBD	O	be	auxpass	9	SENT_304	[p22l849t3563r947b3594],
9	reported	VBN	O	report	_	0	SENT_304	[p22l974t3546r1191b3608],
10	in	IN	O	in	_	0	SENT_304	[p22l1218t3550r1259b3593],
11	each	DT	O	each	det	13	SENT_304	[p22l1284t3546r1401b3594],
12	treatment	NN	O	treatment	nn	13	SENT_304	[p22l1424t3555r1683b3594],
13	group	NN	O	group	prep_in	9	SENT_304	[p22l1705t3563r1858b3609],
14	(	CD	NUMBER	(	npadvmod	15	SENT_304	[p22l1886t3548r2021b3608],
15	<	JJR	O	<	amod	13	SENT_304	[p22l1886t3548r2021b3608],
16	1	CD	PERCENT	1	num	17	SENT_304	[p22l1886t3548r2021b3608],
17	%	NN	PERCENT	%	dep	15	SENT_304	[p22l1886t3548r2021b3608],
18	of	IN	O	of	_	0	SENT_304	[p22l2043t3545r2100b3594],
19	patients	NNS	O	patient	prep_of	13	SENT_304	[p22l62t3622r268b3680],
20	in	IN	O	in	_	0	SENT_304	[p22l294t3622r336b3665],
21	each	DT	O	each	det	23	SENT_304	[p22l360t3617r477b3666],
22	group	NN	O	group	nn	23	SENT_304	[p22l502t3621r693b3681],
23	)	NN	O	)	prep_in	19	SENT_304	[p22l502t3621r693b3681],
24	.	.	O	.	_	0	SENT_304	[p22l502t3621r693b3681],

1	second-line	JJ	O	second-line	amod	2	SENT_305	[p23l12t55r370b114],
2	chemotherapy	NN	O	chemotherapy	nsubj	4	SENT_305	[p23l403t55r850b129],
3	may	MD	O	may	aux	4	SENT_305	[p23l879t74r1011b129],
4	contribute	VB	O	contribute	_	0	SENT_305	[p23l1041t55r1363b114],
5	to	TO	O	to	_	0	SENT_305	[p23l1396t67r1456b114],
6	improving	VBG	O	improve	prepc_to	4	SENT_305	[p23l1488t56r1595b113, p23l10t151r254b225],
7	survival	NN	O	survival	dobj	6	SENT_305	[p23l291t150r555b209],
8	.	.	O	.	_	0	SENT_305	[p23l291t150r555b209],

1	In	IN	O	in	_	0	SENT_306	[p23l598t156r665b208],
2	contrast	NN	O	contrast	prep_in	38	SENT_306	[p23l705t162r983b221],
3	,	,	O	,	_	0	SENT_306	[p23l705t162r983b221],
4	in	IN	O	in	_	0	SENT_306	[p23l1027t151r1089b208],
5	a	DT	O	a	det	8	SENT_306	[p23l1128t169r1161b208],
6	small	JJ	O	small	amod	7	SENT_306	[p23l1200t150r1376b208],
7	retrospective	JJ	O	retrospective	amod	8	SENT_306	[p23l1415t162r1595b209, p23l12t246r265b319],
8	study	NN	O	study	prep_in	38	SENT_306	[p23l297t245r478b319],
9	,	,	O	,	_	0	SENT_306	[p23l297t245r478b319],
10	the	DT	O	the	det	13	SENT_306	[p23l513t245r612b303],
11	median	JJ	O	median	amod	13	SENT_306	[p23l643t245r885b304],
12	overall	JJ	O	overall	amod	13	SENT_306	[p23l916t245r1129b304],
13	survival	NN	O	survival	nsubj	38	SENT_306	[p23l1161t245r1408b304],
14	from	IN	O	from	_	0	SENT_306	[p23l1439t244r1596b304],
15	the	DT	O	the	det	16	SENT_306	[p23l11t340r107b398],
16	time	NN	O	time	prep_from	13	SENT_306	[p23l129t341r269b398],
17	of	IN	O	of	_	0	SENT_306	[p23l291t339r364b399],
18	initiation	NN	O	initiation	prep_of	16	SENT_306	[p23l372t341r655b399],
19	of	IN	O	of	_	0	SENT_306	[p23l678t339r751b399],
20	second-line	JJ	O	second-line	amod	21	SENT_306	[p23l760t340r1110b399],
21	therapy	NN	O	therapy	prep_of	18	SENT_306	[p23l1132t340r1363b414],
22	among	IN	O	among	_	0	SENT_306	[p23l1381t359r1598b415],
23	patients	NNS	O	patient	prep_among	21	SENT_306	[p23l10t436r254b509],
24	with	IN	O	with	_	0	SENT_306	[p23l273t435r414b494],
25	ALK-positive	JJ	O	alk-positive	amod	30	SENT_306	[p23l430t436r806b509],
26	non	JJ	O	non	amod	30	SENT_306	[p23l827t435r1286b494],
27	—	NN	O	—	nn	30	SENT_306	[p23l827t435r1286b494],
28	small-cell	NN	O	small-cell	nn	30	SENT_306	[p23l827t435r1286b494],
29	lung	NN	O	lung	nn	30	SENT_306	[p23l1306t435r1446b510],
30	cancer	NN	O	cancer	prep_with	23	SENT_306	[p23l1465t454r1595b493, p23l12t550r103b590],
31	who	WP	O	who	nsubj	34	SENT_306	[p23l115t531r249b590],
32	had	VBD	O	have	aux	34	SENT_306	[p23l267t531r381b590],
33	not	RB	O	not	neg	34	SENT_306	[p23l399t543r502b590],
34	received	VBN	O	receive	rcmod	16	SENT_306	[p23l516t531r763b590],
35	crizotinib	NN	O	crizotinib	dobj	34	SENT_306	[p23l781t531r1080b590],
36	was	VBD	O	be	cop	38	SENT_306	[p23l1096t551r1214b590],
37	6	CD	DURATION	6	num	38	SENT_306	[p23l1234t536r1269b590],
38	months	NNS	NUMBER	month	_	0	SENT_306	[p23l1287t531r1596b590],
39	.	.	O	.	_	0	SENT_306	[p23l1287t531r1596b590],

1	”	NN	O	”	nsubjpass	7	SENT_307	[p23l1287t531r1596b590],
2	Both	CC	O	both	preconj	1	SENT_307	[p23l106t626r259b685],
3	crizotinib	NN	O	crizotinib	conj	1	SENT_307	[p23l303t626r616b685],
4	and	CC	O	and	_	0	SENT_307	[p23l660t626r777b685],
5	chemotherapy	NN	O	chemotherapy	conj_and	3	SENT_307	[p23l821t626r1277b700],
6	were	VBD	O	be	auxpass	7	SENT_307	[p23l1313t645r1463b685],
7	associated	VBN	O	associate	_	0	SENT_307	[p23l1506t645r1595b684, p23l12t721r274b780],
8	with	IN	O	with	_	0	SENT_307	[p23l311t721r457b780],
9	toxic	JJ	O	toxic	amod	10	SENT_307	[p23l497t722r651b780],
10	effects	NNS	O	effect	prep_with	7	SENT_307	[p23l692t720r901b779],
11	that	WDT	O	that	nsubj	14	SENT_307	[p23l944t721r1072b779],
12	were	VBD	O	be	cop	14	SENT_307	[p23l1106t740r1257b780],
13	primarily	RB	O	primarily	advmod	14	SENT_307	[p23l1296t721r1599b795],
14	grade	NN	O	grade	rcmod	10	SENT_307	[p23l11t816r183b891],
15	1	CD	NUMBER	1	num	14	SENT_307	[p23l208t820r241b873],
16	or	CC	O	or	_	0	SENT_307	[p23l265t835r330b875],
17	2	CD	NUMBER	2	conj_or	14	SENT_307	[p23l351t820r402b875],
18	.	.	O	.	_	0	SENT_307	[p23l351t820r402b875],

1	Two	CD	NUMBER	two	num	4	SENT_308	[p23l427t821r555b875],
2	important	JJ	O	important	amod	4	SENT_308	[p23l579t817r895b890],
3	toxic	JJ	O	toxic	amod	4	SENT_308	[p23l914t817r1062b875],
4	effects	NNS	O	effect	nsubj	13	SENT_308	[p23l1085t815r1285b874],
5	that	WDT	O	that	nsubjpass	7	SENT_308	[p23l1310t816r1434b874],
6	were	VBD	O	be	auxpass	7	SENT_308	[p23l1450t835r1596b875],
7	associated	VBN	O	associate	rcmod	4	SENT_308	[p23l11t912r343b971],
8	with	IN	O	with	_	0	SENT_308	[p23l371t912r517b971],
9	crizotinib	NN	O	crizotinib	prep_with	7	SENT_308	[p23l549t912r863b971],
10	were	VBD	O	be	cop	13	SENT_308	[p23l893t931r1043b971],
11	elevated	JJ	O	elevated	amod	13	SENT_308	[p23l1076t912r1331b971],
12	aminotransferase	NN	O	aminotransferase	nn	13	SENT_308	[p23l1363t913r1595b971, p23l11t1006r351b1065],
13	levels	NNS	O	level	_	0	SENT_308	[p23l394t1007r566b1066],
14	and	CC	O	and	_	0	SENT_308	[p23l612t1007r730b1066],
15	interstitial	JJ	O	interstitial	amod	17	SENT_308	[p23l775t1007r1111b1065],
16	lung	NN	O	lung	nn	17	SENT_308	[p23l1155t1007r1299b1082],
17	disease	NN	O	disease	conj_and	13	SENT_308	[p23l1343t1007r1591b1066],
18	.	.	O	.	_	0	SENT_308	[p23l1343t1007r1591b1066],

1	Treatment-related	JJ	O	treatment-related	amod	2	SENT_309	[p23l9t1103r582b1162],
2	elevation	NN	O	elevation	nsubjpass	10	SENT_309	[p23l617t1103r901b1162],
3	of	IN	O	of	_	0	SENT_309	[p23l936t1102r1010b1162],
4	aminotransferase	NN	O	aminotransferase	nn	5	SENT_309	[p23l1030t1102r1596b1162],
5	levels	NNS	O	level	prep_of	2	SENT_309	[p23l10t1198r182b1257],
6	of	IN	O	of	_	0	SENT_309	[p23l219t1197r294b1257],
7	any	DT	O	any	det	8	SENT_309	[p23l314t1217r426b1272],
8	grade	NN	O	grade	prep_of	5	SENT_309	[p23l458t1198r636b1273],
9	was	VBD	O	be	auxpass	10	SENT_309	[p23l668t1217r789b1257],
10	reported	VBN	O	report	_	0	SENT_309	[p23l825t1198r1099b1272],
11	in	IN	O	in	_	0	SENT_309	[p23l1133t1199r1195b1256],
12	66	CD	NUMBER	66	num	13	SENT_309	[p23l1230t1202r1305b1257],
13	patients	NNS	O	patient	prep_in	10	SENT_309	[p23l1339t1199r1594b1272],

1	N	NN	O	n	nn	3	SENT_310	[p23l571t1358r585b1373],
2	ENGLJ	NN	O	englj	nn	3	SENT_310	[p23l600t1358r678b1380],
3	MED	NN	O	med	_	0	SENT_310	[p23l692t1358r744b1373],
4	368	CD	NUMBER	368	dep	3	SENT_310	[p23l755t1352r834b1380],
5	;	:	O	;	_	0	SENT_310	[p23l755t1352r834b1380],
6	25	CD	NUMBER	25	num	8	SENT_310	[p23l755t1352r834b1380],
7	NEjM.oRG	NN	O	nejm.org	nn	8	SENT_310	[p23l869t1358r993b1380],
8	JUNE	NN	DATE	june	dep	3	SENT_310	[p23l1024t1358r1088b1380],
9	20	CD	DATE	20	dep	8	SENT_310	[p23l1099t1358r1136b1378],
10	,	,	DATE	,	_	0	SENT_310	[p23l1099t1358r1136b1378],
11	2013	CD	DATE	2013	appos	9	SENT_310	[p23l1147t1358r1202b1380],
12	The	DT	O	the	det	16	SENT_310	[p23l702t1391r753b1415],
13	New	NNP	LOCATION	New	nn	16	SENT_310	[p23l762t1392r824b1415],
14	England	NNP	LOCATION	England	nn	16	SENT_310	[p23l833t1391r944b1422],
15	J	NNP	O	J	nn	16	SENT_310	[p23l952t1392r965b1415],
16	oumal	NN	O	oumal	dep	3	SENT_310	[p23l966t1391r1050b1415],
17	of	IN	O	of	_	0	SENT_310	[p23l1059t1391r1088b1415],
18	Medicine	NN	O	medicine	prep_of	16	SENT_310	[p23l1095t1391r1220b1415],

1	The	DT	O	the	det	4	SENT_311	[p23l813t1516r858b1537],
2	NEW	NNP	O	NEW	nn	4	SENT_311	[p23l877t1518r962b1537],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_311	[p23l981t1518r1169b1537],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_311	[p23l1188t1518r1368b1544],
5	of	IN	O	of	_	0	SENT_311	[p23l1387t1516r1416b1543],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_311	[p23l1428t1518r1627b1537],

1	A	DT	O	a	det	3	SENT_312	[p24l393t34r415b59],
2	Overall	JJ	O	overall	amod	3	SENT_312	[p24l437t36r528b60],
3	Change	NNP	O	Change	_	0	SENT_312	[p24l538t36r636b67],
4	from	IN	O	from	_	0	SENT_312	[p24l644t36r704b60],
5	Baseline	NNP	O	Baseline	prep_from	3	SENT_312	[p24l716t36r822b60],
6	in	IN	O	in	_	0	SENT_312	[p24l831t37r853b59],
7	Symptoms	NNPS	O	Symptoms	prep_in	3	SENT_312	[p24l863t38r1000b67],
8	and	CC	O	and	_	0	SENT_312	[p24l1010t36r1056b60],
9	Global	NNP	O	Global	nn	10	SENT_312	[p24l1066t36r1148b60],
10	QOL	NNP	O	QOL	prep_in	3	SENT_312	[p24l1158t38r1221b66],

1	I	PRP	O	I	nsubj	2	SENT_313	[p24l1022t97r1045b121],
2	Crizotinib	VBP	O	crizotinib	_	0	SENT_313	[p24l1059t96r1175b118],
3	I	PRP	O	I	nsubj	4	SENT_313	[p24l1213t97r1237b121],
4	Chemotherapy	NN	O	chemotherapy	xcomp	2	SENT_313	[p24l1250t96r1426b125],

1	P	NN	O	p	_	0	SENT_314	[p24l685t146r781b167],
2	<	JJR	O	<	dep	1	SENT_314	[p24l685t146r781b167],
3	o.	CD	NUMBER	o.	num	4	SENT_314	[p24l685t146r781b167],
4	ool	NN	O	ool	dep	1	SENT_314	[p24l685t146r781b167],
5	for	IN	O	for	_	0	SENT_314	[p24l791t145r824b167],
6	all	DT	O	all	det	7	SENT_314	[p24l832t145r857b167],
7	comparisons	NNS	O	comparison	prep_for	4	SENT_314	[p24l867t147r1022b174],

1	I	PRP	O	I	_	0	SENT_315	[p24l1802t299r1815b301],
2	I	PRP	O	I	dep	1	SENT_315	[p24l1802t220r1815b222],
3	o	NN	O	o	nn	4	SENT_315	[p24l1819t288r1832b309],
4	U1	NN	O	u1	dep	1	SENT_315	[p24l1820t210r1830b230],

1	Improvement	NN	O	improvement	_	0	SENT_316	[p24l1964t133r1993b306],
2	in	IN	O	in	_	0	SENT_316	[p24l1998t292r2021b313],
3	Global	JJ	O	global	amod	4	SENT_316	[p24l1997t200r2021b282],
4	QOL	NN	O	qol	prep_in	1	SENT_316	[p24l1999t127r2028b189],

1	I	PRP	O	I	_	0	SENT_317	[p24l1800t377r1815b380],
2	I	PRP	O	I	nsubj	3	SENT_317	[p24l1818t379r1831b381],
3	UI	VBP	O	ui	rcmod	1	SENT_317	[p24l1833t367r1844b388],

1	Reduction	NN	O	reduction	_	0	SENT_318	[p24l408t468r432b595],
2	in	IN	O	in	_	0	SENT_318	[p24l409t436r431b457],
3	Symptom	NNP	O	Symptom	nn	4	SENT_318	[p24l410t303r439b426],
4	Score	NN	NUMBER	score	prep_in	1	SENT_318	[p24l446t414r467b485],

1	Mean	NN	O	mean	_	0	SENT_319	[p24l530t490r552b559],
2	Change	NNP	O	Change	dep	1	SENT_319	[p24l528t382r559b479],
3	from	IN	O	from	_	0	SENT_319	[p24l528t314r552b374],
4	Baseline	NNP	O	Baseline	prep_from	2	SENT_319	[p24l528t196r552b302],

1	I	PRP	O	I	_	0	SENT_320	[p24l1800t535r1815b538],
2	I	PRP	O	I	advmod	3	SENT_320	[p24l1800t456r1815b459],
3	I	PRP	O	I	dep	1	SENT_320	[p24l1818t525r1844b545],
4	'	''	O	'	_	0	SENT_320	[p24l1818t525r1844b545],
5	.	.	O	.	_	0	SENT_320	[p24l1818t525r1844b545],

1	—	NN	O	—	_	0	SENT_321	[p24l1818t525r1844b545],
2	.	.	O	.	_	0	SENT_321	[p24l1818t525r1844b545],

1	-	:	O	-	_	0	SENT_322	[p24l1818t525r1844b545],
2	IL	NN	O	il	nn	3	SENT_322	[p24l1818t446r1844b466],
3	U1	NN	O	u1	dep	6	SENT_322	[p24l1847t525r1858b545],
4	o	NN	O	o	nn	6	SENT_322	[p24l1847t446r1860b466],
5	Mean	NN	O	mean	nn	6	SENT_322	[p24l1880t496r1901b566],
6	Change	NNP	O	Change	_	0	SENT_322	[p24l1878t388r1909b486],
7	from	IN	O	from	_	0	SENT_322	[p24l1877t320r1901b380],
8	Baseline	NNP	O	Baseline	prep_from	6	SENT_322	[p24l1878t202r1901b308],

1	B	NN	O	b	nn	2	SENT_323	[p24l396t815r414b840],
2	Time	NN	O	time	_	0	SENT_323	[p24l436t817r501b840],
3	to	TO	O	to	_	0	SENT_323	[p24l509t821r534b840],
4	Deterioration	NN	O	deterioration	prep_to	2	SENT_323	[p24l545t817r712b840],
5	with	IN	O	with	dep	2	SENT_323	[p24l722t817r777b840],
6	Respect	NN	O	respect	pobj	5	SENT_323	[p24l789t819r888b847],
7	to	TO	O	to	dep	2	SENT_323	[p24l896t821r921b840],
8	a	DT	O	a	det	12	SENT_323	[p24l930t825r943b840],
9	Composite	NNP	O	Composite	nn	12	SENT_323	[p24l953t817r1092b847],
10	Lung-Cancer-Symptom	NNP	O	Lung-Cancer-Symptom	nn	12	SENT_323	[p24l1103t819r1402b848],
11	End	NNP	O	End	nn	12	SENT_323	[p24l1414t817r1460b840],
12	Point	NN	O	point	pobj	7	SENT_323	[p24l1472t817r1538b840],

1	100	CD	NUMBER	100	_	0	SENT_324	[p24l828t867r869b888],
2	90	CD	NUMBER	90	num	4	SENT_324	[p24l841t914r869b935],
3	Hazard	NN	O	hazard	nn	4	SENT_324	[p24l1302t905r1386b927],
4	ratio	NN	O	ratio	dep	1	SENT_324	[p24l1398t907r1456b931],
5	,	,	O	,	_	0	SENT_324	[p24l1398t907r1456b931],
6	0.54	CD	PERCENT	0.54	appos	4	SENT_324	[p24l1466t906r1516b927],
7	(	CD	PERCENT	(	number	8	SENT_324	[p24l1528t906r1588b934],
8	95	CD	PERCENT	95	num	9	SENT_324	[p24l1528t906r1588b934],
9	%	NN	PERCENT	%	dep	1	SENT_324	[p24l1528t906r1588b934],
10	CI	NN	O	ci	dep	9	SENT_324	[p24l1597t906r1628b931],
11	,	,	O	,	_	0	SENT_324	[p24l1597t906r1628b931],
12	0.40-0	CD	NUMBER	0.40-0	num	14	SENT_324	[p24l1638t906r1764b934],
13	.71	CD	NUMBER	.71	num	14	SENT_324	[p24l1638t906r1764b934],
14	)	NN	O	)	appos	1	SENT_324	[p24l1638t906r1764b934],
15	80	CD	NUMBER	80	num	16	SENT_324	[p24l841t962r869b983],
16	P	NN	O	p	npadvmod	17	SENT_324	[p24l1302t942r1398b962],
17	<	JJR	O	<	amod	14	SENT_324	[p24l1302t942r1398b962],
18	o.	CD	NUMBER	o.	num	19	SENT_324	[p24l1302t942r1398b962],
19	ool	NN	O	ool	dep	1	SENT_324	[p24l1302t942r1398b962],
20	70	CD	NUMBER	70	number	21	SENT_324	[p24l842t1009r869b1030],
21	60	CD	NUMBER	60	dep	19	SENT_324	[p24l842t1056r869b1077],
22	50	CD	NUMBER	50	number	23	SENT_324	[p24l841t1104r869b1124],
23	40	CD	NUMBER	40	dep	1	SENT_324	[p24l841t1151r869b1172],
24	Crizotinib	NNP	O	Crizotinib	dep	23	SENT_324	[p24l1397t1161r1514b1183],
25	30	CD	NUMBER	30	num	24	SENT_324	[p24l842t1198r869b1219],
26	20	CD	NUMBER	20	number	27	SENT_324	[p24l841t1245r869b1266],
27	10	CD	NUMBER	10	num	29	SENT_324	[p24l843t1293r869b1313],
28	Chemotherapy	NN	O	chemotherapy	nn	29	SENT_324	[p24l1225t1285r1400b1314],
29	o	NN	O	o	dep	1	SENT_324	[p24l855t1340r869b1361],
30	I	PRP	O	I	dep	29	SENT_324	[p24l1237t1351r1240b1366],
31	10	CD	NUMBER	10	dep	1	SENT_324	[p24l1227t1373r1253b1394],
32	'	''	O	'	_	0	SENT_324	[p24l769t892r798b912],
33	3	CD	NUMBER	3	dep	31	SENT_324	[p24l769t892r798b912],
34	o	NN	O	o	dep	1	SENT_324	[p24l768t903r792b925],
35	\	CD	NUMBER	\	num	36	SENT_324	[p24l768t903r792b925],
36	_	NN	O	_	dep	34	SENT_324	[p24l769t926r798b933],
37	.	.	O	.	_	0	SENT_324	[p24l769t926r798b933],

1	:	:	O	:	_	0	SENT_325	[p24l775t945r790b959],
2	.9	CD	NUMBER	.9	num	3	SENT_325	[p24l768t961r791b983],
3	III	CD	NUMBER	iii	_	0	SENT_325	[p24l771t984r791b994],
4	‘	NN	O	‘	nn	5	SENT_325	[p24l771t984r791b994],
5	N	NN	O	n	dep	3	SENT_325	[p24l775t995r791b1008],
6	.	.	O	.	_	0	SENT_325	[p24l775t1009r790b1018],

1	.	.	O	.	_	0	SENT_326	[p24l775t1009r790b1018],

1	.9	NN	NUMBER	.9	_	0	SENT_327	[p24l768t1020r791b1042],
2	.	.	O	.	_	0	SENT_327	[p24l775t1043r790b1052],

1	.	.	O	.	_	0	SENT_328	[p24l775t1043r790b1052],

1	.9	CD	NUMBER	.9	num	6	SENT_329	[p24l771t1054r791b1078],
2	Q	NNP	O	Q	nn	6	SENT_329	[p24l775t1079r791b1092],
3	’	CD	NUMBER	’	num	6	SENT_329	[p24l775t1079r791b1092],
4	Q	NNP	O	Q	nn	6	SENT_329	[p24l769t1093r790b1113],
5	o	NN	O	o	nn	6	SENT_329	[p24l775t1123r791b1138],
6	Z	NN	O	z	nsubj	8	SENT_329	[p24l769t1142r791b1160],
7	I	PRP	O	I	nsubj	8	SENT_329	[p24l767t1166r790b1180, p24l775t1180r791b1195],
8	»	VBP	O	»	_	0	SENT_329	[p24l767t1166r790b1180, p24l775t1180r791b1195],
9	o	NN	O	o	dobj	8	SENT_329	[p24l767t1166r790b1180, p24l775t1180r791b1195],
10	:1	CD	NUMBER	:1	num	9	SENT_329	[p24l768t1204r798b1233],
11	"	``	O	"	punct	9	SENT_329	[p24l768t1204r798b1233],
12	3	CD	NUMBER	3	number	13	SENT_329	[p24l767t1243r791b1264],
13	N	NN	O	n	amod	9	SENT_329	[p24l775t1267r791b1280],
14	.	.	O	.	_	0	SENT_329	[p24l767t1281r791b1295],

1	n	NN	O	n	_	0	SENT_330	[p24l767t1281r791b1295],
2	o	NN	O	o	dep	1	SENT_330	[p24l775t1297r791b1312],
3	.	.	O	.	_	0	SENT_330	[p24l775t1313r790b1322],

1	.	.	O	.	_	0	SENT_331	[p24l775t1313r790b1322],

1	a.	IN	O	a.	_	0	SENT_332	[p24l769t1324r790b1338],

1	No.	NN	O	no.	_	0	SENT_333	[p24l656t1479r700b1500],
2	at	IN	O	at	_	0	SENT_333	[p24l710t1481r733b1500],
3	Risk	NN	O	risk	nn	4	SENT_333	[p24l744t1477r795b1500],
4	Crizotinib	NN	O	crizotinib	prep_at	1	SENT_333	[p24l654t1514r770b1536],
5	162	CD	NUMBER	162	num	6	SENT_333	[p24l867t1516r907b1536],
6	Chemotherapy	NN	O	chemotherapy	dep	1	SENT_333	[p24l654t1547r830b1576],
7	151	CD	NUMBER	151	dep	6	SENT_333	[p24l867t1549r906b1569],

1	Figure	NN	O	figure	_	0	SENT_334	[p24l406t1628r490b1660],
2	2	CD	NUMBER	2	dep	1	SENT_334	[p24l500t1630r524b1652],
3	.	.	O	.	_	0	SENT_334	[p24l500t1630r524b1652],

1	Patient-Reported	JJ	O	patient-reported	amod	2	SENT_335	[p24l538t1627r770b1660],
2	Outcomes	NNS	O	outcome	_	0	SENT_335	[p24l782t1629r935b1652],
3	.	.	O	.	_	0	SENT_335	[p24l782t1629r935b1652],

1	Patient-reported	JJ	O	patient-reported	amod	2	SENT_336	[p24l406t1677r631b1710],
2	outcomes	NNS	O	outcome	nsubjpass	4	SENT_336	[p24l644t1682r780b1703],
3	were	VBD	O	be	auxpass	4	SENT_336	[p24l791t1686r856b1703],
4	assessed	VBN	O	assess	_	0	SENT_336	[p24l868t1677r990b1702],
5	with	IN	O	with	_	0	SENT_336	[p24l1002t1677r1059b1703],
6	the	DT	O	the	det	10	SENT_336	[p24l1071t1677r1114b1702],
7	use	NN	O	use	nn	10	SENT_336	[p24l1127t1686r1172b1702],
8	ofthe	NN	O	ofthe	nn	10	SENT_336	[p24l1183t1677r1262b1702],
9	European	JJ	ORGANIZATION	european	amod	10	SENT_336	[p24l1276t1680r1404b1710],
10	Organization	NNP	ORGANIZATION	Organization	prep_with	4	SENT_336	[p24l1417t1679r1598b1710],
11	for	IN	ORGANIZATION	for	_	0	SENT_336	[p24l1610t1677r1649b1702],
12	Research	NNP	ORGANIZATION	Research	prep_for	10	SENT_336	[p24l1661t1677r1782b1702],
13	and	CC	ORGANIZATION	and	_	0	SENT_336	[p24l1796t1677r1844b1702],
14	Treatment	NN	ORGANIZATION	treatment	conj_and	10	SENT_336	[p24l1856t1680r1999b1702],
15	of	IN	ORGANIZATION	of	_	0	SENT_336	[p24l2010t1677r2040b1702],
16	Cancer	NN	ORGANIZATION	cancer	nn	21	SENT_336	[p24l404t1721r500b1744],
17	quality-of-life	NN	O	quality-of-life	nn	21	SENT_336	[p24l511t1719r693b1752],
18	questionnaire	NN	O	questionnaire	nn	21	SENT_336	[p24l704t1721r894b1752],
19	(	CD	NUMBER	(	num	21	SENT_336	[p24l909t1721r1059b1752],
20	QLQ-C30	NN	O	qlq-c30	nn	21	SENT_336	[p24l909t1721r1059b1752],
21	)	NN	O	)	prep_of	14	SENT_336	[p24l909t1721r1059b1752],
22	and	CC	O	and	_	0	SENT_336	[p24l1074t1719r1122b1744],
23	the	DT	O	the	det	25	SENT_336	[p24l1134t1719r1177b1744],
24	corresponding	JJ	O	corresponding	amod	25	SENT_336	[p24l1189t1719r1391b1752],
25	module	NN	O	module	conj_and	21	SENT_336	[p24l1403t1719r1507b1744],
26	for	IN	O	for	_	0	SENT_336	[p24l1518t1719r1557b1744],
27	lung	NN	O	lung	nn	28	SENT_336	[p24l1568t1719r1627b1752],
28	cancer	NN	O	cancer	prep_for	25	SENT_336	[p24l1638t1728r1729b1744],
29	(	CD	NUMBER	(	num	31	SENT_336	[p24l1742t1721r1915b1752],
30	QLQ-LC13	NN	O	qlq-lc13	nn	31	SENT_336	[p24l1742t1721r1915b1752],
31	)	NN	O	)	dep	25	SENT_336	[p24l1742t1721r1915b1752],
32	.	.	O	.	_	0	SENT_336	[p24l1742t1721r1915b1752],

1	The	DT	O	the	det	2	SENT_337	[p24l1926t1719r1978b1744],
2	rates	NNS	O	rate	nsubj	6	SENT_337	[p24l405t1766r470b1786],
3	of	IN	O	of	_	0	SENT_337	[p24l482t1760r512b1786],
4	completion	NN	O	completion	nn	5	SENT_337	[p24l519t1761r675b1794],
5	ofquestionnaires	NNS	O	ofquestionnaire	prep_of	2	SENT_337	[p24l688t1760r929b1794],
6	ranged	VBD	O	range	_	0	SENT_337	[p24l943t1761r1035b1794],
7	from	IN	O	from	_	0	SENT_337	[p24l1047t1760r1112b1786],
8	75	CD	PERCENT	75	number	12	SENT_337	[p24l1126t1762r1184b1787],
9	%	NN	PERCENT	%	dep	12	SENT_337	[p24l1126t1762r1184b1787],
10	to	TO	O	to	dep	12	SENT_337	[p24l1194t1766r1221b1786],
11	100	CD	PERCENT	100	number	12	SENT_337	[p24l1234t1762r1311b1787],
12	%	NN	PERCENT	%	prep_from	6	SENT_337	[p24l1234t1762r1311b1787],
13	across	IN	O	across	_	0	SENT_337	[p24l1322t1770r1409b1786],
14	cycles	NNS	O	cycle	prep_across	6	SENT_337	[p24l1421t1761r1503b1794],
15	in	IN	O	in	_	0	SENT_337	[p24l1516t1763r1537b1786],
16	both	DT	O	both	det	18	SENT_337	[p24l1551t1761r1611b1786],
17	treatment	NN	O	treatment	nn	18	SENT_337	[p24l1623t1766r1761b1786],
18	groups	NNS	O	group	prep_in	14	SENT_337	[p24l1772t1770r1875b1794],
19	.	.	O	.	_	0	SENT_337	[p24l1772t1770r1875b1794],

1	Panel	NN	O	panel	nn	2	SENT_338	[p24l1890t1761r1961b1786],
2	A	NN	O	a	nsubj	3	SENT_338	[p24l1973t1762r1992b1786],
3	shows	VBZ	O	show	_	0	SENT_338	[p24l405t1802r490b1828],
4	the	DT	O	the	det	6	SENT_338	[p24l501t1802r545b1828],
5	overall	JJ	O	overall	amod	6	SENT_338	[p24l556t1802r645b1828],
6	change	NN	O	change	dobj	3	SENT_338	[p24l658t1802r756b1836],
7	from	IN	O	from	_	0	SENT_338	[p24l767t1802r831b1828],
8	baseline	NN	O	baseline	prep_from	3	SENT_338	[p24l845t1802r958b1828],
9	in	IN	O	in	_	0	SENT_338	[p24l970t1805r992b1827],
10	the	DT	O	the	det	12	SENT_338	[p24l1004t1802r1047b1828],
11	symptoms	NNS	O	symptom	nn	12	SENT_338	[p24l1059t1807r1203b1835],
12	ofalopecia	NN	O	ofalopecium	prep_in	8	SENT_338	[p24l1216t1802r1374b1835],
13	,	,	O	,	_	0	SENT_338	[p24l1216t1802r1374b1835],
14	cough	NN	O	cough	conj_and	12	SENT_338	[p24l1387t1802r1479b1836],
15	,	,	O	,	_	0	SENT_338	[p24l1387t1802r1479b1836],
16	dyspnea	NN	O	dyspnea	conj_and	12	SENT_338	[p24l1491t1802r1613b1835],
17	,	,	O	,	_	0	SENT_338	[p24l1491t1802r1613b1835],
18	fatigue	NN	O	fatigue	conj_and	12	SENT_338	[p24l1625t1802r1727b1836],
19	,	,	O	,	_	0	SENT_338	[p24l1625t1802r1727b1836],
20	chest	NN	O	chest	nn	21	SENT_338	[p24l1740t1802r1814b1828],
21	pain	NN	O	pain	conj_and	12	SENT_338	[p24l1826t1805r1890b1835],
22	,	,	O	,	_	0	SENT_338	[p24l1826t1805r1890b1835],
23	arm	NN	O	arm	nn	26	SENT_338	[p24l1903t1811r1955b1828],
24	or	CC	O	or	_	0	SENT_338	[p24l1968t1811r1996b1828],
25	shoulder	NN	O	shoulder	nn	26	SENT_338	[p24l405t1844r526b1869],
26	pain	NN	O	pain	conj_and	12	SENT_338	[p24l538t1846r603b1877],
27	,	,	O	,	_	0	SENT_338	[p24l538t1846r603b1877],
28	and	CC	O	and	_	0	SENT_338	[p24l616t1844r664b1869],
29	pain	NN	O	pain	conj_and	12	SENT_338	[p24l678t1846r734b1877],
30	in	IN	O	in	_	0	SENT_338	[p24l748t1846r770b1869],
31	other	JJ	O	other	amod	32	SENT_338	[p24l783t1844r856b1869],
32	parts	NNS	O	part	prep_in	3	SENT_338	[p24l867t1849r936b1877],
33	ofthe	VBP	O	ofthe	dep	32	SENT_338	[p24l948t1844r1027b1869],
34	body	NN	O	body	dobj	33	SENT_338	[p24l1040t1844r1111b1877],
35	,	,	O	,	_	0	SENT_338	[p24l1040t1844r1111b1877],
36	as	RB	O	as	_	0	SENT_338	[p24l1124t1853r1152b1869],
37	well	RB	O	well	_	0	SENT_338	[p24l1163t1844r1215b1869],
38	as	IN	O	as	_	0	SENT_338	[p24l1229t1853r1256b1869],
39	in	IN	O	in	_	0	SENT_338	[p24l1270t1846r1291b1869],
40	global	JJ	O	global	amod	43	SENT_338	[p24l1304t1844r1386b1877],
41	quality-of-life	JJ	O	quality-of-life	amod	43	SENT_338	[p24l1399t1844r1581b1877],
42	(	NN	O	(	nn	43	SENT_338	[p24l1595t1846r1679b1877],
43	QOL	NN	O	qol	conj_and	32	SENT_338	[p24l1595t1846r1679b1877],
44	)	CD	NUMBER	)	num	45	SENT_338	[p24l1595t1846r1679b1877],
45	scores	NNS	O	score	dep	43	SENT_338	[p24l1694t1853r1789b1869],
46	.	.	O	.	_	0	SENT_338	[p24l1694t1853r1789b1869],

1	Scores	NNS	O	score	nsubj	5	SENT_339	[p24l1802t1846r1892b1869],
2	on	IN	O	on	_	0	SENT_339	[p24l1904t1853r1937b1869],
3	the	DT	O	the	det	4	SENT_339	[p24l1949t1844r1992b1869],
4	questionnaires	NNS	O	questionnaire	prep_on	1	SENT_339	[p24l404t1888r609b1919],
5	range	VBP	O	range	_	0	SENT_339	[p24l622t1895r698b1919],
6	from	IN	O	from	_	0	SENT_339	[p24l708t1885r773b1911],
7	o	NN	O	o	prep_from	5	SENT_339	[p24l785t1887r801b1911],
8	to	TO	O	to	_	0	SENT_339	[p24l811t1891r837b1911],
9	100	CD	NUMBER	100	prep_to	5	SENT_339	[p24l851t1887r905b1911],
10	.	.	O	.	_	0	SENT_339	[p24l851t1887r905b1911],

1	For	IN	O	for	_	0	SENT_340	[p24l920t1888r963b1911],
2	symptoms	NNS	O	symptom	prep_for	6	SENT_340	[p24l974t1891r1127b1919],
3	,	,	O	,	_	0	SENT_340	[p24l974t1891r1127b1919],
4	higher	JJR	O	higher	amod	5	SENT_340	[p24l1141t1886r1227b1919],
5	scores	NNS	O	score	nsubj	6	SENT_340	[p24l1238t1895r1325b1911],
6	indicate	VBP	O	indicate	_	0	SENT_340	[p24l1338t1886r1446b1911],
7	greater	JJR	O	greater	amod	8	SENT_340	[p24l1458t1891r1555b1919],
8	severity	NN	O	severity	dobj	6	SENT_340	[p24l1566t1888r1672b1919],
9	of	IN	O	of	_	0	SENT_340	[p24l1682t1886r1712b1911],
10	symptoms	NNS	O	symptom	prep_of	8	SENT_340	[p24l1719t1891r1872b1919],
11	,	,	O	,	_	0	SENT_340	[p24l1719t1891r1872b1919],
12	and	CC	O	and	_	0	SENT_340	[p24l1885t1886r1934b1911],
13	hence	RB	O	hence	advmod	15	SENT_340	[p24l1948t1886r2028b1911],
14	negative	JJ	O	negative	amod	15	SENT_340	[p24l405t1930r520b1961],
15	changes	NNS	O	change	nsubj	16	SENT_340	[p24l531t1927r644b1961],
16	(	VBP	O	(	conj_and	6	SENT_340	[p24l659t1927r809b1960],
17	downward	JJ	O	downward	amod	18	SENT_340	[p24l659t1927r809b1960],
18	bars	NNS	O	bar	nsubj	20	SENT_340	[p24l823t1927r889b1960],
19	)	RB	O	)	advmod	20	SENT_340	[p24l823t1927r889b1960],
20	indicate	VBP	O	indicate	dep	16	SENT_340	[p24l904t1927r1012b1953],
21	improvement	NN	O	improvement	dobj	20	SENT_340	[p24l1024t1930r1210b1960],
22	from	IN	O	from	_	0	SENT_340	[p24l1221t1927r1285b1953],
23	baseline	NN	O	baseline	prep_from	20	SENT_340	[p24l1299t1927r1419b1957],
24	;	:	O	;	_	0	SENT_340	[p24l1299t1927r1419b1957],
25	for	IN	O	for	_	0	SENT_340	[p24l1431t1927r1469b1953],
26	global	JJ	O	global	amod	28	SENT_340	[p24l1480t1927r1562b1961],
27	quality	NN	O	quality	nn	28	SENT_340	[p24l1574t1927r1667b1960],
28	oflife	NN	O	oflife	prep_for	32	SENT_340	[p24l1677t1927r1761b1957],
29	,	,	O	,	_	0	SENT_340	[p24l1677t1927r1761b1957],
30	higher	JJR	O	higher	amod	31	SENT_340	[p24l1775t1927r1862b1961],
31	scores	NNS	O	score	nsubj	32	SENT_340	[p24l1873t1936r1960b1953],
32	indicate	VBP	O	indicate	parataxis	20	SENT_340	[p24l1973t1927r2032b1953, p24l404t1974r459b1994],
33	better	JJR	O	better	amod	36	SENT_340	[p24l472t1969r554b1994],
34	global	JJ	O	global	amod	36	SENT_340	[p24l564t1969r646b2002],
35	quality	NN	O	quality	nn	36	SENT_340	[p24l659t1969r751b2002],
36	oflife	NN	O	oflife	nsubj	42	SENT_340	[p24l762t1969r845b1999],
37	,	,	O	,	_	0	SENT_340	[p24l762t1969r845b1999],
38	and	CC	O	and	_	0	SENT_340	[p24l858t1969r907b1994],
39	hence	RB	O	hence	advmod	36	SENT_340	[p24l921t1969r1001b1994],
40	positive	JJ	O	positive	amod	41	SENT_340	[p24l1014t1972r1120b2002],
41	changes	NNS	O	change	conj_and	36	SENT_340	[p24l1131t1969r1244b2002],
42	(	VBP	O	(	ccomp	32	SENT_340	[p24l1259t1969r1368b2002],
43	upward	RB	O	upward	advmod	42	SENT_340	[p24l1259t1969r1368b2002],
44	bars	NNS	O	bar	nsubj	46	SENT_340	[p24l1383t1969r1448b2002],
45	)	RB	O	)	advmod	46	SENT_340	[p24l1383t1969r1448b2002],
46	indicate	VBP	O	indicate	dep	20	SENT_340	[p24l1463t1969r1571b1994],
47	improvement	NN	O	improvement	dobj	46	SENT_340	[p24l1583t1971r1770b2002],
48	from	IN	O	from	_	0	SENT_340	[p24l1780t1969r1844b1994],
49	baseline	NN	O	baseline	prep_from	46	SENT_340	[p24l1859t1969r1978b1994],
50	.	.	O	.	_	0	SENT_340	[p24l1859t1969r1978b1994],

1	These	DT	O	these	det	2	SENT_341	[p24l403t2011r485b2036],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_341	[p24l497t2011r612b2044],
3	were	VBD	O	be	auxpass	4	SENT_341	[p24l624t2020r688b2036],
4	based	VBN	O	base	_	0	SENT_341	[p24l701t2011r779b2036],
5	on	IN	O	on	_	0	SENT_341	[p24l792t2020r825b2036],
6	a	DT	O	a	det	9	SENT_341	[p24l838t2020r851b2036],
7	repeated-measures	JJ	O	repeated-measures	amod	9	SENT_341	[p24l864t2011r1130b2044],
8	mixed-effects	NNS	O	mixed-effect	nn	9	SENT_341	[p24l1143t2011r1331b2036],
9	model	NN	O	model	prep_on	4	SENT_341	[p24l1344t2011r1429b2036],
10	with	IN	O	with	mark	12	SENT_341	[p24l1441t2011r1498b2036],
11	an	DT	O	a	nsubj	12	SENT_341	[p24l1511t2020r1541b2036],
12	intercept	VB	O	intercept	dep	9	SENT_341	[p24l1555t2013r1684b2044],
13	,	,	O	,	_	0	SENT_341	[p24l1555t2013r1684b2044],
14	treatment	NN	O	treatment	conj_and	9	SENT_341	[p24l1696t2016r1841b2041],
15	,	,	O	,	_	0	SENT_341	[p24l1696t2016r1841b2041],
16	treatmentby-time	JJ	O	treatmentby-time	amod	17	SENT_341	[p24l1853t2016r1999b2036, p24l405t2052r507b2085],
17	interaction	NN	O	interaction	appos	14	SENT_341	[p24l519t2055r676b2082],
18	,	,	O	,	_	0	SENT_341	[p24l519t2055r676b2082],
19	and	CC	O	and	_	0	SENT_341	[p24l689t2052r737b2078],
20	subscale	JJ	O	subscale	amod	22	SENT_341	[p24l751t2052r869b2078],
21	baseline	NN	O	baseline	nn	22	SENT_341	[p24l882t2052r994b2078],
22	score	NN	NUMBER	score	conj_and	9	SENT_341	[p24l1006t2061r1086b2078],
23	.	.	O	.	_	0	SENT_341	[p24l1006t2061r1086b2078],

1	The	DT	O	the	det	3	SENT_342	[p24l1097t2052r1149b2078],
2	P	NN	O	p	nn	3	SENT_342	[p24l1162t2055r1177b2077],
3	values	NNS	O	value	nsubj	21	SENT_342	[p24l1187t2052r1273b2078],
4	(	CD	NUMBER	(	tmod	3	SENT_342	[p24l1289t2052r1377b2085],
5	which	WDT	O	which	nsubjpass	9	SENT_342	[p24l1289t2052r1377b2085],
6	have	VBP	O	have	aux	9	SENT_342	[p24l1390t2052r1452b2078],
7	not	RB	O	not	neg	9	SENT_342	[p24l1464t2057r1508b2078],
8	been	VBN	O	be	auxpass	9	SENT_342	[p24l1520t2052r1584b2078],
9	adjusted	VBN	O	adjust	rcmod	3	SENT_342	[p24l1597t2052r1714b2085],
10	for	IN	O	for	_	0	SENT_342	[p24l1726t2052r1765b2078],
11	multiple	JJ	O	multiple	amod	13	SENT_342	[p24l1777t2052r1890b2085],
12	testing	NN	O	testing	nn	13	SENT_342	[p24l1900t2055r2004b2086],
13	)	NN	O	)	prep_for	9	SENT_342	[p24l1900t2055r2004b2086],
14	are	VBP	O	be	cop	21	SENT_342	[p24l404t2103r445b2119],
15	for	IN	O	for	_	0	SENT_342	[p24l456t2094r494b2119],
16	the	DT	O	the	det	19	SENT_342	[p24l504t2094r547b2119],
17	between-group	JJ	O	between-group	amod	19	SENT_342	[p24l560t2094r769b2127],
18	comparison	NN	O	comparison	nn	19	SENT_342	[p24l781t2097r944b2127],
19	ofthe	NN	O	ofthe	prep_for	21	SENT_342	[p24l957t2094r1036b2119],
20	overall	JJ	O	overall	amod	21	SENT_342	[p24l1047t2094r1136b2119],
21	change	NN	O	change	_	0	SENT_342	[p24l1149t2094r1247b2127],
22	from	IN	O	from	_	0	SENT_342	[p24l1258t2094r1322b2119],
23	baseline	NN	O	baseline	prep_from	21	SENT_342	[p24l1337t2094r1456b2124],
24	,	,	O	,	_	0	SENT_342	[p24l1337t2094r1456b2124],
25	as	IN	O	as	mark	26	SENT_342	[p24l1469t2103r1497b2119],
26	calculated	VBN	O	calculate	dep	23	SENT_342	[p24l1509t2094r1648b2119],
27	with	IN	O	with	_	0	SENT_342	[p24l1659t2094r1717b2119],
28	the	DT	O	the	det	29	SENT_342	[p24l1729t2094r1772b2119],
29	use	NN	O	use	prep_with	26	SENT_342	[p24l1785t2103r1830b2119],
30	of	IN	O	of	_	0	SENT_342	[p24l1841t2094r1871b2119],
31	repeatedmeasure	NN	O	repeatedmeasure	nn	32	SENT_342	[p24l1879t2094r2009b2127, p24l405t2145r523b2161],
32	analyses	NNS	O	analysis	prep_of	29	SENT_342	[p24l534t2136r658b2169],
33	.	.	O	.	_	0	SENT_342	[p24l534t2136r658b2169],

1	Panel	NN	O	panel	nn	2	SENT_343	[p24l673t2136r744b2161],
2	B	NN	O	b	nsubj	3	SENT_343	[p24l759t2138r774b2161],
3	shows	VBZ	O	show	_	0	SENT_343	[p24l787t2136r872b2161],
4	Kaplan	NNP	PERSON	Kaplan	dobj	3	SENT_343	[p24l886t2136r1080b2169],
5	.	.	O	.	_	0	SENT_343	[p24l886t2136r1080b2169],

1	—	NN	O	—	_	0	SENT_344	[p24l886t2136r1080b2169],
2	.	.	O	.	_	0	SENT_344	[p24l886t2136r1080b2169],

1	Meier	JJR	PERSON	meier	amod	2	SENT_345	[p24l886t2136r1080b2169],
2	estimates	NNS	O	estimate	nsubj	3	SENT_345	[p24l1091t2138r1224b2161],
3	ofthe	VBP	O	ofthe	_	0	SENT_345	[p24l1236t2136r1315b2161],
4	time	NN	O	time	dobj	3	SENT_345	[p24l1325t2138r1387b2161],
5	to	TO	O	to	_	0	SENT_345	[p24l1398t2141r1424b2161],
6	deterioration	NN	O	deterioration	prep_to	4	SENT_345	[p24l1436t2136r1615b2161],
7	with	IN	O	with	_	0	SENT_345	[p24l1627t2136r1684b2161],
8	respect	NN	O	respect	prep_with	6	SENT_345	[p24l1698t2141r1799b2169],
9	to	TO	O	to	_	0	SENT_345	[p24l1809t2141r1836b2161],
10	a	DT	O	a	det	13	SENT_345	[p24l1848t2145r1860b2161],
11	composite	JJ	O	composite	amod	13	SENT_345	[p24l1872t2138r2017b2169],
12	end	NN	O	end	nn	13	SENT_345	[p24l404t2178r453b2203],
13	point	NN	O	point	prep_to	4	SENT_345	[p24l467t2180r538b2210],
14	ofthree	NN	O	ofthree	nn	15	SENT_345	[p24l549t2177r655b2203],
15	symptoms	NNS	O	symptom	dep	3	SENT_345	[p24l667t2182r811b2211],
16	—	JJ	O	—	amod	17	SENT_345	[p24l822t2193r856b2195],
17	cough	NN	O	cough	dep	15	SENT_345	[p24l866t2178r958b2211],
18	,	,	O	,	_	0	SENT_345	[p24l866t2178r958b2211],
19	dyspnea	NN	O	dyspnea	dep	15	SENT_345	[p24l970t2178r1092b2210],
20	,	,	O	,	_	0	SENT_345	[p24l970t2178r1092b2210],
21	or	CC	O	or	_	0	SENT_345	[p24l1105t2186r1133b2203],
22	chest	NN	O	chest	nn	23	SENT_345	[p24l1143t2177r1217b2203],
23	pain	NN	O	pain	dep	15	SENT_345	[p24l1229t2180r1294b2210],
24	.	.	O	.	_	0	SENT_345	[p24l1229t2180r1294b2210],

1	The	DT	O	the	det	3	SENT_346	[p24l1305t2178r1357b2203],
2	median	JJ	O	median	amod	3	SENT_346	[p24l1369t2177r1470b2203],
3	time	NN	O	time	nsubj	8	SENT_346	[p24l1482t2180r1544b2203],
4	to	TO	O	to	_	0	SENT_346	[p24l1554t2182r1581b2203],
5	deterioration	NN	O	deterioration	prep_to	3	SENT_346	[p24l1592t2177r1771b2203],
6	was	VBD	O	be	cop	8	SENT_346	[p24l1783t2186r1835b2203],
7	5.6	CD	DURATION	5.6	num	8	SENT_346	[p24l1847t2180r1886b2203],
8	months	NNS	NUMBER	month	_	0	SENT_346	[p24l1899t2177r2003b2203],
9	with	IN	O	with	_	0	SENT_346	[p24l403t2219r460b2244],
10	crizotinib	NN	O	crizotinib	prep_with	8	SENT_346	[p24l473t2219r602b2244],
11	and	CC	O	and	_	0	SENT_346	[p24l614t2219r662b2244],
12	1.4	CD	DURATION	1.4	num	13	SENT_346	[p24l677t2221r714b2244],
13	months	NNS	NUMBER	month	conj_and	8	SENT_346	[p24l727t2219r832b2244],
14	with	IN	O	with	_	0	SENT_346	[p24l843t2219r900b2244],
15	chemotherapy	NN	O	chemotherapy	prep_with	13	SENT_346	[p24l913t2219r1118b2252],
16	.	.	O	.	_	0	SENT_346	[p24l913t2219r1118b2252],

1	(	NN	O	(	nsubj	82	SENT_347	[p24l379t2351r470b2384],
2	38	CD	PERCENT	38	num	3	SENT_347	[p24l379t2351r470b2384],
3	%	NN	PERCENT	%	dep	1	SENT_347	[p24l379t2351r470b2384],
4	)	CD	NUMBER	)	dep	1	SENT_347	[p24l379t2351r470b2384],
5	in	IN	O	in	_	0	SENT_347	[p24l485t2349r517b2379],
6	the	DT	O	the	det	8	SENT_347	[p24l531t2349r582b2379],
7	crizotinib	JJ	O	crizotinib	amod	8	SENT_347	[p24l596t2348r755b2379],
8	group	NN	O	group	prep_in	4	SENT_347	[p24l769t2358r873b2388],
9	,	,	O	,	_	0	SENT_347	[p24l769t2358r873b2388],
10	including	VBG	O	include	_	0	SENT_347	[p24l889t2348r1045b2388],
11	27	CD	NUMBER	27	number	12	SENT_347	[p24l1057t2351r1095b2379],
12	(	CD	NUMBER	(	prep_including	82	SENT_347	[p24l1111t2351r1198b2384],
13	l6	NN	O	l6	dep	12	SENT_347	[p24l1111t2351r1198b2384],
14	°	CD	NUMBER	°	num	13	SENT_347	[p24l1111t2351r1198b2384],
15	/	:	O	/	punct	16	SENT_347	[p24l1111t2351r1198b2384],
16	o	NN	O	o	dep	12	SENT_347	[p24l1111t2351r1198b2384],
17	)	CD	NUMBER	)	num	18	SENT_347	[p24l1111t2351r1198b2384],
18	incidence	NN	O	incidence	nsubj	41	SENT_347	[p24l1240t2348r1397b2379],
19	of	IN	O	of	_	0	SENT_347	[p24l1415t2348r1453b2379],
20	elevated	JJ	O	elevated	amod	22	SENT_347	[p24l1464t2348r1596b2379],
21	aminotransferase	NN	O	aminotransferase	nn	22	SENT_347	[p24l1613t2348r1907b2379],
22	levels	NNS	O	level	prep_of	18	SENT_347	[p24l1924t2348r2013b2380],
23	of	IN	O	of	prep	22	SENT_347	[p24l2031t2348r2070b2379],
24	with	IN	O	with	pcomp	23	SENT_347	[p24l376t2398r451b2429],
25	grade	NN	O	grade	pobj	24	SENT_347	[p24l471t2398r563b2437],
26	3	CD	NUMBER	3	num	25	SENT_347	[p24l583t2400r600b2429],
27	or	CC	O	or	_	0	SENT_347	[p24l621t2408r656b2428],
28	4	CD	NUMBER	4	num	30	SENT_347	[p24l673t2400r693b2428],
29	elevated	JJ	O	elevated	amod	30	SENT_347	[p24l712t2398r845b2429],
30	levels	NNS	O	level	prep_of	18	SENT_347	[p24l864t2398r963b2435],
31	;	:	O	;	_	0	SENT_347	[p24l864t2398r963b2435],
32	in	IN	O	in	prep_of	18	SENT_347	[p24l984t2398r1016b2428],
33	1	CD	NUMBER	1	num	34	SENT_347	[p24l1037t2400r1054b2428],
34	patient	NN	O	patient	pobj	32	SENT_347	[p24l1073t2398r1198b2437],
35	,	,	O	,	_	0	SENT_347	[p24l1073t2398r1198b2437],
36	grade	NN	O	grade	pobj	32	SENT_347	[p24l1240t2398r1333b2437],
37	3	CD	NUMBER	3	num	36	SENT_347	[p24l1349t2400r1367b2429],
38	or	CC	O	or	_	0	SENT_347	[p24l1385t2408r1419b2428],
39	4	CD	NUMBER	4	pobj	32	SENT_347	[p24l1434t2400r1453b2428],
40	were	VBD	O	be	cop	41	SENT_347	[p24l1468t2408r1546b2429],
41	lower	JJR	O	lower	rcmod	16	SENT_347	[p24l1562t2398r1661b2435],
42	,	,	O	,	_	0	SENT_347	[p24l1562t2398r1661b2435],
43	at	IN	O	at	_	0	SENT_347	[p24l1679t2404r1710b2428],
44	7	CD	PERCENT	7	num	45	SENT_347	[p24l1725t2400r1777b2429],
45	%	NN	PERCENT	%	prep_at	41	SENT_347	[p24l1725t2400r1777b2429],
46	and	CC	O	and	_	0	SENT_347	[p24l1792t2398r1854b2428],
47	9	CD	NUMBER	9	num	48	SENT_347	[p24l1870t2400r1999b2429],
48	°	NN	O	°	prep_at	41	SENT_347	[p24l1870t2400r1999b2429],
49	/	:	O	/	punct	16	SENT_347	[p24l1870t2400r1999b2429],
50	o.	NN	O	o.	nn	53	SENT_347	[p24l1870t2400r1999b2429],
51	11v12	NN	O	11v12	nn	53	SENT_347	[p24l1870t2400r1999b2429],
52	Alconcurrent	JJ	O	alconcurrent	amod	53	SENT_347	[p24l2014t2398r2063b2428, p24l378t2453r560b2478],
53	elevations	NNS	O	elevation	dep	58	SENT_347	[p24l577t2447r741b2478],
54	in	IN	O	in	dep	58	SENT_347	[p24l760t2447r793b2477],
55	bilirubin	NN	O	bilirubin	nn	56	SENT_347	[p24l811t2447r957b2478],
56	levels	NNS	O	level	nsubj	58	SENT_347	[p24l975t2447r1065b2478],
57	not	RB	O	not	neg	58	SENT_347	[p24l1084t2453r1140b2477],
58	re	VB	O	re	advcl	70	SENT_347	[p24l1156t2457r1200b2477],
59	-	:	O	-	_	0	SENT_347	[p24l1156t2457r1200b2477],
60	though	IN	O	though	mark	67	SENT_347	[p24l1240t2447r1358b2486],
61	interstitial	JJ	O	interstitial	amod	63	SENT_347	[p24l1370t2447r1540b2477],
62	lung	NN	O	lung	nn	63	SENT_347	[p24l1552t2447r1626b2486],
63	disease	NN	O	disease	nsubjpass	67	SENT_347	[p24l1637t2447r1755b2477],
64	is	VBZ	O	be	auxpass	67	SENT_347	[p24l1767t2447r1792b2477],
65	much	RB	O	much	advmod	66	SENT_347	[p24l1805t2447r1897b2478],
66	less	JJR	O	less	advmod	67	SENT_347	[p24l1909t2447r1968b2477],
67	comlated	VBN	O	comlate	csubj	70	SENT_347	[p24l1981t2457r2063b2477, p24l377t2496r458b2527],
68	to	TO	O	to	_	0	SENT_347	[p24l478t2503r509b2527],
69	cholestasis	NN	O	cholestasis	prep_to	67	SENT_347	[p24l530t2496r710b2527],
70	progressed	VBD	O	progress	rcmod	12	SENT_347	[p24l730t2496r915b2536],
71	to	TO	O	to	_	0	SENT_347	[p24l934t2503r966b2527],
72	fatal	JJ	O	fatal	amod	74	SENT_347	[p24l986t2496r1060b2527],
73	hepatic	JJ	O	hepatic	amod	74	SENT_347	[p24l1080t2497r1201b2536],
74	mon	NN	DATE	mon	prep_to	70	SENT_347	[p24l1240t2506r1314b2527],
75	than	IN	O	than	_	0	SENT_347	[p24l1330t2496r1406b2527],
76	elevated	JJ	O	elevated	amod	78	SENT_347	[p24l1423t2496r1556b2528],
77	aminotransferase	NN	O	aminotransferase	nn	78	SENT_347	[p24l1572t2496r1866b2527],
78	levels	NNS	O	level	prep_than	70	SENT_347	[p24l1882t2496r1981b2534],
79	,	,	O	,	_	0	SENT_347	[p24l1882t2496r1981b2534],
80	it	PRP	O	it	nsubj	82	SENT_347	[p24l1999t2497r2022b2527],
81	is	VBZ	O	be	cop	82	SENT_347	[p24l2037t2497r2062b2527],
82	failure	NN	O	failure	_	0	SENT_347	[p24l377t2546r494b2578],
83	.	.	O	.	_	0	SENT_347	[p24l377t2546r494b2578],

1	In	IN	O	in	_	0	SENT_348	[p24l514t2549r548b2577],
2	two	CD	NUMBER	two	num	4	SENT_348	[p24l567t2553r628b2578],
3	earlier	JJR	O	earlier	amod	4	SENT_348	[p24l647t2547r753b2577],
4	studies	NNS	O	study	pobj	1	SENT_348	[p24l771t2546r887b2578],
5	of	IN	O	of	_	0	SENT_348	[p24l906t2546r945b2577],
6	crizotinib	NN	O	crizotinib	prep_of	4	SENT_348	[p24l956t2546r1128b2584],
7	,	,	O	,	_	0	SENT_348	[p24l956t2546r1128b2584],
8	the	DT	O	the	det	14	SENT_348	[p24l1149t2547r1200b2577],
9	a	DT	O	a	det	14	SENT_348	[p24l1240t2557r1257b2577],
10	known	VBN	O	know	amod	14	SENT_348	[p24l1271t2546r1385b2578],
11	and	CC	O	and	_	0	SENT_348	[p24l1399t2546r1459b2577],
12	worrisome	JJ	O	worrisome	amod	14	SENT_348	[p24l1472t2547r1649b2578],
13	adverse	JJ	O	adverse	amod	14	SENT_348	[p24l1663t2546r1782b2577],
14	event	NN	O	event	nsubj	15	SENT_348	[p24l1797t2553r1882b2578],
15	associated	VBN	O	associate	rcmod	6	SENT_348	[p24l1894t2546r2063b2577],

1	2392	CD	DATE	2392	num	3	SENT_349	[p24l90t2659r167b2682],
2	NENGLJ	NNP	O	NENGLJ	nn	3	SENT_349	[p24l905t2669r1012b2691],
3	MED	NN	O	med	_	0	SENT_349	[p24l1027t2669r1078b2684],
4	368	CD	NUMBER	368	dep	3	SENT_349	[p24l1089t2663r1168b2691],
5	;	:	O	;	_	0	SENT_349	[p24l1089t2663r1168b2691],
6	25	CD	NUMBER	25	num	8	SENT_349	[p24l1089t2663r1168b2691],
7	NEjM.oRG	NN	O	nejm.org	nn	8	SENT_349	[p24l1203t2669r1327b2691],
8	JUNE20	NN	O	june20	dep	4	SENT_349	[p24l1358t2669r1536b2691],
9	,2013	CD	NUMBER	,2013	dep	8	SENT_349	[p24l1358t2669r1536b2691],

1	The	DT	O	the	det	4	SENT_350	[p24l877t2726r928b2750],
2	New	NNP	O	New	nn	4	SENT_350	[p24l937t2727r999b2750],
3	England	NNP	O	England	nn	4	SENT_350	[p24l1009t2726r1119b2757],
4	Journal	NNP	O	Journal	_	0	SENT_350	[p24l1128t2726r1225b2750],
5	of	IN	O	of	_	0	SENT_350	[p24l1235t2726r1264b2750],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_350	[p24l1271t2726r1396b2750],

1	CRIZOTINIB	NNP	O	CRIZOTINIB	_	0	SENT_351	[p24l696t2914r899b2933],
2	FOR	IN	O	for	_	0	SENT_351	[p24l913t2914r978b2933],
3	ALK-POSITIVE	NNP	O	ALK-POSITIVE	nn	5	SENT_351	[p24l987t2914r1210b2933],
4	LUNG	NN	O	lung	nn	5	SENT_351	[p24l1225t2914r1316b2933],
5	CANCER	NNP	O	CANCER	prep_for	1	SENT_351	[p24l1330t2914r1464b2933],

1	with	IN	O	with	_	0	SENT_352	[p24l7t3127r202b3206],
2	crizotinib	NN	O	crizotinib	pobj	1	SENT_352	[p24l249t3127r692b3205],
3	.	.	O	.	_	0	SENT_352	[p24l249t3127r692b3205],

1	In	IN	O	in	_	0	SENT_353	[p24l743t3134r833b3204],
2	this	DT	O	this	det	3	SENT_353	[p24l880t3127r1039b3204],
3	study	NN	O	study	prep_in	15	SENT_353	[p24l1090t3127r1333b3226],
4	,	,	O	,	_	0	SENT_353	[p24l1090t3127r1333b3226],
5	3	CD	NUMBER	3	num	6	SENT_353	[p24l1387t3133r1430b3206],
6	patients	NNS	O	patient	appos	3	SENT_353	[p24l1480t3128r1821b3226],
7	in	IN	O	in	_	0	SENT_353	[p24l1869t3128r1953b3204],
8	the	DT	O	the	det	11	SENT_353	[p24l2000t3127r2133b3205],
9	crizotinib	JJ	O	crizotinib	amod	11	SENT_353	[p24l12t3255r422b3334],
10	group	NN	O	group	nn	11	SENT_353	[p24l456t3281r704b3356],
11	(	NN	O	(	prep_in	6	SENT_353	[p24l742t3260r924b3346],
12	2	CD	PERCENT	2	number	13	SENT_353	[p24l742t3260r924b3346],
13	%	NN	PERCENT	%	amod	11	SENT_353	[p24l742t3260r924b3346],
14	)	CD	NUMBER	)	nsubj	15	SENT_353	[p24l742t3260r924b3346],
15	had	VBD	O	have	_	0	SENT_353	[p24l962t3255r1116b3334],
16	treatment	NN	O	treatment	nn	17	SENT_353	[p24l1149t3255r1875b3334],
17	—	NN	O	—	nsubj	18	SENT_353	[p24l1149t3255r1875b3334],
18	related	JJ	O	related	ccomp	15	SENT_353	[p24l1149t3255r1875b3334],
19	interstitial	JJ	O	interstitial	amod	21	SENT_353	[p24l1907t3256r2132b3334, p24l12t3383r249b3461],
20	lung	NN	O	lung	nn	21	SENT_353	[p24l293t3383r483b3484],
21	disease	NN	O	disease	dobj	18	SENT_353	[p24l525t3383r829b3462],
22	of	IN	O	of	_	0	SENT_353	[p24l876t3382r975b3462],
23	grade	NN	O	grade	prep_of	21	SENT_353	[p24l1001t3383r1235b3484],
24	3	CD	NUMBER	3	amod	23	SENT_353	[p24l1282t3389r1325b3462],
25	or	CC	O	or	_	0	SENT_353	[p24l1375t3409r1463b3462],
26	higher	JJR	O	higher	amod	23	SENT_353	[p24l1505t3383r1800b3484],
27	;	:	O	;	_	0	SENT_353	[p24l1505t3383r1800b3484],
28	two	CD	NUMBER	two	nsubj	33	SENT_353	[p24l1850t3400r2005b3462],
29	of	IN	O	of	_	0	SENT_353	[p24l2053t3382r2152b3462],
30	the	DT	O	the	det	31	SENT_353	[p24l12t3510r142b3588],
31	cases	NNS	O	case	prep_of	28	SENT_353	[p24l178t3536r396b3588],
32	were	VBD	O	be	cop	33	SENT_353	[p24l429t3536r627b3590],
33	fatal	JJ	O	fatal	parataxis	15	SENT_353	[p24l662t3509r871b3589],
34	.	.	O	.	_	0	SENT_353	[p24l662t3509r871b3589],

1	Across	IN	O	across	_	0	SENT_354	[p24l908t3518r1188b3589],
2	all	DT	O	all	det	4	SENT_354	[p24l1225t3510r1327b3588],
3	crizotinib	JJ	O	crizotinib	amod	4	SENT_354	[p24l1362t3510r1773b3589],
4	studies	NNS	O	study	pobj	1	SENT_354	[p24l1811t3510r2128b3606],
5	,	,	O	,	_	0	SENT_354	[p24l1811t3510r2128b3606],

1	including	VBG	O	include	_	0	SENT_355	[p24l11t3639r421b3740],
2	this	DT	O	this	det	3	SENT_355	[p24l467t3639r627b3717],
3	one	CD	NUMBER	one	prep_including	21	SENT_355	[p24l679t3644r1026b3735],
4	,11	CD	NUMBER	,11	number	5	SENT_355	[p24l679t3644r1026b3735],
5	’12	CD	NUMBER	’12	dep	3	SENT_355	[p24l679t3644r1026b3735],
6	the	DT	O	the	det	8	SENT_355	[p24l1076t3639r1208b3717],
7	estimated	VBN	O	estimate	amod	8	SENT_355	[p24l1258t3639r1680b3718],
8	incidence	NN	O	incidence	nsubj	12	SENT_355	[p24l1728t3639r2133b3718],
9	of	IN	O	of	_	0	SENT_355	[p25l12t20r112b100],
10	treatment	NN	O	treatment	nn	11	SENT_355	[p25l146t21r889b100],
11	—	NN	O	—	prep_of	8	SENT_355	[p25l146t21r889b100],
12	related	JJ	O	related	rcmod	3	SENT_355	[p25l146t21r889b100],
13	interstitial	JJ	O	interstitial	amod	15	SENT_355	[p25l942t21r1392b99],
14	lung	NN	O	lung	nn	15	SENT_355	[p25l1444t21r1637b122],
15	disease	NN	O	disease	dobj	12	SENT_355	[p25l1687t21r1997b100],
16	of	IN	O	of	_	0	SENT_355	[p25l2051t20r2151b100],
17	grade	NN	O	grade	prep_of	15	SENT_355	[p25l11t149r249b250],
18	3	CD	NUMBER	3	amod	17	SENT_355	[p25l289t155r333b228],
19	or	CC	O	or	_	0	SENT_355	[p25l377t175r465b228],
20	higher	JJR	O	higher	amod	17	SENT_355	[p25l501t149r782b250],
21	is	VBZ	O	be	_	0	SENT_355	[p25l818t150r883b227],
22	1	CD	PERCENT	1	num	23	SENT_355	[p25l928t154r1076b245],
23	%	NN	PERCENT	%	nsubj	21	SENT_355	[p25l928t154r1076b245],
24	,	,	O	,	_	0	SENT_355	[p25l928t154r1076b245],
25	an	DT	O	a	det	26	SENT_355	[p25l1120t175r1223b227],
26	incidence	NN	O	incidence	appos	23	SENT_355	[p25l1262t149r1667b228],
27	similar	JJ	O	similar	amod	26	SENT_355	[p25l1708t149r2014b227],
28	to	TO	O	to	_	0	SENT_355	[p25l2050t166r2132b228],
29	that	DT	O	that	det	39	SENT_355	[p25l12t277r184b355],
30	reported	VBN	O	report	amod	39	SENT_355	[p25l240t277r607b376],
31	with	IN	O	with	_	0	SENT_355	[p25l663t277r859b356],
32	EGFR	NN	ORGANIZATION	egfr	nn	34	SENT_355	[p25l919t283r1175b360],
33	kinase	NN	O	kinase	nn	34	SENT_355	[p25l1226t277r1505b356],
34	inhibitors	NNS	O	inhibitor	prep_with	30	SENT_355	[p25l1566t277r1987b355],
35	in	IN	O	in	_	0	SENT_355	[p25l2050t278r2134b354],
36	clinical	JJ	O	clinical	amod	37	SENT_355	[p25l12t406r325b484],
37	studies	NNS	O	study	prep_in	34	SENT_355	[p25l365t406r769b485],
38	.3	NN	NUMBER	.3	nn	39	SENT_355	[p25l365t406r769b485],
39	°	NN	O	°	prep_to	27	SENT_355	[p25l365t406r769b485],

1	Although	IN	O	although	mark	7	SENT_356	[p25l136t534r544b635],
2	the	DT	O	the	det	3	SENT_356	[p25l600t534r733b612],
3	incidence	NN	O	incidence	nsubj	7	SENT_356	[p25l789t534r1194b613],
4	of	IN	O	of	_	0	SENT_356	[p25l1252t533r1352b613],
5	treatment	NN	O	treatment	nn	6	SENT_356	[p25l1391t534r2134b613],
6	—	NN	O	—	prep_of	3	SENT_356	[p25l1391t534r2134b613],
7	related	JJ	O	related	advcl	28	SENT_356	[p25l1391t534r2134b613],
8	serious	JJ	O	serious	amod	10	SENT_356	[p25l12t664r301b742],
9	adverse	JJ	O	adverse	amod	10	SENT_356	[p25l333t663r635b742],
10	events	NNS	O	event	dobj	7	SENT_356	[p25l666t680r919b742],
11	was	VBD	O	be	cop	12	SENT_356	[p25l947t689r1105b742],
12	similar	JJ	O	similar	rcmod	10	SENT_356	[p25l1139t663r1432b741],
13	in	IN	O	in	_	0	SENT_356	[p25l1459t664r1541b741],
14	the	DT	O	the	det	18	SENT_356	[p25l1571t663r1699b741],
15	crizotinib	NN	O	crizotinib	nn	18	SENT_356	[p25l1731t663r2132b742],
16	and	CC	O	and	_	0	SENT_356	[p25l11t791r164b870],
17	chemotherapy	NN	O	chemotherapy	nn	18	SENT_356	[p25l208t791r796b891],
18	groups	NNS	O	group	prep_in	7	SENT_356	[p25l835t817r1142b892],
19	,	,	O	,	_	0	SENT_356	[p25l835t817r1142b892],
20	significantly	RB	O	significantly	advmod	21	SENT_356	[p25l1193t790r1711b892],
21	more	JJR	O	more	amod	23	SENT_356	[p25l1751t817r1964b870],
22	adverse	JJ	O	adverse	amod	23	SENT_356	[p25l2007t791r2132b870, p25l7t944r214b997],
23	events	NNS	O	event	nsubjpass	28	SENT_356	[p25l262t935r526b998],
24	of	IN	O	of	_	0	SENT_356	[p25l578t917r678b997],
25	any	DT	O	any	det	26	SENT_356	[p25l710t944r860b1018],
26	cause	NN	O	cause	prep_of	23	SENT_356	[p25l906t944r1139b998],
27	were	VBD	O	be	auxpass	28	SENT_356	[p25l1184t944r1386b998],
28	observed	VBN	O	observe	_	0	SENT_356	[p25l1437t918r1818b998],
29	in	IN	O	in	_	0	SENT_356	[p25l1867t919r1950b996],
30	the	DT	O	the	det	32	SENT_356	[p25l2001t918r2133b996],
31	crizotinib	JJ	O	crizotinib	amod	32	SENT_356	[p25l12t1047r412b1126],
32	group	NN	O	group	prep_in	28	SENT_356	[p25l442t1073r706b1148],
33	.	.	O	.	_	0	SENT_356	[p25l442t1073r706b1148],

1	Two	CD	NUMBER	two	num	2	SENT_357	[p25l737t1054r909b1126],
2	factors	NNS	O	factor	nsubj	5	SENT_357	[p25l938t1046r1216b1126],
3	may	MD	O	may	aux	5	SENT_357	[p25l1246t1073r1421b1147],
4	have	VB	O	have	aux	5	SENT_357	[p25l1445t1047r1628b1126],
5	contributed	VBN	O	contribute	_	0	SENT_357	[p25l1657t1047r2134b1126],
6	to	TO	O	to	_	0	SENT_357	[p25l12t1192r92b1254],
7	this	DT	O	this	det	8	SENT_357	[p25l129t1175r288b1253],
8	finding	NN	O	finding	prep_to	5	SENT_357	[p25l325t1174r668b1276],
9	.	.	O	.	_	0	SENT_357	[p25l325t1174r668b1276],

1	First	RB	ORDINAL	first	advmod	8	SENT_358	[p25l707t1176r923b1271],
2	,	,	O	,	_	0	SENT_358	[p25l707t1176r923b1271],
3	the	DT	O	the	det	4	SENT_358	[p25l964t1175r1096b1253],
4	duration	NN	O	duration	nsubj	8	SENT_358	[p25l1132t1175r1497b1254],
5	of	IN	O	of	_	0	SENT_358	[p25l1533t1174r1632b1254],
6	study	NN	O	study	nn	7	SENT_358	[p25l1650t1175r1879b1275],
7	treatment	NN	O	treatment	prep_of	4	SENT_358	[p25l1909t1192r2132b1253, p25l11t1320r225b1381],
8	was	VBD	O	be	_	0	SENT_358	[p25l250t1329r408b1382],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_358	[p25l446t1302r964b1404],
10	longer	RBR	O	longer	advmod	8	SENT_358	[p25l992t1303r1257b1404],
11	with	IN	O	with	_	0	SENT_358	[p25l1283t1303r1472b1382],
12	crizotinib	NN	O	crizotinib	prep_with	10	SENT_358	[p25l1507t1303r1907b1382],
13	than	IN	O	than	dep	8	SENT_358	[p25l1944t1303r2134b1381],
14	with	IN	O	with	_	0	SENT_358	[p25l7t1430r202b1510],
15	chemotherapy	NN	O	chemotherapy	prep_with	8	SENT_358	[p25l246t1430r870b1530],
16	,	,	O	,	_	0	SENT_358	[p25l246t1430r870b1530],
17	and	CC	O	and	_	0	SENT_358	[p25l918t1430r1075b1509],
18	the	DT	O	the	det	20	SENT_358	[p25l1119t1430r1252b1508],
19	safety	NN	O	safety	nn	20	SENT_358	[p25l1297t1429r1550b1530],
20	analysis	NN	O	analysis	nsubjpass	23	SENT_358	[p25l1588t1430r1928b1530],
21	was	VBD	O	be	auxpass	23	SENT_358	[p25l1969t1456r2131b1510],
22	not	RB	O	not	neg	23	SENT_358	[p25l11t1575r154b1637],
23	adjusted	VBN	O	adjust	conj_and	8	SENT_358	[p25l186t1558r542b1658],
24	to	TO	O	to	aux	25	SENT_358	[p25l581t1575r662b1637],
25	take	VB	O	take	xcomp	23	SENT_358	[p25l702t1558r882b1638],
26	into	IN	O	into	_	0	SENT_358	[p25l920t1559r1089b1637],
27	account	NN	O	account	prep_into	25	SENT_358	[p25l1129t1575r1466b1638],
28	this	DT	O	this	det	29	SENT_358	[p25l1500t1558r1659b1636],
29	difference	NN	O	difference	dobj	25	SENT_358	[p25l1701t1557r2133b1637],
30	in	IN	O	in	_	0	SENT_358	[p25l11t1688r91b1765],
31	treatment	NN	O	treatment	nn	32	SENT_358	[p25l126t1704r532b1765],
32	durations	NNS	O	duration	prep_in	29	SENT_358	[p25l563t1687r975b1766],
33	.	.	O	.	_	0	SENT_358	[p25l563t1687r975b1766],

1	Second	RB	ORDINAL	second	advmod	10	SENT_359	[p25l1018t1687r1332b1783],
2	,	,	O	,	_	0	SENT_359	[p25l1018t1687r1332b1783],
3	significantly	RB	O	significantly	advmod	4	SENT_359	[p25l1373t1686r1890b1788],
4	more	JJR	O	more	amod	5	SENT_359	[p25l1920t1713r2133b1766],
5	patients	NNS	O	patient	nsubj	10	SENT_359	[p25l10t1816r351b1915],
6	in	IN	O	in	_	0	SENT_359	[p25l391t1816r475b1893],
7	the	DT	O	the	det	9	SENT_359	[p25l514t1815r647b1893],
8	crizotinib	JJ	O	crizotinib	amod	9	SENT_359	[p25l687t1815r1107b1894],
9	group	NN	O	group	prep_in	5	SENT_359	[p25l1147t1841r1399b1916],
10	continued	VBD	O	continue	_	0	SENT_359	[p25l1441t1815r1870b1894],
11	treatment	NN	O	treatment	dobj	10	SENT_359	[p25l1909t1832r2132b1893, p25l11t1960r229b2021],
12	beyond	IN	O	beyond	_	0	SENT_359	[p25l264t1943r566b2043],
13	RECIST	NNP	O	RECIST	prep_beyond	10	SENT_359	[p25l604t1942r1279b2026],
14	—	CD	NUMBER	—	num	13	SENT_359	[p25l604t1942r1279b2026],
15	deﬁned	VBN	O	deﬁned	partmod	13	SENT_359	[p25l604t1942r1279b2026],
16	progression	NN	O	progression	dobj	15	SENT_359	[p25l1317t1944r1818b2044],
17	of	IN	O	of	_	0	SENT_359	[p25l1858t1942r1957b2022],
18	disease	NN	O	disease	prep_of	16	SENT_359	[p25l1979t1943r2132b2022, p25l12t2097r211b2167],
19	,	,	O	,	_	0	SENT_359	[p25l1979t1943r2132b2022, p25l12t2097r211b2167],
20	and	CC	O	and	_	0	SENT_359	[p25l249t2071r404b2150],
21	the	DT	O	the	det	22	SENT_359	[p25l438t2071r568b2149],
22	duration	NN	O	duration	nsubj	26	SENT_359	[p25l603t2071r960b2150],
23	of	IN	O	of	_	0	SENT_359	[p25l995t2070r1093b2150],
24	such	JJ	O	such	amod	25	SENT_359	[p25l1109t2071r1300b2150],
25	therapy	NN	O	therapy	prep_of	22	SENT_359	[p25l1333t2071r1648b2171],
26	was	VBD	O	be	conj_and	10	SENT_359	[p25l1672t2097r1833b2150],
27	longer	RBR	O	longer	advmod	26	SENT_359	[p25l1867t2071r2137b2172],
28	with	IN	O	with	_	0	SENT_359	[p25l7t2199r202b2278],
29	crizotinib	NN	O	crizotinib	prep_with	26	SENT_359	[p25l251t2199r671b2277],
30	than	IN	O	than	prep	26	SENT_359	[p25l722t2199r918b2277],
31	with	IN	O	with	pcomp	30	SENT_359	[p25l963t2199r1158b2278],
32	chemotherapy	NN	O	chemotherapy	pobj	31	SENT_359	[p25l1207t2199r1831b2298],
33	.	.	O	.	_	0	SENT_359	[p25l1207t2199r1831b2298],

1	These	DT	O	these	det	2	SENT_360	[p25l1882t2199r2133b2277],
2	differences	NNS	O	difference	nsubj	5	SENT_360	[p25l9t2325r466b2405],
3	may	MD	O	may	aux	5	SENT_360	[p25l503t2352r679b2426],
4	have	VB	O	have	aux	5	SENT_360	[p25l710t2326r895b2406],
5	resulted	VBN	O	result	_	0	SENT_360	[p25l931t2326r1261b2406],
6	in	IN	O	in	_	0	SENT_360	[p25l1296t2327r1377b2404],
7	an	DT	O	a	det	8	SENT_360	[p25l1413t2352r1514b2404],
8	imbalance	NN	O	imbalance	prep_in	5	SENT_360	[p25l1549t2326r1982b2405],
9	between	IN	O	between	_	0	SENT_360	[p25l2019t2326r2145b2405, p25l9t2472r257b2534],
10	the	DT	O	the	det	12	SENT_360	[p25l293t2455r427b2533],
11	two	CD	NUMBER	two	num	12	SENT_360	[p25l465t2472r624b2534],
12	groups	NNS	O	group	prep_between	8	SENT_360	[p25l662t2481r960b2556],
13	that	WDT	O	that	nsubj	15	SENT_360	[p25l1000t2455r1174b2533],
14	could	MD	O	could	aux	15	SENT_360	[p25l1207t2455r1443b2534],
15	account	VB	O	account	rcmod	8	SENT_360	[p25l1480t2472r1820b2534],
16	in	IN	O	in	_	0	SENT_360	[p25l1851t2456r1936b2533],
17	part	NN	O	part	prep_in	15	SENT_360	[p25l1972t2472r2153b2555],
18	for	IN	O	for	_	0	SENT_360	[p25l8t2583r133b2664],
19	the	DT	O	the	det	21	SENT_360	[p25l177t2584r311b2663],
20	increased	VBN	O	increase	amod	21	SENT_360	[p25l359t2584r770b2664],
21	incidence	NN	O	incidence	prep_for	15	SENT_360	[p25l817t2584r1225b2664],
22	of	IN	O	of	_	0	SENT_360	[p25l1274t2583r1375b2664],
23	all	DT	O	all	det	27	SENT_360	[p25l1404t2584r1783b2664],
24	—	CD	NUMBER	—	num	27	SENT_360	[p25l1404t2584r1783b2664],
25	cause	NN	O	cause	nn	27	SENT_360	[p25l1404t2584r1783b2664],
26	adverse	JJ	O	adverse	amod	27	SENT_360	[p25l1830t2584r2148b2664],
27	events	NNS	O	event	prep_of	21	SENT_360	[p25l9t2730r269b2792],
28	seen	VBN	O	see	partmod	21	SENT_360	[p25l313t2739r500b2791],
29	with	IN	O	with	_	0	SENT_360	[p25l536t2713r729b2792],
30	crizotinib	NN	O	crizotinib	nn	33	SENT_360	[p25l770t2713r1183b2792],
31	(	CD	NUMBER	(	num	33	SENT_360	[p25l1230t2713r1485b2804],
32	Table	NNP	O	Table	nn	33	SENT_360	[p25l1230t2713r1485b2804],
33	S5	NN	O	s5	prep_with	28	SENT_360	[p25l1528t2719r1619b2792],
34	in	IN	O	in	_	0	SENT_360	[p25l1662t2714r1745b2791],
35	the	DT	O	the	det	38	SENT_360	[p25l1785t2713r1917b2791],
36	Supplementary	NNP	O	Supplementary	nn	38	SENT_360	[p25l1960t2719r2145b2813, p25l7t2842r491b2942],
37	Appendix	NNP	O	Appendix	nn	38	SENT_360	[p25l522t2842r991b2942],
38	)	NN	O	)	prep_in	28	SENT_360	[p25l522t2842r991b2942],
39	.	.	O	.	_	0	SENT_360	[p25l522t2842r991b2942],

1	In	IN	O	in	_	0	SENT_361	[p25l137t2979r227b3049],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_361	[p25l275t2971r762b3067],
3	,	,	O	,	_	0	SENT_361	[p25l275t2971r762b3067],
4	this	DT	O	this	det	5	SENT_361	[p25l817t2971r977b3049],
5	study	NN	O	study	nsubj	6	SENT_361	[p25l1029t2971r1260b3071],
6	showed	VBD	O	show	_	0	SENT_361	[p25l1305t2971r1631b3050],
7	that	IN	O	that	complm	21	SENT_361	[p25l1679t2971r1853b3049],
8	crizotinib	NN	O	crizotinib	nsubj	21	SENT_361	[p25l1896t2972r2145b3050, p25l9t3100r229b3196],
9	,	,	O	,	_	0	SENT_361	[p25l1896t2972r2145b3050, p25l9t3100r229b3196],
10	as	IN	O	as	mark	8	SENT_361	[p25l267t3126r352b3178],
11	compared	VBN	O	compare	_	0	SENT_361	[p25l387t3100r809b3200],
12	with	IN	O	with	_	0	SENT_361	[p25l836t3100r1030b3179],
13	chemotherapy	NN	O	chemotherapy	prep_compared_with	8	SENT_361	[p25l1063t3100r1678b3200],
14	,	,	O	,	_	0	SENT_361	[p25l1063t3100r1678b3200],
15	prolonged	JJ	O	prolonged	amod	16	SENT_361	[p25l1715t3100r2148b3201],
16	progression	NN	O	progression	appos	13	SENT_361	[p25l7t3227r688b3330],
17	—	CD	NUMBER	—	num	19	SENT_361	[p25l7t3227r688b3330],
18	free	JJ	O	free	amod	19	SENT_361	[p25l7t3227r688b3330],
19	survival	NN	O	survival	dep	16	SENT_361	[p25l722t3228r1061b3325],
20	,	,	O	,	_	0	SENT_361	[p25l722t3228r1061b3325],
21	increased	VBD	O	increase	ccomp	6	SENT_361	[p25l1097t3228r1492b3308],
22	response	NN	O	response	nn	23	SENT_361	[p25l1523t3254r1892b3329],
23	rates	NNS	O	rate	dobj	21	SENT_361	[p25l1923t3245r2141b3325],
24	,	,	O	,	_	0	SENT_361	[p25l1923t3245r2141b3325],
25	and	CC	O	and	_	0	SENT_361	[p25l8t3356r167b3435],
26	improved	VBD	O	improve	conj_and	21	SENT_361	[p25l204t3356r611b3456],
27	the	DT	O	the	det	28	SENT_361	[p25l649t3356r783b3434],
28	quality	NN	O	quality	dobj	26	SENT_361	[p25l822t3356r1122b3456],
29	of	IN	O	of	_	0	SENT_361	[p25l1157t3355r1257b3435],
30	life	NN	O	life	prep_of	28	SENT_361	[p25l1276t3355r1412b3434],
31	in	IN	O	in	_	0	SENT_361	[p25l1451t3357r1534b3434],
32	patients	NNS	O	patient	prep_in	26	SENT_361	[p25l1571t3357r1915b3456],
33	with	IN	O	with	_	0	SENT_361	[p25l1950t3356r2147b3436],
34	advanced	JJ	O	advanced	prep_with	32	SENT_361	[p25l8t3485r430b3581],
35	,	,	O	,	_	0	SENT_361	[p25l8t3485r430b3581],
36	previously	RB	DATE	previously	advmod	37	SENT_361	[p25l492t3485r935b3585],
37	treated	VBN	O	treat	partmod	34	SENT_361	[p25l988t3485r1289b3564],
38	ALK	NNP	O	ALK	dep	40	SENT_361	[p25l1340t3486r1871b3585],
39	—	CD	NUMBER	—	num	38	SENT_361	[p25l1340t3486r1871b3585],
40	positive	JJ	O	positive	amod	43	SENT_361	[p25l1340t3486r1871b3585],
41	nonsmall-cell	JJ	O	nonsmall-cell	amod	43	SENT_361	[p25l1929t3511r2150b3564, p25l10t3614r431b3693],
42	lung	NN	O	lung	nn	43	SENT_361	[p25l485t3614r679b3716],
43	cancer	NN	O	cancer	dobj	37	SENT_361	[p25l732t3640r1033b3694],
44	.	.	O	.	_	0	SENT_361	[p25l732t3640r1033b3694],

1	The	DT	O	the	det	3	SENT_362	[p25l1091t3614r1252b3693],
2	apparent	JJ	O	apparent	amod	3	SENT_362	[p25l1307t3631r1690b3715],
3	lack	NN	O	lack	nsubj	9	SENT_362	[p25l1738t3614r1916b3694],
4	of	IN	O	of	_	0	SENT_362	[p25l1967t3613r2067b3694],
5	a	DT	O	a	det	7	SENT_362	[p25l2104t3641r2148b3693],
6	survival	NN	O	survival	nn	7	SENT_362	[p26l10t21r336b101],
7	beneﬁt	NN	O	beneﬁt	prep_of	3	SENT_362	[p26l367t20r669b101],
8	probably	RB	O	probably	advmod	9	SENT_362	[p26l692t21r1065b122],
9	reflects	VBZ	O	reflect	_	0	SENT_362	[p26l1091t20r1404b100],
10	the	DT	O	the	det	12	SENT_362	[p26l1438t21r1569b100],
11	confounding	JJ	O	confounding	amod	12	SENT_362	[p26l1601t20r2151b123],
12	effects	NNS	O	effect	dobj	9	SENT_362	[p26l9t148r292b228],
13	of	IN	O	of	_	0	SENT_362	[p26l345t148r445b228],
14	crossover	NN	O	crossover	prep_of	12	SENT_362	[p26l477t175r902b245],
15	,	,	O	,	_	0	SENT_362	[p26l477t175r902b245],
16	effects	NNS	O	effect	appos	14	SENT_362	[p26l958t148r1242b227],
17	that	WDT	O	that	nsubjpass	20	SENT_362	[p26l1294t149r1467b227],
18	have	VBP	O	have	aux	20	SENT_362	[p26l1512t149r1703b228],
19	been	VBN	O	be	auxpass	20	SENT_362	[p26l1754t149r1957b228],
20	observed	VBN	O	observe	rcmod	16	SENT_362	[p26l2007t149r2145b228, p26l10t277r283b357],
21	in	IN	O	in	_	0	SENT_362	[p26l318t278r402b355],
22	other	JJ	O	other	prep_in	20	SENT_362	[p26l439t277r668b356],
23	randomized	VBN	O	randomize	partmod	22	SENT_362	[p26l701t277r1226b356],
24	trials	NNS	O	trial	dobj	23	SENT_362	[p26l1264t277r1484b355],
25	of	IN	O	of	_	0	SENT_362	[p26l1524t276r1624b356],
26	molecularly	RB	O	molecularly	advmod	27	SENT_362	[p26l1642t277r2152b377],
27	targeted	VBN	O	target	amod	28	SENT_362	[p26l8t406r367b507],
28	agents	NNS	O	agent	prep_of	24	SENT_362	[p26l412t423r691b507],
29	in	IN	O	in	_	0	SENT_362	[p26l739t407r822b484],
30	patients	NNS	O	patient	prep_in	28	SENT_362	[p26l869t407r1212b506],
31	with	IN	O	with	_	0	SENT_362	[p26l1257t406r1454b485],
32	non	JJ	O	non	amod	38	SENT_362	[p26l1500t406r2148b485],
33	—	JJ	O	—	amod	38	SENT_362	[p26l1500t406r2148b485],
34	small	JJ	O	small	amod	38	SENT_362	[p26l1500t406r2148b485],
35	—	NN	O	—	nn	38	SENT_362	[p26l1500t406r2148b485],
36	cell	NN	O	cell	nn	38	SENT_362	[p26l1500t406r2148b485],
37	lung	NN	O	lung	nn	38	SENT_362	[p26l7t534r202b635],
38	cancer	NN	O	cancer	prep_with	30	SENT_362	[p26l239t560r540b613],
39	.	.	O	.	_	0	SENT_362	[p26l239t560r540b613],

1	Supported	VBN	O	support	_	0	SENT_363	[p26l96t780r435b856],
2	by	IN	O	by	_	0	SENT_363	[p26l461t780r536b856],
3	Pfizer	NNP	ORGANIZATION	Pfizer	prep_by	1	SENT_363	[p26l557t779r771b839],
4	.	.	O	.	_	0	SENT_363	[p26l557t779r771b839],

1	Disclosure	NN	O	disclosure	nsubj	2	SENT_364	[p26l93t877r443b937],
2	forms	VBZ	O	form	_	0	SENT_364	[p26l476t876r670b936],
3	provided	VBN	O	provide	csubj	8	SENT_364	[p26l704t877r993b953],
4	by	IN	O	by	_	0	SENT_364	[p26l1026t877r1100b953],
5	the	DT	O	the	det	6	SENT_364	[p26l1131t877r1233b936],
6	authors	NNS	O	author	prep_by	3	SENT_364	[p26l1265t877r1514b937],
7	are	VBP	O	be	cop	8	SENT_364	[p26l1548t897r1648b936],
8	available	JJ	O	available	ccomp	2	SENT_364	[p26l1681t877r1968b937],
9	with	IN	O	with	_	0	SENT_364	[p26l1998t877r2148b937],
10	the	DT	O	the	det	12	SENT_364	[p26l8t974r110b1033],
11	full	JJ	O	full	amod	12	SENT_364	[p26l136t973r250b1034],
12	text	NN	O	text	prep_with	8	SENT_364	[p26l276t987r400b1033],
13	of	IN	O	of	_	0	SENT_364	[p26l422t973r499b1033],
14	this	DT	O	this	det	15	SENT_364	[p26l510t974r634b1033],
15	article	NN	O	article	prep_of	12	SENT_364	[p26l661t974r868b1033],
16	at	IN	O	at	_	0	SENT_364	[p26l893t987r953b1033],
17	NEJM.org	NN	O	nejm.org	prep_at	15	SENT_364	[p26l974t979r1315b1050],
18	.	.	O	.	_	0	SENT_364	[p26l974t979r1315b1050],

1	We	PRP	O	we	nsubj	2	SENT_365	[p26l91t1076r193b1130],
2	thank	VBP	O	thank	_	0	SENT_365	[p26l230t1071r427b1131],
3	the	DT	O	the	det	5	SENT_365	[p26l461t1071r563b1130],
4	participating	VBG	O	participate	amod	5	SENT_365	[p26l599t1072r1034b1147],
5	patients	NNS	O	patient	dobj	2	SENT_365	[p26l1066t1072r1330b1147],
6	and	CC	O	and	_	0	SENT_365	[p26l1369t1071r1490b1130],
7	their	PRP$	O	they	poss	8	SENT_365	[p26l1527t1071r1684b1130],
8	families	NNS	O	family	conj_and	5	SENT_365	[p26l1719t1070r2005b1143],
9	;	:	O	;	_	0	SENT_365	[p26l1719t1070r2005b1143],
10	the	DT	O	the	det	11	SENT_365	[p26l2045t1071r2148b1130],
11	network	NN	O	network	conj_and	5	SENT_365	[p26l8t1168r283b1229],
12	of	IN	O	of	_	0	SENT_365	[p26l305t1167r381b1227],
13	investigators	NNS	O	investigator	prep_of	11	SENT_365	[p26l391t1169r815b1244],
14	(	CD	NUMBER	(	num	13	SENT_365	[p26l845t1168r1048b1237],
15	listed	VBN	O	list	partmod	13	SENT_365	[p26l845t1168r1048b1237],
16	in	IN	O	in	_	0	SENT_365	[p26l1071t1169r1135b1227],
17	the	DT	O	the	det	19	SENT_365	[p26l1160t1168r1263b1227],
18	Supplementary	NNP	MISC	Supplementary	nn	19	SENT_365	[p26l1288t1168r1788b1244],
19	Appendix	NNP	MISC	Appendix	prep_in	15	SENT_365	[p26l1806t1168r2144b1244],
20	,	,	O	,	_	0	SENT_365	[p26l1806t1168r2144b1244],
21	available	JJ	O	available	amod	35	SENT_365	[p26l7t1265r294b1324],
22	at	IN	O	at	_	0	SENT_365	[p26l318t1277r379b1323],
23	N	NN	O	n	nn	25	SENT_365	[p26l397t1270r453b1324],
24	EJM.org	NN	O	ejm.org	nn	25	SENT_365	[p26l456t1270r764b1340],
25	)	NN	O	)	prep_at	21	SENT_365	[p26l456t1270r764b1340],
26	,	,	O	,	_	0	SENT_365	[p26l456t1270r764b1340],
27	research	NN	O	research	nn	28	SENT_365	[p26l792t1265r1072b1323],
28	nurses	NNS	O	nurse	conj_and	25	SENT_365	[p26l1095t1284r1329b1336],
29	,	,	O	,	_	0	SENT_365	[p26l1095t1284r1329b1336],
30	study	NN	O	study	nn	31	SENT_365	[p26l1359t1265r1536b1340],
31	coordinators	NNS	O	coordinator	conj_and	25	SENT_365	[p26l1556t1265r2000b1336],
32	,	,	O	,	_	0	SENT_365	[p26l1556t1265r2000b1336],
33	and	CC	O	and	_	0	SENT_365	[p26l2027t1265r2148b1324],
34	operations	NNS	O	operation	conj_and	25	SENT_365	[p26l8t1362r358b1437],
35	staff	NN	O	staff	appos	19	SENT_365	[p26l393t1360r561b1433],
36	;	:	O	;	_	0	SENT_365	[p26l393t1360r561b1433],
37	and	CC	O	and	_	0	SENT_365	[p26l595t1361r716b1420],
38	Wendy	NNP	PERSON	Wendy	nn	39	SENT_365	[p26l745t1361r970b1437],
39	Sacks	NNP	PERSON	Sacks	dobj	2	SENT_365	[p26l1000t1361r1181b1421],
40	at	IN	O	at	_	0	SENT_365	[p26l1213t1373r1274b1420],
41	ACUMED	NNP	O	ACUMED	prep_at	39	SENT_365	[p26l1299t1365r1614b1420],
42	(	CD	NUMBER	(	num	41	SENT_365	[p26l1650t1366r1824b1430],
43	New	NNP	LOCATION	New	nn	45	SENT_365	[p26l1650t1366r1824b1430],
44	York	NNP	LOCATION	York	nn	45	SENT_365	[p26l1850t1361r2019b1430],
45	)	NN	O	)	dep	39	SENT_365	[p26l1850t1361r2019b1430],
46	for	IN	O	for	_	0	SENT_365	[p26l2055t1360r2150b1420],
47	editorial	NN	O	editorial	nn	48	SENT_365	[p26l8t1458r288b1516],
48	assistance	NN	O	assistance	prep_for	45	SENT_365	[p26l312t1459r669b1516],
49	.	.	O	.	_	0	SENT_365	[p26l312t1459r669b1516],

1	REFERENCES	NNS	O	reference	_	0	SENT_366	[p26l16t1641r339b1672],

1	1	LS	NUMBER	1	_	0	SENT_367	[p26l14t1744r51b1783],
2	.	.	O	.	_	0	SENT_367	[p26l14t1744r51b1783],

1	Kwak	NNP	PERSON	Kwak	nn	2	SENT_368	[p26l108t1739r245b1784],
2	EL	NNP	O	EL	_	0	SENT_368	[p26l258t1743r333b1792],
3	,	,	O	,	_	0	SENT_368	[p26l258t1743r333b1792],
4	Bang	NNP	O	Bang	nn	5	SENT_368	[p26l352t1742r478b1795],
5	Y	NN	O	y	appos	2	SENT_368	[p26l491t1743r565b1792],
6	.	.	O	.	_	0	SENT_368	[p26l491t1743r565b1792],

1	—	NN	O	—	_	0	SENT_369	[p26l491t1743r565b1792],
2	.	.	O	.	_	0	SENT_369	[p26l491t1743r565b1792],

1	J	NN	O	j	_	0	SENT_370	[p26l491t1743r565b1792],
2	,	,	O	,	_	0	SENT_370	[p26l491t1743r565b1792],
3	Camidge	NNP	O	Camidge	nn	4	SENT_370	[p26l585t1738r802b1795],
4	DR	NN	O	dr	appos	1	SENT_370	[p26l818t1742r907b1792],
5	,	,	O	,	_	0	SENT_370	[p26l818t1742r907b1792],
6	et	FW	O	et	nn	7	SENT_370	[p26l927t1748r971b1783],
7	al.	FW	O	al.	appos	4	SENT_370	[p26l984t1739r1040b1783],
8	.	.	O	.	_	0	SENT_370	[p26l984t1739r1040b1783],

1	Anaplastic	JJ	O	anaplastic	amod	4	SENT_371	[p26l10t1809r271b1866],
2	lymphoma	NN	O	lymphoma	nn	4	SENT_371	[p26l306t1809r568b1866],
3	kinase	NN	O	kinase	nn	4	SENT_371	[p26l603t1810r762b1854],
4	inhibition	NN	O	inhibition	_	0	SENT_371	[p26l798t1810r1043b1854],
5	in	IN	O	in	_	0	SENT_371	[p26l12t1881r59b1924],
6	non	JJ	O	non	amod	12	SENT_371	[p26l88t1881r455b1925],
7	—	JJ	O	—	amod	12	SENT_371	[p26l88t1881r455b1925],
8	small	JJ	O	small	amod	12	SENT_371	[p26l88t1881r455b1925],
9	—	NN	O	—	nn	12	SENT_371	[p26l88t1881r455b1925],
10	cell	NN	O	cell	nn	12	SENT_371	[p26l88t1881r455b1925],
11	lung	NN	O	lung	nn	12	SENT_371	[p26l483t1881r593b1937],
12	cancer	NN	O	cancer	prep_in	4	SENT_371	[p26l620t1895r791b1925],
13	.	.	O	.	_	0	SENT_371	[p26l620t1895r791b1925],

1	N	NN	O	n	nn	3	SENT_372	[p26l821t1885r863b1925],
2	Engl	NNP	O	Engl	nn	3	SENT_372	[p26l890t1881r1044b1937],
3	]	NNP	O	]	nsubj	4	SENT_372	[p26l890t1881r1044b1937],
4	Med	VBD	O	med	_	0	SENT_372	[p26l11t1952r116b1996],
5	2010	CD	DATE	2010	dobj	4	SENT_372	[p26l133t1955r598b2005],
6	;	:	O	;	_	0	SENT_372	[p26l133t1955r598b2005],
7	363:1693	CD	NUMBER	363:1693	num	8	SENT_372	[p26l133t1955r598b2005],
8	—	NN	O	—	dep	5	SENT_372	[p26l133t1955r598b2005],
9	703	CD	NUMBER	703	dep	8	SENT_372	[p26l133t1955r598b2005],
10	.	.	O	.	_	0	SENT_372	[p26l133t1955r598b2005],

1	[	NN	O	[	nn	2	SENT_373	[p26l623t1955r857b2005],
2	Erratum	NN	O	erratum	nsubj	7	SENT_373	[p26l623t1955r857b2005],
3	,	,	O	,	_	0	SENT_373	[p26l623t1955r857b2005],
4	N	NN	O	n	appos	2	SENT_373	[p26l876t1956r918b1996],
5	Engl	NNP	O	Engl	nn	6	SENT_373	[p26l933t1951r1043b2008],
6	J	NNP	O	J	dep	4	SENT_373	[p26l7t2027r28b2074],
7	Med	VBD	O	med	_	0	SENT_373	[p26l44t2023r150b2067],
8	2011	CD	DATE	2011	dobj	7	SENT_373	[p26l169t2026r525b2076],
9	;	:	O	;	_	0	SENT_373	[p26l169t2026r525b2076],
10	364:588	CD	NUMBER	364:588	dep	8	SENT_373	[p26l169t2026r525b2076],
11	.	.	O	.	_	0	SENT_373	[p26l169t2026r525b2076],
12	]	SYM	O	]	dep	8	SENT_373	[p26l169t2026r525b2076],

1	2	LS	NUMBER	2	_	0	SENT_374	[p26l12t2100r52b2138],
2	.	.	O	.	_	0	SENT_374	[p26l12t2100r52b2138],

1	Gambacorti	NNP	PERSON	Gambacorti	_	0	SENT_375	[p26l109t2095r645b2139],
2	.	.	O	.	_	0	SENT_375	[p26l109t2095r645b2139],

1	—	NN	O	—	_	0	SENT_376	[p26l109t2095r645b2139],
2	.	.	O	.	_	0	SENT_376	[p26l109t2095r645b2139],

1	Passerini	NNP	PERSON	Passerini	nn	2	SENT_377	[p26l109t2095r645b2139],
2	C	NNP	O	C	_	0	SENT_377	[p26l694t2098r741b2148],
3	,	,	O	,	_	0	SENT_377	[p26l694t2098r741b2148],
4	Messa	FW	O	messa	appos	2	SENT_377	[p26l792t2099r945b2138],
5	C	NN	O	c	dep	4	SENT_377	[p26l993t2098r1040b2148],
6	,	,	O	,	_	0	SENT_377	[p26l993t2098r1040b2148],
7	Pogliani	NNP	O	Pogliani	nn	8	SENT_377	[p26l12t2165r216b2221],
8	EM	NNP	O	EM	appos	2	SENT_377	[p26l261t2169r354b2209],
9	.	.	O	.	_	0	SENT_377	[p26l261t2169r354b2209],

1	Crizotinib	NNP	O	Crizotinib	_	0	SENT_378	[p26l403t2165r655b2209],
2	in	IN	O	in	_	0	SENT_378	[p26l701t2165r748b2208],
3	anaplastic	JJ	O	anaplastic	amod	7	SENT_378	[p26l794t2165r1043b2221],
4	large	JJ	O	large	amod	7	SENT_378	[p26l12t2236r242b2292],
5	—	NN	O	—	nn	7	SENT_378	[p26l12t2236r242b2292],
6	cell	NN	O	cell	nn	7	SENT_378	[p26l12t2236r242b2292],
7	lymphoma	NN	O	lymphoma	prep_in	1	SENT_378	[p26l262t2236r537b2292],
8	.	.	O	.	_	0	SENT_378	[p26l262t2236r537b2292],

1	N	NN	O	n	nn	3	SENT_379	[p26l560t2240r602b2280],
2	Engl	NNP	O	Engl	nn	3	SENT_379	[p26l621t2236r731b2292],
3	J	NNP	O	J	nsubj	4	SENT_379	[p26l746t2240r767b2286],
4	Med	VBD	O	med	_	0	SENT_379	[p26l785t2235r891b2280],
5	2011	CD	DATE	2011	dobj	4	SENT_379	[p26l912t2239r1041b2289],
6	;	:	O	;	_	0	SENT_379	[p26l912t2239r1041b2289],
7	364:775	CD	NUMBER	364:775	number	8	SENT_379	[p26l13t2310r268b2351],
8	—	CD	NUMBER	—	dep	5	SENT_379	[p26l13t2310r268b2351],
9	6	CD	NUMBER	6	dep	8	SENT_379	[p26l13t2310r268b2351],
10	.	.	O	.	_	0	SENT_379	[p26l13t2310r268b2351],

1	3	LS	NUMBER	3	_	0	SENT_380	[p26l12t2383r50b2422],
2	.	.	O	.	_	0	SENT_380	[p26l12t2383r50b2422],

1	Mosse	NNP	ORGANIZATION	Mosse	nn	2	SENT_381	[p26l107t2382r262b2422],
2	YP	NNP	ORGANIZATION	YP	_	0	SENT_381	[p26l278t2381r349b2431],
3	,	,	O	,	_	0	SENT_381	[p26l278t2381r349b2431],
4	Balis	NNP	PERSON	Balis	nn	5	SENT_381	[p26l370t2378r489b2421],
5	FM	NNP	O	FM	appos	2	SENT_381	[p26l507t2382r597b2431],
6	,	,	O	,	_	0	SENT_381	[p26l507t2382r597b2431],
7	Lim	NNP	PERSON	Lim	nn	8	SENT_381	[p26l617t2378r713b2421],
8	MS	NN	O	m	appos	2	SENT_381	[p26l729t2381r819b2431],
9	,	,	O	,	_	0	SENT_381	[p26l729t2381r819b2431],
10	et	FW	O	et	nn	11	SENT_381	[p26l841t2387r885b2422],
11	al.	FW	O	al.	appos	2	SENT_381	[p26l900t2377r956b2422],
12	.	.	O	.	_	0	SENT_381	[p26l900t2377r956b2422],

1	Efficacy	NN	O	efficacy	_	0	SENT_382	[p26l976t2377r1042b2421, p26l12t2448r156b2505],
2	of	IN	O	of	_	0	SENT_382	[p26l184t2448r240b2493],
3	crizotinib	NN	O	crizotinib	prep_of	1	SENT_382	[p26l260t2449r501b2493],
4	in	IN	O	in	_	0	SENT_382	[p26l530t2449r578b2492],
5	children	NNS	O	child	prep_in	3	SENT_382	[p26l607t2448r810b2493],
6	with	IN	O	with	_	0	SENT_382	[p26l838t2449r949b2493],
7	relapsed/refractory	JJ	O	relapsed/refractory	amod	9	SENT_382	[p26l978t2463r1042b2493, p26l12t2519r431b2576],
8	ALK	NN	O	alk	nn	9	SENT_382	[p26l459t2519r736b2565],
9	—	NN	O	—	prep_with	5	SENT_382	[p26l459t2519r736b2565],
10	driven	VBN	O	drive	partmod	9	SENT_382	[p26l459t2519r736b2565],
11	tumors	NNS	O	tumor	dobj	10	SENT_382	[p26l769t2529r944b2564],
12	including	VBG	O	include	_	0	SENT_382	[p26l977t2520r1042b2563, p26l13t2590r197b2647],
13	anaplastic	JJ	O	anaplastic	amod	16	SENT_382	[p26l228t2591r478b2647],
14	large	JJ	O	large	amod	16	SENT_382	[p26l510t2591r632b2647],
15	cell	NN	O	cell	nn	16	SENT_382	[p26l666t2591r750b2635],
16	lymphoma	NN	O	lymphoma	prep_including	11	SENT_382	[p26l782t2591r1044b2647],
17	and	CC	O	and	_	0	SENT_382	[p26l12t2661r101b2706],
18	neuroblastoma	NN	O	neuroblastoma	prep_including	11	SENT_382	[p26l123t2661r506b2706],
19	:	:	O	:	_	0	SENT_382	[p26l123t2661r506b2706],
20	a	DT	O	a	det	21	SENT_382	[p26l530t2676r555b2705],
21	Children	NNP	O	Children	poss	25	SENT_382	[p26l575t2661r825b2706],
22	’s	POS	O	’s	_	0	SENT_382	[p26l575t2661r825b2706],
23	Oncology	NNP	O	Oncology	nn	25	SENT_382	[p26l847t2662r1042b2706, p26l12t2747r70b2789],
24	Group	NNP	O	Group	nn	25	SENT_382	[p26l89t2736r242b2789],
25	phase	NN	O	phase	dep	1	SENT_382	[p26l264t2733r406b2789],
26	1	CD	NUMBER	1	num	28	SENT_382	[p26l429t2736r454b2776],
27	consortium	NN	O	consortium	nn	28	SENT_382	[p26l476t2733r760b2777],
28	study	NN	O	study	dep	25	SENT_382	[p26l783t2732r922b2789],
29	.	.	O	.	_	0	SENT_382	[p26l783t2732r922b2789],

1	Presented	VBN	O	present	_	0	SENT_383	[p26l946t2736r1042b2777, p26l13t2804r170b2848],
2	at	IN	O	at	_	0	SENT_383	[p26l213t2813r257b2847],
3	the	DT	O	the	det	4	SENT_383	[p26l297t2804r373b2848],
4	Annual	JJ	SET	annual	prep_at	1	SENT_383	[p26l413t2803r594b2848],
5	Meeting	VBG	O	meet	partmod	4	SENT_383	[p26l634t2804r838b2860],
6	of	IN	O	of	_	0	SENT_383	[p26l878t2803r935b2848],
7	the	DT	O	the	det	9	SENT_383	[p26l968t2804r1043b2847],
8	American	NNP	ORGANIZATION	American	nn	9	SENT_383	[p26l10t2875r250b2919],
9	Society	NNP	ORGANIZATION	Society	prep_of	5	SENT_383	[p26l285t2875r459b2931],
10	of	IN	ORGANIZATION	of	_	0	SENT_383	[p26l491t2874r548b2919],
11	Clinical	JJ	ORGANIZATION	clinical	amod	12	SENT_383	[p26l571t2875r762b2919],
12	Oncology	NN	ORGANIZATION	oncology	prep_of	9	SENT_383	[p26l796t2874r1040b2931],
13	,	,	O	,	_	0	SENT_383	[p26l796t2874r1040b2931],
14	Chicago	NNP	LOCATION	Chicago	nn	16	SENT_383	[p26l12t2946r224b3002],
15	,	,	O	,	_	0	SENT_383	[p26l12t2946r224b3002],
16	June	NNP	DATE	June	appos	12	SENT_383	[p26l241t2950r351b2996],
17	1-5	CD	DATE	1-5	num	16	SENT_383	[p26l372t2949r466b2999],
18	,	,	DATE	,	_	0	SENT_383	[p26l372t2949r466b2999],
19	2012	CD	DATE	2012	num	16	SENT_383	[p26l489t2949r619b2990],
20	.	.	O	.	_	0	SENT_383	[p26l489t2949r619b2990],

1	abstract	JJ	O	abstract	_	0	SENT_384	[p26l641t2946r850b2990],
2	.	.	O	.	_	0	SENT_384	[p26l641t2946r850b2990],

1	4	LS	NUMBER	4	_	0	SENT_385	[p26l11t3023r51b3061],
2	.	.	O	.	_	0	SENT_385	[p26l11t3023r51b3061],

1	Soda	NNP	O	Soda	nn	2	SENT_386	[p26l110t3017r227b3061],
2	M	NNP	O	M	_	0	SENT_386	[p26l250t3021r311b3071],
3	,	,	O	,	_	0	SENT_386	[p26l250t3021r311b3071],
4	Choi	NNP	PERSON	Choi	nn	5	SENT_386	[p26l340t3017r453b3061],
5	YL	NNP	PERSON	YL	appos	2	SENT_386	[p26l476t3021r552b3071],
6	,	,	O	,	_	0	SENT_386	[p26l476t3021r552b3071],
7	Enomoto	NNP	PERSON	Enomoto	nn	8	SENT_386	[p26l580t3021r803b3061],
8	M	NNP	O	M	appos	2	SENT_386	[p26l827t3021r889b3071],
9	,	,	O	,	_	0	SENT_386	[p26l827t3021r889b3071],
10	et	FW	O	et	nn	11	SENT_386	[p26l918t3026r962b3061],
11	al.	FW	O	al.	appos	2	SENT_386	[p26l984t3017r1040b3061],
12	.	.	O	.	_	0	SENT_386	[p26l984t3017r1040b3061],

1	Identification	NN	O	identification	_	0	SENT_387	[p26l12t3087r349b3131],
2	of	IN	O	of	_	0	SENT_387	[p26l369t3087r426b3131],
3	the	DT	O	the	det	5	SENT_387	[p26l436t3087r511b3131],
4	transforming	VBG	O	transform	amod	5	SENT_387	[p26l532t3087r863b3144],
5	EML4	NN	O	eml4	prep_of	1	SENT_387	[p26l880t3091r1042b3131],
6	—	CD	NUMBER	—	num	9	SENT_387	[p26l880t3091r1042b3131],
7	ALK	NN	O	alk	nn	9	SENT_387	[p26l10t3162r118b3204],
8	fusion	NN	O	fusion	nn	9	SENT_387	[p26l146t3158r300b3203],
9	gene	NN	O	gene	dep	5	SENT_387	[p26l330t3173r444b3215],
10	in	IN	O	in	_	0	SENT_387	[p26l473t3159r520b3202],
11	non	JJ	O	non	amod	17	SENT_387	[p26l550t3158r906b3203],
12	—	JJ	O	—	amod	17	SENT_387	[p26l550t3158r906b3203],
13	small	JJ	O	small	amod	17	SENT_387	[p26l550t3158r906b3203],
14	—	NN	O	—	nn	17	SENT_387	[p26l550t3158r906b3203],
15	cell	NN	O	cell	nn	17	SENT_387	[p26l550t3158r906b3203],
16	lung	NN	O	lung	nn	17	SENT_387	[p26l935t3158r1045b3215],
17	cancer	NN	O	cancer	prep_in	1	SENT_387	[p26l13t3244r183b3274],
18	.	.	O	.	_	0	SENT_387	[p26l13t3244r183b3274],

1	Nature	NNP	O	Nature	_	0	SENT_388	[p26l205t3234r373b3275],
2	2007	CD	DATE	2007	num	1	SENT_388	[p26l392t3234r776b3284],
3	;	:	O	;	_	0	SENT_388	[p26l392t3234r776b3284],
4	448:561	CD	NUMBER	448:561	number	5	SENT_388	[p26l392t3234r776b3284],
5	—	CD	NUMBER	—	dep	1	SENT_388	[p26l392t3234r776b3284],
6	6	CD	NUMBER	6	dep	5	SENT_388	[p26l392t3234r776b3284],
7	.	.	O	.	_	0	SENT_388	[p26l392t3234r776b3284],

1	5	CD	NUMBER	5	_	0	SENT_389	[p26l13t3306r50b3344],
2	.	.	O	.	_	0	SENT_389	[p26l13t3306r50b3344],

1	Rikova	NN	PERSON	rikova	nn	2	SENT_390	[p26l108t3300r275b3347],
2	K	NN	PERSON	k	_	0	SENT_390	[p26l293t3304r342b3354],
3	,	,	O	,	_	0	SENT_390	[p26l293t3304r342b3354],
4	Guo	NNP	O	Guo	nn	5	SENT_390	[p26l364t3304r464b3345],
5	A	NNP	O	A	appos	2	SENT_390	[p26l482t3304r531b3354],
6	,	,	O	,	_	0	SENT_390	[p26l482t3304r531b3354],
7	Zeng	NNP	O	Zeng	nn	8	SENT_390	[p26l552t3304r675b3357],
8	Q	NNP	O	Q	appos	2	SENT_390	[p26l692t3304r746b3355],
9	,	,	O	,	_	0	SENT_390	[p26l692t3304r746b3355],
10	et	FW	O	et	nn	11	SENT_390	[p26l768t3310r812b3344],
11	al.	FW	O	al.	appos	2	SENT_390	[p26l828t3300r883b3344],
12	.	.	O	.	_	0	SENT_390	[p26l828t3300r883b3344],

1	Global	JJ	O	global	amod	2	SENT_391	[p26l905t3300r1042b3345, p26l12t3371r54b3415],
2	survey	NN	O	survey	nsubj	6	SENT_391	[p26l91t3386r247b3427],
3	of	IN	O	of	_	0	SENT_391	[p26l281t3371r338b3415],
4	phosphotyrosine	NN	O	phosphotyrosine	nn	5	SENT_391	[p26l363t3371r777b3427],
5	signaling	NN	O	signaling	prep_of	2	SENT_391	[p26l814t3371r1045b3428],
6	identifies	VBZ	O	identify	_	0	SENT_391	[p26l12t3442r243b3487],
7	oncogenic	JJ	O	oncogenic	amod	8	SENT_391	[p26l266t3443r517b3499],
8	kinases	NNS	O	kinase	dobj	6	SENT_391	[p26l537t3442r720b3487],
9	in	IN	O	in	_	0	SENT_391	[p26l742t3443r789b3486],
10	lung	NN	O	lung	nn	11	SENT_391	[p26l810t3442r920b3499],
11	cancer	NN	O	cancer	prep_in	8	SENT_391	[p26l939t3456r1042b3486, p26l13t3528r96b3557],
12	.	.	O	.	_	0	SENT_391	[p26l939t3456r1042b3486, p26l13t3528r96b3557],

1	Cell	NN	O	cell	_	0	SENT_392	[p26l118t3513r212b3557],
2	2007	CD	DATE	2007	num	1	SENT_392	[p26l232t3517r701b3567],
3	;	:	O	;	_	0	SENT_392	[p26l232t3517r701b3567],
4	131:1190	CD	NUMBER	131:1190	num	5	SENT_392	[p26l232t3517r701b3567],
5	—	NN	O	—	dep	1	SENT_392	[p26l232t3517r701b3567],
6	203	CD	NUMBER	203	dep	5	SENT_392	[p26l232t3517r701b3567],
7	.	.	O	.	_	0	SENT_392	[p26l232t3517r701b3567],

1	6	CD	NUMBER	6	_	0	SENT_393	[p26l12t3590r51b3629],
2	.	.	O	.	_	0	SENT_393	[p26l12t3590r51b3629],

1	Camidge	NNP	O	Camidge	nn	2	SENT_394	[p26l109t3584r326b3641],
2	DR	NN	O	dr	_	0	SENT_394	[p26l359t3588r448b3638],
3	,	,	O	,	_	0	SENT_394	[p26l359t3588r448b3638],
4	Doebele	NNP	O	Doebele	nn	5	SENT_394	[p26l485t3584r682b3629],
5	RC	NNP	O	RC	appos	2	SENT_394	[p26l716t3588r800b3631],
6	.	.	O	.	_	0	SENT_394	[p26l716t3588r800b3631],

1	Treating	VBG	O	treat	_	0	SENT_395	[p26l835t3585r1045b3641],
2	ALK	NNP	O	ALK	dep	4	SENT_395	[p26l10t3656r322b3711],
3	—	CD	NUMBER	—	num	2	SENT_395	[p26l10t3656r322b3711],
4	positive	JJ	O	positive	amod	9	SENT_395	[p26l10t3656r322b3711],
5	lung	NN	O	lung	nn	9	SENT_395	[p26l359t3655r469b3712],
6	cancer	NN	O	cancer	nn	9	SENT_395	[p26l504t3669r665b3699],
7	—	RB	O	—	advmod	8	SENT_395	[p26l698t3680r758b3685],
8	early	JJ	O	early	amod	9	SENT_395	[p26l793t3655r910b3711],
9	successes	NNS	O	success	dobj	1	SENT_395	[p26l946t3670r1042b3700, p26l13t3741r163b3770],
10	and	CC	O	and	_	0	SENT_395	[p26l202t3726r292b3770],
11	future	JJ	DATE	future	amod	12	SENT_395	[p26l331t3726r480b3771],
12	challenges	NNS	O	challenge	conj_and	9	SENT_395	[p26l519t3726r792b3783],
13	.	.	O	.	_	0	SENT_395	[p26l519t3726r792b3783],

1	Nat	NNP	O	Nat	nn	2	SENT_396	[p26l833t3730r921b3771],
2	Rev	NN	O	rev	_	0	SENT_396	[p26l956t3730r1045b3773],
3	Lungscape	NNP	O	Lungscape	nn	4	SENT_396	[p26l1118t1743r1379b1795],
4	Project	NNP	O	Project	dep	2	SENT_396	[p26l1430t1739r1613b1795],
5	.	.	O	.	_	0	SENT_396	[p26l1430t1739r1613b1795],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_397	[p26l1665t1743r1769b1782],
2	Oncol	NNP	PERSON	Oncol	_	0	SENT_397	[p26l1821t1739r1965b1783],
3	2012	CD	DATE	2012	dep	2	SENT_397	[p26l2017t1742r2147b1792],
4	;	:	O	;	_	0	SENT_397	[p26l2017t1742r2147b1792],
5	23	CD	NUMBER	23	dep	2	SENT_397	[p26l1119t1810r1330b1866],
6	:	:	O	:	_	0	SENT_397	[p26l1119t1810r1330b1866],
7	Suppl	NNP	O	Suppl	dep	5	SENT_397	[p26l1119t1810r1330b1866],
8	9	CD	NUMBER	9	num	7	SENT_397	[p26l1349t1810r1635b1854],
9	:	:	O	:	_	0	SENT_397	[p26l1349t1810r1635b1854],
10	ix73	CD	NUMBER	ix73	dep	2	SENT_397	[p26l1349t1810r1635b1854],
11	—	CD	NUMBER	—	num	12	SENT_397	[p26l1349t1810r1635b1854],
12	iX94	NN	O	ix94	dep	10	SENT_397	[p26l1349t1810r1635b1854],
13	.	.	O	.	_	0	SENT_397	[p26l1349t1810r1635b1854],

1	8	CD	NUMBER	8	_	0	SENT_398	[p26l1118t1885r1157b1925],
2	.	.	O	.	_	0	SENT_398	[p26l1118t1885r1157b1925],

1	Bray	NNP	O	Bray	nn	12	SENT_399	[p26l1214t1884r1322b1937],
2	F	NN	O	f	nn	12	SENT_399	[p26l1336t1885r1374b1934],
3	,	,	O	,	_	0	SENT_399	[p26l1336t1885r1374b1934],
4	Ren	NNP	O	Ren	dep	12	SENT_399	[p26l1394t1884r1488b1927],
5	JS	NNP	O	JS	nn	12	SENT_399	[p26l1500t1884r1562b1934],
6	,	,	O	,	_	0	SENT_399	[p26l1500t1884r1562b1934],
7	Masuyer	NNP	O	Masuyer	appos	12	SENT_399	[p26l1581t1885r1788b1937],
8	E	NNP	O	E	nn	12	SENT_399	[p26l1803t1885r1846b1934],
9	,	,	O	,	_	0	SENT_399	[p26l1803t1885r1846b1934],
10	Ferlay	NNP	O	Ferlay	appos	12	SENT_399	[p26l1866t1880r2013b1937],
11	J.	NNP	O	J.	nn	12	SENT_399	[p26l2023t1885r2055b1931],
12	Estimates	NNS	O	estimate	_	0	SENT_399	[p26l2075t1885r2148b1924, p26l1119t1952r1304b1996],
13	of	IN	O	of	_	0	SENT_399	[p26l1334t1951r1392b1996],
14	global	JJ	O	global	amod	16	SENT_399	[p26l1410t1952r1566b2008],
15	cancer	NN	O	cancer	nn	16	SENT_399	[p26l1596t1966r1759b1995],
16	prevalence	NN	O	prevalence	prep_of	12	SENT_399	[p26l1785t1952r2050b2008],
17	for	IN	O	for	_	0	SENT_399	[p26l2080t1951r2151b1996],
18	27	CD	NUMBER	27	num	19	SENT_399	[p26l1119t2026r1175b2066],
19	sites	NNS	O	site	prep_for	16	SENT_399	[p26l1201t2023r1308b2067],
20	in	IN	O	in	_	0	SENT_399	[p26l1333t2023r1380b2066],
21	the	DT	O	the	det	23	SENT_399	[p26l1405t2023r1480b2067],
22	adult	JJ	O	adult	amod	23	SENT_399	[p26l1504t2023r1629b2067],
23	population	NN	O	population	prep_in	19	SENT_399	[p26l1649t2023r1918b2079],
24	in	IN	O	in	_	0	SENT_399	[p26l1942t2023r1990b2066],
25	2008	CD	DATE	2008	prep_in	23	SENT_399	[p26l2014t2026r2146b2067],
26	.	.	O	.	_	0	SENT_399	[p26l2014t2026r2146b2067],

1	Int	NN	O	int	_	0	SENT_400	[p26l1118t2099r1220b2145],
2	]	CD	NUMBER	]	num	1	SENT_400	[p26l1118t2099r1220b2145],
3	Cancer	NN	O	cancer	dep	1	SENT_400	[p26l1238t2098r1409b2139],
4	2013	CD	DATE	2013	num	3	SENT_400	[p26l1426t2098r1870b2148],
5	;	:	O	;	_	0	SENT_400	[p26l1426t2098r1870b2148],
6	132:1133	CD	NUMBER	132:1133	number	7	SENT_400	[p26l1426t2098r1870b2148],
7	—	CD	NUMBER	—	dep	1	SENT_400	[p26l1426t2098r1870b2148],
8	45	CD	NUMBER	45	dep	7	SENT_400	[p26l1426t2098r1870b2148],
9	.	.	O	.	_	0	SENT_400	[p26l1426t2098r1870b2148],

1	9	CD	NUMBER	9	_	0	SENT_401	[p26l1118t2170r1156b2209],
2	.	.	O	.	_	0	SENT_401	[p26l1118t2170r1156b2209],

1	Ou	NNP	O	Ou	nn	2	SENT_402	[p26l1215t2168r1285b2209],
2	SH	NNP	O	SH	_	0	SENT_402	[p26l1306t2168r1388b2218],
3	,	,	O	,	_	0	SENT_402	[p26l1306t2168r1388b2218],
4	Kwak	NNP	PERSON	Kwak	nn	5	SENT_402	[p26l1410t2164r1547b2210],
5	EL	NNP	O	EL	appos	2	SENT_402	[p26l1564t2169r1639b2218],
6	,	,	O	,	_	0	SENT_402	[p26l1564t2169r1639b2218],
7	SiWak	NNP	O	SiWak	appos	5	SENT_402	[p26l1663t2165r1938b2221],
8	.	.	O	.	_	0	SENT_402	[p26l1663t2165r1938b2221],

1	—	NN	O	—	_	0	SENT_403	[p26l1663t2165r1938b2221],
2	.	.	O	.	_	0	SENT_403	[p26l1663t2165r1938b2221],

1	Tapp	NN	PERSON	tapp	nn	2	SENT_404	[p26l1663t2165r1938b2221],
2	C	NN	O	c	_	0	SENT_404	[p26l1959t2168r2006b2218],
3	,	,	O	,	_	0	SENT_404	[p26l1959t2168r2006b2218],
4	et	FW	O	et	nn	5	SENT_404	[p26l2030t2174r2074b2209],
5	al.	FW	O	al.	appos	2	SENT_404	[p26l2090t2165r2146b2209],
6	.	.	O	.	_	0	SENT_404	[p26l2090t2165r2146b2209],

1	Activity	NN	O	activity	_	0	SENT_405	[p26l1116t2236r1305b2292],
2	of	IN	O	of	_	0	SENT_405	[p26l1320t2235r1376b2280],
3	crizotinib	NN	O	crizotinib	nn	6	SENT_405	[p26l1382t2236r1623b2280],
4	(	CD	NUMBER	(	num	6	SENT_405	[p26l1643t2239r1984b2289],
5	PF02341066	NN	O	pf02341066	nn	6	SENT_405	[p26l1643t2239r1984b2289],
6	)	NN	O	)	prep_of	1	SENT_405	[p26l1643t2239r1984b2289],
7	,	,	O	,	_	0	SENT_405	[p26l1643t2239r1984b2289],
8	a	DT	O	a	det	13	SENT_405	[p26l2004t2250r2028b2279],
9	dual	JJ	O	dual	amod	13	SENT_405	[p26l2044t2235r2149b2280],
10	mesenchymal	JJ	O	mesenchymal	amod	13	SENT_405	[p26l1118t2307r1708b2363],
11	—	NN	O	—	nn	13	SENT_405	[p26l1118t2307r1708b2363],
12	epithelial	JJ	O	epithelial	amod	13	SENT_405	[p26l1118t2307r1708b2363],
13	transition	NN	O	transition	appos	1	SENT_405	[p26l1731t2307r1972b2351],
14	(	CD	NUMBER	(	num	16	SENT_405	[p26l1998t2310r2146b2357],
15	MET	NN	O	met	nn	16	SENT_405	[p26l1998t2310r2146b2357],
16	)	NN	O	)	dep	13	SENT_405	[p26l1998t2310r2146b2357],
17	and	CC	O	and	_	0	SENT_405	[p26l1118t2378r1208b2422],
18	anaplastic	JJ	O	anaplastic	amod	22	SENT_405	[p26l1240t2377r1489b2434],
19	lymphoma	NN	O	lymphoma	nn	22	SENT_405	[p26l1521t2378r1783b2434],
20	kinase	NN	O	kinase	nn	22	SENT_405	[p26l1814t2378r1973b2422],
21	(	NN	O	(	nn	22	SENT_405	[p26l2008t2381r2146b2428],
22	ALK	NN	O	alk	appos	1	SENT_405	[p26l2008t2381r2146b2428],
23	)	CD	NUMBER	)	num	24	SENT_405	[p26l2008t2381r2146b2428],
24	inhibitor	NN	O	inhibitor	dep	22	SENT_405	[p26l1118t2449r1347b2502],
25	,	,	O	,	_	0	SENT_405	[p26l1118t2449r1347b2502],
26	in	IN	O	in	_	0	SENT_405	[p26l1372t2449r1419b2492],
27	a	DT	O	a	det	34	SENT_405	[p26l1440t2463r1465b2492],
28	non	JJ	O	non	amod	34	SENT_405	[p26l1486t2449r1735b2493],
29	—	CD	NUMBER	—	tmod	28	SENT_405	[p26l1486t2449r1735b2493],
30	small	JJ	O	small	amod	34	SENT_405	[p26l1486t2449r1735b2493],
31	cell	NN	O	cell	nn	34	SENT_405	[p26l1756t2449r1840b2493],
32	lung	NN	O	lung	nn	34	SENT_405	[p26l1860t2448r1970b2505],
33	cancer	NN	O	cancer	nn	34	SENT_405	[p26l1990t2463r2151b2493],
34	patient	NN	O	patient	prep_in	1	SENT_405	[p26l1118t2520r1290b2576],
35	with	IN	O	with	_	0	SENT_405	[p26l1309t2520r1420b2564],
36	de	FW	O	de	nn	38	SENT_405	[p26l1444t2519r1498b2564],
37	novo	FW	O	novo	nn	38	SENT_405	[p26l1522t2534r1637b2564],
38	MET	NN	O	met	prep_with	34	SENT_405	[p26l1660t2523r1777b2563],
39	amplification	NN	O	amplification	dep	38	SENT_405	[p26l1799t2519r2146b2576],
40	.	.	O	.	_	0	SENT_405	[p26l1799t2519r2146b2576],

1	JThorac	NNP	O	JThorac	nn	2	SENT_406	[p26l1113t2590r1321b2641],
2	Oncol	NNP	O	Oncol	_	0	SENT_406	[p26l1340t2591r1485b2635],
3	2011	CD	DATE	2011	num	2	SENT_406	[p26l1504t2594r1832b2644],
4	;	:	O	;	_	0	SENT_406	[p26l1504t2594r1832b2644],
5	6:942	CD	NUMBER	6:942	number	6	SENT_406	[p26l1504t2594r1832b2644],
6	—	CD	NUMBER	—	dep	2	SENT_406	[p26l1504t2594r1832b2644],
7	6	CD	NUMBER	6	dep	6	SENT_406	[p26l1504t2594r1832b2644],
8	.	.	O	.	_	0	SENT_406	[p26l1504t2594r1832b2644],

1	10	CD	NUMBER	10	_	0	SENT_407	[p26l1120t2666r1183b2706],
2	.	.	O	.	_	0	SENT_407	[p26l1120t2666r1183b2706],

1	Bergethon	NNP	O	Bergethon	nn	2	SENT_408	[p26l1214t2662r1469b2718],
2	K	NNP	O	K	_	0	SENT_408	[p26l1486t2666r1536b2715],
3	,	,	O	,	_	0	SENT_408	[p26l1486t2666r1536b2715],
4	Shaw	NNP	ORGANIZATION	Shaw	nn	5	SENT_408	[p26l1558t2661r1687b2706],
5	AT	NNP	O	AT	appos	2	SENT_408	[p26l1700t2665r1779b2715],
6	,	,	O	,	_	0	SENT_408	[p26l1700t2665r1779b2715],
7	Ou	NNP	LOCATION	Ou	nn	8	SENT_408	[p26l1800t2665r1871b2706],
8	S	NNP	LOCATION	S	appos	5	SENT_408	[p26l1890t2665r2011b2715],
9	.	.	O	.	_	0	SENT_408	[p26l1890t2665r2011b2715],

1	—	NN	O	—	_	0	SENT_409	[p26l1890t2665r2011b2715],
2	.	.	O	.	_	0	SENT_409	[p26l1890t2665r2011b2715],

1	HI	NN	O	hus	_	0	SENT_410	[p26l1890t2665r2011b2715],
2	,	,	O	,	_	0	SENT_410	[p26l1890t2665r2011b2715],
3	et	FW	O	et	nn	4	SENT_410	[p26l2032t2671r2076b2706],
4	al.	FW	O	al.	appos	1	SENT_410	[p26l2090t2662r2146b2706],
5	.	.	O	.	_	0	SENT_410	[p26l2090t2662r2146b2706],

1	ROS1	NN	O	ros1	nn	2	SENT_411	[p26l1118t2736r1251b2779],
2	rearrangements	NNS	O	rearrangement	nsubj	3	SENT_411	[p26l1291t2742r1680b2789],
3	define	VBP	O	define	_	0	SENT_411	[p26l1723t2732r1877b2777],
4	a	DT	O	a	det	7	SENT_411	[p26l1917t2747r1942b2776],
5	unique	JJ	O	unique	amod	7	SENT_411	[p26l1982t2733r2149b2789],
6	molecular	JJ	O	molecular	amod	7	SENT_411	[p26l1118t2804r1366b2848],
7	class	NN	O	class	dobj	3	SENT_411	[p26l1397t2804r1513b2847],
8	of	IN	O	of	_	0	SENT_411	[p26l1548t2803r1605b2848],
9	lung	NN	O	lung	nn	10	SENT_411	[p26l1627t2804r1737b2860],
10	cancers	NNS	O	cancer	prep_of	7	SENT_411	[p26l1768t2818r1966b2848],
11	.	.	O	.	_	0	SENT_411	[p26l1768t2818r1966b2848],

1	J	NNP	O	J	nn	3	SENT_412	[p26l1996t2808r2017b2854],
2	Clin	NNP	O	Clin	nn	3	SENT_412	[p26l2048t2804r2149b2848],
3	Oncol	NNP	O	Oncol	_	0	SENT_412	[p26l1119t2875r1263b2919],
4	2012	CD	DATE	2012	num	3	SENT_412	[p26l1282t2878r1666b2928],
5	;	:	O	;	_	0	SENT_412	[p26l1282t2878r1666b2928],
6	30:863	CD	NUMBER	30:863	number	7	SENT_412	[p26l1282t2878r1666b2928],
7	-70	CD	NUMBER	-70	dep	3	SENT_412	[p26l1282t2878r1666b2928],
8	.	.	O	.	_	0	SENT_412	[p26l1282t2878r1666b2928],

1	11	CD	NUMBER	11	_	0	SENT_413	[p26l1120t2951r1183b2989],
2	.	.	O	.	_	0	SENT_413	[p26l1120t2951r1183b2989],

1	Camidge	NNP	O	Camidge	nn	2	SENT_414	[p26l1215t2945r1432b3002],
2	DR	NN	O	dr	_	0	SENT_414	[p26l1449t2949r1539b2999],
3	,	,	O	,	_	0	SENT_414	[p26l1449t2949r1539b2999],
4	Bang	NNP	O	Bang	nn	5	SENT_414	[p26l1559t2949r1685b3002],
5	Y	NN	O	y	appos	2	SENT_414	[p26l1700t2949r1762b2999],
6	]	CD	NUMBER	]	num	5	SENT_414	[p26l1700t2949r1762b2999],
7	,	,	O	,	_	0	SENT_414	[p26l1700t2949r1762b2999],
8	Kwak	NNP	PERSON	Kwak	nn	9	SENT_414	[p26l1783t2945r1919b2991],
9	EL	NNP	O	EL	appos	2	SENT_414	[p26l1934t2949r2009b2999],
10	,	,	O	,	_	0	SENT_414	[p26l1934t2949r2009b2999],
11	et	FW	O	et	nn	12	SENT_414	[p26l2032t2955r2075b2989],
12	al.	FW	O	al.	appos	2	SENT_414	[p26l2090t2945r2146b2989],
13	.	.	O	.	_	0	SENT_414	[p26l2090t2945r2146b2989],

1	Activity	NN	O	activity	_	0	SENT_415	[p26l1116t3018r1305b3073],
2	and	CC	O	and	_	0	SENT_415	[p26l1336t3017r1426b3061],
3	safety	NN	O	safety	conj_and	1	SENT_415	[p26l1461t3017r1605b3073],
4	of	IN	O	of	_	0	SENT_415	[p26l1637t3017r1694b3061],
5	crizotinib	NN	O	crizotinib	prep_of	1	SENT_415	[p26l1718t3017r1959b3061],
6	in	IN	O	in	_	0	SENT_415	[p26l1993t3018r2040b3061],
7	patients	NNS	O	patient	prep_in	5	SENT_415	[p26l2073t3032r2148b3073, p26l1119t3088r1254b3131],
8	with	IN	O	with	_	0	SENT_415	[p26l1293t3087r1404b3132],
9	ALK	NN	O	alk	npadvmod	11	SENT_415	[p26l1442t3088r1754b3143],
10	—	CD	NUMBER	—	num	9	SENT_415	[p26l1442t3088r1754b3143],
11	positive	JJ	O	positive	amod	13	SENT_415	[p26l1442t3088r1754b3143],
12	non	JJ	O	non	amod	13	SENT_415	[p26l1794t3087r2149b3131],
13	—	NN	O	—	prep_with	7	SENT_415	[p26l1794t3087r2149b3131],
14	small	JJ	O	small	amod	18	SENT_415	[p26l1794t3087r2149b3131],
15	—	NN	O	—	nn	18	SENT_415	[p26l1794t3087r2149b3131],
16	cell	NN	O	cell	nn	18	SENT_415	[p26l1794t3087r2149b3131],
17	lung	NN	O	lung	nn	18	SENT_415	[p26l1118t3158r1228b3215],
18	cancer	NN	O	cancer	dep	1	SENT_415	[p26l1244t3173r1416b3202],
19	:	:	O	:	_	0	SENT_415	[p26l1244t3173r1416b3202],
20	updated	VBN	O	update	amod	21	SENT_415	[p26l1436t3158r1633b3214],
21	results	NNS	O	result	dep	1	SENT_415	[p26l1650t3158r1812b3203],
22	from	IN	O	from	_	0	SENT_415	[p26l1830t3158r1950b3203],
23	a	DT	O	a	det	26	SENT_415	[p26l1967t3173r1992b3202],
24	phase	NN	O	phase	nn	26	SENT_415	[p26l2007t3158r2149b3214],
25	1	CD	NUMBER	1	num	26	SENT_415	[p26l1120t3234r1145b3274],
26	study	NN	O	study	prep_from	21	SENT_415	[p26l1165t3230r1305b3286],
27	.	.	O	.	_	0	SENT_415	[p26l1165t3230r1305b3286],

1	Lancet	NNP	O	Lancet	nn	2	SENT_416	[p26l1326t3234r1490b3274],
2	Oncol	NNP	O	Oncol	_	0	SENT_416	[p26l1506t3230r1651b3274],
3	2012	CD	DATE	2012	num	2	SENT_416	[p26l1670t3234r2050b3284],
4	;	:	O	;	_	0	SENT_416	[p26l1670t3234r2050b3284],
5	13:1011	CD	NUMBER	13:1011	number	6	SENT_416	[p26l1670t3234r2050b3284],
6	—	CD	NUMBER	—	dep	2	SENT_416	[p26l1670t3234r2050b3284],
7	9	CD	NUMBER	9	dep	6	SENT_416	[p26l1670t3234r2050b3284],
8	.	.	O	.	_	0	SENT_416	[p26l1670t3234r2050b3284],

1	12	CD	NUMBER	12	_	0	SENT_417	[p26l1120t3306r1185b3344],
2	.	.	O	.	_	0	SENT_417	[p26l1120t3306r1185b3344],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_418	[p26l1214t3301r1318b3346],
2	D-W	NNP	O	D-W	_	0	SENT_418	[p26l1344t3304r1463b3354],
3	,	,	O	,	_	0	SENT_418	[p26l1344t3304r1463b3354],
4	Ahn	NNP	PERSON	Ahn	nn	5	SENT_418	[p26l1491t3300r1594b3344],
5	M	NN	O	m	appos	2	SENT_418	[p26l1619t3304r1715b3354],
6	.	.	O	.	_	0	SENT_418	[p26l1619t3304r1715b3354],

1	—	NN	O	—	_	0	SENT_419	[p26l1619t3304r1715b3354],
2	.	.	O	.	_	0	SENT_419	[p26l1619t3304r1715b3354],

1	J	NNP	O	J	_	0	SENT_420	[p26l1619t3304r1715b3354],
2	,	,	O	,	_	0	SENT_420	[p26l1619t3304r1715b3354],
3	Shi	NNP	O	Shi	nn	4	SENT_420	[p26l1746t3300r1820b3345],
4	Y	NN	O	y	appos	1	SENT_420	[p26l1844t3304r1886b3354],
5	,	,	O	,	_	0	SENT_420	[p26l1844t3304r1886b3354],
6	et	FW	O	et	nn	7	SENT_420	[p26l1915t3309r1959b3344],
7	al.	FW	O	al.	appos	4	SENT_420	[p26l1983t3300r2039b3344],
8	.	.	O	.	_	0	SENT_420	[p26l1983t3300r2039b3344],

1	Results	NNS	O	result	_	0	SENT_421	[p26l2067t3304r2148b3347, p26l1119t3371r1232b3416],
2	of	IN	O	of	_	0	SENT_421	[p26l1250t3371r1307b3415],
3	a	DT	O	a	det	7	SENT_421	[p26l1313t3386r1338b3415],
4	global	JJ	O	global	amod	7	SENT_421	[p26l1354t3371r1507b3428],
5	phase	NN	O	phase	nn	7	SENT_421	[p26l1523t3371r1664b3427],
6	II	CD	NUMBER	ii	num	7	SENT_421	[p26l1681t3375r1718b3415],
7	study	NN	O	study	prep_of	1	SENT_421	[p26l1735t3371r1866b3427],
8	with	IN	O	with	_	0	SENT_421	[p26l1879t3371r1990b3416],
9	crizotinib	NN	O	crizotinib	prep_with	1	SENT_421	[p26l2007t3372r2148b3415, p26l1119t3442r1234b3487],
10	in	IN	O	in	_	0	SENT_421	[p26l1255t3443r1302b3486],
11	advanced	JJ	O	advanced	amod	12	SENT_421	[p26l1323t3442r1549b3487],
12	ALK	NNP	O	ALK	prep_in	9	SENT_421	[p26l1567t3443r1879b3498],
13	—	CD	NUMBER	—	num	12	SENT_421	[p26l1567t3443r1879b3498],
14	positive	JJ	O	positive	amod	16	SENT_421	[p26l1567t3443r1879b3498],
15	non	JJ	O	non	amod	16	SENT_421	[p26l1900t3442r2149b3487],
16	—	NN	O	—	dep	1	SENT_421	[p26l1900t3442r2149b3487],
17	small	JJ	O	small	amod	23	SENT_421	[p26l1900t3442r2149b3487],
18	cell	NN	O	cell	nn	23	SENT_421	[p26l1119t3513r1202b3557],
19	lung	NN	O	lung	nn	23	SENT_421	[p26l1218t3513r1328b3570],
20	cancer	NN	O	cancer	nn	23	SENT_421	[p26l1343t3528r1503b3557],
21	(	CD	NUMBER	(	num	23	SENT_421	[p26l1520t3517r1579b3564],
22	N	NN	O	n	nn	23	SENT_421	[p26l1520t3517r1579b3564],
23	SCLC	NN	O	sclc	dep	16	SENT_421	[p26l1581t3517r1741b3564],
24	)	CD	NUMBER	)	dep	16	SENT_421	[p26l1581t3517r1741b3564],
25	.	.	O	.	_	0	SENT_421	[p26l1581t3517r1741b3564],

1	Presented	VBN	O	present	_	0	SENT_422	[p26l1760t3513r1999b3557],
2	at	IN	O	at	_	0	SENT_422	[p26l2015t3522r2060b3557],
3	the	DT	O	the	det	4	SENT_422	[p26l2074t3513r2149b3557],
4	Annual	JJ	SET	annual	prep_at	1	SENT_422	[p26l1116t3584r1297b3629],
5	Meeting	VBG	O	meet	partmod	4	SENT_422	[p26l1319t3585r1522b3641],
6	of	IN	O	of	_	0	SENT_422	[p26l1545t3584r1601b3628],
7	the	DT	O	the	det	9	SENT_422	[p26l1615t3584r1691b3628],
8	American	NNP	ORGANIZATION	American	nn	9	SENT_422	[p26l1713t3585r1952b3628],
9	Society	NNP	ORGANIZATION	Society	prep_of	5	SENT_422	[p26l1978t3585r2151b3640],
10	of	IN	ORGANIZATION	of	_	0	SENT_422	[p26l1119t3655r1176b3699],
11	Clinical	JJ	ORGANIZATION	clinical	amod	12	SENT_422	[p26l1191t3655r1381b3699],
12	Oncology	NN	ORGANIZATION	oncology	prep_of	9	SENT_422	[p26l1406t3655r1651b3712],
13	,	,	O	,	_	0	SENT_422	[p26l1406t3655r1651b3712],
14	Chicago	NNP	LOCATION	Chicago	nn	16	SENT_422	[p26l1679t3655r1891b3712],
15	,	,	O	,	_	0	SENT_422	[p26l1679t3655r1891b3712],
16	June	NNP	DATE	June	appos	12	SENT_422	[p26l1914t3659r2024b3706],
17	1-5	CD	DATE	1-5	num	16	SENT_422	[p26l2052t3659r2146b3709],
18	,	,	DATE	,	_	0	SENT_422	[p26l2052t3659r2146b3709],
19	2012	CD	DATE	2012	num	16	SENT_422	[p26l1119t3730r1249b3771],
20	.	.	O	.	_	0	SENT_422	[p26l1119t3730r1249b3771],

1	abstract	JJ	O	abstract	_	0	SENT_423	[p26l1271t3726r1480b3771],
2	.	.	O	.	_	0	SENT_423	[p26l1271t3726r1480b3771],

1	Clin	NNP	O	Clin	nn	2	SENT_424	[p27l12t14r113b59],
2	Oncol	NNP	O	Oncol	_	0	SENT_424	[p27l132t14r277b59],
3	2012	CD	DATE	2012	num	2	SENT_424	[p27l296t18r647b67],
4	;	:	O	;	_	0	SENT_424	[p27l296t18r647b67],
5	9:268	CD	NUMBER	9:268	number	6	SENT_424	[p27l296t18r647b67],
6	-77	CD	NUMBER	-77	dep	2	SENT_424	[p27l296t18r647b67],
7	.	.	O	.	_	0	SENT_424	[p27l296t18r647b67],

1	13	CD	NUMBER	13	_	0	SENT_425	[p27l1120t20r1183b59],
2	.	.	O	.	_	0	SENT_425	[p27l1120t20r1183b59],

1	Hanna	NNP	PERSON	Hanna	nn	2	SENT_426	[p27l1214t19r1380b58],
2	N	NNP	PERSON	N	_	0	SENT_426	[p27l1394t19r1447b68],
3	,	,	O	,	_	0	SENT_426	[p27l1394t19r1447b68],
4	Shepherd	NNP	ORGANIZATION	Shepherd	nn	5	SENT_426	[p27l1467t15r1695b71],
5	FA	NNP	ORGANIZATION	FA	appos	2	SENT_426	[p27l1710t19r1786b68],
6	,	,	O	,	_	0	SENT_426	[p27l1710t19r1786b68],
7	Fossella	NNP	PERSON	Fossella	nn	8	SENT_426	[p27l1804t14r2002b59],
8	FV	NNP	O	FV	appos	5	SENT_426	[p27l2017t19r2089b68],
9	,	,	O	,	_	0	SENT_426	[p27l2017t19r2089b68],
10	et	FW	O	et	dep	5	SENT_426	[p27l2108t24r2152b59],
11	7	CD	NUMBER	7	dep	5	SENT_426	[p27l13t91r46b130],
12	.	.	O	.	_	0	SENT_426	[p27l13t91r46b130],

1	Blackhall	NNP	PERSON	Blackhall	nn	2	SENT_427	[p27l108t85r337b130],
2	FH	NN	O	fh	_	0	SENT_427	[p27l353t90r438b139],
3	,	,	O	,	_	0	SENT_427	[p27l353t90r438b139],
4	Peters	NNP	PERSON	Peters	nn	5	SENT_427	[p27l458t89r604b130],
5	S	NN	O	s	appos	2	SENT_427	[p27l624t89r662b139],
6	,	,	O	,	_	0	SENT_427	[p27l624t89r662b139],
7	Kerr	NNP	PERSON	Kerr	nn	8	SENT_427	[p27l682t90r790b131],
8	KM	NNP	O	KM	appos	5	SENT_427	[p27l805t90r906b139],
9	,	,	O	,	_	0	SENT_427	[p27l805t90r906b139],
10	et	FW	O	et	dep	5	SENT_427	[p27l926t95r970b129],
11	al.	FW	O	al.	nn	12	SENT_427	[p27l984t86r1040b130],
12	al.	FW	O	al.	dep	5	SENT_427	[p27l1118t86r1174b130],
13	.	.	O	.	_	0	SENT_427	[p27l1118t86r1174b130],

1	Randomized	VBN	O	randomize	_	0	SENT_428	[p27l1203t86r1518b132],
2	phase	NN	O	phase	nn	4	SENT_428	[p27l1543t86r1686b142],
3	III	CD	NUMBER	iii	num	4	SENT_428	[p27l1712t90r1769b129],
4	trial	NN	O	trial	dobj	1	SENT_428	[p27l1796t86r1898b129],
5	of	IN	O	of	_	0	SENT_428	[p27l1925t85r1981b130],
6	peme	NN	O	peme	nn	8	SENT_428	[p27l1997t100r2148b142],
7	—	CD	NUMBER	—	num	8	SENT_428	[p27l1997t100r2148b142],
8	Prevalence	NN	O	prevalence	prep_of	4	SENT_428	[p27l12t157r271b201],
9	and	CC	O	and	_	0	SENT_428	[p27l295t157r385b201],
10	clinical	JJ	O	clinical	amod	11	SENT_428	[p27l410t156r589b200],
11	outcomes	NNS	O	outcome	conj_and	4	SENT_428	[p27l614t166r849b201],
12	for	IN	O	for	_	0	SENT_428	[p27l875t156r945b201],
13	pa	NN	O	pa	nn	14	SENT_428	[p27l967t171r1042b213],
14	—	NN	O	—	prep_for	11	SENT_428	[p27l967t171r1042b213],
15	trexed	VBD	O	trex	dep	1	SENT_428	[p27l1119t156r1269b201],
16	versus	CC	O	versus	prep	15	SENT_428	[p27l1296t171r1448b201],
17	docetaxel	NN	O	docetaxel	dep	16	SENT_428	[p27l1479t157r1711b201],
18	in	IN	O	in	_	0	SENT_428	[p27l1739t157r1787b200],
19	patients	NNS	O	patient	prep_in	15	SENT_428	[p27l1815t157r2010b213],
20	with	IN	O	with	_	0	SENT_428	[p27l2038t157r2149b201],
21	tients	NNS	O	tient	prep_with	19	SENT_428	[p27l13t228r148b272],
22	with	IN	O	with	_	0	SENT_428	[p27l178t228r289b272],
23	ALK	NN	O	alk	nn	25	SENT_428	[p27l318t232r427b273],
24	gene	NN	O	gene	nn	25	SENT_428	[p27l456t242r569b284],
25	rearrangement	NN	O	rearrangement	prep_with	21	SENT_428	[p27l601t237r967b284],
26	in	IN	O	in	_	0	SENT_428	[p27l996t228r1043b271],
27	non	JJ	O	non	amod	33	SENT_428	[p27l1118t227r1473b272],
28	—	JJ	O	—	amod	33	SENT_428	[p27l1118t227r1473b272],
29	small	JJ	O	small	amod	33	SENT_428	[p27l1118t227r1473b272],
30	—	NN	O	—	nn	33	SENT_428	[p27l1118t227r1473b272],
31	cell	NN	O	cell	nn	33	SENT_428	[p27l1118t227r1473b272],
32	lung	NN	O	lung	nn	33	SENT_428	[p27l1526t228r1637b284],
33	cancer	NN	O	cancer	prep_in	25	SENT_428	[p27l1689t242r1849b271],
34	previously	RB	DATE	previously	advmod	15	SENT_428	[p27l1900t227r2151b284],
35	Europe	NNP	LOCATION	Europe	nsubj	1	SENT_428	[p27l12t303r198b355],
36	:	:	O	:	_	0	SENT_428	[p27l12t303r198b355],
37	preliminary	JJ	O	preliminary	amod	38	SENT_428	[p27l222t299r517b355],
38	results	NNS	O	result	dep	35	SENT_428	[p27l537t299r699b343],
39	from	IN	O	from	_	0	SENT_428	[p27l723t298r842b343],
40	the	DT	O	the	det	42	SENT_428	[p27l866t299r941b343],
41	Eu	NNP	O	Eu	nn	42	SENT_428	[p27l963t303r1042b343],
42	—	NN	O	—	prep_from	38	SENT_428	[p27l963t303r1042b343],
43	treated	VBN	O	treat	partmod	42	SENT_428	[p27l1119t298r1289b343],
44	with	IN	O	with	_	0	SENT_428	[p27l1313t299r1424b343],
45	chemotherapy	NN	O	chemotherapy	prep_with	43	SENT_428	[p27l1451t298r1808b355],
46	.	.	O	.	_	0	SENT_428	[p27l1451t298r1808b355],

1	J	NNP	O	J	nn	7	SENT_429	[p27l1831t303r1853b349],
2	Clin	NNP	O	Clin	nn	7	SENT_429	[p27l1878t298r1978b343],
3	Oncol	NNP	O	Oncol	nn	7	SENT_429	[p27l2005t299r2149b343],
4	ropean	NN	O	ropean	nn	7	SENT_429	[p27l12t384r182b426],
5	Thoracic	NNP	O	Thoracic	nn	7	SENT_429	[p27l248t370r461b414],
6	Oncology	NNP	O	Oncology	nn	7	SENT_429	[p27l528t370r764b426],
7	Platform	NNP	O	Platform	_	0	SENT_429	[p27l829t369r1043b414],
8	2004	CD	DATE	2004	num	7	SENT_429	[p27l1119t373r1534b423],
9	;	:	O	;	_	0	SENT_429	[p27l1119t373r1534b423],
10	22:1589	CD	NUMBER	22:1589	number	11	SENT_429	[p27l1119t373r1534b423],
11	—	CD	NUMBER	—	dep	7	SENT_429	[p27l1119t373r1534b423],
12	97	CD	NUMBER	97	dep	11	SENT_429	[p27l1119t373r1534b423],
13	.	.	O	.	_	0	SENT_429	[p27l1119t373r1534b423],

1	14	CD	NUMBER	14	_	0	SENT_430	[p27l21t736r153b815],
2	.	.	O	.	_	0	SENT_430	[p27l21t736r153b815],

1	Shepherd	NNP	ORGANIZATION	Shepherd	nn	2	SENT_431	[p27l219t726r696b841],
2	FA	NNP	ORGANIZATION	FA	_	0	SENT_431	[p27l779t734r938b835],
3	,	,	O	,	_	0	SENT_431	[p27l779t734r938b835],
4	Rodrigues	NNP	PERSON	Rodrigues	nn	6	SENT_431	[p27l1026t726r1557b841],
5	Pereira	NNP	PERSON	Pereira	nn	6	SENT_431	[p27l1642t726r2002b815],
6	J	NNP	PERSON	J	appos	2	SENT_431	[p27l2073t734r2141b835],
7	,	,	O	,	_	0	SENT_431	[p27l2073t734r2141b835],
8	Ciuleanu	NNP	O	Ciuleanu	nn	9	SENT_431	[p27l18t875r461b965],
9	T	NN	O	t	appos	2	SENT_431	[p27l517t881r605b984],
10	,	,	O	,	_	0	SENT_431	[p27l517t881r605b984],
11	et	FW	O	et	nn	12	SENT_431	[p27l672t893r761b964],
12	al.	FW	O	al.	appos	2	SENT_431	[p27l813t875r926b964],
13	.	.	O	.	_	0	SENT_431	[p27l813t875r926b964],

1	Erlotinib	NNP	O	Erlotinib	nsubj	4	SENT_432	[p27l990t875r1429b964],
2	in	IN	O	in	prep	1	SENT_432	[p27l1489t875r1586b962],
3	previously	RB	DATE	previously	pcomp	2	SENT_432	[p27l1644t875r2151b990],
4	treated	VBN	O	treat	_	0	SENT_432	[p27l18t1024r362b1113],
5	non	JJ	O	non	amod	8	SENT_432	[p27l395t1024r1139b1113],
6	—	JJ	O	—	amod	8	SENT_432	[p27l395t1024r1139b1113],
7	small	JJ	O	small	amod	8	SENT_432	[p27l395t1024r1139b1113],
8	—	NN	O	—	tmod	4	SENT_432	[p27l395t1024r1139b1113],
9	cell	NN	O	cell	nn	11	SENT_432	[p27l395t1024r1139b1113],
10	lung	NN	O	lung	nn	11	SENT_432	[p27l1169t1024r1394b1139],
11	cancer	NN	O	cancer	dep	8	SENT_432	[p27l1423t1052r1769b1113],
12	.	.	O	.	_	0	SENT_432	[p27l1423t1052r1769b1113],

1	N	NN	O	n	nn	2	SENT_433	[p27l1807t1032r1893b1114],
2	Engl	NNP	O	Engl	nsubj	3	SENT_433	[p27l1922t1024r2147b1139],
3	JMed	VBD	O	jmed	_	0	SENT_433	[p27l6t1173r300b1276],
4	2005	CD	DATE	2005	dobj	3	SENT_433	[p27l340t1179r1195b1282],
5	;	:	O	;	_	0	SENT_433	[p27l340t1179r1195b1282],
6	353:123	CD	NUMBER	353:123	number	7	SENT_433	[p27l340t1179r1195b1282],
7	—	CD	NUMBER	—	dep	4	SENT_433	[p27l340t1179r1195b1282],
8	32	CD	NUMBER	32	dep	7	SENT_433	[p27l340t1179r1195b1282],
9	.	.	O	.	_	0	SENT_433	[p27l340t1179r1195b1282],

1	15	CD	NUMBER	15	_	0	SENT_434	[p27l21t1332r151b1411],
2	.	.	O	.	_	0	SENT_434	[p27l21t1332r151b1411],

1	Shepherd	NNP	ORGANIZATION	Shepherd	nn	2	SENT_435	[p27l219t1322r688b1437],
2	FA	NNP	ORGANIZATION	FA	_	0	SENT_435	[p27l733t1330r891b1431],
3	,	,	O	,	_	0	SENT_435	[p27l733t1330r891b1431],
4	Dancey	NNP	PERSON	Dancey	nn	5	SENT_435	[p27l942t1328r1316b1435],
5	J	NNP	PERSON	J	appos	2	SENT_435	[p27l1346t1330r1414b1431],
6	,	,	O	,	_	0	SENT_435	[p27l1346t1330r1414b1431],
7	Ramlau	NNP	O	Ramlau	nn	8	SENT_435	[p27l1465t1322r1861b1417],
8	R	NNP	O	R	appos	2	SENT_435	[p27l1906t1328r2008b1431],
9	,	,	O	,	_	0	SENT_435	[p27l1906t1328r2008b1431],
10	et	FW	O	et	nn	11	SENT_435	[p27l2062t1340r2153b1411],
11	al.	FW	O	al.	appos	2	SENT_435	[p27l16t1471r126b1560],
12	.	.	O	.	_	0	SENT_435	[p27l16t1471r126b1560],

1	Prospective	JJ	O	prospective	amod	3	SENT_436	[p27l165t1471r718b1586],
2	randomized	JJ	O	randomized	amod	3	SENT_436	[p27l751t1471r1342b1560],
3	trial	NN	O	trial	_	0	SENT_436	[p27l1377t1471r1577b1560],
4	of	IN	O	of	_	0	SENT_436	[p27l1612t1469r1726b1560],
5	docetax	NN	O	docetax	nn	7	SENT_436	[p27l1739t1469r2145b1560],
6	—	CD	NUMBER	—	num	7	SENT_436	[p27l1739t1469r2145b1560],
7	el	NN	O	el	prep_of	3	SENT_436	[p27l18t1620r98b1709],
8	versus	CC	O	versus	prep	3	SENT_436	[p27l139t1649r453b1710],
9	best	JJS	O	best	dep	10	SENT_436	[p27l505t1620r714b1709],
10	supportive	JJ	O	supportive	amod	11	SENT_436	[p27l759t1620r1290b1735],
11	care	NN	O	care	dep	8	SENT_436	[p27l1340t1649r1547b1709],
12	in	IN	O	in	_	0	SENT_436	[p27l1596t1620r1694b1707],
13	patients	NNS	O	patient	prep_in	3	SENT_436	[p27l1741t1620r2145b1735],
14	with	IN	O	with	_	0	SENT_436	[p27l12t1769r241b1859],
15	non	JJ	O	non	amod	21	SENT_436	[p27l324t1769r1058b1858],
16	—	JJ	O	—	amod	21	SENT_436	[p27l324t1769r1058b1858],
17	small	JJ	O	small	amod	21	SENT_436	[p27l324t1769r1058b1858],
18	—	NN	O	—	nn	21	SENT_436	[p27l324t1769r1058b1858],
19	cell	NN	O	cell	nn	21	SENT_436	[p27l324t1769r1058b1858],
20	lung	NN	O	lung	nn	21	SENT_436	[p27l1141t1769r1368b1884],
21	cancer	NN	O	cancer	prep_with	3	SENT_436	[p27l1449t1797r1779b1858],
22	previously	RB	DATE	previously	advmod	23	SENT_436	[p27l1857t1769r2145b1884, p27l18t1918r280b2031],
23	treated	VBN	O	treat	partmod	3	SENT_436	[p27l348t1918r700b2007],
24	with	IN	O	with	_	0	SENT_436	[p27l767t1918r996b2008],
25	platinum	NN	O	platinum	nn	26	SENT_436	[p27l1067t1918r1865b2033],
26	—	NN	O	—	prep_with	23	SENT_436	[p27l1067t1918r1865b2033],
27	based	VBN	O	base	partmod	26	SENT_436	[p27l1067t1918r1865b2033],
28	chemotherapy	NN	O	chemotherapy	dobj	27	SENT_436	[p27l1938t1918r2145b2007, p27l16t2067r579b2182],
29	.	.	O	.	_	0	SENT_436	[p27l1938t1918r2145b2007, p27l16t2067r579b2182],

1	吽	NN	O	吽	nn	4	SENT_437	[p27l650t2075r694b2170],
2	*	CD	NUMBER	*	num	4	SENT_437	[p27l650t2075r694b2170],
3	Clin	NNP	O	Clin	nn	4	SENT_437	[p27l767t2067r976b2156],
4	Oncol	NNP	O	Oncol	_	0	SENT_437	[p27l1052t2067r1352b2156],
5	2000	CD	DATE	2000	dep	4	SENT_437	[p27l1427t2073r2145b2176],
6	;	:	O	;	_	0	SENT_437	[p27l1427t2073r2145b2176],
7	18:2095	CD	NUMBER	18:2095	num	8	SENT_437	[p27l1427t2073r2145b2176],
8	—	NN	O	—	dep	4	SENT_437	[p27l1427t2073r2145b2176],
9	103	CD	NUMBER	103	dep	8	SENT_437	[p27l20t2221r217b2304],
10	.	.	O	.	_	0	SENT_437	[p27l20t2221r217b2304],

1	16	CD	NUMBER	16	_	0	SENT_438	[p27l21t2374r151b2453],
2	.	.	O	.	_	0	SENT_438	[p27l21t2374r151b2453],

1	Camidge	NNP	O	Camidge	nn	2	SENT_439	[p27l216t2364r664b2479],
2	DR	NN	O	dr	_	0	SENT_439	[p27l725t2370r909b2473],
3	,	,	O	,	_	0	SENT_439	[p27l725t2370r909b2473],
4	Kono	NNP	PERSON	Kono	nn	5	SENT_439	[p27l978t2372r1243b2455],
5	SA	NNP	O	SA	appos	2	SENT_439	[p27l1310t2370r1465b2473],
6	,	,	O	,	_	0	SENT_439	[p27l1310t2370r1465b2473],
7	Lu	NNP	PERSON	Lu	nn	8	SENT_439	[p27l1533t2372r1656b2454],
8	X	NNP	PERSON	X	appos	2	SENT_439	[p27l1713t2372r1809b2473],
9	,	,	O	,	_	0	SENT_439	[p27l1713t2372r1809b2473],
10	et	FW	O	et	nn	11	SENT_439	[p27l1879t2382r1970b2453],
11	al.	FW	O	al.	appos	2	SENT_439	[p27l2026t2364r2141b2453],
12	.	.	O	.	_	0	SENT_439	[p27l2026t2364r2141b2453],

1	Anaplastic	JJ	O	anaplastic	amod	5	SENT_440	[p27l12t2513r553b2628],
2	lymphoma	NN	O	lymphoma	nn	5	SENT_440	[p27l614t2513r1155b2628],
3	kinase	NN	O	kinase	nn	5	SENT_440	[p27l1218t2513r1547b2604],
4	gene	NN	O	gene	nn	5	SENT_440	[p27l1610t2541r1845b2628],
5	rearrangements	NNS	O	rearrangement	nsubjpass	14	SENT_440	[p27l1910t2542r2145b2602, p27l16t2680r613b2777],
6	in	IN	O	in	_	0	SENT_440	[p27l654t2662r752b2749],
7	non	JJ	O	non	amod	12	SENT_440	[p27l791t2662r1306b2751],
8	—	JJ	O	—	amod	12	SENT_440	[p27l791t2662r1306b2751],
9	small	JJ	O	small	amod	12	SENT_440	[p27l791t2662r1306b2751],
10	cell	NN	O	cell	nn	12	SENT_440	[p27l1346t2662r1519b2751],
11	lung	NN	O	lung	nn	12	SENT_440	[p27l1555t2662r1783b2777],
12	cancer	NN	O	cancer	prep_in	5	SENT_440	[p27l1819t2690r2151b2751],
13	are	VBP	O	be	auxpass	14	SENT_440	[p27l16t2840r167b2900],
14	associated	VBN	O	associate	_	0	SENT_440	[p27l239t2809r766b2900],
15	with	IN	O	with	_	0	SENT_440	[p27l833t2811r1062b2902],
16	prolonged	JJ	O	prolonged	amod	17	SENT_440	[p27l1131t2811r1648b2926],
17	progression	NN	O	progression	prep_with	14	SENT_440	[p27l1719t2839r2145b2926, p27l18t2958r459b3049],
18	—	CD	NUMBER	—	num	20	SENT_440	[p27l1719t2839r2145b2926, p27l18t2958r459b3049],
19	free	JJ	O	free	amod	20	SENT_440	[p27l1719t2839r2145b2926, p27l18t2958r459b3049],
20	survival	NN	O	survival	npadvmod	14	SENT_440	[p27l495t2960r887b3050],
21	on	IN	O	on	_	0	SENT_440	[p27l920t2988r1044b3049],
22	pemetrexed	JJ	O	pemetrexed	prep_on	14	SENT_440	[p27l1075t2960r1696b3075],
23	.	.	O	.	_	0	SENT_440	[p27l1075t2960r1696b3075],

1	J	NNP	O	J	nn	3	SENT_441	[p27l1724t2968r1768b3063],
2	Thorac	NNP	O	Thorac	nn	3	SENT_441	[p27l1795t2960r2147b3049],
3	Oncol	NNP	O	Oncol	_	0	SENT_441	[p27l18t3109r316b3198],
4	2011	CD	DATE	2011	num	3	SENT_441	[p27l356t3115r1091b3216],
5	;	:	O	;	_	0	SENT_441	[p27l356t3115r1091b3216],
6	6:774	CD	NUMBER	6:774	number	7	SENT_441	[p27l356t3115r1091b3216],
7	—	CD	NUMBER	—	dep	3	SENT_441	[p27l356t3115r1091b3216],
8	80	CD	NUMBER	80	dep	7	SENT_441	[p27l356t3115r1091b3216],
9	.	.	O	.	_	0	SENT_441	[p27l356t3115r1091b3216],

1	17	CD	NUMBER	17	_	0	SENT_442	[p27l22t3268r141b3347],
2	.	.	O	.	_	0	SENT_442	[p27l22t3268r141b3347],

1	Lee	NNP	PERSON	Lee	_	0	SENT_443	[p27l214t3264r384b3347],
2	TO	TO	O	to	infmod	1	SENT_443	[p27l425t3264r575b3367],
3	,	,	O	,	_	0	SENT_443	[p27l425t3264r575b3367],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_443	[p27l634t3258r849b3349],
5	TM	NNP	O	TM	appos	1	SENT_443	[p27l896t3264r1092b3367],
6	,	,	O	,	_	0	SENT_443	[p27l896t3264r1092b3367],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_443	[p27l1149t3264r1318b3347],
8	SH	NNP	O	SH	appos	5	SENT_443	[p27l1374t3264r1541b3367],
9	,	,	O	,	_	0	SENT_443	[p27l1374t3264r1541b3367],
10	et	FW	O	et	nn	11	SENT_443	[p27l1600t3276r1692b3347],
11	al.	FW	O	al.	appos	5	SENT_443	[p27l1737t3256r1851b3347],
12	.	.	O	.	_	0	SENT_443	[p27l1737t3256r1851b3347],

1	Anaplastic	JJ	O	anaplastic	amod	4	SENT_444	[p27l1906t3264r2145b3347, p27l16t3405r348b3520],
2	lymphoma	NN	O	lymphoma	nn	4	SENT_444	[p27l390t3405r931b3520],
3	kinase	NN	O	kinase	nn	4	SENT_444	[p27l972t3405r1301b3496],
4	translocation	NN	O	translocation	_	0	SENT_444	[p27l1346t3405r2050b3496],
5	:	:	O	:	_	0	SENT_444	[p27l1346t3405r2050b3496],
6	a	DT	O	a	det	8	SENT_444	[p27l2097t3435r2149b3496],
7	predictive	JJ	O	predictive	amod	8	SENT_444	[p27l16t3554r513b3669],
8	biomarker	NN	O	biomarker	dep	4	SENT_444	[p27l548t3554r1074b3645],
9	of	IN	O	of	_	0	SENT_444	[p27l1107t3554r1223b3645],
10	pemetrexed	VBN	O	pemetrex	prepc_of	8	SENT_444	[p27l1234t3554r1827b3669],
11	in	IN	O	in	_	0	SENT_444	[p27l1861t3556r1958b3643],
12	pa	NN	O	pa	nn	13	SENT_444	[p27l1990t3584r2145b3669],
13	—	NN	O	—	prep_in	10	SENT_444	[p27l1990t3584r2145b3669],

1	tients	NNS	O	tient	_	0	SENT_445	[p28l18t26r296b115],
2	with	IN	O	with	_	0	SENT_445	[p28l365t24r595b115],
3	non	JJ	O	non	amod	8	SENT_445	[p28l666t24r1179b115],
4	—	JJ	O	—	amod	8	SENT_445	[p28l666t24r1179b115],
5	small	JJ	O	small	amod	8	SENT_445	[p28l666t24r1179b115],
6	cell	NN	O	cell	nn	8	SENT_445	[p28l1250t24r1423b115],
7	lung	NN	O	lung	nn	8	SENT_445	[p28l1493t24r1720b141],
8	cancer	NN	O	cancer	prep_with	1	SENT_445	[p28l1787t54r2139b115],
9	.	.	O	.	_	0	SENT_445	[p28l1787t54r2139b115],

1	IThorac	NNP	O	IThorac	nn	2	SENT_446	[p28l6t173r436b278],
2	Oncol	NNP	O	Oncol	_	0	SENT_446	[p28l475t173r773b264],
3	2011	CD	DATE	2011	num	2	SENT_446	[p28l813t181r1603b282],
4	;	:	O	;	_	0	SENT_446	[p28l813t181r1603b282],
5	6:1474	CD	NUMBER	6:1474	number	6	SENT_446	[p28l813t181r1603b282],
6	—	CD	NUMBER	—	dep	2	SENT_446	[p28l813t181r1603b282],
7	80	CD	NUMBER	80	dep	6	SENT_446	[p28l813t181r1603b282],
8	.	.	O	.	_	0	SENT_446	[p28l813t181r1603b282],

1	18	CD	NUMBER	18	_	0	SENT_447	[p28l22t332r157b413],
2	.	.	O	.	_	0	SENT_447	[p28l22t332r157b413],

1	Eisenhauer	NNP	PERSON	Eisenhauer	nn	2	SENT_448	[p28l215t322r789b413],
2	EA	NN	PERSON	ea	_	0	SENT_448	[p28l833t330r1004b433],
3	,	,	O	,	_	0	SENT_448	[p28l833t330r1004b433],
4	Therasse	NN	ORGANIZATION	therasse	nn	5	SENT_448	[p28l1054t322r1513b413],
5	P	NN	ORGANIZATION	p	appos	2	SENT_448	[p28l1560t330r1638b433],
6	,	,	O	,	_	0	SENT_448	[p28l1560t330r1638b433],
7	Bogaerts	NNPS	ORGANIZATION	Bogaerts	appos	2	SENT_448	[p28l1692t330r2145b439],
8	T	NN	ORGANIZATION	t	dep	7	SENT_448	[p28l6t479r74b582],
9	,	,	O	,	_	0	SENT_448	[p28l6t479r74b582],
10	et	FW	O	et	nn	11	SENT_448	[p28l125t491r217b562],
11	al.	FW	O	al.	appos	2	SENT_448	[p28l256t471r374b562],
12	.	.	O	.	_	0	SENT_448	[p28l256t471r374b562],

1	New	JJ	O	new	amod	4	SENT_449	[p28l423t479r656b562],
2	response	NN	O	response	nn	4	SENT_449	[p28l696t501r1155b586],
3	evaluation	NN	O	evaluation	nn	4	SENT_449	[p28l1201t471r1734b562],
4	criteria	NNS	O	criterion	_	0	SENT_449	[p28l1779t473r2149b562],
5	in	IN	O	in	_	0	SENT_449	[p28l16t622r115b709],
6	solid	JJ	O	solid	amod	7	SENT_449	[p28l161t620r408b711],
7	tumours	NNS	O	tumour	prep_in	4	SENT_449	[p28l453t640r921b711],
8	:	:	O	:	_	0	SENT_449	[p28l453t640r921b711],
9	revised	VBN	O	revise	amod	12	SENT_449	[p28l972t620r1334b711],
10	RECTST	NNP	O	RECTST	nn	12	SENT_449	[p28l1378t628r1776b717],
11	guideline	NN	O	guideline	nn	12	SENT_449	[p28l1817t620r2145b737, p28l16t769r207b860],
12	(	NN	O	(	dep	4	SENT_449	[p28l266t771r666b874],
13	version	NN	O	version	prep	12	SENT_449	[p28l266t771r666b874],
14	1.1	CD	NUMBER	1.1	num	15	SENT_449	[p28l723t777r933b874],
15	)	NN	O	)	dep	13	SENT_449	[p28l723t777r933b874],
16	.	.	O	.	_	0	SENT_449	[p28l723t777r933b874],

1	Eur	NNP	O	Eur	nn	3	SENT_450	[p28l992t777r1251b874],
2	}	NNP	O	}	nn	3	SENT_450	[p28l992t777r1251b874],
3	Cancer	NNP	O	Cancer	_	0	SENT_450	[p28l1302t777r1660b860],
4	2009	CD	DATE	2009	num	3	SENT_450	[p28l1710t777r2143b878],
5	;	:	O	;	_	0	SENT_450	[p28l1710t777r2143b878],
6	4	CD	NUMBER	4	num	7	SENT_450	[p28l1710t777r2143b878],
7	§	CD	NUMBER	§	dep	3	SENT_450	[p28l1710t777r2143b878],
8	:	:	O	:	_	0	SENT_450	[p28l1710t777r2143b878],
9	228-47	CD	NUMBER	228-47	dep	7	SENT_450	[p28l18t925r384b1008],
10	.	.	O	.	_	0	SENT_450	[p28l18t925r384b1008],

1	19	CD	NUMBER	19	_	0	SENT_451	[p28l22t1078r149b1157],
2	.	.	O	.	_	0	SENT_451	[p28l22t1078r149b1157],

1	Oken	NNP	O	Oken	nn	2	SENT_452	[p28l216t1066r481b1157],
2	MM	NN	O	mm	_	0	SENT_452	[p28l517t1074r748b1177],
3	,	,	O	,	_	0	SENT_452	[p28l517t1074r748b1177],
4	Creech	NNP	PERSON	Creech	nn	5	SENT_452	[p28l793t1066r1139b1157],
5	RH	NNP	O	RH	appos	2	SENT_452	[p28l1177t1074r1368b1177],
6	,	,	O	,	_	0	SENT_452	[p28l1177t1074r1368b1177],
7	Tormey	NNP	ORGANIZATION	Tormey	nn	8	SENT_452	[p28l1411t1074r1797b1181],
8	DC	NNP	ORGANIZATION	DC	appos	2	SENT_452	[p28l1831t1074r2014b1177],
9	,	,	O	,	_	0	SENT_452	[p28l1831t1074r2014b1177],
10	et	FW	O	et	nn	11	SENT_452	[p28l2061t1086r2153b1157],
11	al.	FW	O	al.	appos	2	SENT_452	[p28l16t1215r131b1306],
12	.	.	O	.	_	0	SENT_452	[p28l16t1215r131b1306],

1	Toxicity	NN	O	toxicity	nn	4	SENT_453	[p28l195t1217r598b1330],
2	and	CC	O	and	_	0	SENT_453	[p28l654t1215r839b1306],
3	response	NN	O	response	nn	4	SENT_453	[p28l900t1245r1350b1330],
4	criteria	NNS	O	criterion	_	0	SENT_453	[p28l1413t1217r1772b1306],
5	of	IN	O	of	_	0	SENT_453	[p28l1833t1215r1950b1306],
6	the	DT	O	the	det	10	SENT_453	[p28l1992t1215r2147b1306],
7	Eastern	NNP	ORGANIZATION	Eastern	nn	10	SENT_453	[p28l16t1372r396b1455],
8	Cooperative	NNP	ORGANIZATION	Cooperative	nn	10	SENT_453	[p28l431t1366r1034b1479],
9	Oncology	NNP	ORGANIZATION	Oncology	nn	10	SENT_453	[p28l1069t1364r1557b1481],
10	Group	NNP	ORGANIZATION	Group	prep_of	4	SENT_453	[p28l1588t1372r1932b1479],
11	.	.	O	.	_	0	SENT_453	[p28l1588t1372r1932b1479],

1	Am	VBP	O	be	cop	3	SENT_454	[p28l1970t1372r2147b1453],
2	TClin	NN	O	tclin	nn	3	SENT_454	[p28l6t1513r294b1618],
3	Oncol	NN	O	oncol	_	0	SENT_454	[p28l334t1513r632b1604],
4	1982	CD	DATE	1982	dep	3	SENT_454	[p28l676t1521r1408b1622],
5	;	:	O	;	_	0	SENT_454	[p28l676t1521r1408b1622],
6	§	CD	NUMBER	§	number	7	SENT_454	[p28l676t1521r1408b1622],
7	:649	CD	NUMBER	:649	dep	3	SENT_454	[p28l676t1521r1408b1622],
8	—	NN	O	—	dep	7	SENT_454	[p28l676t1521r1408b1622],
9	55	CD	NUMBER	55	num	8	SENT_454	[p28l676t1521r1408b1622],
10	.	.	O	.	_	0	SENT_454	[p28l676t1521r1408b1622],

1	20	CD	NUMBER	20	_	0	SENT_455	[p28l16t1672r155b1753],
2	.	.	O	.	_	0	SENT_455	[p28l16t1672r155b1753],

1	Aaronson	NNP	PERSON	Aaronson	nn	3	SENT_456	[p28l211t1672r706b1753],
2	N	NNP	PERSON	N	nn	3	SENT_456	[p28l747t1672r835b1754],
3	K	NNP	PERSON	K	_	0	SENT_456	[p28l841t1672r941b1773],
4	,	,	O	,	_	0	SENT_456	[p28l841t1672r941b1773],
5	Ahmedzai	NNP	PERSON	Ahmedzai	nn	6	SENT_456	[p28l988t1662r1511b1753],
6	S	NNP	O	S	appos	3	SENT_456	[p28l1555t1670r1634b1773],
7	,	,	O	,	_	0	SENT_456	[p28l1555t1670r1634b1773],
8	Bergman	NNP	PERSON	Bergman	nn	9	SENT_456	[p28l1682t1670r2147b1779],
9	B	NNP	O	B	appos	3	SENT_456	[p28l16t1819r110b1922],
10	,	,	O	,	_	0	SENT_456	[p28l16t1819r110b1922],
11	et	FW	O	et	nn	12	SENT_456	[p28l173t1831r263b1902],
12	al.	FW	O	al.	appos	3	SENT_456	[p28l314t1813r428b1902],
13	.	.	O	.	_	0	SENT_456	[p28l314t1813r428b1902],

1	The	DT	O	the	det	3	SENT_457	[p28l487t1813r674b1902],
2	European	NNP	ORGANIZATION	European	nn	3	SENT_457	[p28l730t1821r1217b1928],
3	Organization	NNP	ORGANIZATION	Organization	_	0	SENT_457	[p28l1272t1813r1950b1928],
4	for	IN	ORGANIZATION	for	_	0	SENT_457	[p28l2006t1811r2151b1902],
5	Research	NNP	ORGANIZATION	Research	prep_for	3	SENT_457	[p28l16t1962r477b2057],
6	and	CC	O	and	_	0	SENT_457	[p28l527t1960r712b2051],
7	Treatment	NN	O	treatment	conj_and	3	SENT_457	[p28l757t1968r1286b2051],
8	of	IN	O	of	_	0	SENT_457	[p28l1332t1960r1449b2051],
9	Cancer	NN	O	cancer	nn	10	SENT_457	[p28l1477t1968r1829b2051],
10	QLQ	NN	O	qlq	prep_of	7	SENT_457	[p28l1876t1968r2145b2073],
11	—	CD	NUMBER	—	num	12	SENT_457	[p28l1876t1968r2145b2073],
12	C30	NN	O	c30	dep	3	SENT_457	[p28l18t2117r237b2200],
13	:	:	O	:	_	0	SENT_457	[p28l18t2117r237b2200],
14	a	DT	O	a	det	18	SENT_457	[p28l300t2140r352b2200],
15	quality	NN	O	quality	nn	18	SENT_457	[p28l408t2109r1100b2226],
16	—	CD	NUMBER	—	num	18	SENT_457	[p28l408t2109r1100b2226],
17	of-life	JJ	O	of-life	amod	18	SENT_457	[p28l408t2109r1100b2226],
18	instrument	NN	O	instrument	dep	12	SENT_457	[p28l1157t2111r1730b2201],
19	for	IN	O	for	_	0	SENT_457	[p28l1781t2109r1927b2200],
20	use	NN	O	use	prep_for	18	SENT_457	[p28l1982t2140r2147b2201],

1	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	CD	NUMBER	iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii	num	2	SENT_458	[p28l696t2532r1418b2551],
2	ER	NN	O	er	_	0	SENT_458	[p28l1423t2532r1464b2551],

1	in	IN	O	in	_	0	SENT_459	[p28l11t2853r109b2941],
2	international	JJ	O	international	amod	4	SENT_459	[p28l159t2851r828b2943],
3	clinical	JJ	O	clinical	amod	4	SENT_459	[p28l879t2851r1253b2941],
4	trials	NNS	O	trial	pobj	1	SENT_459	[p28l1304t2851r1564b2941],
5	in	IN	O	in	_	0	SENT_459	[p28l1618t2853r1716b2941],
6	oncolo	JJ	O	oncolo	amod	7	SENT_459	[p28l1768t2851r2149b2943],
7	—	NN	O	—	prep_in	4	SENT_459	[p28l1768t2851r2149b2943],

1	gy	NN	O	gy	_	0	SENT_460	[p28l11t3031r147b3119],
2	.	.	O	.	_	0	SENT_460	[p28l11t3031r147b3119],

1	J	NNP	O	J	nn	4	SENT_461	[p28l182t3009r227b3107],
2	Natl	NNP	O	Natl	nn	4	SENT_461	[p28l261t3001r476b3093],
3	Cancer	NNP	O	Cancer	nn	4	SENT_461	[p28l516t3009r870b3093],
4	Inst	NNP	O	Inst	_	0	SENT_461	[p28l905t3009r1105b3091],
5	1993	CD	DATE	1993	num	4	SENT_461	[p28l1143t3009r1927b3111],
6	;	:	O	;	_	0	SENT_461	[p28l1143t3009r1927b3111],
7	85:365	CD	NUMBER	85:365	number	8	SENT_461	[p28l1143t3009r1927b3111],
8	—	CD	NUMBER	—	dep	4	SENT_461	[p28l1143t3009r1927b3111],
9	76	CD	NUMBER	76	dep	8	SENT_461	[p28l1143t3009r1927b3111],
10	.	.	O	.	_	0	SENT_461	[p28l1143t3009r1927b3111],

1	21	CD	NUMBER	21	_	0	SENT_462	[p28l9t3163r147b3241],
2	.	.	O	.	_	0	SENT_462	[p28l9t3163r147b3241],

1	Bergman	NNP	PERSON	Bergman	nn	2	SENT_463	[p28l209t3159r676b3267],
2	B	NNP	PERSON	B	_	0	SENT_463	[p28l715t3159r810b3261],
3	,	,	O	,	_	0	SENT_463	[p28l715t3159r810b3261],
4	Aaronson	NNP	PERSON	Aaronson	nn	6	SENT_463	[p28l853t3159r1351b3243],
5	N	NNP	PERSON	N	nn	6	SENT_463	[p28l1388t3159r1475b3243],
6	K	NNP	PERSON	K	appos	2	SENT_463	[p28l1482t3159r1584b3261],
7	,	,	O	,	_	0	SENT_463	[p28l1482t3159r1584b3261],
8	Ahmedzai	NNP	PERSON	Ahmedzai	nn	9	SENT_463	[p28l1626t3151r2151b3243],
9	S	NNP	O	S	appos	2	SENT_463	[p28l15t3309r93b3411],
10	,	,	O	,	_	0	SENT_463	[p28l15t3309r93b3411],
11	Kaasa	NNP	PERSON	Kaasa	nn	12	SENT_463	[p28l142t3309r444b3395],
12	S	NNP	PERSON	S	appos	2	SENT_463	[p28l488t3309r568b3411],
13	,	,	O	,	_	0	SENT_463	[p28l488t3309r568b3411],
14	Sullivan	NNP	PERSON	Sullivan	nn	18	SENT_463	[p28l620t3301r1025b3393],
15	M.	NNP	O	M.	nn	18	SENT_463	[p28l1065t3309r1191b3393],
16	The	NNP	O	The	nn	18	SENT_463	[p28l1236t3301r1425b3391],
17	EORTC	NNP	O	EORTC	nn	18	SENT_463	[p28l1466t3309r1832b3397],
18	QLQ	NNP	O	QLQ	appos	2	SENT_463	[p28l1878t3309r2149b3415],
19	—	CD	NUMBER	—	num	20	SENT_463	[p28l1878t3309r2149b3415],
20	LC13	NN	O	lc13	dep	18	SENT_463	[p28l9t3459r295b3543],
21	:	:	O	:	_	0	SENT_463	[p28l9t3459r295b3543],
22	a	DT	O	a	det	24	SENT_463	[p28l404t3481r456b3541],
23	modular	JJ	O	modular	amod	24	SENT_463	[p28l560t3451r995b3543],
24	supplement	NN	O	supplement	dep	18	SENT_463	[p28l1099t3451r1690b3567],
25	to	TO	O	to	_	0	SENT_463	[p28l1790t3471r1886b3543],
26	the	DT	O	the	det	29	SENT_463	[p28l1993t3451r2151b3541],
27	EORTC	NNP	O	EORTC	nn	29	SENT_463	[p28l9t3609r375b3697],
28	Core	NNP	O	Core	nn	29	SENT_463	[p28l454t3609r688b3693],
29	Quality	NNP	O	Quality	prep_to	24	SENT_463	[p28l764t3601r1141b3717],
30	of	IN	O	of	_	0	SENT_463	[p28l1213t3601r1331b3693],
31	Life	NNP	O	Life	nn	32	SENT_463	[p28l1384t3601r1574b3691],
32	Questionnaire	NNP	O	Questionnaire	prep_of	29	SENT_463	[p28l1650t3603r2149b3715, p29l11t26r269b114],

1	(	NN	O	(	nn	3	SENT_464	[p29l338t32r874b138],
2	QLQ-C30	NN	O	qlq-c30	nn	3	SENT_464	[p29l338t32r874b138],
3	)	NN	O	)	_	0	SENT_464	[p29l338t32r874b138],
4	for	IN	O	for	_	0	SENT_464	[p29l943t24r1087b116],
5	use	NN	O	use	prep_for	3	SENT_464	[p29l1147t54r1313b116],
6	in	IN	O	in	_	0	SENT_464	[p29l1374t26r1472b114],
7	lung	NN	O	lung	nn	10	SENT_464	[p29l1534t24r1762b140],
8	cancer	NN	O	cancer	nn	10	SENT_464	[p29l1821t54r2153b114],
9	clinical	JJ	O	clinical	amod	10	SENT_464	[p29l13t174r385b264],
10	trials	NNS	O	trial	prep_in	3	SENT_464	[p29l422t174r712b266],
11	.	.	O	.	_	0	SENT_464	[p29l422t174r712b266],

1	Eur	NNP	MISC	Eur	nn	3	SENT_465	[p29l755t182r997b280],
2	]	NNP	O	]	nn	3	SENT_465	[p29l755t182r997b280],
3	Cancer	NNP	O	Cancer	_	0	SENT_465	[p29l1031t182r1385b266],
4	1994	CD	DATE	1994	num	3	SENT_465	[p29l1422t182r2149b284, p29l9t486r151b564],
5	;	:	O	;	_	0	SENT_465	[p29l1422t182r2149b284, p29l9t486r151b564],
6	30A	CD	NUMBER	30a	number	7	SENT_465	[p29l1422t182r2149b284, p29l9t486r151b564],
7	:63522	CD	NUMBER	:63522	dep	3	SENT_465	[p29l1422t182r2149b284, p29l9t486r151b564],
8	.	.	O	.	_	0	SENT_465	[p29l1422t182r2149b284, p29l9t486r151b564],

1	Shavv	NNP	O	Shavv	nn	2	SENT_466	[p29l214t474r480b566],
2	AT	NNP	O	AT	_	0	SENT_466	[p29l508t482r672b584],
3	,	,	O	,	_	0	SENT_466	[p29l508t482r672b584],
4	Yeap	NNP	PERSON	Yeap	nn	5	SENT_466	[p29l708t482r940b590],
5	BY	NNP	O	BY	appos	2	SENT_466	[p29l975t482r1125b584],
6	,	,	O	,	_	0	SENT_466	[p29l975t482r1125b584],
7	Mino-Kenudson	NNP	O	Mino-Kenudson	nn	8	SENT_466	[p29l1163t474r1986b568],
8	M	NNP	O	M	appos	2	SENT_466	[p29l2017t482r2143b584],
9	,	,	O	,	_	0	SENT_466	[p29l2017t482r2143b584],
10	et	FW	O	et	nn	11	SENT_466	[p29l13t644r103b714],
11	al.	FW	O	al.	appos	2	SENT_466	[p29l133t624r249b716],
12	.	.	O	.	_	0	SENT_466	[p29l133t624r249b716],

1	Clinical	JJ	O	clinical	amod	2	SENT_467	[p29l291t624r686b716],
2	features	NNS	O	feature	_	0	SENT_467	[p29l721t624r1127b716],
3	and	CC	O	and	_	0	SENT_467	[p29l1167t624r1353b716],
4	outcome	NN	O	outcome	conj_and	2	SENT_467	[p29l1390t644r1826b716],
5	of	IN	O	of	_	0	SENT_467	[p29l1863t624r1980b716],
6	patients	NNS	O	patient	prep_of	2	SENT_467	[p29l1993t654r2149b740, p29l11t776r293b864],
7	with	IN	O	with	_	0	SENT_467	[p29l374t774r606b866],
8	non-small-cell	JJ	O	non-small-cell	amod	10	SENT_467	[p29l690t774r1428b866],
9	lung	NN	O	lung	nn	10	SENT_467	[p29l1510t774r1740b890],
10	cancer	NN	O	cancer	prep_with	6	SENT_467	[p29l1821t804r2153b864],
11	who	WP	O	who	nsubj	12	SENT_467	[p29l7t924r221b1016],
12	harbor	VBP	O	harbor	rcmod	10	SENT_467	[p29l314t924r660b1016],
13	EML4	NN	O	eml4	dobj	12	SENT_467	[p29l745t932r1333b1018],
14	.	.	O	.	_	0	SENT_467	[p29l745t932r1333b1018],

1	—	NN	O	—	_	0	SENT_468	[p29l745t932r1333b1018],
2	.	.	O	.	_	0	SENT_468	[p29l745t932r1333b1018],

1	ALK	NNP	O	ALK	_	0	SENT_469	[p29l745t932r1333b1018],
2	.	.	O	.	_	0	SENT_469	[p29l745t932r1333b1018],

1	J	NNP	O	J	nn	3	SENT_470	[p29l1418t932r1462b1030],
2	Clin	NNP	O	Clin	nn	3	SENT_470	[p29l1550t924r1760b1016],
3	Oncol	NNP	O	Oncol	_	0	SENT_470	[p29l1851t924r2151b1016],

1	23	CD	NUMBER	23	_	0	SENT_471	[p29l9t1236r147b1314],
2	.	.	O	.	_	0	SENT_471	[p29l9t1236r147b1314],

1	Wong	NNP	PERSON	Wong	nn	2	SENT_472	[p29l206t1232r506b1340],
2	DW	NNP	O	DW	_	0	SENT_472	[p29l534t1232r740b1334],
3	,	,	O	,	_	0	SENT_472	[p29l534t1232r740b1334],
4	Leung	NNP	PERSON	Leung	nn	5	SENT_472	[p29l777t1232r1095b1340],
5	EL	NNP	O	EL	appos	2	SENT_472	[p29l1123t1232r1277b1334],
6	,	,	O	,	_	0	SENT_472	[p29l1123t1232r1277b1334],
7	So	RB	O	so	advmod	8	SENT_472	[p29l1320t1232r1435b1316],
8	KK	NNP	O	KK	appos	2	SENT_472	[p29l1468t1232r1652b1334],
9	,	,	O	,	_	0	SENT_472	[p29l1468t1232r1652b1334],
10	et	FW	O	et	nn	11	SENT_472	[p29l1694t1244r1784b1314],
11	al.	FW	O	al.	appos	8	SENT_472	[p29l1811t1224r1926b1316],
12	.	.	O	.	_	0	SENT_472	[p29l1811t1224r1926b1316],

1	The	DT	O	the	det	2	SENT_473	[p29l1961t1224r2151b1314],
2	EML4	NN	O	eml4	_	0	SENT_473	[p29l9t1382r570b1468],
3	.	.	O	.	_	0	SENT_473	[p29l9t1382r570b1468],

1	—	NN	O	—	_	0	SENT_474	[p29l9t1382r570b1468],
2	.	.	O	.	_	0	SENT_474	[p29l9t1382r570b1468],

1	ALK	NN	O	alk	nn	3	SENT_475	[p29l9t1382r570b1468],
2	fusion	NN	O	fusion	nn	3	SENT_475	[p29l602t1374r922b1466],
3	gene	NN	O	gene	nsubjpass	5	SENT_475	[p29l957t1404r1193b1492],
4	is	VBZ	O	be	auxpass	5	SENT_475	[p29l1227t1376r1305b1464],
5	involved	VBN	O	involve	_	0	SENT_475	[p29l1342t1374r1760b1466],
6	in	IN	O	in	_	0	SENT_475	[p29l1794t1376r1892b1464],
7	various	JJ	O	various	amod	9	SENT_475	[p29l1923t1376r2149b1466, p29l13t1554r183b1616],
8	histologic	JJ	O	histologic	amod	9	SENT_475	[p29l226t1524r732b1640],
9	types	NNS	O	type	prep_in	5	SENT_475	[p29l771t1544r1035b1640],
10	of	IN	O	of	_	0	SENT_475	[p29l1079t1524r1197b1616],
11	lung	NN	O	lung	nn	12	SENT_475	[p29l1214t1524r1443b1640],
12	cancers	NNS	O	cancer	prep_of	9	SENT_475	[p29l1480t1554r1860b1614],
13	from	IN	O	from	_	0	SENT_475	[p29l1901t1524r2149b1616],
14	nonsmokers	NNS	O	nonsmoker	prep_from	5	SENT_475	[p29l11t1674r634b1766],
15	with	IN	O	with	_	0	SENT_475	[p29l717t1674r947b1766],
16	vvild-type	JJ	O	vvild-type	amod	17	SENT_475	[p29l1027t1674r1508b1790],
17	EGFR	NN	ORGANIZATION	egfr	prep_with	14	SENT_475	[p29l1592t1682r1892b1770],
18	and	CC	O	and	advmod	17	SENT_475	[p29l1965t1674r2151b1766],

1	KRAS	NNP	ORGANIZATION	KRAS	_	0	SENT_476	[p29l11t1832r335b1920],
2	.	.	O	.	_	0	SENT_476	[p29l11t1832r335b1920],

1	Cancer	NN	O	cancer	_	0	SENT_477	[p29l382t1832r736b1916],
2	2009	CD	DATE	2009	num	1	SENT_477	[p29l773t1832r1694b1932],
3	;	:	O	;	_	0	SENT_477	[p29l773t1832r1694b1932],
4	115:1723	CD	NUMBER	115:1723	number	5	SENT_477	[p29l773t1832r1694b1932],
5	-33	CD	NUMBER	-33	dep	1	SENT_477	[p29l773t1832r1694b1932],
6	.	.	O	.	_	0	SENT_477	[p29l773t1832r1694b1932],

1	24	CD	NUMBER	24	_	0	SENT_478	[p29l12t2082r79b2120],
2	.	.	O	.	_	0	SENT_478	[p29l12t2082r79b2120],

1	Reuben	NNP	PERSON	Reuben	nn	3	SENT_479	[p29l108t2076r293b2123],
2	A.	NNP	PERSON	A.	nn	3	SENT_479	[p29l345t2080r395b2120],
3	Hy	NNP	PERSON	Hy	poss	5	SENT_479	[p29l453t2080r555b2132],
4	’s	POS	O	’s	_	0	SENT_479	[p29l453t2080r555b2132],
5	law	NN	O	law	_	0	SENT_479	[p29l611t2076r705b2121],
6	.	.	O	.	_	0	SENT_479	[p29l611t2076r705b2121],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_480	[p29l762t2076r1046b2133],
2	2004	CD	DATE	2004	num	1	SENT_480	[p29l13t2151r372b2201],
3	;	:	O	;	_	0	SENT_480	[p29l13t2151r372b2201],
4	39:574	CD	NUMBER	39:574	number	5	SENT_480	[p29l13t2151r372b2201],
5	-8	CD	NUMBER	-8	dep	1	SENT_480	[p29l13t2151r372b2201],
6	.	.	O	.	_	0	SENT_480	[p29l13t2151r372b2201],

1	25	CD	NUMBER	25	_	0	SENT_481	[p29l12t2224r78b2262],
2	.	.	O	.	_	0	SENT_481	[p29l12t2224r78b2262],

1	Scagliotti	NNP	PERSON	Scagliotti	nn	2	SENT_482	[p29l111t2218r343b2275],
2	G	NNP	PERSON	G	_	0	SENT_482	[p29l367t2221r420b2272],
3	,	,	O	,	_	0	SENT_482	[p29l367t2221r420b2272],
4	Hanna	NNP	PERSON	Hanna	nn	5	SENT_482	[p29l447t2222r612b2262],
5	N	NNP	PERSON	N	appos	2	SENT_482	[p29l635t2222r688b2271],
6	,	,	O	,	_	0	SENT_482	[p29l635t2222r688b2271],
7	Fossella	NNP	PERSON	Fossella	nn	8	SENT_482	[p29l715t2218r913b2262],
8	F	NN	O	f	appos	2	SENT_482	[p29l936t2222r974b2271],
9	,	,	O	,	_	0	SENT_482	[p29l936t2222r974b2271],
10	et	FW	O	et	nn	11	SENT_482	[p29l1002t2227r1046b2262],
11	al.	FW	O	al.	appos	2	SENT_482	[p29l13t2290r68b2334],
12	.	.	O	.	_	0	SENT_482	[p29l13t2290r68b2334],

1	The	DT	O	the	det	3	SENT_483	[p29l86t2290r177b2334],
2	differential	JJ	O	differential	amod	3	SENT_483	[p29l194t2290r472b2334],
3	efficacy	NN	O	efficacy	_	0	SENT_483	[p29l489t2290r681b2346],
4	of	IN	O	of	_	0	SENT_483	[p29l695t2290r752b2334],
5	pemetrexed	JJ	O	pemetrexed	prep_of	3	SENT_483	[p29l757t2290r1044b2346],
6	according	VBG	O	accord	_	0	SENT_483	[p29l13t2360r256b2417],
7	to	TO	O	to	prepc_according_to	5	SENT_483	[p29l271t2369r317b2404],
8	NSCLC	NNP	ORGANIZATION	NSCLC	nn	9	SENT_483	[p29l334t2363r505b2405],
9	histology	NN	O	histology	pobj	5	SENT_483	[p29l523t2360r764b2417],
10	:	:	O	:	_	0	SENT_483	[p29l523t2360r764b2417],
11	a	DT	O	a	det	12	SENT_483	[p29l782t2375r807b2404],
12	review	NN	O	review	dep	3	SENT_483	[p29l823t2361r983b2405],
13	of	IN	O	of	_	0	SENT_483	[p29l998t2360r1054b2404],
14	two	CD	NUMBER	two	num	15	SENT_483	[p29l13t2440r102b2476],
15	Phase	NN	O	phase	prep_of	12	SENT_483	[p29l133t2431r273b2475],
16	III	CD	NUMBER	iii	num	17	SENT_483	[p29l303t2435r361b2475],
17	studies	NNS	O	study	dep	12	SENT_483	[p29l392t2431r578b2476],
18	.	.	O	.	_	0	SENT_483	[p29l392t2431r578b2476],

1	Oncologist	NN	O	oncologist	_	0	SENT_484	[p29l612t2431r881b2488],
2	2009	CD	DATE	2009	num	1	SENT_484	[p29l909t2434r1041b2484],
3	;	:	O	;	_	0	SENT_484	[p29l909t2434r1041b2484],
4	14:253	CD	NUMBER	14:253	number	5	SENT_484	[p29l15t2506r265b2548],
5	-63	CD	NUMBER	-63	dep	1	SENT_484	[p29l15t2506r265b2548],
6	.	.	O	.	_	0	SENT_484	[p29l15t2506r265b2548],

1	26	CD	NUMBER	26	_	0	SENT_485	[p29l12t2578r80b2617],
2	.	.	O	.	_	0	SENT_485	[p29l12t2578r80b2617],

1	Fukuoka	NNP	LOCATION	Fukuoka	nn	2	SENT_486	[p29l108t2573r322b2618],
2	M	NNP	O	M	_	0	SENT_486	[p29l345t2577r406b2626],
3	,	,	O	,	_	0	SENT_486	[p29l345t2577r406b2626],
4	Wu	NNP	PERSON	Wu	nn	5	SENT_486	[p29l433t2577r515b2618],
5	YL	NNP	PERSON	YL	appos	2	SENT_486	[p29l538t2577r614b2627],
6	,	,	O	,	_	0	SENT_486	[p29l538t2577r614b2627],
7	Thongprasert	NNP	O	Thongprasert	nn	8	SENT_486	[p29l641t2573r978b2630],
8	S	NNP	O	S	appos	2	SENT_486	[p29l1002t2576r1041b2626],
9	,	,	O	,	_	0	SENT_486	[p29l1002t2576r1041b2626],
10	et	FW	O	et	nn	11	SENT_486	[p29l13t2654r57b2689],
11	al.	FW	O	al.	appos	2	SENT_486	[p29l70t2645r126b2689],
12	.	.	O	.	_	0	SENT_486	[p29l70t2645r126b2689],

1	Biomarker	NN	O	biomarker	nn	2	SENT_487	[p29l145t2645r404b2690],
2	analyses	NNS	O	analysis	nsubj	7	SENT_487	[p29l418t2645r624b2701],
3	and	CC	O	and	_	0	SENT_487	[p29l642t2645r731b2689],
4	final	JJ	O	final	amod	6	SENT_487	[p29l747t2645r864b2689],
5	overall	JJ	O	overall	amod	6	SENT_487	[p29l881t2645r1044b2690],
6	survival	NN	O	survival	conj_and	2	SENT_487	[p29l14t2716r203b2761],
7	results	VBZ	O	result	_	0	SENT_487	[p29l221t2716r383b2761],
8	from	IN	O	from	_	0	SENT_487	[p29l403t2716r522b2760],
9	a	DT	O	a	det	10	SENT_487	[p29l541t2731r565b2760],
10	phase	NN	O	phase	prep_from	7	SENT_487	[p29l582t2716r724b2772],
11	III	CD	NUMBER	iii	num	10	SENT_487	[p29l741t2720r811b2769],
12	,	,	O	,	_	0	SENT_487	[p29l741t2720r811b2769],
13	randomized	VBN	O	randomize	dep	7	SENT_487	[p29l833t2716r1043b2760, p29l13t2786r127b2839],
14	,	,	O	,	_	0	SENT_487	[p29l833t2716r1043b2760, p29l13t2786r127b2839],
15	open-label	JJ	O	open-label	amod	18	SENT_487	[p29l159t2786r428b2842],
16	,	,	O	,	_	0	SENT_487	[p29l159t2786r428b2842],
17	first-line	JJ	O	first-line	amod	18	SENT_487	[p29l459t2786r671b2830],
18	study	NN	O	study	dobj	13	SENT_487	[p29l700t2786r831b2842],
19	of	IN	O	of	_	0	SENT_487	[p29l856t2786r913b2830],
20	gefitinib	NN	O	gefitinib	prep_of	18	SENT_487	[p29l930t2786r1043b2843, p29l13t2857r126b2901],
21	versus	CC	O	versus	prep	20	SENT_487	[p29l143t2872r292b2902],
22	carboplatinlpaclitaxel	NN	O	carboplatinlpaclitaxel	dep	21	SENT_487	[p29l312t2857r836b2913],
23	in	IN	O	in	_	0	SENT_487	[p29l854t2858r901b2901],
24	clinically	RB	O	clinically	advmod	25	SENT_487	[p29l920t2857r1043b2901, p29l13t2928r124b2984],
25	selected	VBN	O	select	amod	26	SENT_487	[p29l175t2928r365b2972],
26	patients	NNS	O	patient	prep_in	22	SENT_487	[p29l417t2929r608b2984],
27	with	IN	O	with	_	0	SENT_487	[p29l661t2928r770b2973],
28	advanced	JJ	O	advanced	amod	31	SENT_487	[p29l822t2928r1044b2973],
29	non-small-cell	JJ	O	non-small-cell	amod	31	SENT_487	[p29l13t2999r360b3043],
30	lung	NN	O	lung	nn	31	SENT_487	[p29l376t2999r484b3056],
31	cancer	NN	O	cancer	prep_with	26	SENT_487	[p29l499t3013r656b3043],
32	in	IN	O	in	_	0	SENT_487	[p29l671t3000r718b3043],
33	Asia	NNP	LOCATION	Asia	prep_in	31	SENT_487	[p29l732t3000r836b3043],
34	(	CD	NUMBER	(	num	33	SENT_487	[p29l855t3002r1040b3050],
35	IPASS	NNP	O	IPASS	dep	18	SENT_487	[p29l855t3002r1040b3050],
36	)	CD	NUMBER	)	num	35	SENT_487	[p29l855t3002r1040b3050],
37	.	.	O	.	_	0	SENT_487	[p29l855t3002r1040b3050],

1	J	NNP	O	J	nn	3	SENT_488	[p29l7t3075r28b3122],
2	Clin	NNP	O	Clin	nn	3	SENT_488	[p29l46t3071r147b3115],
3	Oncol	NNP	O	Oncol	_	0	SENT_488	[p29l166t3071r311b3115],
4	2011	CD	DATE	2011	num	3	SENT_488	[p29l330t3074r743b3124],
5	;	:	O	;	_	0	SENT_488	[p29l330t3074r743b3124],
6	29:2866	CD	NUMBER	29:2866	number	7	SENT_488	[p29l330t3074r743b3124],
7	-74	CD	NUMBER	-74	dep	3	SENT_488	[p29l330t3074r743b3124],
8	.	.	O	.	_	0	SENT_488	[p29l330t3074r743b3124],

1	27	CD	NUMBER	27	_	0	SENT_489	[p29l12t3148r74b3186],
2	.	.	O	.	_	0	SENT_489	[p29l12t3148r74b3186],

1	Maemondo	NNP	O	Maemondo	nn	2	SENT_490	[p29l108t3142r383b3186],
2	M	NNP	O	M	_	0	SENT_490	[p29l403t3146r465b3195],
3	,	,	O	,	_	0	SENT_490	[p29l403t3146r465b3195],
4	Inoue	NNP	PERSON	Inoue	nn	5	SENT_490	[p29l488t3146r626b3187],
5	A	NNP	O	A	appos	2	SENT_490	[p29l646t3146r695b3195],
6	,	,	O	,	_	0	SENT_490	[p29l646t3146r695b3195],
7	Kobayashi	NNP	LOCATION	Kobayashi	nn	8	SENT_490	[p29l720t3142r971b3198],
8	K	NNP	LOCATION	K	appos	2	SENT_490	[p29l992t3146r1040b3195],
9	,	,	O	,	_	0	SENT_490	[p29l992t3146r1040b3195],
10	et	FW	O	et	nn	11	SENT_490	[p29l13t3222r57b3257],
11	al.	FW	O	al.	appos	2	SENT_490	[p29l74t3213r129b3257],
12	.	.	O	.	_	0	SENT_490	[p29l74t3213r129b3257],

1	Geﬁtinib	NN	O	geﬁtinib	_	0	SENT_491	[p29l152t3213r377b3257],
2	or	CC	O	or	_	0	SENT_491	[p29l398t3227r448b3257],
3	chemotherapy	NN	O	chemotherapy	conj_or	1	SENT_491	[p29l467t3213r815b3269],
4	for	IN	O	for	_	0	SENT_491	[p29l833t3213r903b3257],
5	nonsmall-cell	JJ	O	nonsmall-cell	amod	7	SENT_491	[p29l921t3227r1046b3257, p29l14t3283r253b3327],
6	lung	NN	O	lung	nn	7	SENT_491	[p29l306t3283r416b3340],
7	cancer	NN	O	cancer	prep_for	1	SENT_491	[p29l468t3297r628b3327],
8	with	IN	O	with	_	0	SENT_491	[p29l678t3283r788b3328],
9	mutated	VBN	O	mutate	amod	10	SENT_491	[p29l842t3283r1044b3328],
10	EGFR	NN	ORGANIZATION	egfr	prep_with	7	SENT_491	[p29l12t3357r166b3401],
11	.	.	O	.	_	0	SENT_491	[p29l12t3357r166b3401],

1	N	NN	O	n	nn	3	SENT_492	[p29l187t3358r229b3398],
2	Engl	NNP	O	Engl	nn	3	SENT_492	[p29l247t3354r357b3411],
3	J	NNP	O	J	nsubj	4	SENT_492	[p29l371t3358r392b3405],
4	Med	VBD	O	med	_	0	SENT_492	[p29l408t3354r514b3398],
5	2010	CD	DATE	2010	dobj	4	SENT_492	[p29l533t3357r953b3407],
6	;	:	O	;	_	0	SENT_492	[p29l533t3357r953b3407],
7	362:2380	CD	NUMBER	362:2380	num	8	SENT_492	[p29l533t3357r953b3407],
8	-8	CD	NUMBER	-8	dep	5	SENT_492	[p29l533t3357r953b3407],
9	.	.	O	.	_	0	SENT_492	[p29l533t3357r953b3407],

1	28	CD	NUMBER	28	_	0	SENT_493	[p29l1118t2081r1186b2121],
2	.	.	O	.	_	0	SENT_493	[p29l1118t2081r1186b2121],

1	Rosell	NNP	PERSON	Rosell	nn	2	SENT_494	[p29l1215t2076r1367b2123],
2	R	NNP	PERSON	R	_	0	SENT_494	[p29l1393t2080r1442b2129],
3	,	,	O	,	_	0	SENT_494	[p29l1393t2080r1442b2129],
4	Carcereny	NNP	ORGANIZATION	Carcereny	nn	5	SENT_494	[p29l1473t2079r1717b2132],
5	E	NNP	ORGANIZATION	E	appos	2	SENT_494	[p29l1742t2080r1786b2130],
6	,	,	O	,	_	0	SENT_494	[p29l1742t2080r1786b2130],
7	Gervais	NNP	PERSON	Gervais	nn	8	SENT_494	[p29l1816t2077r2001b2121],
8	R	NNP	O	R	appos	2	SENT_494	[p29l2029t2080r2078b2129],
9	,	,	O	,	_	0	SENT_494	[p29l2029t2080r2078b2129],
10	et	FW	O	et	nn	11	SENT_494	[p29l2109t2085r2152b2120],
11	al.	FW	O	al.	appos	2	SENT_494	[p29l1119t2148r1174b2192],
12	.	.	O	.	_	0	SENT_494	[p29l1119t2148r1174b2192],

1	Erlotinib	NNP	O	Erlotinib	_	0	SENT_495	[p29l1196t2148r1413b2192],
2	versus	CC	O	versus	prep	1	SENT_495	[p29l1431t2162r1584b2193],
3	standard	JJ	O	standard	amod	4	SENT_495	[p29l1605t2148r1821b2192],
4	chemotherapy	NN	O	chemotherapy	dep	2	SENT_495	[p29l1841t2148r2149b2192, p29l1118t2232r1175b2274],
5	as	IN	O	as	_	0	SENT_495	[p29l1206t2233r1255b2262],
6	first-line	JJ	O	first-line	amod	7	SENT_495	[p29l1291t2218r1503b2262],
7	treatment	NN	O	treatment	prep_as	4	SENT_495	[p29l1538t2227r1780b2262],
8	for	IN	O	for	_	0	SENT_495	[p29l1812t2218r1882b2262],
9	European	JJ	MISC	european	amod	10	SENT_495	[p29l1914t2222r2150b2274],
10	patients	NNS	O	patient	prep_for	7	SENT_495	[p29l1118t2291r1313b2346],
11	with	IN	O	with	_	0	SENT_495	[p29l1342t2290r1453b2335],
12	advanced	JJ	O	advanced	amod	13	SENT_495	[p29l1483t2290r1709b2335],
13	EGFR	NN	ORGANIZATION	egfr	prep_with	10	SENT_495	[p29l1738t2293r1883b2337],
14	mutationpositive	JJ	O	mutationpositive	amod	17	SENT_495	[p29l1907t2291r2149b2335, p29l1118t2361r1308b2416],
15	non-small-cell	JJ	O	non-small-cell	amod	17	SENT_495	[p29l1381t2360r1736b2404],
16	lung	NN	O	lung	nn	17	SENT_495	[p29l1809t2360r1919b2417],
17	cancer	NN	O	cancer	dep	1	SENT_495	[p29l1991t2374r2151b2404],
18	(	CD	NUMBER	(	num	19	SENT_495	[p29l1122t2434r1382b2482],
19	EURTAC	NN	O	eurtac	dep	17	SENT_495	[p29l1122t2434r1382b2482],
20	)	CD	NUMBER	)	dep	17	SENT_495	[p29l1122t2434r1382b2482],
21	:	:	O	:	_	0	SENT_495	[p29l1122t2434r1382b2482],
22	a	DT	O	a	det	28	SENT_495	[p29l1401t2446r1426b2475],
23	multicentre	JJ	O	multicentre	amod	28	SENT_495	[p29l1442t2431r1740b2484],
24	,	,	O	,	_	0	SENT_495	[p29l1442t2431r1740b2484],
25	open-label	JJ	O	open-label	amod	28	SENT_495	[p29l1760t2431r2030b2487],
26	,	,	O	,	_	0	SENT_495	[p29l1760t2431r2030b2487],
27	randomised	JJ	O	randomised	amod	28	SENT_495	[p29l2051t2445r2149b2475, p29l1120t2503r1329b2547],
28	phase	NN	O	phase	dep	1	SENT_495	[p29l1374t2503r1516b2559],
29	3	CD	NUMBER	3	num	30	SENT_495	[p29l1562t2506r1587b2548],
30	trial	NN	O	trial	dep	28	SENT_495	[p29l1635t2503r1750b2547],
31	.	.	O	.	_	0	SENT_495	[p29l1635t2503r1750b2547],

1	Lancet	NNP	O	Lancet	nn	2	SENT_496	[p29l1799t2507r1962b2547],
2	Oncol	NNP	O	Oncol	_	0	SENT_496	[p29l2006t2503r2150b2547],
3	2012	CD	DATE	2012	num	2	SENT_496	[p29l1119t2576r1511b2626],
4	;	:	O	;	_	0	SENT_496	[p29l1119t2576r1511b2626],
5	13:239	CD	NUMBER	13:239	number	6	SENT_496	[p29l1119t2576r1511b2626],
6	-46	CD	NUMBER	-46	dep	2	SENT_496	[p29l1119t2576r1511b2626],
7	.	.	O	.	_	0	SENT_496	[p29l1119t2576r1511b2626],

1	29	CD	NUMBER	29	_	0	SENT_497	[p29l1118t2650r1184b2689],
2	.	.	O	.	_	0	SENT_497	[p29l1118t2650r1184b2689],

1	Shaw	NNP	ORGANIZATION	Shaw	nn	2	SENT_498	[p29l1217t2645r1345b2690],
2	AT	NNP	O	AT	_	0	SENT_498	[p29l1364t2649r1443b2698],
3	,	,	O	,	_	0	SENT_498	[p29l1364t2649r1443b2698],
4	Yeap	NNP	PERSON	Yeap	nn	5	SENT_498	[p29l1467t2649r1579b2701],
5	BY	NNP	O	BY	appos	2	SENT_498	[p29l1602t2649r1675b2698],
6	,	,	O	,	_	0	SENT_498	[p29l1602t2649r1675b2698],
7	Solomon	NNP	PERSON	Solomon	nn	9	SENT_498	[p29l1702t2645r1917b2689],
8	B	NNP	O	B	nn	9	SENT_498	[p29l1940t2649r2001b2698],
9	]	NN	O	]	appos	2	SENT_498	[p29l1940t2649r2001b2698],
10	,	,	O	,	_	0	SENT_498	[p29l1940t2649r2001b2698],
11	et	FW	O	et	nn	12	SENT_498	[p29l2028t2654r2071b2689],
12	al.	FW	O	al.	appos	2	SENT_498	[p29l2091t2645r2147b2689],
13	.	.	O	.	_	0	SENT_498	[p29l2091t2645r2147b2689],

1	Effect	NN	O	effect	_	0	SENT_499	[p29l1118t2716r1263b2760],
2	of	IN	O	of	_	0	SENT_499	[p29l1284t2716r1341b2760],
3	crizotinib	NN	O	crizotinib	prep_of	1	SENT_499	[p29l1354t2716r1595b2760],
4	on	IN	O	on	_	0	SENT_499	[p29l1619t2730r1679b2760],
5	overall	JJ	O	overall	amod	6	SENT_499	[p29l1703t2716r1866b2761],
6	survival	NN	O	survival	prep_on	1	SENT_499	[p29l1890t2716r2080b2761],
7	in	IN	O	in	_	0	SENT_499	[p29l2103t2717r2150b2760],
8	patients	NNS	O	patient	prep_in	1	SENT_499	[p29l1118t2787r1313b2842],
9	with	IN	O	with	_	0	SENT_499	[p29l1361t2786r1472b2831],
10	advanced	JJ	O	advanced	amod	13	SENT_499	[p29l1520t2786r1746b2831],
11	non-small-cell	JJ	O	non-small-cell	amod	13	SENT_499	[p29l1795t2786r2150b2830],
12	lung	NN	O	lung	nn	13	SENT_499	[p29l1119t2857r1229b2914],
13	cancer	NN	O	cancer	prep_with	1	SENT_499	[p29l1258t2871r1418b2901],
14	harbouring	VBG	O	harbour	partmod	13	SENT_499	[p29l1447t2857r1728b2914],
15	ALK	NN	O	alk	nn	17	SENT_499	[p29l1754t2861r1862b2902],
16	gene	NN	O	gene	nn	17	SENT_499	[p29l1891t2871r2004b2914],
17	rearrangement	NN	O	rearrangement	dobj	14	SENT_499	[p29l2035t2871r2149b2901, p29l1119t2937r1398b2985],
18	:	:	O	:	_	0	SENT_499	[p29l2035t2871r2149b2901, p29l1119t2937r1398b2985],
19	a	DT	O	a	det	21	SENT_499	[p29l1422t2943r1447b2972],
20	retrospective	JJ	O	retrospective	amod	21	SENT_499	[p29l1468t2929r1785b2984],
21	analysis	NN	O	analysis	dep	17	SENT_499	[p29l1807t2928r2016b2984],
22	.	.	O	.	_	0	SENT_499	[p29l1807t2928r2016b2984],

1	Lancet	NNP	O	Lancet	nn	2	SENT_500	[p29l2040t2932r2149b2972, p29l1120t3008r1189b3043],
2	Oncol	NNP	O	Oncol	_	0	SENT_500	[p29l1206t2999r1351b3043],
3	2011	CD	DATE	2011	num	2	SENT_500	[p29l1370t3002r1787b3052],
4	;	:	O	;	_	0	SENT_500	[p29l1370t3002r1787b3052],
5	12:1004	CD	DATE	12:1004	number	6	SENT_500	[p29l1370t3002r1787b3052],
6	-12	CD	DATE	-12	dep	2	SENT_500	[p29l1370t3002r1787b3052],
7	.	.	O	.	_	0	SENT_500	[p29l1370t3002r1787b3052],

1	30	CD	NUMBER	30	_	0	SENT_501	[p29l1119t3076r1185b3115],
2	.	.	O	.	_	0	SENT_501	[p29l1119t3076r1185b3115],

1	Peerzada	NNP	ORGANIZATION	Peerzada	nn	2	SENT_502	[p29l1214t3071r1434b3115],
2	MM	NN	ORGANIZATION	mm	_	0	SENT_502	[p29l1448t3075r1560b3124],
3	,	,	O	,	_	0	SENT_502	[p29l1448t3075r1560b3124],
4	Spiro	NNP	PERSON	Spiro	nn	5	SENT_502	[p29l1581t3072r1707b3127],
5	TP	NNP	O	TP	appos	2	SENT_502	[p29l1723t3075r1796b3124],
6	,	,	O	,	_	0	SENT_502	[p29l1723t3075r1796b3124],
7	Daw	NNP	PERSON	Daw	nn	8	SENT_502	[p29l1815t3075r1925b3116],
8	HA	NNP	O	HA	appos	5	SENT_502	[p29l1940t3075r2033b3115],
9	.	.	O	.	_	0	SENT_502	[p29l1940t3075r2033b3115],

1	Pulmonary	JJ	O	pulmonary	amod	2	SENT_503	[p29l2053t3071r2149b3116, p29l1119t3156r1309b3198],
2	toxicities	NNS	O	toxicity	_	0	SENT_503	[p29l1337t3143r1558b3186],
3	of	IN	O	of	_	0	SENT_503	[p29l1590t3142r1646b3186],
4	tyrosine	NN	O	tyrosine	nn	6	SENT_503	[p29l1666t3143r1864b3198],
5	kinase	NN	O	kinase	nn	6	SENT_503	[p29l1895t3142r2054b3187],
6	inhibitors	NNS	O	inhibitor	prep_of	2	SENT_503	[p29l2084t3143r2149b3186, p29l1119t3213r1323b3257],
7	.	.	O	.	_	0	SENT_503	[p29l2084t3143r2149b3186, p29l1119t3213r1323b3257],

1	Clin	NNP	O	Clin	nn	4	SENT_504	[p29l1356t3213r1457b3257],
2	Adv	NNP	O	Adv	nn	4	SENT_504	[p29l1484t3213r1578b3258],
3	Hematol	NNP	O	Hematol	nn	4	SENT_504	[p29l1605t3213r1815b3257],
4	Oncol	NNP	O	Oncol	_	0	SENT_504	[p29l1845t3213r1989b3257],
5	2011	CD	DATE	2011	num	4	SENT_504	[p29l2018t3216r2147b3266],
6	;	:	O	;	_	0	SENT_504	[p29l2018t3216r2147b3266],
7	9:824	CD	NUMBER	9:824	number	8	SENT_504	[p29l1119t3286r1341b3328],
8	-36	CD	NUMBER	-36	dep	4	SENT_504	[p29l1119t3286r1341b3328],
9	.	.	O	.	_	0	SENT_504	[p29l1119t3286r1341b3328],

1	Copyright	NN	O	copyright	_	0	SENT_505	[p29l1121t3362r1300b3409],
2	©	CD	NUMBER	©	num	6	SENT_505	[p29l1318t3365r1358b3405],
3	2013	CD	DATE	2013	num	6	SENT_505	[p29l1377t3364r1470b3398],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_505	[p29l1489t3362r1758b3398],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_505	[p29l1776t3361r1923b3398],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_505	[p29l1938t3363r2077b3409],
7	.	.	O	.	_	0	SENT_505	[p29l1938t3363r2077b3409],

1	Ubud	NNP	O	Ubud	nn	3	SENT_506	[p30l90t1552r153b1577],
2	Rice	NNP	O	Rice	nn	3	SENT_506	[p30l160t1553r209b1577],
3	Terrace	NNP	O	Terrace	_	0	SENT_506	[p30l215t1554r305b1582],
4	,	,	O	,	_	0	SENT_506	[p30l215t1554r305b1582],
5	Bali	NNP	PERSON	Bali	nn	9	SENT_506	[p30l314t1552r361b1577],
6	Justin	NNP	PERSON	Justin	nn	9	SENT_506	[p30l1774t1553r1855b1581],
7	Mitchell	NNP	PERSON	Mitchell	nn	9	SENT_506	[p30l1865t1552r1984b1582],
8	,	,	O	,	_	0	SENT_506	[p30l1865t1552r1984b1582],
9	M.D.	NNP	O	M.D.	appos	3	SENT_506	[p30l1995t1554r2060b1577],

1	2394	CD	DATE	2394	num	4	SENT_507	[p30l93t1657r170b1680],
2	N	NN	O	n	nn	4	SENT_507	[p30l908t1667r922b1682],
3	ENGLJ	NN	O	englj	nn	4	SENT_507	[p30l937t1667r1015b1689],
4	MED	NN	O	med	_	0	SENT_507	[p30l1029t1667r1081b1682],
5	368	CD	NUMBER	368	dep	4	SENT_507	[p30l1091t1661r1170b1689],
6	;	:	O	;	_	0	SENT_507	[p30l1091t1661r1170b1689],
7	25	CD	NUMBER	25	num	9	SENT_507	[p30l1091t1661r1170b1689],
8	NEjM.ORG	NN	O	nejm.org	nn	9	SENT_507	[p30l1206t1667r1330b1689],
9	JUNE20	NN	O	june20	dep	5	SENT_507	[p30l1361t1667r1539b1689],
10	,2013	CD	NUMBER	,2013	dep	9	SENT_507	[p30l1361t1667r1539b1689],

1	The	DT	O	the	det	4	SENT_508	[p30l880t1700r931b1723],
2	New	NNP	O	New	nn	4	SENT_508	[p30l940t1700r1002b1723],
3	England	NNP	O	England	nn	4	SENT_508	[p30l1011t1700r1122b1730],
4	Journal	NNP	O	Journal	_	0	SENT_508	[p30l1131t1700r1228b1723],
5	of	IN	O	of	_	0	SENT_508	[p30l1238t1700r1267b1723],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_508	[p30l1273t1700r1399b1723],

